PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Panda, S; Provencio, I; Tu, DC; Pires, SS; Rollag, MD; Castrucci, AM; Pletcher, MT; Sato, TK; Wiltshire, T; Andahazy, M; Kay, SA; Van Gelder, RN; Hogenesch, JB				Panda, S; Provencio, I; Tu, DC; Pires, SS; Rollag, MD; Castrucci, AM; Pletcher, MT; Sato, TK; Wiltshire, T; Andahazy, M; Kay, SA; Van Gelder, RN; Hogenesch, JB			Melanopsin is required for non-image-forming photic responses in blind mice	SCIENCE			English	Article							RETINAL GANGLION-CELLS; CIRCADIAN CLOCK; NON-CONE; NON-ROD; LIGHT; PHOTORECEPTORS; ENTRAINMENT; PINEAL; PHOTOSENSITIVITY; CRYPTOCHROMES	Although mice lacking rod and cone photoreceptors are blind, they retain many eye-mediated responses to light, possibly through photosensitive retinal ganglion cells. These cells express melanopsin, a photopigment that confers this photosensitivity. Mice lacking melanopsin still retain nonvisual photoreception, suggesting that rods and cones could operate in this capacity. We observed that mice with both outer-retinal degeneration and a deficiency in melanopsin exhibited complete loss of photoentrainment of the circadian oscillator, pupillary light responses, photic suppression of arylalkylamine-N-acetyltransferase transcript, and acute suppression of locomotor activity by light. This indicates the importance of both nonvisual and classical visual photoreceptor systems for nonvisual photic responses in mammals.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Sao Paulo, Dept Physiol, Biosci Inst, BR-05508900 Sao Paulo, Brazil	Novartis; Scripps Research Institute; Scripps Research Institute; Uniformed Services University of the Health Sciences - USA; Washington University (WUSTL); Washington University (WUSTL); Universidade de Sao Paulo	Hogenesch, JB (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA.		Castrucci, Ana Maria L/C-3296-2014; Jansen, Heiko T./A-5770-2008; Van Gelder, Russell/ABB-4225-2021; Panda, Satchidananda/J-6891-2012; Kay, Steve A/F-6025-2011	Jansen, Heiko T./0000-0003-0178-396X; Van Gelder, Russell/0000-0001-5368-3659; Kay, Steve A/0000-0002-0402-2878; Castrucci, Ana Maria/0000-0002-2065-8198; Provencio, Ignacio/0000-0003-1175-920X	NEI NIH HHS [R01-EY14988, K08-EY00403] Funding Source: Medline; NIMH NIH HHS [MH 62405, MH51573] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014988, K08EY000403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062405, R01MH051573] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FARADJI H, 1980, BRAIN RES, V202, P41, DOI 10.1016/0006-8993(80)90642-3; Foster RG, 2002, PROG RETIN EYE RES, V21, P507, DOI 10.1016/S1350-9462(02)00036-8; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PANDA S, UNPUB; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Van Gelder RN, 2002, J NEUROGENET, V16, P181, DOI 10.1080/01677060215306; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Wee R, 2002, J NEUROSCI, V22, P10427	23	529	543	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					525	527		10.1126/science.1086179	http://dx.doi.org/10.1126/science.1086179			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12829787				2022-12-01	WOS:000184340500045
J	Ruo, B; Rumsfeld, JS; Hlatky, MA; Liu, HY; Browner, WS; Whooley, MA				Ruo, B; Rumsfeld, JS; Hlatky, MA; Liu, HY; Browner, WS; Whooley, MA			Depressive symptoms and health-related quality of life - The heart and soul study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-RATED HEALTH; FUNCTIONAL STATUS; PRIMARY-CARE; PERCEIVED HEALTH; FOLLOW-UP; PRIME-MD; CORONARY; MORTALITY; DISEASE; ANGINA	Context Little is known regarding the extent to which patient-reported health status, including symptom burden, physical limitation, and quality of life, is determined by psychosocial vs physiological factors among patients with chronic disease. Objective To compare the contributions of depressive symptoms and measures of cardiac function to the health status of patients with coronary artery disease. Design, Setting, and Participants Cross-sectional study of 1024 adults with stable coronary artery disease recruited from outpatient clinics in the San Francisco Bay Area between September 2000 and December 2002. Main Measures Measurement of depressive symptoms using the Patient Health Questionnaire (PHQ); assessment of cardiac function by measuring left ventricular ejection fraction on echocardiography, exercise capacity on treadmill testing, and ischemia on stress echocardiography; and measurement of a range of health status outcomes, including symptom burden, physical limitation, and quality of life, using the Seattle Angina Questionnaire. Participants were also asked to rate their overall health as excellent, very good, good, fair, or poor. Results Of the 1024 participants, 201 (20%) had depressive symptoms (PHQ score :10). Participants with depressive symptoms were more likely than those without depressive symptoms to report at least mild symptom burden (60% vs 33%; P<.001), mild physical limitation (73% vs 40%; P<.001), mildly diminished quality of life (67% vs 31%; P<.001), and fair or poor overall health (66% vs 30%; P<.001). In multivariate analyses adjusting for measures of cardiac function and other patient characteristics, depressive symptoms were strongly associated with greater symptom burden (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.3-2.7; P=.002), greater physical limitation (OR, 3.1; 95% Cl, 2.1-4.6; P<.001), worse quality of life (OR, 3.1; 95% Cl, 2.2-4.6; P<.001), and worse overall health (OR, 2.0; 95% Cl, 1.3-2.9; P<.001). Although decreased exercise capacity was associated with worse health status, left ventricular ejection fraction and ischemia were not. Conclusions Among patients with coronary disease, depressive symptoms are strongly associated with patient-reported health status, including symptom burden, physical limitation, quality of life, and overall health. Conversely, 2 traditional measures of cardiac function-ejection fraction and ischemia-are not. Efforts to improve health status should include assessment and treatment of depressive symptoms.	Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Denver Vet Affairs Med Ctr, Cardiol & Hlth Serv Res, Denver, CO USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Stanford University; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco	Whooley, MA (corresponding author), Vet Affairs Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	whooley@itsa.ucsf.edu		Hlatky, Mark/0000-0003-4686-9441	NHLBI NIH HHS [R01 HL079235-01A1, R01 HL079235] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alonso J, 1997, EUR HEART J, V18, P414; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BURDON JGW, 1982, AM REV RESPIR DIS, V126, P825; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cossette S, 2001, PSYCHOSOM MED, V63, P257, DOI 10.1097/00006842-200103000-00009; CROOG SH, 1986, NEW ENGL J MED, V314, P1657, DOI 10.1056/NEJM198606263142602; CUNNY KA, 1991, PSYCHOL REP, V69, P127, DOI 10.2466/PR0.69.5.127-130; DWOSH IL, 1983, NEW ENGL J MED, V308, P1124, DOI 10.1056/NEJM198305123081903; FISHER L, 1983, CIRCULATION, V68, P951; FRIMODTMOLLER PC, 1984, J UROLOGY, V132, P272, DOI 10.1016/S0022-5347(17)49587-5; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; GORKIN L, 1994, QUAL LIFE RES, V3, P111, DOI 10.1007/BF00435254; GUYATT G, 1991, CONTROL CLIN TRIALS, V12, pS81, DOI 10.1016/S0197-2456(05)80014-5; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; IDLER EL, 1990, AM J PUBLIC HEALTH, V80, P446, DOI 10.2105/AJPH.80.4.446; IDLER EL, 1990, AM J EPIDEMIOL, V131, P91, DOI 10.1093/oxfordjournals.aje.a115489; KAPLAN GA, 1983, AM J EPIDEMIOL, V117, P292, DOI 10.1093/oxfordjournals.aje.a113541; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; Mattera JA, 2000, AM HEART J, V140, P409, DOI 10.1067/mhj.2000.108518; Miller MD, 1996, AM J PSYCHIAT, V153, P1350; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NELSON CL, 1991, AM J CARDIOL, V68, P973, DOI 10.1016/0002-9149(91)90423-I; NERENZ DR, 1992, MED CARE, V30, pMS112, DOI 10.1097/00005650-199205001-00010; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; PETERSON WL, 1977, NEW ENGL J MED, V297, P341, DOI 10.1056/NEJM197708182970701; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Pilote L, 2002, ARCH INTERN MED, V162, P553, DOI 10.1001/archinte.162.5.553; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Rumsfeld JS, 2003, AM HEART J, V145, P493, DOI 10.1067/mhj.2003.177; Rumsfeld JS, 2002, CIRCULATION, V106, P5, DOI 10.1161/01.CIR.0000020805.31531.48; Rumsfeld JS, 2001, AM J CARDIOL, V88, P781, DOI 10.1016/S0002-9149(01)01852-5; Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SJOLAND H, 1995, INT J CARDIOL, V51, P221, DOI 10.1016/0167-5273(95)02424-U; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spertus JA, 2000, AM HEART J, V140, P105, DOI 10.1067/mhj.2000.106600; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sullivan MD, 2000, AM J CARDIOL, V86, P1135, DOI 10.1016/S0002-9149(00)01174-7; Sullivan MD, 1997, AM J MED, V103, P348, DOI 10.1016/S0002-9343(97)00167-8; Sullivan MD, 2001, PSYCHOSOM MED, V63, P248, DOI 10.1097/00006842-200103000-00008; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; WENGER NK, 1984, AM J CARDIOL, V54, P908, DOI 10.1016/S0002-9149(84)80232-5; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003; WIKLUND I, 1991, CLIN CARDIOL, V14, P204, DOI 10.1002/clc.4960140306; WILLIAMS RB, 1992, JAMA-J AM MED ASSOC, V267, P520, DOI 10.1001/jama.267.4.520; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Ziegelstein RC, 2001, JAMA-J AM MED ASSOC, V286, P1621, DOI 10.1001/jama.286.13.1621	55	574	595	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2003	290	2					215	221		10.1001/jama.290.2.215	http://dx.doi.org/10.1001/jama.290.2.215			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	698GH	12851276	Green Accepted, Bronze			2022-12-01	WOS:000183989800026
J	Ahmadi, S; Muth-Selbach, U; Lauterbach, A; Lipfert, P; Neuhuber, WL; Zeilhofer, HU				Ahmadi, S; Muth-Selbach, U; Lauterbach, A; Lipfert, P; Neuhuber, WL; Zeilhofer, HU			Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine	SCIENCE			English	Article							D-ASPARTATE RECEPTOR; EXTRASYNAPTIC GLUTAMATE SPILLOVER; XENOPUS OOCYTES; D-SERINE; SITE; BRAIN; NEUROTRANSMITTER; TRANSMISSION; HIPPOCAMPUS; ACTIVATION	In the mammalian CNS, N-methyl-D-aspartate ( NMDA) receptors serve prominent roles in many physiological and pathophysiological processes including pain transmission. For full activation, NMDA receptors require the binding of glycine. It is not known whether the brain uses changes in extracellular glycine to modulate synaptic NMDA responses. Here, we show that synaptically released glycine facilitates NMDA receptor currents in the superficial dorsal horn, an area critically involved in pain processing. During high presynaptic activity, glycine released from inhibitory interneurons escapes the synaptic cleft and reaches nearby NMDA receptors by so-called spillover. In vivo, this process may contribute to the development of inflammatory hyperalgesia.	Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany; Univ Klinikum Dusseldorf, Anasthesiol Klin, D-40225 Dusseldorf, Germany; Univ Erlangen Nurnberg, Inst Anat, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Erlangen Nuremberg	Zeilhofer, HU (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, Fahrstr 17, D-91054 Erlangen, Germany.		Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629				Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; DOUBELL TP, 1999, TXB PAIN, pCH6; Fern R, 1996, NEUROREPORT, V7, P1953, DOI 10.1097/00001756-199608120-00018; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; KEMP JA, 1988, P NATL ACAD SCI USA, V85, P6547, DOI 10.1073/pnas.85.17.6547; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; KISHIMOTO H, 1981, J NEUROCHEM, V37, P1015, DOI 10.1111/j.1471-4159.1981.tb04489.x; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LARSON AA, 1988, J NEUROSCI, V8, P3822; Lopez-Corcuera B, 2001, MOL MEMBR BIOL, V18, P13, DOI 10.1080/09687680120521; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Supplisson S, 1997, J NEUROSCI, V17, P4580; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; WESTERGREN I, 1994, J NEUROCHEM, V62, P159; Zeilhofer HU, 2000, J NEUROSCI, V20, P4922	26	108	110	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2094	2097		10.1126/science.1083970	http://dx.doi.org/10.1126/science.1083970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829784	Green Accepted			2022-12-01	WOS:000183774900047
J	Gundersen, GG; Bretscher, A				Gundersen, GG; Bretscher, A			Microtubule asymmetry	SCIENCE			English	Editorial Material							ORIENTATION; SPINDLE; YEAST		Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Columbia University; Columbia University; Cornell University	Gundersen, GG (corresponding author), Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA.							Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	14	43	44	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2040	2041		10.1126/science.1084938	http://dx.doi.org/10.1126/science.1084938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829769				2022-12-01	WOS:000183774900029
J	Benson, J; Britten, N				Benson, J; Britten, N			Patients' views about taking antihypertensive drugs: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION		Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England; Peninsula Med Sch, Inst Clin Educ, Exeter EX1 2LU, Devon, England	University of Cambridge; University of Exeter	Benson, J (corresponding author), Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England.	jab62@medschl.cam.ac.uk						Benson J, 2002, BRIT MED J, V325, P873, DOI 10.1136/bmj.325.7369.873; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; ROST K, 1989, SOC SCI MED, V28, P315, DOI 10.1016/0277-9536(89)90032-4; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Wallenius SH, 1995, ANN PHARMACOTHER, V29, P1213, DOI 10.1177/106002809502901204	5	33	40	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2003	326	7402					1314	1315		10.1136/bmj.326.7402.1314	http://dx.doi.org/10.1136/bmj.326.7402.1314			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805171	Bronze, Green Published			2022-12-01	WOS:000183626500035
J	Mace, GM; Gittleman, JL; Purvis, A				Mace, GM; Gittleman, JL; Purvis, A			Preserving the Tree of Life	SCIENCE			English	Editorial Material							EXTINCTION RISK; HABITAT LOSS; CONSERVATION; HOTSPOTS	Phylogenies provide new ways to measure biodiversity, to assess conservation priorities, and to quantify the evolutionary history in any set of species. Methodological problems and a lack of knowledge about most species have so far hampered their use. In the future, as techniques improve and more data become accessible, we will have an expanded set of conservation options, including ways to prioritize outcomes from evolutionary and ecological processes.	Zool Soc London, Inst Zool, London NW1 4RY, England; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England	Zoological Society of London; University of Virginia; Imperial College London	Mace, GM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.		Purvis, Andy/A-7529-2008; Mace, Georgina M/I-3072-2016	Purvis, Andy/0000-0002-8609-6204; Mace, Georgina M/0000-0001-8965-5211				Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Avise J.C., 2000, PHYLOGEOGRAPHY; Barraclough TG, 1998, PHILOS T R SOC B, V353, P241, DOI 10.1098/rstb.1998.0206; Bromham L, 1999, TRENDS ECOL EVOL, V14, P113, DOI 10.1016/S0169-5347(98)01507-9; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; COLLAR LNJH, 1994, BIRDS WATCH, V2; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Cracraft J., 1983, Current Ornithology, V1, P159; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Heard SB, 2002, SYST BIOL, V51, P889, DOI 10.1080/10635150290155917; HEYWOOD VH, 1994, NATURE, V368, P105, DOI 10.1038/368105a0; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; May Robert M., 1995, P1; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nee Sean, 1996, P230; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; RODRIGUES ASL, PHYLOGENY CONSERVATI; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Schwartz MW, 2001, ECOL LETT, V4, P464, DOI 10.1046/j.1461-0248.2001.00241.x; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X	30	258	271	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1707	1709		10.1126/science.1085510	http://dx.doi.org/10.1126/science.1085510			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805539				2022-12-01	WOS:000183459700040
J	Narita, M; Nunez, S; Heard, E; Narita, M; Lin, AW; Hearn, SA; Spector, DL; Hannon, GJ; Lowe, SW				Narita, M; Nunez, S; Heard, E; Narita, M; Lin, AW; Hearn, SA; Spector, DL; Hannon, GJ; Lowe, SW			Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence	CELL			English	Article							HUMAN-DIPLOID FIBROBLASTS; HISTONE H3; ONCOGENIC RAS; TUMOR-CELLS; X-CHROMOSOME; G(1) CONTROL; LYSINE 9; IN-VIVO; P53; HP1	Cellular senescence is an extremely stable form of cell cycle arrest that limits the proliferation of damaged cells and may act as a natural barrier to cancer progression. In this study, we describe a distinct heterochromatic structure that accumulates in senescent human fibroblasts, which we designated senescence-associated heterochromatic foci (SAHF). SAHF formation coincides with the recruitment of heterochromatin proteins and the retinoblastoma (Rb) tumor suppressor to E2F-responsive promoters and is associated with the stable repression of E2F target genes. Notably, both SAHF formation and the silencing of E2F target genes depend on the integrity of the Rb pathway and do not occur in reversibly arrested cells. These results provide a molecular explanation for the stability of the senescent state, as well as new insights into the action of Rb as a tumor suppressor.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Inst Curie, CNRS, UMR 218, F-75248 Paris 05, France	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite	Lowe, SW (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Heard, Edith/D-7197-2017; Hannon, Gregory/AAB-3568-2019	Heard, Edith/0000-0001-8052-7117; Hearn, Stephen/0000-0002-2489-2424; Narita, Masako/0000-0002-9774-4908; Narita, Masashi/0000-0001-7764-577X	NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016379, R56AG016379] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, CA13106] Funding Source: Medline; NIA NIH HHS [AG16379] Funding Source: Medline; NIGMS NIH HHS [GM42694, R01 GM042694] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Chang BD, 1999, CANCER RES, V59, P3761; CHENICLET C, 1990, J HISTOCHEM CYTOCHEM, V38, P551, DOI 10.1177/38.4.1690766; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Dimri GP, 1996, BIOL SIGNAL, V5, P154; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Good LF, 1996, J CELL PHYSIOL, V168, P580, DOI 10.1002/(SICI)1097-4652(199609)168:3<580::AID-JCP10>3.0.CO;2-3; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; HENIKOFF S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P1; Humbert PO, 2000, GENE DEV, V14, P690; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; LEUBA SH, 1994, J MOL BIOL, V235, P871, DOI 10.1006/jmbi.1994.1045; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Spector DL, 2001, J CELL SCI, V114, P2891; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Takahashi Y, 2000, GENE DEV, V14, P804; te Poele RH, 2002, CANCER RES, V62, P1876; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806	52	1619	1684	3	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					703	716		10.1016/S0092-8674(03)00401-X	http://dx.doi.org/10.1016/S0092-8674(03)00401-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809602	Bronze			2022-12-01	WOS:000183514400006
J	Kmietowicz, Z				Kmietowicz, Z			Commentary: Information for patients: removal of lice and eggs by combing	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ Publishing Grp, BestTreatments, London WC1H 9JR, England	BMJ Publishing Group Ltd	Kmietowicz, Z (corresponding author), BMJ Publishing Grp, BestTreatments, London WC1H 9JR, England.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1258	1258		10.1136/bmj.326.7401.1258	http://dx.doi.org/10.1136/bmj.326.7401.1258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791747	Green Published			2022-12-01	WOS:000183480700023
J	Kelly-Welch, AE; Hanson, EM; Boothby, MR; Keegan, AD				Kelly-Welch, AE; Hanson, EM; Boothby, MR; Keegan, AD			Interleukin-4 and interleukin-13 signaling connections maps	SCIENCE			English	Editorial Material							IL-4 RECEPTOR; STAT6	Cytokines are inflammatory mediators important in responding to pathogens and other foreign challenges. Interleukin-4 (IL-4) and IL-13 are two cytokines produced by T helper type 2 cells, mast cells, and basophils. In addition to their physiological roles, these cytokines are also implicated in pathological conditions such as asthma and allergy. IL-4 can stimulate two receptors, type I and type II, whereas IL-13 signaling is mediated only by the type II receptor (see the STKE Connections Maps). These cytokines activate the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling cascades, which may contribute to allergic responses. In addition, stimulation of the phosphatidylinositol 3-kinase (PI3K) pathway through recruitment of members of the insulin receptor substrate family may contribute to survival and proliferation.	Amer Red Cross, Dept Immunol, Holland Lab, Rockville, MD 20855 USA; George Washington Med Ctr, Inst Biomed Sci, Washington, DC 20037 USA; Vanderbilt Univ, Dept Microbiol, Nashville, TN 37232 USA	American Red Cross; George Washington University; Vanderbilt University	Keegan, AD (corresponding author), Amer Red Cross, Dept Immunol, Holland Lab, Rockville, MD 20855 USA.	keegana@usa.redcross.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038985, R01AI045662, R21AI049460, R01AI049460, R01AI038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042550, R29GM042550] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61752] Funding Source: Medline; NIAID NIH HHS [AI45662, AI38985, AI49460] Funding Source: Medline; NIGMS NIH HHS [GM42550] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AARONSON DS, 2003, SCI STKE; Andrews RP, 2002, J BIOL CHEM, V277, P36563, DOI 10.1074/jbc.M200986200; Boothby M, 2001, CRIT REV IMMUNOL, V21, P487; CANTLEY LC, 2003, SCI STKE; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Hanson EM, 2003, J BIOL CHEM, V278, P3903, DOI 10.1074/jbc.M211747200; Kashiwada M, 2001, J IMMUNOL, V167, P6382, DOI 10.4049/jimmunol.167.11.6382; KEEGAN AD, 2003, SCI STKE; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Perez-G M, 2002, J IMMUNOL, V168, P1428, DOI 10.4049/jimmunol.168.3.1428; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; Shelburne CP, 2002, CYTOKINE, V19, P218, DOI 10.1006/cyto.2002.1957; Sherman MA, 2002, J IMMUNOL, V169, P3811, DOI 10.4049/jimmunol.169.7.3811; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Wurster AL, 2002, J BIOL CHEM, V277, P27169, DOI 10.1074/jbc.M201207200; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5	21	303	355	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1527	1528		10.1126/science.1085458	http://dx.doi.org/10.1126/science.1085458			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791978				2022-12-01	WOS:000183333100038
J	Rosenberg, AL; Hofer, TP; Strachan, C; Watts, CM; Hayward, RA				Rosenberg, AL; Hofer, TP; Strachan, C; Watts, CM; Hayward, RA			Accepting critically ill transfer patients: Adverse effect on a referral center's outcome and benchmark measures	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE-CARE-UNIT; QUALITY-OF-CARE; ACADEMIC-MEDICAL-CENTER; LEAD-TIME BIAS; MANAGED CARE; HOSPITAL MORTALITY; INTERHOSPITAL TRANSFERS; ACUTE PHYSIOLOGY; RISK ADJUSTMENT; SCORING SYSTEM	Background: Common methods of benchmarking clinical performance rarely, if ever, account for admission source and, in particular, the effect of a patient being transferred from one medical center to another. Small biases in comparisons of observed versus expected deaths can substantially affect how high-quality institutions compare with peer hospitals. With the most sophisticated and validated set of case-mix measures available for patients, the intensive care unit is an ideal setting in which to study the effect of a patient's being transferred from another hospital. Objective: To determine the extent of bias in benchmarking outcomes when performance measures do not account for transfer patients' greater severity of illness. Design: Prospectively developed cohort study. Setting: Medical intensive care unit (MICU) at a tertiary care university hospital. Patients: 4579 consecutive admissions for 4208 patients from 1 January 1994 to 1 April 1998. Measurements: MICU and hospital lengths of stay, MICU readmission, and hospital mortality rates. Results: Compared with directly admitted patients, MICU patients transferred from another hospital had significantly higher Acute Physiology Scores at the time of admission and discharge (P = 0.001). Even after full adjustment for case mix and severity of illness, transfer patients had a 38% longer MICU stay (95% CI, 32% to 45%), a 41% longer hospital stay (CI, 34% to 50%), and a 2.2 times greater odds of hospital mortality (CI, 1.7 to 2.8) than directly admitted patients. With identical efficiency and quality, a referral hospital with a 25% MICU transfer rate compared with another with a 0% transfer rate would be penalized by 14 excess deaths per 1000 admissions when a benchmarking program adjusts only for case mix and severity of illness and not for the source of admission. Conclusions: In a setting with the most thorough diagnostic-based, case-mix adjustment and the most physiologically precise severity-of-illness information, accepting transfer patients can adversely affect efficiency and quality benchmarks. Benchmarking and profiling efforts beyond intensive care units must also recognize and account for this phenomenon; otherwise, referral centers may have an incentive to refuse care for patients who could benefit from being transferred to their facility.	Univ Michigan, Ctr Med, Dept Anesthesiol & Crit Care, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Healthcare Syst, Dept Vet Affairs Hlth Serv Res & Dev Serv, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Rosenberg, AL (corresponding author), Univ Michigan, Ctr Med, Dept Anesthesiol & Crit Care, Room 1G323,Box 0048, Ann Arbor, MI 48109 USA.	arosen@umich.edu	Hofer, Timothy Philip/AAC-9238-2022	Hofer, Timothy/0000-0003-0434-8787				Albertson GA, 2000, J GEN INTERN MED, V15, P242, DOI 10.1046/j.1525-1497.2000.015004242.x; Angus DC, 2000, CRIT CARE MED, V28, P2145, DOI 10.1097/00003246-200006000-00088; Bailey JE, 1999, JAMA-J AM MED ASSOC, V282, P1067, DOI 10.1001/jama.282.11.1067; Bernard AM, 1996, ACAD MED, V71, P262, DOI 10.1097/00001888-199603000-00019; Bindman AB, 1999, JAMA-J AM MED ASSOC, V281, P2142, DOI 10.1001/jama.281.22.2142; Blumenthal D, 1996, NEW ENGL J MED, V335, P891, DOI 10.1056/NEJM199609193351213; BORLASE BC, 1991, J TRAUMA, V31, P915, DOI 10.1097/00005373-199107000-00006; Chernew ME, 1998, MED CARE RES REV, V55, P259, DOI 10.1177/107755879805500301; CLEMMITT M, 2001, MED HLTH S, V55, P1; DRAGSTED L, 1989, CRIT CARE MED, V17, P418, DOI 10.1097/00003246-198905000-00008; DUNCAN RP, 1988, HOSP HEALTH SERV ADM, V33, P237; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Fihn SD, 2000, JAMA-J AM MED ASSOC, V283, P1740, DOI 10.1001/jama.283.13.1740; FRANKLIN C, 1983, CRIT CARE MED, V11, P61, DOI 10.1097/00003246-198302000-00001; Goodman DC, 1996, JAMA-J AM MED ASSOC, V276, P1811, DOI 10.1001/jama.276.22.1811; Gordon HS, 1996, MED CARE, V34, P295, DOI 10.1097/00005650-199604000-00002; Green J, 1997, JAMA-J AM MED ASSOC, V277, P1152, DOI 10.1001/jama.277.14.1152; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; HAYWARD RA, 1995, J GEN INTERN MED, V10, P504, DOI 10.1007/BF02602402; Hofer T P, 1997, Jt Comm J Qual Improv, V23, P455; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hofer TP, 1996, MED CARE, V34, P737, DOI 10.1097/00005650-199608000-00002; Huerta J A, 1995, J Clin Eng, V20, P48; HURLEY J, 1990, HEALTH SERV RES, V25, P239; Iezzoni LI, 1996, AM J PUBLIC HEALTH, V86, P1379, DOI 10.2105/AJPH.86.10.1379; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; JACOBS P, 1990, CRIT CARE MED, V18, P1282, DOI 10.1097/00003246-199011000-00020; JENCKS SF, 1988, MED CARE, V26, P948, DOI 10.1097/00005650-198810000-00003; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P3611, DOI 10.1001/jama.260.24.3611; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS W, 1989, CRIT CARE MED, V17, pS176, DOI 10.1097/00003246-198912001-00005; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Krakauer H, 1998, J Eval Clin Pract, V4, P11, DOI 10.1046/j.1365-2753.1998.t01-1-00002.x; Kulu-Glasgow I, 1998, HEALTH POLICY, V45, P221, DOI 10.1016/S0168-8510(98)00045-1; Langenbrunner J C, 1989, Health Care Financ Rev, V10, P91; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1994, JAMA-J AM MED ASSOC, V272, P1049, DOI 10.1001/jama.272.13.1049; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; MILLER MG, 1994, JAMA-J AM MED ASSOC, V271, P1493, DOI 10.1001/jama.271.19.1493; OBREMSKEY W, 1994, J TRAUMA, V36, P373, DOI 10.1097/00005373-199403000-00016; OYE RK, 1991, CHEST, V99, P685, DOI 10.1378/chest.99.3.685; *PHC4, 1995, FOC HEART ATT W PENN; RAPOPORT J, 1990, CRIT CARE MED, V18, P1231, DOI 10.1097/00003246-199011000-00009; RAPOPORT J, 1992, ARCH INTERN MED, V152, P2207, DOI 10.1001/archinte.152.11.2207; ROMANO PS, 1994, J CLIN EPIDEMIOL, V47, P249, DOI 10.1016/0895-4356(94)90006-X; Rosenberg AL, 2001, CRIT CARE MED, V29, P511, DOI 10.1097/00003246-200103000-00008; Rosenthal G E, 1997, Am J Med Qual, V12, P103, DOI 10.1177/0885713X9701200204; ROSENTHAL GE, 1994, JOINT COMM J QUAL IM, V20, P425, DOI 10.1016/S1070-3241(16)30088-8; Rubenfeld GD, 1999, AM J RESP CRIT CARE, V160, P358, DOI 10.1164/ajrccm.160.1.9807118; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; SCHIFF RL, 1986, NEW ENGL J MED, V314, P552, DOI 10.1056/NEJM198602273140905; Schroeder J, 1996, Am J Med Qual, V11, pS58; SCHWARTZ WB, 1987, JAMA-J AM MED ASSOC, V257, P220, DOI 10.1001/jama.257.2.220; SHAPIRO MF, 1994, HEALTH SERV RES, V29, P95; Spoeri RK, 1997, ANN INTERN MED, V127, P726, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00058; TERES D, 1993, CRIT CARE CLIN, V9, P543, DOI 10.1016/S0749-0704(18)30184-2; Tunnell RD, 1998, ANAESTHESIA, V53, P1045, DOI 10.1046/j.1365-2044.1998.00566.x; Weissman NW, 1999, J EVAL CLIN PRACT, V5, P269, DOI 10.1046/j.1365-2753.1999.00203.x; ZIMMERMAN JE, 1994, CRIT CARE MED, V22, P1373, DOI 10.1097/00003246-199409000-00005; Zimmerman JE, 1998, CRIT CARE MED, V26, P1317, DOI 10.1097/00003246-199808000-00012; Zimmerman JE, 2000, CRIT CARE MED, V28, P258, DOI 10.1097/00003246-200001000-00048; 2001, MED HEALTHC S, P6	62	170	171	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2003	138	11					882	890		10.7326/0003-4819-138-11-200306030-00009	http://dx.doi.org/10.7326/0003-4819-138-11-200306030-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	686AB	12779298				2022-12-01	WOS:000183296400003
J	Dalton, R				Dalton, R			Threat of closure hangs heavy over primate centre	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					471	471		10.1038/423471b	http://dx.doi.org/10.1038/423471b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774087	Bronze			2022-12-01	WOS:000183162900012
J	Gray, J; Orr, D; Majeed, A				Gray, J; Orr, D; Majeed, A			Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registers	BRITISH MEDICAL JOURNAL			English	Article							MELLITUS; PEOPLE	Objective To establish current practice in the use of Read codes for diabetes. Design Cross sectional study. Setting 17 practices in the Battersea primary care group in southwest London. Data sources Computerised medical records. Main outcome measures Number of codes in use in all practices; variation in the use of codes between practices; and prevalence of Read code use in diabetic patients. Results At least 9 separate Read code groupings and 25 individual diabetes codes were in use in the 17 general practices. Only one Read code (C 10, diabetes mellitus) and its subcodes was being used in all 17 practices, but its use varied from 14% to 98% of patients with diabetes. The use of other key Read codes for monitoring the care of patients with diabetes also varied widely between practices; for example, < 20% of practices used the code for the location of care. Less than half of patients (45%) with diabetes had their type of diabetes coded, and even fewer (21%) had measures such as the examination of the retina coded. Conclusions The use of Read codes for diabetes needs to be standardised and coding levels improved if valid diabetic registers are to be constructed and the quality of care is to be monitored effectively. Until all patients with diabetes have the C 10 Read code recorded, clinicians will have to use a wide range of Read codes and prescribing data to ensure that diabetes registers are complete.	Bolingbroke Hosp, Battersea Res Grp, London SW11 6HN, England; UCL, Sch Publ Policy, Primary Care Res Unit, London WC1H 9QU, England	University of London; University College London	Gray, J (corresponding author), Bolingbroke Hosp, Battersea Res Grp, London SW11 6HN, England.			Majeed, Azeem/0000-0002-2357-9858				Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; [Anonymous], 2002, HLTH STAT Q; BARDSLEY M, 2000, MAPPING HLTH PRIMARY; Benson T, 2002, BRIT MED J, V325, P1090, DOI 10.1136/bmj.325.7372.1090; BURNETT SD, 1992, BRIT MED J, V305, P627, DOI 10.1136/bmj.305.6854.627; Buxton C, 1996, DIABETIC MED, V13, pS122; CONNOLLY V, 1995, DIABETIC MED, V12, pS31; Currie CJ, 1997, DIABETIC MED, V14, P686, DOI 10.1002/(SICI)1096-9136(199708)14:8<686::AID-DIA434>3.3.CO;2-4; *DEP HLTH, 2002, DEL IT NHS; *DEP HLTH, 2000, CM4818; Department of Health, 2002, NAT SERV FRAM DIAB S; Gatling W, 1998, DIABETIC MED, V15, P1015, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1015::AID-DIA719>3.0.CO;2-K; HOWITT AJ, 1993, BRIT MED J, V307, P1046, DOI 10.1136/bmj.307.6911.1046; Khunti K, 2001, BRIT J GEN PRACT, V51, P356; Khunti K, 2000, J ROY SOC MED, V93, P183, DOI 10.1177/014107680009300407; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; MACKINNON M, 1995, DIABETIC MED S, V12, pS10; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524; Okkes IM, 2000, FAM PRACT, V17, P101, DOI 10.1093/fampra/17.2.101; WHITFORD DL, 1995, DIABETIC MED, V12, P691, DOI 10.1111/j.1464-5491.1995.tb00571.x	20	53	53	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 24	2003	326	7399					1130	1132A		10.1136/bmj.326.7399.1130	http://dx.doi.org/10.1136/bmj.326.7399.1130			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	685DF	12763987	Green Published, Bronze			2022-12-01	WOS:000183245000024
J	McKone, EF; Emerson, SS; Edwards, KL; Aitken, ML				McKone, EF; Emerson, SS; Edwards, KL; Aitken, ML			Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study	LANCET			English	Article							DISEASE SEVERITY; MESSENGER-RNA; MUTATION; CFTR; GENE; IDENTIFICATION; DELTA-F508	Background Over 1000 mutations of the cystic fibrosis transmembrane conductance regulator gene (CFTR) that cause cystic fibrosis have been identified. We examined the effect of CFTR genotype on mortality and disease phenotype. Methods Using the US Cystic Fibrosis Foundation National Registry, we did a retrospective cohort study to compare standardised mortality rates for the 11 most common genotypes heterozygous for DeltaF508 with those homozygous for DeltaF508. Of the 28455 patients enrolled in the registry at the time of our analysis, :17 853 (63%) were genotyped. We also compared the clinical phenotype, including lung function, age at diagnosis, and nutritional measures, of 22 DeltaF508 heterozygous genotypes. Mortality rates and clinical phenotype were also compared between genotypes classified into six classes on the basis of their functional effect on CFTR production. Findings Between 1991 and 1999, genetic and clinical data were available for 17 853 patients with cystic fibrosis, which was 63% of the total cohort. There were :1547 deaths during the 9 years of follow-up. In the analysis of the 11 most common genotypes, DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/3849+10 kbC-->T, and DeltaF508/2789+5G-->A had a significantly lower mortality rate (4.7, 8.0, 11.9, and 4.4, respectively) than the genotype homozygous for DeltaF508 (21.8, p=0.0060). DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/ 3849+10 kbC-->T, DeltaF508/2789+5G-->A, and DeltaF508/A455E have a milder clinical phenotype. Outcomes for all functional classes were compared with that of class II (containing DeltaF508 homozygotes) and classes IV and V had a significantly lower mortality rate and milder clinical phenotype. Interpretation Patients with cystic fibrosis have distinct genetic subgroups that are associated with mild clinical manifestations and low mortality. These differences in phenotype are also related to the functional classification of CFTR genotype.	Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; Univ Washington, Adult Cyst Fibrosis Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McKone, EF (corresponding author), Univ Washington, Med Ctr, Div Pulm & Crit Care Med, BB1253 Hlth Sci Bldg,Box 356522, Seattle, WA 98195 USA.				NATIONAL CANCER INSTITUTE [R01CA149051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL070849] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA149051] Funding Source: Medline; NHLBI NIH HHS [K23 HL/70849-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Accurso FJ, 2003, AM J RESP CRIT CARE, V167, P289, DOI 10.1164/rccm.2210006; [Anonymous], CYSTIC FIBROSIS MUTA; *CYST FIBR FDN PAT, 2000, 1999 ANN DAT REP; Drumm ML, 2001, RESPIR RES, V2, P125, DOI 10.1186/rr47; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; GAN KH, 1995, NEW ENGL J MED, V333, P95, DOI 10.1056/NEJM199507133330204; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Highsmith WE, 1997, HUM MUTAT, V9, P332, DOI 10.1002/(SICI)1098-1004(1997)9:4<332::AID-HUMU5>3.3.CO;2-P; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Hull J, 1998, THORAX, V53, P1018, DOI 10.1136/thx.53.12.1018; JOHANSEN HK, 1991, LANCET, V337, P631, DOI 10.1016/0140-6736(91)92449-C; Kerem B, 1996, EUR J HUM GENET, V4, P65; Kerem E, 1996, PEDIATR PULM, V22, P387, DOI 10.1002/(SICI)1099-0496(199612)22:6<387::AID-PPUL7>3.3.CO;2-Y; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Koch C, 2001, PEDIATR PULM, V31, P1, DOI 10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Massie RJH, 2001, EUR RESPIR J, V17, P1195, DOI 10.1183/09031936.01.00057001; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; RIORDAN JR, 1989, SCIENCE, V245, P1066; SANTIS G, 1990, LANCET, V336, P1081, DOI 10.1016/0140-6736(90)92566-Z; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; STERN RC, 1995, LANCET, V346, P274, DOI 10.1016/S0140-6736(95)92165-6; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Tzetis M, 2001, HUM GENET, V109, P592, DOI 10.1007/s00439-001-0631-0; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Welsh MJ., 2001, METABOLIC MOL BASES, P5121	30	288	294	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 17	2003	361	9370					1671	1676		10.1016/S0140-6736(03)13368-5	http://dx.doi.org/10.1016/S0140-6736(03)13368-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KB	12767731				2022-12-01	WOS:000182919700006
J	Moore, JD; Kirk, JA; Hunt, T				Moore, JD; Kirk, JA; Hunt, T			Unmasking the S-phase-promoting potential of cyclin B1	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; CELL-CYCLE; NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; LOCALIZATION; MITOSIS; SPECIFICITY; ACTIVATION; KINASE	In higher eukaryotes, the S phase and M phase of the cell cycle are triggered by different cyclin-dependent kinases (CDKs). For example, in frog egg extracts, Cdk1-cyclin B catalyzes entry into mitosis but cannot trigger DNA replication. Two hypotheses can explain this observation: Either Cdk1-cyclin B fails to recognize the key substrates of its S-phase-promoting counterparts, or its activity is somehow regulated to prevent it from activating DNA synthesis. Here, we show that Cdk1-cyclin B1 has cryptic S-phase-promoting abilities that can be unmasked by relocating it from the cytoplasm to the nucleus and moderately stimulating its activity. Subcellular localization of vertebrate CDKs and the control of their activity are thus critical factors for determining their specificity.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Hunt, T (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.							AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; BUENO A, 1993, MOL CELL BIOL, V13, P2286, DOI 10.1128/MCB.13.4.2286; Chen W, 2000, BIOCHEMISTRY-US, V39, P10781, DOI 10.1021/bi000909u; CLARKE PR, 1992, EMBO J, V11, P1751, DOI 10.1002/j.1460-2075.1992.tb05227.x; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; GAUTIER J, 1991, EMBO J, V10, P177, DOI 10.1002/j.1460-2075.1991.tb07934.x; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000; Miller ME, 2001, J CELL SCI, V114, P1811; Moore JD, 2002, MOL BIOL CELL, V13, P4388, DOI 10.1091/mbc.e02-07-0449; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; MOORE JS, UNPUB; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Stern B, 1996, TRENDS GENET, V12, P345; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131	30	108	108	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					987	990		10.1126/science.1081418	http://dx.doi.org/10.1126/science.1081418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738867				2022-12-01	WOS:000182719800059
J	Frey, JJ				Frey, JJ			Time to myself	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Williams William Carlos, 1968, SELECTED POEMS	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2185	2186		10.1001/jama.289.17.2185	http://dx.doi.org/10.1001/jama.289.17.2185			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	675ET	12734116				2022-12-01	WOS:000182680700001
J	Lorenz, K; Lynn, J				Lorenz, K; Lynn, J			Moral and practical challenges of physician-assisted suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OREGON; EUTHANASIA; DEATH		Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA; Washington Home Ctr Palliat Care Studies, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lorenz, K (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.							Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Covinsky KE, 1996, ARCH INTERN MED, V156, P1737, DOI 10.1001/archinte.156.15.1737; CRENSHAW A, 2000, WASHINGTON POST 0425, P1; Drought Theresa S, 2002, Gerontologist, V42 Spec No 3, P114; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; FIELD MJ, 1997, APPRAOCHING DEATH IM; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Gelband, 2001, IMPROVING PALLIATIVE; Iwashyna TJ, 2002, HEALTH SERV RES, V37, P1531, DOI 10.1111/1475-6773.10562; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 2003, ANN INTERN MED, V138, P208, DOI 10.7326/0003-4819-138-3-200302040-00013; *RW JOHNS FDN, 2003, ACC REP; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Veldink JH, 2002, NEW ENGL J MED, V346, P1638, DOI 10.1056/NEJMsa012739; Virnig BA, 2000, J AM GERIATR SOC, V48, P1117, DOI 10.1111/j.1532-5415.2000.tb04789.x; ZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M	17	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2282	2282		10.1001/jama.289.17.2282	http://dx.doi.org/10.1001/jama.289.17.2282			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	675ET	12734143				2022-12-01	WOS:000182680700034
J	Brakefield, PM; Gates, J; Keys, D; Kesbeke, F; Wijngaarden, PJ; Monteiro, A; French, V; Carroll, SB				Brakefield, PM; Gates, J; Keys, D; Kesbeke, F; Wijngaarden, PJ; Monteiro, A; French, V; Carroll, SB			Development, plasticity and evolution of butterfly eyespot patterns	NATURE			English	Article							WESTERN WHITE BUTTERFLIES; PRECIS-COENIA LEPIDOPTERA; REACTION NORMS; SEASONAL POLYPHENISM; QUANTITATIVE CHARACTER; PHENOTYPIC PLASTICITY; BICYCLUS BUTTERFLIES; WING PATTERNS; GENETICS; NUMBER	The developmental and genetic bases for the formation, plasticity and diversity of eyespot patterns in butterflies are examined. Eyespot pattern mutants, regulatory gene expression, and transplants of the eyespot developmental organizer demonstrate that eyespot position, number, size and colour are determined progressively in a developmental pathway largely uncoupled from those regulating other wing-pattern elements and body structures. Species comparisons and selection experiments suggest that the evolution of eyespot patterns can occur rapidly through modulation of different stages of this pathway, and requires only single, of very few, changes in regulatory genes.	UNIV WISCONSIN, HOWARD HUGHES MED INST, MADISON, WI 53706 USA; UNIV WISCONSIN, MOL BIOL LAB, MADISON, WI 53706 USA; UNIV EDINBURGH, INST CELL ANIM & POPULAT BIOL, EDINBURGH EH9 3JT, MIDLOTHIAN, SCOTLAND	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Edinburgh	Brakefield, PM (corresponding author), LEIDEN UNIV, INST EVOLUTIONARY & ECOL SCI, KAISERSTR 63, POSTBUS 9516, NL-2300 RA LEIDEN, NETHERLANDS.		Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X				[Anonymous], 1940, ADAPTIVE COLORATION; BRAKEFIELD PM, 1993, ACTA BIOTHEOR, V41, P447, DOI 10.1007/BF00709376; BRAKEFIELD PM, 1995, J EVOLUTION BIOL, V8, P559, DOI 10.1046/j.1420-9101.1995.8050559.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; COCKERHAM CC, 1986, GENETICS, V114, P659; Endler J.A., 1986, Monographs in Population Biology, pviii; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; HOLLOWAY GJ, 1993, HEREDITY, V70, P179, DOI 10.1038/hdy.1993.27; KING RB, 1993, CAN J ZOOL, V71, P1985, DOI 10.1139/z93-282; KINGSOLVER JG, 1995, EVOLUTION, V49, P942, DOI [10.2307/2410416, 10.1111/j.1558-5646.1995.tb02329.x]; KINGSOLVER JG, 1995, EVOLUTION, V49, P932, DOI 10.1111/j.1558-5646.1995.tb02328.x; Koch PB, 1996, J INSECT PHYSIOL, V42, P223, DOI 10.1016/0022-1910(95)00103-4; KOOI RE, 1994, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 5, 1994, P47; LANDE R, 1981, GENETICS, V99, P541; MONTEIRO AF, 1994, EVOLUTION, V48, P1147, DOI 10.2307/2410374; NIJHOUT H.F., 1994, INSECT HORMONES; NIJHOUT HF, 1980, DEV BIOL, V80, P275, DOI 10.1016/0012-1606(80)90404-2; Nijhout HF, 1991, DEV EVOLUTION BUTTER; Pigliucci M, 1996, TRENDS ECOL EVOL, V11, P168, DOI 10.1016/0169-5347(96)10008-2; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P1141, DOI 10.1016/0022-1910(95)00051-U; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P987, DOI 10.1016/0022-1910(95)00046-W; SCHLICHTING CD, 1995, EVOL ECOL, V9, P154, DOI 10.1007/BF01237754; Shapiro A. M., 1976, EVOL BIOL, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; SHEPPARD PM, 1960, NATURAL SELECTION HE; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; VANNOORDWIJK AJ, 1989, BIOSCIENCE, V39, P453, DOI 10.2307/1311137; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Wright S., 1968, EVOLUTION GENETICS P, V1; ZENG ZB, 1990, GENETICS, V126, P235; ZWEIFEL RG, 1981, J HERED, V72, P238, DOI 10.1093/oxfordjournals.jhered.a109487	34	363	374	1	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	1996	384	6606					236	242		10.1038/384236a0	http://dx.doi.org/10.1038/384236a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VU381	12809139				2022-12-01	WOS:A1996VU38100042
J	Diebold, SS; Montoya, M; Unger, H; Alexopoulou, L; Roy, P; Haswell, LE; Al-Shamkhani, A; Flavell, R; Borrow, P; Sousa, CRE				Diebold, SS; Montoya, M; Unger, H; Alexopoulou, L; Roy, P; Haswell, LE; Al-Shamkhani, A; Flavell, R; Borrow, P; Sousa, CRE			Viral infection switches non-plasmacytoid dendritic cells into high interferon producers	NATURE			English	Article								Type I interferons (IFN-I) are important cytokines linking innate and adaptive immunity(1). Plasmacytoid dendritic cells make high levels of IFN-I in response to viral infection and are thought to be the major source of the cytokines in vivo(2). Here, we show that conventional non-plasmacytoid dendritic cells taken from mice infected with a dendritic-cell-tropic strain of lymphocytic choriomeningitis virus make similarly high levels of IFN-I on subsequent culture. Similarly, non-plasmacytoid dendritic cells secrete high levels of IFN-I in response to double-stranded RNA (dsRNA), a major viral signature(3), when the latter is introduced into the cytoplasm to mimic direct viral infection. This response is partially dependent on the cytosolic dsRNA-binding enzyme protein kinase R-4 and does not require signalling through toll-like receptor (TLR) 3, a surface receptor for dsRNA(5). Furthermore, we show that sequestration of dsRNA by viral NS1 (refs 6,7) explains the inability of conventional dendritic cells to produce IFN-I on infection with influenza. Our results suggest that multiple dendritic cell types, not just plasmacytoid cells, can act as specialized interferon-producing cells in certain viral infections, and reveal the existence of a TLR-independent pathway for dendritic cell activation that can be the target of viral interference.	Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3PX, England; Edward Jenner Inst Vaccine Res, Compton RG20 7NN, Berks, England; Univ Vet Med, Inst Virol, A-1210 Vienna, Austria; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA; London Sch Hyg & Trop Med, London WC1A 7HT, England; Southampton Gen Hosp, Sch Med, Canc Sci Div, Tenovus Res Lab, Southampton SO16 6YD, Hants, England	Cancer Research UK; University of Veterinary Medicine Vienna; Yale University; Howard Hughes Medical Institute; University of London; London School of Hygiene & Tropical Medicine; University of Southampton	Sousa, CRE (corresponding author), Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3PX, England.		Montoya, Maria/G-3430-2015; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Alexopoulou, Lena/A-5041-2017	Montoya, Maria/0000-0002-5703-7360; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Alexopoulou, Lena/0000-0003-4619-697X; Borrow, Persephone/0000-0002-3877-9780; Roy, Polly/0000-0001-6535-6911; Haswell, Linsey/0000-0002-5663-8834				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; MARCUS PI, 1988, J GEN VIROL, V69, P1637, DOI 10.1099/0022-1317-69-7-1637; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	30	472	501	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					324	328		10.1038/nature01783	http://dx.doi.org/10.1038/nature01783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12819664				2022-12-01	WOS:000184183900045
J	Atkinson, RC; Beachy, RN; Conway, G; Cordova, FA; Fox, MA; Holbrook, KA; Klessig, DF; McCormick, RL; McPherson, PM; Rawlings, HR; Rapson, R; Vanderhoef, LN; Wiley, JD; Young, CE				Atkinson, RC; Beachy, RN; Conway, G; Cordova, FA; Fox, MA; Holbrook, KA; Klessig, DF; McCormick, RL; McPherson, PM; Rawlings, HR; Rapson, R; Vanderhoef, LN; Wiley, JD; Young, CE			Public sector collaboration for agricultural IP management	SCIENCE			English	Editorial Material									Univ Calif, Oakland, CA 94607 USA; Donald Danforth Plant Sci Ctr, St Louis, MO USA; Rockefeller Fdn, New York, NY 10018 USA; Univ Calif Riverside, Riverside, CA 92521 USA; N Carolina State Univ, Raleigh, NC 27695 USA; Ohio State Univ, Columbus, OH 43210 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Rutgers State Univ, New Brunswick, NJ 08901 USA; Michigan State Univ, E Lansing, MI 48824 USA; Cornell Univ, Ithaca, NY 14853 USA; McKnight Fdn, Minneapolis, MN 55401 USA; Univ Calif Davis, Davis, CA 95616 USA; Univ Wisconsin, Madison, WI 53706 USA	University of California System; University of California Berkeley; Donald Danforth Plant Science Center; University of California System; University of California Riverside; University of North Carolina; North Carolina State University; Ohio State University; Cornell University; Boyce Thompson Institute for Plant Research; Rutgers State University New Brunswick; Michigan State University; Cornell University; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison	Atkinson, RC (corresponding author), Univ Calif, Oakland, CA 94607 USA.							Beachy RN, 2003, SCIENCE, V299, P473, DOI 10.1126/science.299.5606.473; Conway G, 1999, NATURE, V402, pC55, DOI 10.1038/990141; GRAFF G, UNPUB; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; KRYDER RD, 2000, 20 ISAAA; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; PAULSON L, COMMUNICATION; Phipps RH, 2002, J ANIM FEED SCI, V11, P1; RUFF M, COMMUNICATION; Wright B. D., 1998, California Agriculture, V52, P8, DOI 10.3733/ca.v052n06p8	11	72	74	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					174	175		10.1126/science.1085553	http://dx.doi.org/10.1126/science.1085553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	699KN	12855794	Green Submitted			2022-12-01	WOS:000184056200026
J	Papp, B; Pal, C; Hurst, LD				Papp, B; Pal, C; Hurst, LD			Dosage sensitivity and the evolution of gene families in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN; GENOME; ORGANIZATION; DATABASE; DOMINANCE; CELLS	According to what we term the balance hypothesis, an imbalance in the concentration of the subcomponents of a protein - protein complex can be deleterious(1). If so, there are two consequences: first, both underexpression and overexpression of protein complex subunits should lower fitness, and second, the accuracy of transcriptional co-regulation of subunits should reflect the deleterious consequences of imbalance. Here we show that all these predictions are upheld in yeast ( Saccharomyces cerevisiae). This supports the hypothesis(2,3) that dominance is a by-product of physiology and metabolism rather than the result of selection to mask the deleterious effects of mutations. Beyond this, single-gene duplication of protein subunits is expected to be harmful, as this, too, leads to imbalance. As then expected, we find that members of large gene families are rarely involved in complexes. The balance hypothesis therefore provides a single theoretical framework for understanding components both of dominance and of gene family size.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1117 Budapest, Hungary	University of Bath; Eotvos Lorand University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssldh@bath.ac.uk	; Hurst, Laurence/F-9215-2010	Papp, Balazs/0000-0003-3093-8852; Hurst, Laurence/0000-0002-1002-1054				Abruzzi KC, 2002, MOL CELL BIOL, V22, P138, DOI 10.1128/MCB.22.1.138-147.2002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Carroll S.B., 2001, DNA DIVERSITY; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fisher R.A., 1930, GENETICAL THEORY NAT; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; HODGKIN J, 1993, TRENDS GENET, V9, P1, DOI 10.1016/0168-9525(93)90050-R; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; KACSER H, 1981, GENETICS, V97, P639; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kratz E, 2002, TRENDS GENET, V18, P29, DOI 10.1016/S0168-9525(01)02579-3; Li BJ, 1996, P NATL ACAD SCI USA, V93, P1596, DOI 10.1073/pnas.93.4.1596; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Sokal R., 2000, BIOMETRY, V3rd ed., P451; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Stevens RC, 1998, J CELL BIOL, V142, P711, DOI 10.1083/jcb.142.3.711; VANHOLDE KE, 1998, PRINCIPLES PHYSICAL; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WRIGHT S, 1934, AM NAT, V68, P25; Wu X, 2001, MOL GENET GENOMICS, V265, P622, DOI 10.1007/s004380100455; YUAN J, 1995, BLOOD, V86, P3945, DOI 10.1182/blood.V86.10.3945.bloodjournal86103945	30	613	619	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					194	197		10.1038/nature01771	http://dx.doi.org/10.1038/nature01771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853957				2022-12-01	WOS:000184032700042
J	Mocroft, A; Ledergerber, B; Katlama, C; Kirk, O; Reiss, P; Monforte, AD; Knsyz, B; Dietrich, M; Phillips, AN; Lundgren, JD				Mocroft, A; Ledergerber, B; Katlama, C; Kirk, O; Reiss, P; Monforte, AD; Knsyz, B; Dietrich, M; Phillips, AN; Lundgren, JD		EuroSIDA Study Grp	Decline in the AIDS and death rates in the EuroSIDA study: an observational study	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIRUS-INFECTED PATIENTS; CLINICAL PROGRESSION; VIROLOGICAL FAILURE; HIV-INFECTION; CELL COUNTS; EUROPE; RECOMMENDATIONS; INDIVIDUALS; PREDICTORS	Background Since the introduction of highly active antiretroviral therapy (HAART), little is known about whether changes in HIV-1-mortality and morbidity rates have been sustained. We aimed to assess possible changes in these rates across Europe. Methods We analysed data for 9803 patients in 70 European HIV centres including ones in Israel and Argentina. Incidence rates of AIDS or death were calculated for overall and most recent CD4 count in 6-monthly periods and in three treatment eras (pre-HAART, 1994-1995; early-HAART, 1996-1997; and late-HAART, 1998-2002). Findings The incidence of AIDS or death fell after September, 1998, by 8% per 6-month period (rate ratio 0.92, 95% CI 0.88-0.95, p<0.0001). When AIDS and death were analysed separately, the incidence of all deaths during the late-HAART era was significantly lower than that during the early-HAART era in patients whose latest CD4 count was 20 cells/mu L or less (0.43, 0.35-0.53, p<0.0001), but at higher CD4 counts, did not differ between early-HAART and late-HAART. Incidence of AIDS was about 50% lower in late-HAART than in early-HAART, irrespective of latest CD4 count (p<0.0001). In multivariate Cox's models, with early-HAART as the reference, there was an increased risk of AIDS (relative hazard 1.39; 95% CI 1.16-1.67, p=0.0004) and all deaths (1.29; 1.08-1.56, p=0.0065) in the pre-HAART era, and a reduced risk of AIDS (0.62; 0.50-0.77, p<0.0001) and all deaths (0.66; 0.53-0.82, p=0.0002) in the late-HAART era. Interpretation The initial drop in mortality and morbidity after the introduction of HAART has been sustained. Potential long-term adverse effects associated with HAART have not altered its effectiveness in treating AIDS.	UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England; UCL Royal Free & UCL Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Univ Hosp, Zurich, Switzerland; Hop La Pitie Salpetriere, Paris, France; Univ Copenhagen, Hvidovre Hosp, DK-2650 Hvidovre, Denmark; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Osped L Sacco, Milan, Italy; Univ Wroclaw, Dept Infect Dis, PL-50138 Wroclaw, Poland; Bernhard Nocht Inst Trop Med, Hamburg, Germany	University of London; University College London; University of London; University College London; University of Zurich; University Zurich Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; University of Milan; Luigi Sacco Hospital; University of Wroclaw; Bernhard Nocht Institut fur Tropenmedizin	Mocroft, A (corresponding author), UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	a.mocroft@pcps.ucl.ac.uk	VALLET, Yannick/F-9979-2011; Ledergerber, Bruno/B-5656-2009; Lundgren, Jens/AAE-6876-2019; Mocroft, Amanda/C-1527-2008; Phillips, Andrew N/B-4427-2008; Mocroft, Amanda/G-8748-2011; kirk, ole/ABB-4746-2021	Ledergerber, Bruno/0000-0002-6881-4401; Phillips, Andrew N/0000-0003-2384-4807; Mocroft, Amanda/0000-0001-8316-1122; Johnson, Anne/0000-0003-1330-7100; Lundgren, Jens/0000-0001-8901-7850				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Benson CA, 2002, J INFECT DIS, V185, P599, DOI 10.1086/339014; *BHIVA, 2001, HIV MED, V2, P276; Coakley EPG, 2000, AIDS, V14, P1147, DOI 10.1097/00002030-200006160-00011; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Flandre P, 2002, AIDS, V16, P561, DOI 10.1097/00002030-200203080-00007; Grulich AE, 2002, AIDS, V16, P1155, DOI 10.1097/00002030-200205240-00009; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Kirk O, 1998, AIDS, V12, P2031, DOI 10.1097/00002030-199815000-00015; Le Moing V, 2002, J INFECT DIS, V185, P471, DOI 10.1086/338929; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Lundgren JD, 1997, J ACQ IMMUN DEF SYND, V16, P153, DOI 10.1097/00042560-199711010-00003; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; Miller V, 2002, J INFECT DIS, V186, P189, DOI 10.1086/341466; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	29	980	1011	1	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2003	362	9377					22	29		10.1016/S0140-6736(03)13802-0	http://dx.doi.org/10.1016/S0140-6736(03)13802-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699KW	12853195				2022-12-01	WOS:000184056900009
J	Mora, JR; Bono, MR; Manjunath, N; Weninger, W; Cavanagh, LL; Rosemblatt, M; von Andrian, UH				Mora, JR; Bono, MR; Manjunath, N; Weninger, W; Cavanagh, LL; Rosemblatt, M; von Andrian, UH			Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells	NATURE			English	Article							CHEMOKINE RECEPTOR; IN-VIVO; LYMPHOCYTE; TISSUE; DIFFERENTIATION; LOCALIZATION; MIGRATION; INTEGRINS; EFFECTOR; ACQUISITION	Whereas naive T cells migrate only to secondary lymphoid organs(1,2), activation by antigen confers to T cells the ability to home to non-lymphoid sites(3,4). Activated effector/memory T cells migrate preferentially to tissues that are connected to the secondary lymphoid organs where antigen was first encountered(5-7). Thus, oral antigens induce effector/memory cells that express essential receptors for intestinal homing, namely the integrin alpha4beta7 and CCR9, the receptor for the gut-associated chemokine TECK/CCL25 (refs 6, 8, 9). Here we show that this imprinting of gut tropism is mediated by dendritic cells from Peyer's patches. Stimulation of CD8-expressing T cells by dendritic cells from Peyer's patches, peripheral lymph nodes and spleen induced equivalent activation markers and effector activity in T cells, but only Peyer's patch dendritic cells induced high levels of alpha4beta7, responsiveness to TECK and the ability to home to the small intestine. These findings establish that Peyer's patch dendritic cells imprint gut-homing specificity on T cells, and thus license effector/memory cells to access anatomical sites most likely to contain their cognate antigen.	Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Chile, Fdn Ciencias Vida, Fac Ciencias, Lab Inmunol, Santiago 6842301, Chile; Millennium Inst Fundamental & Appl Biol, Santiago 6842301, Chile	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Universidad de Chile	von Andrian, UH (corresponding author), Ctr Blood Res, 800 Huntington Ave, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Bono, Maria/G-7461-2014	Weninger, Wolfgang/0000-0003-3133-8699				ANDREW DP, 1994, J IMMUNOL, V153, P3847; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Carramolino L, 2001, BLOOD, V97, P850, DOI 10.1182/blood.V97.4.850; Davenport MP, 2000, IMMUNOL TODAY, V21, P315, DOI 10.1016/S0167-5699(00)01644-3; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kantele A, 1999, J IMMUNOL, V162, P5173; Kelsall BL, 2002, NAT IMMUNOL, V3, P699, DOI 10.1038/ni0802-699; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Maurice MM, 2001, P NATL ACAD SCI USA, V98, P7437, DOI 10.1073/pnas.141143298; NAKACHE M, 1989, NATURE, V337, P179, DOI 10.1038/337179a0; Schott E, 2002, EUR J IMMUNOL, V32, P3425, DOI 10.1002/1521-4141(2002012)32:12<3425::AID-IMMU3425>3.0.CO;2-Q; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; Xie HJ, 1999, J EXP MED, V189, P1765, DOI 10.1084/jem.189.11.1765; Zaballos A, 1999, J IMMUNOL, V162, P5671; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	30	838	869	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					88	93		10.1038/nature01726	http://dx.doi.org/10.1038/nature01726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840763				2022-12-01	WOS:000183912800046
J	Pham, P; Bransteitter, R; Petruska, J; Goodman, MF				Pham, P; Bransteitter, R; Petruska, J; Goodman, MF			Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation	NATURE			English	Article							IMMUNOGLOBULIN GENES; POLYMERASE-ETA; RECOMBINATION; MECHANISMS; MUTATIONS; FIDELITY; SEQUENCE; REGION; REPAIR	Activation-induced cytidine deaminase (AID) is a protein required for B cells to undergo class switch recombination and somatic hypermutation (SHM)-two processes essential for producing high-affinity antibodies(1). Purified AID catalyses the deamination of C to U on single-stranded (ss) DNA(2-4). Here, we show in vitro that AID-catalysed C deaminations occur preferentially on 5' WRC sequences in accord with SHM spectra observed in vivo. Although about 98% of DNA clones suffer no mutations, most of the remaining mutated clones have 10-70 C to T transitions per clone. Therefore, AID carries out multiple C deaminations on individual DNA strands, rather than jumping from one strand to another. The avid binding of AID to ssDNA could result from its large net positive charge (+11) at pH 7.0, owing to a basic amino-terminal domain enriched in arginine and lysine. Furthermore, AID exhibits a 15-fold preference for C deamination on the non-transcribed DNA strand exposed by RNA polymerase than the transcribed strand protected as a RNA-DNA hybrid. These deamination results on ssDNA bear relevance to three characteristic features of SHM: preferential mutation at C sites within WRC hotspot sequences, the broad clonal mutagenic heterogeneity of antibody variable regions targeted for mutation(5,6), and the requirement for active transcription to obtain mutagenesis(7),(8).	Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Univ Pk, Los Angeles, CA 90089 USA.	mgoodman@usc.edu						Bebenek K, 1995, METHOD ENZYMOL, V262, P217; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dorner T, 1998, IMMUNOL REV, V162, P161, DOI 10.1111/j.1600-065X.1998.tb01439.x; GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Michael N, 2002, IMMUNITY, V16, P123, DOI 10.1016/S1074-7613(02)00261-3; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Shapiro GS, 2002, J IMMUNOL, V168, P2302, DOI 10.4049/jimmunol.168.5.2302	27	507	524	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					103	107		10.1038/nature01760	http://dx.doi.org/10.1038/nature01760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12819663				2022-12-01	WOS:000183912800049
J	Sharp, D				Sharp, D			Anyone for GM decaff?	LANCET			English	Editorial Material							COFFEE; CAFFEINE		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6; GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504; Michaud DS, 2001, CANCER EPIDEM BIOMAR, V10, P429; Ogita S, 2003, NATURE, V423, P823, DOI 10.1038/423823a; Shlonsky AK, 2003, ANN EPIDEMIOL, V13, P273, DOI 10.1016/S1047-2797(02)00414-3	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2003	361	9376					2172	2172		10.1016/S0140-6736(03)13786-5	http://dx.doi.org/10.1016/S0140-6736(03)13786-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695DJ	12842367				2022-12-01	WOS:000183815600006
J	Ghattas, H; Fulford, T; Prentice, A				Ghattas, H; Fulford, T; Prentice, A			Effect of moderate anaemia on later mortality in rural African children	LANCET			English	Article							ANEMIA	Severe anaemia in childhood is associated with increased mortality, although evidence relating moderate anaemia to child survival is scarce. We aimed to investigate this association. We did a case-control study of children with moderate anaemia, and compared haemoglobin concentrations measured up to a year before death for 403 children (age range 28 days to 15 years) with those from children who survived (matched for age and sex). Data were obtained from long-term health records (1950-97) of a rural Gambian research centre. Excluding an acute effect In this last week of life, no evidence was recorded of lower haemoglobin concentrations in the children who died than in survivors, or of any general or disease-specific effects of non-severe anaemia (70-110 g/L) on mortality.	St George Hosp, Sch Med, Dept Infect Dis, London SW17 0RE, England; MRC Labs, Banjul, Gambia; London Sch Hyg & Trop Med, MRC, Int Nutr Grp, Publ Hlth Nutr Unit, London WC1B 3DP, England	St Georges University London; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine	Ghattas, H (corresponding author), St George Hosp, Sch Med, Dept Infect Dis, Cranmer Terrace, London SW17 0RE, England.		Prentice, Andrew/AAG-1961-2019; Ghattas, Hala/K-5661-2016					BATES CJ, 1994, EUR J CLIN NUTR, V48, P660; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Gonzalez MA, 2000, B WORLD HEALTH ORGAN, V78, P97; SMITH AW, 1989, ANN TROP PAEDIATR, V2, P6; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S	5	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2048	2050		10.1016/S0140-6736(03)13617-3	http://dx.doi.org/10.1016/S0140-6736(03)13617-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814719				2022-12-01	WOS:000183488900015
J	Salmeen, A; Andersen, JN; Myers, MP; Meng, TC; Hinks, JA; Tonks, NK; Barford, D				Salmeen, A; Andersen, JN; Myers, MP; Meng, TC; Hinks, JA; Tonks, NK; Barford, D			Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate	NATURE			English	Article							HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; INSULIN SENSITIVITY; GENERATION; MECHANISM; KINASES	The second messenger hydrogen peroxide is required for optimal activation of numerous signal transduction pathways, particularly those mediated by protein tyrosine kinases(1-6). One mechanism by which hydrogen peroxide regulates cellular processes is the transient inhibition of protein tyrosine phosphatases through the reversible oxidization of their catalytic cysteine, which suppresses protein dephosphorylation(7-9). Here we describe a structural analysis of the redox-dependent regulation of protein tyrosine phosphatase 1B (PTP1B), which is reversibly inhibited by oxidation after cells are stimulated with insulin(8) and epidermal growth factor(9). The sulphenic acid intermediate produced in response to PTP1B oxidation is rapidly converted into a previously unknown sulphenyl-amide species, in which the sulphur atom of the catalytic cysteine is covalently linked to the main chain nitrogen of an adjacent residue. Oxidation of PTP1B to the sulphenyl-amide form is accompanied by large conformational changes in the catalytic site that inhibit substrate binding. We propose that this unusual protein modification both protects the active-site cysteine residue of PTP1B from irreversible oxidation to sulphonic acid and permits redox regulation of the enzyme by promoting its reversible reduction by thiols.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cold Spring Harbor Laboratory	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk	Meng, Tzu-Ching/G-5426-2019	Meng, Tzu-Ching/0000-0001-7693-2021; Andersen, Jannik/0000-0003-4528-2120	NATIONAL CANCER INSTITUTE [R37CA053840] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Rao GN, 1996, ONCOGENE, V13, P713; Rhee S. G., 2000, SCI STKE, V53; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6	26	725	752	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2003	423	6941					769	773		10.1038/nature01680	http://dx.doi.org/10.1038/nature01680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802338				2022-12-01	WOS:000183443400047
J	Moens, V; Baruch, G; Fearon, P				Moens, V; Baruch, G; Fearon, P			Opportunistic screening for Chlamydia at a community based contraceptive service for young people	BRITISH MEDICAL JOURNAL			English	Article								Problem The suspected high prevalence of Chlamydia infection that is undiagnosed and untreated among high risk women who attend a contraceptive service for young people. Design Cross sectional study from a community screening service. Background and setting An inner city contraceptive and psychotherapy service for young people aged 12-21 years. Key measure for improvement Prevalence of infection commensurate with or above findings from the national screening pilot (13.8% for > 16 year olds, 10.5% for 16-19 year olds, and 7.2% for 20 to 24 year olds). Strategies for change Offering testing (of a first catch urine sample) for Chlamydia to all young people using the contraceptive service who were not previously screened; launching a publicity campaign about the new service; training medical staff and reception staff to deliver the service to maximise take up of screening and of treatment by infected cases; and surveying results from testing to monitor significant patterns of infection requiring further action. Effects of change Percentage of clients with infection exceeded targets for each age group, 76% with a positive or equivocal result returned for treatment, 87% of those treated returned for a test of cure, and 99% of tests of cure were negative. Prevention work was initiated in a school with a particularly heavy concentration of infected clients. Lessons learnt A contraceptive service for young women is a highly acceptable location for effective Chlamydia screening.	Brandon Ctr Counselling & Psychotherapy Young Peo, London NW5 3LG, England; UCL, Subdept Clin Hlth Psychol, London WC1E 6BT, England	University of London; University College London	Baruch, G (corresponding author), Brandon Ctr Counselling & Psychotherapy Young Peo, London NW5 3LG, England.	G.Baruch@compuserve.com						BARUCH G., 2001, COMMUNITY BASED PSYC; *CAMD ISL HLTH AUT, 2001, PUBL HLTH REP HLTH I; *DEP HLTH, 2002, PIL STUD OPP SCREEN; Department of Health, 2001, NAT STRAT SEX HLTH H; DiClemente RJ, 2001, LANCET, V358, P1828, DOI 10.1016/S0140-6736(01)06878-7; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6	6	15	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1252	1255		10.1136/bmj.326.7401.1252	http://dx.doi.org/10.1136/bmj.326.7401.1252			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791743	Green Published			2022-12-01	WOS:000183480700020
J	Petit, RJ; Aguinagalde, I; de Beaulieu, JL; Bittkau, C; Brewer, S; Cheddadi, R; Ennos, R; Fineschi, S; Grivet, D; Lascoux, M; Mohanty, A; Muller-Starck, GM; Demesure-Musch, B; Palme, A; Martin, JP; Rendell, S; Vendramin, GG				Petit, RJ; Aguinagalde, I; de Beaulieu, JL; Bittkau, C; Brewer, S; Cheddadi, R; Ennos, R; Fineschi, S; Grivet, D; Lascoux, M; Mohanty, A; Muller-Starck, GM; Demesure-Musch, B; Palme, A; Martin, JP; Rendell, S; Vendramin, GG			Glacial refugia: Hotspots but not melting pots of genetic diversity	SCIENCE			English	Article							POSTGLACIAL COLONIZATION ROUTES; SOUTHEASTERN EUROPE; CHLOROPLAST DNA; ICE AGES; DIFFERENTIATION; PHYLOGEOGRAPHY; CONSEQUENCES; POPULATIONS; FORESTS; PLANTS	Glacial refuge areas are expected to harbor a large fraction of the intraspecific biodiversity of the temperate biota. To test this hypothesis, we studied chloroplast DNA variation in 22 widespread European trees and shrubs sampled in the same forests. Most species had genetically divergent populations in Mediterranean regions, especially those with low seed dispersal abilities. However, the genetically most diverse populations were not located in the south but at intermediate latitudes, a likely consequence of the admixture of divergent lineages colonizing the continent from separate refugia.	INRA, UMR Biodivers Genes & Ecosyst, F-33612 Cestas, France; Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, E-28040 Madrid, Spain; Fac Sci & Tech St Jerome, Inst Mediterraneen Ecol & Paleoecol, F-13397 Marseille, France; Tech Univ Munich, Fachgebiet Forstgenet, D-85354 Freising Weihenstephan, Germany; Univ Edinburgh, Inst Ecol & Resource Management, Edinburgh EH9 3JU, Midlothian, Scotland; CNR, Ist Biol Agroambientale & Forestale, I-05010 Porano, TR, Italy; Uppsala Univ, Dept Conservat Biol & Genet, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; Off Natl Forets, Dept Rech Tech Conservatoire Genet Arbres Foresti, F-45160 Ardon, France; CNR, Ist Genet Vegetale, Sez Firenze, I-50134 Florence, Italy	INRAE; Universidad Politecnica de Madrid; UDICE-French Research Universities; Aix-Marseille Universite; Technical University of Munich; University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); Uppsala University; Consiglio Nazionale delle Ricerche (CNR)	Petit, RJ (corresponding author), INRA, UMR Biodivers Genes & Ecosyst, F-33612 Cestas, France.	petit@pierroton.inra.fr	Vendramin, Giovanni G/K-9731-2014; Grivet, Delphine/G-9708-2012; Petit, Remy/AAD-9078-2019; Clemente, Juan Pedro Martín/F-3218-2016; Fineschi, Silvia/ABF-9775-2020; Petit, Rémy/A-8842-2008	Vendramin, Giovanni G/0000-0001-9921-7872; Grivet, Delphine/0000-0001-8168-4456; Clemente, Juan Pedro Martín/0000-0002-8180-5489; Petit, Rémy/0000-0002-4809-1453; Brewer, Simon/0000-0002-6810-1911; FINESCHI, SILVIA/0000-0002-3583-6073; Lascoux, Martin/0000-0003-1699-9042				Austerlitz F, 2000, GENETICS, V154, P1309; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Bennett KD., 1997, EVOLUTION ECOLOGY PA; Carcaillet C, 2001, QUATERNARY RES, V55, P385, DOI 10.1006/qres.2001.2226; Comps B, 2001, GENETICS, V157, P389; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Grivet D, 2003, CONSERV GENET, V4, P47, DOI 10.1023/A:1021804009832; Grivet D, 2002, MOL ECOL, V11, P1351, DOI 10.1046/j.1365-294X.2002.01522.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; PALME AE, IN PRESS HEREDITY; PETIT RJ, 1993, HEREDITY, V71, P630, DOI 10.1038/hdy.1993.188; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 2001, INTEGRATING ECOLOGY, P295; Pons O, 1996, GENETICS, V144, P1237; Rendell S, 2002, MOL ECOL, V11, P69, DOI 10.1046/j.0962-1083.2001.01413.x; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119	25	1350	1406	5	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1563	1565		10.1126/science.1083264	http://dx.doi.org/10.1126/science.1083264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791991				2022-12-01	WOS:000183333100053
J	Gandhi, SP; Stevens, CF				Gandhi, SP; Stevens, CF			Three modes of synaptic vesicular recycling revealed by single-vesicle imaging	NATURE			English	Article							RETINAL BIPOLAR CELLS; HIPPOCAMPAL SYNAPSES; NERVE-TERMINALS; MEMBRANE RETRIEVAL; CHROMAFFIN CELLS; ENDOCYTOSIS; EXOCYTOSIS; CALCIUM; FUSION; PH	Synapses recycle their spent vesicles in order to keep up with on-going neurotransmitter release. To investigate vesicle recycling in the small synapses of hippocampal neurons, we have used an optical recording method that permits us to resolve single-vesicle events. Here we show that an exocytic event can terminate with three modes of vesicle retrieval: a fast (400-860 ms) 'kiss-and-run' mode that has a selective fusion pore; a slow (8-21 s) 'compensatory' mode; and a 'stranded' mode of recycling, in which a vesicle is left on the cell surface until a nerve impulse triggers its retrieval. We have also observed that, in response to a nerve impulse, synapses with low release probability primarily use the kiss-and-run mode, whereas high release probability terminals predominantly use the compensatory mode of vesicle retrieval.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.							Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Huang EP, 1997, J NEUROPHYSIOL, V78, P2870, DOI 10.1152/jn.1997.78.6.2870; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	37	346	356	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					607	613		10.1038/nature01677	http://dx.doi.org/10.1038/nature01677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789331				2022-12-01	WOS:000183301200032
J	Mizutani, A; Chahl, JS; Srinivasan, MV				Mizutani, A; Chahl, JS; Srinivasan, MV			Motion camouflage in dragonflies	NATURE			English	Article									Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia; Def Sci & Technol Org, Weapons Syst Div, Edinburgh, SA 5111, Australia	Australian National University; Defence Science & Technology	Mizutani, A (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, POB 475, Canberra, ACT 2601, Australia.		Srinivasan, Mandyam V/G-5571-2010	Chahl, Javaan/0000-0001-6496-0543; Muthukumarasamy, Srinivasan/0000-0002-2948-6206				COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; CURLO E, 1976, ETHOLOGY PREDATION; SRINIVASAN MV, 1995, P ROY SOC B-BIOL SCI, V259, P19, DOI 10.1098/rspb.1995.0004; SRINIVASAN MV, 1903, VISUAL MOTION ITS RO, P139; TSAI RY, 1987, IEEE T ROBOTIC AUTOM, V3, P323, DOI 10.1109/JRA.1987.1087109; *US OFF NAV RES, INS VIS BAS SEEK CON	6	96	102	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					604	604		10.1038/423604a	http://dx.doi.org/10.1038/423604a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789327	Bronze			2022-12-01	WOS:000183301200028
J	Crackower, MA; Kolas, NK; Noguchi, J; Sarao, R; Kikuchi, K; Kaneko, H; Kobayashi, E; Kawai, Y; Kozieradzki, I; Landers, R; Mo, R; Hui, CC; Nieves, E; Cohen, PE; Osborne, LR; Wada, T; Kunieda, T; Moens, PB; Penninger, JM				Crackower, MA; Kolas, NK; Noguchi, J; Sarao, R; Kikuchi, K; Kaneko, H; Kobayashi, E; Kawai, Y; Kozieradzki, I; Landers, R; Mo, R; Hui, CC; Nieves, E; Cohen, PE; Osborne, LR; Wada, T; Kunieda, T; Moens, PB; Penninger, JM			Essential role of Fkbp6 in male fertility and homologous chromosome pairing in meiosis	SCIENCE			English	Article							SYNAPTONEMAL COMPLEX; MEIOTIC PROPHASE; GENE; RAT; SYNAPSIS; SPERMATOCYTES; RECOMBINATION; MOUSE; AS/AS	Meiosis is a critical stage of gametogenesis in which alignment and synapsis of chromosomal pairs occur, allowing for the recombination of maternal and paternal genomes. Here we show that FK506 binding protein (Fkbp6) localizes to meiotic chromosome cores and regions of homologous chromosome synapsis. Targeted inactivation of Fkbp6 in mice results in aspermic males and the absence of normal pachytene spermatocytes. Moreover, we identified the deletion of Fkbp6 exon 8 as the causative mutation in spontaneously male sterile as/as mutant rats. Loss of Fkbp6 results in abnormal pairing and misalignments between homologous chromosomes, nonhomologous partner switches, and autosynapsis of X chromosome cores in meiotic spermatocytes. Fertility and meiosis are normal in Fkbp6 mutant females. Thus, Fkbp6 is a component of the synaptonemal complex essential for sex-specific fertility and for the fidelity of homologous chromosome pairing in meiosis.	Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Albert Einstein Coll Med, AECOM, Dept Biochem, Lab Macromol Anal & Proteom, Bronx, NY 10461 USA; Natl Inst Agrobiol Sci, Germ Cell Conservat Lab, Tsukuba, Ibaraki 3058602, Japan; Natl Lifestock Breeding Ctr, Fukushima 961851, Japan; Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7000082, Japan; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; York Univ, Dept Biol, N York, ON M3J 1P3, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Yeshiva University; Albert Einstein College of Medicine; National Institute of Agrobiological Sciences - Japan; Okayama University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; York University - Canada	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, Dr Bohrgasse 7, A-1030 Vienna, Austria.	josef.penninger@oeaw.ac.at	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777	Canadian Institutes of Health Research [38103] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		ATAGI Y, 1993, J VET MED SCI, V55, P301, DOI 10.1292/jvms.55.301; Bayes M, 2001, MOL REPROD DEV, V60, P414, DOI 10.1002/mrd.1104; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Dix DJ, 1997, DEVELOPMENT, V124, P4595; DRESSER ME, 1980, CHROMOSOMA, V76, P1, DOI 10.1007/BF00292222; FAWCETT DW, 1956, J BIOPHYS BIOCHEM CY, V2, P403, DOI 10.1083/jcb.2.4.403; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; IKADAI H, 1992, J VET MED SCI, V54, P745, DOI 10.1292/jvms.54.745; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Meng X, 1998, GENOMICS, V52, P130, DOI 10.1006/geno.1998.5412; Moens PB, 2002, J CELL SCI, V115, P1611; MOSES MJ, 1956, J BIOPHYS BIOCHEM CY, V2, P215, DOI 10.1083/jcb.2.2.215; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Noguchi J, 1999, MAMM GENOME, V10, P189, DOI 10.1007/s003359900967; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Osborne LR, 1999, MOL GENET METAB, V67, P1, DOI 10.1006/mgme.1999.2844; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	23	152	169	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1291	1295		10.1126/science.1083022	http://dx.doi.org/10.1126/science.1083022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764197	Green Accepted			2022-12-01	WOS:000183042400049
J	Kim, JM; Wu, H; Green, G; Winkler, CA; Kopp, JB; Miner, JH; Unanue, ER; Shaw, AS				Kim, JM; Wu, H; Green, G; Winkler, CA; Kopp, JB; Miner, JH; Unanue, ER; Shaw, AS			CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility	SCIENCE			English	Article							NEPHROTIC SYNDROME; DOWN-REGULATION; COMPLEX; MEMBRANE	Loss of CD2-associated protein (CD2AP), a component of the filtration complex in the kidney, causes death in mice at 6 weeks of age. Mice with CD2AP haploin-sufficiency developed glomerular changes at 9 months of age and had increased susceptibility to glomerular injury by nephrotoxic antibodies or immune complexes. Electron microscopic analysis of podocytes revealed defects in the formation of multivesicular bodies, suggesting an impairment of the intracellular degradation pathway. Two human patients with focal segmental glomerulosclerosis had a mutation predicted to ablate expression of one CD2AP allele, implicating CD2AP as a determinant of human susceptibility to glomerular disease.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; NCI, Mol Epidemiol Sect, Lab Genom Divers, NIH, Frederick, MD 21702 USA; NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	shaw@pathology.wustl.edu	Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043308, Z01DK043308] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALPERS CE, 1993, AM J KIDNEY DIS, V22, P448, DOI 10.1016/S0272-6386(12)70151-8; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; KANWAR YS, 1981, RENAL PHYSIOL BIOCH, V4, P121; Kaplan J, 2001, CURR OPIN NEPHROL HY, V10, P183, DOI 10.1097/00041552-200103000-00005; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; KELLEY VE, 1972, LAB INVEST, V27, P149; KERJASCHKI D, 1989, J IMMUNOL, V143, P546; Kerjaschki D, 1997, J CLIN INVEST, V100, P2303, DOI 10.1172/JCI119768; KIM J, UNPUB; KORBET SM, 1985, MEDICINE, V64, P228, DOI 10.1097/00005792-198507000-00004; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Lemmon SK, 2000, CURR OPIN CELL BIOL, V12, P457, DOI 10.1016/S0955-0674(00)00117-4; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; RENNKE HG, 1975, J CELL BIOL, V67, P638, DOI 10.1083/jcb.67.3.638; ROSENMANN E, 1977, NEPHRON, V18, P301, DOI 10.1159/000180846; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tucker JK, 2002, AM J MED SCI, V323, P90, DOI 10.1097/00000441-200202000-00006; XIAO W, 2001, HUM MUTAT, V17, P349; Yo Y, 2003, NEPHRON EXP NEPHROL, V93, P92, DOI 10.1159/000069551	23	364	410	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1298	1300		10.1126/science.1081068	http://dx.doi.org/10.1126/science.1081068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764198				2022-12-01	WOS:000183042400051
J	Sanford, E; Roth, MS; Johns, GC; Wares, JP; Somero, GN				Sanford, E; Roth, MS; Johns, GC; Wares, JP; Somero, GN			Local selection and latitudinal variation in a marine predator-prey interaction	SCIENCE			English	Article							GEOGRAPHIC-VARIATION; INTERACTION STRENGTH; GRADIENT; BIOGEOGRAPHY; EVOLUTION	Although pairs of species often interact over broad geographic ranges, few studies have explored how interactions vary across these large spatial scales. Surveys along 1500 kilometers of the Pacific coast of North America documented marked variation in the frequency of predation by the snail Nucella canaliculata on the intertidal mussel Mytilus californianus. Laboratory rearing experiments suggest that regional differences in drilling behavior have a genetic basis, and mitochondrial sequence variation confirms that gene flow is low among these snail populations. Marine communities separated by hundreds of kilometers may have intrinsically different dynamics, with interactions shaped by restricted gene flow and spatially varying selection.	Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Stanford University; Brown University; University of California System; University of California Davis	Sanford, E (corresponding author), Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	eric_sanford@brown.edu	Somero, George/AAC-3321-2019	Wares, John/0000-0003-1827-0669; Somero, George/0000-0003-1431-6455; Roth, Melissa/0000-0001-7389-5982				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; BRAY NA, 1993, J GEOPHYS RES-OCEANS, V98, P18119, DOI 10.1029/93JC01142; Brown J.H., 1995, MACROECOLOGY; Connolly SR, 1998, AM NAT, V151, P311, DOI 10.1086/286121; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; DETHIER MN, 1988, MAR ECOL PROG SER, V50, P97, DOI 10.3354/meps050097; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Endler J.A., 1977, Monographs in Population Biology, pi; Foster SA, 1999, GEOGRAPHIC VARIATION; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; LEIGHTON BJ, 1991, DIS AQUAT ORGAN, V10, P71, DOI 10.3354/dao010071; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; SANFORD E, UNPUB; Sotka EE, 2002, ECOLOGY, V83, P2721, DOI 10.1890/0012-9658(2002)083[2721:GVAHPI]2.0.CO;2; SOTKA EE, UNPUB; Stachowicz JJ, 2000, AM NAT, V156, P59, DOI 10.1086/303366; Suchanek T.H., 1986, ECOLOGY ROCKY COASTS, P71; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0	26	116	116	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1135	+		10.1126/science.1083437	http://dx.doi.org/10.1126/science.1083437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750518				2022-12-01	WOS:000182886500042
J	Dunn, N				Dunn, N			10-minute consultation - Adverse drug event	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Sch Med, Southampton SO16 5ST, Hants, England	University of Southampton	Dunn, N (corresponding author), Univ Southampton, Sch Med, Southampton SO16 5ST, Hants, England.								0	1	2	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 10	2003	326	7397					1018	1018		10.1136/bmj.326.7397.1018	http://dx.doi.org/10.1136/bmj.326.7397.1018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KG	12742925	Bronze, Green Published			2022-12-01	WOS:000182920500019
J	Tsuda, A; Takeda, S; Saito, H; Nishioka, J; Nojiri, Y; Kudo, I; Kiyosawa, H; Shiomoto, A; Imai, K; Ono, T; Shimamoto, A; Tsumune, D; Yoshimura, T; Aono, T; Hinuma, A; Kinugasa, M; Suzuki, K; Sohrin, Y; Noiri, Y; Tani, H; Deguchi, Y; Tsurushima, N; Ogawa, H; Fukami, K; Kuma, K; Saino, T				Tsuda, A; Takeda, S; Saito, H; Nishioka, J; Nojiri, Y; Kudo, I; Kiyosawa, H; Shiomoto, A; Imai, K; Ono, T; Shimamoto, A; Tsumune, D; Yoshimura, T; Aono, T; Hinuma, A; Kinugasa, M; Suzuki, K; Sohrin, Y; Noiri, Y; Tani, H; Deguchi, Y; Tsurushima, N; Ogawa, H; Fukami, K; Kuma, K; Saino, T			A mesoscale iron enrichment in the western Subarctic Pacific induces a large centric diatom bloom	SCIENCE			English	Article							PHYTOPLANKTON BLOOM; SOUTHERN-OCEAN; FERTILIZATION; PRODUCTIVITY	We have performed an in situ test of the iron limitation hypothesis in the subarctic North Pacific Ocean. A single enrichment of dissolved iron caused a large increase in phytoplankton standing stock and decreases in macronutrients and dissolved carbon dioxide. The dominant phytoplankton species shifted after the iron addition from pennate diatoms to a centric diatom, Chaetoceros debilis, that showed a very high growth rate, 2.6 doublings per day. We conclude that the bioavailability of iron regulates the magnitude of the phytoplankton biomass and the key phytoplankton species that determine the biogeochemical sensitivity to iron supply of high-nitrate, low-chlorophyll waters.	Hokkaido Natl Res Inst, Kushira, Hokkaido 0850802, Japan; Univ Tokyo, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi 9850001, Japan; Cent Res Inst Elect Power Ind, Chiba 2701194, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; Marine Biol Res Inst Japan, Shinagawa Ku, Tokyo 1420042, Japan; Natl Res Inst Far Seas Fisheries, Shizuoka 4248633, Japan; Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan; Kansai Environm Engn Ctr, Osaka 5410052, Japan; Natl Inst Radiol Sci, Hitachinaka, Ibaraki 3111202, Japan; Nagoya Univ, Hydrospher Atmospher Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Kochi Univ, Nanko Ku, Kochi 7838502, Japan	University of Tokyo; Fisheries Research Agency - Japan; Central Research Institute of Electric Power Industry - Japan; National Institute for Environmental Studies - Japan; Hokkaido University; Fisheries Research Agency - Japan; Japan Science & Technology Agency (JST); National Institutes for Quantum Science & Technology; Nagoya University; Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Kochi University	Tsuda, A (corresponding author), Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan.		Sohrin, Yoshiki/A-8133-2011; Suzuki, Koji/A-4349-2013; Kuma, Kenshi/B-2799-2012; Nojiri, Yukihiro/D-1999-2010; Nishioka, Jun/F-5314-2011; SAITO, HIROAKI/J-6948-2017; Suzuki, Koji/AAD-2630-2022; Suzuki, Koji/GVS-9807-2022; 毅, 芳村/M-1778-2017; Tsurushima, Nobuo/L-6336-2018	Sohrin, Yoshiki/0000-0001-6744-6048; Suzuki, Koji/0000-0001-5354-1044; Kuma, Kenshi/0000-0001-8851-5997; Nojiri, Yukihiro/0000-0001-9885-9195; Nishioka, Jun/0000-0003-1723-9344; SAITO, HIROAKI/0000-0002-5502-9076; Suzuki, Koji/0000-0001-5354-1044; 毅, 芳村/0000-0001-5700-2590; Tsurushima, Nobuo/0000-0002-4741-7482; Takeda, Shigenobu/0000-0002-4997-1583				Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014210; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Cavender-Bares KK, 1999, LIMNOL OCEANOGR, V44, P237, DOI 10.4319/lo.1999.44.2.0237; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Dalton R, 2002, NATURE, V420, P722, DOI 10.1038/420722a; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; Harrison PJ, 1999, PROG OCEANOGR, V43, P205, DOI 10.1016/S0079-6611(99)00015-4; KUDO I, UNPUB; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; NISHIOKA J, IN PRESS GEOPHYS RES; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SAINO T, 1990, J OCEANOGR, V54, P583; Suzuki Y, 1995, J PHYCOL, V31, P880, DOI 10.1111/j.0022-3646.1995.00880.x	22	391	415	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					958	961		10.1126/science.1082000	http://dx.doi.org/10.1126/science.1082000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738858				2022-12-01	WOS:000182719800050
J	Evenson, RE; Gollin, D				Evenson, RE; Gollin, D			Assessing the impact of the Green Revolution, 1960 to 2000	SCIENCE			English	Review								We summarize the findings of a recently completed study of the productivity impacts of international crop genetic improvement research in developing countries. Over the period 1960 to 2000, international agricultural research centers, in collaboration with national research programs, contributed to the development of "modern varieties" for many crops. These varieties have contributed to large increases in crop production. Productivity gains, however, have been uneven across crops and regions. Consumers generally benefited from declines in food prices. Farmers benefited only where cost reductions exceeded price reductions.	Yale Univ, Dept Econ, New Haven, CT 06520 USA; Williams Coll, Dept Econ, Williamstown, MA 01267 USA	Yale University; Williams College	Evenson, RE (corresponding author), Yale Univ, Dept Econ, New Haven, CT 06520 USA.							[Anonymous], 2003, CROP VARIETY IMPROVE; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; DALTON TJ, 2003, CROP VARIETY IMPROVE, pCH6; EVENSON RE, 2003, CROP VARIET IMPROVEM, pCH23; EVENSON RE, 2003, CROP VFARIETY IMPROV, pCH21; Griffin Keith, 1979, POLITICAL EC AGRARIA, V2nd; Hewitt de Alcantara Cynthia, 1976, MODERNIZING MEXICAN; JOHNSON NL, 2003, CROP VARIETY IMPROVE, pCH16; JOHNSON NL, 2003, CROP VARIETY IMPROVE, pCH12; MANYONG VM, 2003, CROP VARIETY IMPROVE, pCH8; MCKINSEY JW, 2003, CROP VARIETY IMPROVE, pCH19; Shiva V, 1993, MONOCULTURES MIND PE	12	1063	1109	15	582	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					758	762		10.1126/science.1078710	http://dx.doi.org/10.1126/science.1078710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730592				2022-12-01	WOS:000182579800038
J	Balague, F; Dudler, J; Nordin, M				Balague, F; Dudler, J; Nordin, M			Low-back pain in children	LANCET			English	Editorial Material									Hop Cantonal Fribourg, Serv Rhumatol Med Phys & Rehabil, CH-1708 Fribourg, Switzerland; CHU Vaudois, Serv Rhumatol Med Phys & Rehabil, CH-1011 Lausanne, Switzerland; NYU Med Ctr, Hosp Joint Dis, Occupat & Ind Orthoped Ctr, New York, NY 10016 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Balague, F (corresponding author), Hop Cantonal Fribourg, Serv Rhumatol Med Phys & Rehabil, CH-1708 Fribourg, Switzerland.			Dudler, Jean/0000-0001-8533-5800				Chambers CT, 1997, ARCH PEDIAT ADOL MED, V151, P449, DOI 10.1001/archpedi.1997.02170420019003; de Inocencio J, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.6.e63; KING AJC, 1992, HLTH CANADAS YOUTH V; Roese I, 1996, Rehabilitation (Stuttg), V35, P103; Silman A., 2001, EPIDEMIOLOGY RHEUMAT, V2nd; Waddell G, 2002, BACK PAIN INCAPACITY; Watson KD, 2003, ARCH DIS CHILD, V88, P12, DOI 10.1136/adc.88.1.12; Watson KD, 2002, PAIN, V97, P87, DOI 10.1016/S0304-3959(02)00008-8	8	54	55	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 26	2003	361	9367					1403	1404		10.1016/S0140-6736(03)13148-0	http://dx.doi.org/10.1016/S0140-6736(03)13148-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727390				2022-12-01	WOS:000182516300005
J	Greenberg, EP				Greenberg, EP			Tiny teamwork	NATURE			English	Editorial Material									Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Greenberg, EP (corresponding author), Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA.			Greenberg, Everett/0000-0001-9474-8041				Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x	4	69	75	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					134	134		10.1038/424134a	http://dx.doi.org/10.1038/424134a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853935	Bronze			2022-12-01	WOS:000184032700022
J	Joron, M; Brakefield, PM				Joron, M; Brakefield, PM			Captivity masks inbreeding effects on male mating success in butterflies	NATURE			English	Article							BICYCLUS-ANYNANA; CONSERVATION BIOLOGY; EXTINCTION RISK; SONG SPARROWS; DEPRESSION; POPULATIONS; DROSOPHILA; FITNESS; METAPOPULATION; SATYRIDAE	Small isolated populations are frequently genetically less diverse than core populations, resulting in higher homozygosity that can hamper their long-term survival(1-4). The decrease in fitness of organisms owing to matings between relatives is well known from captive and laboratory animals. Such inbreeding can have strongly deleterious effects on life-history traits and survival(5-11), and can be critical to the success of population conservation(2,4,12). Because pedigrees are hard to follow in the wild, most field studies have used marker loci to establish that fitness declines with increasing homozygosity(1,13,14). Very few have experimentally explored the effects of inbreeding in the wild(15), or compared observations in the laboratory with field conditions(8,9). Here, using a technique involving the transfer of marker dusts during copulation, we show that a small decrease in mating success of captive inbred male butterflies in cages is greatly accentuated in conditions with unconstrained flight. Our results have important implications for conservation and for studies of sexual selection because they show that the behaviours underlying patterns of mating can be profoundly influenced by a history of inbreeding or by any restraining experimental conditions.	Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Joron, M (corresponding author), UCL, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	m.joron@ucl.ac.uk; brakefield@rulsfb.leidenuniv.nl	Joron, Mathieu/C-9178-2009	Joron, Mathieu/0000-0003-1043-4147				Armbruster P, 2000, P ROY SOC B-BIOL SCI, V267, P1939, DOI 10.1098/rspb.2000.1233; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Brakefield PM, 2001, J EVOLUTION BIOL, V14, P148, DOI 10.1046/j.1420-9101.2001.00248.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Breuker CJ, 2002, P ROY SOC B-BIOL SCI, V269, P1233, DOI 10.1098/rspb.2002.2005; Coulson TN, 1998, J ANIM ECOL, V67, P434, DOI 10.1046/j.1365-2656.1998.00205.x; DeRose MA, 1999, EVOLUTION, V53, P1288, DOI 10.2307/2640831; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Hanski I., 1996, METAPOPULATION BIOL; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Hoglund J, 2002, P ROY SOC B-BIOL SCI, V269, P711, DOI 10.1098/rspb.2001.1937; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lynch M., 1998, AM J HUM GENET; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Marr AB, 2002, EVOLUTION, V56, P131; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MEFFERT LM, 1991, EVOLUTION, V45, P293, DOI 10.1111/j.1558-5646.1991.tb04404.x; MILLER PS, 1993, GENETICA, V88, P29, DOI 10.1007/BF02424449; MILLER PS, 1993, ZOO BIOL, V12, P333, DOI 10.1002/zoo.1430120404; Nieminen M, 2001, AM NAT, V157, P237, DOI 10.1086/318630; Roff DA, 2001, EVOLUTION, V55, P111, DOI 10.1111/j.0014-3820.2001.tb01277.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saccheri IJ, 1996, EVOLUTION, V50, P2000, DOI 10.1111/j.1558-5646.1996.tb03587.x; Saccheri IJ, 2002, P ROY SOC B-BIOL SCI, V269, P1073, DOI 10.1098/rspb.2002.1963; SMITH J. M., 1956, JOUR GENETICS, V54, P261, DOI 10.1007/BF02982781; Sokal RR, 2012, BIOMETRY, V4th; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; van Oosterhout C, 2000, EVOLUTION, V54, P218, DOI 10.1554/0014-3820(2000)054[0218:IDAGLI]2.0.CO;2	30	129	130	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					191	194		10.1038/nature01713	http://dx.doi.org/10.1038/nature01713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853956				2022-12-01	WOS:000184032700041
J	Miller-Butterworth, CM; Jacobs, DS; Harley, EH				Miller-Butterworth, CM; Jacobs, DS; Harley, EH			Strong population substructure is correlated with morphology and ecology in a migratory bat	NATURE			English	Article							LONG-FINGERED BAT; MITOCHONDRIAL-DNA; MINIOPTERUS-SCHREIBERSII; GENETIC-STRUCTURE; MICROSATELLITE DATA; PHILOPATRY; DISPERSAL; MTDNA	Examining patterns of inter-population genetic diversity can provide valuable information about both historical and current evolutionary processes affecting a species. Population genetic studies of flying and migratory species such as bats and birds have traditionally shown minimal population substructure, characterized by high levels of gene flow between populations(1,2). In general, strongly substructured mammalian populations either are separated by non-traversable barriers or belong to terrestrial species with low dispersal abilities(3). Species with female philopatry ( the tendency to remain in or consistently return to the natal territory) might show strong substructure when examined with maternally inherited mitochondrial DNA, but this substructure generally disappears when biparentally inherited markers are used, owing to male-mediated gene flow(4). Male-biased dispersal is considered typical for mammals(5), and philopatry in both sexes is rare. Here we show strong population substructure in a migratory bat species, and philopatry in both sexes, as indicated by concordance of nuclear and mtDNA findings. Furthermore, the genetic structure correlates with local biomes and differentiation in wing morphology. There is therefore a close correlation of genetic and morphological differentiation in sympatric subspecific populations of this mammalian species.	Univ Cape Town, Dept Zool, ZA-7701 Rondebosch, South Africa; Univ Cape Town, Div Chem Pathol, Wildlife Genet Unit, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Miller-Butterworth, CM (corresponding author), NCI, Lab Genom Divers, POB B, Frederick, MD 21702 USA.	cbutterworth@mail.ncifcrf.gov	Miller-Butterworth, Cassandra/H-5994-2013; Jacobs, David Steve/L-9118-2013	Jacobs, David Steve/0000-0002-3243-8571				AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; [Anonymous], 1997, VEGETATION SO AFRICA; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BALL RM, 1988, P NATL ACAD SCI USA, V85, P1558, DOI 10.1073/pnas.85.5.1558; BERNARD RTF, 1994, J ZOOL, V232, P485, DOI 10.1111/j.1469-7998.1994.tb01589.x; Burland TM, 1999, P ROY SOC B-BIOL SCI, V266, P975, DOI 10.1098/rspb.1999.0732; Cardinal BR, 2000, AUST J ZOOL, V48, P1, DOI 10.1071/ZO99067; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HARLEY EH, 2000, BAT RES NEWS, V41, P99; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; MCCRACKEN GF, 1994, J MAMMAL, V75, P500, DOI 10.2307/1382574; Miller-Butterworth CM, 2002, MOL ECOL NOTES, V2, P139, DOI 10.1046/j.1471-8286.2002.00170.x; Moore SS, 1998, ANIM GENET, V29, P33, DOI 10.1046/j.1365-2052.1998.00234.x; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; NORMAN JA, 1994, MOL ECOL, V3, P363, DOI 10.1111/j.1365-294X.1994.tb00076.x; Paetkau D, 1997, GENETICS, V147, P1943; Palmeirim JM, 1995, SYM ZOOL S, P219; Petit E, 1999, P ROY SOC B-BIOL SCI, V266, P1717, DOI 10.1098/rspb.1999.0837; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; RAUTENBACH IL, 1988, KOEDOE, V31, P77; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SAUNDERS MB, 1992, ECOLOGY, V73, P1335, DOI 10.2307/1940680; THOMPSON MJA, 1992, J ZOOL, V228, P673, DOI 10.1111/j.1469-7998.1992.tb04466.x; Van der Merwe M., 1973, Mammalia, V37, P379, DOI 10.1515/mamm.1973.37.3.379; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P123; WILKINSON GS, 1991, GENETICS, V128, P607; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Worthington Wilmer J., 1994, Proceedings of the Royal Society of London Series B Biological Sciences, V257, P193	30	96	98	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					187	191		10.1038/nature01742	http://dx.doi.org/10.1038/nature01742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853955				2022-12-01	WOS:000184032700040
J	Molina-Heredia, FP; Wastl, J; Navarro, JA; Bendall, DS; Hervas, M; Howe, CJ; De la Rosa, MA				Molina-Heredia, FP; Wastl, J; Navarro, JA; Bendall, DS; Hervas, M; Howe, CJ; De la Rosa, MA			A new function for an old cytochrome?	NATURE			English	Article							PHOTOSYSTEM-I; PLASTOCYANIN; C(6); MECHANISMS		Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; CSIC, Ctr Isla Cartuja, Seville 41092, Spain; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC); University of Cambridge	Molina-Heredia, FP (corresponding author), Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Americo Vespucio S-N, Seville 41092, Spain.		Hervas, Manuel/K-9279-2014; navarro, jose a/B-6354-2015; De la Rosa, Miguel/B-2545-2014; Molina-Heredia, Fernando P./F-7877-2015; Wastl, Juergen/C-6876-2016	Hervas, Manuel/0000-0003-4523-8891; navarro, jose a/0000-0002-0536-6074; De la Rosa, Miguel/0000-0003-1187-5737; Molina-Heredia, Fernando P./0000-0002-3637-0519; Wastl, Juergen/0000-0001-7757-8001				De la Rosa MA, 2002, BIOELECTROCHEMISTRY, V55, P41, DOI 10.1016/S1567-5394(01)00136-0; Gupta R, 2002, NATURE, V417, P567, DOI 10.1038/417567a; HERVAS M, 1995, BIOCHEMISTRY-US, V34, P11321, DOI 10.1021/bi00036a004; Hope AB, 2000, BBA-BIOENERGETICS, V1456, P5, DOI 10.1016/S0005-2728(99)00101-2; Metzger SU, 1995, PHOTOSYNTHESIS LIGHT, V2, P823; Navarro JA, 1997, J BIOL INORG CHEM, V2, P11, DOI 10.1007/s007750050101; Wastl J, 2002, TRENDS PLANT SCI, V7, P244, DOI 10.1016/S1360-1385(02)02280-X	7	61	66	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					33	34		10.1038/424033b	http://dx.doi.org/10.1038/424033b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840749				2022-12-01	WOS:000183912800030
J	Schaal, B; Coureaud, G; Langlois, D; Ginies, C; Semon, E; Perrier, G				Schaal, B; Coureaud, G; Langlois, D; Ginies, C; Semon, E; Perrier, G			Chemical and behavioural characterization of the rabbit mammary pheromone	NATURE			English	Article							NEWBORN RABBITS; OLFACTION; ODORS; RATS; PUP	Mammals owe part of their evolutionary success to the harmonious exchanges of information, energy and immunity between females and their offspring. This functional reciprocity is vital for the survival and normal development of infants, and for the inclusive fitness of parents(1,2). It is best seen in the intense exchanges taking place around the mother's offering of, and the infant's quest for, milk. All mammalian females have evolved behavioural and sensory methods of stimulating and guiding their inexperienced newborns to their mammae, whereas newborns have coevolved means to respond to them efficiently(3). Among these cues, maternal odours have repeatedly been shown to be involved(4-6), but the chemical identity and pheromonal nature of these cues have not been definitively characterized until now. Here we focus on the nature of an odour signal emitted by the female rabbit to which newborn pups respond by attraction and oral grasping, and provide a complete chemical and behavioural description of a pheromone of mammary origin in a mammalian species.	Ctr Europeen Sci Gout, CNRS, Fre 2328, F-21000 Dijon, France; INRA, Unite Mixte Rech Aromes, F-21000 Dijon, France; Etab Natl Enseignement Super Agr, F-21000 Dijon, France	Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; INRAE	Schaal, B (corresponding author), Ctr Europeen Sci Gout, CNRS, Fre 2328, F-21000 Dijon, France.	schaal@cesg.cnrs.fr	Coureaud, Gérard/ABF-1205-2020; Coureaud, Gérard/N-9108-2017	Coureaud, Gérard/0000-0001-6754-3884; Coureaud, Gérard/0000-0001-6754-3884				ABBOTT N, 1993, J AGR FOOD CHEM, V41, P1698, DOI 10.1021/jf00034a034; BEAUCHAMP GK, 1976, OLFACTION BEHAV MAMM, P143; BLASS EM, 1980, SCIENCE, V210, P15, DOI 10.1126/science.6997992; Clutton-Brock TH., 1991, EVOLUTION PARENTAL C, DOI [10.1515/9780691206981, DOI 10.1515/9780691206981, DOI 10.104641420-9101.1992.5040719.X]; Coureaud G, 2002, DEV PSYCHOBIOL, V40, P372, DOI 10.1002/dev.10038; Coureaud G, 2001, ANIM BEHAV, V61, P153, DOI 10.1006/anbe.2000.1563; Coureaud G, 2000, DEV PSYCHOBIOL, V36, P271, DOI 10.1002/(SICI)1098-2302(200005)36:4<271::AID-DEV2>3.0.CO;2-3; Coureaud G, 2000, REPROD NUTR DEV, V40, P19, DOI 10.1051/rnd:2000117; COUREAUD G, 2001, THESIS U PARIS 13; GALEF BG, 1988, PHYSIOL BEHAV, V42, P119, DOI 10.1016/0031-9384(88)90285-5; GOODRICH BS, 1981, J CHEM ECOL, V7, P817, DOI 10.1007/BF00992380; HUDSON R, 1983, BEHAVIOUR, V85, P260, DOI 10.1163/156853983X00255; Johnson BA, 2000, J COMP NEUROL, V426, P330, DOI 10.1002/1096-9861(20001016)426:2<330::AID-CNE12>3.0.CO;2-5; JOHNSTON RE, 2000, NEUROBIOLOGY TASTE S, P101; KEIL W, 1990, PHYSIOL BEHAV, V47, P525, DOI 10.1016/0031-9384(90)90120-S; LEBAS F, 1970, ANN ZOOTECH, V19, P223, DOI 10.1051/animres:19700207; LEON M, 1971, PHYSIOL BEHAV, V7, P265, DOI 10.1016/0031-9384(71)90296-4; Macfarlane A, 1975, Ciba Found Symp, P103; MORROWTESCH J, 1990, PHYSIOL BEHAV, V47, P1, DOI 10.1016/0031-9384(90)90034-2; Pedersen P. E., 1981, DEV PERCEPTION PSYCH, P359; ROSENBLATT JS, 1983, DEV PSYCHOBIOL, V16, P347, DOI 10.1002/dev.420160502; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCHLEY P, 1981, KLEINTIERPRAXIS, V26, P261; SCHLEY P, 1976, THESIS U GIESEN; Snowdon C.T., 1996, PARENTAL CARE EVOLUT; TEICHER MH, 1977, SCIENCE, V198, P635, DOI 10.1126/science.918660; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506; [No title captured]	30	258	272	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					68	72		10.1038/nature01739	http://dx.doi.org/10.1038/nature01739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840760				2022-12-01	WOS:000183912800041
J	Iribarne, A				Iribarne, A			Orphan diseases and adoptive initiatives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEGLECTED DISEASES; DRUGS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Iribarne, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Davies D M, 1983, Lancet, V1, P290; FRANCISCO A, 2002, LANCET, V360, P1102; Kettler HE, 2001, B WORLD HEALTH ORGAN, V79, P742; Lavandeira A, 2002, HAEMOPHILIA, V8, P194, DOI 10.1046/j.1365-2516.2002.00643.x; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Schieppati A, 2001, LANCET, V358, P1638, DOI 10.1016/S0140-6736(01)06658-2; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; *US DEP HHS, 1989, PUBL US DEP HLTH HUM; Wheeler C, 2001, B WORLD HEALTH ORGAN, V79, P728	9	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					116	116		10.1001/jama.290.1.116	http://dx.doi.org/10.1001/jama.290.1.116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837724				2022-12-01	WOS:000183868600032
J	Maki, M; Mustalahti, K; Kokkonen, J; Kulmala, P; Haapalahti, M; Karttunen, T; Ilonen, J; Laurila, K; Dahlbom, I; Hansson, T; Hopfl, P; Knip, M				Maki, M; Mustalahti, K; Kokkonen, J; Kulmala, P; Haapalahti, M; Karttunen, T; Ilonen, J; Laurila, K; Dahlbom, I; Hansson, T; Hopfl, P; Knip, M			Prevalence of celiac disease among children in Finland	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMALL-BOWEL BIOPSY; TISSUE TRANSGLUTAMINASE; DIABETES-MELLITUS; VILLOUS ATROPHY; ANTIBODY TESTS; FOLLOW-UP; SCHOOLCHILDREN; NETHERLANDS; RETICULIN; ICEBERG	BACKGROUND: Wheat, rye, and barley proteins induce celiac disease, an autoimmune type of gastrointestinal disorder, in genetically susceptible persons. Because the disease may be underdiagnosed, we estimated the prevalence of the disease and tested the hypothesis that assays for serum autoantibodies can be used to detect untreated celiac disease and that positive findings correlate with specific HLA haplotypes. METHODS: Serum samples were collected from 3654 students (age range, 7 to 16 years) in 1994 and screened in 2001 for endomysial and tissue transglutaminase antibodies. HLA typing was also performed on stored blood samples. All antibody-positive subjects were asked to undergo small-bowel biopsy in 2001. RESULTS: Of the 3654 subjects, 56 (1.5 percent) had positive antibody tests, as determined in 2001. Results of the two antibody tests were highly concordant. As of 1994, none of the subjects had received a clinical diagnosis of celiac disease, but 10 who had positive tests for both antibodies in serum obtained in 1994 received the diagnosis between 1994 and 2001. Of the 36 other subjects with positive antibody assays who agreed to undergo biopsy in 2001, 27 had evidence of celiac disease on biopsy. Thus, the estimated biopsy-proved prevalence was 1 case in 99 children. All but two of the antibody-positive subjects had either the HLA-DQ2 or the HLA-DQ8 haplotype. The prevalence of the combination of antibody positivity and an HLA haplotype associated with celiac disease was 1 in 67. CONCLUSIONS: The presence of serum tissue transglutaminase and endomysial autoantibodies is predictive of small-bowel abnormalities indicative of celiac disease. There is a good correlation between autoantibody positivity and specific HLA haplotypes. We estimate that the prevalence of celiac disease among Finnish schoolchildren is at least 1 case in 99 children.	Univ Tampere, Sch Med, Pediat Res Ctr, Celiac Dis Study Grp, Tampere, Finland; Tampere Univ Hosp, Dept Pediat, Tampere, Finland; Oulu Univ Hosp, Dept Pediat, Oulu, Finland; Oulu Univ Hosp, Dept Pathol, Oulu, Finland; Univ Turku, Turku Immunol Ctr, Turku, Finland; Univ Turku, Dept Virol, Turku, Finland; Pharmacia Diagnost AB, S-75182 Uppsala, Sweden; Pharmacia Diagnost AB, Freiburg, Germany; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Turku; University of Turku; Pfizer; Pharmacia Corporation; Pfizer; University of Helsinki	Maki, M (corresponding author), Univ Tampere, Sch Med, Pediat Res Ctr, Celiac Dis Study Grp, Bldg FM3, Tampere, Finland.	markku.maki@uta.fi	Knip, Mikael/AAL-3773-2020	Knip, Mikael/0000-0003-0474-0033; Karttunen, Tuomo/0000-0002-8843-7957; Hyytinen, Mila Maarit/0000-0001-5361-6421				CATASSI C, 1994, LANCET, V343, P200, DOI 10.1016/S0140-6736(94)90989-X; COLLIN P, 1993, SCAND J GASTROENTERO, V28, P595, DOI 10.3109/00365529309096094; Collin P, 1997, SCAND J GASTROENTERO, V32, P1129, DOI 10.3109/00365529709002992; Collin P, 2002, ENDOCR REV, V23, P464, DOI 10.1210/er.2001-0035; Csizmadia CGDS, 1999, LANCET, V353, P813, DOI 10.1016/S0140-6736(99)00243-3; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852; GEORGE EK, 1995, PEDIATR RES, V37, P213, DOI 10.1203/00006450-199502000-00015; Hansson T, 2002, PEDIATR RES, V51, P700, DOI 10.1023/01.PDR.0000015105.38277.9B; Hill I, 2000, J PEDIATR-US, V136, P86, DOI 10.1016/S0022-3476(00)90055-6; Iltanen S, 1999, AUTOIMMUNITY, V29, P179, DOI 10.3109/08916939908998533; Kaukinen K, 1998, SCAND J GASTROENTERO, V33, P944; Kaukinen K, 2001, DIGEST DIS SCI, V46, P879, DOI 10.1023/A:1010729207320; Kaukinen K, 2000, SCAND J GASTROENTERO, V35, P942, DOI 10.1080/003655200750022995; Korponay-Szabo IR, 1999, J PEDIATR GASTR NUTR, V28, P26, DOI 10.1097/00005176-199901000-00008; Kulmala P, 2001, DIABETES CARE, V24, P171, DOI 10.2337/diacare.24.1.171-a; KUTLU T, 1993, GUT, V34, P208, DOI 10.1136/gut.34.2.208; MAKI M, 1991, LANCET, V338, P1350, DOI 10.1016/0140-6736(91)92234-S; Maki M, 1997, LANCET, V349, P1755, DOI 10.1016/S0140-6736(96)70237-4; Meloni G, 1999, LANCET, V353, P37, DOI 10.1016/S0140-6736(05)74871-6; Mustalahti K, 2002, SCAND J GASTROENTERO, V37, P161, DOI 10.1080/003655202753416812; Mustalahti Kirsi, 2002, Eff Clin Pract, V5, P105; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; PAGANO M, 1993, PRINCIPLES BIOSTATIS; ROSSI TM, 1993, J PEDIATR-US, V123, P262, DOI 10.1016/S0022-3476(05)81699-3; Sblattero D, 2000, AM J GASTROENTEROL, V95, P1253; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stern M, 2000, J PEDIATR GASTR NUTR, V31, P513, DOI 10.1097/00005176-200011000-00012; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Sulkanen S, 1998, SCAND J GASTROENTERO, V33, P251; Troncone R, 1996, ACTA PAEDIATR, V85, P10, DOI 10.1111/j.1651-2227.1996.tb14240.x; Valdimarsson T, 1996, DIGEST DIS SCI, V41, P83, DOI 10.1007/BF02208588	33	732	758	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2003	348	25					2517	2524		10.1056/NEJMoa021687	http://dx.doi.org/10.1056/NEJMoa021687			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690YC	12815137				2022-12-01	WOS:000183577200006
J	Viswanath, V; Story, GM; Peier, AM; Petrus, MJ; Hwang, SW; Patapoutian, A; Jegla, T				Viswanath, V; Story, GM; Peier, AM; Petrus, MJ; Hwang, SW; Patapoutian, A; Jegla, T			Ion channels - Opposite thermosensor in fruitfly and mouse	NATURE			English	Editorial Material							TRP CHANNEL; DROSOPHILA; RECEPTOR		Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Viswanath, V (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.			Hwang, Sun Wook/0000-0001-8460-7480; Jegla, Timothy/0000-0001-8616-2390				Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Guler AD, 2002, J NEUROSCI, V22, P6408; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	11	203	215	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					822	823		10.1038/423822a	http://dx.doi.org/10.1038/423822a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815418				2022-12-01	WOS:000183585300031
J	Harris, RS; Bishop, KN; Sheehy, AM; Craig, HM; Petersen-Mahrt, SK; Watt, IN; Neuberger, MS; Malim, MH				Harris, RS; Bishop, KN; Sheehy, AM; Craig, HM; Petersen-Mahrt, SK; Watt, IN; Neuberger, MS; Malim, MH			DNA determination mediates innate immunity to retroviral infection	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; VIRAL VIF PROTEIN; REVERSE TRANSCRIPTION; SOR GENE; TYPE-1; HYPERMUTATION; CELLS; HIV-1; TRANSMISSION	CEM15/APOBEC3G is a cellular protein required for resistance to infection by virion infectivity factor (Vif)-deficient human immunodeficiency virus (HIV). Here, using a murine leukemia virus (MLV)-based system, we provide evidence that CEM15/APOBEC3G is a DNA deaminase that is incorporated into virions during viral production and subsequently triggers massive deamination of deoxycytidine to deoxyuridine within the retroviral minus (first)-strand cDNA, thus providing a probable trigger for viral destruction. Furthermore, HIV Vif can protect MLV from this CEM15/APOBEC3G-dependent restriction. These findings imply that targeted DNA deamination is a major strategy of innate immunity to retroviruses and likely also contributes to the sequence variation observed in many viruses (including HIV).	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England	MRC Laboratory Molecular Biology; University of London; King's College London	Harris, RS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	rsharris@mrc-imb.cam.ac.uk		Malim, Michael/0000-0002-7699-2064				Bock M, 2000, J VIROL, V74, P7422, DOI 10.1128/JVI.74.16.7422-7430.2000; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; HARRIS RS, 2003, IN PRESS NAT IMMUNOL; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; NEUBERGER MS, 2003, IN PRESS TRENDS 0523; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; SOVA P, 1993, J VIROL, V67, P6322, DOI 10.1128/JVI.67.10.6322-6326.1993; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993	23	1095	1137	3	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 13	2003	113	6					803	809		10.1016/S0092-8674(03)00423-9	http://dx.doi.org/10.1016/S0092-8674(03)00423-9			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809610	Bronze			2022-12-01	WOS:000183514400014
J	Golder, M; Burleigh, DE; Belai, A; Ghali, L; Ashby, D; Lunniss, PJ; Navsaria, HA; Williams, NS				Golder, M; Burleigh, DE; Belai, A; Ghali, L; Ashby, D; Lunniss, PJ; Navsaria, HA; Williams, NS			Smooth muscle cholinergic denervation hypersensitivity in diverticular disease	LANCET			English	Article							IRRITABLE-COLON-SYNDROME; INTRALUMINAL PRESSURE; SIGMOID COLON; MOTILITY; FOOD	Background Evidence from clinical and laboratory investigations into the causes of diverticular disease suggests that disturbances in cholinergic activity are important, the effector mechanisms of which have yet to be established. We aimed to investigate the role of smooth muscle and neural cholinergic activity in the pathogenesis of this disease. Methods Two investigators independently did a blinded immunohistochemical image analysis of localising antibodies to choline acetyltransferase, co-localised with protein gene product (PGP)-a marker of general neural tissue-and smooth muscle muscarinic M3 receptors, on three histological sections of sigmoid colons from ten patients with diverticular disease and ten controls, after resections for rectal tumours. We also did isotonic organ bath experiments to assess muscle strip sensitivities to exogenous acetylcholine. Findings In circular muscle, activity of choline acetyltransferase was lower in patients with diverticular disease than in controls: median percentage surface area of choline acetyltransferase over PGIP was 17.5% (range 10.0-37.0) in patients with diverticular disease and 47.0% (29.0-54.0) in controls (p<0.0001). M3 receptors were upregulated in patients with diverticular disease compared with controls: the median surface area was 13.2% (6.0-23.3) in patients with diverticular disease and 2.5% (1.6-3.7) in controls (p<0.0001). The sensitivity to exogenous acetylcholine was increased in patients with diverticular disease (mean -log EC50 5.6 [SD 0.3]) compared with controls (4.9 [0.5]; difference 0.7 [95% Cl 0.3-1.1], p=0.006). In longitudinal muscle, choline acetyltransferase activity was lower in patients with diverticular disease (median 19.5%, range 12.0-30.0) than in controls (47.0%, 35.0-60.0; p<0.0001), with upregulation of M3 receptors in diverticular disease (diverticular disease 7.8% [1.9-20.4], controls 1.7% [0-8-3.0]; p<0.0001). However, sensitivity to exogenous acetylcholine did not differ between the two groups (diverticular disease mean 5.6% [SD 0.3], controls 5.2% [0.4]; difference 0.4% [95% Cl -0.02-0.7], p=0.06). Interpretation Our results suggest that cholinergic denervation hypersensitivity can affect smooth muscle. Upregulation of smooth muscle M3 receptors might account for specific clinical, physiological, and pharmacological abnormalities associated with diverticular disease.	Barts & London Queen Marys Sch Med & Dent, Acad Dept Surg, London, England; Barts & London Queen Marys Sch Med & Dent, Dept Adult & Paediat Gastroenterol, London, England; Barts & London Queen Marys Sch Med & Dent, Ctr Cutaneous Res, London, England; Barts & London Queen Marys Sch Med & Dent, Dept Environm & Prevent Med, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London	Golder, M (corresponding author), Royal London Hosp, Acad Dept Surg, 4th Floor Alex Wing, London E1 1BB, England.	m.s.golder@qmul.ac.uk		Belai, Abi (Abebech)/0000-0001-9113-006X				BELAI A, 1988, GASTROENTEROLOGY, V95, P1234, DOI 10.1016/0016-5085(88)90356-3; BURLEIGH DE, 1990, DIGEST DIS SCI, V35, P617, DOI 10.1007/BF01540410; Delahaye N, 2001, CIRCULATION, V104, P2911, DOI 10.1161/hc4901.100380; DOYLE JR, 1981, J HAND SURG-AM, V6, P40, DOI 10.1016/S0363-5023(81)80009-3; Eggenberger, 1999, Curr Treat Options Gastroenterol, V2, P507, DOI 10.1007/s11938-999-0054-x; Gomes OA, 1997, GERONTOLOGY, V43, P210, DOI 10.1159/000213852; HAVIA T, 1971, ACTA CHIR SCAND, V137, P569; Huizinga JD, 1999, SCAND J GASTROENTERO, V34, P683; KERR PM, 1995, BRIT J PHARMACOL, V115, P1518, DOI 10.1111/j.1476-5381.1995.tb16645.x; Kobayashi S, 2001, JPN J PHARMACOL, V86, P281, DOI 10.1254/jjp.86.281; Li JC, 2001, WORLD J GASTROENTERO, V7, P16; Lin WM, 1997, NEUROREPORT, V8, P2999, DOI 10.1097/00001756-199709290-00002; MANOUSOS O, 1985, GUT, V26, P544, DOI 10.1136/gut.26.6.544; MANOUSOS ON, 1967, BRIT MED J, V3, P760, DOI 10.1136/bmj.3.5568.760; OTTE JJ, 1986, AM J GASTROENTEROL, V81, P529; PAINTER NS, 1971, BMJ-BRIT MED J, V2, P450, DOI 10.1136/bmj.2.5759.450; PAINTER NS, 1964, GUT, V5, P201, DOI 10.1136/gut.5.3.201; PARKS TG, 1969, GUT, V10, P534, DOI 10.1136/gut.10.7.534; Porter AJ, 1996, GASTROENTEROLOGY, V111, P401, DOI 10.1053/gast.1996.v111.pm8690205; REES BI, 1980, BRIT J CLIN PHARMACO, V9, P229, DOI 10.1111/j.1365-2125.1980.tb04831.x; SMITH AN, 1986, CLIN GASTROENTEROL, V15, P917; STRETTON CD, 1990, AM REV RESPIR DIS, V142, P1030, DOI 10.1164/ajrccm/142.5.1030; SUCHOWIECKY M, 1987, DIGEST DIS SCI, V32, P833, DOI 10.1007/BF01296705; SUGIHARA K, 1983, GUT, V24, P1130, DOI 10.1136/gut.24.12.1130; Tomita R, 1999, HEPATO-GASTROENTEROL, V46, P2839; TROTMAN IF, 1988, GUT, V29, P218, DOI 10.1136/gut.29.2.218; WEINREICH J, 1976, SCAND J GASTROENTERO, V11, P581; WHITEWAY J, 1985, GUT, V26, P258, DOI 10.1136/gut.26.3.258; WHITEWAY J, 1985, CLIN GASTROENTEROL, V14, P829; YAP I, 1991, SMJ Singapore Medical Journal, V32, P218	30	90	90	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2003	361	9373					1945	1951		10.1016/S0140-6736(03)13583-0	http://dx.doi.org/10.1016/S0140-6736(03)13583-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801738				2022-12-01	WOS:000183359700010
J	Ishii, D; Kinbara, K; Ishida, Y; Ishii, N; Okochi, M; Yohda, M; Aida, T				Ishii, D; Kinbara, K; Ishida, Y; Ishii, N; Okochi, M; Yohda, M; Aida, T			Chaperonin-mediated stabilization and ATP-triggered release of semiconductor nanoparticles	NATURE			English	Article							CADMIUM-SULFIDE; THERMOPHILIC BACTERIUM; THERMUS-THERMOPHILUS; CDS NANOCRYSTALLITES; HOLO-CHAPERONIN; QUANTUM DOTS; GROEL; PROTEIN; NANOCOMPOSITES; NANOCLUSTERS	Various properties of semiconductor nanoparticles, including photoluminescence and catalytic activity, make these materials attractive for a range of applications(1,2). As nanoparticles readily coagulate and so lose their size-dependent properties, shape-persistent three-dimensional stabilizers that enfold nanoparticles have been exploited(3-9). However, such wrapping approaches also make the nanoparticles insensitive to external stimuli, and so may limit their application. The chaperonin proteins GroEL (from Escherichia coli) and T.th ('T.th cpn', from Thermus thermophilus HB8) encapsulate denatured proteins inside a cylindrical cavity; after refolding, the encapsulated proteins are released by the action of ATP inducing a conformational change of the cavity(10,11). Here we report that GroEL and T.th cpn can also enfold CdS semiconductor nanoparticles, giving them high thermal and chemical stability in aqueous media. Analogous to the biological function of the chaperonins, the nanoparticles can be readily released from the protein cavities by the action of ATP. We expect that integration of such biological mechanisms into materials science will open a door to conceptually new bioresponsive devices.	Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan; Tokyo Univ Agr & Technol, Fac Technol, Dept Biotechnol, Tokyo 1848588, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Agriculture & Technology	Aida, T (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Ishida, Yasuhiro/I-8204-2012; Aida, Takuzo/I-9117-2012; Yohda, Masafumi/A-5149-2013; Ishii, Noriyuki/E-5661-2011; Kinbara, Kazushi/E-6347-2017	Yohda, Masafumi/0000-0001-8307-9671; Ishii, Noriyuki/0000-0002-4120-6203; Kinbara, Kazushi/0000-0002-5945-9612				Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; AMADA K, 1995, J BIOCHEM-TOKYO, V118, P347, DOI 10.1093/oxfordjournals.jbchem.a124913; Balogh L, 1998, J AM CHEM SOC, V120, P7355, DOI 10.1021/ja980861w; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRUS LE, 1984, J CHEM PHYS, V80, P4403, DOI 10.1063/1.447218; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HENGLEIN A, 1982, J PHYS CHEM-US, V86, P2291, DOI 10.1021/j100210a010; Hosokawa H, 1996, J PHYS CHEM-US, V100, P6649, DOI 10.1021/jp952603g; ISHII N, 1992, FEBS LETT, V299, P169, DOI 10.1016/0014-5793(92)80240-H; ISHII N, 1994, J MOL BIOL, V236, P691, DOI 10.1006/jmbi.1994.1181; Lemon BI, 2000, J AM CHEM SOC, V122, P12886, DOI 10.1021/ja0031321; Llorca O, 1998, J BIOL CHEM, V273, P32587, DOI 10.1074/jbc.273.49.32587; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; McMillan RA, 2002, NAT MATER, V1, P247, DOI 10.1038/nmat775; MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086; Murakoshi K, 1998, J CHEM SOC FARADAY T, V94, P579, DOI 10.1039/a707192b; RAMSDEN JJ, 1984, J CHEM SOC FARAD T 1, V80, P919, DOI 10.1039/f19848000919; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Schmid G, 1999, CHEM SOC REV, V28, P179, DOI 10.1039/a801153b; Shenton W, 1997, NATURE, V389, P585, DOI 10.1038/39287; Shenton W, 2001, ANGEW CHEM INT EDIT, V40, P442, DOI 10.1002/1521-3773(20010119)40:2<442::AID-ANIE442>3.0.CO;2-2; TAGUCHI H, 1991, J BIOL CHEM, V266, P22411; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114	26	198	204	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					628	632		10.1038/nature01663	http://dx.doi.org/10.1038/nature01663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789335				2022-12-01	WOS:000183301200037
J	Savvidou, MD; Hingorani, AD; Tsikas, D; Frolich, JC; Vallance, P; Nicolaides, KH				Savvidou, MD; Hingorani, AD; Tsikas, D; Frolich, JC; Vallance, P; Nicolaides, KH			Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia	LANCET			English	Article							NITRIC-OXIDE SYNTHASE; HYPERTENSIVE DISORDERS; MEDIATED VASODILATION; ENOS-GENE; RISK; INHIBITOR; LOCUS	Background Maternal endothelial dysfunction is a feature of established pre-eclampsia but whether this is a cause or consequence of the disorder is not clear. We tested the hypothesis that endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine (ADMA), the endogenous inhibitor of endothelial nitric oxide synthase, precede and contribute to the development of pre-eclampsia. Methods We assessed uterine artery doppler waveforms in 86 women, at 23-25 weeks' gestation. We tested endothelial function in all women using flow-mediated dilation of the brachial artery at 23-25 weeks' gestation. Plasma concentrations of ADMA were also measured. Findings 43 women had normal uterine artery doppler waveforms and subsequently had a normal outcome. The second group of 43 had evidence of impaired placental perfusion and of these, 19 (44%) had normal outcome, 14 (33%) developed intrauterine growth restriction of the fetus (IUGR), and pre-eclampsia arose in ten (23%). Women who developed pre-eclampsia had significantly lower flow-mediated dilation than did women who had normal outcome (3-58% [SD 2.76] vs 8.59% [2.76]; p<0.0001). Irrespective of pregnancy outcome, women with evidence of impaired placental perfusion had significantly higher levels of ADMA than did women with normal doppler waveforms (2.4 mu mol/L [IQR 1.97-3.14] vs 0.81 mu mol/L [0.49-1.08]; p<0.0001). There was a strong inverse correlation between ADMA and flow-mediated dilation but only in the group of women who eventually developed pre-eclampsia (r= -0.8, p=0.005). Interpretation Maternal endothelial function is impaired in women who eventually develop pre-eclampsia and it occurs before the development of the clinical syndrome. Furthermore, women with high resistance placental circulation at risk of pre-eclampsia, IUGR, or both have raised concentrations of ADMA, which is a potential contributory factor for pre-eclampsia, and is associated with endothelial dysfunction in some women.	Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London SE5 8RS, England; UCL, Dept Med, British Heart Fdn Labs, Ctr Clin Pharmacol, London WC1E 6BT, England; Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of London; University College London; Hannover Medical School	Nicolaides, KH (corresponding author), Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, Denmark Hill, London SE5 8RS, England.	Kypros@technocom.com		SAVVIDOU, MAKRINA/0000-0002-0125-2299; Nicolaides, Kypros/0000-0003-1266-0711; Hingorani, Aroon/0000-0001-8365-0081				Albaiges G, 2000, OBSTET GYNECOL, V96, P559, DOI 10.1016/S0029-7844(00)00946-7; Arngrimsson R, 1997, AM J HUM GENET, V61, P354, DOI 10.1086/514843; Bosio PM, 1999, OBSTET GYNECOL, V94, P978, DOI 10.1016/S0029-7844(99)00430-5; CALVER A, 1993, J HUM HYPERTENS, V7, P193; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Cockell AP, 1997, HYPERTENSION, V30, P247, DOI 10.1161/01.HYP.30.2.247; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; Dorup I, 1999, AM J PHYSIOL-HEART C, V276, pH821; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Holden DP, 1998, AM J OBSTET GYNECOL, V178, P551, DOI 10.1016/S0002-9378(98)70437-5; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Lade JA, 1999, HYPERTENS PREGNANCY, V18, P81, DOI 10.3109/10641959909009613; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; MACALLISTER RJ, 1994, KIDNEY INT, V45, P737, DOI 10.1038/ki.1994.98; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; MEREDITH JT, 1996, AM J PHYSIOL, V270, pH1435; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; Savvidou MD, 2001, HYPERTENSION, V38, P1289, DOI 10.1161/hy1201.097305; Savvidou MD, 2000, ULTRASOUND OBST GYN, V15, P502, DOI 10.1046/j.1469-0705.2000.00131.x; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P364, DOI 10.1016/S0002-9378(00)70225-0; Sikkema JM, 2001, PLACENTA, V22, P304, DOI 10.1053/plac.2001.0629; Tsikas D, 1998, J CHROMATOGR B, V705, P174; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; Williams DJ, 1997, AM J PHYSIOL-HEART C, V272, pH748, DOI 10.1152/ajpheart.1997.272.2.H748	30	383	414	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2003	361	9368					1511	1517		10.1016/S0140-6736(03)13177-7	http://dx.doi.org/10.1016/S0140-6736(03)13177-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737861				2022-12-01	WOS:000182658900010
J	Gonzalez-Pastor, JE; Hobbs, EC; Losick, R				Gonzalez-Pastor, JE; Hobbs, EC; Losick, R			Cannibalism by sporulating bacteria	SCIENCE			English	Article							BACILLUS-SUBTILIS; ANTIBIOTICS; EXPRESSION; INITIATION; SIGMA(W); GROWTH; GENES	Spore formation by the bacterium Bacillus subtilis is an elaborate developmental process that is triggered by nutrient limitation. Here we report that cells that have entered the pathway to sporulate produce and export a killing factor and a signaling protein that act cooperatively to block sister cells from sporulating and to cause them to lyse. The sporulating cells feed on the nutrients thereby released, which allows them to keep growing rather than to complete morphogenesis. We propose that sporulation is a stress-response pathway of last resort and that B. subtilis delays a commitment to spore formation by cannibalizing its siblings.	Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.		González-Pastor, José/I-2118-2015	González-Pastor, José/0000-0002-7615-7042	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R37GM018568] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM18568] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; CHUNG JD, 1994, J BACTERIOL, V176, P1977, DOI 10.1128/jb.176.7.1977-1984.1994; COZENS RM, 1986, ANTIMICROB AGENTS CH, V29, P797, DOI 10.1128/AAC.29.5.797; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; GONZALEZPASTOR JE, UNPUB; KOLTER R, 1992, ANNU REV MICROBIOL, V46, P141, DOI 10.1146/annurev.mi.46.100192.001041; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lin D, 2001, J APPL MICROBIOL, V91, P1044, DOI 10.1046/j.1365-2672.2001.01475.x; Pei JM, 2001, TRENDS BIOCHEM SCI, V26, P275, DOI 10.1016/S0968-0004(01)01813-8; Piggot P. J., 2002, BACILLUS SUBTILIS IT, P473; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Siezen RJ, 1996, ANTON LEEUW INT J G, V69, P171, DOI 10.1007/BF00399422; Sonenshein AL, 2000, PROKARYOTIC DEVELOPMENT, P133; Sonenshein AL, 2000, BACTERIAL STRESS RESPONSES, P199; Turner MS, 2000, J BACTERIOL, V182, P5202, DOI 10.1128/JB.182.18.5202-5210.2000; WIREMAN JW, 1975, SCIENCE, V189, P516, DOI 10.1126/science.806967; Zheng GL, 1999, J BACTERIOL, V181, P7346, DOI 10.1128/JB.181.23.7346-7355.1999	21	410	442	7	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					510	513		10.1126/science.1086462	http://dx.doi.org/10.1126/science.1086462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12817086				2022-12-01	WOS:000184340500041
J	Chen, J; Larochelle, S; Li, XM; Suter, B				Chen, J; Larochelle, S; Li, XM; Suter, B			Xpd/Ercc2 regulates CAK activity and mitotic progression	NATURE			English	Article							CDK-ACTIVATING KINASE; RNA-POLYMERASE-II; CELL-CYCLE; IN-VIVO; TRANSCRIPTION; TFIIH; EMBRYOS; PHOSPHORYLATION; REPRESSION; MITOSIS	General transcription factor IIH (TFIIH) consists of nine subunits: cyclin-dependent kinase 7 (Cdk7), cyclin H and MAT1 ( forming the Cdk-activating-kinase or CAK complex), the two helicases Xpb/Hay and Xpd, and p34, p44, p52 and p62 (refs 1 - 3). As the kinase subunit of TFIIH, Cdk7 participates in basal transcription by phosphorylating the carboxy-terminal domain of the largest subunit of RNA polymerase II1,4,5. As part of CAK, Cdk7 also phosphorylates other Cdks, an essential step for their activation(6-9). Here we show that the Drosophila TFIIH component Xpd negatively regulates the cell cycle function of Cdk7, the CAK activity. Excess Xpd titrates CAK activity, resulting in decreased Cdk T-loop phosphorylation, mitotic defects and lethality, whereas a decrease in Xpd results in increased CAK activity and cell proliferation. Moreover, Xpd is downregulated at the beginning of mitosis when Cdk1, a cell cycle target of Cdk7, is most active. Downregulation of Xpd thus seems to contribute to the upregulation of mitotic CAK activity and to regulate mitotic progression positively. Simultaneously, the downregulation of Xpd might be a major mechanism of mitotic silencing of basal transcription.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Suter, B (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Larochelle, Stephane/D-3662-2012	Larochelle, Stephane/0000-0002-4594-4342				Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541; AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Austin RJ, 1996, P NATL ACAD SCI USA, V93, P5788, DOI 10.1073/pnas.93.12.5788; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Egly JM, 2001, FEBS LETT, V498, P124, DOI 10.1016/S0014-5793(01)02458-9; FISHER RP, 1996, BIOCHIM BIOPHYS ACTA, V1288, P7; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; Foe Victoria E., 1993, P149; Frit P, 1999, BIOCHIMIE, V81, P27, DOI 10.1016/S0300-9084(99)80035-2; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Larochelle S, 2001, EMBO J, V20, P3749, DOI 10.1093/emboj/20.14.3749; Long JJ, 1998, MOL CELL BIOL, V18, P1467, DOI 10.1128/MCB.18.3.1467; MAKELA TP, 1995, P NATL ACAD SCI USA, V92, P5174, DOI 10.1073/pnas.92.11.5174; MALDONADOCODINA G, 1993, J CELL SCI, V105, P711; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Sandrock B, 2001, J BIOL CHEM, V276, P35328, DOI 10.1074/jbc.M105570200; Wallenfang MR, 2002, P NATL ACAD SCI USA, V99, P5527, DOI 10.1073/pnas.082618399	21	101	104	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					228	232		10.1038/nature01746	http://dx.doi.org/10.1038/nature01746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853965				2022-12-01	WOS:000184032700050
J	Takeda, S; Yamashita, A; Maeda, K; Maeda, Y				Takeda, S; Yamashita, A; Maeda, K; Maeda, Y			Structure of the core domain of human cardiac troponin in the Ca2+-saturated form	NATURE			English	Article							SKELETAL-MUSCLE TROPONIN; SUBFRAGMENT 1 ATPASE; THIN FILAMENT; ACTIN-TROPOMYOSIN; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; CENTRAL HELIX; T FRAGMENTS; 3 STATES; RABBIT	Troponin is essential in Ca2+ regulation of skeletal and cardiac muscle contraction. It consists of three subunits (TnT, TnC and TnI) and, together with tropomyosin, is located on the actin filament. Here we present crystal structures of the core domains (relative molecular mass of 46,000 and 52,000) of human cardiac troponin in the Ca2+-saturated form. Analysis of the four-molecule structures reveals that the core domain is further divided into structurally distinct subdomains that are connected by flexible linkers, making the entire molecule highly flexible. The alpha-helical coiled-coil formed between TnT and TnI is integrated in a rigid and asymmetric structure (about 80 Angstrom long), the IT arm, which bridges putative tropomyosin-anchoring regions. The structures of the troponin ternary complex imply that Ca2+ binding to the regulatory site of TnC removes the carboxy-terminal portion of TnI from actin, thereby altering the mobility and/or flexibility of troponin and tropomyosin on the actin filament.	SPring 8, RIKEN Harima Inst, Lab Struct Biochem, Sayo, Hyogo 6795148, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST)	Takeda, S (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, 5-7-1 Fujishiro Dai, Osaka 5658565, Japan.		Yamashita, Atsuko/H-5566-2017	Yamashita, Atsuko/0000-0002-8001-4642				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BABU A, 1993, J BIOL CHEM, V268, P19232; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; FARAH CS, 1994, J BIOL CHEM, V269, P5230; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; FUJITABECKER S, 1993, J BIOCHEM, V114, P438, DOI 10.1093/oxfordjournals.jbchem.a124194; Gasmi-Seabrook GMC, 1999, BIOCHEMISTRY-US, V38, P8313, DOI 10.1021/bi9902642; Geeves MA, 2000, BIOCHEMISTRY-US, V39, P9345, DOI 10.1021/bi0002232; Hai H, 2002, J BIOCHEM, V131, P407, DOI 10.1093/oxfordjournals.jbchem.a003116; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Li ZX, 2001, BIOPHYS J, V81, P321, DOI 10.1016/S0006-3495(01)75702-5; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MORRIS EP, 1984, BIOCHEMISTRY-US, V23, P2214, DOI 10.1021/bi00305a018; OHTSUKI I, 1979, J BIOCHEM, V86, P491, DOI 10.1093/oxfordjournals.jbchem.a132549; OHTSUKI I, 1988, J BIOCHEM-TOKYO, V103, P913, DOI 10.1093/oxfordjournals.jbchem.a122387; OHTSUKI I, 1986, ADV PROTEIN CHEM, V38, P1, DOI 10.1016/S0065-3233(08)60525-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; PEARLSTONE JR, 1983, J BIOL CHEM, V258, P2534; PEARLSTONE JR, 1985, CAN J BIOCHEM CELL B, V63, P212, DOI 10.1139/o85-030; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Ramakrishnan S, 1995, BIOCHEMISTRY-US, V34, P16789, DOI 10.1021/bi00051a029; ROUSSEL A, 1996, TURBO FRODO MANUAL; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Slupsky CM, 1995, BIOCHEMISTRY-US, V34, P15953, DOI 10.1021/bi00049a010; Stefancsik R, 1998, P NATL ACAD SCI USA, V95, P957, DOI 10.1073/pnas.95.3.957; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 1997, EUR J BIOCHEM, V246, P611, DOI 10.1111/j.1432-1033.1997.00611.x; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; TANOKURA M, 1983, J BIOCHEM, V93, P331, DOI 10.1093/oxfordjournals.jbchem.a134185; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	50	612	624	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					35	41		10.1038/nature01780	http://dx.doi.org/10.1038/nature01780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840750				2022-12-01	WOS:000183912800031
J	Ogita, S; Uefuji, H; Yamaguchi, Y; Koizumi, N; Sano, H				Ogita, S; Uefuji, H; Yamaguchi, Y; Koizumi, N; Sano, H			RNA interference - Producing decaffeinated coffee plants	NATURE			English	Editorial Material							CAFFEINE; GENE		Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan	Nara Institute of Science & Technology	Ogita, S (corresponding author), Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan.		Yamaguchi, Yube/B-9594-2012					Ashihara H, 1996, PLANT PHYSIOL, V111, P747, DOI 10.1104/pp.111.3.747; Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6; Hatanaka T, 1999, PLANT CELL REP, V19, P106, DOI 10.1007/s002990050719; Ogawa M, 2001, J BIOL CHEM, V276, P8213, DOI 10.1074/jbc.M009480200; OHTA S, 1990, PLANT CELL PHYSIOL, V31, P805; Uefuji H, 2003, PLANT PHYSIOL, V132, P372, DOI 10.1104/pp.102.019679	6	149	196	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					823	823		10.1038/423823a	http://dx.doi.org/10.1038/423823a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815419	Bronze			2022-12-01	WOS:000183585300032
J	Schiermeier, Q				Schiermeier, Q			Researchers rattled as Kyoto Protocol hangs in the balance	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					792	792		10.1038/423792b	http://dx.doi.org/10.1038/423792b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815393	Bronze			2022-12-01	WOS:000183585300010
J	Verghese, J; Lipton, RB; Katz, MJ; Hall, CB; Derby, CA; Kuslansky, G; Ambrose, AF; Sliwinski, M; Buschke, H				Verghese, J; Lipton, RB; Katz, MJ; Hall, CB; Derby, CA; Kuslansky, G; Ambrose, AF; Sliwinski, M; Buschke, H			Leisure activities and the risk of dementia in the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; COGNITIVE IMPAIRMENT; DIETARY-INTAKE; LATE-LIFE; MEMORY; ASSOCIATION; PREVALENCE; DIAGNOSIS; EDUCATION	BACKGROUND: Participation in leisure activities has been associated with a lower risk of dementia. It is unclear whether increased participation in leisure activities lowers the risk of dementia or participation in leisure activities declines during the preclinical phase of dementia. METHODS: We examined the relation between leisure activities and the risk of dementia in a prospective cohort of 469 subjects older than 75 years of age who resided in the community and did not have dementia at base line. We examined the frequency of participation in leisure activities at enrollment and derived cognitive-activity and physical-activity scales in which the units of measure were activity-days per week. Cox proportional-hazards analysis was used to evaluate the risk of dementia according to the base-line level of participation in leisure activities, with adjustment for age, sex, educational level, presence or absence of chronic medical illnesses, and base-line cognitive status. RESULTS: Over a median follow-up period of 5.1 years, dementia developed in 124 subjects (Alzheimer's disease in 61 subjects, vascular dementia in 30, mixed dementia in 25, and other types of dementia in 8). Among leisure activities, reading, playing board games, playing musical instruments, and dancing were associated with a reduced risk of dementia. A one-point increment in the cognitive-activity score was significantly associated with a reduced risk of dementia (hazard ratio, 0.93 [95 percent confidence interval, 0.90 to 0.97]), but a one-point increment in the physical-activity score was not (hazard ratio, 1.00). The association with the cognitive-activity score persisted after the exclusion of the subjects with possible preclinical dementia at base line. Results were similar for Alzheimer's disease and vascular dementia. In linear mixed models, increased participation in cognitive activities at base line was associated with reduced rates of decline in memory. CONCLUSIONS: Participation in leisure activities is associated with a reduced risk of dementia, even after adjustment for base-line cognitive status and after the exclusion of subjects with possible preclinical dementia. Controlled trials are needed to assess the protective effect of cognitive leisure activities on the risk of dementia.	Albert Einstein Coll Med, Einstein Aging Study, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Phys Med & Rehabil, Bronx, NY 10467 USA; Syracuse Univ, Dept Psychol, Syracuse, NY USA; Syracuse Univ, Ctr Hlth & Behav, Syracuse, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Syracuse University; Syracuse University	Verghese, J (corresponding author), Albert Einstein Coll Med, Einstein Aging Study, 1165 Morris Pk Ave, Bronx, NY 10461 USA.	jverghes@aecom.yu.edu	Lipton, Richard Bruce/AAY-2818-2021; Ambrose, Anne Felicia/ABE-4161-2020; Lipton, Richard B/B-5060-2011; Hall, Charles B./AAX-8216-2020; Ambrose, Anne Felicia/AAQ-9668-2021	Hall, Charles/0000-0001-9982-8120	NATIONAL INSTITUTE ON AGING [P01AG003949] Funding Source: NIH RePORTER; NIA NIH HHS [AGO3949-15] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; ARONSON MK, 1990, NEUROLOGY, V40, P1102, DOI 10.1212/WNL.40.7.1102; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Christmas C, 2000, J AM GERIATR SOC, V48, P318, DOI 10.1111/j.1532-5415.2000.tb02654.x; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; COX DR, 1972, J R STAT SOC B, V34, P187; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; Fleiss JL, 1981, STAT METHODS RATES P, P38; Fratiglioni L, 1999, DRUG AGING, V15, P365, DOI 10.2165/00002512-199915050-00004; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; FULD PA, 1990, J CLIN EXP NEUROPSYC, V12, P520, DOI 10.1080/01688639008400998; Fuld PA., 1978, ALZHEIMERS DIS SENIL, V7, P185; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Hall CB, 2001, STAT MED, V20, P3695, DOI 10.1002/sim.1113; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; KONDO K, 1994, DEMENTIA, V5, P314, DOI 10.1159/000106741; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Mazzeo RS, 1998, MED SCI SPORT EXER, V30, P992, DOI 10.1097/00005768-199806000-00033; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wechsler D, 1955, MANUAL WECHSLER ADUL; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, J NEUROL NEUROSUR PS, V73, P672, DOI 10.1136/jnnp.73.6.672; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; ZUNG WWK, 1967, PSYCHOSOMATICS, V8, P287	43	1128	1159	9	328	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2003	348	25					2508	2516		10.1056/NEJMoa022252	http://dx.doi.org/10.1056/NEJMoa022252			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690YC	12815136				2022-12-01	WOS:000183577200005
J	Enquist, BJ; Economo, EP; Huxman, TE; Allen, AP; Ignace, DD; Gillooly, JF				Enquist, BJ; Economo, EP; Huxman, TE; Allen, AP; Ignace, DD; Gillooly, JF			Scaling metabolism from organisms to ecosystems	NATURE			English	Article							CARBON-DIOXIDE; WATER-VAPOR; TEMPERATURE; RESPIRATION; SIZE; EXCHANGE; ECOLOGY; FLUXES; RATES; SOIL	Understanding energy and material fluxes through ecosystems is central to many questions in global change biology and ecology(1-11). Ecosystem respiration is a critical component of the carbon cycle(1,5-7) and might be important in regulating biosphere response to global climate change(1-3). Here we derive a general model of ecosystem respiration based on the kinetics of metabolic reactions(11-13) and the scaling of resource use by individual organisms(14,15). The model predicts that fluxes of CO2 and energy are invariant of ecosystem biomass, but are strongly influenced by temperature, variation in cellular metabolism and rates of supply of limiting resources (water and/or nutrients). Variation in ecosystem respiration within sites, as calculated from a network of CO2 flux towers(5,7), provides robust support for the model's predictions. However, data indicate that variation in annual flux between sites is not strongly dependent on average site temperature or latitude. This presents an interesting paradox with regard to the expected temperature dependence. Nevertheless, our model provides a basis for quantitatively understanding energy and material flux between the atmosphere and biosphere.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of Arizona; University of New Mexico	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	benquist@u.arizona.edu	Enquist, Brian J/B-6436-2008; Allen, Andrew/B-8045-2011	Enquist, Brian J/0000-0002-6124-7096; Allen, Andrew/0000-0003-0304-7544				Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; EARNSHAW MJ, 1981, ARCTIC ALPINE RES, V13, P425, DOI 10.2307/1551053; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; ENQUIST BJ, IN PRESS MACROECOLOG; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; HEMMINGSEN AXEL M., 1960, REPTS STENO HOSP COPENHAGEN, V9, P7; Huxman TE, 2003, OECOLOGIA, V134, P537, DOI 10.1007/s00442-002-1131-1; JORDAN CF, 1971, AM SCI, V59, P425; Keeling C.D., 1994, TRENDS 93 COMPENDIUM, P16; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MOONEY HA, 1961, ECOL MONOGR, V31, P1, DOI 10.2307/1950744; Nelson D. L., 2000, LEHNINGER PRINCIPLES; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; NOBEL PS, 1999, PHYSIOCHEMICAL ENV P; PEARCY RW, 1977, PLANT PHYSIOL, V59, P795, DOI 10.1104/pp.59.5.795; RAISON J K, 1976, Australian Journal of Plant Physiology, V3, P291; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Running SW, 1999, REMOTE SENS ENVIRON, V70, P108, DOI 10.1016/S0034-4257(99)00061-9; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; VETTER RAH, 1995, J COMP PHYSIOL B, V165, P46, DOI 10.1007/BF00264685; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799	33	272	289	6	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					639	642		10.1038/nature01671	http://dx.doi.org/10.1038/nature01671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789338	Bronze			2022-12-01	WOS:000183301200040
J	Rossouw, M; Nel, HJ; Cooke, GS; van Helden, PD; Hoal, EG				Rossouw, M; Nel, HJ; Cooke, GS; van Helden, PD; Hoal, EG			Association between tuberculosis and a polymorphic NF kappa B binding site in the interferon gamma gene	LANCET			English	Article								Interferon gamma is believed to be crucial for host defence against many infections. To test the hypothesis that a polymorphism in the gene for interferon gamma (IFNG) is associated with susceptibility to tuberculosis, we did two independent investigations. In a case-control study of 313 tuberculosis cases, we noted a significant association between a polymorphism (+874A-->T) in IFNG and tuberculosis in a South African population (p=0.0055). This finding was replicated in a family-based study, in which the transmission disequilibrium test was used in 131 families (p=0.005). The transcription factor NFkappaB binds preferentially to the +874T allele, which is over-represented in controls. This preferential binding suggests that genetically determined variability in interferon gamma and expression might be important for the development of tuberculosis.	Univ Stellenbosch, MRC, Ctr Cellular & Mol Biol, ZA-7505 Tygerberg, South Africa; Univ Stellenbosch, Fac Hlth Sci, Dept Med Biochem, ZA-7505 Tygerberg, South Africa; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Stellenbosch University; Stellenbosch University; University of Oxford; Wellcome Centre for Human Genetics	Hoal, EG (corresponding author), Univ Stellenbosch, MRC, Ctr Cellular & Mol Biol, ZA-7505 Tygerberg, South Africa.			Hoal, Eileen/0000-0002-6444-5688; Cooke, Graham/0000-0001-6475-5056				Bream JH, 2000, IMMUNOGENETICS, V51, P50, DOI 10.1007/s002510050008; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001	5	185	189	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1871	1872		10.1016/S0140-6736(03)13491-5	http://dx.doi.org/10.1016/S0140-6736(03)13491-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788577				2022-12-01	WOS:000183205800015
J	Kang, RS; Daniels, CM; Francis, SA; Shih, SC; Salerno, WJ; Hicke, L; Radhakrishnan, I				Kang, RS; Daniels, CM; Francis, SA; Shih, SC; Salerno, WJ; Hicke, L; Radhakrishnan, I			Solution structure of a CUE-ubiquitin complex reveals a conserved mode of ubiquitin binding	CELL			English	Article							NMR-SPECTROSCOPY; INTERACTING MOTIF; UBA DOMAINS; MACROMOLECULAR STRUCTURE; PROTEIN; SURFACE; DEGRADATION; PATHWAY; RECOGNITION; ENDOCYTOSIS	Monoubiquitination serves as a regulatory signal in a variety of cellular processes. Monoubiquitin signals are transmitted by binding to a small but rapidly expanding class of ubiquitin binding motifs. Several of these motifs, including the CUE domain, also promote intramolecular monoubiquitination. The solution structure of a CUE domain of the yeast Cue2 protein in complex with ubiquitin reveals intermolecular interactions involving conserved hydrophobic surfaces, including the Leu8-IIe44-Val70 patch on ubiquitin. The contact surface extends beyond this patch and encompasses Lys48, a site of polyubiquitin chain formation. This suggests an occlusion mechanism for inhibiting polyubiquitin chain formation during monoubiquitin signaling. The CUE domain shares a similar overall architecture with the UBA domain, which also contains a conserved hydrophobic patch. Comparative modeling suggests that the UBA domain interacts analogously with ubiquitin. The structure of the CUE-ubiquitin complex may thus serve as a paradigm for ubiquitin recognition and signaling by ubiquitin binding proteins.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Radhakrishnan, I (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.		Radhakrishnan, Ishwar/AHA-7392-2022; Radhakrishnan, Ishwar/R-8442-2018	Radhakrishnan, Ishwar/0000-0002-0195-9710; Radhakrishnan, Ishwar/0000-0002-0195-9710				BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BAX A, 1994, METHOD ENZYMOL, V239, P79; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1997, MACROMOLECULAR CRYST, P493; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee AL, 1999, J BIOMOL NMR, V13, P101, DOI 10.1023/A:1008304220445; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Radhakrishnan I, 1999, J MOL BIOL, V287, P859, DOI 10.1006/jmbi.1999.2658; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	52	188	191	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					621	630		10.1016/S0092-8674(03)00362-3	http://dx.doi.org/10.1016/S0092-8674(03)00362-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787503	Bronze			2022-12-01	WOS:000183397600012
J	Karamysheva, Z; Wang, LB; Shrode, T; Bednenko, J; Hurley, LA; Shippen, DE				Karamysheva, Z; Wang, LB; Shrode, T; Bednenko, J; Hurley, LA; Shippen, DE			Developmentally programmed gene elimination in Euplotes crassus facilitates a switch in the telomerase catalytic subunit	CELL			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; CILIATED PROTOZOA; DNA; RNA; OCTOCARINATUS; MACRONUCLEAR; REPLICATION; CONTAINS; ELEMENTS; TEMPLATE	The primary function of telomerase is to maintain preexisting telomere tracts. In the ciliate Euplotes crassus, however, telomerase RNP structure and substrate recognition are altered during macronuclear development to facilitate de novo telomere addition. We found that E. crassus harbors three TERT genes encoding the telomerase catalytic subunit that not only vary in their nucleotide and predicted protein sequences, but also in their expression profiles. Expression of EcTERT-1 and -3 correlates with the requirement for telomere maintenance, while that of EcTERT-2 correlates with de novo telomere synthesis. All three genes appear to require ribosomal frameshifting for expression of catalytically active protein. The transcriptionally active form of EcTERT-2 exists only transiently in mated cells and is absent from the vegetative macronucleus. Thus, telomerase expression in Euplotes is controlled by unique regulatory mechanisms that culminate in a developmental switch to a different catalytic subunit with properties suited to de novo telomere addition.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Shippen, DE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.			Bednenko, Janna/0000-0001-9220-3531	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049157, R01GM049157] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49157] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aigner S, 2000, EMBO J, V19, P6230, DOI 10.1093/emboj/19.22.6230; Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Bachand F, 2001, MOL CELL BIOL, V21, P1888, DOI 10.1128/MCB.21.5.1888-1897.2001; Bednenko J, 1997, EMBO J, V16, P2507, DOI 10.1093/emboj/16.9.2507; Bednenko J, 1998, NUCLEIC ACIDS RES, V26, P3998, DOI 10.1093/nar/26.17.3998; Bryan TM, 1998, P NATL ACAD SCI USA, V95, P8479, DOI 10.1073/pnas.95.15.8479; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Collins K, 1999, ANNU REV BIOCHEM, V68, P187, DOI 10.1146/annurev.biochem.68.1.187; Doak TG, 2003, EUKARYOT CELL, V2, P95, DOI 10.1128/EC.2.1.95-102.2003; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Fan QC, 1996, MOL CELL BIOL, V16, P1267; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; FRELS JS, 1995, MOL CELL BIOL, V15, P6488; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Greene EC, 1998, GENE DEV, V12, P2921, DOI 10.1101/gad.12.18.2921; HARPER DS, 1989, P NATL ACAD SCI USA, V86, P3252, DOI 10.1073/pnas.86.9.3252; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Jacobs ME, 2003, EUKARYOT CELL, V2, P103, DOI 10.1128/EC.2.1.103-114.2003; Jacobs ME, 1996, J EUKARYOT MICROBIOL, V43, P442, DOI 10.1111/j.1550-7408.1996.tb04503.x; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; JAHN CL, 1993, GENE, V133, P71, DOI 10.1016/0378-1119(93)90226-S; JARACZEWSKI JW, 1993, GENE DEV, V7, P95, DOI 10.1101/gad.7.1.95; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; Klobutcher LA, 2002, CELL, V111, P763, DOI 10.1016/S0092-8674(02)01138-8; KLOBUTCHER LA, 1993, GENE DEV, V7, P84, DOI 10.1101/gad.7.1.84; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Metz AM, 2001, BIOTECHNOL APPL BIOC, V34, P47, DOI 10.1042/BA20010021; Miller MC, 2000, EMBO J, V19, P4412, DOI 10.1093/emboj/19.16.4412; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; PRICE CM, 1994, J EUKARYOT MICROBIOL, V41, P267, DOI 10.1111/j.1550-7408.1994.tb01507.x; Ray S, 2002, MOL CELL BIOL, V22, P5859, DOI 10.1128/MCB.22.16.5859-5868.2002; ROTH M, 1985, CELL, V41, P411, DOI 10.1016/S0092-8674(85)80014-3; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P575, DOI 10.1111/j.1550-7408.2001.tb00193.x; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P80, DOI 10.1111/j.1550-7408.2001.tb00418.x; VERMEESCH JR, 1994, MOL CELL BIOL, V14, P554, DOI 10.1128/MCB.14.1.554; WANG L, 2002, NUCLEIC ACIDS RES, V30, P1	43	39	42	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					565	576		10.1016/S0092-8674(03)00363-5	http://dx.doi.org/10.1016/S0092-8674(03)00363-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787498	Bronze			2022-12-01	WOS:000183397600007
J	Mourier, T; Jeffares, DC				Mourier, T; Jeffares, DC			Eukaryotic intron loss	SCIENCE			English	Article							PSEUDOGENES; GENES		Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen	Mourier, T (corresponding author), Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, Univ Pk 15, DK-2100 Copenhagen, Denmark.		Mourier, Tobias/C-1164-2015; Jeffares, Daniel/N-2632-2018	Mourier, Tobias/0000-0003-2727-1903; Jeffares, Daniel/0000-0001-7320-0706				Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Derr LK, 1998, GENETICS, V148, P937; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; GIROUX MJ, 1994, P NATL ACAD SCI USA, V91, P12150, DOI 10.1073/pnas.91.25.12150; GLOCKNER G, COMMUNICATION; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; SCHANDORFF S, 2000, THESIS U COPENHAGEN; Simpson AGB, 2002, NATURE, V419, P270, DOI 10.1038/419270a; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.biochem.55.1.631	14	164	174	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1393	1393		10.1126/science.1080559	http://dx.doi.org/10.1126/science.1080559			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775832				2022-12-01	WOS:000183181800034
J	Jacobsson, LTH; Jacobsson, ME; Askling, J; Knowler, WC				Jacobsson, LTH; Jacobsson, ME; Askling, J; Knowler, WC			Perinatal characteristics and risk of rheumatoid arthritis	BRITISH MEDICAL JOURNAL			English	Article									Malmo Univ Hosp, Dept Rheumatol, S-20502 Malmo, Sweden; Karolinska Hosp & Inst, Clin Epidemiol Unit, S-17176 Stockholm, Sweden; NIDDK, Diabet & Arthrit Epidemiol Sect, Phoenix, AZ 85014 USA	Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Jacobsson, LTH (corresponding author), Malmo Univ Hosp, Dept Rheumatol, S-20502 Malmo, Sweden.							Enzer I, 2002, ARTHRITIS RHEUM, V46, P1729, DOI 10.1002/art.10360; KaipiainenSeppanen O, 1996, CLIN EXP RHEUMATOL, V14, P537; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Symmons D, 2000, RHEUMATOLOGY, V39, P835, DOI 10.1093/rheumatology/39.8.835; Walker-Bone K, 2002, RHEUMATOLOGY, V41, P69	5	61	62	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2003	326	7398					1068	1069		10.1136/bmj.326.7398.1068	http://dx.doi.org/10.1136/bmj.326.7398.1068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681ZD	12750209	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000183064700017
J	Mounkes, LC; Kozlov, S; Hernandez, L; Sullivan, T; Stewart, CL				Mounkes, LC; Kozlov, S; Hernandez, L; Sullivan, T; Stewart, CL			A progeroid syndrome in mice is caused by defects in A-type lamins	NATURE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; GENE; EXPRESSION; MUTATIONS; DISEASE; CELLS	Numerous studies of the underlying causes of ageing have been attempted by examining diseases associated with premature ageing, such as Werner's syndrome and Hutchinson - Gilford progeria syndrome (HGPS). HGPS is a rare genetic disorder resulting in phenotypes suggestive of accelerated ageing, including shortened stature, craniofacial disproportion, very thin skin, alopecia and osteoporosis, with death in the early teens predominantly due to atherosclerosis(1). However, recent reports suggest that developmental abnormalities may also be important in HGPS(1,2). Here we describe the derivation of mice carrying an autosomal recessive mutation in the lamin A gene (Lmna) encoding A-type lamins, major components of the nuclear lamina(3). Homozygous mice display defects consistent with HGPS, including a marked reduction in growth rate and death by 4 weeks of age. Pathologies in bone, muscle and skin are also consistent with progeria. The Lmna mutation resulted in nuclear morphology defects and decreased lifespan of homozygous fibroblasts, suggesting premature cell death. Here we present a mouse model for progeria that may elucidate mechanisms of ageing and development in certain tissue types, especially those developing from the mesenchymal cell lineage.	NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stewart, CL (corresponding author), NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA.				NATIONAL CANCER INSTITUTE [Z01BC010377] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ackerman J, 2002, PEDIATR PATHOL MOL M, V21, P1, DOI 10.1080/15227950252774110; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Hoeffel JC, 2000, SKELETAL RADIOL, V29, P668, DOI 10.1007/s002560000280; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lewis M, 2003, AGEING RES REV, V2, P95, DOI 10.1016/S1568-1637(02)00044-2; LUFKIN T, 1992, NATURE, V359, P835, DOI 10.1038/359835a0; Morris GE, 2001, TRENDS MOL MED, V7, P572, DOI 10.1016/S1471-4914(01)02128-1; OZAKI T, 1994, ONCOGENE, V9, P2649; Raharjo WH, 2001, J CELL SCI, V114, P4447; Rodrigues GHD, 2002, ANN GENET-PARIS, V45, P151, DOI 10.1016/S0003-3995(02)01119-X; ROEBER R-A, 1990, Journal of Cell Science, V95, P587; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sarkar PK, 2001, POSTGRAD MED J, V77, P312, DOI 10.1136/pmj.77.907.312; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Uitto Jouni, 2002, Trends in Endocrinology and Metabolism, V13, P140, DOI 10.1016/S1043-2760(02)00595-7; Upchurch DA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e69; Vigouroux C, 2001, J CELL SCI, V114, P4459; Worman HJ, 2002, TRENDS CELL BIOL, V12, P591, DOI 10.1016/S0962-8924(02)02401-7	26	266	277	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					298	301		10.1038/nature01631	http://dx.doi.org/10.1038/nature01631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748643	Green Published			2022-12-01	WOS:000182853100045
J	Zhang, LI; Tan, AYY; Schreiner, CE; Merzenich, MM				Zhang, LI; Tan, AYY; Schreiner, CE; Merzenich, MM			Topography and synaptic shaping of direction selectivity in primary auditory cortex	NATURE			English	Article							RECEPTIVE-FIELDS; CORTICAL-NEURONS; UNIT RESPONSES; IN-VIVO; CAT; FREQUENCY; RAT; ORGANIZATION; INHIBITION; PATTERNS	The direction of frequency-modulated ( FM) sweeps is an important temporal cue in animal and human communication. FM direction-selective neurons are found in the primary auditory cortex (A1)(1,2), but their topography and the mechanisms underlying their selectivity remain largely unknown. Here we report that in the rat A1, direction selectivity is topographically ordered in parallel with characteristic frequency (CF): low CF neurons preferred upward sweeps, whereas high CF neurons preferred downward sweeps. The asymmetry of 'inhibitory sidebands', suppressive regions flanking the tonal receptive field (TRF) of the spike response, also co-varied with CF. In vivo whole-cell recordings showed that the direction selectivity already present in the synaptic inputs was enhanced by cortical synaptic inhibition, which suppressed the synaptic excitation of the nonpreferred direction more than that of the preferred. The excitatory and inhibitory synaptic TRFs had identical spectral tuning, but with inhibition delayed relative to excitation. The spectral asymmetry of the synaptic TRFs co-varied with CF, as had direction selectivity and sideband asymmetry, and thus suggested a synaptic mechanism for the shaping of FM direction selectivity and its topographic ordering.	Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zhang, LI (corresponding author), Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA.	lizhang@phy.ucsf.edu	Tan, Andrew/E-7752-2011	Tan, Andrew/0000-0002-4696-1347; Schreiner, Christoph/0000-0002-4571-4328	NIDCD NIH HHS [R01 DC002260-08, R01 DC002260] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRITT R, 1976, J NEUROPHYSIOL, V39, P179, DOI 10.1152/jn.1976.39.1.179; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CLOPTON BM, 1974, EXP NEUROL, V42, P532, DOI 10.1016/0014-4886(74)90076-4; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; MENDELSON JR, 1985, BRAIN RES, V327, P331, DOI 10.1016/0006-8993(85)91530-6; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nelken I, 2000, EUR J NEUROSCI, V12, P549, DOI 10.1046/j.1460-9568.2000.00935.x; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; Poon PWF, 2000, NEUROSCI LETT, V289, P9, DOI 10.1016/S0304-3940(00)01251-9; Rao RPN, 2000, ADV NEUR IN, V12, P164; Ricketts C, 1998, HEARING RES, V123, P27, DOI 10.1016/S0378-5955(98)00086-0; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; SHAMMA SA, 1993, J NEUROPHYSIOL, V69, P367, DOI 10.1152/jn.1993.69.2.367; SUGA N, 1965, J PHYSIOL-LONDON, V181, P671, DOI 10.1113/jphysiol.1965.sp007791; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	30	298	302	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					201	205		10.1038/nature01796	http://dx.doi.org/10.1038/nature01796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853959				2022-12-01	WOS:000184032700044
J	He, JZ; Ritalahti, KM; Yang, KL; Koenigsberg, SS; Loffler, FE				He, JZ; Ritalahti, KM; Yang, KL; Koenigsberg, SS; Loffler, FE			Detoxification of vinyl chloride to ethene coupled to growth of an anaerobic bacterium	NATURE			English	Article							CHLOROETHENE-CONTAMINATED SITES; CIS-DICHLOROETHENE; REDUCTIVE DEHALOGENATION; TETRACHLOROETHENE; DECHLORINATION; DESULFUROMONAS; HYDROGEN; ACETATE	Tetrachloroethene (PCE) and trichloroethene (TCE) are ideal solvents for numerous applications, and their widespread use makes them prominent groundwater pollutants. Even more troubling, natural biotic and abiotic processes acting on these solvents lead to the accumulation of toxic intermediates (such as dichloroethenes) and carcinogenic intermediates (such as vinyl chloride)(1-4). Vinyl chloride was found in at least 496 of the 1,430 National Priorities List sites identified by the US Environmental Protection Agency, and its precursors PCE and TCE are present in at least 771 and 852 of these sites, respectively(5). Here we describe an unusual, strictly anaerobic bacterium that destroys dichloroethenes and vinyl chloride as part of its energy metabolism, generating environmentally benign products (biomass, ethene and inorganic chloride). This organism might be useful for cleaning contaminated subsurface environments and restoring drinking-water reservoirs.	Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Regenesis Bioremediat Prod, San Clemente, CA 92672 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Loffler, FE (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.		Ritalahti, Kirsti M/B-4624-2010; Yang, Kun-Lin/C-2247-2011; Loeffler, Frank E/M-8216-2013; He, Jianzhong/J-2704-2018	Yang, Kun-Lin/0000-0002-7958-9334; He, Jianzhong/0000-0003-1895-6628				Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Bunge M, 2003, NATURE, V421, P357, DOI 10.1038/nature01237; Coleman NV, 2002, APPL ENVIRON MICROB, V68, P6162, DOI 10.1128/AEM.68.12.6162-6171.2002; Coleman NV, 2002, APPL ENVIRON MICROB, V68, P2726, DOI 10.1128/AEM.68.6.2726-2730.2002; Cupples AM, 2003, APPL ENVIRON MICROB, V69, P953, DOI 10.1128/AEM.69.2.953-959.2003; Duhamel M, 2002, WATER RES, V36, P4193, DOI 10.1016/S0043-1354(02)00151-3; Gerhardt P., 1981, MANUAL METHODS GEN B; GRIBBLE GW, 1998, CHLORINATED COMPOUND, P972; He JZ, 2002, ENVIRON SCI TECHNOL, V36, P3945, DOI 10.1021/es025528d; He JZ, 2003, APPL ENVIRON MICROB, V69, P996, DOI 10.1128/AEM.69.2.996-1003.2003; Hendrickson ER, 2002, APPL ENVIRON MICROB, V68, P485, DOI 10.1128/AEM.68.2.485-495.2002; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Keppler F, 2002, ENVIRON SCI TECHNOL, V36, P2479, DOI 10.1021/es015611l; Kielhorn J, 2000, ENVIRON HEALTH PERSP, V108, P579, DOI 10.2307/3434875; Lendvay JM, 2003, ENVIRON SCI TECHNOL, V37, P1422, DOI 10.1021/es025985u; Loffler FE, 1999, APPL ENVIRON MICROB, V65, P4049; Loffler FE, 1997, APPL ENVIRON MICROB, V63, P4982, DOI 10.1128/AEM.63.12.4982-4985.1997; Loffler FE, 2003, DEHALOGENATION: MICROBIAL PROCESSES AND ENVIRONMENTAL APPLICATIONS, P53; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; MOHN WW, 1992, MICROBIOL REV, V56, P482, DOI 10.1128/MMBR.56.3.482-507.1992; Roberts AL, 1996, ENVIRON SCI TECHNOL, V30, P2654, DOI 10.1021/es9509644; Sung Y, 2003, APPL ENVIRON MICROB, V69, P2964, DOI 10.1128/AEM.69.5.2964-2974.2003; *US EPA, 1996, AG TOX SUBST DIS REG; VOGEL TM, 1987, ENVIRON SCI TECHNOL, V21, P722, DOI 10.1021/es00162a001	25	387	403	22	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					62	65		10.1038/nature01717	http://dx.doi.org/10.1038/nature01717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840758				2022-12-01	WOS:000183912800039
J	Fahrner, KA; Ryu, WS; Berg, HC				Fahrner, KA; Ryu, WS; Berg, HC			Biomechanics: Bacterial flagellar switching under load	NATURE			English	Editorial Material							ESCHERICHIA-COLI; MOTOR; CHEMOTAXIS; ROTATION		Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA	Harvard University; Harvard University	Fahrner, KA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Chen XB, 2000, BIOPHYS J, V78, P1036, DOI 10.1016/S0006-3495(00)76662-8; Chen XB, 2000, BIOPHYS J, V78, P2280, DOI 10.1016/S0006-3495(00)76774-9; HARSHEY RM, 1994, MOL MICROBIOL, V13, P389, DOI 10.1111/j.1365-2958.1994.tb00433.x; Kawagishi I, 1996, MOL MICROBIOL, V20, P693, DOI 10.1111/j.1365-2958.1996.tb02509.x; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Prasad K, 1998, J MOL BIOL, V280, P821, DOI 10.1006/jmbi.1998.1922; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201	11	49	50	4	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					938	938		10.1038/423938a	http://dx.doi.org/10.1038/423938a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827190	Bronze			2022-12-01	WOS:000183753900037
J	Trichopoulou, A; Costacou, T; Bamia, C; Trichopoulos, D				Trichopoulou, A; Costacou, T; Bamia, C; Trichopoulos, D			Adherence to a Mediterranean diet and survival in a Greek population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; FOOD FREQUENCY QUESTIONNAIRE; ENERGY-INTAKE; SUBSEQUENT MORTALITY; EATING PATTERNS; RISK; COHORT; MEN; REPRODUCIBILITY; VALIDITY	BACKGROUND: Adherence to a Mediterranean diet may improve longevity, but relevant data are limited. METHODS: We conducted a population-based, prospective investigation involving 22,043 adults in Greece who completed an extensive, validated, food-frequency questionnaire at base line. Adherence to the traditional Mediterranean diet was assessed by a 10-point Mediterranean-diet scale that incorporated the salient characteristics of this diet (range of scores, 0 to 9, with higher scores indicating greater adherence). We used proportional-hazards regression to assess the relation between adherence to the Mediterranean diet and total mortality, as well as mortality due to coronary heart disease and mortality due to cancer, with adjustment for age, sex, body-mass index, physical-activity level, and other potential confounders. RESULTS: During a median of 44 months of follow-up, there were 275 deaths. A higher degree of adherence to the Mediterranean diet was associated with a reduction in total mortality (adjusted hazard ratio for death associated with a two-point increment in the Mediterranean-diet score, 0.75 [95 percent confidence interval, 0.64 to 0.87]). An inverse association with greater adherence to this diet was evident for both death due to coronary heart disease (adjusted hazard ratio, 0.67 [95 percent confidence interval, 0.47 to 0.94]) and death due to cancer (adjusted hazard ratio, 0.76 [95 percent confidence interval, 0.59 to 0.98]). Associations between individual food groups contributing to the Mediterranean-diet score and total mortality were generally not significant. CONCLUSIONS: Greater adherence to the traditional Mediterranean diet is associated with a significant reduction in total mortality.	Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health	Trichopoulou, A (corresponding author), Univ Athens, Sch Med, Dept Hyg & Epidemiol, 75 Mikras Asias St, GR-11527 Athens, Greece.	antonia@nut.uoa.gr	TRICHOPOULOU, ANTONIA/ABF-8727-2021	TRICHOPOULOU, ANTONIA/0000-0002-7204-6396				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; CHATFIELD C, 1995, INTRO MULTIVARIATE A; COSTACOU T, IN PRESS EUR J CLIN; DELORGERIL, 1995, LANCET, V345, P738; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; FARCHI G, 1995, EUR J CLIN NUTR, V49, P408; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; GNARDELLIS C, 1995, EPIDEMIOLOGY, V6, P74, DOI 10.1097/00001648-199501000-00015; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1; Johnson W. J., 1998, NUTR EPIDEMIOLOGY, P22, DOI [DOI 10.1093/ACPROF:OSO/9780195122978.003.11, 10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001]; KANT AK, 1993, AM J CLIN NUTR, V57, P434, DOI 10.1093/ajcn/57.3.434; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Katsouyanni K, 1997, INT J EPIDEMIOL, V26, pS118, DOI 10.1093/ije/26.suppl_1.S118; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; Kouris-Blazos A, 1999, BRIT J NUTR, V82, P57, DOI 10.1017/S0007114599001129; Kumagai S, 1999, J Nutr Health Aging, V3, P29; Lasheras C, 2000, AM J CLIN NUTR, V71, P987; Michels KB, 2002, INT J EPIDEMIOL, V31, P847, DOI 10.1093/ije/31.4.847; NUBE M, 1987, J AM DIET ASSOC, V87, P171; Osler M, 1997, INT J EPIDEMIOL, V26, P155, DOI 10.1093/ije/26.1.155; Osler M, 2002, EUR J CLIN NUTR, V56, P568, DOI 10.1038/sj.ejcn.1601360; Osler M, 2001, BRIT J NUTR, V85, P219, DOI 10.1079/BJN2000240; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; SAS, 1999, SAS STAT US GUID VER; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; Terry P, 2001, AM J EPIDEMIOL, V154, P1143, DOI 10.1093/aje/154.12.1143; TOMASSON H, 1995, STAT MED, V14, P1331, DOI 10.1002/sim.4780141206; Trichopoulos D, 2001, BRIT J NUTR, V85, P133, DOI 10.1079/BJN2000282; Trichopoulou A, 2001, AM J CLIN NUTR, V74, P574; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2000, EPIDEMIOLOGY, V11, P333, DOI 10.1097/00001648-200005000-00018; TRICHOPOULOU A, 1992, COMPOSITION GREEK FO; TRICHOPOULOU A, IN PRESS COMPOSITION; *WHO, 1997 1999 WORLD HLTH; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT W, 1998, NUTR EPIDEMIOLOGY, P414; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; *WORLD CANC RES FU, 1997, FLOOD NUTR PREV CANC, P92; World Health Organisation, 1977, INT CLASS DIS MAN IN	43	2791	2849	5	265	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2003	348	26					2599	2608		10.1056/NEJMoa025039	http://dx.doi.org/10.1056/NEJMoa025039			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693PN	12826634	Bronze			2022-12-01	WOS:000183726400003
J	Milani, A				Milani, A			Astronomy - Extraterrestrial material - Virtual or real hazards?	SCIENCE			English	Editorial Material							ASTEROIDS; EARTH; IMPACTS		Univ Pisa, Dipartimento Matemat, I-56127 Pisa, Italy	University of Pisa	Milani, A (corresponding author), Univ Pisa, Dipartimento Matemat, Via Buonarroti 2, I-56127 Pisa, Italy.							Beust H, 1996, ASTRON ASTROPHYS, V310, P181; CARUSI A, 1994, HAZARDS DUE COMETS A, P127; CHAPMAN CR, 1994, NATURE, V367, P33, DOI 10.1038/367033a0; Chesley SR, 2002, ICARUS, V159, P423, DOI 10.1006/icar.2002.6910; FARINELLA P, 1994, NATURE, V371, P314, DOI 10.1038/371314a0; HARRIS AW, 2002, DIV PLAN SCI AM ASTR, V34; Milani A, 1999, ICARUS, V137, P269, DOI 10.1006/icar.1999.6045; Milani A, 1999, ASTRON ASTROPHYS, V346, pL65; MILANI A, 2003, ASTEROIDS, V3, P55; Morbidelli A, 2002, ICARUS, V158, P329, DOI 10.1006/icar.2002.6887; MORRISON D, 1994, HAZARDS DUE COMETS A, P59	11	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1882	1883		10.1126/science.1077708	http://dx.doi.org/10.1126/science.1077708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817129				2022-12-01	WOS:000183619400023
J	Chung, HJ; Steinberg, JP; Huganir, RL; Linden, DJ				Chung, HJ; Steinberg, JP; Huganir, RL; Linden, DJ			Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression	SCIENCE			English	Article							KINASE-C INHIBITOR; PURKINJE-CELLS; GLUTAMATE SENSITIVITY; PROTEIN; PKC; EXPRESSION; BINDING; LTD; NSF; ACTIVATION	Cerebellar long-term depression (LTD) is a model of synaptic memory that requires protein kinase C (PKC) activation and is expressed as a reduction in the number of postsynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate ( AMPA) receptors. LTD was absent in cultured cerebellar Purkinje cells from mutant mice lacking the AMPA receptor GluR2 subunit and could be rescued by transient transfection with the wild-type GluR2 subunit. Transfection with a point mutant that eliminated PKC phosphorylation of Ser(880) in the carboxyterminal PDZ ligand of GluR2 failed to restore LTD. In contrast, transfection with a point mutant that mimicked phosphorylation at Ser(880) occluded subsequent LTD. Thus, PKC phosphorylation of GluR2 Ser(880) is a critical event in the induction of cerebellar LTD.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	Steinberg, Jordan P./AAP-5568-2020	Steinberg, Jordan P./0000-0001-7930-3394; Chung, Hee Jung/0000-0002-5555-9907	NIMH NIH HHS [MH01590, MH51106] Funding Source: Medline; NINDS NIH HHS [NS36715, R01 NS036715] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051106, R01MH051106, R37MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bear MF, 2001, SYNAPSES, P455; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chung HJ, 2000, J NEUROSCI, V20, P7258; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Freeman JH, 1998, NEUROREPORT, V9, P2237, DOI 10.1097/00001756-199807130-00016; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	33	252	271	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1751	1755		10.1126/science.1082915	http://dx.doi.org/10.1126/science.1082915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805550				2022-12-01	WOS:000183459700053
J	Adams, RB; Gordon, HL; Baird, AA; Ambady, N; Kleck, RE				Adams, RB; Gordon, HL; Baird, AA; Ambady, N; Kleck, RE			Effects of gaze on amygdala sensitivity to anger and fear faces	SCIENCE			English	Article									Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Dartmouth College; Harvard University	Adams, RB (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, 6207 Moore Hall, Hanover, NH 03755 USA.		Tudusciuc, Oana/C-1339-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH067294] Funding Source: NIH RePORTER; NIMH NIH HHS [1F32MH067294-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS RB, IN PRESS PSYCHOL SCI; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Wicker B, 2003, NEUROPSYCHOLOGIA, V41, P139, DOI 10.1016/S0028-3932(02)00144-6; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15	5	324	328	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1536	1536		10.1126/science.1082244	http://dx.doi.org/10.1126/science.1082244			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791983				2022-12-01	WOS:000183333100043
J	Xiang, Y; Kobilka, BK				Xiang, Y; Kobilka, BK			Myocyte adrenoceptor signaling pathways	SCIENCE			English	Editorial Material							CARDIAC MYOCYTES; RECEPTOR INTERNALIZATION; ADENYLYL-CYCLASE; MICE; HYPERTROPHY; APOPTOSIS; PROTEINS; HEART; ASSOCIATION; CAVEOLAE	Adrenoceptors (ARs), members of the G protein-coupled receptor superfamily, form the interface between the sympathetic nervous system and the cardiovascular system, with integral roles in the rapid regulation of myocardial function. However, in heart failure, chronic catecholamine stimulation of adrenoceptors has been linked to pathologic cardiac remodeling, including myocyte apoptosis and hypertrophy. In cardiac myocytes, activation of AR subtypes results in coupling to different G proteins and induction of specific signaling pathways, which is partly regulated by the subtype-specific distribution of receptors in plasma membrane compartments containing distinct complexes of signaling molecules. The Connections Maps of the Adrenergic and Myocyte Adrenergic Signaling Pathways bring into focus the specific signaling pathways of individual AR subtypes and their relevant functions in vivo.	Stanford Med Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Kobilka, BK (corresponding author), Stanford Med Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.			Kobilka, Brian/0000-0001-5958-3990				Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chalothorn D, 2003, J PHARMACOL EXP THER, V305, P1045, DOI 10.1124/jpet.102.048553; Chen CH, 1999, P NATL ACAD SCI USA, V96, P12784, DOI 10.1073/pnas.96.22.12784; Clerk A, 2000, CIRC RES, V86, P1019, DOI 10.1161/01.RES.86.10.1019; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Devic E, 2001, MOL PHARMACOL, V60, P577; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Hein L, 1997, TRENDS CARDIOVAS MED, V7, P137, DOI 10.1016/S1050-1738(97)00034-0; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Kohout TA, 2001, CIRCULATION, V104, P2485, DOI 10.1161/hc4501.098933; Marks AR, 2002, CIRCULATION, V105, P272, DOI 10.1161/circ.105.3.272; OCONNELL TD, 2000, AM HEART ASS NEW ORL; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Steinberg SF, 2002, J MOL CELL CARDIOL, V34, P1141, DOI 10.1006/jmcc.2002.2057; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Sugden PH, 2001, ANN MED, V33, P611; Tanoue A, 2003, TRENDS ENDOCRIN MET, V14, P107, DOI 10.1016/S1043-2760(03)00026-2; Vecchione C, 2002, CIRCULATION, V105, P1700, DOI 10.1161/01.CIR.0000012750.08480.55; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; XIANG Y, 2003, SCI STKE; Xiao RP, 2000, CIRC RES, V87, P635, DOI 10.1161/01.RES.87.8.635; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	36	169	174	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1530	1532		10.1126/science.1079206	http://dx.doi.org/10.1126/science.1079206			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791980				2022-12-01	WOS:000183333100040
J	Zou, L; Elledge, SJ				Zou, L; Elledge, SJ			Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes	SCIENCE			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; CHECKPOINT PROTEINS; GENOTOXIC STRESS; BINDING-PROTEIN; BUDDING YEAST; HUMAN RAD17; IN-VIVO; PHOSPHORYLATION	The function of the ATR (ataxia-telangiectasia mutated- and Rad3-related) ATRIP (ATR-interacting protein) protein kinase complex is crucial for the cellular response to replication stress and DNA damage. Here, we show that replication protein A (RPA), a protein complex that associates with single-stranded DNA (ssDNA), is required for the recruitment of ATR to sites of DNA damage and for ATR-mediated Chk1 activation in human cells. In vitro, RPA stimulates the binding of ATRIP to ssDNA. The binding of ATRIP to RPA-coated ssDNA enables the ATR-ATRIP complex to associate with DNA and stimulates phosphorylation of the Rad17 protein that is bound to DNA. Furthermore, Ddc2, the budding yeast homolog of ATRIP, is specifically recruited to double-strand DNA breaks in an RPA-dependent manner. A checkpoint-deficient mutant of RPA, rfa1-t11, is defective for recruiting Ddc2 to ssDNA both in vivo and in vitro. Our data suggest that RPA-coated ssDNA is the critical structure at sites of DNA damage that recruits the ATR-ATRIP complex and facilitates its recognition of substrates for phosphorylation and the initiation of checkpoint signaling.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.				NIGMS NIH HHS [GM44664] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM044664] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Brush GS, 2000, NUCLEIC ACIDS RES, V28, P3725, DOI 10.1093/nar/28.19.3725; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Liu QH, 2000, GENE DEV, V14, P1448; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Melo JA, 2001, GENE DEV, V15, P2809; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Paciotti V, 2000, GENE DEV, V14, P2046; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Post S, 2001, P NATL ACAD SCI USA, V98, P13102, DOI 10.1073/pnas.231364598; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Umezu K, 1998, GENETICS, V148, P989; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; ZOU L, 1906, UNPUB	38	1980	2033	5	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1542	1548		10.1126/science.1083430	http://dx.doi.org/10.1126/science.1083430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791985				2022-12-01	WOS:000183333100046
J	Clark, JS; McLachlan, JS				Clark, JS; McLachlan, JS			Stability of forest biodiversity	NATURE			English	Article							EASTERN NORTH-AMERICA; SOUTHERN ONTARIO; COMPETITION; HISTORY; POLLEN; DIVERSITY; DISTURBANCE; DYNAMICS	Two hypotheses to explain potentially high forest biodiversity have different implications for the number and kinds of species that can coexist and the potential loss of biodiversity in the absence of speciation. The first hypothesis involves stabilizing mechanisms, which include tradeoffs between species in terms of their capacities to disperse to sites where competition is weak(1-4), to exploit abundant resources effectively(5,6) and to compete for scarce resources(7). Stabilization results because competitors thrive at different times and places. An alternative, 'neutral model' suggests that stabilizing mechanisms may be superfluous. This explanation emphasizes 'equalizing' mechanisms(8), because competitive exclusion of similar species is slow. Lack of ecologically relevant differences means that abundances experience random 'neutral drift', with slow extinction(9-11). The relative importance of these two mechanisms is unknown, because assumptions and predictions involve broad temporal and spatial scales. Here we demonstrate that predictions of neutral drift are testable using palaeodata. The results demonstrate strong stabilizing forces. By contrast with the neutral prediction of increasing variance among sites over time, we show that variances in post-Glacial tree abundances among sites stabilize rapidly, and abundances remain coherent over broad geographical scales.	Duke Univ, Ctr Global Change, Durham, NC 27708 USA; Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University; Duke University	Clark, JS (corresponding author), Duke Univ, Ctr Global Change, Durham, NC 27708 USA.	jimclark@duke.edu	Bond, Alexander L/A-3786-2010					ALLISON TD, 1986, ECOLOGY, V67, P1101, DOI 10.2307/1939835; BENNETT KD, 1987, CAN J BOT, V65, P1792, DOI 10.1139/b87-248; Bennett KD, 2002, HOLOCENE, V12, P421, DOI 10.1191/0959683602hl556rp; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; BURDEN ET, 1986, CAN J EARTH SCI, V23, P43, DOI 10.1139/e86-005; Bush MB, 2000, HOLOCENE, V10, P543, DOI 10.1191/095968300672647521; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK JS, IN PRESS ECOLOGY; CLARK JS, IN PRESS ECOLOGICAL; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Fuller JL, 1997, CAN J BOT, V75, P1714, DOI 10.1139/b97-886; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; Hixon MA, 2002, ECOLOGY, V83, P1490, DOI 10.2307/3071969; HORN HS, 1972, ECOLOGY, V53, P749, DOI 10.2307/1934797; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; Huntley B., 1983, ATLAS PAST PRESENT P; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Jackson ST, 1997, QUATERNARY SCI REV, V16, P1, DOI 10.1016/S0277-3791(96)00047-9; JACOBSON GL, 1981, QUATERNARY RES, V16, P80, DOI 10.1016/0033-5894(81)90129-0; McAndrews JH, 1993, CANADIAN GLOBAL CHAN, P22; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; PRENTICE IC, 1985, QUATERNARY RES, V23, P76, DOI 10.1016/0033-5894(85)90073-0; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; SZEICZ JM, 1991, CAN J BOT, V69, P1507, DOI 10.1139/b91-195; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1998, PLANT STRATEGIES DYN	29	140	152	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					635	638		10.1038/nature01632	http://dx.doi.org/10.1038/nature01632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789337	Bronze			2022-12-01	WOS:000183301200039
J	Phiel, CJ; Wilson, CA; Lee, VMY; Klein, PS				Phiel, CJ; Wilson, CA; Lee, VMY; Klein, PS			GSK-3 alpha regulates production of Alzheimer's disease amyloid-beta peptides	NATURE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PRECURSOR PROTEIN; INTRACELLULAR DOMAIN; SECRETASE CLEAVAGE; HUMAN NEURONS; PRESENILIN; CELLS; LITHIUM; NOTCH; PHOSPHORYLATION	Alzheimer's disease is associated with increased production and aggregation of amyloid-beta (Abeta) peptides(1). Abeta peptides are derived from the amyloid precursor protein (APP) by sequential proteolysis, catalysed by the aspartyl protease BACE(2), followed by presenilin-dependent gamma-secretase cleavage(3). Presenilin interacts with nicastrin(4,5), APH-1 and PEN-2 (ref. 6), all of which are required for gamma-secretase function. Presenilins also interact with alpha-catenin, beta-catenin(7,8) and glycogen synthase kinase-3beta (GSK-3beta)(9-11), but a functional role for these proteins in gamma-secretase activity has not been established. Here we show that therapeutic concentrations of lithium, a GSK-3 inhibitor(12), block the production of Abeta peptides by interfering with APP cleavage at the gamma-secretase step, but do not inhibit Notch processing. Importantly, lithium also blocks the accumulation of Abeta peptides in the brains of mice that overproduce APP. The target of lithium in this setting is GSK-3alpha, which is required for maximal processing of APP. Since GSK-3 also phosphorylates tau protein, the principal component of neurofibrillary tangles, inhibition of GSK-3alpha offers a new approach to reduce the formation of both amyloid plaques and neurofibrillary tangles, two pathological hallmarks of Alzheimer's disease.	Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Klein, PS (corresponding author), Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, 415 Curie Blvd, Philadelphia, PA 19104 USA.							Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Forman MS, 1997, J BIOL CHEM, V272, P32247, DOI 10.1074/jbc.272.51.32247; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kang DE, 1999, J NEUROSCI, V19, P4229; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kirschenbaum F, 2001, J BIOL CHEM, V276, P7366, DOI 10.1074/jbc.M004697200; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Siman R, 2000, J NEUROSCI, V20, P8717; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Sun X, 2002, NEUROSCI LETT, V321, P61, DOI 10.1016/S0304-3940(01)02583-6; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	30	988	1057	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					435	439		10.1038/nature01640	http://dx.doi.org/10.1038/nature01640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761548				2022-12-01	WOS:000183012000041
J	Read, J; Winceslaus, SJ				Read, J; Winceslaus, SJ			New strategies for increasing the detection of HIV: analysis of routine data	BRITISH MEDICAL JOURNAL			English	Article									Preston Hall Hosp, Maidstone ME17 7NJ, Kent, England; Guys King Coll, London SE5 9RJ, England; St Thomass Sch Med, London SE5 9RJ, England	University of London; King's College London; University of London; King's College London	Winceslaus, SJ (corresponding author), Preston Hall Hosp, Maidstone ME17 7NJ, Kent, England.			Winceslaus, SJ/0000-0002-9757-1007				Department of Health, 2001, NAT STRAT SEX HLTH H; *PUBL HLTH LAB SER, 2000, TRENDS SEX TRANSM IN; *PUBL HLTH LAB SER, 2001, PHLS EP HIV AIDS	3	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2003	326	7398					1066	1067		10.1136/bmj.326.7398.1066	http://dx.doi.org/10.1136/bmj.326.7398.1066			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681ZD	12750208	Green Published, Bronze			2022-12-01	WOS:000183064700016
J	Chen, HK; Fernandez-Funez, P; Acevedo, SF; Lam, YC; Kaytor, MD; Fernandez, MH; Aitken, A; Skoulakis, EMC; Orr, HT; Botas, J; Zoghbi, HY				Chen, HK; Fernandez-Funez, P; Acevedo, SF; Lam, YC; Kaytor, MD; Fernandez, MH; Aitken, A; Skoulakis, EMC; Orr, HT; Botas, J; Zoghbi, HY			Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1	CELL			English	Article							SELECTIVE NEURODEGENERATION; SIGNALING PATHWAY; ALPHA-SYNUCLEIN; PROTEIN; GROWTH; DROSOPHILA; DISEASE; 14-3-3-PROTEINS; SCA1; CELL	Spinocerebellar ataxia type 1 (SCA1) is one of several neurological disorders caused by a CAG repeat expansion. In SCA1, this expansion produces an abnormally long polyglutamine tract in the protein ataxin-1. Mutant polyglutamine proteins accumulate in neurons, inducing neurodegeneration, but the mechanism underlying this accumulation has been unclear. We have discovered that the 14-3-3 protein, a multifunctional regulatory molecule, mediates the neurotoxicity of ataxin-1 by binding to and stabilizing ataxin-1, thereby slowing its normal degradation. The association of ataxin-1 with 14-3-3 is regulated by Akt phosphorylation, and in a Drosophila model of SCA1, both 14-3-3 and Akt modulate neurodegeneration. Our finding that phosphatidylinositol 3-kinase/Akt signaling and 14-3-3 cooperate to modulate the neurotoxicity of ataxin-1 provides insight into SCA1 pathogenesis and identifies potential targets for therapeutic intervention.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Texas A&M Univ, Genet Program, College Stn, TX 77843 USA; CSRC A Fleming, Inst Mol Biol & Genet, Vari 16672, Greece; Univ Edinburgh, Div Biomed & Clin Lab Sci, Edinburgh EH8 9XD, Midlothian, Scotland	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Edinburgh	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.			Orr, Harry/0000-0001-6118-741X; Chen, Hung-Kai/0000-0002-2169-4924; Zoghbi, Huda/0000-0002-0700-3349; Acevedo, Summer/0000-0002-3206-6819	NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS22920, NS42179, NS27699] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027699, R56NS042179, R01NS022920, R01NS027699, R37NS022920, R01NS042179] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dawson TM, 2002, NEURON, V35, P219, DOI 10.1016/S0896-6273(02)00780-8; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wei WL, 2002, J BIOL CHEM, V277, P17649, DOI 10.1074/jbc.M111704200; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	33	322	339	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					457	468		10.1016/S0092-8674(03)00349-0	http://dx.doi.org/10.1016/S0092-8674(03)00349-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757707	Bronze			2022-12-01	WOS:000182981500008
J	Snyder, EL; Rinder, HM				Snyder, EL; Rinder, HM			Platelet storage - Time to come in from the cold?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Lab Med, Blood Bank Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Lab Med, Hematol Sect, New Haven, CT 06510 USA	Yale University; Yale University	Snyder, EL (corresponding author), Yale Univ, Sch Med, Dept Lab Med, Blood Bank Sect, New Haven, CT 06510 USA.							BECKER GA, 1973, TRANSFUSION, V13, P61, DOI 10.1111/j.1537-2995.1973.tb05442.x; Gousset K, 2002, J CELL PHYSIOL, V190, P117, DOI 10.1002/jcp.10039; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Kermode JC, 1999, BLOOD, V94, P199, DOI 10.1182/blood.V94.1.199.413k14_199_207; Tablin F, 2000, J LAB CLIN MED, V135, P339, DOI 10.1067/mlc.2000.105619	5	19	19	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					2032	2033		10.1056/NEJMcibr035099	http://dx.doi.org/10.1056/NEJMcibr035099			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12748320				2022-12-01	WOS:000182823400014
J	Zschocke, J; Schaefer, JR				Zschocke, J; Schaefer, JR			Homozygous familial hypercholesterolaemia in identical twins	LANCET			English	Editorial Material									Univ Heidelberg, Dept Paediat, D-69120 Heidelberg, Germany; Univ Heidelberg, Inst Human Genet, D-69120 Heidelberg, Germany; Univ Marburg, Dept Internal Med, D-35033 Marburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Philipps University Marburg	Zschocke, J (corresponding author), Univ Heidelberg, Dept Paediat, D-69120 Heidelberg, Germany.		Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274					0	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1641	1641		10.1016/S0140-6736(03)13303-X	http://dx.doi.org/10.1016/S0140-6736(03)13303-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747894				2022-12-01	WOS:000182746300024
J	Yu, EW; McDermott, G; Zgurskaya, HI; Nikaido, H; Koshland, DE				Yu, EW; McDermott, G; Zgurskaya, HI; Nikaido, H; Koshland, DE			Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump	SCIENCE			English	Article							LARGE PERIPLASMIC LOOPS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; RESISTANCE; TRANSPORTER; RECOGNITION; MECHANISMS	Multidrug efflux pumps cause serious problems in cancer chemotherapy and treatment of bacterial infections. Yet high-resolution structures of ligand-transporter complexes have previously been unavailable. We obtained x-ray crystallographic structures of the trimeric AcrB pump from Escherichia coli with four structurally diverse ligands. The structures show that three molecules of ligands bind simultaneously to the extremely large central cavity of 5000 cubic angstroms, primarily by hydrophobic, aromatic stacking and van der Waals interactions. Each ligand uses a slightly different subset of AcrB residues for binding. The bound ligand molecules often interact with each other, stabilizing the binding.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Koshland, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009644, R01AI009644] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 09644] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERT A, 1956, J CHEM SOC, P1294, DOI 10.1039/jr9560001294; Avila-Sakar AJ, 2001, J STRUCT BIOL, V136, P81, DOI 10.1006/jsbi.2001.4418; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Elkins CA, 2002, J BACTERIOL, V184, P6490, DOI 10.1128/JB.184.23.6490-6499.2002; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; NIKAIDO H, 1993, ANTIMICROB AGENTS CH, V37, P1393, DOI 10.1128/AAC.37.7.1393; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Tikhonova EB, 2002, J BACTERIOL, V184, P6499, DOI 10.1128/JB.184.23.6499-6507.2002; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298; Zgurskaya HI, 2000, J BACTERIOL, V182, P4264, DOI 10.1128/JB.182.15.4264-4267.2000; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	21	322	339	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					976	980		10.1126/science.1083137	http://dx.doi.org/10.1126/science.1083137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738864				2022-12-01	WOS:000182719800056
J	Huang, C; Rajfur, Z; Borchers, C; Schaller, MD; Jacobson, K				Huang, C; Rajfur, Z; Borchers, C; Schaller, MD; Jacobson, K			JNK phosphorylates paxillin and regulates cell migration	NATURE			English	Article							JUN NH2-TERMINAL KINASE; FOCAL ADHESION KINASE; N-TERMINAL KINASE; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; ACTIVATION; FIBRONECTIN; SERINE; MORPHOGENESIS	The c-Jun amino-terminal kinase (JNK) is generally thought to be involved in inflammation, proliferation and apoptosis(1,2). Accordingly, its substrates are transcription factors and antiapoptotic proteins(2). However, JNK has also been shown to be required for Drosophila dorsal closure(3,4), and MAP kinase/ERK kinase kinase 1, an upstream kinase in the JNK pathway, has been shown to be essential for cell migration(5,6). Both results imply that JNK is important in cell migration. Here we show that JNK1 is required for the rapid movement of both fish keratocytes and rat bladder tumour epithelial cells (NBT-II). Moreover, JNK1 phosphorylates serine 178 on paxillin, a focal adhesion adaptor, both in vitro and in intact cells. NBT-II cells expressing the Ser 178 --> Ala mutant of paxillin (Pax(S178A)) formed focal adhesions and exhibited the limited movement associated with such contacts in both single-cell-migration and wound-healing assays. In contrast, cells expressing wild-type paxillin moved rapidly and retained close contacts as the predominant adhesion. Expression of Pax(S178A) also inhibited the migration of two other cell lines. Thus, phosphorylation of paxillin by JNK seems essential for maintaining the labile adhesions required for rapid cell migration.	Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Comprehens Ctr Inflammatory Disorders, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jacobson, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	frap@med.unc.edu	Rajfur, Zenon/H-2506-2013; BORCHERS, Christoph/U-5964-2019	Rajfur, Zenon/0000-0003-1265-6480				Abassi YA, 2002, EMBO J, V21, P4571, DOI 10.1093/emboj/cdf446; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Brown MC, 1998, MOL BIOL CELL, V9, P1803, DOI 10.1091/mbc.9.7.1803; Christerson LB, 1999, CELL MOTIL CYTOSKEL, V43, P186, DOI 10.1002/(SICI)1097-0169(1999)43:3<186::AID-CM2>3.0.CO;2-1; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hauck CR, 2001, CANCER RES, V61, P7079; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; ILLC D, 1995, NATURE, V377, P539; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lee J, 1997, J CELL SCI, V110, P2833; Liu JL, 1999, ONCOGENE, V18, P6700, DOI 10.1038/sj.onc.1203050; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Uyen HD, 2002, J CELL SCI, V115, P3073; Vadlamudi R, 1999, ONCOGENE, V18, P7253, DOI 10.1038/sj.onc.1203163; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697	30	398	416	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					219	223		10.1038/nature01745	http://dx.doi.org/10.1038/nature01745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853963				2022-12-01	WOS:000184032700048
J	Traversa, G; Bianchi, C; Da Cas, R; Abraha, I; Menniti-Ippolito, F; Venegoni, M				Traversa, G; Bianchi, C; Da Cas, R; Abraha, I; Menniti-Ippolito, F; Venegoni, M			Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To estimate the risk of acute hepatotoxicity associated with nimesulide compared with other non-steroidal anti-inflammatory drugs. Design Retrospective cohort and nested case-control study. Setting Umbria region, Italy. Participants 400 000 current, recent, and past users (almost 2 million prescriptions) of non-steroidal anti-inflammatory drugs between I January 1997 and 31 December 2001. Main outcome measures Admissions to hospital for acute non-viral hepatitis and incidence of all hepatopathies and liver injury among users of nimesulide and other non-steroidal anti-inflammatory drugs. Results Cur-rent use of non-steroidal anti-inflammatory drugs was associated with a 1.4 (95% confidence interval 1.0 to 2.1) increased risk of hepatopathy compared with past use. In current users of nimesulide the rate ratio for all heparopathies and more severe liver injury was 1.3 (0.7 to 2.3) and 1.9 (1.1 to 3.8), respectively. Conclusion The risk of liver injury in patients taking nimesulide and other non-steroidal anti-inflammatory drugs is small.	Natl Inst Hlth, Dept Epidemiol, I-00161 Rome, Italy; Reg Hlth Author Umbria Reg, I-06124 Perugia, Italy; Fatebenefratelli Hosp, Dept Internal Med, I-20121 Milan, Italy	Istituto Superiore di Sanita (ISS)	Traversa, G (corresponding author), Natl Inst Hlth, Dept Epidemiol, Regina Elena 299, I-00161 Rome, Italy.	giuseppe.traversa@iss.it	Abraha, Iosief/K-4327-2018; Venegoni, Mauro/H-3416-2019	Abraha, Iosief/0000-0002-5440-775X; Venegoni, Mauro/0000-0002-5462-5327				BENICHOU C, 1990, J HEPATOL, V11, P272; Conforti A, 2001, DRUG SAFETY, V24, P1081, DOI 10.2165/00002018-200124140-00006; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; DANAN G, 1994, ADVERSE DRUG REACTIO; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; Macia MA, 2002, CLIN PHARMACOL THER, V72, P596, DOI 10.1067/mcp.2002.128869; Menniti-Ippolito F, 1998, EUR J CLIN PHARMACOL, V54, P393, DOI 10.1007/s002280050481; RODRIGUEZ LAG, 1992, BRIT MED J, V305, P865, DOI 10.1136/bmj.305.6858.865; Rodriguez LAG, 1998, ARCH INTERN MED, V158, P33, DOI 10.1001/archinte.158.1.33; RODRIQUEZ LAG, 1994, ARCH INTERN MED, V154, P311, DOI 10.1001/archinte.1994.00420030117012; TRAVERSA G, 1995, EPIDEMIOLOGY, V6, P49, DOI 10.1097/00001648-199501000-00010; Walker AM, 1997, ARTHRITIS RHEUM, V40, P201, DOI 10.1002/art.1780400204	13	130	163	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2003	327	7405					18	22		10.1136/bmj.327.7405.18	http://dx.doi.org/10.1136/bmj.327.7405.18			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699NK	12842950	Bronze, Green Published			2022-12-01	WOS:000184062700017
J	Ruthazer, ES; Akerman, CJ; Cline, HT				Ruthazer, ES; Akerman, CJ; Cline, HT			Control of axon branch dynamics by correlated activity in vivo	SCIENCE			English	Article							RECEPTOR ANTAGONISTS DISRUPT; NMDA RECEPTOR; VISUAL-CORTEX; SYNAPSE ELIMINATION; RETINOTECTAL AXONS; RANA-PIPIENS; TIME-LAPSE; PROJECTION; MAP; ZEBRAFISH	To determine how patterned visual activity regulates the development of axonal projections, we collected in vivo time-lapse images of retinal axons from albino Xenopus tadpoles in which binocular innervation of the optic tectum was induced. Axons added branch tips with nearly equal probability in all territories, but eliminated them preferentially from territory dominated by the opposite eye. This selective branch elimination was abolished by blockade of N-methyl-D-aspartate receptors. These results describe a correlation-based mechanism by which visual experience directly governs axon branch dynamics that contribute to the development of topographic maps.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Ruthazer, Edward S/P-5935-2014; Ruthazer, Edward/H-4782-2019	Ruthazer, Edward S/0000-0003-0452-3151; Ruthazer, Edward/0000-0003-0452-3151	NATIONAL EYE INSTITUTE [F32EY006963] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY006963-03] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Antonini A, 1996, J COMP NEUROL, V369, P64; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BOSS VC, 1984, J NEUROSCI, V4, P2891; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; CONSTANTINEPATON M, 1978, SCIENCE, V202, P639, DOI 10.1126/science.309179; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dawson AJ, 2001, J COMP NEUROL, V434, P40, DOI 10.1002/cne.1163; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GAZE RM, 1979, J EMBRYOL EXP MORPH, V53, P103; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; KATZ LC, 1996, SCIENCE, V274, P1132; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; MEYER RL, 1982, SCIENCE, V218, P589, DOI 10.1126/science.7123262; OLSON MD, 1991, J COMP NEUROL, V303, P412, DOI 10.1002/cne.903030307; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; REH TA, 1984, J NEUROSCI, V4, P442; REH TA, 1985, J NEUROSCI, V5, P1132; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STRAZNICKY C, 1979, J EMBRYOL EXP MORPH, V50, P111; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	33	188	191	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					66	70		10.1126/science.1082545	http://dx.doi.org/10.1126/science.1082545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843386				2022-12-01	WOS:000183914700032
J	Whitehouse, PJ				Whitehouse, PJ			Lessons and responses in Alzheimer disease research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNIZATION; TRIAL		Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University	Whitehouse, PJ (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.							Bishop GM, 2002, NATURE, V416, P677, DOI 10.1038/416677d; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Ernst RL, 1997, ALZ DIS ASSOC DIS, V11, P135; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Kodish E, 1996, ACAD MED, V71, P1287, DOI 10.1097/00001888-199612000-00009; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SUMMERS WK, 1986, NEW ENGL J MED, V315, P1241, DOI 10.1056/NEJM198611133152001; Whitehouse P. J., 1999, J AM GERIATR SOC, V47, P1; Whitehouse Peter J, 2000, CONCEPTS ALZHEIMER D; PARKINSON STUDY GROU	12	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					115	115		10.1001/jama.290.1.115	http://dx.doi.org/10.1001/jama.290.1.115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837723	Bronze			2022-12-01	WOS:000183868600031
J	Graf, P				Graf, P			Hive beetle causes a buzz in Europe	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					793	793		10.1038/423793b	http://dx.doi.org/10.1038/423793b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815395	Bronze			2022-12-01	WOS:000183585300012
J	Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW				Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW			Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus	LANCET			English	Article							NITRIC-OXIDE	The outbreak of SARS warrants the search for antiviral compounds to treat the disease. At present, no specific treatment has been identified for SARS-associated coronavirus Infection. We assessed the antiviral potential of ribavirin, 6-azauridine, pyrazofurin, mycophenolic acid, and glycyrrhizin against two clinical Isolates of coronavirus (FFM-1 and FFM-2) from patients with SARS admitted to the clinical centre of Frankfurt University, Germany. Of all the compounds, glycyrrhizin was the most active in inhibiting replication of the SARS-associated virus. Our findings suggest that glycyrrhizin should be assessed for treatment of SARS.	Goethe Univ Frankfurt, Sch Med, Inst Med Virol, D-60596 Frankfurt, Germany	Goethe University Frankfurt	Cinatl, J (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Med Virol, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	cinatl@em.uni-frankfurt.de						Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Jeong HG, 2002, FEBS LETT, V513, P208, DOI 10.1016/S0014-5793(02)02311-6; Lin YL, 1997, J VIROL, V71, P5227, DOI 10.1128/JVI.71.7.5227-5235.1997	5	757	870	4	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2003	361	9374					2045	2046		10.1016/S0140-6736(03)13615-X	http://dx.doi.org/10.1016/S0140-6736(03)13615-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814717	Green Published, Bronze			2022-12-01	WOS:000183488900013
J	Szostak, JW				Szostak, JW			Molecular messages	NATURE			English	Editorial Material									Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.							Adami C, 2000, PHYSICA D, V137, P62, DOI 10.1016/S0167-2789(99)00179-7; HAMMING RW, 1987, CODING INFORMATION T; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; ZUREK WH, 1991, STUDIES SCI COMPLEXI, V8	4	57	61	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					689	689		10.1038/423689a	http://dx.doi.org/10.1038/423689a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802312	Bronze			2022-12-01	WOS:000183443400022
J	Reddel, RR; Bryan, TM				Reddel, RR; Bryan, TM			Alternative lengthening of telomeres: dangerous road less travelled	LANCET			English	Editorial Material							MECHANISM; CELLS		Childrens Med Res Inst, Canc Res Unit, Sydney, NSW 2145, Australia; Childrens Med Res Inst, Cell Biol Unit, Sydney, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney; Children's Medical Research Institute - Australia; University of Sydney	Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, Sydney, NSW 2145, Australia.		Reddel, Roger R/A-6635-2014; Bryan, Tracy M/B-8468-2014	Reddel, Roger R/0000-0002-6302-6107; Bryan, Tracy/0000-0002-7990-5501				Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Greenwood E, 2003, NAT REV CANCER, V3, P84, DOI 10.1038/nrc1008; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Ulaner GA, 2003, CANCER RES, V63, P1759	10	32	34	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1840	1841		10.1016/S0140-6736(03)13538-6	http://dx.doi.org/10.1016/S0140-6736(03)13538-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788566				2022-12-01	WOS:000183205800004
J	Stanley, B; Fraser, J				Stanley, B; Fraser, J			Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSMISSION		Cumberland Infirm, N Cumbria Acute Hosp Trust, Dept Genitourinary Med, Carlisle CA2 7HY, England; N Cumbria Acute Hosp Trust, Dept Dermatol, Carlisle, England		Stanley, B (corresponding author), Cumberland Infirm, N Cumbria Acute Hosp Trust, Dept Genitourinary Med, Carlisle CA2 7HY, England.	Belinda.Stanley@ncumbria-acute.nhs.uk						Bird SM, 2001, BMJ-BRIT MED J, V323, P1174, DOI 10.1136/bmj.323.7322.1174; Carne C, 2000, SEX TRANSM INFECT, V76, P307, DOI 10.1136/sti.76.4.307; Catchpole MA, 1996, BRIT MED J, V312, P539, DOI 10.1136/bmj.312.7030.539; Department of Health, 2001, NAT STRAT SEX HLTH H; *UNL AN SURV STEER, 2001, PREV HIV HEP INF UK	5	37	38	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2003	326	7400					1174	1174		10.1136/bmj.326.7400.1174	http://dx.doi.org/10.1136/bmj.326.7400.1174			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	686FC	12775616	Green Published, Bronze			2022-12-01	WOS:000183309900018
J	Eastham, JA; Riedel, E; Scardino, PT; Shike, M; Fleisher, M; Schatzkin, A; Lanza, E; Latkany, L; Begg, CB				Eastham, JA; Riedel, E; Scardino, PT; Shike, M; Fleisher, M; Schatzkin, A; Lanza, E; Latkany, L; Begg, CB		Poly Prevention Trial Study Grp	Variation of serum prostate-specific antigen levels - An evaluation of year-to-year fluctuations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIGITAL RECTAL EXAMINATION; HIGH-FIBER DIET; RADICAL PROSTATECTOMY; BIOLOGICAL VARIATION; CANCER MORTALITY; LOW-FAT; MEN; TRIAL; AGE; BIOPSY	Context Serum prostate-specific antigen (PSA) testing is frequently used in early detection programs for prostate cancer. While PSA testing has resulted in an increase in prostate cancer detection, its routine use has been questioned because of a lack of specificity. Objective To determine whether year-to-year fluctuations in PSA levels are due to natural variation and render a single PSA test result unreliable. Design, Setting, and Participants Retrospective analysis of an unscreened population of 972 men (median age, 62 years) participating in the Polyp Prevention Trial (1991-1998). Five consecutive blood samples were obtained during a 4-year period and were assessed for total and free PSA levels. Main Outcome Measure Abnormal PSA test result based on a PSA level higher than 4 ng/mL; a PSA level higher than 2.5 ng/mL; a PSA level above the age-specific cutoff; a PSA level in the range of 4 to 10 ng/mL and a free-to-total ratio of less than 0.25 ng/mL; or a PSA velocity higher than 0.75 ng/mL per year. Results Prostate biopsy would have been recommended in 207 participants (21%) with a PSA level higher than 4 ng/mL; in 358 (37%) with a level higher than 2.5 ng/mL; in 172 (18%) with a level above the age-specific cutoff; in 190 (20%) with a level between 4 and 10 ng/mL and a free-to-total ratio of less than 0.25 ng/mL; and in 145 (15%) with a velocity higher than 0.75 ng/mL per year. Among men with an abnormal PSA finding, a high proportion had a normal PSA finding at 1 or more subsequent visits during 4-year follow-up: 68 (44%) of 154 participants with a PSA level higher than 4 ng/mL; 116 (40%) of 291 had a level higher than 2.5 ng/mL; 64 (55%) of 117 had an elevated level above the age-specific cutoff; and 76 (53%) of 143 had a level between 4 and 10 ng/mL and a free-to-total ratio of less than 0.25 ng/mL. Conclusion An isolated elevation in PSA level should be confirmed several weeks later before proceeding with further testing, including prostate biopsy.	Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Eastham, JA (corresponding author), 353 E 68th St,Suite 527, New York, NY 10021 USA.	easthamj@mskcc.org		Russo, Lianne/0000-0002-6966-250X	DIVISION OF CLINICAL SCIENCES - NCI [N01SC005318] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CN000151] Funding Source: NIH RePORTER; NCI NIH HHS [N01-SC-05318] Funding Source: Medline	DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartsch G, 2001, UROLOGY, V58, P417, DOI 10.1016/S0090-4295(01)01264-X; CARTER HB, 1992, CANCER RES, V52, P3323; Carter HB, 1999, UROLOGY, V53, P126, DOI 10.1016/S0090-4295(98)00466-X; Catalona WJ, 2000, UROLOGY, V55, P791, DOI 10.1016/S0090-4295(99)00602-0; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Chapple A, 2002, BRIT MED J, V325, P737, DOI 10.1136/bmj.325.7367.737; COPLEN DE, 1991, J UROLOGY, V146, P75, DOI 10.1016/S0022-5347(17)37717-0; Crawford ED, 1999, PROSTATE, V38, P296; EPSTEIN JI, 1994, J UROLOGY, V152, P1721, DOI 10.1016/S0022-5347(17)32370-4; Epstein JI, 2001, J UROLOGY, V166, P1688, DOI 10.1016/S0022-5347(05)65654-6; FEIGHTNER JW, 1994, CANADIAN GUIDE CLIN, P812; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Hakama M, 2001, J UROLOGY, V166, P2189, DOI 10.1016/S0022-5347(05)65532-2; HAMMER P, 1996, J UROLOGY, V151, P99; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; JACOBSEN SJ, 1995, UROLOGY, V45, P447, DOI 10.1016/S0090-4295(99)80014-4; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Lanza E, 1996, CANCER EPIDEM BIOMAR, V5, P385; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; Nixon RG, 1997, J UROLOGY, V157, P2183, DOI 10.1016/S0022-5347(01)64711-6; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; OHORI M, 1994, J UROLOGY, V152, P1714, DOI 10.1016/S0022-5347(17)32369-8; Ornstein DK, 1997, J UROLOGY, V157, P2179, DOI 10.1016/S0022-5347(01)64708-6; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Schatzkin A, 1996, CANCER EPIDEM BIOMAR, V5, P375; Shike M, 2002, J CLIN ONCOL, V20, P3592, DOI 10.1200/JCO.2002.02.040; STAMEY TA, 1989, J UROLOGY, V141, P1070; Steele CB, 2000, AM J PUBLIC HEALTH, V90, P1595, DOI 10.2105/AJPH.90.10.1595; STENMAN UH, 1991, CANCER RES, V51, P222; Tchetgen MBN, 1997, UROL CLIN N AM, V24, P283, DOI 10.1016/S0094-0143(05)70374-8; *US PREV SERV TASK, REC RAT SCREEN PROST; *US PREV SERV TASK, REC PROST CANC SCREE	34	168	175	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2003	289	20					2695	2700		10.1001/jama.289.20.2695	http://dx.doi.org/10.1001/jama.289.20.2695			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682DG	12771116	Bronze			2022-12-01	WOS:000183075600028
J	Hwang, HY; Olson, SK; Esko, JD; Horvitz, HR				Hwang, HY; Olson, SK; Esko, JD; Horvitz, HR			Caenorhabditis elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis	NATURE			English	Article							UDP-GLUCURONIC ACID; HEPARAN-SULFATE; EPITHELIAL INVAGINATION; MOLECULAR-CLONING; GENE; PROTEOGLYCAN; EXPRESSION; SQV-7; GLYCOSAMINOGLYCANS; GALACTOSE	Defects in glycosaminoglycan biosynthesis disrupt animal development and can cause human disease(1-4). So far much of the focus on glycosaminoglycans has been on heparan sulphate. Mutations in eight squashed vulva (sqv) genes in Caenorhabditis elegans cause defects in cytokinesis during embryogenesis and in vulval morphogenesis during postembryonic development(5,6). Seven of the eight sqv genes have been shown to control the biosynthesis of the glycosaminoglycans chondroitin and heparan sulphate(6-11). Here we present the molecular identification and characterization of the eighth gene, sqv-5. This gene encodes a bifunctional glycosyltransferase that is probably localized to the Golgi apparatus and is responsible for the biosynthesis of chondroitin but not heparan sulphate. Our findings show that chondroitin is crucial for both cytokinesis and morphogenesis during C. elegans development.	MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Horvitz, HR (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Room 68-425,77 Massachusetts Ave, Cambridge, MA 02139 USA.			Hwang, Ho-Yon/0000-0003-0204-8932				Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Austin C. R., 1965, FERTILIZATION; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; COMPER WD, 1978, PHYSIOL REV, V58, P255, DOI 10.1152/physrev.1978.58.1.255; ELLIS RE, 1995, GENETICS, V139, P561; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; ESKO JD, 1993, CURRENT PROTOCOLS MO; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; LANE MC, 1993, DEVELOPMENT, V117, P1049; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Wei G, 2000, J BIOL CHEM, V275, P27733; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6	30	154	158	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					439	443		10.1038/nature01634	http://dx.doi.org/10.1038/nature01634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761549				2022-12-01	WOS:000183012000042
J	Pergams, ORW; Barnes, WM; Nyberg, D				Pergams, ORW; Barnes, WM; Nyberg, D			Rapid change in mouse mitochondrial DNA	NATURE			English	Article							PCR; AMPLIFICATION; FIDELITY		Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Pergams, ORW (corresponding author), Nature Conservancy, Chicago Zool Soc, Dept Conservat Biol, Brookfield, IL 60513 USA.							BARNES WM, 1994, TRENDS BIOCHEM SCI, V19, P342, DOI 10.1016/0968-0004(94)90075-2; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BARNES WM, 1992, GENE, V112, P29, DOI 10.1016/0378-1119(92)90299-5; BARNES WM, 1995, Patent No. 5436149; Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; GOODYEAR PD, 1994, BIOTECHNIQUES, V16, P232; Pergams ORW, 2001, J MAMMAL, V82, P984, DOI 10.1644/1545-1542(2001)082<0984:MCOMCT>2.0.CO;2; PERGAMS ORW, UNPUB P R SOC LOND B; Steinberg EK, 1999, MOL ECOL, V8, P1075; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018	10	33	35	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					397	397		10.1038/423397a	http://dx.doi.org/10.1038/423397a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761536	Bronze			2022-12-01	WOS:000183012000027
J	Huang, E; Cheng, SH; Dressman, H; Pittman, J; Tsou, MH; Horng, CF; Bild, A; Iversen, ES; Liao, M; Chen, CM; West, M; Nevins, JR; Huang, AT				Huang, E; Cheng, SH; Dressman, H; Pittman, J; Tsou, MH; Horng, CF; Bild, A; Iversen, ES; Liao, M; Chen, CM; West, M; Nevins, JR; Huang, AT			Gene expression predictors of breast cancer outcomes	LANCET			English	Article							LYMPH-NODE METASTASIS; PROGNOSTIC FACTORS; CLASSIFICATION; DISCOVERY	Background Correlation of risk factors with genomic data promises to provide specific treatment for individual patients, and needs interpretation of complex, multivariate patterns in gene expression data, as well as assessment of their ability to improve clinical predictions. We aimed to predict nodal metastatic states and relapse for breast cancer patients.. Methods We analysed DNA microarray data from samples of primary breast tumours, using non-linear statistical analyses to assess multiple patterns of interactions of groups of genes that have predictive value for the individual patient, with respect to lymph node metastasis and cancer recurrence. Findings We identified aggregate patterns of gene expression (metagenes) that associate with lymph node status and recurrence, and that are capable of predicting outcomes in individual patients with about 90% accuracy. The metagenes defined distinct groups of genes, suggesting different biological processes underlying these two characteristics of breast cancer. Initial external validation came from similarly accurate predictions of nodal status of a small sample in a distinct population. Interpretation Multiple aggregate measures of profiles of gene expression define valuable predictive associations with lymph node metastasis and disease recurrence for individual patients. Gene expression data have the potential to aid accurate, individualised, prognosis. Importantly, these data are assessed in terms of precise numerical predictions, with ranges of probabilities of outcome. Precise and statistically valid assessments of risks specific for patients, will ultimately be of most value to clinicians faced with treatment decisions.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; Duke Univ, Dept Med, Durham, NC 27708 USA; Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA; Duke Univ, Inst Stat & Decis Sci, Durham, NC 27708 USA; Koo Fdn Sun Yat Sen Canc Ctr, Taipei, Taiwan; Howard Hughes Med Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.		Huang, Erich/B-1894-2008	Huang, Erich/0000-0001-5547-9408; Clarke, Jennifer/0000-0002-2723-7249				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Cheng SH, 2000, BREAST CANCER RES TR, V63, P213, DOI 10.1023/A:1006468514396; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; MCGUIRE WL, 1987, BREAST CANCER RES TR, V10, P5, DOI 10.1007/BF01806129; MITTRA I, 1991, EUR J CANCER, V27, P1574, DOI 10.1016/0277-5379(91)90418-D; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Spang Rainer, 2002, In Silico Biology, V2, P369; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; 2001, LANCET, V352, P930	17	493	533	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1590	1596		10.1016/S0140-6736(03)13308-9	http://dx.doi.org/10.1016/S0140-6736(03)13308-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747878				2022-12-01	WOS:000182746300008
J	Vasconcelos, PFC				Vasconcelos, PFC			Diagnosis of viral disease	LANCET			English	Editorial Material									Minist Hlth, FUNASA, Inst Evandro Chagas, Dept Arbovirus, BR-66090000 Belem, Para, Brazil	Instituto Evandro Chagas	Vasconcelos, PFC (corresponding author), Minist Hlth, FUNASA, Inst Evandro Chagas, Dept Arbovirus, BR-66090000 Belem, Para, Brazil.		Vasconcelos, Pedro/AAH-3142-2019						0	0	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1589	1589		10.1016/S0140-6736(03)13307-7	http://dx.doi.org/10.1016/S0140-6736(03)13307-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747877				2022-12-01	WOS:000182746300007
J	Ashworth, AC; Thompson, FC				Ashworth, AC; Thompson, FC			A fly in the biogeographic ointment	NATURE			English	Article							TRANSANTARCTIC MOUNTAINS; SIRIUS GROUP; ANTARCTICA		N Dakota State Univ, Dept Geosci, Fargo, ND 58105 USA; Smithsonian Inst, USDA, Systemat Entomol Lab, Washington, DC 20560 USA	North Dakota State University Fargo; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA)	Ashworth, AC (corresponding author), N Dakota State Univ, Dept Geosci, Fargo, ND 58105 USA.							Ashworth AC, 2003, PALAEOGEOGR PALAEOCL, V191, P191, DOI 10.1016/S0031-0182(02)00712-5; Ashworth AC, 2003, J MOLLUS STUD, V69, P89, DOI 10.1093/mollus/69.1.89; Askin RA., 2000, TERRA ANTARTICA, V7, P493; CONEY P, 1996, EUR J ENTOMOL, V93, P1; de Souza DA, 2002, ANN SOC ENTOMOL FR, V38, P177; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Hill RS, 1996, REV PALAEOBOT PALYNO, V94, P11, DOI 10.1016/S0034-6667(96)00003-6; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; Webb PN, 1996, MAR MICROPALEONTOL, V27, P273, DOI 10.1016/0377-8398(95)00066-6; WYGODZINSKY P, 1966, PAC INSECTS MONOGR, V9, P1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	11	22	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					135	136		10.1038/423135a	http://dx.doi.org/10.1038/423135a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736672				2022-12-01	WOS:000182699600033
J	Looger, LL; Dwyer, MA; Smith, JJ; Hellinga, HW				Looger, LL; Dwyer, MA; Smith, JJ; Hellinga, HW			Computational design of receptor and sensor proteins with novel functions	NATURE			English	Article							BINDING; CHALLENGES; DOMAIN	The formation of complexes between proteins and ligands is fundamental to biological processes at the molecular level. Manipulation of molecular recognition between ligands and proteins is therefore important for basic biological studies(1) and has many biotechnological applications, including the construction of enzymes(2-4), biosensors(5,6), genetic circuits(7), signal transduction pathways(8) and chiral separations(9). The systematic manipulation of binding sites remains a major challenge. Computational design offers enormous generality for engineering protein structure and function(10). Here we present a structure-based computational method that can drastically redesign protein ligand-binding specificities. This method was used to construct soluble receptors that bind trinitrotoluene, L-lactate or serotonin with high selectivity and affinity. These engineered receptors can function as biosensors for their new ligands; we also incorporated them into synthetic bacterial signal transduction pathways, regulating gene expression in response to extracellular trinitrotoluene or L-lactate. The use of various ligands and proteins shows that a high degree of control over biomolecular recognition has been established computationally. The biological and biosensing activities of the designed receptors illustrate potential applications of computational design.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Hellinga, HW (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	hwh@biochem.duke.edu						Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Benson DE, 2002, BIOCHEMISTRY-US, V41, P3262, DOI 10.1021/bi011359i; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Burlage R. S., 1999, U.S. Patent, Patent No. [5,972,638., 5972638, US5972638A]; BURTIS CA, 1999, TIME TXB CLIN CHEM; Cumming CJ, 2001, IEEE T GEOSCI REMOTE, V39, P1119, DOI 10.1109/36.927423; Dahiyat BI, 1996, PROTEIN SCI, V5, P895, DOI 10.1002/pro.5560050511; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Daunert S, 2000, CHEM REV, V100, P2705, DOI 10.1021/cr990115p; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Fersht A, 1999, STRUCTURE MECH PROTE; Harris JL, 1998, CURR OPIN CHEM BIOL, V2, P127, DOI 10.1016/S1367-5931(98)80044-6; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hellinga HW, 1998, TRENDS BIOTECHNOL, V16, P183, DOI 10.1016/S0167-7799(98)01174-3; Koh JT, 2002, CHEM BIOL, V9, P17, DOI 10.1016/S1074-5521(02)00087-X; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Looger LL, 2001, J MOL BIOL, V307, P429, DOI 10.1006/jmbi.2000.4424; Maier NM, 2001, J CHROMATOGR A, V906, P3, DOI 10.1016/S0021-9673(00)00532-X; Mead KS, 2002, TRENDS BIOTECHNOL, V20, P276, DOI 10.1016/S0167-7799(02)01979-0; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; VYAS MN, 1994, BIOCHEMISTRY-US, V33, P4762, DOI 10.1021/bi00182a003; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004; Yinon J, 2002, TRAC-TREND ANAL CHEM, V21, P292, DOI 10.1016/S0165-9936(02)00408-9	30	506	546	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					185	190		10.1038/nature01556	http://dx.doi.org/10.1038/nature01556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736688				2022-12-01	WOS:000182699600050
J	Trotter, CL; McVernon, J; Andrews, NJ; Burrage, M; Ramsay, ME				Trotter, CL; McVernon, J; Andrews, NJ; Burrage, M; Ramsay, ME			Antibody to Haemophilus influenzae type b after routine and catch-up vaccination	LANCET			English	Article								Since 1999, the number of cases of Haemophilus Influenzae type b (Hib) disease in the UK has risen. We investigated the role of population immunity in this change by testing more than 2600 serum samples from children aged 1-15 years. After the introduction of the routine Hib conjugate vaccination programme for infants, median antibody titres rose significantly in 1-year-olds. Individuals who received their first dose of vaccine at age 1-4 years in the original catch-up campaign initially had much higher concentrations of antibody than those who had been immunised in infancy. A second catch-up campaign in children aged 6 months to 4 years should be highly effective in boosting immunity and reducing disease in the short term.	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England; Hlth Protect Agcy, Ctr Appl Microbiol & Res, Immunoassay Lab, Salisbury, Wilts, England	Health Protection Agency; Health Protection Agency	Trotter, CL (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Div, 61 Colindale Ave, London NW9 5EQ, England.	caroline.trotter@hpa.org.uk	Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	McVernon, Jodie/0000-0001-9774-1961; Ramsay, Mary Elizabeth/0000-0002-7156-7640; Trotter, Caroline/0000-0003-4000-2708				Heath PT, 2000, JAMA-J AM MED ASSOC, V284, P2334, DOI 10.1001/jama.284.18.2334; KAYHTY H, 1983, J INFECT DIS, V147, P1100; PHIPPS DC, 1990, J IMMUNOL METHODS, V135, P121, DOI 10.1016/0022-1759(90)90264-V; Trotter C L, 2003, Commun Dis Public Health, V6, P55; van Alphen L, 1997, J PEDIATR-US, V131, P869, DOI 10.1016/S0022-3476(97)70035-0	5	54	55	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2003	361	9368					1523	1524		10.1016/S0140-6736(03)13172-8	http://dx.doi.org/10.1016/S0140-6736(03)13172-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737867				2022-12-01	WOS:000182658900015
J	Radermacher, J; Mengel, M; Ellis, S; Stuht, S; Hiss, M; Schwarz, A; Eisenberger, U; Burg, M; Luft, FC; Gwinner, W; Haller, H				Radermacher, J; Mengel, M; Ellis, S; Stuht, S; Hiss, M; Schwarz, A; Eisenberger, U; Burg, M; Luft, FC; Gwinner, W; Haller, H			The renal arterial resistance index and renal allograft survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLOR DOPPLER SONOGRAPHY; RESISTIVE INDEX; KIDNEY-TRANSPLANTATION; HYPERTENSIVE PATIENTS; VASCULAR-RESISTANCE; CYCLOSPORINE-A; GRAFT FUNCTION; FOLLOW-UP; FAILURE; ULTRASONOGRAPHY	BACKGROUND: Most renal transplants fail because of chronic allograft nephropathy or because the recipient dies, but no reliable factor predicting long-term outcome has been identified. We tested whether a renal arterial resistance index of less than 80 was predictive of long-term allograft survival. METHODS: The renal segmental arterial resistance index (the percentage reduction of the end-diastolic flow as compared with the systolic flow) was measured by Doppler ultrasonography in 601 patients at least three months after transplantation between August 1997 and November 1998. All patients were followed for three or more years. The combined end point was a decrease of 50 percent or more in the creatinine clearance rate, allograft failure (indicated by the need for dialysis), or death. RESULTS: A total of 122 patients (20 percent) had a resistance index of 80 or higher. Eighty-four of these patients (69 percent) had a decrease of 50 percent or more in creatinine clearance, as compared with 56 of the 479 patients with a resistance index of less than 80 (12 percent); 57 patients with a higher resistance index (47 percent) required dialysis, as compared with 43 patients with a lower resistance index (9 percent); and 36 patients with a higher resistance index (30 percent) died, as compared with 33 patients with a lower resistance index (7 percent) (P<0.001 for all comparisons). A total of 107 patients with a higher resistance index (88 percent) reached the combined end point, as compared with 83 of those with a lower resistance index (17 percent, P<0.001). The multivariate relative risk of graft loss among patients with a higher resistance index was 9.1 (95 percent confidence interval, 6.6 to 12.7). Proteinuria (protein excretion, 1 g per day or more), symptomatic cytomegalovirus infection, and a creatinine clearance rate of less than 30 ml per minute per 1.73 m(2) of body-surface area after transplantation also increased the risk. CONCLUSIONS: A renal arterial resistance index of 80 or higher measured at least three months after transplantation is associated with poor subsequent allograft performance and death.	Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany; Hannover Med Sch, Dept Pathol, Hannover, Germany; Humboldt Univ, HELIOS Klinikum Berlin, Franz Volhard Clin, Berlin, Germany	Hannover Medical School; Hannover Medical School; Franz-Volhard Clinical Research Center; Helios Kliniken; Humboldt University of Berlin	Radermacher, J (corresponding author), Hannover Med Sch, Dept Nephrol, POB 610180, D-30625 Hannover, Germany.			Luft, Friedrich/0000-0002-8635-1199; Eisenberger, Ute/0000-0003-3862-6933				Alterini B, 1996, Ann Ital Med Int, V11, P107; BITTARD H, 1991, J UROLOGY, V146, P1; Boddi M, 1996, AM J HYPERTENS, V9, P461, DOI 10.1016/0895-7061(96)00027-1; BREITENSEHER M, 1994, ULTRASCHALL MED, V15, P24, DOI 10.1055/s-2007-1004000; DON S, 1989, RADIOLOGY, V171, P709, DOI 10.1148/radiology.171.3.2655003; Drudi F M, 2001, Radiol Med, V101, P243; GAULT MH, 1992, NEPHRON, V62, P249, DOI 10.1159/000187054; Gerhardt U, 1999, INT J CARDIOL, V68, P203, DOI 10.1016/S0167-5273(98)00368-4; Giral-Classe M, 1998, KIDNEY INT, V54, P972, DOI 10.1046/j.1523-1755.1998.00071.x; HENNIGE M, 1986, TRANSPLANTATION, V42, P491, DOI 10.1097/00007890-198611000-00009; Howard RJ, 2002, TRANSPLANTATION, V73, P1923, DOI 10.1097/00007890-200206270-00013; Kosch M, 2002, J HYPERTENS, V20, P501, DOI 10.1097/00004872-200203000-00026; Kreis HA, 2001, TRANSPLANTATION, V71, pSS5; Krumme B, 1997, J AM SOC NEPHROL, V8, P813; Leoncini G, 2002, NEPHRON, V90, P169, DOI 10.1159/000049038; Mange KC, 2000, JAMA-J AM MED ASSOC, V283, P633, DOI 10.1001/jama.283.5.633; Martinoli C, 1998, EUR RADIOL, V8, P765, DOI 10.1007/s003300050469; OPELZ G, 1978, TRANSPLANTATION, V25, P212, DOI 10.1097/00007890-197804000-00011; Petersen LJ, 1997, NEPHROL DIAL TRANSPL, V12, P1376, DOI 10.1093/ndt/12.7.1376; Ponticelli C, 2002, KIDNEY INT, V62, P1848, DOI 10.1046/j.1523-1755.2002.00612.x; Pontremoli R, 1999, NEPHROL DIAL TRANSPL, V14, P360, DOI 10.1093/ndt/14.2.360; POZNIAK MA, 1988, INVEST RADIOL, V23, P899, DOI 10.1097/00004424-198812000-00004; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Radermacher J, 2001, NEW ENGL J MED, V344, P410, DOI 10.1056/NEJM200102083440603; Radermacher J, 1998, TRANSPLANT INT, V11, P3, DOI 10.1111/j.1432-2277.1998.tb00948.x; Radermacher J, 2000, CLIN NEPHROL, V53, P333; Radermacher J, 2002, HYPERTENSION, V39, P699, DOI 10.1161/hy0202.103782; RADERMACHER J, 2002, IMAGING DECIS, V6, P15; Restrepo-Schafer IK, 1999, ULTRASCHALL MED, V20, P87, DOI 10.1055/s-1999-14242; SCHWERK WB, 1993, ULTRASCHALL MED, V14, P117, DOI 10.1055/s-2007-1005230; Scorza R, 1997, J RHEUMATOL, V24, P1944; Shimizu Y, 2001, HYPERTENS RES, V24, P13, DOI 10.1291/hypres.24.13; SKOTNICKI SH, 1989, TRANSPLANT INT, V2, P16; Takano R, 2001, J CLIN ULTRASOUND, V29, P384; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; Trillaud H, 1998, AM J ROENTGENOL, V171, P1611, DOI 10.2214/ajr.171.6.9843297	36	287	302	1	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2003	349	2					115	124		10.1056/NEJMoa022602	http://dx.doi.org/10.1056/NEJMoa022602			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698XH	12853584	Green Accepted			2022-12-01	WOS:000184024400004
J	Maiuri, L; Ciacci, C; Ricciardelli, I; Vacca, L; Raia, V; Auricchio, S; Picard, J; Osman, M; Quaratino, S; Londei, M				Maiuri, L; Ciacci, C; Ricciardelli, I; Vacca, L; Raia, V; Auricchio, S; Picard, J; Osman, M; Quaratino, S; Londei, M			Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease	LANCET			English	Article							BLOOD MONOCYTES; DENDRITIC CELLS; ORGAN-CULTURE; MESSENGER-RNA; GLUTEN; CHALLENGE; MACROPHAGES; EXPRESSION; PEPTIDES; TOXICITY	Background The adaptive immune system is central to the development of coeliac disease. Adaptive immune responses are, however, controlled by a preceding activation of the innate immune system. We investigated whether gliadin, a protein present in wheat flour, could activate an innate as well as an adaptive immune response in patients with coeliac disease. Methods Duodenal biopsy samples from 42 patients with untreated coeliac disease, 37 treated patients, and 18 controls, were cultured in vitro for 3 h or 24 h, in the presence of either immunodominant gliadin epitopes (palpha-2 and palpha-9) or a non-immunodominant peptide.(p31-43) known to induce small intestine damage in coeliac disease. We also incubated biopsy samples from nine untreated and six treated patients with a non-immunodominant peptide for 3 h, before incubation with immunodominant gliadin epitopes. Different combinations of interleukin-15 or signal transduction inhibitors were added to selected incubations. Findings Only the non-immunodominant peptide induced rapid expression of interleukin-15, CD83, cyclo-oxygenase (COX)-2, and CD25 by CD3- cells (p=0.005 vs medium alone) and enterocyte apoptosis (p<0.0001). Only the non-immunodominant peptide induced p38 MAP kinase activation in CD3- cells. Pre-incubation with the non-immunodominant peptide enabled immunodominant epitopes to induce T-cell activation (p=0.001) and enterocyte apoptosis. Inhibition of interleukin-15 or of p38 MAP kinase controlled such activity. Interpretation A gliadin fragment can activate the innate immune system, affecting the in situ T-cell recognition of dominant gliadin epitopes. Although our findings emphasise the key role of gliadin-specific T cells, they suggest a complex pathogenic situation; and show that inhibition of interleukin-15 or p38 MAP kinase might have the potential to control coeliac disease.	UCL, Inst Child Hlth, London WC1N 1EH, England; Univ Naples Federico 2, Dept Paediat, Naples, Italy; Univ Naples Federico 2, Dept Gastroenterol, Naples, Italy; European Lab Invest Food Induced Dis, Naples, Italy; Hammersmith Hosp, MRC, Ctr Clin Sci, London, England; Univ Southampton, Southampton Gen Hosp, Canc Res UK Canc Sci Div, Southampton, Hants, England	University of London; University College London; University of Naples Federico II; University of Naples Federico II; Imperial College London; University of Southampton	Londei, M (corresponding author), UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	m.londei@ich.ucl.ac.uk	carolina, ciacci/A-2594-2012; Raia, Valeria/AAC-3029-2022	carolina, ciacci/0000-0002-7426-1145; 				Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Cammarota G, 2000, LANCET, V356, P1494, DOI 10.1016/S0140-6736(00)02880-4; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; HALSTENSEN TS, 1993, SCAND J IMMUNOL, V38, P581, DOI 10.1111/j.1365-3083.1993.tb03245.x; HEMPEL SL, 1994, J CLIN INVEST, V93, P391, DOI 10.1172/JCI116971; Hmama Z, 1998, J IMMUNOL, V161, P4882; Lohmann T, 2000, LANCET, V356, P31, DOI 10.1016/S0140-6736(00)02431-4; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 1998, GASTROENTEROLOGY, V115, P564, DOI 10.1016/S0016-5085(98)70135-0; Maiuri L, 1996, GASTROENTEROLOGY, V110, P1368, DOI 10.1053/gast.1996.v110.pm8613040; Maiuri L, 2001, GUT, V48, P418, DOI 10.1136/gut.48.3.418; MARSH MN, 1995, GASTROENTEROLOGY, V108, pA871; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McAdam SN, 2000, GUT, V47, P743, DOI 10.1136/gut.47.6.743; MEAGHER L, 1994, J IMMUNOL METHODS, V175, P237, DOI 10.1016/0022-1759(94)90366-2; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Quaratino S, 2000, P NATL ACAD SCI USA, V97, P10911, DOI 10.1073/pnas.190204697; Schuppan D, 2000, GASTROENTEROLOGY, V119, P234, DOI 10.1053/gast.2000.8521; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; SHIDRAWI RG, 1995, SCAND J GASTROENTERO, V30, P758, DOI 10.3109/00365529509096324; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; Subbarayan V, 2001, CANCER RES, V61, P2720; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	30	465	483	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 5	2003	362	9377					30	37		10.1016/S0140-6736(03)13803-2	http://dx.doi.org/10.1016/S0140-6736(03)13803-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699KW	12853196				2022-12-01	WOS:000184056900010
J	Peng, WT; Robinson, MD; Mnaimneh, S; Krogan, NJ; Cagney, G; Morris, Q; Davierwala, AP; Grigull, J; Yang, XQ; Zhang, W; Mitsakakis, N; Ryan, OW; Datta, N; Jojic, V; Pal, C; Canadien, V; Richards, D; Beattie, B; Wu, LF; Altschuler, SJ; Roweis, S; Frey, BJ; Emili, A; Greenblatt, JF; Hughes, TR				Peng, WT; Robinson, MD; Mnaimneh, S; Krogan, NJ; Cagney, G; Morris, Q; Davierwala, AP; Grigull, J; Yang, XQ; Zhang, W; Mitsakakis, N; Ryan, OW; Datta, N; Jojic, V; Pal, C; Canadien, V; Richards, D; Beattie, B; Wu, LF; Altschuler, SJ; Roweis, S; Frey, BJ; Emili, A; Greenblatt, JF; Hughes, TR			Panoramic view of yeast noncoding RNA processing	CELL			English	Article							PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PROTEIN; BIOGENESIS; MATURATION; SNORNA; IDENTIFICATION; MULTIPLE; HOMOLOG	Predictive analysis using publicly available yeast functional genomics and proteomics data suggests that many more proteins may be involved in biogenesis of ribonucleoproteins than are currently known. Using a microarray that monitors abundance and processing of noncoding RNAs, we analyzed 468 yeast strains carrying mutations in protein-coding genes, most of which have not previously been associated with RNA or RNP synthesis. Many strains mutated in uncharacterized genes displayed aberrant noncoding RNA profiles. Ten factors involved in noncoding RNA biogenesis were verified by further experimentation, including a protein required for 20S pre-rRNA processing (Tsr2p), a protein associated with the nuclear exosome (Lrp1p), and a factor required for box C/D snoRNA accumulation (Bcd1p). These data present a global View of yeast noncoding RNA processing and confirm that many currently uncharacterized yeast proteins are involved in biogenesis of noncoding RNA.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Elect & Comp Engn, Probabilist & Stat Inference Grp, Toronto, ON M5S 3G4, Canada; Univ Toronto, Dept Comp Sci, Probabilist & Stat Inference Grp, Toronto, ON M5S 3G4, Canada; Affinium Pharmaceut, Toronto, ON M5J 1V6, Canada; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	University of Toronto; University of Toronto; University of Toronto; Harvard University	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	t.hughes@utoronto.ca	Morris, Quaid/ABE-8343-2020; Robinson, Mark D/A-6432-2015; Cagney, Gerard/A-4648-2009; Robinson, Mark D./O-2254-2019	Robinson, Mark D/0000-0002-3048-5518; Robinson, Mark D./0000-0002-3048-5518; Morris, Quaid/0000-0002-2760-6999; Cagney, Gerard/0000-0001-7189-9496				AbouElela S, 1996, CELL, V85, P115, DOI 10.1016/S0092-8674(00)81087-9; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BISHOP C, 1995, NEURAL NETOWRKS PATT; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erdemir T, 2002, MOL MICROBIOL, V46, P947, DOI 10.1046/j.1365-2958.2002.03224.x; Fatica A, 2002, RNA, V8, P1502, DOI 10.1017/S1355838202022094; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Galardi S, 2002, MOL CELL BIOL, V22, P6663, DOI 10.1128/MCB.22.19.6663-6668.2002; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Gromadka R, 2000, ACTA BIOCHIM POL, V47, P993, DOI 10.18388/abp.2000_3953; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOPPER AK, 1990, J CELL BIOL, V111, P309, DOI 10.1083/jcb.111.2.309; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Juhnke H, 2000, MOL MICROBIOL, V35, P936, DOI 10.1046/j.1365-2958.2000.01768.x; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kufel J, 1999, RNA, V5, P909, DOI 10.1017/S135583829999026X; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LEE WC, 1992, MOL CELL BIOL, V12, P3865, DOI 10.1128/MCB.12.9.3865; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Milkereit P, 2003, NUCLEIC ACIDS RES, V31, P799, DOI 10.1093/nar/gkg165; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; Nguyen Allen, 2002, BMC Biotechnol, V2, P14, DOI 10.1186/1472-6750-2-14; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pestov DG, 2001, NUCLEIC ACIDS RES, V29, P3621, DOI 10.1093/nar/29.17.3621; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Sasaki T, 2000, MOL CELL BIOL, V20, P7971, DOI 10.1128/MCB.20.21.7971-7979.2000; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Stork D.G., 2001, PATTERN CLASSIFICATI, V2nd; Tone Y, 2002, GENE DEV, V16, P3142, DOI 10.1101/gad.1025602; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Verheggen C, 2001, EMBO J, V20, P5480, DOI 10.1093/emboj/20.19.5480; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xing F, 2002, RNA, V8, P370, DOI 10.1017/S1355838202029825; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	69	203	217	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2003	113	7					919	933		10.1016/S0092-8674(03)00466-5	http://dx.doi.org/10.1016/S0092-8674(03)00466-5			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837249	Bronze, Green Submitted			2022-12-01	WOS:000183817900015
J	Choi, KH; Liu, H; Guo, YQ; Han, L; Mandel, JS; Rutherford, GW				Choi, KH; Liu, H; Guo, YQ; Han, L; Mandel, JS; Rutherford, GW			Emerging HIV-1 epidemic in China in men who have sex with men	LANCET			English	Article								China is currently undergoing a serious HIV-1 epidemic in intravenous drug users, sex workers, and former plasma donors. Little is known, however, about HIV-1 risk in Chinese men who have sex with men. In this study of seroprevalence in such men in Beijing, we recorded 15 (3.1%, 95% Cl 1.8-5.1) of 481 men infected with HIV-1. Overall, 238 (49%) of participants reported unprotected anal intercourse during the previous 6 months. HIV-1 seropositivtty was independently associated with being older than 39 years and having had more than 20 male sexual partners. Most men older than 39 years had been married. Our findings suggest the potential for spread of HIV-1 between men who have sex with men and to their heterosexual partners.	Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94105 USA; Beijing Municipal STD Clin, Beijing, Peoples R China; Beijing Tongzhi Hotline Programme, Beijing, Peoples R China	University of California System; University of California San Francisco	Choi, KH (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, 74 New Montgomery,Suite 600, San Francisco, CA 94105 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER; NIMH NIH HHS [MH42459] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Beach M, 2001, LANCET, V358, P1792, DOI 10.1016/S0140-6736(01)06856-8; KUMTA S, 2002, 14 INT C AIDS BARC S; United Nations Theme Group on HIV/AIDS in China, 2002, HIV AIDS CHIN TIT PE; Zhang BC, 2000, AM J PUBLIC HEALTH, V90, P1949, DOI 10.2105/AJPH.90.12.1949; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803	5	117	138	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 21	2003	361	9375					2125	2126		10.1016/S0140-6736(03)13690-2	http://dx.doi.org/10.1016/S0140-6736(03)13690-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	692GY	12826438				2022-12-01	WOS:000183654200014
J	Dillingham, MS; Spies, M; Kowalczykowski, SC				Dillingham, MS; Spies, M; Kowalczykowski, SC			RecBCD enzyme is a bipolar DNA helicase	NATURE			English	Article							SINGLE-STRANDED-DNA; RECOMBINATION HOTSPOT-CHI; ESCHERICHIA-COLI; NUCLEASE ACTIVITY; ATP HYDROLYSIS; PCRA HELICASE; STEP-SIZE; PROTEIN; TRANSLOCATION; SEQUENCE	Escherichia coli RecBCD is a heterotrimeric helicase/nuclease that catalyses a complex reaction in which double-strand breaks in DNA are processed for repair by homologous recombination(1). For some time it has been clear that the RecB subunit possesses a 3'-->5' DNA helicase activity(2-4), which was thought to drive DNA translocation and unwinding in the RecBCD holoenzyme. Here we show that purified RecD protein is also a DNA helicase, but one that possesses a 5'-->3' polarity. We also show that the RecB and RecD helicases are both active in intact RecBCD, because the enzyme remains capable of processive DNA unwinding when either of these subunits is inactivated by mutation. These findings point to a bipolar translocation model for RecBCD in which the two DNA helicases are complementary, travelling with opposite polarities, but in the same direction, on each strand of the antiparallel DNA duplex. This bipolar motor organization helps to explain various biochemical properties of RecBCD, notably its exceptionally high speed and processivity, and offers a mechanistic insight into aspects of RecBCD function.	Univ Calif Davis, Ctr Genet & Dev, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Microbiol Sect, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Spies, Maria/0000-0002-7375-8037; Dillingham, Mark/0000-0002-4612-7141				Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Arnold DA, 1998, J BIOL CHEM, V273, P16476, DOI 10.1074/jbc.273.26.16476; ARNOLD DA, 1999, ENCY LIFE SCI; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; BOEHMER PE, 1991, GENE, V102, P1, DOI 10.1016/0378-1119(91)90529-K; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; JONGENEEL CV, 1984, J BIOL CHEM, V259, P2925; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KORANGY F, 1992, J BIOL CHEM, V267, P1727; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Phillips RJ, 1997, MOL GEN GENET, V254, P319, DOI 10.1007/PL00008605; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; TAYLOR AF, 2003, NATURE; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981; Zhang XJJ, 1999, NUCLEIC ACIDS RES, V27, P4200, DOI 10.1093/nar/27.21.4200	30	161	170	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2003	423	6942					893	897		10.1038/nature01673	http://dx.doi.org/10.1038/nature01673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815438				2022-12-01	WOS:000183585300052
J	Itoh, S; Yurimoto, H				Itoh, S; Yurimoto, H			Contemporaneous formation of chondrules and refractory inclusions in the early Solar System	NATURE			English	Article							ALUMINUM-RICH INCLUSIONS; CRYSTALLIZATION SEQUENCES; OXYGEN ISOTOPES; ALLENDE; NEBULA; CHONDRITES; METEORITES; MELILITE; ORIGIN; RAYS	Chondrules and calcium-aluminium-rich inclusions (CAIs) are preserved materials from the early history of the Solar System, where they resulted from thermal processing of pre-existing solids during various flash heating episodes which lasted for several million years(1). CAIs are believed to have formed about two million years before the chondrules(2-5). Here we report the discovery of a chondrule fragment embedded in a CAI. The chondrule's composition is poor in O-16, while the CAI has a O-16-poor melilite (Ca, Mg, Al-Silicate) core surrounded by a O-16-rich igneous mantle. These observations, when combined with the previously reported CAI-bearing chondrules(6-9),strongly suggest that the formation of chondrules and CAIs overlapped in time and space, and that there were large fluctuations in the oxygen isotopic compositions in the solar nebula probably synchronizing astrophysical pulses.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology	Yurimoto, H (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.		Yurimoto, Hisayoshi/S-9938-2018	Yurimoto, Hisayoshi/0000-0003-0702-0533; Itoh, Shoichi/0000-0001-9431-0525				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; BISCHOFF A, 1984, GEOCHIM COSMOCHIM AC, V48, P693, DOI 10.1016/0016-7037(84)90096-6; CAMERON AGW, 1995, METEORITICS, V30, P133, DOI 10.1111/j.1945-5100.1995.tb01110.x; CHEN JH, 1976, GEOCHIM COSMOCHIM AC, V40, P635, DOI 10.1016/0016-7037(76)90109-5; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.ea.21.050193.000555; Gounelle M, 2001, ASTROPHYS J, V548, P1051, DOI 10.1086/319019; Hewins R., 1996, CHONDRULES PROTOPLAN, P55; ITOH S, 2000, LUNAR PLANET SCI, V31, P1323; ITOH S, IN PRESS GEOCHIM COS; Jones RH, 2000, METEORIT PLANET SCI, V35, P849, DOI 10.1111/j.1945-5100.2000.tb01468.x; Kojima T., 1995, PROC NIPR S ANTARCT, V8, P79; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; Krot AN, 2001, METEORIT PLANET SCI, V36, P1189, DOI 10.1111/j.1945-5100.2001.tb01954.x; Krot AN, 1999, METEORIT PLANET SCI, V34, pA68; LASAGA AC, 1983, KINETICS EQUILIBRIUM, P81; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; Maruyama S, 1999, EARTH PLANET SC LETT, V169, P165, DOI 10.1016/S0012-821X(99)00075-8; Noguchi T., 1989, P NIPR S ANT MET, V2, P169; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; Shu FH, 2001, ASTROPHYS J, V548, P1029, DOI 10.1086/319018; Srinivasan G, 1998, METEORIT PLANET SCI, V33, pA148; STOLPER E, 1986, GEOCHIM COSMOCHIM AC, V50, P1785, DOI 10.1016/0016-7037(86)90139-0; STOLPER E, 1982, GEOCHIM COSMOCHIM AC, V46, P2159, DOI 10.1016/0016-7037(82)90192-2; TATSUMOTO M, 1976, GEOCHIM COSMOCHIM AC, V40, P617, DOI 10.1016/0016-7037(76)90108-3; Wasson JT, 2000, METEORIT PLANET SCI, V35, pA166; Wasson JT, 2001, GEOCHIM COSMOCHIM AC, V65, P4539, DOI 10.1016/S0016-7037(01)00738-4; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; YURIMOTO H, 1989, GEOCHIM COSMOCHIM AC, V53, P2387, DOI 10.1016/0016-7037(89)90360-8; YURIMOTO H, 2001, METEORIT PLANET SCI, V36, pA230	30	95	96	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					728	731		10.1038/nature01699	http://dx.doi.org/10.1038/nature01699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802328				2022-12-01	WOS:000183443400037
J	Andersen, JH; Thomsen, JF; Overgaard, E; Lassen, CF; Brandt, LPA; Vilstrup, I; Kryger, AI; Mikkelsen, S				Andersen, JH; Thomsen, JF; Overgaard, E; Lassen, CF; Brandt, LPA; Vilstrup, I; Kryger, AI; Mikkelsen, S			Computer use and carpal tunnel syndrome - A 1-year follow-up study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MUSCULOSKELETAL DISORDERS; GENERAL-POPULATION; RISK-FACTORS; WORK; PREVALENCE; SYMPTOMS	Context Computer use is increasingly common among many working populations, and concern exists about possible adverse effects of computer use, such as carpal tunnel syndrome (CTS). Objectives To estimate the prevalence and incidence of possible CTS and to evaluate the contribution of use of mouse devices and keyboards to the risk of possible CTS. Design and Setting A 1-year follow-up study with questionnaires conducted in 2000 and 2001 at 3500 workplaces in Denmark, followed on each of the 2 occasions by a clinical interview on symptom distribution and frequency. Participants The questionnaire was sent to 9480 members of a trade union, with an initial response rate of 73% (n=6943), and 82% (n=5658) at follow-up. Main Outcome Measures At baseline, there were 3 outcome measures: tingling/numbness in the right hand once a week or more as reported in the questionnaire; tingling, numbness, and pain in the median nerve in the right hand confirmed by clinical interview; and tingling, numbness, and pain in the median nerve in the right hand at night confirmed by clinical interview. At 1 year of follow-up the main outcome of interest was onset of symptoms among participants who had no or minor symptoms at baseline. Results The overall self-reported prevalence of tingling/numbness in the right hand at baseline was 10.9%. The interview confirmed that prevalence of tingling/numbness in the median nerve was 4.8%, of which about one third, corresponding to a prevalence of 1.4%, experienced symptoms at night. Onset of new symptoms in the 1-year follow-up was 5.5%. In the cross-sectional comparisons and in the follow-up analyses, there was an association between use of a mouse device for more than 20 h/wk and risk of possible CTS but no statistically significant association with keyboard use. Conclusions The occurrence of possible CTS in the right hand was low. The study emphasizes that computer use does riot pose a severe occupational hazard for developing symptoms of CTS.	Herning Hosp, Dept Occupat Med, DK-7400 Herning, Denmark; Copenhagen Univ Hosp, Dept Occupat Med, Glostrup, Denmark; Odense Univ Hosp, Dept Occupat & Environm Med, DK-5000 Odense, Denmark	Aarhus University; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Andersen, JH (corresponding author), Herning Hosp, Dept Occupat Med, DK-7400 Herning, Denmark.	hecjha@ringamt.dk	Andersen, Johan Hviid/AAI-2086-2019	Andersen, Johan Hviid/0000-0003-1638-8276				Abbas M A, 1998, Int J Occup Environ Health, V4, P160; Atcheson SG, 1998, ARCH INTERN MED, V158, P1506, DOI 10.1001/archinte.158.14.1506; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; BERNARD B, 1994, SCAND J WORK ENV HEA, V20, P417, DOI 10.5271/sjweh.1379; DEKROM MCTFM, 1992, J CLIN EPIDEMIOL, V45, P373, DOI 10.1016/0895-4356(92)90038-O; Dembe A. E., 1996, OCCUPATION DIS SOCIA; Frost P, 1998, SCAND J WORK ENV HEA, V24, P285, DOI 10.5271/sjweh.322; Gerr F, 2002, AM J IND MED, V41, P221, DOI 10.1002/ajim.10066; HALES TR, 1994, ERGONOMICS, V37, P1603, DOI 10.1080/00140139408964940; Kristensen TS, 2002, SCAND J PUBLIC HEALT, V30, P41, DOI 10.1177/14034948020300032401; National Research Council and the Institute of Medicine, 2001, MUSC DIS WORKPL LOW; Nordstrom DL, 1998, EPIDEMIOLOGY, V9, P342, DOI 10.1097/00001648-199805000-00021; Palmer KT, 2001, OCCUP MED-OXFORD, V51, P392, DOI 10.1093/occmed/51.6.392; Rossignol M, 1997, OCCUP ENVIRON MED, V54, P519, DOI 10.1136/oem.54.7.519; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; Stevens JC, 2001, NEUROLOGY, V56, P1568; Thomsen JF, 2002, AM J IND MED, V42, P344, DOI 10.1002/ajim.10115; Tittiranonda P, 1999, OCCUP MED, V14, P17	18	146	147	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2003	289	22					2963	2969		10.1001/jama.289.22.2963	http://dx.doi.org/10.1001/jama.289.22.2963			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687XZ	12799404	Bronze			2022-12-01	WOS:000183403400019
J	Gambacorti-Passerini, C; Tornaghi, L; Cavagnini, F; Rossi, P; Pecori-Giraldi, F; Mariani, L; Cambiaghi, N; Pogliani, E; Corneo, G; Gnessi, L				Gambacorti-Passerini, C; Tornaghi, L; Cavagnini, F; Rossi, P; Pecori-Giraldi, F; Mariani, L; Cambiaghi, N; Pogliani, E; Corneo, G; Gnessi, L			Gynaecomastia in men with chronic myeloid leukaemia after imatinib	LANCET			English	Article							STEM-CELL FACTOR; GROWTH	cKit and platelet-derived growth-factor receptor (PDGFR) are receptor tyrosine kinases expressed in the testis, are involved in testosterone production, and are inhibited by imatinib. We measured hormone concentrations in 38 men receiving imatinib for chronic myeloid leukaemia at baseline and during treatment. Mean follow-up was 23-6 months (SD 7.5). We noted seven cases of gynaecomastia (18%, 95% CI 6-30%). A comparison of hormone concentrations in 21 patients before and during treatment showed that patients who developed gynaecomastia had a reduction in free testosterone concentrations of 29.53 pmol/L (95% Cl 11.63-47.43), while patients who did not had a decrease of 6.36 pmol/L (-1.02 to 13.74). In most men with chronic myeloid leukaemia studied here, imatinib was associated with a reduction in the production of testicular hormones and in some, with the development of gynaecomastia.	Ist Nazl Tumori, I-20133 Milan, Italy; Univ Milano Bicocca, Monza, Italy; Univ Milan, Ist Auxol Italiano, Milan, Italy; Univ Roma Tor Vergata, Rome, Italy; Univ Roma La Sapienza, Rome, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milano-Bicocca; IRCCS Istituto Auxologico Italiano; University of Milan; University of Rome Tor Vergata; Sapienza University Rome	Gambacorti-Passerini, C (corresponding author), Ist Nazl Tumori, Via Venezian 1, I-20133 Milan, Italy.		Rossi, Pellegrino/AAA-7072-2019; Giraldi, Francesca Pecori/F-5081-2011; Mariani, Luigi/AAB-9464-2019; Gnessi, Lucio/K-8025-2016; Mariani, Luigi/C-2580-2017	Giraldi, Francesca Pecori/0000-0001-6065-7803; Gnessi, Lucio/0000-0001-8217-2372; Mariani, Luigi/0000-0001-6208-4084; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; ROSSI, PELLEGRINO/0000-0003-4796-327X				Basciani S, 2002, J CLIN ENDOCR METAB, V87, P2310, DOI 10.1210/jc.87.5.2310; Griffin J, 2001, SEMIN ONCOL, V28, P3, DOI 10.1016/S0093-7754(01)90097-1; Huang CTF, 2001, BIOL REPROD, V64, P451, DOI 10.1095/biolreprod64.2.451; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Sette C, 2000, INT J DEV BIOL, V44, P599	5	72	76	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1954	1956		10.1016/S0140-6736(03)13554-4	http://dx.doi.org/10.1016/S0140-6736(03)13554-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801741	Green Submitted			2022-12-01	WOS:000183359700013
J	Du, KY; Herzig, S; Kulkarni, RN; Montminy, M				Du, KY; Herzig, S; Kulkarni, RN; Montminy, M			TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver	SCIENCE			English	Article							PROTEIN-KINASE-B; GLYCOGEN-SYNTHASE KINASE-3; NEGATIVE REGULATOR; DROSOPHILA; MORPHOGENESIS; INACTIVATION; GLUCOSE; CELLS; PKB; RESISTANCE	Insulin resistance is a major hallmark in the development of type II diabetes, which is characterized by the failure of insulin to promote glucose uptake in muscle and to suppress glucose production in liver. The serine-threonine kinase Akt (PKB) is a principal target of insulin signaling that inhibits hepatic glucose output when glucose is available from food. Here we show that TRB3, a mammalian homolog of Drosophila tribbles, functions as a negative modulator of Akt. TRB3 expression is induced in liver under fasting conditions, and TRB3 disrupts insulin signaling by binding directly to Akt and blocking activation of the kinase. Amounts of TRB3 RNA and protein were increased in livers of db/db diabetic mice compared with those in wild-type mice. Hepatic overexpression of TRB3 in amounts comparable to those in db/db mice promoted hyperglycemia and glucose intolerance. Our results suggest that, by interfering with Akt activation, TRB3 contributes to insulin resistance in individuals with susceptibility to type II diabetes.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr, Boston, MA 02215 USA	Salk Institute; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Herzig, Stephan/0000-0003-3950-3652				Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Brady MJ, 1998, J BIOL CHEM, V273, P14063, DOI 10.1074/jbc.273.23.14063; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Buren J, 2002, EUR J ENDOCRINOL, V146, P419, DOI 10.1530/eje.0.1460419; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dirlewanger M, 2000, CLIN NUTR, V19, P29, DOI 10.1054/clnu.1999.0064; DU K, UNPUB; GANNON MC, 1984, J NUTR, V114, P2147, DOI 10.1093/jn/114.11.2147; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Mitsuuchi Y, 1998, J CELL BIOCHEM, V70, P433, DOI 10.1002/(SICI)1097-4644(19980915)70:4<433::AID-JCB1>3.0.CO;2-K; Paez-Espinosa EV, 1999, MOL CELL ENDOCRINOL, V156, P121, DOI 10.1016/S0303-7207(99)00137-9; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; RAO RH, 1995, METABOLISM, V44, P817, DOI 10.1016/0026-0495(95)90199-X; Rorth P, 2000, MOL CELL, V6, P23; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150	24	687	722	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1574	1577		10.1126/science.1079817	http://dx.doi.org/10.1126/science.1079817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791994				2022-12-01	WOS:000183333100056
J	Janssens, IA; Freibauer, A; Ciais, P; Smith, P; Nabuurs, GJ; Folberth, G; Schlamadinger, B; Hutjes, RWA; Ceulemans, R; Schulze, ED; Valentini, R; Dolman, AJ				Janssens, IA; Freibauer, A; Ciais, P; Smith, P; Nabuurs, GJ; Folberth, G; Schlamadinger, B; Hutjes, RWA; Ceulemans, R; Schulze, ED; Valentini, R; Dolman, AJ			Europe's terrestrial biosphere absorbs 7 to 12% of European anthropogenic CO2 emissions	SCIENCE			English	Article							CARBON-CYCLE; ATMOSPHERIC TRANSPORT; CLIMATE-CHANGE; FORESTS; LAND; SINK; EXCHANGES; BALANCE; FLUXES; OCEANS	Most inverse atmospheric models report considerable uptake of carbon dioxide in Europe's terrestrial biosphere. In contrast, carbon stocks in terrestrial ecosystems increase at a much smaller rate, with carbon gains in forests and grassland soils almost being offset by carbon losses from cropland and peat soils. Accounting for non-carbon dioxide carbon transfers that are not detected by the atmospheric models and for carbon dioxide fluxes bypassing the ecosystem carbon stocks considerably reduces the gap between the small carbon-stock changes and the larger carbon dioxide uptake estimated by atmospheric models. The remaining difference could be because of missing components in the stock-change approach, as well as the large uncertainty in both methods. With the use of the corrected atmosphere- and land-based estimates as a dual constraint, we estimate a net carbon sink between 135 and 205 teragrams per year in Europe's terrestrial biosphere, the equivalent of 7 to 12% of the 1995 anthropogenic carbon emissions.	Univ Antwerp, Dept Biol, B-2160 Antwerp, Belgium; Max Planck Inst Biogeochem, D-07701 Jena, Germany; Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Univ Aberdeen, Dept Plant & Soil Sci, Aberdeen AB24 3FX, Scotland; Alterra Green World Res, NL-6700 AC Wageningen, Netherlands; European Forest Inst, Joensuu 80100, Finland; Joanneum Res, A-8010 Graz, Austria; Univ Tuscia, Dept Forest Sci & Environm, I-01100 Viterbo, Italy; Free Univ Amsterdam, Dept Geoenvironm Sci, NL-1081 HV Amsterdam, Netherlands	University of Antwerp; Max Planck Society; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Aberdeen; Wageningen University & Research; Tuscia University; Vrije Universiteit Amsterdam	Janssens, IA (corresponding author), Univ Antwerp, Dept Biol, B-2160 Antwerp, Belgium.	ijanssen@uia.ua.ac.be	Schulze, Ernst-Detlef/K-9627-2014; Smith, Pete/G-1041-2010; Nabuurs, Gert-Jan/D-8048-2015; Janssens, Ivan A/P-1331-2014; Ciais, Philippe M/A-6840-2011; Folberth, Gerd A./F-7376-2010; Ceulemans, Reinhart J M/F-2109-2016; Valentini, Riccardo/D-1226-2010	Smith, Pete/0000-0002-3784-1124; Janssens, Ivan A/0000-0002-5705-1787; Ciais, Philippe M/0000-0001-8560-4943; Folberth, Gerd A./0000-0002-1075-440X; Ceulemans, Reinhart J M/0000-0003-4773-9358; Valentini, Riccardo/0000-0002-6756-5634; Dolman, A.J./0000-0003-0099-0457				ARMENTANO TV, 1986, J ECOL, V74, P755, DOI 10.2307/2260396; ARMENTANO TV, 1990, WETLANDS SHALLOW CON, P281; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; BOTCH MS, 1995, GLOBAL BIOGEOCHEM CY, V9, P37, DOI 10.1029/94GB03156; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Bousquet P, 1999, J GEOPHYS RES-ATMOS, V104, P26161, DOI 10.1029/1999JD900342; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dersch G, 1997, BODENSCHUTZ OSTERREI, P411; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; FREIBAUER A, IN PRESS SOIL SCI RE; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Kaminski T, 1999, J GEOPHYS RES-ATMOS, V104, P18555, DOI 10.1029/1999JD900146; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Lappalainen E., 1996, GLOBAL PEAT RESOURCE; Liski J, 2002, FOREST ECOL MANAG, V169, P159, DOI 10.1016/S0378-1127(02)00306-7; Liski J., 2000, ENVIRON SCI POLICY, V3, P91, DOI [10.1016/S1462-9011(00)00020-4, DOI 10.1016/S1462-9011(00)00020-4]; Ludwig W, 1998, AM J SCI, V298, P265, DOI 10.2475/ajs.298.4.265; MILNE R, 2001, UK EMISSIONS SOURCES; MUCHER CA, 2000, PELCOM PAN EUROPEAN; Nabuurs GJ, 2003, GLOBAL CHANGE BIOL, V9, P152, DOI 10.1046/j.1365-2486.2003.00570.x; Nabuurs GJ, 1997, BIOMASS BIOENERG, V13, P345, DOI 10.1016/S0961-9534(97)00036-6; Nabuurs GJ, 2001, THESIS U JOENSUU FIN; NABUURS GJ, 2001, LONG TERM EFFECTS CL, P220; Olivier J. G. J., 1999, ENVIRON SCI POLICY, V2, P241, DOI DOI 10.1016/S1462-9011(99)00027-1; OLIVIER JGJ, 2002, THESIS U UTRECHT NET; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Papale D, 2003, GLOBAL CHANGE BIOL, V9, P525, DOI 10.1046/j.1365-2486.2003.00609.x; Penman J., 2000, IPCC GOOD PRACTICE G; PISARENKO AI, 2000, DEV FOREST RESOURCES; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Schulze E.D., 2000, CARBON NITROGEN CYCL; Schulze E.D., 1998, IGBP SERIES, P145; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Shvidenko A, 2002, CLIMATIC CHANGE, V55, P5, DOI 10.1023/A:1020243304744; SLEUTEL S, IN PRESS SOIL USE MA; Smith P, 2000, GLOB CHANGE BIOL, V6, P525, DOI 10.1046/j.1365-2486.2000.00331.x; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; *TBFRA UN ECE FAO, 2000, TIMB FOR STUD PAP, V17; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Vleeshouwers LM, 2002, GLOBAL CHANGE BIOL, V8, P519, DOI 10.1046/j.1365-2486.2002.00485.x	44	454	522	7	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1538	1542		10.1126/science.1083592	http://dx.doi.org/10.1126/science.1083592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12764201				2022-12-01	WOS:000183333100045
J	Pardo, M; Nurse, P				Pardo, M; Nurse, P			Equatorial retention of the contractile actin ring by microtubules during cytokinesis	SCIENCE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CELL-DIVISION; SPINDLE FORMATION; F-ACTIN; GENE; CHECKPOINT; CYCLE; EUKARYOTES; PLACEMENT	In most eukaryotes cytokinesis is brought about by a contractile actin ring located at the division plane. Here, in fission yeast the actin ring was found to be required to generate late-mitotic microtubular structures located at the division plane, and these in turn maintained the medial position of the actin ring. When these microtubular structures were disrupted, the actin ring migrated away from the cell middle in a membrane traffic-dependent manner, resulting in asymmetrical cell divisions that led to genomic instability. We propose that these microtubular structures contribute to a checkpoint control that retains the equatorial position of the ring when progression through cytokinesis is delayed.	Canc Res UK London Res Inst, Cell Cycle Lab, London WC2A 3PX, England	Cancer Research UK	Pardo, M (corresponding author), Canc Res UK London Res Inst, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.			Pardo, Mercedes/0000-0002-3477-9695				Arai R, 2002, J CELL SCI, V115, P887; Ayscough K, 1998, METHOD ENZYMOL, V298, P18, DOI 10.1016/S0076-6879(98)98004-1; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Balasubramanian MK, 2000, J CELL SCI, V113, P1503; Chang F, 1996, J CELL SCI, V109, P131; Ding DQ, 1998, J CELL SCI, V111, P701; DRABIKOWSKI W, 1973, BIOCHIM BIOPHYS ACTA, V291, P61, DOI 10.1016/0005-2736(73)90060-6; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Finger FP, 2002, CELL, V108, P727, DOI 10.1016/S0092-8674(02)00668-2; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Gatti M, 2000, MICROSC RES TECHNIQ, V49, P202, DOI 10.1002/(SICI)1097-0029(20000415)49:2<202::AID-JEMT13>3.0.CO;2-8; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hagan IM, 1998, J CELL SCI, V111, P1603; Heitz MJ, 2001, J CELL SCI, V114, P4521; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Le Goff X, 1999, MOL GEN GENET, V262, P163; Liu JH, 1999, GENETICS, V153, P1193; Liu JH, 2000, J CELL SCI, V113, P1223; MARKS J, 1985, EUR J CELL BIOL, V39, P27; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TURI TG, 1994, J BIOL CHEM, V269, P24229; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839	31	62	62	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1569	1574		10.1126/science.1084671	http://dx.doi.org/10.1126/science.1084671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791993				2022-12-01	WOS:000183333100055
J	Shen, Y; Knoll, AH; Walter, MR				Shen, Y; Knoll, AH; Walter, MR			Evidence for low sulphate and anoxia in a mid-Proterozoic marine basin	NATURE			English	Article							PROTEROZOIC OCEAN CHEMISTRY; VELKERRI FORMATION; BELT SUPERGROUP; MCARTHUR BASIN; SULFUR-ISOTOPE; EVOLUTION; IRON; GEOCHEMISTRY; CONSTRAINTS; SEDIMENTS	Many independent lines of evidence document a large increase in the Earth's surface oxidation state 2,400 to 2,200 million years ago(1-4), and a second biospheric oxygenation 800 to 580 million years ago, just before large animals appear in the fossil record(5,6). Such a two-staged oxidation implies a unique ocean chemistry for much of the Proterozoic eon, which would have been neither completely anoxic and iron-rich as hypothesized for Archaean seas, nor fully oxic as supposed for most of the Phanerozoic eon(7). The redox chemistry of Proterozoic oceans has important implications for evolution(8), but empirical constraints on competing environmental models are scarce. Here we present an analysis of the iron chemistry of shales deposited in the marine Roper Basin, Australia, between about 1,500 and 1,400 million years ago, which record deep-water anoxia beneath oxidized surface water. The sulphur isotopic compositions of pyrites in the shales show strong variations along a palaeodepth gradient, indicating low sulphate concentrations in mid-Proterozoic oceans. Our data help to integrate a growing body of evidence favouring a long-lived intermediate state of the oceans, generated by the early Proterozoic oxygen revolution and terminated by the environmental transformation late in the Proterozoic eon.	Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; Macquarie Univ, Australian Ctr Astrobiol, N Ryde, NSW 2109, Australia	Harvard University; Macquarie University	Shen, Y (corresponding author), Harvard Univ, Bot Museum, 26 Oxford St, Cambridge, MA 02138 USA.	yshen@oeb.harvard.edu	Shen, Yanan/L-3724-2018	Shen, Yanan/0000-0001-8343-6763				Abbott ST, 2000, AUST J EARTH SCI, V47, P637, DOI 10.1046/j.1440-0952.2000.00795.x; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; BAKER PA, 1981, SCIENCE, V213, P214, DOI 10.1126/science.213.4504.214; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; DONNELLY TH, 1988, PRECAMBRIAN RES, V42, P165, DOI 10.1016/0301-9268(88)90015-0; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; GAUTIER DL, 1986, GEOLOGY, V14, P225, DOI 10.1130/0091-7613(1986)14<225:CSFTWI>2.0.CO;2; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; JACKSON MJ, 1991, PRECAMBRIAN RES, V54, P81, DOI 10.1016/0301-9268(91)90070-Q; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Lyons TW, 1997, GEOCHIM COSMOCHIM AC, V61, P3367, DOI 10.1016/S0016-7037(97)00174-9; Lyons TW, 2000, GEOCHIM COSMOCHIM AC, V64, P427, DOI 10.1016/S0016-7037(99)00323-3; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MUIR MD, 1985, AUST J EARTH SCI, V32, P239, DOI 10.1080/08120098508729328; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Raiswell R, 2001, J SEDIMENT RES, V71, P286, DOI 10.1306/070300710286; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; STRAUSS H, 1990, GEOCHIM COSMOCHIM AC, V54, P197, DOI 10.1016/0016-7037(90)90207-2; Wijsman JWM, 2001, MAR CHEM, V74, P261, DOI 10.1016/S0304-4203(01)00019-6; ZABACK DA, 1993, GEOLOGY, V21, P141, DOI 10.1130/0091-7613(1993)021<0141:TAROSA>2.3.CO;2	30	211	231	3	67	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					632	635		10.1038/nature01651	http://dx.doi.org/10.1038/nature01651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789336				2022-12-01	WOS:000183301200038
J	Houston, F; Goldmann, W; Chong, A; Jeffrey, M; Gonzalez, L; Foster, J; Parnham, D; Hunter, N				Houston, F; Goldmann, W; Chong, A; Jeffrey, M; Gonzalez, L; Foster, J; Parnham, D; Hunter, N			Prion diseases: BSE in sheep bred for resistance to infection	NATURE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRP; SCRAPIE; AGENT; ONSET		Inst Anim Hlth, Newbury RG20 7NN, Berks, England; IAH Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland; Vet Labs Agcy Lasswade, Penicuik EH26 0PZ, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Houston, F (corresponding author), Inst Anim Hlth, Newbury RG20 7NN, Berks, England.		Jeffrey, Martin/D-2251-2009; González, Lorenzo/A-5325-2010; Houston, Eleanor/A-8036-2011	González, Lorenzo/0000-0003-4199-4526; 				Bossers A, 2000, J VIROL, V74, P1407, DOI 10.1128/JVI.74.3.1407-1414.2000; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Hope J, 2000, J GEN VIROL, V81, P851, DOI 10.1099/0022-1317-81-3-851; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; IKEDA T, 1995, J GEN VIROL, V76, P2577, DOI 10.1099/0022-1317-76-10-2577; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Kao RR, 2002, SCIENCE, V295, P332, DOI 10.1126/science.1067475; ORourke KI, 1997, J GEN VIROL, V78, P975, DOI 10.1099/0022-1317-78-4-975; Ryder SJ, 2000, J COMP PATHOL, V122, P131, DOI 10.1053/jcpa.1999.0349; VONKEULEN LJ, 1996, J CLIN MICROBIOL, V34, P1228	12	121	125	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					498	498		10.1038/423498a	http://dx.doi.org/10.1038/423498a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774113				2022-12-01	WOS:000183162900033
J	Donnelly, CA; Ghani, AC; Leung, GM; Hedley, AJ; Fraser, C; Riley, S; Abu-Raddad, LJ; Ho, LM; Thach, TQ; Chau, P; Chan, KP; Lam, TH; Tse, LY; Tsang, T; Liu, SH; Kong, JHB; Lau, EMC; Ferguson, NM; Anderson, RM				Donnelly, CA; Ghani, AC; Leung, GM; Hedley, AJ; Fraser, C; Riley, S; Abu-Raddad, LJ; Ho, LM; Thach, TQ; Chau, P; Chan, KP; Lam, TH; Tse, LY; Tsang, T; Liu, SH; Kong, JHB; Lau, EMC; Ferguson, NM; Anderson, RM			Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong	LANCET			English	Article								Background Health authorities worldwide, especially in the Asia Pacific region, are seeking effective public-health interventions in the continuing epidemic of severe acute respiratory syndrome (SARS). We assessed the epidemiology of SARS in Hong Kong. Methods We included 1425 cases reported up to April 28, 2003. An integrated database was constructed from several sources containing information on epidemiological, demographic, and clinical variables. We estimated the key epidemiological distributions: infection to onset, onset to admission, admission to death, and admission to discharge. We measured associations between the estimated case fatality rate and patients' age and the time from onset to admission. Findings After the initial phase of exponential growth, the rate of confirmed cases fell to less than 20 per day by April 28. Public-health interventions included encouragement to report to hospital rapidly after the onset of clinical symptoms, contact tracing for confirmed and suspected cases, and quarantining, monitoring, and restricting the travel of contacts. The mean incubation period of the disease is estimated to be 6.4 days (95% CI 5.2-7.7). The mean time from onset of clinical symptoms to admission to hospital varied between 3 and 5 days, with longer times earlier in the epidemic. The estimated case fatality rate was 13.2% (9.8-16.8) for patients younger than 60 years and 43.3% (35.2-52.4) for patients aged 60 years or older assuming a parametric gamma distribution. A non-parametric method yielded estimates of 6.8% (4.0-9.6) and 55.0% (45.3-64.7), respectively. Case clusters have played an important part in the course of the epidemic. Interpretation Patients' age was strongly associated with outcome. The time between onset of symptoms and admission to hospital did not alter outcome, but shorter intervals will be important to the wider population by restricting the infectious period before patients are placed in quarantine.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Hong Kong, Hong Kong, Peoples R China; Hong Kong Hosp Author, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Community & Family Med, Hong Kong, Hong Kong, Peoples R China	Imperial College London; University of Hong Kong; Chinese University of Hong Kong	Donnelly, CA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.		Ghani, Azra/B-8560-2009; Abu-Raddad, Laith J/AAY-1441-2020; Thach, Thuan-Quoc/C-4416-2009; Lam, Tai Hing/C-4317-2009; Fraser, Christophe/A-8109-2008; Hedley, Anthony/C-4305-2009; Leung, Gabriel Matthew/C-4336-2009; Ferguson, Neil/B-8578-2008; Chan, King Pan/C-4523-2009; Hedley, Anthony J/A-9113-2013	Abu-Raddad, Laith J/0000-0003-0790-0506; Thach, Thuan-Quoc/0000-0003-3404-3888; Fraser, Christophe/0000-0003-2399-9657; Ferguson, Neil/0000-0002-1154-8093; Leung, Gabriel/0000-0002-2503-6283; Anderson, Roy/0000-0002-9528-3175; Donnelly, Christl/0000-0002-0195-2463; Riley, Steven/0000-0001-7904-4804; Ghani, Azra/0000-0002-0007-4910; ho, lm/0000-0002-2709-927X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], COM NUMB REP PROB CA; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; TSANG KW, CLUSTER CASES SEVERE; *WHO, COR SEEN HUM CAUS SA	4	612	664	1	77	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1761	1766		10.1016/S0140-6736(03)13410-1	http://dx.doi.org/10.1016/S0140-6736(03)13410-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781533	Green Published, Bronze			2022-12-01	WOS:000183074800006
J	Mizuguchi, S; Uyama, T; Kitagawa, H; Nomura, KH; Dejima, K; Gengyo-Ando, K; Mitani, S; Sugahara, K; Nomura, K				Mizuguchi, S; Uyama, T; Kitagawa, H; Nomura, KH; Dejima, K; Gengyo-Ando, K; Mitani, S; Sugahara, K; Nomura, K			Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN LINKAGE REGION; MOLECULAR-CLONING; IN-VIVO; BIOSYNTHESIS; DROSOPHILA; GLYCOSAMINOGLYCANS; EXPRESSION; INITIATION; ELONGATION	Glycosaminoglycans such as heparan sulphate and chondroitin sulphate are extracellular sugar chains involved in intercellular signalling. Disruptions of genes encoding enzymes that mediate glycosaminoglycan biosynthesis have severe consequences in Drosophila and mice(1-5). Mutations in the Drosophila gene sugarless, which encodes a UDP-glucose dehydrogenase, impair developmental signalling through the Wnt family member Wingless, and signalling by the fibroblast growth factor and Hedgehog pathways. Heparan sulphate is involved in these pathways(6-8), but little is known about the involvement of chondroitin. Undersulphated and oversulphated chondroitin sulphate chains have been implicated in other biological processes, however, including adhesion of erythrocytes infected with malaria parasite to human placenta and regulation of neural development(9,10). To investigate chondroitin functions, we cloned a chondroitin synthase homologue of Caenorhabditis elegans and depleted expression of its product by RNA-mediated interference and deletion mutagenesis. Here we report that blocking chondroitin synthesis results in cytokinesis defects in early embryogenesis. Reversion of cytokinesis is often observed in chondroitin-depleted embryos, and cell division eventually stops, resulting in early embryonic death. Our findings show that chondroitin is required for embryonic cytokinesis and cell division.	Kyushu Univ, Fac Sci 33, Dept Biol, Fukuoka 8128581, Japan; Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Tokyo Womens Med Univ Sch Med, Dept Physiol, Tokyo 1628666, Japan	Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kobe Pharmaceutical University; Tokyo Women's Medical University	Nomura, K (corresponding author), Kyushu Univ, Fac Sci 33, Dept Biol, Fukuoka 8128581, Japan.	k-sugar@kobepharma-u.ac.jp; knomuscb@mbox.nc.kyushu-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020; Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019	Kitagawa, Hiroshi/0000-0002-9307-7079; 				Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Christensen M, 2001, J BIOL CHEM, V276, P45024, DOI 10.1074/jbc.M107652200; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI200113561; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Hacker U, 1997, DEVELOPMENT, V124, P3565; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Iozzo RV, 2001, J CLIN INVEST, V108, P165, DOI 10.1172/JCI13560; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Lin XH, 1999, DEVELOPMENT, V126, P3715; Lindahl U., 1972, GLYCOPROTEINS THEIR, P491; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7	30	194	207	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2003	423	6938					443	448		10.1038/nature01635	http://dx.doi.org/10.1038/nature01635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761550				2022-12-01	WOS:000183012000043
J	Lecossier, D; Bouchonnet, F; Clavel, F; Hance, AJ				Lecossier, D; Bouchonnet, F; Clavel, F; Hance, AJ			Hypermutation of HIV-1 DNA in the absence of the Vif protein	SCIENCE			English	Article									INSERM, U552, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Hance, AJ (corresponding author), INSERM, U552, Paris, France.							HANCE AJ, UNPUB; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; MARTINEZ MA, 1994, P NATL ACAD SCI USA, V91, P11787, DOI 10.1073/pnas.91.25.11787; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939	5	560	588	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1112	1112		10.1126/science.1083338	http://dx.doi.org/10.1126/science.1083338			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750511				2022-12-01	WOS:000182886500034
J	Staddon, PL; Ramsey, CB; Ostle, N; Ineson, P; Fitter, AH				Staddon, PL; Ramsey, CB; Ostle, N; Ineson, P; Fitter, AH			Rapid turnover of hyphae of mycorrhizal fungi determined by AMS microanalysis of C-14	SCIENCE			English	Article							GLOBAL CLIMATE-CHANGE; PHOSPHORUS INFLOW; UPLAND GRASSLAND; EXTERNAL HYPHAE; ATMOSPHERIC CO2; PLANT-GROWTH; CARBON; SOIL; RADIOCARBON; MYCELIUM	Processes in the soil remain among the least well-characterized components of the carbon cycle. Arbuscular mycorrhizal (AM) fungi are ubiquitous root symbionts in many terrestrial ecosystems and account for a large fraction of photosynthate in a wide range of ecosystems; they therefore play a key role in the terrestrial carbon cycle. A large part of the fungal mycelium is outside the root ( the extraradical mycelium, ERM) and, because of the dispersed growth pattern and the small diameter of the hyphae (<5 micrometers), exceptionally difficult to study quantitatively. Critically, the longevity of these. ne hyphae has never been measured, although it is assumed to be short. To quantify carbon turnover in these hyphae, we exposed mycorrhizal plants to fossil ("carbon-14 - dead") carbon dioxide and collected samples of ERM hyphae ( up to 116 micrograms) over the following 29 days. Analyses of their carbon-14 content by accelerator mass spectrometry (AMS) showed that most ERM hyphae of AM fungi live, on average, 5 to 6 days. This high turnover rate reveals a large and rapid mycorrhizal pathway of carbon in the soil carbon cycle.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Oxford, Archaeol & Hist Art Res Lab, Radiocarbon Accelerator Unit, Oxford OX1 3QJ, England; Inst Terr Ecol, Merlewood Res Stn, Ctr Ecol & Hydrol, Grange Over Sands LA11 6JU, Cumbria, England	University of York - UK; University of Oxford; UK Centre for Ecology & Hydrology (UKCEH)	Staddon, PL (corresponding author), Riso Natl Lab, Plant Res Dept, Bldg 313,Postbox 49, DK-4000 Roskilde, Denmark.		Ramsey, Christopher Bronk/A-3277-2012; Ostle, Nick J/K-6891-2012; Ramsey, Christopher Bronk/AAQ-2227-2021; Ostle, Nicholas J/E-4847-2014	Ramsey, Christopher Bronk/0000-0002-8641-9309; Ramsey, Christopher Bronk/0000-0002-8641-9309; Ostle, Nicholas J/0000-0003-3263-3702				Atkinson D, 2000, APPL SOIL ECOL, V15, P99, DOI 10.1016/S0929-1393(00)00084-6; Bago B, 1998, NEW PHYTOL, V139, P375, DOI 10.1046/j.1469-8137.1998.00199.x; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; BRONKRAMSEY C, 1997, NUCL INSTR METHODS P, V123, P539; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Fitter AH, 2000, NEW PHYTOL, V147, P179, DOI 10.1046/j.1469-8137.2000.00680.x; Fitter AH, 1997, NEW PHYTOL, V137, P247, DOI 10.1046/j.1469-8137.1997.00804.x; FRIESE CF, 1991, MYCOLOGIA, V83, P409, DOI 10.2307/3760351; Gange A, 2000, TRENDS ECOL EVOL, V15, P369, DOI 10.1016/S0169-5347(00)01940-6; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Hewitt E.J., 1975, PLANT MINERAL NUTR; Hobbie EA, 2002, NEW PHYTOL, V156, P129, DOI 10.1046/j.1469-8137.2002.00496.x; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; JAKOBSEN I, 1990, NEW PHYTOL, V115, P77, DOI 10.1111/j.1469-8137.1990.tb00924.x; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Johnson D, 2002, NEW PHYTOL, V153, P327, DOI 10.1046/j.0028-646X.2001.00316.x; Johnson D, 2002, SOIL BIOL BIOCHEM, V34, P1521, DOI 10.1016/S0038-0717(02)00126-8; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Ostle N, 2000, RAPID COMMUN MASS SP, V14, P1345, DOI 10.1002/1097-0231(20000815)14:15<1345::AID-RCM22>3.0.CO;2-B; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; Sokal R., 1981, BIOMETRY; Staddon PL, 1999, SOIL BIOL BIOCHEM, V31, P1067, DOI 10.1016/S0038-0717(99)00020-6; Staddon PL, 1999, GLOBAL CHANGE BIOL, V5, P347, DOI 10.1046/j.1365-2486.1999.00230.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932	27	266	288	9	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1138	1140		10.1126/science.1084269	http://dx.doi.org/10.1126/science.1084269			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750519	Green Accepted			2022-12-01	WOS:000182886500043
J	Tseng, CW; Brook, RH; Keeler, E; Mangione, CM				Tseng, CW; Brook, RH; Keeler, E; Mangione, CM			Impact of an annual dollar limit or "cap" on prescription drug benefits for medicare patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BENEFICIARIES; COVERAGE; COST	Context Annual dollar limits, or "caps," on drug benefits are common in Medicare managed care (Medicare + Choice) and have been part of several proposals for a national Medicare drug benefit. Objectives To determine how cap levels affect the percentage of patients exceeding the cap and their out-of-pocket drug costs and to identify the medications that contribute most to prescription costs. Design and Setting Cross-sectional analysis of 2001 pharmacy claims data from a large Medicare + Choice plan in a mature market with caps of $750 to $2000 per year applied to the plan's share of prescription costs. Participants Patients who filled at least 1 prescription in 2001 (n=438802). Main Outcome Measures Percentages of patients exceeding caps, identified from prescription claims; out-of-pocket patient costs before exceeding caps, calculated from patients' co-payments; and out-of-pocket patient costs after exceeding caps, estimated from total prescription costs before exceeding the cap. Each unique drug was ranked by total expenditures, which included spending by patients who exceeded caps and by the plan for that drug. Results A total of 22%, 14%, and 4% of Medicare patients exceeded caps of $750, $1000, and $2000, respectively. Across caps, patients faced a potential 2- to 3-fold increase in median out-of-pocket costs after exceeding caps ($179-$305/mo) to continue the same prescription use as before exceeding caps ($794100/mo). For patients who exceeded a cap of $750, yearly out-of-pocket drug costs ranged from $564 to $4201 (5th-95th percentiles). Fifteen of the 20 medications with the highest total prescription expenditures for patients who exceeded the cap were for chronic conditions. Seven had lower-cost generic versions or a generic medication available in the same treatment class. Conclusions At lower caps, a substantial proportion of Medicare patients exceeded their annual drug benefit. To continue the same medication use as before exceeding caps, these patients faced potentially high increases in out-of-pocket costs for medications used primarily to treat chronic conditions. Generic options were not available for many of these drugs.	Univ Hawaii, Dept Family Practice & Community Hlth, Honolulu, HI 96822 USA; Pacific Hlth Res Inst, Honolulu, HI USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, Los Angeles, CA USA; RAND Corp, Hlth, Santa Monica, CA USA	University of Hawaii System; Pacific Health Research & Education Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Robert Wood Johnson Foundation (RWJF); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation	Tseng, CW (corresponding author), 846 S Hotel St,Suite 303, Honolulu, HI 96813 USA.				NIA NIH HHS [AG-02-004] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams AS, 2001, HEALTH AFFAIR, V20, P276, DOI 10.1377/hlthaff.20.1.276; *C BUDG OFF, 2002, ISS DES PRESCR DRUG; *COMM FUND, 1999, TRENDS MED PLUS CHOI; Cox ER, 2001, MED CARE, V39, P296, DOI 10.1097/00005650-200103000-00009; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; *HJ KAIS FAM FDN C, SEN PRESCR DRUGS FIN; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; LASCHOBER MA, 1996, TRENDS MEDICARE S IN; Lichtenberg FR, 2001, HEALTH AFFAIR, V20, P241, DOI 10.1377/hlthaff.20.5.241; McClellan M, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.2.26; Poisal JA, 2001, HEALTH AFFAIR, V20, P74, DOI 10.1377/hlthaff.20.2.74; Rector TS, 2000, JAMA-J AM MED ASSOC, V283, P2163, DOI 10.1001/jama.283.16.2163; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; Steinman MA, 2001, J GEN INTERN MED, V16, P793, DOI 10.1046/j.1525-1497.2001.10412.x; Stuart B, 1998, MED CARE, V36, P202, DOI 10.1097/00005650-199802000-00009; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; 2002, HJ KAISER FAMILY FDN	18	42	42	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2003	290	2					222	227		10.1001/jama.290.2.222	http://dx.doi.org/10.1001/jama.290.2.222			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698GH	12851277	Green Submitted, Bronze			2022-12-01	WOS:000183989800027
J	Seo, HS; Yang, JY; Ishikawa, M; Bolle, C; Ballesteros, ML; Chua, NH				Seo, HS; Yang, JY; Ishikawa, M; Bolle, C; Ballesteros, ML; Chua, NH			LAF1 ubiquitination by COP1 controls photomorphogenesis and is stimulated by SPA1	NATURE			English	Article							RING FINGER MOTIF; PHYTOCHROME-A; SIGNAL-TRANSDUCTION; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; LIGHT CONTROL; PROTEIN; REPRESSOR; INTERACTS; DEFINES	Far-red light regulates many aspects of seedling development, such as inhibition of hypocotyl elongation and the promotion of greening(1), acting in part through phytochrome A ( phyA). The RING motif protein COP1 is also important because cop1 mutants exhibit constitutive photomorphogenesis in darkness(2,3). COP1 is present in the nucleus in darkness but is gradually relocated to the cytoplasm upon illumination(4). Here we show that COP1 functions as an E3 ligase ubiquitinating both itself and the myb transcription activator LAF1, which is required for complete phyA responses(5). In transgenic plants, inducible COP1 overexpression leads to a decrease in LAF1 concentrations, but is blocked by the proteasome inhibitor MG132. The coiled-coil domain of SPA1, a negative regulator of phyA signalling(6), has no effect on COP1 auto-ubiquitination but facilitates LAF1 ubiquitination at low COP1 concentrations. These results indicate that, in darkness, COP1 functions as a repressor of photomorphogenesis by promoting the ubiquitin-mediated proteolysis of a subset of positive regulators, including LAF1. After the activation of phyA, SPA1 stimulates the E3 activity of residual nuclear COP1 to ubiquitinate LAF1, thereby desensitizing phyA signals.	Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Chua, NH (corresponding author), Rockefeller Univ, Plant Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.		Yang, Jun-Yi/ABA-2044-2021; Ishikawa, Masaki/AAC-8162-2022; Ishikawa, Masaki/Q-7598-2018; Bolle, Cordelia/C-5569-2011	Yang, Jun-Yi/0000-0002-6332-6265; Ishikawa, Masaki/0000-0002-6491-5539; Ishikawa, Masaki/0000-0002-6491-5539; Bolle, Cordelia/0000-0002-4399-0070				Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Ballesteros ML, 2001, GENE DEV, V15, P2613, DOI 10.1101/gad.915001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Hardtke CS, 2002, PLANT J, V30, P385, DOI 10.1046/j.1365-313X.2002.01298.x; Hardtke CS, 2000, PLANT PHYSIOL, V124, P1548, DOI 10.1104/pp.124.4.1548; Hoecker U, 1998, PLANT CELL, V10, P19, DOI 10.1105/tpc.10.1.19; Hoecker U, 2001, J BIOL CHEM, V276, P38173; Hoecker U, 1999, SCIENCE, V284, P496, DOI 10.1126/science.284.5413.496; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Stacey MG, 1999, J BIOL CHEM, V274, P27231, DOI 10.1074/jbc.274.38.27231; Torii KU, 1999, J BIOL CHEM, V274, P27674, DOI 10.1074/jbc.274.39.27674; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; VONARNIM AG, 1993, J BIOL CHEM, V268, P19626; vonArnim AG, 1997, PLANT PHYSIOL, V114, P779, DOI 10.1104/pp.114.3.779; Wilson JF, 2002, LANCET NEUROL, V1, P4, DOI 10.1016/S1474-4422(02)00025-X; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	30	373	408	6	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					995	999		10.1038/nature01696	http://dx.doi.org/10.1038/nature01696			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827204				2022-12-01	WOS:000183753900052
J	Li, CI; Malone, KE; Porter, PL; Weiss, NS; Tang, MTC; Cushing-Haugen, KL; Daling, JR				Li, CI; Malone, KE; Porter, PL; Weiss, NS; Tang, MTC; Cushing-Haugen, KL; Daling, JR			Relationship between long durations and different regimens of hormone therapy and risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; RECEPTOR STATUS; ESTROGEN USE; CARCINOMA; PROGESTIN; HEALTH; METAANALYSIS; INFORMATION; RELIABILITY	Context Women using combined estrogen and progestin hormone replacement therapy (CHRT) have an increased risk of breast cancer; however, data on use for long durations and on risk associated with patterns of use are lacking. Objective To evaluate relationships between durations and patterns of CHRT use and risk of breast cancer by histological type and hormone receptor status. Design Population-based case-control study. Setting Three counties in western Washington State. Participants Nine hundred seventy-five women 65-79 years of age diagnosed with invasive breast cancer from April 1, 1997, through May 31, 1999 (histology: 196 lobular cases, 656 ductal cases, 114 cases with other histological type, and 9 cases with an unspecified histological type; estrogen receptor (ER)/progesterone receptor (PR) status: 646 ER+/PR+ cases, 147 ER+/PR- cases, and 101 ER-/PR- cases [6 ER-/PR+ cases and 75 cases with unknown ER/PR status were not included in the analyses herein]) and 1007 population controls. Main Outcome Measures Risks of invasive lobular, ductal, ER+/PR+, ER+/PR-, and ER-/PR- breast carcinomas. Results Women using unopposed estrogen replacement therapy (ERT) (exclusive ERT use), even for 25 years or longer, had no appreciable increase in risk of breast cancer, although the associated odds ratios were not inconsistent with a possible small effect. Ever users of CHRT (includes CHRT users who also had used ERT) had a 1.7-fold (95% confidence interval (01, 1.3-2.2) increased risk of breast cancer, including a 2.7-fold (95% Cl, 1.7-4.3) increased risk of invasive lobular carcinoma, a 1.5-fold (95% Cl, 1.1-2.0) increased risk of invasive ductal carcinoma, and a 2.0-fold (95% Cl, 1.5-2.7) increased risk of ER+/PR+ breast cancers. The increase in risk was greatest in those using CHRT for longer durations (users for 5-14.9 years and 15 years had 1.5-fold [95% Cl, 1.0-2.3] and 1.6-fold [95% Cl, 1.0-2.6] increases in risk of invasive ductal carcinoma, respectively, and 3.7-fold [95% Cl, 2.0-6.6] and 2.6-fold [95% Cl, 1.3-5.3] increases in risk of invasive lobular carcinoma, respectively. Associations of similar magnitudes were seen among users of both sequential and continuous CHRT. Risks of ER+/PR- and ER-/ PR- tumors were not increased by use of any form of hormone replacement therapy; however,,small numbers of these tumors limited power to detect possible associations. Conclusion These data suggest that use of CHRT is associated with an increased risk of breast cancer, particularly invasive lobular tumors, whether the progestin component was taken in a sequential or in a continuous manner.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Li, CI (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,MP 381,POB 19024, Seattle, WA 98109 USA.				NATIONAL CANCER INSTITUTE [R01CA072787] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA072787] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEGG CB, 1984, BIOMETRIKA, V71, P11, DOI 10.2307/2336391; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Breslow NE, 1980, ANAL CASE CONTROL ST; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Cobleigh MA, 1999, JAMA-J AM MED ASSOC, V281, P1528, DOI 10.1001/jama.281.16.1528; COLDITZ GA, 1990, JAMA-J AM MED ASSOC, V264, P2648, DOI 10.1001/jama.264.20.2648; COLDITZ GA, 1992, CANCER CAUSE CONTROL, V3, P433, DOI 10.1007/BF00051356; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Daling JR, 2002, CANCER-AM CANCER SOC, V95, P2455, DOI 10.1002/cncr.10984; DIXON JM, 1982, HISTOPATHOLOGY, V6, P149, DOI 10.1111/j.1365-2559.1982.tb02712.x; DUTOIT RS, 1991, EUR J SURG ONCOL, V17, P251; *F HUTCH CANC RES, CSS REP PUBL FAQS; GOODMAN MT, 1990, AM J EPIDEMIOL, V131, P815, DOI 10.1093/oxfordjournals.aje.a115572; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Jain MG, 1999, EPIDEMIOLOGY, V10, P260, DOI 10.1097/00001648-199905000-00012; Kirsh V, 2002, CANCER CAUSE CONTROL, V13, P583, DOI 10.1023/A:1016330024268; Li CI, 2000, CANCER, V88, P2561, DOI 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421; Li CI, 2000, CANCER, V88, P2570, DOI 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O; Lower EE, 1999, BREAST CANCER RES TR, V58, P205, DOI 10.1023/A:1006315607241; *NCI, 2003, SEER; Newcomb PA, 2002, CANCER EPIDEM BIOMAR, V11, P593; Newcomer LM, 1999, AM J EPIDEMIOL, V149, pS79; PAGANINIHILL A, 1982, AM J EPIDEMIOL, V116, P114; PERSSON I, 1987, INT J EPIDEMIOL, V16, P222, DOI 10.1093/ije/16.2.222; POTTER JD, 1995, CANCER EPIDEM BIOMAR, V4, P319; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; STEINBERG KK, 1994, EPIDEMIOLOGY, V5, P415, DOI 10.1097/00001648-199407000-00007; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; World Health Organization, 2000, INT CLASSIFICATION D	31	296	313	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3254	3263		10.1001/jama.289.24.3254	http://dx.doi.org/10.1001/jama.289.24.3254			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693EX	12824206	Bronze			2022-12-01	WOS:000183704600018
J	Hunt, GM; Oakeshott, P				Hunt, GM; Oakeshott, P			Outcome in people with open spina bifida at age 35: prospective community based cohort study	BRITISH MEDICAL JOURNAL			English	Article									Addenbrookes Hosp, Cambridge CB2 2QQ, England; St George Hosp, Sch Med, Dept Community Hlth, London SW17 0RE, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; St Georges University London	Hunt, GM (corresponding author), 65 Grantchester St, Cambridge CB3 9HZ, England.			Oakeshott, Pippa/0000-0003-2568-8211				HUNT G, 1973, BRIT MED J, V4, P197, DOI 10.1136/bmj.4.5886.197; HUNT GM, 1995, DEV MED CHILD NEUROL, V37, P19; Hunt GM, 1999, J NEUROL NEUROSUR PS, V67, P591, DOI 10.1136/jnnp.67.5.591; LAURENCE KM, 1974, LANCET, V1, P301; SMITH GK, 1973, BRIT MED J, V4, P189, DOI 10.1136/bmj.4.5886.189	5	72	74	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2003	326	7403					1365	1366		10.1136/bmj.326.7403.1365	http://dx.doi.org/10.1136/bmj.326.7403.1365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694CN	12816823	Bronze, Green Published			2022-12-01	WOS:000183756400021
J	Baldwin, E				Baldwin, E			Time for a fresh look at complementary medicine	BRITISH MEDICAL JOURNAL			English	Article									House Lords, London SW1A 0PW, England		Baldwin, E (corresponding author), House Lords, London SW1A 0PW, England.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1322	1322		10.1136/bmj.326.7402.1322	http://dx.doi.org/10.1136/bmj.326.7402.1322			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805177	Green Published			2022-12-01	WOS:000183626500041
J	Gold, ER				Gold, ER			SARS genome patent: symptom or disease?	LANCET			English	Editorial Material									McGill Univ, Fac Law, Ctr Intellectual Property Policy, Montreal, PQ H3A 1W9, Canada	McGill University	Gold, ER (corresponding author), McGill Univ, Fac Law, Ctr Intellectual Property Policy, Montreal, PQ H3A 1W9, Canada.	Richard.Gold2@McGill.ca		Gold, E. Richard/0000-0002-3789-9238				BRICKLEY P, 2003, SCIENTIST       0509; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Gold ER, 2002, NAT GENET, V30, P359, DOI 10.1038/ng0402-359; Gold ER, 2002, LANCET, V359, P2268, DOI 10.1016/S0140-6736(02)09298-X; GOLD ER, 2002, DEBATING BIOTECHNOLO, P163; Gold ER, 1999, COMMERCIALIZATION GE, P63; Gold R, 2002, CAN MED ASSOC J, V167, P256; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a; *MIN HLTH LONG TER, 2002, GEN TEST GEN PAT CHA; *ORG EC COOP DEV, 2002, GEN INV INT PROP RIT	10	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2003	361	9374					2002	2003		10.1016/S0140-6736(03)13674-4	http://dx.doi.org/10.1016/S0140-6736(03)13674-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814707	Green Published, hybrid			2022-12-01	WOS:000183488900004
J	Wu, XL; Li, Y; Crise, B; Burgess, SM				Wu, XL; Li, Y; Crise, B; Burgess, SM			Transcription start regions in the human genome are favored targets for MLV integration	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; RETROVIRAL INTEGRATION; GENE-THERAPY; DIRECTS INTEGRATION; DNA; MINICHROMOSOMES; ISLANDS; SITES	Factors contributing to retroviral integration have been intractable because past studies have not precisely located genomic sites of proviruses in sufficient numbers for significant analysis. In this study, 903 murine leukemia virus (MLV) and 379 human immunodeficiency virus-1 (HIV-1) integrations in the human genome were mapped. The data showed that MLV preferred integration near the start of transcriptional units ( either upstream or downstream) whereas HIV-1 preferred integration anywhere in the transcriptional unit but not upstream of the transcriptional start. Defining different integration site preferences for retroviruses will have important rami. cations for gene therapy and may aid in our understanding of the factors directing the integration process.	NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Sci Applicat Int Corp, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Science Applications International Corporation (SAIC)	Burgess, SM (corresponding author), NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.	burgess@mail.nih.gov	Wilson, Matthew H/K-3193-2013	Burgess, Shawn/0000-0003-1147-0596	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000183] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BUSHMAN FD, 1994, P NATL ACAD SCI USA, V91, P9233, DOI 10.1073/pnas.91.20.9233; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Kaiser J, 2003, SCIENCE, V299, P495, DOI 10.1126/science.299.5606.495; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; MOOSLEHNER K, 1990, J VIROL, V64, P3056, DOI 10.1128/JVI.64.6.3056-3058.1990; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, P NATL ACAD SCI USA, V89, P9237, DOI 10.1073/pnas.89.19.9237; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; SCATCHERI P, COMMUNICATION; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Weidhaas JB, 2000, J VIROL, V74, P8382, DOI 10.1128/JVI.74.18.8382-8389.2000	18	1033	1101	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1749	1751		10.1126/science.1083413	http://dx.doi.org/10.1126/science.1083413			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805549				2022-12-01	WOS:000183459700052
J	Fenton, KA; Ison, C; Johnson, AP; Rudd, E; Soltani, M; Martin, I; Nichols, T; Livermore, DM				Fenton, KA; Ison, C; Johnson, AP; Rudd, E; Soltani, M; Martin, I; Nichols, T; Livermore, DM		GRASP Collaboration	Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002	LANCET			English	Article								The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) monitors trends in antimicrobial resistance in consecutive gonococcal isolates from 26 genitourinary medicine clinics in England and Wales. In 2002, 2204 gonococcal isolates were tested, and the overall prevalence of ciprofloxacin resistance (minimum Inhibitory concentration greater than or equal to1 mg/L) was 9.8%, compared with 3.1% in 2001 and 2.1% in 2000. Between 2001 and 2002, prevalence of ciprofloxacin resistance increased two to three-fold, irrespective of recent sexual contact overseas, sex, or residence within or outside of London. These findings suggest that national and local treatment guidelines need to be reviewed urgently.	Hlth Protect Agcy, HIV STI Div, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Hlth Protect Agcy, Cent Publ Hlth Lab, London NW9 5EQ, England; UCL Royal Free & UCL Med Sch, Ctr Infect Dis Epidemiol, Dept Primary Care, London, England; UCL Royal Free & UCL Med Sch, Ctr Infect Dis Epidemiol, Dept Populat Sci, London, England; UCL Royal Free & UCL Med Sch, Ctr Infect Dis Epidemiol, Dept Sexually Transmitted Dis, London, England; Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Microbiol, London, England	Health Protection Agency; Health Protection Agency; Public Health England; University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Fenton, KA (corresponding author), Hlth Protect Agcy, HIV STI Div, Ctr Communicable Dis Surveillance, 61 Colindale Ave, London NW9 5EQ, England.	kevin.fenton@hpa.org.uk	Johnson, Alan P/F-4420-2014					*CDC, 2002, SEX TRANSM DIS SURV; *CLIN EFF GROUP AS, 2001 NAT GUID MAN GO; *GRASP STEER GROUP, 2002, GON RES ANT SURV PRO; HARDIH J, SMALL SAMPLE ADJUSTM; Ross JDC, 2002, INT J STD AIDS, V13, P499, DOI 10.1258/09564620260079671	5	75	78	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1867	1869		10.1016/S0140-6736(03)13489-7	http://dx.doi.org/10.1016/S0140-6736(03)13489-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788575				2022-12-01	WOS:000183205800013
J	Kryukov, GV; Castellano, S; Novoselov, SV; Lobanov, AV; Zehtab, O; Guigo, R; Gladyshev, VN				Kryukov, GV; Castellano, S; Novoselov, SV; Lobanov, AV; Zehtab, O; Guigo, R; Gladyshev, VN			Characterization of mammalian selenoproteomes	SCIENCE			English	Article							RNA STRUCTURAL MOTIF; SELENOCYSTEINE INSERTION; CONTAINING PROTEINS; MESSENGER-RNAS; HUMAN GENOME; IN-SILICO; SELENIUM; IDENTIFICATION; SEQUENCE; TRANSLATION	In the genetic code, UGA serves as a stop signal and a selenocysteine codon, but no computational methods for identifying its coding function are available. Consequently, most selenoprotein genes are misannotated. We identified selenoprotein genes in sequenced mammalian genomes by methods that rely on identification of selenocysteine insertion RNA structures, the coding potential of UGA codons, and the presence of cysteine-containing homologs. The human selenoproteome consists of 25 selenoproteins.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Pompeu Fabra, Ctr Regulacio Genom, Inst Municipal Invest Med, Grp Recerca Informat Biomed, Barcelona 08003, Catalonia, Spain	University of Nebraska System; University of Nebraska Lincoln; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	; Castellano, Sergi/A-7437-2016	Novoselov, Sergey/0000-0003-0104-6492; Kryukov, Gregory/0000-0002-6131-9483; Gladyshev, Vadim/0000-0002-0372-7016; Castellano, Sergi/0000-0002-5819-4210	NIGMS NIH HHS [GM61603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behne D, 1996, BIOL TRACE ELEM RES, V55, P99, DOI 10.1007/BF02784172; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bock A, 2000, Biofactors, V11, P77; Burk RF, 1999, BIOESSAYS, V21, P231, DOI 10.1002/(SICI)1521-1878(199903)21:3<231::AID-BIES7>3.3.CO;2-4; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Cataldo L, 1996, MOL REPROD DEV, V45, P320, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;320::AID-MRD9&gt;3.0.CO;2-U; Combs GF, 2001, BIOFACTORS, V14, P153, DOI 10.1002/biof.5520140120; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; DEAR TN, 1991, BIOCHEMISTRY-US, V30, P10376, DOI 10.1021/bi00107a003; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Kent WJ, 2001, GENOME RES, V11, P1541, DOI 10.1101/gr.183201; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kryukov GV, 2002, METHOD ENZYMOL, V347, P84; KRYUKOV GV, UNPUB; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Martin-Romero FJ, 2001, J BIOL CHEM, V276, P29798, DOI 10.1074/jbc.M100422200; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walczak R, 1996, RNA, V2, P367	27	1673	1783	14	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2003	300	5624					1439	1443		10.1126/science.1083516	http://dx.doi.org/10.1126/science.1083516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775843	Green Submitted			2022-12-01	WOS:000183181800048
J	Horsley, V; Jansen, KM; Mills, ST; Pavlath, GK				Horsley, V; Jansen, KM; Mills, ST; Pavlath, GK			IL-4 acts as a myoblast recruitment factor during mammalian muscle growth	CELL			English	Article							MEDIATED GENE-THERAPY; SKELETAL-MUSCLE; FUSION; CELLS; EXPRESSION; RECEPTOR; DIFFERENTIATION; TRANSCRIPTION; PATHWAY; HYPERTROPHY	Skeletal muscle formation and growth require the fusion of myoblasts to form multinucleated myofibers or myotubes, but few molecules are known to regulate myoblast fusion in mammals. The transcription factor NFATc2 controls myoblast fusion at a specific stage of myogenesis after the initial formation of a myotube and is necessary for further cell growth. By examining genes regulated by NFATc2 in muscle, this study identifies the cytokine IL-4 as a molecular signal that controls myoblast fusion with myotubes. Muscle cells lacking IL-4 or the IL-4alpha receptor subunit form normally but are reduced in size and myonuclear number. IL-4 is expressed by a subset of muscle cells in fusing muscle cultures and requires the IL-4alpha receptor subunit on myoblasts to promote fusion and growth. These data demonstrate that following myotube formation, myotubes recruit myoblast fusion by secretion of IL-4, leading to muscle growth.	Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Pavlath, GK (corresponding author), Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA.		Jansen, Kaspar/AAF-2762-2019		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047314, R01AR048884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-48884, AR-47314] Funding Source: Medline; NIDCR NIH HHS [DE-13040] Funding Source: Medline; NIGMS NIH HHS [T32-GM08367] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Barks JL, 1997, J IMMUNOL, V159, P4532; Barnoy S, 1996, BIOCHEM BIOPH RES CO, V220, P933, DOI 10.1006/bbrc.1996.0509; BLAU HM, 1995, NEW ENGL J MED, V333, P1554, DOI 10.1056/NEJM199512073332308; Constantin B, 1996, CELL CALCIUM, V19, P365, DOI 10.1016/S0143-4160(96)90109-8; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827; DeFife KM, 1997, J IMMUNOL, V158, P3385; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; DOERING JL, 1977, EXP CELL RES, V105, P437, DOI 10.1016/0014-4827(77)90140-9; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Gorza L, 2000, FASEB J, V14, P461, DOI 10.1096/fasebj.14.3.461; HARRIS AJ, 1989, DEVELOPMENT, V107, P771; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Huerta L, 2002, CYTOMETRY, V47, P100, DOI 10.1002/cyto.10051; KITAZAWA S, 1995, J BIOL CHEM, V270, P4115, DOI 10.1074/jbc.270.8.4115; KONIGSBERG IR, 1971, DEV BIOL, V26, P133, DOI 10.1016/0012-1606(71)90113-8; LIND M, 1995, CYTOKINE, V7, P78, DOI 10.1006/cyto.1995.1010; Marino M, 2001, J NEUROIMMUNOL, V116, P94, DOI 10.1016/S0165-5728(01)00287-9; MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; MNALLY AK, 2002, AM J PATH9OL, V160, P621; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Murata T, 1998, BLOOD, V91, P3884; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Phelan JN, 1997, ANAT REC, V247, P179, DOI 10.1002/(SICI)1097-0185(199702)247:2<179::AID-AR4>3.0.CO;2-T; Rahaman SO, 2002, CANCER RES, V62, P1103; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rau A, 2001, DEVELOPMENT, V128, P5061; Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; ROSEN SD, 1992, TRENDS GLYCOSCI GLYC, V4, P1; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1; WAKELAM MJO, 1985, BIOCHEM J, V228, P1; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; YEOH GCT, 1977, EXP CELL RES, V104, P63, DOI 10.1016/0014-4827(77)90069-6; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207	44	370	399	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					483	494		10.1016/S0092-8674(03)00319-2	http://dx.doi.org/10.1016/S0092-8674(03)00319-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757709	Bronze			2022-12-01	WOS:000182981500010
J	Strang, J; McCambridge, J; Best, D; Beswick, T; Bearn, J; Rees, S; Gossop, M				Strang, J; McCambridge, J; Best, D; Beswick, T; Bearn, J; Rees, S; Gossop, M			Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England; Maudsley Hosp & Inst Psychiat, London SE5 8AF, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Strang, J (corresponding author), Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.	j.strang@iop.kcl.ac.uk	Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; Best, David/0000-0002-6792-916X; McCambridge, Jim/0000-0002-5461-7001				Advisory Council on the Misuse of Drugs, 2000, RED DRUG REL DEATHS; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; Caplehorn JRM, 1998, DRUG ALCOHOL REV, V17, P9, DOI 10.1080/09595239800187551; Farrell M, 1996, ADDICTION, V91, P321, DOI 10.1111/j.1360-0443.1996.tb02282.x; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x	5	207	211	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2003	326	7396					959	960		10.1136/bmj.326.7396.959	http://dx.doi.org/10.1136/bmj.326.7396.959			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676JC	12727768	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000182746700016
J	Lin, SY; Elledge, SJ				Lin, SY; Elledge, SJ			Multiple tumor suppressor pathways negatively regulate telomerase	CELL			English	Article							REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; CELLULAR SENESCENCE; MENIN INTERACTS; DOWN-REGULATION; IMMORTAL CELLS; CANCER-CELLS; LIFE-SPAN; EXPRESSION; P53	Telomerase expression is repressed in most somatic cells but is observed in stem cells and a high percentage of human cancers and has been hypothesized to contribute to tumorigenesis and maintenance of stem cell states. To explore telomerase regulation, we employed a general genetic screen to identify negative regulators of hTERT. We discovered three tumor suppressor/oncogene pathways involved in hTERT repression. One, the Mad1/c-Myc pathway, had been previously implicated in hTERT regulation. The second, SIPI, a transcriptional target of the TGF-beta pathway, mediates the TGF-beta regulated repression of hTERT. The third, the tumor suppressor Menin, is a direct repressor of hTERT. Depleting Menin immortalizes primary human fibroblasts and causes a transformation phenotype when coupled with expression of SV40 Large and Small T antigen and oncogenic ras. These studies suggest that multiple tumor suppressor/oncogene pathways coordinately repress hTERT expression and imply that telomerase is reactivated in human tumors through oncogenic mutations.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	selledge@bcm.tmc.edu			NCI NIH HHS [1 F32 CA93943] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; AYER DE, 1996, MOL CELL BIOL, V38, P2222; Blasco MA, 2002, EUR J CANCER, V38, P2222, DOI 10.1016/S0959-8049(02)00450-1; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; CRAVEN RJ, 1995, CANCER RES, V55, P3969; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hahn WC, 2001, ANN MED, V33, P123, DOI 10.3109/07853890109002067; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liu D, 2000, ONCOGENE, V19, P5964, DOI 10.1038/sj.onc.1203992; LUSKY M, 1981, NATURE, V293, P79, DOI 10.1038/293079a0; Marx S, 1998, ANN INTERN MED, V129, P484, DOI 10.7326/0003-4819-129-6-199809150-00011; Mason PJ, 2003, BIOESSAYS, V25, P126, DOI 10.1002/bies.10229; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Minamino T, 2001, MOL CELL BIOL, V21, P3336, DOI 10.1128/MCB.21.10.3336-3342.2001; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Oh S, 2000, ONCOGENE, V19, P1485, DOI 10.1038/sj.onc.1203439; Oshimura M, 1997, EUR J CANCER, V33, P710, DOI 10.1016/S0959-8049(97)00090-7; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; REARDON DB, 1993, J BIOL CHEM, V268, P18136; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rufer N, 2001, BLOOD, V98, P597, DOI 10.1182/blood.V98.3.597; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sood AK, 2002, CANCER BIOL THER, V1, P511, DOI 10.4161/cbt.1.5.167; Stampfer MR, 2001, P NATL ACAD SCI USA, V98, P4498, DOI 10.1073/pnas.071483998; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Takakura M, 1999, CANCER RES, V59, P551; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Xu DW, 2001, P NATL ACAD SCI USA, V98, P3826, DOI 10.1073/pnas.071043198; Yang H, 2001, CELL GROWTH DIFFER, V12, P119; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	68	349	371	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2003	113	7					881	889		10.1016/S0092-8674(03)00430-6	http://dx.doi.org/10.1016/S0092-8674(03)00430-6			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837246	Bronze			2022-12-01	WOS:000183817900012
J	Miyazawa, A; Fujiyoshi, Y; Unwin, N				Miyazawa, A; Fujiyoshi, Y; Unwin, N			Structure and gating mechanism of the acetylcholine receptor pore	NATURE			English	Article							ION-CHANNEL; M2 DOMAIN; TUBULAR CRYSTALS; LIGAND-BINDING; DELTA-SUBUNIT; ALPHA-SUBUNIT; PROTEIN; RESOLUTION; LOCATION; SEGMENT	The nicotinic acetylcholine receptor controls electrical signalling between nerve and muscle cells by opening and closing a gated, membrane-spanning pore. Here we present an atomic model of the closed pore, obtained by electron microscopy of crystalline postsynaptic membranes. The pore is shaped by an inner ring of 5 alpha-helices, which curve radially to create a tapering path for the ions, and an outer ring of 15 alpha-helices, which coil around each other and shield the inner ring from the lipids. The gate is a constricting hydrophobic girdle at the middle of the lipid bilayer, formed by weak interactions between neighbouring inner helices. When acetylcholine enters the ligand-binding domain, it triggers rotations of the protein chains on opposite sides of the entrance to the pore. These rotations are communicated through the inner helices, and open the pore by breaking the girdle apart.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; RIKEN, Harima Inst, Sayo, Hyogo 6795148, Japan; Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	MRC Laboratory Molecular Biology; RIKEN; Kyoto University	Unwin, N (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	mas@mrc-lmb.cam.ac.uk	Fujiyoshi, Yoshinori/E-5989-2012	Fujiyoshi, Yoshinori/0000-0002-8070-1493				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Beckstein O, 2001, J PHYS CHEM B, V105, P12902, DOI 10.1021/jp012233y; Beroukhim R, 1997, ULTRAMICROSCOPY, V70, P57, DOI 10.1016/S0304-3991(97)00070-3; Blanton MP, 1998, J BIOL CHEM, V273, P8659, DOI 10.1074/jbc.273.15.8659; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BRISSON A, 1984, J CELL BIOL, V99, P1202, DOI 10.1083/jcb.99.4.1202; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Colquhoun D., 2003, BURGERS MED CHEM DRU, P357; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Croxen R, 1997, HUM MOL GENET, V6, P767, DOI 10.1093/hmg/6.5.767; DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; HENDERSON R, 1992, ULTRAMICROSCOPY, V46, P1, DOI 10.1016/0304-3991(92)90003-3; HEUSER JE, 1979, J CELL BIOL, V82, P150, DOI 10.1083/jcb.82.1.150; Hille B., 2001, ION CHANNELS EXCITAB, V3; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KLUG A, 1958, ACTA CRYSTALLOGR, V11, P199, DOI 10.1107/S0365110X58000517; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; TOYOSHIMA C, 1988, NATURE, V336, P247, DOI 10.1038/336247a0; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m	48	1020	1058	4	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2003	423	6943					949	955		10.1038/nature01748	http://dx.doi.org/10.1038/nature01748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827192				2022-12-01	WOS:000183753900040
J	Grabenstein, JD; Winkenwerder, W				Grabenstein, JD; Winkenwerder, W			US military smallpox vaccination program experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS; VACCINIA; RISKS	Context The United States recently implemented smallpox vaccination of selected military personnel in a national program of preparedness against use of smallpox as a biological. weapon. The resumption of smallpox vaccinations raises important questions regarding implementation and safety. Objective To describe the US military smallpox vaccination program. Design Descriptive study of the vaccination program from its inception on December 13, 2002, through May 28, 2003. Setting US Department of Defense (DoD) fixed and field medical treatment facilities on multiple continents and ships at sea. Subjects US service members and DoD civilian workers eligible for smallpox vaccination. Main Outcome Measures Numbers of vaccinations and rates of vaccination exemptions, symptoms, and adverse events. Data were collected via reports to headquarters and rigorous surveillance for sentinel events. Results In 5.5 months, the DoD administered 450293 smallpox vaccinations (70.5% primary vaccinees and 29.5% revaccinees). In 2 settings, 0.5% and 3.0% of vaccine recipients needed short-term sick leave. Most adverse events occurred at rates below historical rates. One case of encephalitis and 37 cases of acute myopericarditis developed after vaccination; all cases recovered. Among 19461 worker-months of clinical contact, there were no cases of transmission of vaccinia from worker to patient, no cases of eczema vaccinatum or progressive vaccinia, and no attributed deaths. Conclusions Mass smallpox vaccinations can be conducted safely with very low rates of serious adverse events. Program implementation emphasized human factors: careful staff training, contraindication screening, recipient education, and attention to bandaging. Our experience suggests that broad smallpox vaccination programs may be implemented with fewer serious adverse events than previously believed.	USA, Mil Vaccine Agcy, Med Command, Falls Church, VA 22041 USA; Pentagon, Washington, DC USA		Grabenstein, JD (corresponding author), USA, Mil Vaccine Agcy, Med Command, 5111 Leesburg Pike,Suite 401, Falls Church, VA 22041 USA.	john.grabenstein@us.army.mil	Grabenstein, John/Y-7322-2019					*ADV COMM IMM PRAC, 2003, MMWR RECOMM REP, V52, P1; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P1; *ARM FORC EP BOARD, 1977, REP AD HOC SUBC SMAL; *ARM FORC EP BOARD, 1981, MIN JUN 11 1981 M; CDC Center for Disease Control and Prevention, 1985, MMWR-MORBID MORTAL W, V34, P182; *CDCP, 1982, MMWR-MORBID MORTAL W, V31, P682; *CDCP, 1984, MMWR-MORBID MORTAL W, V33, P37; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P419; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P191; *CDCP, 2002, SMALL POX RESP PLAN; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P180; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P256; *CDCP, 1983, MMWR-MORBID MORTAL W, V32, P403; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P386; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P278; COATES JB, 1964, MED DEP US ARMY WORL, V7, P17; COATES JB, 1955, MED DEP US ARMY WORL, V3, P280; DUNCAN LC, 1932, MIL SURG, V71, P439; Fenner F., 1988, SMALLPOX ITS ERADICA; GILLETT MC, 1981, ARMY MED DEP 1775 18, P56; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; *I MED, 2003, 1 I MED NAT AC SCI; KARJALAINEN J, 1983, ACTA MED SCAND, V213, P65; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; Lane JM, 2003, ANN INTERN MED, V138, P488, DOI 10.7326/0003-4819-138-6-200303180-00014; LANE JM, 1971, AM J EPIDEMIOL, V93, P238, DOI 10.1093/oxfordjournals.aje.a121252; LANE JM, 1971, ANNU REV MED, V22, P251, DOI 10.1146/annurev.me.22.020171.001343; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; *WYETH LAB, 2002, SMALLP VACC DRIED CA; 1995, US DEP DEFENSE SMALL	32	152	156	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3278	3282		10.1001/jama.289.24.3278	http://dx.doi.org/10.1001/jama.289.24.3278			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693EX	12824209	Bronze			2022-12-01	WOS:000183704600021
J	Ackermann, M; Stearns, SC; Jenal, U				Ackermann, M; Stearns, SC; Jenal, U			Senescence in a bacterium with asymmetric division	SCIENCE			English	Article									Univ Basel, Bioctr, Div Mol Microbiol, CH-4056 Basel, Switzerland; Yale Univ, Osborn Mem Labs, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	University of Basel; Yale University	Ackermann, M (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	MKAckerm@ucsd.edu	Ackermann, Martin/V-4554-2017	Ackermann, Martin/0000-0003-0087-4819; Stearns, Stephen/0000-0002-6621-4373				Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; MEDAWAR PB, 2002, UNSOLVED PROBLEM BIO; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Rose MR, 1991, EVOLUTIONARY BIOL AG; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	8	183	188	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1920	1920		10.1126/science.1083532	http://dx.doi.org/10.1126/science.1083532			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817142				2022-12-01	WOS:000183619400037
J	Sakai, T; Larsen, M; Yamada, KM				Sakai, T; Larsen, M; Yamada, KM			Fibronectin requirement in branching morphogenesis	NATURE			English	Article							CELL-MATRIX ADHESIONS; SALIVARY-GLAND; SUBMANDIBULAR-GLAND; EPITHELIUM; CADHERIN; SURFACE; LUNG	Many organs, including salivary glands, lung and kidney, are formed during embryonic development by epithelial branching. In branching morphogenesis, repetitive epithelial cleft and bud formation create the complex three-dimensional branching structures characteristic of many organs(1-3). Although the mechanisms are poorly understood, one might involve the site-specific accumulation of some regulatory protein. Here we show that the extracellular matrix protein fibronectin(4,5) is essential for cleft formation during the initiation of epithelial branching. Fibronectin messenger RNA and fibrils appeared transiently and focally in forming cleft regions of submandibular salivary-gland epithelia, accompanied by an adjacent loss of cadherin localization. Decreasing the fibronectin concentration by using small interfering RNA and inhibition by anti-fibronectin or anti-integrin antibodies blocked cleft formation and branching. Exogenous fibronectin accelerated cleft formation and branching. Similar effects of fibronectin suppression and augmentation were observed in developing lung and kidney. Mechanistic studies revealed that fibrillar fibronectin can induce cell-matrix adhesions on cultured human salivary epithelial cells with a local loss of cadherins at cell-cell junctions. Thus, fibronectin expression is required for cleft formation in branching morphogenesis associated with the conversion of cell-cell adhesions to cell-matrix adhesions.	Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Yamada, KM (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.		Sakai, Takayoshi/L-1456-2019	Sakai, Takayoshi/0000-0003-4348-4896; Yamada, Kenneth/0000-0003-1512-6805; Larsen, Melinda/0000-0002-5026-2012	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000525, ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524, Z01DE000525] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BERNFIELD MR, 1972, J CELL BIOL, V52, P674, DOI 10.1083/jcb.52.3.674; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davies JA, 2002, BIOESSAYS, V24, P937, DOI 10.1002/bies.10161; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; GILBERT SF, 1997, DEV BIOL, P683; GROBSTEIN C, 1953, NATURE, V172, P869, DOI 10.1038/172869a0; GROBSTEIN C, 1965, SCIENCE, V150, P626, DOI 10.1126/science.150.3696.626; HARDMAN P, 1992, ANAT REC, V234, P452, DOI 10.1002/ar.1092340315; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hogan BLM, 1998, CURR OPIN GENET DEV, V8, P481, DOI 10.1016/S0959-437X(98)80121-4; Hynes R. O., 1990, FIBRONECTINS; Jiang ST, 2000, KIDNEY INT, V57, P1860, DOI 10.1046/j.1523-1755.2000.00035.x; KADOYA Y, 1995, J CELL BIOL, V129, P521, DOI 10.1083/jcb.129.2.521; Kashimata M, 2000, DEV BIOL, V220, P183, DOI 10.1006/dbio.2000.9639; Levenberg S, 1998, J CELL SCI, V111, P347; Menko AS, 2002, DEV DYNAM, V224, P321, DOI 10.1002/dvdy.10111; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Mosher DF, 1989, FIBRONECTIN; NAKANISHI Y, 1986, DEV BIOL, V113, P201, DOI 10.1016/0012-1606(86)90122-3; NAKANISHI Y, 1988, DEVELOPMENT, V104, P51; NOGAWA H, 1991, DEVELOPMENT, V112, P855; Roman J, 1997, EXP LUNG RES, V23, P147, DOI 10.3109/01902149709074027; SAKAI T, 2002, CURRENT PROTOCOLS CE; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; SPOONER BS, 1972, DEV BIOL, V27, P38, DOI 10.1016/0012-1606(72)90111-X; Spooner BS, 1986, DEV BIOL COMPREHENSI, V3, P225; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0	30	386	393	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					876	881		10.1038/nature01712	http://dx.doi.org/10.1038/nature01712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815434				2022-12-01	WOS:000183585300048
J	Whitney, D; Westwood, DA; Goodale, MA				Whitney, D; Westwood, DA; Goodale, MA			The influence of visual motion on fast reaching movements to a stationary object	NATURE			English	Article							PERCEIVED POSITION; SPACE; PERCEPTION; TARGET; HAND; DISPLACEMENT; INFORMATION; LOCATION; SYSTEMS; VISION	One of the most important functions of vision is to direct actions to objects(1). However, every time that vision is used to guide an action, retinal motion signals are produced by the movement of the eye and head as the person looks at the object or by the motion of other objects in the scene. To reach for the object accurately, the visuomotor system must separate information about the position of the stationary target from background retinal motion signals-a long-standing problem that is poorly understood(2-7). Here we show that the visuomotor system does not distinguish between these two information sources: when observers made fast reaching movements to a briefly presented stationary target, their hand shifted in a direction consistent with the motion of a distant and unrelated stimulus, a result contrary to most other findings(8,9). This can be seen early in the hand's trajectory (similar to120 ms) and occurs continuously from programming of the movement through to its execution. The visuomotor system might make use of the motion signals arising from eye and head movements to update the positions of targets rapidly and redirect the hand to compensate for body movements.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada; Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS B3H 3J5, Canada	Western University (University of Western Ontario); Dalhousie University	Whitney, D (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada.		Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561; Westwood, David/0000-0003-3317-0447	NEI NIH HHS [F32 EY013899-02, F32 EY013899-03, F32 EY013899-01, F32 EY013899] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY013899] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAMS RA, 1990, PERCEPT PSYCHOPHYS, V47, P349, DOI 10.3758/BF03210875; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; [Anonymous], [No title captured]; BACON JH, 1982, PERCEPT PSYCHOPHYS, V32, P353, DOI 10.3758/BF03206241; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BLOUIN J, 1995, NEUROREPORT, V6, P1165, DOI 10.1097/00001756-199505300-00023; Brenner E, 1997, J MOTOR BEHAV, V29, P297, DOI 10.1080/00222899709600017; BRIDGEMAN B, 1979, J EXP PSYCHOL HUMAN, V5, P692, DOI 10.1037/0096-1523.5.4.692; Bridgeman B, 1997, PERCEPT PSYCHOPHYS, V59, P456, DOI 10.3758/BF03211912; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Hayes A, 2000, P ROY SOC B-BIOL SCI, V267, P1341, DOI 10.1098/rspb.2000.1148; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; LEPECQ JC, 1993, PERCEPTION, V22, P49, DOI 10.1068/p220049; MASSON G, 1995, VISION RES, V35, P837, DOI 10.1016/0042-6989(94)00185-O; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; PAULIGNAN Y, 1990, EXP BRAIN RES, V79, P431, DOI 10.1007/BF00608255; PELISSON D, 1986, EXP BRAIN RES, V62, P303; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Sheth BR, 2000, PERCEPTION, V29, P1279, DOI 10.1068/p3114; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; Snowden RJ, 1998, CURR BIOL, V8, P1343, DOI 10.1016/S0960-9822(07)00567-2; Whitaker D, 1999, VISION RES, V39, P2999, DOI 10.1016/S0042-6989(99)00010-3; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; WONG E, 1981, ACTA PSYCHOL, V48, P123, DOI 10.1016/0001-6918(81)90054-8; Yamagishi N, 2001, P ROY SOC B-BIOL SCI, V268, P973, DOI 10.1098/rspb.2001.1603	30	93	93	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					869	873		10.1038/nature01693	http://dx.doi.org/10.1038/nature01693			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691BQ	12815432	Green Accepted			2022-12-01	WOS:000183585300046
J	Ellwood, BB; Benoist, SL; El Hassani, A; Wheeler, C; Crick, RE				Ellwood, BB; Benoist, SL; El Hassani, A; Wheeler, C; Crick, RE			Impact ejecta layer from the mid-Devonian: Possible connection to global mass extinctions	SCIENCE			English	Article							MAGNETOSUSCEPTIBILITY EVENT; CYCLOSTRATIGRAPHY MSEC; ANTI-ATLAS; BOUNDARY; MOROCCO; MOUNDS; ROCKS	We have found evidence for a bolide impacting Earth in the mid-Devonian (similar to380 million years ago), including high concentrations of shocked quartz, Ni, Cr, As, V, and Co anomalies; a large negative carbon isotope shift (-9 per mil); and microspherules and microcrysts at Jebel Mech Irdane in the Anti Atlas desert near Rissani, Morocco. This impact is important because it is coincident with a major global extinction event (Kacak/otomari event), suggesting a possible cause-and-effect relation between the impact and the extinction. The result may represent the extinction of as many as 40% of all living marine animal genera.	Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; Inst Sci, Dept Geol, Rabat, Morocco; Univ Texas, Dept Geol, Arlington, TX 76019 USA	Louisiana State University System; Louisiana State University; Mohammed V University in Rabat; University of Texas System; University of Texas Arlington	Ellwood, BB (corresponding author), Louisiana State Univ, Dept Geol & Geophys, E235 Howe Russell Geosci Complex, Baton Rouge, LA 70803 USA.			EL HASSANI, Ahmed/0000-0002-2272-817X				Crick RE, 1997, EPISODES, V20, P167, DOI 10.18814/epiiugs/1997/v20i3/004; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Ellwood BB, 2003, EARTH PLANET SC LETT, V206, P529, DOI 10.1016/S0012-821X(02)01124-X; Ellwood BB, 2000, GEOLOGY, V28, P1135, DOI 10.1130/0091-7613(2000)028<1135:MEACMA>2.3.CO;2; Ellwood BB, 1999, AAPG BULL, V83, P1119; FRENCH BM, 1998, LUNAR PLANET I CONTR, V954; GRIEVE RAF, 1988, CAN J EARTH SCI, V25, P1530, DOI 10.1139/e88-144; HLADIL J, 2002, CORAL RES B, V7, P65; HOUSE MR, 1985, NATURE, V313, P17, DOI 10.1038/313017a0; HSU KJ, 1985, NATURE, V316, P809, DOI 10.1038/316809a0; IRWIN H, 1977, NATURE, V269, P209, DOI 10.1038/269209a0; JOHNSON JG, 1985, GEOL SOC AM BULL, V96, P567, DOI 10.1130/0016-7606(1985)96<567:DEFIE>2.0.CO;2; Kaufmann B, 1997, J SEDIMENT RES, V67, P945; KUMP LR, 1991, GEOLOGY, V19, P299, DOI 10.1130/0091-7613(1991)019<0299:ICIESO>2.3.CO;2; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Salvador A, 1994, INT STRATIGRAPHIC GU; SMIT J, 1997, MICROPALEONTOLOGY, V29, P65; SMIT J, 1982, CRETACEOUS RES, V3, P307, DOI DOI 10.1016/0195-6671(82)90031-3; SPEKOSKI JJ, 1996, GLOBAL EVENTS EVENT, P35; TALENT JA, 1993, PALAEOGEOGR PALAEOCL, V104, P139, DOI 10.1016/0031-0182(93)90126-4; Walliser OH, 1995, EPISODES, V18, P107, DOI 10.18814/epiiugs/1995/v18i3/002; Wendt J, 1997, J SEDIMENT RES, V67, P424	22	39	42	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1734	1737		10.1126/science.1081544	http://dx.doi.org/10.1126/science.1081544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805544				2022-12-01	WOS:000183459700047
J	Zhao, J; Kilman, VL; Keegan, KP; Peng, Y; Emery, P; Rosbash, M; Allada, R				Zhao, J; Kilman, VL; Keegan, KP; Peng, Y; Emery, P; Rosbash, M; Allada, R			Drosophila clock can generate ectopic circadian clocks	CELL			English	Article							PER-TIM COMPLEX; MUSHROOM BODIES; TIMELESS GENES; EXPRESSION; TRANSCRIPTION; RHYTHMS; PROTEIN; VRILLE; FLIES; PHOTORECEPTORS	Circadian rhythms of behavior, physiology, and gene expression are present in diverse tissues and organisms. The function of the transcriptional activator, Clock, is necessary in both Drosophila and mammals for the expression of many core clock components. We demonstrate in Drosophila that Clock misexpression in naive brain regions induces circadian gene expression. This includes major components of the pacemaker program, as Clock also activates the rhythmic expression of cryptochrome, a gene that CLOCK normally represses. Moreover, this ectopic clock expression has potent effects on behavior, radically altering locomotor activity patterns. We propose that Clock is uniquely able to induce and organize the core elements of interdependent feedback loops necessary for circadian rhythms.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA	Northwestern University; Brandeis University; Howard Hughes Medical Institute	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.							Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bonini NM, 1997, DEVELOPMENT, V124, P4819; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 1998, CURR OPIN NEUROBIOL, V8, P652, DOI 10.1016/S0959-4388(98)80095-0; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; YANG MY, 1995, NEURON, V15, P45	36	100	101	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 13	2003	113	6					755	766		10.1016/S0092-8674(03)00400-8	http://dx.doi.org/10.1016/S0092-8674(03)00400-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809606	Bronze			2022-12-01	WOS:000183514400010
J	Atkinson, MR; Savageau, MA; Myers, JT; Ninfa, AJ				Atkinson, MR; Savageau, MA; Myers, JT; Ninfa, AJ			Development of genetic circuitry exhibiting toggle switch or oscillatory behavior in Escherichia coli	CELL			English	Article							GLUTAMINE-SYNTHETASE; NITROGEN STARVATION; GLNA PROMOTER; EXPRESSION; OPERON; CYANOBACTERIA; TRANSCRIPTION; RHYTHMS; PROTEIN; PRODUCT	Analysis of the system design principles of signaling systems requires model systems where all components and regulatory interactions are known. Components of the Lac and Ntr systems were used to construct genetic circuits that display toggle switch or oscillatory behavior. Both devices contain an "activator module" consisting of a modified glnA promoter with lac operators, driving the expression of the activator, NRI. Since NRI activates the glnA promoter, this creates an autoactivated circuit repressible by Lacl. The oscillator contains a "repressor module" consisting of the NRI-activated glnK promoter driving Lacl expression. This circuitry produced synchronous damped oscillations in turbidostat cultures, with periods much longer than the cell cycle. For the toggle switch, Lacl was provided constitutively; the level of active repressor was controlled by using a lacY mutant and varying the concentration of IPTG. This circuitry provided nearly discontinuous expression of activator.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ninfa, AJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.				NIGMS NIH HHS [R01-GM63642] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063642] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkinson MR, 2002, MOL MICROBIOL, V46, P1247, DOI 10.1046/j.1365-2958.2002.03211.x; Atkinson MR, 2002, J BACTERIOL, V184, P5358, DOI 10.1128/JB.184.19.5358-5363.2002; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Beckwith J, 1987, ESCHERICHIA COLI SAL, P1444; Blauwkamp TA, 2002, MOL MICROBIOL, V46, P203, DOI 10.1046/j.1365-2958.2002.03153.x; CHEN YM, 1982, J BACTERIOL, V150, P214, DOI 10.1128/JB.150.1.214-220.1982; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Kondo T, 1997, SCIENCE, V275, P224, DOI 10.1126/science.275.5297.224; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Ninfa AJ, 2000, CURR TOP CELL REGUL, V36, P31; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; REITZER LJ, 1985, P NATL ACAD SCI USA, V82, P1979, DOI 10.1073/pnas.82.7.1979; RHEE SG, 1985, METHOD ENZYMOL, V113, P213; ROTHSTEIN DM, 1980, P NATL ACAD SCI-BIOL, V77, P7372, DOI 10.1073/pnas.77.12.7372; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1975, NATURE, V258, P208, DOI 10.1038/258208a0; Savageau MA, 2002, MATH BIOSCI, V180, P237, DOI 10.1016/S0025-5564(02)00113-X; Silhavy T. J., 1984, EXPT GENE FUSIONS, P107; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504	25	513	527	5	81	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					597	607		10.1016/S0092-8674(03)00346-5	http://dx.doi.org/10.1016/S0092-8674(03)00346-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787501	Bronze			2022-12-01	WOS:000183397600010
J	Seto, WH; Tsang, D; Yung, RWH; Ching, TY; Ng, TK; Ho, M; Ho, LM; Peiris, JSM				Seto, WH; Tsang, D; Yung, RWH; Ching, TY; Ng, TK; Ho, M; Ho, LM; Peiris, JSM		Advisors Expert SARS Grp Hosp Auth	Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)	LANCET			English	Article								We did a case-control study in five Hong Kong hospitals, with 241 non-infected and 13 infected staff with documented exposures to 31 index patients with severe acute respiratory syndrome (SARS) during patient care. All participants were surveyed about use of mask, gloves, gowns, and hand-washing, as recommended under droplets and contact precautions when caring for index patients with SARS. 69 staff who reported use of all four measures were not infected, whereas all Infected staff had omitted at least one measure (p=0.0224). Fewer staff who wore masks (p=0.0001), gowns (p=0.006), and washed their hands (p=0.047) became infected compared with those who didn't, but stepwise logistic regression was significant only for masks (p=0.011). Practice of droplets precaution and contact precaution is adequate in significantly reducing the risk of infection after exposures to patients with SARS. The protective role of the mask suggests that in hospitals, infection is transmitted by droplets.	Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Queen Elizabeth Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Pamela Nethersole Youde Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Kwong Wah Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Kwong Wah Hospital; University of Hong Kong; University of Hong Kong	Seto, WH (corresponding author), Queen Mary Hosp, Dept Microbiol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		; Peiris, Joseph Sriyal Malik/C-4380-2009	Seto, Wing Hong/0000-0002-1139-9200; ho, lm/0000-0002-2709-927X; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	PHS HHS [A95357] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Garner JS, 1996, AM J INFECT CONTROL, V24, P24; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Rosling L, 2003, BRIT MED J, V326, P416, DOI 10.1136/bmj.326.7386.416; *US CDC, 2003, INF CONTR PREC AER G; World Health Organization, 2003, WHO ISS GLOB AL CAS	5	551	590	2	54	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 3	2003	361	9368					1519	1520		10.1016/S0140-6736(03)13168-6	http://dx.doi.org/10.1016/S0140-6736(03)13168-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737864	Green Published, Bronze			2022-12-01	WOS:000182658900012
J	Bibikova, M; Beumer, K; Trautman, JK; Carroll, D				Bibikova, M; Beumer, K; Trautman, JK; Carroll, D			Enhancing gene targeting with designed zinc finger nucleases	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; RESTRICTION ENZYMES; DROSOPHILA; CLEAVAGE; MUTAGENESIS; REPLACEMENT; SELECTION; DOMAINS		Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Carroll, D (corresponding author), Univ Utah, Sch Med, Dept Biochem, 20 North 1900 East, Salt Lake City, UT 84132 USA.		Wilson, Matthew H/K-3193-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058504] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58504] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Segal DJ, 2002, METHODS, V26, P76, DOI 10.1016/S1046-2023(02)00009-9; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; WONG WJ, 2003, P NATL ACAD SCI USA, V100, P2556	16	595	733	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					764	764		10.1126/science.1079512	http://dx.doi.org/10.1126/science.1079512			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730594				2022-12-01	WOS:000182579800040
J	Manzke, T; Guenther, U; Ponimaskin, EG; Haller, M; Dutschmann, M; Schwarzacher, S; Richter, DW				Manzke, T; Guenther, U; Ponimaskin, EG; Haller, M; Dutschmann, M; Schwarzacher, S; Richter, DW			5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia	SCIENCE			English	Article							5-HYDROXYTRYPTAMINE 4(A) RECEPTOR; ISOLATED RESPIRATORY NETWORK; PREBOTZINGER COMPLEX; RAT-BRAIN; NEURONS; PHARMACOLOGY; SEROTONIN; CLONING; RHYTHM	Opiates are widely used analgesics in anesthesiology, but they have serious adverse effects such as depression of breathing. This is caused by direct inhibition of rhythm-generating respiratory neurons in the Pre-Boetzinger complex (PBC) of the brainstem. We report that serotonin 4(a) [5-HT4(a)] receptors are strongly expressed in respiratory PBC neurons and that their selective activation protects spontaneous respiratory activity. Treatment of rats with a 5-HT4 receptor specific agonist overcame fentanyl-induced respiratory depression and reestablished stable respiratory rhythm without loss of fentanyl's analgesic effect. These findings imply the prospect of a fine-tuned recovery from opioid-induced respiratory depression, through adjustment of intracellular adenosine 3', 5'-monophosphate levels through the convergent signaling pathways in neurons.	Univ Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; Univ Gottingen, Ctr Anesthesiol, D-37075 Gottingen, Germany; Dept Anat, D-37075 Gottingen, Germany	University of Gottingen; University of Gottingen	Richter, DW (corresponding author), Univ Gottingen, Dept Neuro & Sensory Physiol, Humboldtallee 23, D-37073 Gottingen, Germany.			Dutschmann, Mathias/0000-0002-0692-746X; Ponimaskin, evgeni/0000-0002-4570-5130				Ballanyi K, 1997, J PHYSIOL-LONDON, V504, P127, DOI 10.1111/j.1469-7793.1997.127bf.x; BOCKAERT J, 1990, MOL PHARMACOL, V37, P408; Claeysen S, 1996, FEBS LETT, V398, P19, DOI 10.1016/S0014-5793(96)01132-5; Compan V, 1996, EUR J NEUROSCI, V8, P2591, DOI 10.1111/j.1460-9568.1996.tb01553.x; DENAVITSAUBIE M, 1978, BRAIN RES, V155, P55, DOI 10.1016/0006-8993(78)90305-0; Dunn EB, 2000, VET HUM TOXICOL, V42, P36; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guyenet PG, 2001, J NEUROPHYSIOL, V86, P438, DOI 10.1152/jn.2001.86.1.438; Heine M, 2002, PFLUG ARCH EUR J PHY, V443, P418, DOI 10.1007/s004240100690; HOYER D, 1994, PHARMACOL REV, V46, P157; Hynie S, 1995, Cesk Fysiol, V44, P135; LI YW, 1997, AM J PHYSIOL, V273, P805; MANZKE T, 2002, FENS FOR ABSTR, V1, P77; MORIN D, 1990, BRAIN RES, V535, P281, DOI 10.1016/0006-8993(90)91611-J; PATON JF, 1996, J NEUROSCI METH, V65, P6; Ponimaskin EG, 2002, J BIOL CHEM, V277, P20812, DOI 10.1074/jbc.M112216200; Ponimaskin EG, 2001, BIOCHEM J, V353, P627, DOI 10.1042/0264-6021:3530627; Richter DW, 1997, RESP PHYSIOL, V110, P113, DOI 10.1016/S0034-5687(97)00077-7; Richter DW, 2000, NEUROSCIENTIST, V6, P181, DOI 10.1177/107385840000600309; SMITH JC, 1992, NEUROSCI LETT, V134, P153, DOI 10.1016/0304-3940(92)90504-Z; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Takeda S, 2001, ANESTHESIOLOGY, V95, P740, DOI 10.1097/00000542-200109000-00029; Vilaro MT, 2002, NEUROPHARMACOLOGY, V42, P60, DOI 10.1016/S0028-3908(01)00154-X; Vilaro MT, 1996, MOL BRAIN RES, V43, P356, DOI 10.1016/S0169-328X(96)00248-3	25	204	230	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					226	229		10.1126/science.1084674	http://dx.doi.org/10.1126/science.1084674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855812				2022-12-01	WOS:000184056200047
J	van der Wal, CH; Eisaman, MD; Andre, A; Walsworth, RL; Phillips, DF; Zibrov, AS; Lukin, MD				van der Wal, CH; Eisaman, MD; Andre, A; Walsworth, RL; Phillips, DF; Zibrov, AS; Lukin, MD			Atomic memory for correlated photon states	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; QUANTUM-NOISE-REDUCTION; SINGLE PHOTONS; LIGHT; ENSEMBLES; COMMUNICATION; ENTANGLEMENT; GENERATION; COHERENCE; STORAGE	We experimentally demonstrate emission of two quantum-mechanically correlated light pulses with a time delay that is coherently controlled via temporal storage of photonic states in an ensemble of rubidium atoms. The experiment is based on Raman scattering, which produces correlated pairs of spin-flipped atoms and photons, followed by coherent conversion of the atomic states into a different photon beam after a controllable delay. This resonant nonlinear optical process is a promising technique for potential applications in quantum communication.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; PN Lebedev Phys Inst, Moscow 117924, Russia	Harvard University; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu	Eisaman, Matthew/E-8006-2011; van der Wal, Caspar H./D-9206-2013; Zibrov, Alexander S/G-7419-2014	Eisaman, Matthew/0000-0002-3814-6430; van der Wal, Caspar H./0000-0002-9843-3220; 				AYTUR O, 1990, PHYS REV LETT, V65, P1551, DOI 10.1103/PhysRevLett.65.1551; BOLLER KJ, 1991, PHYS REV LETT, V66, P2593, DOI 10.1103/PhysRevLett.66.2593; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; FLEISCHHAUER M, 1992, PHYS REV A, V46, P5856, DOI 10.1103/PhysRevA.46.5856; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; GHERI KM, 1994, PHYS REV A, V50, P1871, DOI 10.1103/PhysRevA.50.1871; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; HARRIS SE, 1967, PHYS REV LETT, V18, P732, DOI 10.1103/PhysRevLett.18.732; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; HARRIS SE, 1990, PHYS REV LETT, V64, P1107, DOI 10.1103/PhysRevLett.64.1107; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; HEIDMANN A, 1987, PHYS REV LETT, V59, P2555, DOI 10.1103/PhysRevLett.59.2555; HEMMER PR, 1995, OPT LETT, V20, P982, DOI 10.1364/OL.20.000982; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Hood CJ, 2000, SCIENCE, V287, P1447, DOI 10.1126/science.287.5457.1447; Imamoglu A, 1998, PHYS REV LETT, V81, P2836, DOI 10.1103/PhysRevLett.81.2836; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Kuzmich A, 1997, PHYS REV LETT, V79, P4782, DOI 10.1103/PhysRevLett.79.4782; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lukin MD, 2000, ADV ATOM MOL OPT PHY, V42, P347, DOI 10.1016/S1049-250X(08)60190-1; Lukin MD, 1999, PHYS REV LETT, V82, P1847, DOI 10.1103/PhysRevLett.82.1847; Lukin MD, 2003, REV MOD PHYS, V75, P457, DOI 10.1103/RevModPhys.75.457; Lukin MD, 2000, PHYS REV LETT, V84, P4232, DOI 10.1103/PhysRevLett.84.4232; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Pinkse PWH, 2000, NATURE, V404, P365, DOI 10.1038/35006006; RAYMER MG, 1990, PROG OPTICS, V28, P181, DOI 10.1016/S0079-6638(08)70290-7; Scully M. O., 1997, QUANTUM OPT; SMITHEY DT, 1992, PHYS REV LETT, V69, P2650, DOI 10.1103/PhysRevLett.69.2650; VANDERWAL CH, IN PRESS FLUCTUATION; Zibrov AS, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.103601; [No title captured]	37	397	397	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					196	200		10.1126/science.1085946	http://dx.doi.org/10.1126/science.1085946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12764202				2022-12-01	WOS:000184056200037
J	Wehrens, XHT; Lehnart, SE; Huang, F; Vest, JA; Reiken, SR; Mohler, PJ; Sun, J; Guatimosim, S; Song, LS; Rosemblit, N; D'Armiento, JM; Napolitano, C; Memmi, M; Priori, SG; Lederer, WJ; Marks, AR				Wehrens, XHT; Lehnart, SE; Huang, F; Vest, JA; Reiken, SR; Mohler, PJ; Sun, J; Guatimosim, S; Song, LS; Rosemblit, N; D'Armiento, JM; Napolitano, C; Memmi, M; Priori, SG; Lederer, WJ; Marks, AR			FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death	CELL			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; FAILING HEARTS; PHOSPHORYLATION; PROTEIN; ARRHYTHMIAS; MECHANISMS; GENE; AFTERDEPOLARIZATIONS; MUTATIONS; FAILURE	Arrhythmias, a common cause of sudden cardiac death, can occur in structurally normal hearts, although the mechanism is not known. In cardiac muscle, the ryanodine receptor (RyR2) on the sarcoplasmic reticulum releases the calcium required for muscle contraction. The FK506 binding protein (FKBP12.6) stabilizes RyR2, preventing aberrant activation of the channel during the resting phase of the cardiac cycle. We show that during exercise, RyR2 phosphorylation by cAMP-dependent protein kinase A (PKA) partially dissociates FKBP12.6 from the channel, increasing intracellular Ca2+ release and cardiac contractility. FKBP12.6(-/-) mice consistently exhibited exercise-induced cardiac ventricular arrhythmias that cause sudden cardiac death. Mutations in RyR2 linked to exercise-induced arrhythmias (in patients with catecholaminergic polymorphic ventricular tachycardia [CPVT]) reduced the affinity of FKBP12.6 for RyR2 and increased single-channel activity under conditions that simulate exercise. These data suggest that "leaky" RyR2 channels can trigger fatal cardiac arrhythmias, providing a possible explanation for CPVT.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Dept Med, Ctr Mol Cardiol, New York, NY 10032 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Cell Biol, Durham, NC 27710 USA; Univ Maryland, Sch Med, Dept Physiol, Biotechnol Inst,Med Biotechnol Ctr, Baltimore, MD 21201 USA; Univ Pavia, IRCCS, I-27100 Pavia, Italy	Columbia University; Duke University; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; University of Pavia	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Dept Med, Ctr Mol Cardiol, 630 W 168th St, New York, NY 10032 USA.		memmi, mirella/AAB-9428-2020; Priori, Silvia G/ABH-6894-2020; Wehrens, Xander/AAQ-9574-2020; Priori, Silvia G G/A-6116-2014; Lederer, William/B-1285-2010; Song, Long-Sheng/D-5899-2012; Napolitano, Carlo/K-4760-2016; napolitano, carlo/ABI-4608-2020; Guatimosim, Silvia/AAN-7441-2021	memmi, mirella/0000-0003-4006-5661; Priori, Silvia G/0000-0001-6877-0288; Wehrens, Xander/0000-0001-5044-672X; Priori, Silvia G G/0000-0001-6877-0288; Napolitano, Carlo/0000-0002-7643-4628; napolitano, carlo/0000-0002-7643-4628; Guatimosim, Silvia/0000-0001-8386-3722; Song, Long-Sheng/0000-0002-6035-8106	Telethon [GP0227Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bennett JA, 1998, MAMM GENOME, V9, P1069, DOI 10.1007/s003359900928; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Fisher JD, 1999, J AM COLL CARDIOL, V34, P2015, DOI 10.1016/S0735-1097(99)00438-6; FOZZARD HA, 1992, BASIC RES CARDIOL, V87, P105; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Pogwizd SM, 1998, CIRCULATION, V98, P2404, DOI 10.1161/01.CIR.98.22.2404; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; SONG YJ, 1994, AM J PHYSIOL-HEART C, V267, pH2005, DOI 10.1152/ajpheart.1994.267.5.H2005; Swan H, 1999, J AM COLL CARDIOL, V34, P2035, DOI 10.1016/S0735-1097(99)00461-1; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; WIT AL, 1983, AM HEART J, V106, P798, DOI 10.1016/0002-8703(83)90003-0; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a	29	550	585	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 27	2003	113	7					829	840		10.1016/S0092-8674(03)00434-3	http://dx.doi.org/10.1016/S0092-8674(03)00434-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837242	Bronze			2022-12-01	WOS:000183817900008
J	Basole, A; White, LE; Fitzpatrick, D				Basole, A; White, LE; Fitzpatrick, D			Mapping multiple features in the population response of visual cortex	NATURE			English	Article							CATS STRIATE CORTEX; COMPLEX CELLS; SPATIAL-FREQUENCY; DOT PATTERNS; DIRECTION; MOTION; MAPS; ORIENTATION; ORGANIZATION; SELECTIVITY	Stimulus features such as edge orientation, motion direction and spatial frequency are thought to be encoded in the primary visual cortex by overlapping feature maps arranged so that the location of neurons activated by a particular combination of stimulus features can be predicted from the intersections of these maps(1-8). This view is based on the use of grating stimuli, which limit the range of stimulus combinations that can be examined. We used optical imaging of intrinsic signals(9) in ferrets to assess patterns of population activity evoked by the motion of a texture ( a field of iso-oriented bars). Here we show that the same neural population can be activated by multiple combinations of orientation, length, motion axis and speed. Rather than reflecting the intersection of multiple maps, our results indicate that population activity in primary visual cortex is better described as a single map of spatiotemporal energy.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA	Duke University; Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.							ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Bonhoeffer Tobias, 1996, P55; Carandini M., 1999, CEREB CORTEX, V13, P401, DOI DOI 10.1007/978-1-4615-4903-1_7; DEVALOIS KK, 1979, J PHYSIOL-LONDON, V291, P483, DOI 10.1113/jphysiol.1979.sp012827; DeValois RL, 1988, SPATIAL VISION; Everson RM, 1998, P NATL ACAD SCI USA, V95, P8334, DOI 10.1073/pnas.95.14.8334; GALUSKE RAW, 2001, SOC NEUR ABSTR, V27; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; HAMMOND P, 1983, J PHYSIOL-LONDON, V342, P35, DOI 10.1113/jphysiol.1983.sp014838; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; SKOTTUN BC, 1988, J NEUROPHYSIOL, V59, P1719, DOI 10.1152/jn.1988.59.6.1719; SKOTTUN BC, 1994, VISUAL NEUROSCI, V11, P885, DOI 10.1017/S0952523800003849; Swindale NV, 2000, CEREB CORTEX, V10, P633, DOI 10.1093/cercor/10.7.633; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317	29	128	131	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					986	990		10.1038/nature01721	http://dx.doi.org/10.1038/nature01721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827202				2022-12-01	WOS:000183753900050
J	Loayza, D; de Lange, T				Loayza, D; de Lange, T			POT1 as a terminal transducer of TRF1 telomere length control	NATURE			English	Article							MAMMALIAN TELOMERES; HUMAN-CELLS; PROTEIN; CANCER; END; CHROMOSOMES; PROTECTION; TANKYRASE; BINDING; YEAST	Human telomere maintenance is essential for the protection of chromosome ends, and changes in telomere length have been implicated in ageing and cancer(1-4). Human telomere length is regulated by the TTAGGG-repeat-binding protein TRF1 and its interacting partners tankyrase 1, TIN2 and PINX1 ( refs 5-9). As the TRF1 complex binds to the duplex DNA of the telomere, it is unclear how it can affect telomerase, which acts on the single-stranded 30 telomeric overhang. Here we show that the TRF1 complex interacts with a single-stranded telomeric DNA-binding protein - protection of telomeres 1 (POT1) - and that human POT1 controls telomerase-mediated telomere elongation. The presence of POT1 on telomeres was diminished when the amount of single-stranded DNA was reduced. Furthermore, POT1 binding was regulated by the TRF1 complex in response to telomere length. A mutant form of POT1 lacking the DNA-binding domain abrogated TRF1-mediated control of telomere length, and induced rapid and extensive telomere elongation. We propose that the interaction between the TRF1 complex and POT1 affects the loading of POT1 on the single-stranded telomeric DNA, thus transmitting information about telomere length to the telomere terminus, where telomerase is regulated.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.		de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X				Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; de Lange T, 2001, SCIENCE, V292, P1075; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Evans SK, 2000, J CELL SCI, V113, P3357; Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lei M, 2002, BIOCHEMISTRY-US, V41, P14560, DOI 10.1021/bi026674z; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Sprung CN, 1999, EXP CELL RES, V247, P29, DOI 10.1006/excr.1998.4293; Sprung CN, 1999, P NATL ACAD SCI USA, V96, P6781, DOI 10.1073/pnas.96.12.6781; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	29	522	559	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					1013	1018		10.1038/nature01688	http://dx.doi.org/10.1038/nature01688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12768206				2022-12-01	WOS:000183753900056
J	Kramer, HJ; Nguyen, QD; Curhan, G; Hsu, CY				Kramer, HJ; Nguyen, QD; Curhan, G; Hsu, CY			Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERIAL-HYPERTENSION; NEPHROPATHY; PREVALENCE; MICROALBUMINURIA; DISEASE; CREATININE; PREDICTION; HEALTH; STAGE	Context Kidney disease in type 2 diabetes mellitus (DM) is more heterogeneous than in type 1 DM. Reduced glomerular-filtration rate (GFR) among individuals with type 2 DM may not always be due to classic diabetic glomerulosclerosis, which is associated with albuminuria and retinopathy. Objective To determine the prevalence of chronic renal insufficiency (CRI), defined as a GFR less than 60 mL/min per 1.73 m(2) body surface area (BSA) in the absence of microalbuminuria or macroalbuminuria and diabetic retinopathy among adults with type 2 DM. Design, Setting, and Participants Cross-sectional analysis of adults aged 40 years or older with type 2 DM in the Third National Health and Nutrition Examination Survey, a probability sample of the total civilian US non institutionalized population conducted from 1988-1994. Main Outcome Measures The GFR per 1.73 m(2) BSA, calculated with serum creatinine, urea nitrogen, and serum albumin levels using the Modification of Diet in Renal Disease Study prediction equation; albuminuria, assessed using spot urine albumin/ creatinine ratio; and presence of retinopathy, determined with fundus photography. Results Overall, 13% (sampled n=171) of adults with type 2 DM (n=1197) had CRI with a population estimate of 1.1 million. Among these adults with CRI, diabetic retinopathy was noted in 28% (n=58), while the frequencies of microalbuminuria and macroalbuminuria were 45% (n=64) and 19% (n=47), respectively. Retinopathy and albuminuria (microalbuminuria or macroalbuminuria) were both absent in 30% (n=51) of adults with type 2 DM and CRI. The population estimate of adults with type 2 DM and CRI in the absence of diabetic retinopathy or albuminuria was approximately 0.3 million. Conclusions A substantial burden of CRI among persons with type 2 DM in the United States is likely due to renal parenchymal disease other than classic diabetic glomerulosclerosis. Approaches to screening renal disease in the type 2 DM population should incorporate assessment of GFR in addition to monitoring urine albumin excretion and funduscopic changes to ensure that individuals with type 2 DM and CRI not due to diabetic glomerulosclerosis will receive appropriate intervention.	Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Div Nephrol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Med, Div Nephrol, Maywood, IL 60153 USA; Johns Hopkins Med Inst, Wilmer Ophthalmol Inst, Baltimore, MD 21205 USA; Massachusetts Gen Hosp, Gen Med Unit, Boston, MA 02114 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA	Loyola University Chicago; Loyola University Chicago; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Kramer, HJ (corresponding author), Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Div Nephrol, 2160 S 1st Ave, Maywood, IL 60153 USA.	hkramer@lumc.edu		Hsu, Chi-yuan/0000-0001-8182-1238; Kramer, Holly/0000-0002-6374-837X	NATIONAL EYE INSTITUTE [K23EY013552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK061520, R01DK052866] Funding Source: NIH RePORTER; NEI NIH HHS [EY13552] Funding Source: Medline; NIDDK NIH HHS [DK52866, DK61520] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1981, INVEST OPHTH VIS SCI, V21, P210; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; GALL MA, 1991, DIABETOLOGIA, V34, P655, DOI 10.1007/BF00400995; Gavin JR, 1997, DIABETES CARE, V20, P1183; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MATHIESEN ER, 1984, DIABETOLOGIA, V26, P406; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; MOGENSEN CE, 1983, DIABETES, V32, P64, DOI 10.2337/diab.32.2.S64; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; *NIH NAT I DIAB DI, 2002, USRDS 2002 ANN DAT R; OLSON JL, 1998, HEPTINSTALLS PATHOLO, P1247; PARVING HH, 1988, BMJ-BRIT MED J, V296, P156, DOI 10.1136/bmj.296.6616.156; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Ritz E, 1996, AM J KIDNEY DIS, V27, P167, DOI 10.1016/S0272-6386(96)90538-7; Rychlik I., 1999, NEPHROPATHY TYPE 2 D, P7; VIBERTI GC, 1982, LANCET, V1, P1430; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; Wilmer WA, 1999, AM J KIDNEY DIS, V34, P308, DOI 10.1016/S0272-6386(99)70360-4; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	26	433	470	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3273	3277		10.1001/jama.289.24.3273	http://dx.doi.org/10.1001/jama.289.24.3273			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693EX	12824208	Bronze			2022-12-01	WOS:000183704600020
J	Zhou, Q; Tao, HZW; Poo, MM				Zhou, Q; Tao, HZW; Poo, MM			Reversal and stabilization of synaptic modifications in a developing visual system	SCIENCE			English	Article							LONG-TERM POTENTIATION; DEVELOPING RETINOTECTAL SYNAPSES; LOW-FREQUENCY STIMULATION; NMDA RECEPTOR; IN-VIVO; PLASTICITY; MEMORY; INPUT; LTP; HIPPOCAMPUS	Persistent synaptic modi. cations are essential for experience-dependent refinement of developing circuits. However, in the developing Xenopus retinotectal system, activity-induced synaptic modi. cations were quickly reversed either by subsequent spontaneous activity in the tectum or by exposure to random visual inputs. This reversal depended on the burst spiking and activation of the N-methyl-D-aspartate subtype of glutamate receptors. Stabilization of synaptic modi. cations can be achieved by an appropriately spaced pattern of induction stimuli. These findings underscore the vulnerable nature of activity-induced synaptic modi. cations in vivo and suggest a temporal constraint on the pattern of visual inputs for effective induction of stable synaptic modifications.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Tao, Huizhong W/HDM-9767-2022		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Huang CC, 1999, J NEUROSCI, V19, P9728; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nieuwkoop P.D., 1994, NORMAL TABLES XENOPU; O'Dell T J, 1994, Learn Mem, V1, P129; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Staubli U, 1996, J NEUROSCI, V16, P853; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Udin SB, 1999, PROG NEUROBIOL, V59, P81, DOI 10.1016/S0301-0082(98)00096-3; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	24	115	117	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1953	1957		10.1126/science.1082212	http://dx.doi.org/10.1126/science.1082212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817152				2022-12-01	WOS:000183619400050
J	Zhong, WW; Feng, H; Santiago, FE; Kipreos, ET				Zhong, WW; Feng, H; Santiago, FE; Kipreos, ET			CUL-4 ubiquitin ligase maintains genome stability by restraining DNA-replication licensing	NATURE			English	Article							MITOTIC CHROMOSOME CONDENSATION; CAENORHABDITIS-ELEGANS; C-ELEGANS; CELL-CYCLE; S-PHASE; PROTEIN; CDT1; PROLIFERATION; INTERFERENCE; EXPRESSION	To maintain genome stability, DNA replication is strictly regulated to occur only once per cell cycle. In eukaryotes, the presence of 'licensing proteins' at replication origins during the G1 cell-cycle phase allows the formation of the pre-replicative complex(1). The removal of licensing proteins from chromatin during the S phase ensures that origins fire only once per cell cycle(1). Here we show that the CUL-4 ubiquitin ligase temporally restricts DNA-replication licensing in Caenorhabditis elegans. Inactivation of CUL-4 causes massive DNA re-replication, producing cells with up to 100C DNA content. The C. elegans orthologue of the replication-licensing factor Cdt1 (refs 2, 3) is required for DNA replication. C. elegans CDT-1 is present in G1-phase nuclei but disappears as cells enter S phase. In cells lacking CUL-4, CDT-1 levels fail to decrease during S phase and instead remain constant in the re-replicating cells. Removal of one genomic copy of cdt-1 suppresses the cul-4 re-replication phenotype. We propose that CUL-4 prevents aberrant re-initiation of DNA replication, at least in part, by facilitating the degradation of CDT-1.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Kipreos, ET (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.		Santiago, Fernando Enrique/GLS-9127-2022; Feng, Hui/L-4343-2019; Feng, Hui/D-4423-2019	Feng, Hui/0000-0003-1318-821X; Santiago, Fernando/0000-0001-9514-3722				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hong Y, 1998, DEVELOPMENT, V125, P3585; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; MILLER DM, 1995, CAENORHABDITIS ELEGA, P365; Nayak S, 2002, CURR BIOL, V12, P277, DOI 10.1016/S0960-9822(02)00682-6; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Praitis V, 2001, GENETICS, V157, P1217; Seydoux G, 2001, INT REV CYTOL, V203, P139; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yanow SK, 2001, EMBO J, V20, P4648, DOI 10.1093/emboj/20.17.4648	30	251	260	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					885	889		10.1038/nature01747	http://dx.doi.org/10.1038/nature01747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815436				2022-12-01	WOS:000183585300050
J	Burgess, I				Burgess, I			Commentary: How to advise a patient when over the counter products have failed	BRITISH MEDICAL JOURNAL			English	Editorial Material									Insect Res & Dev Ltd, Cambridge CB1 5EL, England		Burgess, I (corresponding author), Insect Res & Dev Ltd, Cambridge CB1 5EL, England.		Burgess, Ian/E-4049-2016; Burgess, Ian/N-2977-2013	Burgess, Ian/0000-0001-9348-2915; Burgess, Ian/0000-0003-0747-3938					0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1257	1257		10.1136/bmj.326.7401.1257	http://dx.doi.org/10.1136/bmj.326.7401.1257			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791745	Green Published			2022-12-01	WOS:000183480700022
J	Durbin, DR; Elliott, MR; Winston, FK				Durbin, DR; Elliott, MR; Winston, FK			Belt-positioning booster seats and reduction in risk of injury among children in vehicle crashes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESTRAINT; SAMPLE	Context Although more than a dozen states have ratified laws that require booster seats for children older than 4 years, most states continue to have child restraint laws that only cover children through age 4 years. Lack of booster seat effectiveness data may be a barrier to passage of stronger child restraint laws. Objectives To quantify the association of belt-positioning booster seats compared with seat belts alone and risk of injury among 4- to 7-year-old children and to assess patterns of injury among children in booster seats vs seat belts. Design, Setting, and Population Cross-sectional study of children aged 4 to 7 years in crashes of insured vehicles in 15 states, with data collected via insurance claims records and a telephone survey. A probability sample of 3616 crashes involving 4243 children, weighted to represent 56593 children in 48257 crashes was collected between December 1, 1998, and May 31, 2002. Main Outcome Measure Parent report of clinically significant injuries. Results Injuries occurred among 1.81% of all 4- to 7-year-olds, including 1.95% of those in seat belts and 0.77% of those in belt-positioning booster seats. The odds of injury, adjusting for child, driver, crash, and vehicle characteristics, were 59% lower for children aged 4 to 7 years in belt-positioning boosters than in seat belts (odds ratio, 0.41; 95% confidence interval, 0.20-0.86). Children in belt-positioning booster seats had no injuries to the abdomen, neck/spine/back, or lower extremities, while children in seat belts alone had injuries to all body regions. Conclusion Belt-positioning booster seats were associated with added safety benefits compared with seat belts to children through age 7 years, including reduction of injuries classically associated with improper seat belt fit in children.	Childrens Hosp Philadelphia, Dept Pediat, Div Emergency Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Durbin, DR (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Emergency Med, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.		Durbin, Dennis/AAD-7829-2022					*ADV HIGHW AUT SAF, STAT BOOST SEAT LAW; AGRAN PF, 1987, J TRAUMA, V27, P58, DOI 10.1097/00005373-198701000-00011; *AM AC PED, SEL US MOST APPR CAR; Arbogast KB, 2002, J TRAUMA, V52, P693, DOI 10.1097/00005373-200204000-00014; *ASS ADV AUT MED, 1990, ABBR INJ SCAL; Braver E R, 1998, Inj Prev, V4, P181; Davidson A.C., 1997, BOOTSTRAP METHODS TH; Durbin DR, 2001, PEDIATR EMERG CARE, V17, P474, DOI 10.1097/00006565-200112000-00021; Durbin DR, 1999, ARCH PEDIAT ADOL MED, V153, P404; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; Durbin DR, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.6.e109; GARRETT J W, 1962, J Trauma, V2, P220, DOI 10.1097/00005373-196205000-00002; KLINICH K, 1994, STUDY OLDER CHILD RE; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; KULOWSKI J, 1956, ARCH SURG-CHICAGO, V73, P970, DOI 10.1001/archsurg.1956.01280060070015; Miller Ted, 2002, Annu Proc Assoc Adv Automot Med, V46, P249; *NAT HIGHW TRAFF S, CHILD PASS SAF; National Center for Health Statistics. Centers for Disease Control and Prevention (CDC), CLIN GROWTH CHARTS; Simpson EM, 2002, PEDIATRICS, V110, P729, DOI 10.1542/peds.110.4.729; Webber K., 2000, UMTRI RES REV, V31, P1; WILLIAMS AF, 1977, ACCIDENT ANAL PREV, V9, P69, DOI 10.1016/0001-4575(77)90007-0; Winston FK, 2000, PEDIATRICS, V105, P1179, DOI 10.1542/peds.105.6.1179; WINSTON FK, 2000, DTNH2298C05142 NAT H	23	228	236	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2003	289	21					2835	2840		10.1001/jama.289.21.2835	http://dx.doi.org/10.1001/jama.289.21.2835			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KH	12783914				2022-12-01	WOS:000183205500032
J	Abbott, A				Abbott, A			Anthropologists cast doubt on human DNA evidence	NATURE			English	News Item																			0	16	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					468	468		10.1038/423468b	http://dx.doi.org/10.1038/423468b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774081	Bronze			2022-12-01	WOS:000183162900006
J	Veaute, X; Jeusset, J; Soustelle, C; Kowalczykowski, SC; Le Cam, E; Fabre, F				Veaute, X; Jeusset, J; Soustelle, C; Kowalczykowski, SC; Le Cam, E; Fabre, F			The Srs2 helicase prevents recombination by disrupting Rad51 nucleoprotein filaments	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA HELICASE; HOMOLOGOUS RECOMBINATION; YEAST RAD51; MUTATIONS; REPAIR; GENE; SEQUENCE; MUTANTS; PROTEIN	Homologous recombination is a ubiquitous process with key functions in meiotic and vegetative cells for the repair of DNA breaks. It is initiated by the formation of single-stranded DNA on which recombination proteins bind to form a nucleoprotein filament that is active in searching for homology, in the formation of joint molecules and in the exchange of DNA strands(1). This process contributes to genome stability but it is also potentially dangerous to cells if intermediates are formed that cannot be processed normally and thus are toxic or generate genomic rearrangements. Cells must therefore have developed strategies to survey recombination and to prevent the occurrence of such deleterious events. In Saccharomyces cerevisiae, genetic data have shown that the Srs2 helicase negatively modulates recombination(2,3), and later experiments suggested that it reverses intermediate recombination structures(4-7). Here we show that DNA strand exchange mediated in vitro by Rad51 is inhibited by Srs2, and that Srs2 disrupts Rad51 filaments formed on single-stranded DNA. These data provide an explanation for the antirecombinogenic role of Srs2 in vivo and highlight a previously unknown mechanism for recombination control.	CNRS, CEA, DSV,Dept Radiobiol & Radiopathol, UMR 217, F-92265 Fontenay Aux Roses, France; Inst Gustave Roussy, IGR,UPS, CNRS, UMR 81126, F-94805 Villejuif, France; Univ Calif Davis, Ctr Genet & Dev, Sect Microbiol & Mol & Cellular Biol, Davis, CA 95616 USA	CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California Davis	Veaute, X (corresponding author), CNRS, CEA, DSV,Dept Radiobiol & Radiopathol, UMR 217, BP6, F-92265 Fontenay Aux Roses, France.	xavier.veaute@cea.fr; francis.fabre@cea.fr		Le cam, Eric/0000-0002-6832-6117				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; AGUILERA A, 1988, GENETICS, V119, P779; Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; HEUDE M, 1995, MOL GEN GENET, V248, P59, DOI 10.1007/BF02456614; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; KAYTOR MD, 1995, GENETICS, V140, P1441; Klein H, 2001, GENETICS, V157, P557; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LOVETT ST, 1987, GENETICS, V116, P547; MILNE GT, 1995, GENETICS, V139, P1189; PALLADINO F, 1992, GENETICS, V132, P23; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; RONG L, 1993, J BIOL CHEM, V268, P1252; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SCHILD D, 1995, GENETICS, V140, P115; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2	24	469	473	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2003	423	6937					309	312		10.1038/nature01585	http://dx.doi.org/10.1038/nature01585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748645				2022-12-01	WOS:000182853100048
J	Hamilton, JTG; McRoberts, WC; Keppler, F; Kalin, RM; Harper, DB				Hamilton, JTG; McRoberts, WC; Keppler, F; Kalin, RM; Harper, DB			Chloride methylation by plant pectin: An efficient environmentally significant process	SCIENCE			English	Article							EMISSIONS; CHLOROMETHANE; HALOCARBONS; ATMOSPHERE; COMBUSTION; AFRICA; MATTER	Atmospheric chloromethane (CH3Cl) plays an important role in stratospheric ozone destruction, but many uncertainties exist regarding the strengths of its sources and sinks and particularly regarding the processes generating this naturally occurring gas. Evidence is presented here that CH3Cl is produced in many terrestrial environments by a common mechanism. Abiotic conversion of chloride to CH3Cl occurs readily in plant material, with the widespread plant component pectin acting as a methyl donor. Significant CH3Cl emissions from senescent and dead leaves were observed at ambient temperatures; those emissions rose dramatically when temperatures increased. This ubiquitous process acting in terrestrial ecosystems and during biomass burning could contribute the bulk of atmospheric CH3Cl.	Dept Agr & Rural Dev No Ireland, Belfast BT9 5PX, Antrim, North Ireland; Queens Univ Belfast, Belfast BT9 5PX, Antrim, North Ireland; Queens Univ Belfast, Questor Res Ctr, Belfast BT9 5AG, Antrim, North Ireland; Queens Univ Belfast, Environm Engn Res Ctr, Belfast BT9 5AG, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Queens University Belfast	Hamilton, JTG (corresponding author), Dept Agr & Rural Dev No Ireland, Newforge Lane, Belfast BT9 5PX, Antrim, North Ireland.		Keppler, Frank/F-4401-2012; Kalin, Robert/E-8620-2011	Keppler, Frank/0000-0003-2766-8812; Kalin, Robert/0000-0003-3768-3848				Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Andreae MO, 1996, J GEOPHYS RES-ATMOS, V101, P23603, DOI 10.1029/95JD01733; Attieh J, 2000, PLANT CELL ENVIRON, V23, P165, DOI 10.1046/j.1365-3040.2000.00541.x; Bowen H. J. M, 1979, ENV CHEM ELEMENTS; Dimmer CH, 2001, ATMOS ENVIRON, V35, P321, DOI 10.1016/S1352-2310(00)00151-5; EKLUND G, 1988, CHEMOSPHERE, V17, P575, DOI 10.1016/0045-6535(88)90032-X; FUNG I, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P166; Hafren J, 2001, NORD PULP PAP RES J, V16, P284, DOI 10.3183/npprj-2001-16-04-p284-290; Harper DB, 1999, NEW PHYTOL, V142, P5, DOI 10.1046/j.1469-8137.1999.00382.x; Harper DB, 2003, HANDB ENVIRON CHEM, V3, P17; Harper DB, 2000, NAT PROD REP, V17, P337, DOI 10.1039/a809400d; Hu HN, 1996, J EXP BOT, V47, P227, DOI 10.1093/jxb/47.2.227; Keppler F, 2000, NATURE, V403, P298, DOI 10.1038/35002055; Khalil MAK, 1999, ATMOS ENVIRON, V33, P1305, DOI 10.1016/S1352-2310(98)00234-9; Lobert JM, 1999, J GEOPHYS RES-ATMOS, V104, P8373, DOI 10.1029/1998JD100077; LOVELOCK JE, 1975, NATURE, V256, P193, DOI 10.1038/256193a0; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; MONTZKA SA, 2003, 47 WORLD MET ORG, pCH1; Moore RM, 1996, J GEOPHYS RES-OCEANS, V101, P28529, DOI 10.1029/96JC02915; Myneni SCB, 2002, SCIENCE, V295, P1039, DOI 10.1126/science.1067153; PALMER TY, 1976, NATURE, V263, P44, DOI 10.1038/263044a0; RASMUSSEN RA, 1980, J GEOPHYS RES-OCEANS, V85, P7350, DOI 10.1029/JC085iC12p07350; REINHARDT TE, 1995, ENVIRON SCI TECHNOL, V29, P825, DOI 10.1021/es00003a034; Rhew RC, 2000, NATURE, V403, P292, DOI 10.1038/35002043; RUDOLPH J, 1995, J ATMOS CHEM, V22, P67, DOI 10.1007/BF00708182; Saxena D, 1998, APPL ENVIRON MICROB, V64, P2831; Warneke C, 1999, GLOBAL BIOGEOCHEM CY, V13, P9, DOI 10.1029/98GB02428; Watling R, 1998, MYCOL RES, V102, P769, DOI 10.1017/S0953756298006157; Yokouchi Y, 2002, NATURE, V416, P163, DOI 10.1038/416163a	29	148	152	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					206	209		10.1126/science.1085036	http://dx.doi.org/10.1126/science.1085036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855805				2022-12-01	WOS:000184056200040
J	Rider, TH; Petrovick, MS; Nargi, FE; Harper, JD; Schwoebel, ED; Mathews, RH; Blanchard, DJ; Bortolin, LT; Young, AM; Chen, JZ; Hollis, MA				Rider, TH; Petrovick, MS; Nargi, FE; Harper, JD; Schwoebel, ED; Mathews, RH; Blanchard, DJ; Bortolin, LT; Young, AM; Chen, JZ; Hollis, MA			A B cell-based sensor for rapid identification of pathogens	SCIENCE			English	Article							PHOTOPROTEIN; BACTERIA; FOOD; SITE	We report the use of genetically engineered cells in a pathogen identification sensor. This sensor uses B lymphocytes that have been engineered to emit light within seconds of exposure to specific bacteria and viruses. We demonstrated rapid screening of relevant samples and identification of a variety of pathogens at very low levels. Because of its speed, sensitivity, and specificity, this pathogen identification technology could prove useful for medical diagnostics, biowarfare defense, food- and water-quality monitoring, and other applications.	MIT, Lincoln Lab, Lexington, MA 02420 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Rider, TH (corresponding author), MIT, Lincoln Lab, Lexington, MA 02420 USA.	thor@ll.mit.edu	Harper, James D/B-8701-2011	Harper, James/0000-0001-7895-8268				Ackers ML, 1998, J INFECT DIS, V177, P1588, DOI 10.1086/515323; Belgrader P, 1999, SCIENCE, V284, P449, DOI 10.1126/science.284.5413.449; BUTTON D, 1993, CELL CALCIUM, V14, P663, DOI 10.1016/0143-4160(93)90091-J; CORMIER MJ, 1989, PHOTOCHEM PHOTOBIOL, V49, P509, DOI 10.1111/j.1751-1097.1989.tb09202.x; Hough AJ, 2002, J FOOD PROTECT, V65, P1329, DOI 10.4315/0362-028X-65.8.1329; Lindqvist R, 1997, INT J FOOD MICROBIOL, V37, P73, DOI 10.1016/S0168-1605(97)00054-8; Lucore LA, 2000, APPL ENVIRON MICROB, V66, P1769, DOI 10.1128/AEM.66.5.1769-1776.2000; PARIKH VS, 1991, J EXP MED, V174, P1103, DOI 10.1084/jem.174.5.1103; Pourahmadi F, 2000, CLIN CHEM, V46, P1511; ROEHRIG JT, 1985, VIROLOGY, V142, P347, DOI 10.1016/0042-6822(85)90343-5; Rowe CA, 1999, ANAL CHEM, V71, P3846, DOI 10.1021/ac981425v; SHIMOMURA O, 1989, BIOCHEM J, V261, P913, DOI 10.1042/bj2610913; SHIMOMURA O, 1978, P NATL ACAD SCI USA, V75, P2611, DOI 10.1073/pnas.75.6.2611; TSUJI FI, 1986, P NATL ACAD SCI USA, V83, P8107, DOI 10.1073/pnas.83.21.8107; WILSON HA, 1987, J EXP MED, V166, P601, DOI 10.1084/jem.166.2.601	15	204	248	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					213	215		10.1126/science.1084920	http://dx.doi.org/10.1126/science.1084920			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855808				2022-12-01	WOS:000184056200043
J	Sage, J; Miller, AL; Perez-Mancera, PA; Wysocki, JM; Jacks, T				Sage, J; Miller, AL; Perez-Mancera, PA; Wysocki, JM; Jacks, T			Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry	NATURE			English	Article							TUMOR-SUPPRESSOR; G(1) CONTROL; RB; SENESCENCE; GROWTH; INACTIVATION; FIBROBLASTS; EXPRESSION; APOPTOSIS; SYSTEM	Cancer cells arise from normal cells through the acquisition of a series of mutations in oncogenes and tumour suppressor genes(1). Mouse models of human cancer often rely on germline alterations that activate or inactivate genes of interest. One limitation of this approach is that germline mutations might have effects other than somatic mutations, owing to developmental compensation(2,3). To model sporadic cancers associated with inactivation of the retinoblastoma (RB) tumour suppressor gene in humans, we have produced a conditional allele of the mouse Rb gene. We show here that acute loss of Rb in primary quiescent cells is sufficient for cell cycle entry and has phenotypic consequences different from germline loss of Rb function. This difference is explained in part by functional compensation by the Rb-related gene p107. We also show that acute loss of Rb in senescent cells leads to reversal of the cellular senescence programme. Thus, the use of conditional knockout strategies might refine our understanding of gene function and help to model human cancer more accurately.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Jacks, T (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu						Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Carneiro C, 2003, ONCOGENE, V22, P361, DOI 10.1038/sj.onc.1206163; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; Jonkers J, 2002, NAT REV CANCER, V2, P251, DOI 10.1038/nrc777; Lomazzi M, 2002, NAT GENET, V31, P190, DOI 10.1038/ng891; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; Marino S, 2000, GENE DEV, V14, P994; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169	24	423	430	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					223	228		10.1038/nature01764	http://dx.doi.org/10.1038/nature01764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853964				2022-12-01	WOS:000184032700049
J	Sampson, JR; Dolwani, S; Jones, S; Eccles, D; Ellis, A; Evans, DG; Frayling, I; Jordan, S; Maher, ER; Mak, T; Maynard, J; Pigatto, F; Shaw, J; Cheadle, JP				Sampson, JR; Dolwani, S; Jones, S; Eccles, D; Ellis, A; Evans, DG; Frayling, I; Jordan, S; Maher, ER; Mak, T; Maynard, J; Pigatto, F; Shaw, J; Cheadle, JP			Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH	LANCET			English	Article								Familial, adenomatous polyposis (FAP) and attenuated FAP are autosomal dominant disorders characterised by multiple colorectal adenomas and cancers. Both are caused by inherited mutations in the APC gene, and management includes genetic testing, colonoscopic surveillance, and prophylactic surgery for the relatives of index cases. Among 614 families recorded in six regional registers of polyposis in the UK, we identified 111 with neither dominant transmission nor evidence of APC mutation. Molecular genetic analysis showed that 25 had biallelic mutations of the MYH gene. Since our data show that MYH polyposis can be transmitted as an autosomal recessive trait, a change in genetic counselling, testing, and surveillance Is needed.	Univ Wales Coll Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; Royal Liverpool Hosp, Dept Gastroenterol, Liverpool L7 8XP, Merseyside, England; St Marys Hosp, Acad Unit med Genet, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Addenbrookes Hosp, Dept Med Genet, Genet Mol Lab, Cambridge, England; Univ Birmingham, Sect Med & Mol Genet, Birmingham, W Midlands, England; W Midlands Reg Genet Serv, Birmingham, W Midlands, England	Cardiff University; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Birmingham	Sampson, JR (corresponding author), Univ Wales Coll Med, Inst Med Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.		Eccles, Diana/K-6327-2019; Evans, D Gareth/AAB-4308-2022; MAHER, EAMONN R/A-9507-2008; Dolwani, Sunil/M-4241-2016; Jones, Sian/A-5050-2012; Dolwani, Sunil/G-9730-2012; Dolwani, Sunil/C-9187-2013	Eccles, Diana/0000-0002-9935-3169; Evans, D Gareth/0000-0002-8482-5784; MAHER, EAMONN R/0000-0002-6226-6918; Frayling, Ian/0000-0002-3420-0794					0	317	332	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 5	2003	362	9377					39	41		10.1016/S0140-6736(03)13805-6	http://dx.doi.org/10.1016/S0140-6736(03)13805-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699KW	12853198				2022-12-01	WOS:000184056900012
J	Hattar, S; Lucas, RJ; Mrosovsky, N; Thompson, S; Douglas, RH; Hankins, MW; Lem, J; Biel, M; Hofmann, F; Foster, RG; Yau, KW				Hattar, S; Lucas, RJ; Mrosovsky, N; Thompson, S; Douglas, RH; Hankins, MW; Lem, J; Biel, M; Hofmann, F; Foster, RG; Yau, KW			Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice	NATURE			English	Article							RETINAL GANGLION-CELLS; CIRCADIAN-RHYTHMS; RETINOHYPOTHALAMIC TRACT; LIGHT; RESPONSES; MASKING; LACKING; CLOCK; PHOTOTRANSDUCTION; PHOTOSENSITIVITY	In the mammalian retina, besides the conventional rod-cone system, a melanopsin-associated photoreceptive system exists that conveys photic information for accessory visual functions such as pupillary light reflex and circadian photo-entrainment(1-7). On ablation of the melanopsin gene, retinal ganglion cells that normally express melanopsin are no longer intrinsically photosensitive(8). Furthermore, pupil reflex(8), light-induced phase delays of the circadian clock(9,10) and period lengthening of the circadian rhythm in constant light(9,10) are all partially impaired. Here, we investigated whether additional photoreceptive systems participate in these responses. Using mice lacking rods and cones, we measured the action spectrum for phase-shifting the circadian rhythm of locomotor behaviour. This spectrum matches that for the pupillary light reflex in mice of the same genotype(11), and that for the intrinsic photosensitivity of the melanopsin-expressing retinal ganglion cells(7). We have also generated mice lacking melanopsin coupled with disabled rod and cone phototransduction mechanisms. These animals have an intact retina but fail to show any significant pupil reflex, to entrain to light/dark cycles, and to show any masking response to light. Thus, the rod-cone and melanopsin systems together seem to provide all of the photic input for these accessory visual functions.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, London W6 8RF, England; Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 3G5, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G5, Canada; City Univ London, Dept Optometry & Visual Sci, Appl Vis Res Ctr, London EC1V 0HB, England; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA; Univ Munich, Zentrum Pharmaforsch, Lehrstuhl Pharmakol Nat Wissensch, D-81377 Munich, Germany; Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Imperial College London; University of Toronto; University of Toronto; University of Toronto; City University London; Tufts University; University of Munich; Technical University of Munich	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.		Biel, Martin/G-1175-2014; Hattar, Samer/W-6927-2019	Biel, Martin/0000-0002-9974-3052; Lucas, Robert/0000-0002-1088-8029; FOSTER, RUSSELL/0000-0001-6055-2067	NEI NIH HHS [R37 EY006837-15, R01 EY006837-16A1, R37 EY006837-14, R37 EY006837-13, R37 EY006837, R01 EY014596-01, R37 EY006837-15S1, R01 EY006837, R01 EY014596] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014596, R01EY006837, R37EY006837] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aschoff J., 1988, Advances in the Biosciences, V73, P149; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Bradley J, 2001, SCIENCE, V294, P2095, DOI 10.1126/science.294.5549.2095; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CONE RA, 1967, SCIENCE, V155, P1128, DOI 10.1126/science.155.3766.1128; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Mrosovsky N, 2001, CHRONOBIOL INT, V18, P613, DOI 10.1081/CBI-100106076; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; MURAKAMI M, 1970, VISION RES, V10, P965, DOI 10.1016/0042-6989(70)90074-X; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Redlin U, 1999, J COMP PHYSIOL A, V184, P429, DOI 10.1007/s003590050342; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Van Gelder R N, 2001, Ophthalmic Genet, V22, P195, DOI 10.1076/opge.22.4.195.2215; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Wee R, 2002, J NEUROSCI, V22, P10427; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	32	853	879	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					76	81		10.1038/nature01761	http://dx.doi.org/10.1038/nature01761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12808468	Green Accepted			2022-12-01	WOS:000183912800043
J	Cohn, BA; Cirillo, PM; Wolff, MS; Schwingi, PJ; Cohen, RD; Sholtz, RI; Ferrara, A; Christianson, RE; van den Berg, BJ; Siiteri, PK				Cohn, BA; Cirillo, PM; Wolff, MS; Schwingi, PJ; Cohen, RD; Sholtz, RI; Ferrara, A; Christianson, RE; van den Berg, BJ; Siiteri, PK			DDT and DDE exposure in mothers and time to pregnancy in daughters	LANCET			English	Article							ORGANOCHLORINES	Reproductive-tract anomalies after administration of the potent oestrogen, diethylstilboestrol, in pregnant women raised concerns about the reproductive effects of exposure to weakly oestrogenic environmental contaminants such as bis[4-chlorophenyl]-1,1,1-trichloroethane (p,p'-DDT) or its metabolites, such as bis[4-chlorophenyl]-1,1-dichloroethene (p,p'-DDE). We measured p,p'-DDT and p,p'-DDE in preserved maternal serum samples drawn 1-3 days after delivery between 1960 and 1963. We recorded time to pregnancy In 289 eldest daughters 28-31 years later. Daughters' probability of pregnancy fell by 32% per 10 mug/L p,p'-DDT in maternal serum (95% CI 11-48). By contrast, the probability of pregnancy increased 16% per 10 mug/L p,p'-DDE (6-27). The decreased fecundability associated with prenatal p,p'-DDT remains unexplained. We speculate that the antiandrogenic activity of p,p'-DDE may mitigate harmful androgen effects on the ovary during gestation or early life.	Inst Publ Hlth, Ctr Res Womens & Childrens Hlth, Berkeley, CA 94709 USA; Mt Sinai Sch Med, New York, NY USA; Univ N Carolina, Chapel Hill, NC USA; Kaiser Permanente, Div Res, Oakland, CA USA; Univ Calif San Francisco, Sch Med, Dept Obstet, San Francisco, CA USA; Univ Calif San Francisco, Sch Med, Dept Gynecol, San Francisco, CA USA; Univ Calif San Francisco, Sch Med, Dept Reprod Sci, San Francisco, CA USA	Public Health Institute; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cohn, BA (corresponding author), Inst Publ Hlth, Ctr Res Womens & Childrens Hlth, 1683 Shattuck Ave,Suite B, Berkeley, CA 94709 USA.				NICHD NIH HHS [N01 HD 63258] Funding Source: Medline; NIEHS NIH HHS [R01 ES08345] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD063258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008345] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; BAIRD DD, 1986, AM J EPIDEMIOL, V124, P47; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Longnecker MP, 1997, ANNU REV PUBL HEALTH, V18, P211, DOI 10.1146/annurev.publhealth.18.1.211; Longnecker MP, 1999, ARCH ENVIRON HEALTH, V54, P110, DOI 10.1080/00039899909602244; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; SAXENA MC, 1981, ARCH TOXICOL, V48, P127, DOI 10.1007/BF00310482; van den Berg B J, 1988, Paediatr Perinat Epidemiol, V2, P265; WEINBERG CR, 1989, AM J EPIDEMIOL, V129, P1072, DOI 10.1093/oxfordjournals.aje.a115211	9	104	106	1	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 28	2003	361	9376					2205	2206		10.1016/S0140-6736(03)13776-2	http://dx.doi.org/10.1016/S0140-6736(03)13776-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695DJ	12842376				2022-12-01	WOS:000183815600015
J	Chan, RC; Chan, A; Jeon, M; Wu, TF; Pasqualone, D; Rougvie, AE; Meyer, BJ				Chan, RC; Chan, A; Jeon, M; Wu, TF; Pasqualone, D; Rougvie, AE; Meyer, BJ			Chromosome cohesion is regulated by a clock gene paralogue TIM-1	NATURE			English	Article							SISTER-CHROMATID COHESION; CAENORHABDITIS-ELEGANS; C-ELEGANS; X-CHROMOSOME; DOSAGE COMPENSATION; MEIOTIC PROPHASE; PROTEIN; RECOMBINATION; CONDENSATION; DROSOPHILA	Faithful transmission of the genome requires that a protein complex called cohesin establishes and maintains the regulated linkage between replicated chromosomes before their segregation(1,2). Here we report the unforeseen participation of Caenorhabditis elegans TIM-1, a paralogue of the Drosophila clock protein TIMELESS, in the regulation of chromosome cohesion. Our biochemical experiments defined the C. elegans cohesin complex and revealed its physical association with TIM-1. Functional relevance of the interaction was demonstrated by aberrant mitotic chromosome behaviour, embryonic lethality and defective meiotic chromosome cohesion caused by the disruption of either TIM-1 or cohesin. TIM-1 depletion prevented the assembly of non-SMC ( structural maintenance of chromosome) cohesin subunits onto meiotic chromosomes; however, unexpectedly, a partial cohesin complex composed of SMC components still loaded. Further disruption of cohesin activity in meiosis by the simultaneous depletion of TIM-1 and an SMC subunit decreased homologous chromosome pairing before synapsis, revealing a new role for cohesin in metazoans. On the basis of comparisons between TIMELESS homologues in worms, flies and mice, we propose that chromosome cohesion, rather than circadian clock regulation, is the ancient and conserved function for TIMELESS-like proteins.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Minnesota, Dept Biochem, St Paul, MN 55108 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.			Chan, Raymond/0000-0003-3397-2351; Meyer, Barbara/0000-0002-6530-4588				Benna C, 2000, CURR BIOL, V10, pR512, DOI 10.1016/S0960-9822(00)00594-7; BROVERMAN SA, 1994, GENETICS, V136, P119; Chu DS, 2002, GENE DEV, V16, P796, DOI 10.1101/gad.972702; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hartman T, 2000, J CELL BIOL, V151, P613, DOI 10.1083/jcb.151.3.613; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; HODGKIN J, 1979, GENETICS, V91, P67; Howe M, 2001, J CELL BIOL, V153, P1227, DOI 10.1083/jcb.153.6.1227; HOWELL AM, 1987, GENET RES, V49, P207, DOI 10.1017/S0016672300027099; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; SCHEDL T, 1997, C ELEGANS, V2, P241; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Vodovar N, 2002, CURR BIOL, V12, pR610, DOI 10.1016/S0960-9822(02)01130-2; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	29	128	143	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					1002	1009		10.1038/nature01697	http://dx.doi.org/10.1038/nature01697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827206				2022-12-01	WOS:000183753900054
J	Baker, KD; Shewchuk, LM; Kozlova, T; Makishima, M; Hassell, A; Wisely, B; Caravella, JA; Lambert, MH; Reinking, JL; Krause, H; Thummel, CS; Willson, TM; Mangelsdorf, DJ				Baker, KD; Shewchuk, LM; Kozlova, T; Makishima, M; Hassell, A; Wisely, B; Caravella, JA; Lambert, MH; Reinking, JL; Krause, H; Thummel, CS; Willson, TM; Mangelsdorf, DJ			The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway	CELL			English	Article							RETINOID-X-RECEPTOR; LIGAND-BINDING DOMAIN; ECDYSONE RECEPTOR; NGFI-B; CRYSTAL-STRUCTURE; COACTIVATOR RECRUITMENT; MOLECULAR-BASIS; MANDUCA-SEXTA; ULTRASPIRACLE; MELANOGASTER	Ecdysteroid pulses trigger the major developmental transitions during the Drosophila life cycle. These hormonal responses are thought to be mediated by the ecdysteroid receptor (EcR) and its heterodimeric partner Ultraspiracle (USP). We provide evidence for a second ecdysteroid signaling pathway mediated by DHR38, the Drosophila ortholog of the mammalian NGFI-B subfamily of orphan nuclear receptors. DHR38 also heterodimerizes with USP, and this complex responds to a distinct class of ecdysteroids in a manner that is independent of EcR. This response is unusual in that it does not involve direct binding of ecdysteroids to either DHR38 or USP. X-ray crystallographic analysis of DHR38 reveals the absence of both a classic ligand binding pocket and coactivator binding site, features that seem to be common to all NGFI-B subfamily members. Taken together, these data reveal the existence of a separate structural class of nuclear receptors that is conserved from fly to humans.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; GlaxoSmithKline, Discovery Res, Res Triangle Pk, NC 27709 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C4, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C4, Canada; Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; GlaxoSmithKline; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu	ID, IMCACAT/D-5867-2014; feinstein, doug/M-9414-2019	Baker, Keith/0000-0002-6755-1697; Mangelsdorf, David/0000-0002-4355-0796; Krause, Henry/0000-0002-6182-7074				ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; ANDRES AJ, 1992, DEVELOPMENT, V116, P865; ANDRES AJ, 1993, DEV BIOL, V160, P388, DOI 10.1006/dbio.1993.1315; Baker KD, 2000, INSECT BIOCHEM MOLEC, V30, P1037, DOI 10.1016/S0965-1748(00)00075-8; BASHIRULLAH A, 2003, IN PRESS DEV BI 0325, DOI DOI 10.1016/S0012-1606(3)00063-0; BENYAJATI C, 1983, CELL, V33, P125, DOI 10.1016/0092-8674(83)90341-0; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Botling J, 1997, J BIOL CHEM, V272, P9443; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Champlin DT, 1998, DEVELOPMENT, V125, P269; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; CHERBAS L, 1970, BIOL BULL, V138, P115, DOI 10.2307/1540196; CHERBAS L, 1980, ROUX ARCH DEV BIOL, V189, P1, DOI 10.1007/BF00848562; Clayton GM, 2001, P NATL ACAD SCI USA, V98, P1549, DOI 10.1073/pnas.041611298; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; DELACRUZ EM, 1996, J AESTHET EDUC, V30, P85, DOI 10.2307/3333235; Dinan L, 2001, PHYTOCHEMISTRY, V57, P325, DOI 10.1016/S0031-9422(01)00078-4; FISK GJ, 1995, P NATL ACAD SCI USA, V92, P10604, DOI 10.1073/pnas.92.23.10604; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gilbert Lawrence I., 1997, Invertebrate Neuroscience, V3, P205, DOI 10.1007/BF02480376; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; GILLILAND GL, 1984, METHOD ENZYMOL, V104, P370; GRAU V, 1994, INSECT BIOCHEM MOLEC, V24, P49, DOI 10.1016/0965-1748(94)90122-8; Hall BL, 1998, DEVELOPMENT, V125, P4709; HENRICH VC, 1994, DEV BIOL, V165, P38, DOI 10.1006/dbio.1994.1232; Hiruma K, 1997, GEN COMP ENDOCR, V107, P84, DOI 10.1006/gcen.1997.6901; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; KOELLE MR, 1992, THESIS STANFORD U ST; Kozlova T, 1998, GENETICS, V149, P1465; Kozlova T, 2002, DEVELOPMENT, V129, P1739; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MOUGNEAU E, 1993, MOL CELL BIOL, V13, P184, DOI 10.1128/MCB.13.1.184; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Paulsen RE, 1995, J MOL NEUROSCI, V6, P249, DOI 10.1007/BF02736784; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; PERRIMON N, 1985, GENETICS, V111, P23; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; RIDDIFORD LM, 1996, DEV DROSOPHILA MELAN, P899; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; SOMMEMARTIN G, 1990, ARCH INSECT BIOCHEM, V15, P43, DOI 10.1002/arch.940150105; SOMMEMARTIN G, 1988, INSECT BIOCHEM, V18, P729, DOI 10.1016/0020-1790(88)90082-0; SUTHERLAND JD, 1995, P NATL ACAD SCI USA, V92, P7966, DOI 10.1073/pnas.92.17.7966; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656	64	181	196	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					731	742		10.1016/S0092-8674(03)00420-3	http://dx.doi.org/10.1016/S0092-8674(03)00420-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809604	Bronze, Green Published			2022-12-01	WOS:000183514400008
J	Kimmel, AR; Parent, CA				Kimmel, AR; Parent, CA			The signal to move: D-discoideum go orienteering	SCIENCE			English	Editorial Material							DICTYOSTELIUM; CHEMOTAXIS; CELLS; SUPPRESSOR; GRADIENTS; MODEL	Cells migrating directionally toward a chemoattractant source display a highly polarized cytoskeletal organization, with F-actin localized predominantly at the anterior and myosin II at the lateral and posterior regions. Dictyostelium discoideum has proven a useful system for elucidating signaling pathways that regulate this chemotactic response. During development, extracellular adenosine 3', 5' monophosphate (cAMP) functions as a primary signal to activate cell surface cAMP receptors (cARs). These receptors transduce different signals depending on whether or not they are coupled to heterotrimeric guanine nucleotide-binding proteins (G proteins) (see the STKE Connections Maps). Multiple G protein-stimulated pathways interact to establish polarity in chemotaxing D. discoideum cells by localizing F-actin at their leading edge and by regulating the phosphorylation state and assembly of myosin II. Many of the molecular interactions described are fundamental to the regulation of chemotaxis in other eukaryotic cells.	NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [Z01BC010418, ZIABC010418] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; DELAROCHE MA, IN PRESS J MUSCLE RE; DRAYER AL, 1994, EMBO J, V13, P1601, DOI 10.1002/j.1460-2075.1994.tb06423.x; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; KIMMEL AR, 2003, SCI STKE; Kreppel L, 2002, NUCLEIC ACIDS RES, V30, P84, DOI 10.1093/nar/30.1.84; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Narang A, 2001, ANN BIOMED ENG, V29, P677, DOI 10.1114/1.1385805; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Postma M, 2001, BIOPHYS J, V81, P1314, DOI 10.1016/S0006-3495(01)75788-8; Traynor D, 2000, EMBO J, V19, P4846, DOI 10.1093/emboj/19.17.4846; Wessels DJ, 2000, MOL BIOL CELL, V11, P2803, DOI 10.1091/mbc.11.8.2803; Wilkins A, 2001, TRENDS GENET, V17, P41, DOI 10.1016/S0168-9525(00)02181-8; Zhang H, 2003, EUKARYOT CELL, V2, P62, DOI 10.1128/EC.2.1.62-75.2003; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	22	67	68	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1525	1527		10.1126/science.1085439	http://dx.doi.org/10.1126/science.1085439			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791977				2022-12-01	WOS:000183333100037
J	Yu, YS; Rambo, T; Currie, J; Saski, C; Kim, HR; Collura, K; Thompson, S; Simmons, J; Yang, TJ; Nah, G; Patel, AJ; Thurmond, S; Henry, D; Oates, R; Palmer, M; Pries, G; Gibson, J; Anderson, H; Paradkar, M; Crane, L; Dale, J; Carver, MB; Wood, T; Frisch, D; Engler, F; Soderlund, C; Palmer, LE; Tetylman, L; Nascimento, L; de la Bastide, M; Spiegel, L; Ware, D; O'Shaughnessy, A; Dike, S; Dedhia, N; Preston, R; Huang, E; Ferraro, K; Kuit, K; Miller, B; Zutavern, T; Katzenberger, F; Muller, S; Balija, V; Martienssen, RA; Stein, L; Minx, P; Johnson, D; Cordum, H; Mardis, E; Cheng, ZK; Jiang, JM; Wilson, R; McCombie, WR; Wing, RA; Yuan, QP; Shu, OY; Liu, J; Jones, KM; Gansberger, K; Moffat, K; Hill, J; Tsitrin, T; Overton, L; Bera, J; Kim, M; Jin, SH; Tallon, L; Ciecko, A; Pai, G; Van Aken, S; Utterback, T; Reidmuller, S; Bormann, J; Feldblyum, T; Hsiao, J; Zismann, V; Blunt, S; de Vazeilles, A; Shaffer, T; Koo, H; Suh, B; Yang, Q; Haas, B; Peterson, J; Pertea, M; Volfovsky, N; Wortman, J; White, O; Salzberg, SL; Fraser, CM; Buell, CR; Messing, J; Song, RT; Fuks, G; Llaca, V; Kovchak, S; Young, S; Bowers, JE; Paterson, AH; Johns, MA; Mao, L; Pan, HQ; Dean, RA				Yu, YS; Rambo, T; Currie, J; Saski, C; Kim, HR; Collura, K; Thompson, S; Simmons, J; Yang, TJ; Nah, G; Patel, AJ; Thurmond, S; Henry, D; Oates, R; Palmer, M; Pries, G; Gibson, J; Anderson, H; Paradkar, M; Crane, L; Dale, J; Carver, MB; Wood, T; Frisch, D; Engler, F; Soderlund, C; Palmer, LE; Tetylman, L; Nascimento, L; de la Bastide, M; Spiegel, L; Ware, D; O'Shaughnessy, A; Dike, S; Dedhia, N; Preston, R; Huang, E; Ferraro, K; Kuit, K; Miller, B; Zutavern, T; Katzenberger, F; Muller, S; Balija, V; Martienssen, RA; Stein, L; Minx, P; Johnson, D; Cordum, H; Mardis, E; Cheng, ZK; Jiang, JM; Wilson, R; McCombie, WR; Wing, RA; Yuan, QP; Shu, OY; Liu, J; Jones, KM; Gansberger, K; Moffat, K; Hill, J; Tsitrin, T; Overton, L; Bera, J; Kim, M; Jin, SH; Tallon, L; Ciecko, A; Pai, G; Van Aken, S; Utterback, T; Reidmuller, S; Bormann, J; Feldblyum, T; Hsiao, J; Zismann, V; Blunt, S; de Vazeilles, A; Shaffer, T; Koo, H; Suh, B; Yang, Q; Haas, B; Peterson, J; Pertea, M; Volfovsky, N; Wortman, J; White, O; Salzberg, SL; Fraser, CM; Buell, CR; Messing, J; Song, RT; Fuks, G; Llaca, V; Kovchak, S; Young, S; Bowers, JE; Paterson, AH; Johns, MA; Mao, L; Pan, HQ; Dean, RA		Rice Chromosome 10 Sequencing Cons	In-depth view of structure, activity, and evolution of rice chromosome 10	SCIENCE			English	Article							GENOME SEQUENCE; DRAFT SEQUENCE; RESISTANCE; GENES	Rice is the world's most important food crop and a model for cereal research. At 430 megabases in size, its genome is the most compact of the cereals. We report the sequence of chromosome 10, the smallest of the 12 rice chromosomes (22.4 megabases), which contains 3471 genes. Chromosome 10 contains considerable heterochromatin with an enrichment of repetitive elements on 10S and an enrichment of expressed genes on 10L. Multiple insertions from organellar genomes were detected. Collinearity was apparent between rice chromosome 10 and sorghum and maize. Comparison between the draft and finished sequence demonstrates the importance of finished sequence.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Arizona, Arizona Genom Inst, Tucson, AZ 85721 USA; Univ Arizona, Arizona Genom Computat Lab, Dept Plant Sci, Tucson, AZ 85721 USA; Clemson Univ, Genom Inst, Clemson, SC 29634 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Inst Genome Res, Rockville, MD 20850 USA; Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Rutgers State Univ, PGIR Waksman Inst, Piscataway, NJ 08854 USA; Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; N Carolina State Univ, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA	Cold Spring Harbor Laboratory; University of Arizona; University of Arizona; Clemson University; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; J. Craig Venter Institute; Johns Hopkins University; Johns Hopkins University; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; Northern Illinois University; University of North Carolina; North Carolina State University	McCombie, WR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mccombie@cshl.edu; rwing@ag.arizona.edu; rbuell@tigr.org; messing@waksman.rutgers.edu	Bowers, John/AAD-7601-2019; Wing, Rod A/Z-2885-2019; Pertea, Mihaela/AAT-2705-2021; Salzberg, Steven/Q-6514-2019; Yang, Tae-Jin/AAT-5274-2020; Song, Rentao/A-6544-2012; Mardis, Elaine/W-2202-2019; Salzberg, Steven L/F-6162-2011; Bowers, John/B-9245-2009; Jiang, Jiming/V-6060-2019; Jiang, Jiming/A-9614-2009; Song, Rentao/AAG-9107-2021	Wing, Rod A/0000-0001-6633-6226; Pertea, Mihaela/0000-0003-0762-8637; Salzberg, Steven/0000-0002-8859-7432; Song, Rentao/0000-0003-1810-9875; Salzberg, Steven L/0000-0002-8859-7432; Bowers, John/0000-0001-8984-9796; Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Song, Rentao/0000-0003-1810-9875; Yuan, Qiaoping/0000-0002-5880-8702; McCombie, W. Richard/0000-0003-1899-0682; Fraser, Claire/0000-0003-1462-2428; Messing, Joachim/0000-0001-8260-2643; Pan, Huaqin/0000-0002-7166-108X; Buell, C Robin/0000-0002-6727-4677; Iobst, Stacey E./0000-0002-6954-2903	NLM NIH HHS [R01-LM06845] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [DOI 10.1007/BF02672069, 10.1007/BF02672069]; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Barry GF, 2001, PLANT PHYSIOL, V125, P1164, DOI 10.1104/pp.125.3.1164; BOWERS JE, IN PRESS GENETICS; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Harushima Y, 1998, GENETICS, V148, P479; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Song R, 2002, GENOME RES, V12, P1549, DOI 10.1101/gr.268302; Thomas CM, 1998, PHILOS T ROY SOC B, V353, P1413, DOI 10.1098/rstb.1998.0296; Yamazaki M, 2001, MOL GENET GENOMICS, V265, P336, DOI 10.1007/s004380000421; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1	22	148	353	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1566	1569						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791992				2022-12-01	WOS:000183333100054
J	Snaith, HA; Sawin, KE				Snaith, HA; Sawin, KE			Fission yeast mod5p regulates polarized growth through anchoring of tea1p at cell tips	NATURE			English	Article							SCHIZOSACCHAROMYCES-POMBE; MICROTUBULAR CYTOSKELETON; PROTEINS; MECHANISMS; DYNAMICS; ESTABLISHMENT; END	Microtubules have a central role in eukaryotic cell polarity(1), in part through interactions between microtubule end-binding proteins and the cell cortex(2,3). In the fission yeast Schizosaccharomyces pombe, microtubules and the polarity modulator tea1p maintain cylindrical cell shape and strictly antipodal cell growth(4-7). The tea1p protein is transported to cell tips by association with growing microtubule plus ends(8); once at cell tips, tea1p releases from microtubule ends and associates with the cell cortex, where it coordinates polarized growth(4,6). Here we describe a cortical protein, mod5p, that regulates the dynamic behaviour of tea1p. In mod5Delta cells, tea1p is efficiently transported on microtubules to cell tips but fails to anchor properly at the cortex and thus fails to accumulate to normal levels. mod5p contains a signal for carboxy-terminal prenylation and in wildtype cells is associated with the plasma membrane at cell tips. However, in tea1Delta cells, although mod5p remains localized to the plasma membrane, mod5p is no longer restricted to the cell tips. We propose that tea1p and mod5p act in a positive-feedback loop in the microtubule-mediated regulation of cell polarity.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Sawin, KE (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Swann Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	ken.sawin@ed.ac.uk		Snaith, Hilary/0000-0003-4863-8436; Sawin, Kenneth/0000-0002-2607-2219				ADACHI Y, 1986, MOL CELL BIOL, V6, P2168, DOI 10.1128/MCB.6.6.2168; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Arellano M, 2002, CURR BIOL, V12, P751, DOI 10.1016/S0960-9822(02)00821-7; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Chang F, 2001, TRENDS GENET, V17, P273, DOI 10.1016/S0168-9525(01)02279-X; Ding DQ, 1998, J CELL SCI, V111, P701; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; WOODS A, 1989, J CELL SCI, V93, P491; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	30	97	100	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					647	651		10.1038/nature01672	http://dx.doi.org/10.1038/nature01672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789340	Green Published			2022-12-01	WOS:000183301200042
J	Larson, DR; Zipfel, WR; Williams, RM; Clark, SW; Bruchez, MP; Wise, FW; Webb, WW				Larson, DR; Zipfel, WR; Williams, RM; Clark, SW; Bruchez, MP; Wise, FW; Webb, WW			Water-soluble quantum dots for multiphoton fluorescence imaging in vivo	SCIENCE			English	Article							CORRELATION SPECTROSCOPY; MICROSCOPY; NANOCRYSTALS; EXCITATION; INTERMITTENCY	The use of semiconductor nanocrystals (quantum dots) as fluorescent labels for multiphoton microscopy enables multicolor imaging in demanding biological environments such as living tissue. We characterized water-soluble cadmium selenide-zinc sulfide quantum dots for multiphoton imaging in live animals. These fluorescent probes have two-photon action cross sections as high as 47,000 Goeppert-Mayer units, by far the largest of any label used in multiphoton microscopy. We visualized quantum dots dynamically through the skin of living mice, in capillaries hundreds of micrometers deep. We found no evidence of blinking (fluorescence intermittency) in solution on nanosecond to millisecond time scales.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Quantum Dot Corp, Hayward, CA 94545 USA	Cornell University	Webb, WW (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.		Bruchez, Marcel P/C-2271-2009; Larson, Daniel R/B-9829-2008; Webb, Watt W./B-5905-2011	Bruchez, Marcel P/0000-0002-7370-4848; Larson, Daniel R/0000-0001-9253-3055; Williams, Rebecca/0000-0002-1391-5846	NATIONAL CANCER INSTITUTE [R44CA088391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004224] Funding Source: NIH RePORTER; NCI NIH HHS [R44CA8839102] Funding Source: Medline; NCRR NIH HHS [NCRR P41-RR04224, RR10675] Funding Source: Medline; PHS HHS [R33-645644] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; BLANTON SA, 1994, CHEM PHYS LETT, V229, P317, DOI 10.1016/0009-2614(94)01057-9; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; CHAN W, 2002, CURR OPIN BIOTECH, V13, P140; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Ebenstein Y, 2002, APPL PHYS LETT, V80, P4033, DOI 10.1063/1.1482785; Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488; Kuno M, 2000, J CHEM PHYS, V112, P3117, DOI 10.1063/1.480896; Lounis B, 2000, CHEM PHYS LETT, V329, P399, DOI 10.1016/S0009-2614(00)01042-3; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; Neuhauser RG, 2000, PHYS REV LETT, V85, P3301, DOI 10.1103/PhysRevLett.85.3301; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Williams RM, 2001, CURR OPIN CHEM BIOL, V5, P603, DOI 10.1016/S1367-5931(00)00241-6; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Yoder EJ, 2002, MICROSC RES TECHNIQ, V56, P304, DOI 10.1002/jemt.10002	20	2004	2125	11	896	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1434	1436		10.1126/science.1083780	http://dx.doi.org/10.1126/science.1083780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775841				2022-12-01	WOS:000183181800046
J	Kalnay, E; Cai, M				Kalnay, E; Cai, M			Impact of urbanization and land-use change on climate	NATURE			English	Article							TEMPERATURE TRENDS; HEAT-ISLAND	The most important anthropogenic influences on climate are the emission of greenhouse gases(1) and changes in land use, such as urbanization and agriculture(2). But it has been difficult to separate these two influences because both tend to increase the daily mean surface temperature(3,4). The impact of urbanization has been estimated by comparing observations in cities with those in surrounding rural areas, but the results differ significantly depending on whether population data(5) or satellite measurements of night light(6-8) are used to classify urban and rural areas(7,8). Here we use the difference between trends in observed surface temperatures in the continental United States and the corresponding trends in a reconstruction of surface temperatures determined from a reanalysis of global weather over the past 50 years, which is insensitive to surface observations, to estimate the impact of land-use changes on surface warming. Our results suggest that half of the observed decrease in diurnal temperature range is due to urban and other land-use changes. Moreover, our estimate of 0.27degreesC mean surface warming per century due to land-use changes is at least twice as high as previous estimates based on urbanization alone(7,8).	Univ Maryland, College Pk, MD 20770 USA	University System of Maryland; University of Maryland College Park	Kalnay, E (corresponding author), Univ Maryland, College Pk, MD 20770 USA.	ekalnay@atmos.umd.edu	Kalnay, Eugenia/F-4393-2010	Kalnay, Eugenia/0000-0002-9984-9906				Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Gallezot P, 1996, APPL CATAL B-ENVIRON, V9, pL11; Gallo KP, 1999, J CLIMATE, V12, P1344, DOI 10.1175/1520-0442(1999)012<1344:TTOTUS>2.0.CO;2; Gallo KP, 1999, J APPL METEOROL, V38, P806, DOI [10.1175/1520-0450(1999)038<0806:SBAFTU>2.0.CO;2, 10.1175/1520-0450(1993)032<0899:TUONAD>2.0.CO;2]; Hansen J, 2001, J GEOPHYS RES-ATMOS, V106, P23947, DOI 10.1029/2001JD000354; IPCC, 2001, CLIMATE CHANGE 2001; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; NRC, 2000, REV US NAV EXP STAND, P1; Owen TW, 1998, INT J REMOTE SENS, V19, P3451, DOI 10.1080/014311698214127; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Runnalls KE, 2000, PHYS GEOGR, V21, P283, DOI 10.1080/02723646.2000.10642711; Travis DJ, 2002, NATURE, V418, P601, DOI 10.1038/418601a	13	1492	1698	68	1329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2003	423	6939					528	531		10.1038/nature01675	http://dx.doi.org/10.1038/nature01675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774119	Bronze			2022-12-01	WOS:000183162900040
J	Wang, ZL; Benoit, G; Liu, JS; Prasad, S; Aarnisalo, P; Liu, XH; Xu, HD; Walker, NPC; Perlmann, T				Wang, ZL; Benoit, G; Liu, JS; Prasad, S; Aarnisalo, P; Liu, XH; Xu, HD; Walker, NPC; Perlmann, T			Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors	NATURE			English	Article							BINDING DOMAIN; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; SUPERFAMILY; ACTIVATION; EVOLUTION	Members of the nuclear receptor (NR) superfamily of transcription factors modulate gene transcription in response to small lipophilic molecules(1). Transcriptional activity is regulated by ligands binding to the carboxy-terminal ligand-binding domains (LBDs) of cognate NRs. A subgroup of NRs referred to as 'orphan receptors' lack identified ligands, however, raising issues about the function of their LBDs(2). Here we report the crystal structure of the LBD of the orphan receptor Nurr1 at 2.2 Angstrom resolution. The Nurr1 LBD adopts a canonical protein fold resembling that of agonist-bound, transcriptionally active LBDs in NRs(3), but the structure has two distinctive features. First, the Nurr1 LBD contains no cavity as a result of the tight packing of side chains from several bulky hydrophobic residues in the region normally occupied by ligands. Second, Nurr1 lacks a 'classical' binding site for coactivators. Despite these differences, the Nurr1 LBD can be regulated in mammalian cells. Notably, transcriptional activity is correlated with the Nurr1 LBD adopting a more stable conformation. Our findings highlight a unique structural class of NRs and define a model for ligand-independent NR function.	Tularik Inc, Dept Biol Struct, San Francisco, CA 94080 USA; Karolinska Inst, Dept Cell Biol, Ludwig Inst Canc Res, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Mol Biol, Ludwig Inst Canc Res, S-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Ludwig Institute for Cancer Research	Walker, NPC (corresponding author), Tularik Inc, Dept Biol Struct, 1120 Vet Blvd, San Francisco, CA 94080 USA.	walker@tularik.com; thomas.perlmann@licr.ki.se		BENOIT, Gerard/0000-0001-9462-6570				Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DESCOTEAUX A, 1993, METHODS MOL GENETICS, V1, P22; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maruyama K, 1998, INT J ONCOL, V12, P1237; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pissios P, 2000, MOL CELL, V6, P245, DOI 10.1016/S1097-2765(00)00026-5; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Renaud JP, 2000, MOL ENDOCRINOL, V14, P700, DOI 10.1210/me.14.5.700; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	30	441	464	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2003	423	6939					555	560		10.1038/nature01645	http://dx.doi.org/10.1038/nature01645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774125				2022-12-01	WOS:000183162900047
J	Liu, JG; Ouyang, ZY; Pimm, SL; Raven, PH; Wang, XK; Miao, H; Han, NY				Liu, JG; Ouyang, ZY; Pimm, SL; Raven, PH; Wang, XK; Miao, H; Han, NY			Protecting China's biodiversity	SCIENCE			English	Editorial Material							GIANT		Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Key Lab Syst Ecol, Beijing, Peoples R China; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA; Missouri Bot Garden, St Louis, MO 63166 USA; Chinas Natl Comm Man & Biosphere, Beijing, Peoples R China	Michigan State University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Duke University; Missouri Botanical Gardens	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	jliu@panda.msu.edu	pimm, stuart/ABF-1082-2020; Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039789] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD39789] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; [Anonymous], 2002, PEOPLES REPUBLIC CHI; Axelrod A.I., 1998, FLORISTIC CHARACTERI, P43; China's National Committee on Man and Biosphere, 2000, STUD SUST MAN POL CH; *COMP GROUP, 1998, CHIN BIOD COUNT STUD; Dale VH, 2002, CAM STU LAN, P265, DOI 10.1017/CBO9780511613654.015; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; HAN N, 2000, STUDY SUSTAINABLE MA, P1; LI W, 2000, STUD SUST MAN POL CH, P92; Liu JG, 2001, SCIENCE, V293, P603; Liu JG, 1999, POPUL ENVIRON, V21, P45, DOI 10.1007/BF02436120; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; Miao H, 2000, STUDY SUSTAINABLE MA, P57; RAVEN PH, 1994, P INT WORKSH SCI FRO, P137; WANG X, 2000, STUDY SUSTAINABLE MA, P81; *WORLD BANK, 2001, WORLD DEV IND 2001; XU H, 2000, STUDY SUSTAINABLE MA, P72; 1994, ACTION PLAN BIODIVER	18	198	235	10	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1240	1241		10.1126/science.1078868	http://dx.doi.org/10.1126/science.1078868			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764180				2022-12-01	WOS:000183042400029
J	Jumaa, H; Bossaller, L; Portugal, K; Storch, B; Lotz, M; Flemming, A; Schrappe, M; Postila, V; Riikonen, P; Pelkonen, J; Niemeyer, CM; Reth, M				Jumaa, H; Bossaller, L; Portugal, K; Storch, B; Lotz, M; Flemming, A; Schrappe, M; Postila, V; Riikonen, P; Pelkonen, J; Niemeyer, CM; Reth, M			Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia	NATURE			English	Article							DROSOPHILA-TRITHORAX; ANTIGEN RECEPTOR; ACUTE LEUKEMIAS; LINKER PROTEIN; EXPRESSION; CHILDHOOD; TRANSLOCATIONS; ACTIVATION; GENE; MICE	Acute lymphoblastic leukaemia (ALL) is the commonest form of childhood malignancy, and most cases arise from B-cell clones arrested at the pre-B-cell stage of differentiation(1,2). The molecular events that arrest pre-B-cell differentiation in the leukaemic pre-B cells have not been well characterized. Here we show that the differentiation regulator SLP-65 (an adaptor protein also called BLNK or BASH(3-6)) inhibits pre-B-cell leukaemia in mice. Reconstitution of SLP-65 expression in a SLP-65(-/-) pre-B-cell line led to enhanced differentiation in vitro and prevented the development of pre-B-cell leukaemia in immune-deficient mice. Tyrosine 96 of SLP-65 was required for this activity. The murine SLP-65(-/-) pre-B-cell leukaemia resembles human childhood pre-B ALL. Indeed, 16 of the 34 childhood pre-B ALL samples that were tested showed a complete loss or drastic reduction of SLP-65 expression. This loss is probably due to the incorporation of alternative exons into SLP-65 transcripts, leading to premature stop codons. Thus, the somatic loss of SLP-65 and the accompanying block in pre-B-cell differentiation might be one of the primary causes of childhood pre-B ALL.	Univ Freiburg, D-79108 Freiburg, Germany; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Med Sch Hanover, Childrens Hosp, D-30625 Hannover, Germany; Univ Kuopio, Dept Clin Microbiol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Clin Microbiol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pediat, FIN-70211 Kuopio, Finland; Freiburg Univ Hosp, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, D-79106 Freiburg, Germany	University of Freiburg; Max Planck Society; University of Eastern Finland; Kuopio University Hospital; Kuopio University Hospital; University of Freiburg	Reth, M (corresponding author), Univ Freiburg, D-79108 Freiburg, Germany.		Schrappe, Martin/A-8109-2010; Schrappe, Martin/ABA-6144-2020	Bossaller, Lukas/0000-0003-0789-4062				Advani AS, 2002, LEUKEMIA RES, V26, P713, DOI 10.1016/S0145-2126(01)00197-7; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; BEISHUIZEN A, 1991, LEUKEMIA, V5, P657; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; EDERY I, 1983, J BIOL CHEM, V258, P1398; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Goodman PA, 2001, ONCOGENE, V20, P3969, DOI 10.1038/sj.onc.1204515; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Jennings CD, 1997, BLOOD, V90, P2863, DOI 10.1182/blood.V90.8.2863; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Ma SK, 1999, HEMATOL ONCOL, V17, P91, DOI 10.1002/(SICI)1099-1069(199909)17:3<91::AID-HON643>3.0.CO;2-Y; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Nishii K, 2000, INT J HEMATOL, V71, P372; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; UMIEL T, 1993, LEUKEMIA, V7, P435; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	28	109	111	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					452	456		10.1038/nature01608	http://dx.doi.org/10.1038/nature01608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761551				2022-12-01	WOS:000183012000045
J	Ohbayashi, M; Ohki, K; Miyashita, Y				Ohbayashi, M; Ohki, K; Miyashita, Y			Conversion of working memory to motor sequence in the monkey premotor cortex	SCIENCE			English	Article							PREFRONTAL CORTEX; FRONTAL-CORTEX; DECISIONS; SELECTION; MOVEMENT; PRIMATE; AREAS	To plan a serial order behavior, we hold serial sensory information in our minds and convert it to a movement program. We trained monkeys to memorize a sequence of positional cues and to reproduce it by making saccades in either the original or reverse order. The order was determined in the middle of a trial on the basis of an instruction stimulus. Triggered by the instruction stimulus, single neurons in the dorsal premotor cortex became transiently active only when the order needed to be determined. These transient neurons, together with nearby sustained neurons that hold information on cue or movement sequences, appear to mediate the generation of a motor program from the maintained information.	Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Ohbayashi, M (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ohbayashi-tky@umin.ac.jp; yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019; Ohbayashi, Machiko/A-6910-2018	Miyashita, Yasushi/0000-0003-3496-8637; Ohbayashi, Machiko/0000-0003-2563-9049				BARONE P, 1989, EXP BRAIN RES, V78, P447; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Boussaoud D, 1996, BEHAV BRAIN RES, V72, P1; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; Georgopoulos AP, 2000, CURR OPIN NEUROBIOL, V10, P238, DOI 10.1016/S0959-4388(00)00072-6; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; HALSBAND U, 1985, BEHAV BRAIN RES, V18, P269, DOI 10.1016/0166-4328(85)90035-X; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; Lashley K. S., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; LUPPINO G, 1990, EXP BRAIN RES, V82, P214; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miller GA, 1960, PLANS STRUCTURE BEHA; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; Passingham RE., 1993, FRONTAL LOBES VOLUNT; PETRIDES M, 1986, J NEUROSCI, V6, P2054; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Stern CE, 2000, NEUROIMAGE, V11, P392, DOI 10.1006/nimg.2000.0569; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; WISE SP, 1985, ANNU REV NEUROSCI, V8, P1, DOI 10.1146/annurev.ne.08.030185.000245	27	111	113	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					233	236		10.1126/science.1084884	http://dx.doi.org/10.1126/science.1084884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855814				2022-12-01	WOS:000184056200049
J	Sidi, S; Friedrich, RW; Nicolson, T				Sidi, S; Friedrich, RW; Nicolson, T			NompC TRP channel required for vertebrate sensory hair cell mechanotransduction	SCIENCE			English	Article							MECHANOSENSORY TRANSDUCTION; DROSOPHILA; MUTANTS	The senses of hearing and balance in vertebrates rely on the sensory hair cells (HCs) of the inner ear. The central element of the HC's transduction apparatus is a mechanically gated ion channel of unknown identity. Here we report that the zebrafish ortholog of Drosophila no mechanoreceptor potential C (nompC), which encodes a transient receptor potential (TRP) channel, is critical for HC mechanotransduction. In zebrafish larvae, nompC is selectively expressed in sensory HCs. Morpholino-mediated removal of nompC function eliminated transduction-dependent endocytosis and electrical responses in HCs, resulting in larval deafness and imbalance. These observations indicate that nompC encodes a vertebrate HC mechanotransduction channel.	Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society	Nicolson, T (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.			Friedrich, Rainer/0000-0001-9107-0482				ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Colbert HA, 1997, J NEUROSCI, V17, P8259; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1983, J NEUROSCI, V3, P942; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MONELL C, 2003, SCI STKE 2003; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strassmaier M, 2002, CURR OPIN NEUROBIOL, V12, P380, DOI 10.1016/S0959-4388(02)00344-6; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	19	228	249	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					96	99		10.1126/science.1084370	http://dx.doi.org/10.1126/science.1084370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12805553				2022-12-01	WOS:000183914700041
J	Yandulov, DV; Schrock, RR				Yandulov, DV; Schrock, RR			Catalytic reduction of dinitrogen to ammonia at a single molybdenum center	SCIENCE			English	Article							NITROGEN-FIXATION; IRON PROTEIN; MOFE-PROTEIN; COMPLEXES; CHEMISTRY; TUNGSTEN; MECHANISM; MODELS	Dinitrogen (N-2) was reduced to ammonia at room temperature and 1 atmosphere with molybdenum catalysts that contain tetradentate [HIPTN3N](3-) triamidoamine ligands {such as [HIPTN3N]Mo(N-2), where [HIPTN3N](3-) is[{3,5-(2,4,6-i-Pr3C6H2)(2)C6H3NCH2CH2}(3)N](3-)} in heptane. Slow addition of the proton source [{2,6-lutidinium}{BAr'(4)}, where Ar' is 3,5-(CF3)(2)C6H3] and reductant (decamethyl chromocene) was critical for achieving high efficiency (similar to66% in four turnovers). Numerous x-ray studies, along with isolation and characterization of six proposed intermediates in the catalytic reaction under noncatalytic conditions, suggest that N-2 was reduced at a sterically protected, single molybdenum center that cycled from Mo(III) through Mo(VI) states.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schrock, RR (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	rrs@mit.edu	Yandulov, Dmitry/GXG-1415-2022	Yandulov, Dmitry/0000-0003-2272-9030	NIGMS NIH HHS [GM 31978] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031978] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN AD, 1965, CHEM COMMUN, P621, DOI 10.1039/c19650000621; Barriere F, 2003, COORDIN CHEM REV, V236, P71, DOI 10.1016/S0010-8545(02)00183-2; BAZHENOVA TA, 1995, COORDIN CHEM REV, V144, P69, DOI 10.1016/0010-8545(95)01139-G; BOLIN JT, 1993, P NATL ACAD SCI USA, V90, P1078, DOI 10.1073/pnas.90.3.1078; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; BURGESS BK, 1990, CHEM REV, V90, P1377, DOI 10.1021/cr00106a002; CHANEY AL, 1962, CLIN CHEM, V8, P130; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; CHEN J, 1993, ANGEW CHEM INT EDIT, V32, P1592; Connelly NG, 1996, CHEM REV, V96, P877, DOI 10.1021/cr940053x; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; DICKSON CR, 1978, J AM CHEM SOC, V100, P8007, DOI 10.1021/ja00493a039; DZIEGIELEWSKI JO, 1990, POLYHEDRON, V9, P645, DOI 10.1016/S0277-5387(00)80270-3; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Eady RR, 2001, J INORG BIOCHEM, V86, P42; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fryzuk MD, 2000, COORDIN CHEM REV, V200, P379, DOI 10.1016/S0010-8545(00)00264-2; Greco GE, 2001, INORG CHEM, V40, P3861, DOI 10.1021/ic001123n; Greco GE, 2001, INORG CHEM, V40, P3850, DOI 10.1021/ic001122v; HENDERSON RA, 1983, ADV INORG CHEM RAD, V27, P197, DOI 10.1016/S0898-8838(08)60108-7; HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; Hidai M, 1999, COORDIN CHEM REV, V185-6, P99, DOI 10.1016/S0010-8545(98)00250-1; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; KOMORI K, 1989, J AM CHEM SOC, V111, P1939, DOI 10.1021/ja00187a092; Pickett CJ, 1996, J BIOL INORG CHEM, V1, P601, DOI 10.1007/s007750050099; PICKETT CJ, 1985, NATURE, V317, P652, DOI 10.1038/317652a0; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Rees DC, 1993, ADV INORG CHEM, V40, P89; Richards RL, 1996, COORDIN CHEM REV, V154, P83, DOI 10.1016/0010-8545(96)01186-1; ROBBINS JL, 1982, J AM CHEM SOC, V104, P1882, DOI 10.1021/ja00371a017; Schrock RR, 1997, PURE APPL CHEM, V69, P2197, DOI 10.1351/pac199769102197; SHILOV AE, 1987, J MOL CATAL, V41, P221, DOI 10.1016/0304-5102(87)80030-5; TANAKA K, 1982, CHEM LETT, P1203, DOI 10.1246/cl.1982.1203; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Yandulov DV, 2002, J AM CHEM SOC, V124, P6252, DOI 10.1021/ja020186x; Yandulov DV, 2003, INORG CHEM, V42, P796, DOI 10.1021/ic020505l; YANDULOV DV, UNPUB	39	1022	1035	25	582	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					76	78		10.1126/science.1085326	http://dx.doi.org/10.1126/science.1085326			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	696YG	12843387				2022-12-01	WOS:000183914700034
J	Anderson, P; Doyle, LW				Anderson, P; Doyle, LW		Victorian Infant Collaborative Stu	Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE-ABILITIES; PARENTING STRESS; GESTATIONAL-AGE; INFANTS; BRAIN; IMPACT; LESS; ADOLESCENTS; ATTAINMENT; DISORDERS	Context The outcome into school age of regional cohorts of children born in the 1990s with birth weights less than 1000 g (extremely low birth weight, ELBW) or earlier than 28 weeks' gestation (very preterm) is not known. Objective To determine the cognitive, educational, and behavioral outcome of ELBW or very preterm infants born in the 1990s compared with normal birth weight (NBW) controls. Design Regional cohort study. Setting Victoria, Australia. Participants The ELBW or very preterm cohort was composed of 298 consecutive survivors born during 1991-1992. The NBW cohort was composed of 262 randomly selected children with birth weights of more than 2499 g. Main Outcome Measures Cognitive ability, educational progress, and behavioral problems. Results The follow-up rates from birth to 8 years of age for survivors were 92.3% (275/298) for the ELBW or very preterm cohort and 85.1% (223/262) for the NBW cohort. The ELBW or very preterm children scored significantly below NBW controls on full-scale IQ (mean difference, -9.4; 95% confidence interval [CI], -12.1 to -6.7; P<.001) and indices of verbal comprehension (mean difference, -6.8; 95% Cl, -9.5 to -4.2; P<001), perceptual organization (mean difference, -9.9; 95% Cl, -12.7 to -7.2; P<001), freedom from distractibility (mean difference, -8.1; 95% Cl, -10.8 to -5.5; P<001), and processing speed (mean difference, -6.7; 95% Cl, -9.4 to -4.0; P<001). The ELBW or very preterm children performed significantly worse than the NBW cohort on tests of reading (mean difference, -6.7; 95% Cl, -9.5 to -3.9; P<001), spelling (mean difference, -5.6; 95% Cl, -8.0 to -3.3; P<.001), and arithmetic (mean difference, -8.8; 95% Cl, -11.3 to -6.2; P<.001). Attentional difficulties, internalizing behavior problems, and immature adaptive skills were more prevalent in the ELBW or very preterm cohort. Conclusion School-aged ELBW or very preterm children born in the 1990s continue to display cognitive, educational, and behavioral impairments.	Royal Womens Hosp, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Melbourne, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne	Doyle, LW (corresponding author), Royal Womens Hosp, Dept Obstet & Gynaecol, 132 Grattan St, Carlton, Vic 3053, Australia.	lwd@unimelb.edu.au	Anderson, Peter J/B-6839-2015; Doyle, Lex/AAJ-5205-2021; Anderson, Peter John/O-5302-2019	Anderson, Peter J/0000-0001-7430-868X; Doyle, Lex/0000-0002-7667-7312; Anderson, Peter John/0000-0001-7430-868X				[Anonymous], 1997, Arch Dis Child Fetal Neonatal Ed, V77, pF91; AYLWARD GP, 1992, J DEV BEHAV PEDIATR, V13, P222; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; Breslau N, 1996, BIOL PSYCHIAT, V40, P389, DOI 10.1016/0006-3223(95)00399-1; Doyle LW, 1997, J PAEDIATR CHILD H, V33, P161; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Emsley HCA, 1998, ARCH DIS CHILD-FETAL, V78, pF99, DOI 10.1136/fn.78.2.F99; FERRARA TB, 1994, J PEDIATR-US, V124, P119, DOI 10.1016/S0022-3476(94)70266-7; Grantham-McGregor SM, 1998, J PEDIATR-US, V132, P661, DOI 10.1016/S0022-3476(98)70357-9; Gross SJ, 2001, J PEDIATR-US, V138, P169, DOI 10.1067/mpd.2001.111945; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 1996, PEDIATRICS, V98, P931; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hall A, 1995, DEV MED CHILD NEUROL, V37, P1037; HAMMILL DD, 1994, COMPREHENSIVE SCALE; Hille ETM, 2001, LANCET, V357, P1641, DOI 10.1016/S0140-6736(00)04818-2; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; LEVYSHIFF R, 1994, J PEDIATR PSYCHOL, V19, P63, DOI 10.1093/jpepsy/19.1.63; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Prifitera A., 1998, WISC 3 CLIN USE INTE, P1, DOI DOI 10.1016/B978-012564930-8/50002-4; Resnick MB, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e74; Reynolds C. R., 1992, BEHAV ASSESSMENT SYS; Rickards AL, 2001, J DEV BEHAV PEDIATR, V22, P11, DOI 10.1097/00004703-200102000-00002; Robson AL, 1997, J PEDIATR PSYCHOL, V22, P297, DOI 10.1093/jpepsy/22.3.297; Rose SA, 1996, CHILD DEV, V67, P2005, DOI 10.1111/j.1467-8624.1996.tb01840.x; Saigal S, 2000, J PEDIATR-US, V137, P701, DOI 10.1067/mpd.2000.109001; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Skranes JS, 1998, PEDIATR RADIOL, V28, P471, DOI 10.1007/s002470050387; SOMMERFELT K, 1993, ACTA PAEDIATR, V82, P723, DOI 10.1111/j.1651-2227.1993.tb12546.x; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; SZATMARI P, 1990, DEV MED CHILD NEUROL, V32, P954; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Taylor HG, 2000, CHILD NEUROPSYCHOL, V6, P49, DOI 10.1076/0929-7049(200003)6:1;1-B;FT049; Taylor HG, 1998, CHILD NEUROPSYCHOL, V4, P21, DOI 10.1076/chin.4.1.21.3188; TAYLOR HG, 1995, J PEDIATR PSYCHOL, V20, P703, DOI 10.1093/jpepsy/20.6.703; Wechsler D, 1991, WECHSLER INTELLIGENC, V3rd; Wilkinson G. S., 2006, WIDE RANGE ACHIEVEME; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201	46	661	674	1	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3264	3272		10.1001/jama.289.24.3264	http://dx.doi.org/10.1001/jama.289.24.3264			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	693EX	12824207	Bronze			2022-12-01	WOS:000183704600019
J	Hu, C; Ahmed, M; Melia, TJ; Sollner, TH; Mayer, T; Rothman, JE				Hu, C; Ahmed, M; Melia, TJ; Sollner, TH; Mayer, T; Rothman, JE			Fusion of cells by flipped SNAREs	SCIENCE			English	Article							DEPENDENT MEMBRANE-FUSION; COMPLEX-FORMATION; 3-DIMENSIONAL STRUCTURE; EXOCYTOSIS; VESICLE; SPECIFICITY; REQUIRES; PROTEINS; SNAP-25; PATHWAY	The SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) hypothesis suggests that pairs of proteins known as vesicle (v-) SNAREs and target membrane (t-) SNAREs interact specifically to control and mediate intracellular membrane fusion events. Here, cells expressing the interacting domains of v- and t- SNAREs on the cell surface were found to fuse spontaneously, demonstrating that SNAREs are sufficient to fuse biological membranes.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rothman, JE (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave,Box 251, New York, NY 10021 USA.	j-rothman@ski.mskcc.org		Mayer, Thomas/0000-0001-6954-2287				Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; ELBEIN AD, 1984, CRC CR REV BIOCH MOL, V16, P21, DOI 10.3109/10409238409102805; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; HU CY, UNPUB; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Witze E, 2002, CURR BIOL, V12, pR467, DOI 10.1016/S0960-9822(02)00948-X	28	172	179	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1745	1749		10.1126/science.1084909	http://dx.doi.org/10.1126/science.1084909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805548				2022-12-01	WOS:000183459700051
J	Chauhan, AJ; Inskip, HM; Linaker, CH; Smith, S; Schreiber, J; Johnston, SL; Holgate, ST				Chauhan, AJ; Inskip, HM; Linaker, CH; Smith, S; Schreiber, J; Johnston, SL; Holgate, ST			Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children	LANCET			English	Article							RESPIRATORY SYMPTOMS; AIR-POLLUTION; RISK-FACTORS; IN-VITRO; ASSOCIATION; INFECTION; COOKING; ADULTS; CELLS; GAS	Background A link between exposure to the air pollutant nitrogen dioxide (NO2) and respiratory disease has been suggested. Viral infections are the major cause of asthma exacerbations. We aimed to assess whether there is a relation between NO2 exposure and the severity of asthma exacerbations caused by proven respiratory viral infections in children. Methods A cohort of 114 asthmatic children aged between 8 and 11 years recorded daily upper and lower respiratory-tract symptoms, peak expiratory flow (PEF), and measured personal NO2 exposures every week for up to 13 months. We took nasal aspirates during reported episodes of upper respiratory-tract illness and tested for infection by common respiratory viruses and atypical bacteria with RT-PCR assays. We used generalised estimating equations to assess the relation between low (<7.5 &mu;g/m(3) medium (7.5-14 &mu;g/m(3)), and high (>14 mug/m(3)) tertiles of NO2 exposure in the week before or after upper respiratory-tract infection and the severity of asthma exacerbation in the week after the start of an infection. Findings One or more viruses were detected in 78% of reported infection episodes, and the medians of NO2 exposure were 5 (IQR 3.6-6.3), 10 (8.7-12.0), and 21 mug/m(3) (16.8-42.9) for low, medium, and high tertiles, respectively. There were significant increases in the severity of lower respiratory-tract symptom scores across the three tertiles (0.6 for all viruses [p=0.05] and >2 for respiratory syncytial virus [p=0.01]) and a reduction in PEF of more than 12 L/min for picornavirus (p=0.04) for high compared with low NO2 exposure before the start of the virus-induced exacerbation. Interpretation High exposure to NO2 in the week before the start of a respiratory viral infection, and at levels within current air quality standards, is associated with an increase in the severity of a resulting asthma exacerbation.	Univ Southampton, Resp Cell & Mol Biol Res Div, Southampton, Hants, England; Univ Southampton, MRC, Environm Epidemiol Unit, Southampton, Hants, England; Natl Heart & Lung Inst, London, England; Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst Infect & Immun, London, England	University of Southampton; University of Southampton; Imperial College London; Imperial College London	Chauhan, AJ (corresponding author), St Marys Hosp, Portsmouth PO3 6AD, Hants, England.		Johnston, Sebastian Lennox/I-2423-2012; Inskip, Hazel/L-5467-2018	Johnston, Sebastian Lennox/0000-0003-3009-9200; Inskip, Hazel/0000-0001-8897-1749				*ADV GROUP MED ASP, 1993, 3 DEP HLTH ADV GROUP, P29; Ando M, 2001, ARCH ENVIRON HEALTH, V56, P227, DOI 10.1080/00039890109604446; Boezen HM, 1999, LANCET, V353, P874, DOI 10.1016/S0140-6736(98)06311-9; BRUNEKREEF B, 1982, INT ARCH OCC ENV HEA, V50, P299, DOI 10.1007/BF00378091; CARSON JL, 1993, AM J RESP CELL MOL, V9, P264, DOI 10.1165/ajrcmb/9.3.264; Chauhan A. J., 1998, Reviews on Environmental Health, V13, P73; CLAUSING P, 1986, Environment International, V12, P413, DOI 10.1016/0160-4120(86)90056-5; Dennekamp M, 2001, OCCUP ENVIRON MED, V58, P511, DOI 10.1136/oem.58.8.511; DEVALIA JL, 1993, AM J RESP CELL MOL, V9, P271, DOI 10.1165/ajrcmb/9.3.271; DEVALIA JL, 1993, EUR RESPIR J, V6, P1308; EHRLICH R, 1966, BACTERIOL REV, V30, P604, DOI 10.1128/MMBR.30.3.604-614.1966; FRAMPTON MW, 1989, ENVIRON RES, V48, P179, DOI 10.1016/S0013-9351(89)80033-7; Frampton MW, 2002, AM J PHYSIOL-LUNG C, V282, pL155, DOI 10.1152/ajplung.2002.282.1.L155; GOINGS SAJ, 1989, AM REV RESPIR DIS, V139, P1075, DOI 10.1164/ajrccm/139.5.1075; HASSELBLAD V, 1992, J AIR WASTE MANAGE, V42, P662, DOI 10.1080/10473289.1992.10467018; INFANTERIVARD C, 1993, AM J EPIDEMIOL, V137, P834, DOI 10.1093/oxfordjournals.aje.a116745; JAKAB GJ, 1987, ENVIRON RES, V42, P215, DOI 10.1016/S0013-9351(87)80023-3; Jarvis D, 1996, LANCET, V347, P426, DOI 10.1016/S0140-6736(96)90009-4; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; KAWAMOTO T, 1993, ARCH ENVIRON CON TOX, V25, P534; Linaker CH, 2000, OCCUP ENVIRON MED, V57, P472, DOI 10.1136/oem.57.7.472; Linaker CH, 1996, OCCUP ENVIRON MED, V53, P200, DOI 10.1136/oem.53.3.200; NEAS LM, 1991, AM J EPIDEMIOL, V134, P204, DOI 10.1093/oxfordjournals.aje.a116073; NOY D, 1990, ATMOS ENVIRON A-GEN, V24, P2903, DOI 10.1016/0960-1686(90)90470-8; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; SAMET JM, 1993, AM REV RESPIR DIS, V148, P1258, DOI 10.1164/ajrccm/148.5.1258; SANDSTROM T, 1992, EUR RESPIR J, V5, P1092; SCHENKER MB, 1983, AM REV RESPIR DIS, V128, P1038; Siegel PD, 1997, TOXICOL APPL PHARM, V144, P356, DOI 10.1006/taap.1997.8148; Spannhake EW, 2002, ENVIRON HEALTH PERSP, V110, P665, DOI 10.1289/ehp.02110665; TUNNICLIFFE WS, 1994, LANCET, V344, P1733, DOI 10.1016/S0140-6736(94)92886-X; WHO, 2000, EUR SER, Vsecond; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	35	215	223	0	35	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1939	1944		10.1016/S0140-6736(03)13582-9	http://dx.doi.org/10.1016/S0140-6736(03)13582-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801737	Bronze, Green Published			2022-12-01	WOS:000183359700009
J	Olveczky, BP; Baccus, SA; Meister, M				Olveczky, BP; Baccus, SA; Meister, M			Segregation of object and background motion in the retina	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; POLYAXONAL AMACRINE CELLS; MACAQUE MONKEY RETINA; GANGLION-CELLS; SPATIAL SUMMATION; CONTRAST SENSITIVITY; RABBIT RETINA; RESPONSES; PHYSIOLOGY; SIGNALS	An important task in vision is to detect objects moving within a stationary scene. During normal viewing this is complicated by the presence of eye movements that continually scan the image across the retina, even during fixation. To detect moving objects, the brain must distinguish local motion within the scene from the global retinal image drift due to fixational eye movements. We have found that this process begins in the retina: a subset of retinal ganglion cells responds to motion in the receptive field centre, but only if the wider surround moves with a different trajectory. This selectivity for differential motion is independent of direction, and can be explained by a model of retinal circuitry that invokes pooling over nonlinear interneurons. The suppression by global image motion is probably mediated by polyaxonal, wide-field amacrine cells with transient responses. We show how a population of ganglion cells selective for differential motion can rapidly flag moving objects, and even segregate multiple moving objects.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02138 USA; Harvard Univ, Program Neurosci, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Olveczky, Bence/0000-0003-2499-2705; Meister, Markus/0000-0003-2136-6506				[Anonymous], [No title captured]; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BENDER DB, 1986, BRAIN RES, V381, P372, DOI 10.1016/0006-8993(86)90092-2; BLAKEMORE C, 1986, J PHYSIOL-LONDON, V380, P453, DOI 10.1113/jphysiol.1986.sp016297; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cook PB, 1998, J NEUROSCI, V18, P2301; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V302, P49; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P406, DOI 10.1002/cne.903160403; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; Gibson J.J., 1950, PERCEPTION VISUAL WO, DOI DOI 10.2307/1419017; GRAHAM CH, 1965, VISION VISUAL PERCEP, P575; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; GROSSMAN GE, 1989, J NEUROPHYSIOL, V62, P264, DOI 10.1152/jn.1989.62.1.264; HAMMOND P, 1982, EXP BRAIN RES, V47, P457; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; MANTEUFFEL G, 1977, NATURWISSENSCHAFTEN, V64, P533, DOI 10.1007/BF00483559; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Ouchi H, 1977, JAPANESE OPTICAL GEO; Passaglia CL, 2001, J NEUROSCI, V21, P5794, DOI 10.1523/JNEUROSCI.21-15-05794.2001; Regan David, 2000, HUMAN PERCEPTION OBJ; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SHAPLEY R, 1981, NATURE, V292, P543, DOI 10.1038/292543a0; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SKAVENSKI AA, 1979, VISION RES, V19, P675, DOI 10.1016/0042-6989(79)90243-8; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; STEINMAN RM, 1980, VISION RES, V20, P415, DOI 10.1016/0042-6989(80)90032-2; STERLING P, 1969, J NEUROPHYSIOL, V32, P1, DOI 10.1152/jn.1969.32.1.1; VANDERSTEEN J, 1984, EXP BRAIN RES, V56, P263, DOI 10.1007/BF00236282; Vernon Magdalen D., 1962, PSYCHOL PERCEPTION; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Volgyi B, 2001, J COMP NEUROL, V440, P109, DOI 10.1002/cne.1373; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WERBLIN F, 1988, VISUAL NEUROSCI, V1, P317, DOI 10.1017/S0952523800001978; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; Yarbus A. L., 1967, EYE MOVEMENTS VISION	43	274	277	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					401	408		10.1038/nature01652	http://dx.doi.org/10.1038/nature01652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12754524				2022-12-01	WOS:000183012000033
J	Schmitz, B; Haggstrom, T; Tassinari, M				Schmitz, B; Haggstrom, T; Tassinari, M			Sediment-dispersed extraterrestrial chromite traces a major asteroid disruption event	SCIENCE			English	Article							METEORITES; IMPACT; ARENIG; SWEDEN; FAMILY	Abundant extraterrestrial chromite grains from decomposed meteorites occur in middle Ordovician (480 million years ago) marine limestone over an area of similar to250,000 square kilometers in southern Sweden. The chromite anomaly gives support for an increase of two orders of magnitude in the influx of meteorites to Earth during the mid-Ordovician, as previously indicated by fossil meteorites. Extraterrestrial chromite grains in mid-Ordovician limestone can be used to constrain in detail the temporal variations influx of extraterrestrial matter after one of the largest asteroid disruption events in the asteroid belt in late solar-system history.	Rice Univ, Dept Earth Sci, Houston, TX 77251 USA; Ctr Earth Sci, SE-40530 Gothenburg, Sweden	Rice University	Schmitz, B (corresponding author), Rice Univ, Dept Earth Sci, POB 1892, Houston, TX 77251 USA.							Bland P. A., 2001, ACCRETION EXTRATERRE, P267; BOGARD DD, 1995, METEORITICS, V30, P244, DOI 10.1111/j.1945-5100.1995.tb01124.x; BUNCH TE, 1967, GEOCHIM COSMOCHIM AC, V31, P1569; Dronov A., 2001, WOGOGOB 2001, P8; Gersonde R, 1997, NATURE, V390, P357, DOI 10.1038/37044; Grieve R.A.F., 2001, ACCRETION EXTRATERRE, P379, DOI DOI 10.1007/978-1-4419-8694-8_19; HESSLAND I, 1949, B GEOLOGICAL I U UPP, V33, P1; HEYMANN D, 1967, ICARUS, V6, P189, DOI 10.1016/0019-1035(67)90017-6; JIANHUA Z, 1998, THESIS STOCKHOLM U; KEIL K, 1994, PLANET SPACE SCI, V42, P1109, DOI 10.1016/0032-0633(94)90011-6; KEIL K, 1962, J GEOPHYS RES, V67, P4055, DOI 10.1029/JZ067i010p04055; Kunz J, 1997, METEORIT PLANET SCI, V32, P647, DOI 10.1111/j.1945-5100.1997.tb01550.x; Lindstrom M, 1979, GEOL PALAEONTOL, V13, P9; LINDSTROM M, 1971, GEOL RUNDSCH, V60, P419, DOI DOI 10.1007/BF02000464; LOFGREN A, 1995, GEOL MAG, V132, P693, DOI 10.1017/S0016756800018926; Lofgren A, 2000, GEOL MAG, V137, P53, DOI 10.1017/S0016756800003484; Nesvorny D, 2002, ICARUS, V157, P155, DOI 10.1006/icar.2002.6830; NYSTROM JO, 1988, NATURE, V336, P572, DOI 10.1038/336572a0; Rubin AE, 1997, METEORIT PLANET SCI, V32, P231, DOI 10.1111/j.1945-5100.1997.tb01262.x; Schmitz B, 2001, EARTH PLANET SC LETT, V194, P1, DOI 10.1016/S0012-821X(01)00559-3; Stouge S., 2001, WOGOGOB 2001, P42; Villumsen J., 2001, WOGOGOB 2001; Zappala V, 1998, ICARUS, V134, P176, DOI 10.1006/icar.1998.5946	23	112	113	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					961	964		10.1126/science.1082182	http://dx.doi.org/10.1126/science.1082182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738859				2022-12-01	WOS:000182719800051
J	Anderson, RM; Bitterman, KJ; Wood, JG; Medvedik, O; Sinclair, DA				Anderson, RM; Bitterman, KJ; Wood, JG; Medvedik, O; Sinclair, DA			Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae	NATURE			English	Article							NAD(+) SALVAGE PATHWAY; SILENCING PROTEIN SIR2; DEACETYLASE ACTIVITY; YEAST; SPAN; EXPRESSION; LONGEVITY; GENE; METHYLTRANSFERASE; IDENTIFICATION	Calorie restriction extends lifespan in a broad range of organisms, from yeasts to mammals. Numerous hypotheses have been proposed to explain this phenomenon, including decreased oxidative damage and altered energy metabolism. In Saccharomyces cerevisiae, lifespan extension by calorie restriction requires the NAD(+)-dependent histone deacetylase, Sir2 (ref. 1). We have recently shown that Sir2 and its closest human homologue SIRT1, a p53 deacetylase, are strongly inhibited by the vitamin B3 precursor nicotinamide2. Here we show that increased expression of PNC1 (pyrazinamidase/nicotinamidase 1), which encodes an enzyme that deaminates nicotinamide, is both necessary and sufficient for lifespan extension by calorie restriction and low-intensity stress. We also identify PNC1 as a longevity gene that is responsive to all stimuli that extend lifespan. We provide evidence that nicotinamide depletion is sufficient to activate Sir2 and that this is the mechanism by which PNC1 regulates longevity. We conclude that yeast lifespan extension by calorie restriction is the consequence of an active cellular response to a low-intensity stress and speculate that nicotinamide might regulate critical cellular processes in higher organisms.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.			Sinclair, David/0000-0002-9936-436X	NIA NIH HHS [R37 AG028730, R01 AG019972, R01 AG019719, R01 AG028730, P01 AG027916] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019972, R01AG028730, R01AG019719, P01AG027916, R37AG028730] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKSOY S, 1994, J BIOL CHEM, V269, P14835; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Grant RS, 1998, J NEUROCHEM, V70, P1759; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Kassem HS, 2002, INT J CANCER, V101, P454, DOI 10.1002/ijc.10631; Lal A, 1999, CANCER RES, V59, P5403; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Perichon R, 1998, CELL MOL LIFE SCI, V54, P641, DOI 10.1007/s000180050192; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Sandmeier JJ, 2002, GENETICS, V160, P877; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Swiecilo A, 2000, ACTA BIOCHIM POL, V47, P355; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; UNKEFER CJ, 1984, J BIOL CHEM, V259, P2311; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	30	574	602	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					181	185		10.1038/nature01578	http://dx.doi.org/10.1038/nature01578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736687	Green Accepted			2022-12-01	WOS:000182699600049
J	Glynn, SA; Busch, MP; Schreiber, GB; Murphy, EL; Wright, DJ; Tu, Y; Kleinman, SH				Glynn, SA; Busch, MP; Schreiber, GB; Murphy, EL; Wright, DJ; Tu, Y; Kleinman, SH		NHLBI REDS Study Grp	Effect of a national disaster on blood supply and safety - The September 11 experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DONORS; RECRUITMENT; RISK	Context An understanding of characteristics of blood donors donating in times of crisis may help. predict blood supply safety and donor return patterns. Objectives. To characterize the volume of donations and prevalence of infectious disease markers in blood donated by US donors responding to the September 11, 2001, terrorist attacks, and. to evaluate return rates in those who donated for the first time. Design Cross-sectional survey data from the National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study for 4 weeks before:and 4 weeks starting with September 11, 2001, and the corresponding 8-week period in 2000. Setting and Participants A total of 327065 volunteer blood donors making 373628 allogeneic donations at 5 large regional US blood centers. Main Outcome.-Measures Changes in number of donations overall and by first-time and repeat status, prevalence of infectious disease markers, estimated risks of transfusion-transmitted viral infections, and first-time donor return rates. Results About 20000 allogeneic donations were collected Weekly in the 4 weeks preceding September 11, whereas approximate to49000 (2.5-fold increase) and approximate to26000 to 28000 (1.3-fold to 1.4-fold increases) donations were made per week in the first and in the second through fourth weeks starting with September 11; respectively. All demographic groups donated more than usual after the attacks, and after adjusting for seasonal and annual variation there was a 5.2-fold (95% confidence interval, 5.0-5.4) increase in the number of first-time donations vs a 1.5-fold (1.4-1.5) increase in the number of repeat donations made in the first week starting on September 11 vs the 4 weeks before. The weekly proportion of repeat donors returning after not donating for 10 or more years increased from 2% before September 11 to 6% in the first week starting with September 11. Donations confirmed positive for human immunodeficiency virus (HIV); hepatitis C virus (HCV), and hepatitis B surface antigen nearly tripled between 1 week before September 11 (0.1%) and 1 week after the attacks'(0.3%), largely explained by the increase in first-time and lapsed repeat donors: Estimated viral residual risks increased slightly after the attacks (HIV, 1/1.5 million vs 1/1.8 million donations; HCV, 1/1.3 million vs 1/1.6 million; hepatitis B virus, 1/140 000 vs 1/170000). First-time donor 12-month return rates for 2000 and 2001 were similar, approximate to28% (P=.37) for donors in the first week starting with September 11 (or September 12, 2000) and 30% (P=.69) for the second to,fourth weeks. Conclusions The September 11 events resulted in an influx of first-time donors without substantial increase in absolute risk of transfusion-transmissible viral infections. First-time donor return rates were equally relatively low before and after the attacks, suggesting that those donating in times of crisis have return behaviors similar to those of other first-time donors. Their relatively low return rates reinforce the need for education about. the importance of donating regularly.	Westat Corp, Rockville, MD 20850 USA; Blood Ctr Pacific, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Westat; University of California System; University of California San Francisco	Glynn, SA (corresponding author), Westat Corp, WB 280,1441 W Montgomery Ave, Rockville, MD 20850 USA.				DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097077, N01HB097079, N01HB047114, N01HB097082, N01HB097080, N01HB097081, N01HB097078] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HB-97077, N01-HB-97079, N01-HB-47114, N01-HB-97080, N01-HB-97082, N01-HB-97081, N01-HB-97078] Funding Source: Medline	DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*ADV COMM BLOOD SA, 2002, 16 M ADV COMM BLOOD; *AM ASS BLOOD BANK, 2002, REP REC; *AM ASS BLOOD BANK, 2001, REC DEP HLTH HUM SER; *AM ASS BLOOD BANK, 2001, AABB WKLY REP, V7, P1; Becker C, 2001, MOD HLTH, P18; BUSCH M, 2002, 27 C INT SOC BLOOD T; BUSCH MP, 1991, TRANSFUSION, V31, P719, DOI 10.1046/j.1537-2995.1991.31892023497.x; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Dodd RY, 2002, TRANSFUSION, V42, P1240, DOI 10.1046/j.1537-2995.2002.00231.x; DOHERTY B, 2001, AM BLOOD CTR NE 0919; DRAKE AW, 1978, PUBLIC ATTITUDES DEC, P1; EDWARDS PW, 1985, PERS INDIV DIFFER, V6, P743, DOI 10.1016/0191-8869(85)90085-6; FIENBERG SE, 1980, ANAL CROSS CLASSIFIE, P16; GIMBLE JG, 1994, TRANSFUSION, V34, P586, DOI 10.1046/j.1537-2995.1994.34794330012.x; Glynn SA, 2002, TRANSFUSION, V42, P966, DOI 10.1046/j.1537-2995.2002.00200.x; Glynn SA, 2002, TRANSFUSION, V42, P216, DOI 10.1046/j.1537-2995.2002.00008.x; Glynn SA, 2001, TRANSFUSION, V41, P736, DOI 10.1046/j.1537-2995.2001.41060736.x; HONAWAR V, 2001, WASHINGTON TIME 0921, pB4; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; MECKLER L, 2002, STANDARD TIMES  0910, pA7; OSWALT RM, 1977, TRANSFUSION, V17, P123, DOI 10.1046/j.1537-2995.1977.17277151916.x; PILIAVIN JA, 1990, TRANSFUSION, V30, P444, DOI 10.1046/j.1537-2995.1990.30590296381.x; *SAS I INC, 1989, SAS STAT US GUID VER, P405; Schmidt PJ, 2002, NEW ENGL J MED, V346, P617, DOI 10.1056/NEJM200202213460813; Schmidt PJ, 1985, SUPPORTIVE THERAPY H, P371; US Food and Drug Administration (FDA), 2002, REV PREV MEAS RED PO; Villarosa L, 2001, NY TIMES        1220, pB6; Williams AE, 1997, JAMA-J AM MED ASSOC, V277, P967, DOI 10.1001/jama.277.12.967; Wu Y, 2000, TRANSFUSION, V40, p16S; Wu Y, 2001, TRANSFUSION, V41, P360, DOI 10.1046/j.1537-2995.2001.41030360.x; [No title captured]	31	79	85	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2246	2253		10.1001/jama.289.17.2246	http://dx.doi.org/10.1001/jama.289.17.2246			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	675ET	12734136				2022-12-01	WOS:000182680700027
J	Porteus, MH; Baltimore, D				Porteus, MH; Baltimore, D			Chimeric nucleases stimulate gene targeting in human cells	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; RESTRICTION ENZYMES; CLEAVAGE		CALTECH, Dept Biol, Pasadena, CA 91125 USA	California Institute of Technology	Porteus, MH (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Pediat & Biochem, Dallas, TX 75390 USA.	matthew.porteus@UTSouthwestern.edu; baltimo@caltech.edu	Wilson, Matthew H/K-3193-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM39458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chandrasegaran S, 1999, BIOL CHEM, V380, P841, DOI 10.1515/BC.1999.103; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; SEDIVY JM, 1989, P NATL ACAD SCI USA, V86, P227, DOI 10.1073/pnas.86.1.227; SHI YG, 1995, SCIENCE, V268, P282, DOI 10.1126/science.7536342; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	10	544	695	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					763	763		10.1126/science.1078395	http://dx.doi.org/10.1126/science.1078395			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730593	Green Accepted			2022-12-01	WOS:000182579800039
J	Schlessinger, J				Schlessinger, J			Autoinhibition control	SCIENCE			English	Editorial Material							RECEPTOR; REVEALS; KINASE		Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Schlessinger, J (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	joseph.schlessinger@yale.edu						Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2	10	88	89	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					750	752		10.1126/science.1082024	http://dx.doi.org/10.1126/science.1082024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730587				2022-12-01	WOS:000182579800033
J	Nunnari, G; Nigro, L; Palermo, F; Attanasio, M; Berger, A; Doerr, HW; Pomerantz, RJ; Cacopardo, B				Nunnari, G; Nigro, L; Palermo, F; Attanasio, M; Berger, A; Doerr, HW; Pomerantz, RJ; Cacopardo, B			Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-Helper 1 cytokine profile	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATITIS-G VIRUS; RNA; DISEASE; TYPE-1; CELLS	Background: Progression to AIDS is slower in persons infected with both HIV-1 and GB virus C (GBV-C), also known as hepatitis G virus. Objective: To compare clinical, virologic, and immunologic variables in HIV-1-seropositive patients with and without GBV-C co-infection. Design: Subanalysis of a prospective cohort study. Setting: Institute of Infectious Diseases, University of Catania, Catania, Italy. Patients: go asymptomatic HIV-1-seropositive patients. Measurements: GBV-C RNA level; plasma HIV-1 viral load; CD4(+) cell counts; and serum levels of interleukin (IL)-2, IL-4, IL-10, and IL-12. Results: At the start of the study, plasma GBV-C RNA was detected in 17 patients (21%). During follow-up, IL-2 and IL-12 levels decreased significantly (P = 0.005 and P = 0.01, respectively) and IL-4 and IL-10 levels increased significantly (P = 0.01 and P = 0.004, respectively) in the GBV-C-negative group but did not change substantially in the GBV-C-positive group. Each measured variable differed significantly between GBV-C-positive and GBV-C-negative groups during follow-up (P < 0.001 for IL-12, IL-4, and IL-10; P = 0.002 for IL-2). Conclusion: GB virus C may immunologically interfere with progression of HIV-1 infection to AIDS by maintaining an intact T-helper 1 cytokine profile.	Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Univ Catania, Catania, Italy; Univ Palermo, Palermo, Italy; Goethe Univ Frankfurt, D-6000 Frankfurt, Germany	Jefferson University; University of Catania; University of Palermo; Goethe University Frankfurt	Nunnari, G (corresponding author), Thomas Jefferson Univ, Jefferson Alumni Hall,1020 Locust St,Suite 329, Philadelphia, PA 19107 USA.	gnunnari@hotmail.com	Attanasio, Massimo/A-6295-2016; Nunnari, Giuseppe/AAC-1928-2019	Attanasio, Massimo/0000-0003-2684-5530; Nunnari, Giuseppe/0000-0002-8113-8452; cacopardo, bruno/0000-0002-7465-0714				Aikawa T, 1996, NEW ENGL J MED, V334, P195, DOI 10.1056/NEJM199601183340316; Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056/NEJM199703133361102; Cacopardo B, 1998, J INFECTION, V36, P179, DOI 10.1016/S0163-4453(98)80010-8; Campo N, 2000, HEPATO-GASTROENTEROL, V47, P1385; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; HAND D, 1996, PRACTICAL LONGITUDIN; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006	16	75	82	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2003	139	1					26	30		10.7326/0003-4819-139-1-200307010-00009	http://dx.doi.org/10.7326/0003-4819-139-1-200307010-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695GR	12834315				2022-12-01	WOS:000183823200004
J	McGlynn, EA; Asch, SM; Adams, J; Keesey, J; Hicks, J; DeCristofaro, A; Kerr, EA				McGlynn, EA; Asch, SM; Adams, J; Keesey, J; Hicks, J; DeCristofaro, A; Kerr, EA			The quality of health care delivered to adults in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ELDERLY MEDICARE BENEFICIARIES; STANDARDIZED PATIENTS; UNDERUSE; APPROPRIATENESS; OUTCOMES; TRIALS; WOMEN	BACKGROUND: We have little systematic information about the extent to which standard processes involved in health care -- a key element of quality -- are delivered in the United States. METHODS: We telephoned a random sample of adults living in 12 metropolitan areas in the United States and asked them about selected health care experiences. We also received written consent to copy their medical records for the most recent two-year period and used this information to evaluate performance on 439 indicators of quality of care for 30 acute and chronic conditions as well as preventive care. We then constructed aggregate scores. RESULTS: Participants received 54.9 percent (95 percent confidence interval, 54.3 to 55.5) of recommended care. We found little difference among the proportion of recommended preventive care provided (54.9 percent), the proportion of recommended acute care provided (53.5 percent), and the proportion of recommended care provided for chronic conditions (56.1 percent). Among different medical functions, adherence to the processes involved in care ranged from 52.2 percent for screening to 58.5 percent for follow-up care. Quality varied substantially according to the particular medical condition, ranging from 78.7 percent of recommended care (95 percent confidence interval, 73.3 to 84.2) for senile cataract to 10.5 percent of recommended care (95 percent confidence interval, 6.8 to 14.6) for alcohol dependence. CONCLUSIONS: The deficits we have identified in adherence to recommended processes for basic care pose serious threats to the health of the American public. Strategies to reduce these deficits in care are warranted.	RAND Corp, Santa Monica, CA 90407 USA; Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; VA Ann Arbor Hlth Care Syst, VA Ctr Practice Management & Outcomes Res, Ann Arbor, MI USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	McGlynn, EA (corresponding author), RAND Corp, 1700 Main St,POB 2138, Santa Monica, CA 90407 USA.	beth_mcglynn@rand.org	Greiver, Michelle/N-8764-2015; Wilkins, Thad/G-2541-2010; Young, Alexander/A-1523-2009	Greiver, Michelle/0000-0001-8957-0285; Young, Alexander/0000-0002-9367-9213				ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Asch S, 2000, QUALITY CARE ONCOLOG; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Asch SM, 2001, ARCH INTERN MED, V161, P1329, DOI 10.1001/archinte.161.10.1329; Asch SM, 2001, J ACQ IMMUN DEF SYND, V28, P340, DOI 10.1097/00126334-200112010-00006; Berwick DM, 2003, MED CARE, V41, pI30; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; Brook R. H., 1994, AHCPR PUB, P59; CHERRY DK, 1999, ADV DATA VITAL HLTH, V322; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cunningham PJ, 2002, MED CARE RES REV, V59, P79, DOI 10.1177/107755870205900104; Draper DA, 2002, HEALTH AFFAIR, V21, P11, DOI 10.1377/hlthaff.21.1.11; Dresselhaus TR, 2002, J MED ETHICS, V28, P293, DOI 10.1136/jme.28.5.291; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; HYMAN DJ, 2002, NEW ENGL J MED, V346, P544; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kerr EA, 2000, QUALITY CARE CARDIOP; KERR EA, 2000, QUALITY CARE GEN MED; Kravitz RL, 1997, HEALTH POLICY, V42, P135, DOI 10.1016/S0168-8510(97)00064-X; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luck J, 2002, BMJ-BRIT MED J, V325, P679, DOI 10.1136/bmj.325.7366.679; McGlynn E A, 1998, Jt Comm J Qual Improv, V24, P470; McGlynn EA, 2001, HEALTH AFFAIR, V20, P82, DOI 10.1377/hlthaff.20.3.82; McGlynn EA, 1999, WOMEN HEALTH ISS, V9, P184, DOI 10.1016/S1049-3867(99)00009-2; McGlynn EA, 2000, QUALITY CARE WOMEN; MILLER RH, 1994, JAMA-J AM MED ASSOC, V271, P1512, DOI 10.1001/jama.271.19.1512; Murata PJ, 1994, ARCH FAM MED, V3, P41; *NAT COMM QUAL ASS, 2002, STAT HLTH CAR QUAL; Nelson DE, 2002, JAMA-J AM MED ASSOC, V287, P2659, DOI 10.1001/jama.287.20.2659; PAYNE SMC, 1995, ARCH PEDIAT ADOL MED, V149, P162, DOI 10.1001/archpedi.1995.02170140044006; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Shekelle PG, 1998, INT J TECHNOL ASSESS, V14, P707, DOI 10.1017/S0266462300012022; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; STARFIELD B, 1994, JAMA-J AM MED ASSOC, V272, P1903, DOI 10.1001/jama.272.24.1903; STRUNK BC, 2001, TRACKING HLTH CARE C; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UDVARHELYI IS, 1991, ANN INTERN MED, V115, P394, DOI 10.7326/0003-4819-115-5-394; Woolf SH, 1999, JAMA-J AM MED ASSOC, V282, P2358, DOI 10.1001/jama.282.24.2358	50	3440	3468	1	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2003	348	26					2635	2645		10.1056/NEJMsa022615	http://dx.doi.org/10.1056/NEJMsa022615			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	693PN	12826639				2022-12-01	WOS:000183726400008
J	Cerdan, PD; Chory, J				Cerdan, PD; Chory, J			Regulation of flowering time by light quality	NATURE			English	Article							PHYTOCHROME-B; ARABIDOPSIS-THALIANA; CONSTANS; GENE; DOMAIN; ROLES	The transition to flowering in plants is regulated by environmental factors such as temperature and light(1). Plants grown under dense canopies or at high density perceive a decrease in the ratio of red to far-red incoming light. This change in light quality serves as a warning of competition, triggering a series of responses known collectively as the 'shade-avoidance syndrome'. During shade avoidance, stems elongate at the expense of leaf expansion, and flowering is accelerated(2,3). Of the five phytochromes-a family of red/far-red light photoreceptors-in Arabidopsis, phytochrome B (phyB) has the most significant role in shade-avoidance responses(4,5), but the mechanisms by which phyB regulates flowering in response to altered ratios of red to far-red light are largely unknown. Here we identify PFT1(PHYTOCHROME AND FLOWERING TIME 1), a nuclear protein that acts in a phyB pathway and induces flowering in response to suboptimal light conditions. PFT1 functions downstream of phyB to regulate the expression of FLOWERING LOCUS T (FT), providing evidence for the existence of a light-quality pathway that regulates flowering time in plants.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.				NIGMS NIH HHS [GM52413] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Ballare CL, 1999, TRENDS PLANT SCI, V4, P201, DOI 10.1016/S1360-1385(99)01408-9; Blazquez MA, 2002, PLANT PHYSIOL, V130, P1770, DOI 10.1104/pp.007625; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; Cerdan PD, 1999, PLANT J, V18, P499, DOI 10.1046/j.1365-313X.1999.00475.x; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Escher D, 2000, MOL CELL BIOL, V20, P2774, DOI 10.1128/MCB.20.8.2774-2782.2000; HALLIDAY KJ, 1994, PLANT PHYSIOL, V104, P1311, DOI 10.1104/pp.104.4.1311; Hennig L, 2001, PLANT PHYSIOL, V125, P1036, DOI 10.1104/pp.125.2.1036; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Hinshelwood J, 2000, J MOL BIOL, V298, P135, DOI 10.1006/jmbi.2000.3632; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1995, PHYSIOL PLANTARUM, V95, P260, DOI 10.1111/j.1399-3054.1995.tb00836.x; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Levy YY, 1998, CURR OPIN PLANT BIOL, V1, P49, DOI 10.1016/S1369-5266(98)80127-1; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Lin CT, 2000, PLANT PHYSIOL, V123, P39, DOI 10.1104/pp.123.1.39; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	27	359	403	11	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					881	885		10.1038/nature01636	http://dx.doi.org/10.1038/nature01636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815435				2022-12-01	WOS:000183585300049
J	Ashraf, H				Ashraf, H			Alliance offers healthy diet	LANCET			English	News Item																			0	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2051	2051						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814720				2022-12-01	WOS:000183488900017
J	Cao, D; Parker, R				Cao, D; Parker, R			Computational modeling and experimental analysis of nonsense-mediated decay in yeast	CELL			English	Article							MESSENGER-RNA SURVEILLANCE; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; TURNOVER; DEADENYLATION; MECHANISMS; MUTATIONS; STABILITY; ELEMENTS; PROTEIN	A conserved mRNA surveillance system, referred to as nonsense-mediated decay (NMD), exists in eukaryotic cells to degrade mRNAs containing nonsense codons. This process is important in checking that mRNAs; have been properly synthesized and functions, at least in part, to increase the fidelity of gene expression by degrading aberrant mRNAs; that, if translated, would produce truncated proteins. Using computational modeling and experimental analysis, we define the alterations in mRNA turnover triggered by NMD in yeast. We demonstrate that the nonsense-containing transcripts are efficiently recognized, targeted for deadenylation-independent decapping, and show NMD triggered accelerated deadenylation regardless of the position of the nonsense codon. We also show that 5' nonsense codons trigger faster rates of decapping than 3' nonsense codons, thereby providing a mechanistic basis for the polar effect of NMD. Finally, we construct a computational model that accurately describes the process of NMD and serves as an explanatory and predictive tool.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM045443-13, GM45443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; Brogna S, 1999, RNA, V5, P562, DOI 10.1017/S1355838299981359; Cao D, 2001, RNA, V7, P1192, DOI 10.1017/S1355838201010330; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; Dahlseid JN, 1998, GENETICS, V150, P1019; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Gonzalez CI, 2001, GENE, V274, P15, DOI 10.1016/S0378-1119(01)00552-2; HAGAN KW, 1995, MOL CELL BIOL, V15, P809; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MAQUAT LE, 1995, RNA, V1, P453; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Ruiz-Echevarria MJ, 2001, J BIOL CHEM, V276, P30995, DOI 10.1074/jbc.M010833200; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Tharun S, 1999, GENETICS, V151, P1273; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; vanHoof A, 1996, PLANT J, V10, P415, DOI 10.1046/j.1365-313x.1996.10030415.x; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Wilusz CJ, 2001, GENE DEV, V15, P2781	32	113	115	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					533	545		10.1016/S0092-8674(03)00353-2	http://dx.doi.org/10.1016/S0092-8674(03)00353-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757713	Bronze			2022-12-01	WOS:000182981500014
J	Iakova, P; Awad, SS; Timchenko, NA				Iakova, P; Awad, SS; Timchenko, NA			Aging reduces proliferative capacities of liver by switching pathways of C/EBP alpha growth arrest	CELL			English	Article							TERMINAL ADIPOCYTE DIFFERENTIATION; ENHANCER BINDING-PROTEIN; RETINOBLASTOMA PROTEIN; NEWBORN MICE; C-MYC; REGENERATION; TARGET; GRANULOPOIESIS; ADIPOGENESIS; EXPRESSION	The liver is capable of completely regenerating itself in response to injury and after partial hepatectomy. In liver of old animals, the proliferative response is dramatically reduced, the mechanism for which is unknown. The liver specific protein, C/EBPalpha, normally arrests proliferation of hepatocytes through inhibiting cyclin dependent kinases (cdks). We present evidence that aging switches the liver-specific pathway of C/EBPalpha growth arrest to repression of E2F transcription. We identified an age-specific C/EBPalpha-Rb-E2F4 complex that binds to E2F-dependent promoters and represses these genes. The C/EBPalpha-Rb-E2F4 complex occupies the c-myc promoter and blocks induction of c-myc in livers of old animals after partial hepatectomy. Our results show that the age-dependent switch from cdk inhibition to repression of E2F transcription causes a loss of proliferative response in the liver because of an inability to induce E2F target genes after partial hepatectomy providing a possible mechanism for the age-dependent loss of liver regenerative capacity.	Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.				NIA NIH HHS [AG20752-01, AG00765] Funding Source: Medline; NIGMS NIH HHS [GM55188] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG020752] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arora V, 2000, J PHARMACOL EXP THER, V292, P921; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BUCHER NLR, 1964, CANCER RES, V24, P509; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302; JANSENDURR P, 1994, CELL CYCLE MAT METHO, P243; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; STROBER BE, 1996, MOL CELL BIOL, V16, P1567; Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	26	189	194	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					495	506		10.1016/S0092-8674(03)00318-0	http://dx.doi.org/10.1016/S0092-8674(03)00318-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757710	Bronze			2022-12-01	WOS:000182981500011
J	Richmond, TJ; Davey, CA				Richmond, TJ; Davey, CA			The structure of DNA in the nucleosome core	NATURE			English	Article							B-DNA; HELIX GEOMETRY; SEQUENCE; CHROMATIN; PARTICLE; TRANSCRIPTION; RESOLUTION; CURVATURE; STABILITY; COMPLEXES	The 1.9-Angstrom-resolution crystal structure of the nucleosome core particle containing 147 DNA base pairs reveals the conformation of nucleosomal DNA with unprecedented accuracy. The DNA structure is remarkably different from that in oligonucleotides and nonhistone protein-DNA complexes. The DNA base-pair-step geometry has, overall, twice the curvature necessary to accommodate the DNA superhelical path in the nucleosome. DNA segments bent into the minor groove are either kinked or alternately shifted. The unusual DNA conformational parameters induced by the binding of histone protein have implications for sequence-dependent protein recognition and nucleosome positioning and mobility. Comparison of the 147-base-pair structure with two 146-base-pair structures reveals alterations in DNA twist that are evidently common in bulk chromatin, and which are of probable importance for chromatin fibre formation and chromatin remodelling.	ETH Honggerberg, Inst Mol Biol & Biophys, ETH Zurich, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Richmond, TJ (corresponding author), ETH Honggerberg, Inst Mol Biol & Biophys, ETH Zurich, CH-8093 Zurich, Switzerland.	richmond@mol.biol.ethz.ch	Davey, Curt A/A-2182-2011					Anselmi C, 1999, J MOL BIOL, V286, P1293, DOI 10.1006/jmbi.1998.2575; ARNOTT S, 1969, ACTA CRYSTALL B-STRU, VB 25, P2192, DOI 10.1107/S0567740869005450; CALLADINE CR, 1986, J MOL BIOL, V192, P907, DOI 10.1016/0022-2836(86)90036-7; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dickerson RE, 1997, BIOPOLYMERS, V44, P361, DOI 10.1002/(SICI)1097-0282(1997)44:4<361::AID-BIP4>3.0.CO;2-X; Dickerson RE, 1998, NUCLEIC ACIDS RES, V26, P1906, DOI 10.1093/nar/26.8.1906; El Hassan MA, 1998, J MOL BIOL, V282, P331, DOI 10.1006/jmbi.1998.1994; ELGIN SC, 2000, CHROMATIN STRUCTURE; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; Flaus A, 1998, J MOL BIOL, V275, P427, DOI 10.1006/jmbi.1997.1464; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; GOODSELL DS, 1994, NUCLEIC ACIDS RES, V22, P5497, DOI 10.1093/nar/22.24.5497; KLUG A, 1981, NUCLEIC ACIDS RES, V9, P4267, DOI 10.1093/nar/9.17.4267; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Olson WK, 1996, CURR OPIN STRUC BIOL, V6, P242, DOI 10.1016/S0959-440X(96)80082-0; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Packer MJ, 1998, J MOL BIOL, V280, P407, DOI 10.1006/jmbi.1998.1865; Packer MJ, 2001, J AM CHEM SOC, V123, P7399, DOI 10.1021/ja003385u; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Richmond TJ, 2000, CHROMATIN STRUCTURE, P1; SHIMIZU M, 1991, EMBO J, V10, P3033, DOI 10.1002/j.1460-2075.1991.tb07854.x; SHRADER TE, 1990, J MOL BIOL, V216, P69, DOI 10.1016/S0022-2836(05)80061-0; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; van Holde K E, 1988, CHROMATIN; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wolffe AP, 1998, PROG NUCLEIC ACID RE, V61, P379, DOI 10.1016/S0079-6603(08)60832-6; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L; YOUNG MA, 1995, BIOPHYS J, V68, P2454, DOI 10.1016/S0006-3495(95)80427-3; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P267, DOI 10.1016/0022-2836(88)90239-2	40	908	936	3	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					145	150		10.1038/nature01595	http://dx.doi.org/10.1038/nature01595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736678				2022-12-01	WOS:000182699600039
J	Tishler, PV; Larkin, EK; Schluchter, MD; Redline, S				Tishler, PV; Larkin, EK; Schluchter, MD; Redline, S			Incidence of sleep-disordered breathing in an urban adult population - The relative importance of risk factors in the development of sleep-disordered breathing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR-DISEASE; FAMILIAL AGGREGATION; AFRICAN-AMERICANS; APNEA-HYPOPNEA; MEN; PREVALENCE; COMMUNITY; GENETICS; VALIDITY	Context Sleep-disordered breathing (SDB) is both prevalent and associated with serious chronic illness. The incidence of SDB and the effect of risk factors on this incidence are unknown. Objective To determine the 5-year incidence of SDB overall and as influenced by risk factors. Design, Setting, and Participants Of the 1149 participants in the Cleveland Family Study, those aged 18 years or older, from either case or control families, who had 2 in-home sleep studies 5 years apart. The first had to have been performed before June 30, 1997, and had to have normal results (apnea hypopnea index [AHI] <5). Data included questionnaire information on medical and family history, SDB symptoms; measurement of height, weight, blood pressure, waist and hip circumference, and serum cholesterol concentration; and overnight sleep monitoring. Main Outcome Measure Apnea hypopnea index, defined as number of apneas and hypopneas per hour of sleep. Sleep-disordered breathing was defined by an AHI of at least 10 (mild to moderate) or of at least 15 (moderate). Results Forty-seven (16%) of 286 eligible participants, (95% confidence interval [CI], 13%-21%) had a second-study AHI of at least 10 and 29 (10%) participants (95% CI, 7%-14%) had a second-study AHI result of at least 15. For the AHI results of at least 15, we estimate that about 2.5% may represent test variability. By ordinal logistic regression analysis, AHI was significantly associated with age (odds ratio [OR] per 10-year increase, 1.79; 95% CI, 1.41-2.27), body mass index (BMI; OR per 1-unit increase, 1.14; 95% CI, 1.10-1.19), sex (OR for men Vs women, 4.12; 95% CI, 2.29-7.43), waist-hip ratio (OR per 0.1 unit increase, 1.61; 95% CI, 1.04-2.28), and serum cholesterol concentration (OR per 10-mg/dL [0.25-mmol/L] increase, 1.11; 95% Cl, 1.03-1.19). Interactions were noted between age and both sex (P=.003) and BMI (P=.05). The OR for increased AHI per 10-year age increase was 2.41 in women (95% CI, 1.78-3.26) and 1.15 in men (95% CI, 0.78-1.68), with the male vs female OR decreasing from 5.04 (95% CI, 2.19-11.6) at age 30 years to 0.54 (95% CI, 0.15-1.99) at age 60 years. The OR for increased AHI per 1-unit increase in BMI decreased from 1.21 (95% CI, 1.11-1.31) at age 20 years to 1.05 (95% CI, 0.96-1.15) at age 60 years. Conclusions The 5-year incidence is about 7.5% for moderately severe SDB and 16% (or less) for mild to moderately severe SDB. Incidence of SDB is influenced independently by age, sex, BMI, waist-hip ratio, and serum cholesterol concentration. Predominance in men diminishes with increasing age, and by age 50 years, incidence rates among men and women are similar. The effect of BMI also decreases with age and may be negligible at age 60 years.	Vet Affairs Boston Healthcare Syst, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Tishler, PV (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	peter.tishler@channing.harvard.edu			NCRR NIH HHS [M01 RR00080-39] Funding Source: Medline; NHLBI NIH HHS [HL46380, T32-HL07567] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046380, T32HL007567] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alchanatis M, 2001, RESPIRATION, V68, P566, DOI 10.1159/000050574; Asplund R, 1999, DRUG AGING, V14, P91, DOI 10.2165/00002512-199914020-00002; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; BRESNITZ EA, 1994, EPIDEMIOL REV, V16, P210, DOI 10.1093/oxfordjournals.epirev.a036151; Buxbaum SG, 2002, GENET EPIDEMIOL, V22, P243, DOI 10.1002/gepi.0170; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Ficker JH, 1998, EUR RESPIR J, V11, P14, DOI 10.1183/09031936.98.11010014; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FLIER JS, 1998, WILLIAMS TXB ENDOCRI, P1061; GISLASON T, 1988, J CLIN EPIDEMIOL, V41, P571, DOI 10.1016/0895-4356(88)90061-3; GORDON T, 1973, DHEW PUBLICATION NIH; Henriksson KM, 2001, EUR J EPIDEMIOL, V17, P521, DOI 10.1023/A:1014508422504; Ip MSM, 2001, CHEST, V119, P62, DOI 10.1378/chest.119.1.62; Javaheri S, 2000, CIRCULATION, V101, P392, DOI 10.1161/01.CIR.101.4.392; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; KUMP K, 1994, AM J RESP CRIT CARE, V150, P735, DOI 10.1164/ajrccm.150.3.8087345; LAVIE P, 1995, SLEEP, V18, P149, DOI 10.1093/sleep/18.3.149; Leung RST, 2001, AM J RESP CRIT CARE, V164, P2147, DOI 10.1164/ajrccm.164.12.2107045; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Mooe T, 2001, AM J RESP CRIT CARE, V164, P1910, DOI 10.1164/ajrccm.164.10.2101072; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Quan SF, 2002, SLEEP, V25, P843; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1997, AM J RESP CRIT CARE, V155, P186, DOI 10.1164/ajrccm.155.1.9001310; REDLINE S, 1992, AM REV RESPIR DIS, V145, P440, DOI 10.1164/ajrccm/145.2_Pt_1.440; REDLINE S, 1991, CHEST, V100, P1281, DOI 10.1378/chest.100.5.1281; Redline S, 2002, LUNG BIOL HEALTH DIS, V166, P235; Redline S, 2001, SLEEP, V24, pA294; REDLINE S, 1994, AM J RESP CRIT CARE, V149, P722, DOI 10.1164/ajrccm.149.3.8118642; REDLINE S, 1991, SLEEP RESPIRATION AG, P189; Saarelainen S, 1998, CLIN GENET, V53, P147; SAHAR E, 2003, IN PRESS AM J RESP C; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Stokes ME, 2000, CATEGORICAL DATA ANA; Williamson JM, 1999, COMPUT METH PROG BIO, V58, P25, DOI 10.1016/S0169-2607(98)00063-7; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	40	308	320	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2230	2237		10.1001/jama.289.17.2230	http://dx.doi.org/10.1001/jama.289.17.2230			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	675ET	12734134	Bronze			2022-12-01	WOS:000182680700025
J	Shulman, KI; Rochon, P; Sykora, K; Anderson, G; Mamdani, M; Bronskill, S; Tran, CTT				Shulman, KI; Rochon, P; Sykora, K; Anderson, G; Mamdani, M; Bronskill, S; Tran, CTT			Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Toronto, Fac Med, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, ICES, Toronto, ON, Canada; Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6S 2E1, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Baycrest	Shulman, KI (corresponding author), Univ Toronto, Fac Med, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada.	ken.shulman@sw.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151				Baldessarini R J, 1999, Bipolar Disord, V1, P17, DOI 10.1034/j.1399-5618.1999.10106.x; Dinan TG, 2002, BRIT MED J, V324, P989, DOI 10.1136/bmj.324.7344.989; Johnson G, 1998, NEUROPSYCHOPHARMACOL, V19, P200, DOI 10.1016/S0893-133X(98)00019-0; MACRITCHIE KA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003196; Sival RC, 2002, INT J GERIATR PSYCH, V17, P579, DOI 10.1002/gps.653	5	67	69	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2003	326	7396					960	961		10.1136/bmj.326.7396.960	http://dx.doi.org/10.1136/bmj.326.7396.960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676JC	12727769	Green Published, Bronze			2022-12-01	WOS:000182746700017
J	Lim, BCB; Ariens, RAS; Carter, AM; Weisel, JW; Grant, PJ				Lim, BCB; Ariens, RAS; Carter, AM; Weisel, JW; Grant, PJ			Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk	LANCET			English	Article							FACTOR-XIII GENE; COAGULATION-FACTOR-XIII; MYOCARDIAL-INFARCTION; THR312ALA POLYMORPHISM; VAL34LEU POLYMORPHISM; COMMON POLYMORPHISM; PLASMA-FIBRINOGEN; FXIII VAL34LEU; HEART-DISEASE; ASSOCIATION	Background Polymorphisms in the fibrinogen and factor XIII genes are associated with atherothrombotic risk, but clinical studies have produced inconsistent results and laboratory studies have not explained these findings. We aimed to investigate interactions between polymorphisms in the factor XIII and fibrinogen genes, fibrinogen concentrations, and other cardiovascular risk factors in relation to fibrin structure and function. Methods We used permeation analysis and electron microscopy to investigate interactions between fibrin structure, factor XIII Val34Leu, fibrinogen Aalpha Thr312Ala, fibrinogen 130 Arg448Lys, and fibrinogen concentrations in plasma and purified systems. Findings Increased fibrinogen concentrations were associated with decreases in permeability, with tighter clot structures in the presence of factor XIII 34Val alleles compared with those in the presence of 34Leu alleles. Findings were confirmed by scanning electron microscopy of fibrin. Similar changes in permeability were noted for Aalpha fibrinogen 312Ala compared with that for 312Thr. Interpretation Our results show interactions between coding polymorphisms in fibrinogen and factor XIII and fibrinogen concentrations that modify fibrin and explain the apparent paradox between epidemiological studies of factor XIII 34Leu and reported in-vitro effects on fibrin structure and function. We suggest a potential complexity of gene-gene and gene-environment interactions in determining cardiovascular risk.	Univ Leeds, Acad Unit Mol Vasc Med, Leeds, W Yorkshire, England; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Leeds; University of Pennsylvania	Grant, PJ (corresponding author), Gen Infirm, Acad Unit Mol Vasc Med, G Floor,Martin Wing, Leeds LS1 3EX, W Yorkshire, England.	p.j.grant@leeds.ac.uk		Ariens, Robert/0000-0002-6310-5745	NHLBI NIH HHS [HL30954] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030954] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ariens RAS, 2000, BLOOD, V96, P988, DOI 10.1182/blood.V96.3.988.015k57_988_995; BAUMANN RE, 1993, BLOOD, V82, P2117; Behague I, 1996, CIRCULATION, V93, P440, DOI 10.1161/01.CIR.93.3.440; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P96, DOI 10.1016/0167-4838(89)90140-4; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; Carter AM, 1999, CIRCULATION, V99, P2423, DOI 10.1161/01.CIR.99.18.2423; Carter AM, 1997, ARTERIOSCL THROM VAS, V17, P589, DOI 10.1161/01.ATV.17.3.589; Catto AJ, 1998, STROKE, V29, P813, DOI 10.1161/01.STR.29.4.813; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; COLLET JP, 1993, BLOOD, V82, P2462; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Corral J, 2000, HAEMATOLOGICA, V85, P293; Dotevall Annika, 1994, Annals of Epidemiology, V4, P369; Elbaz A, 2000, BLOOD, V95, P586, DOI 10.1182/blood.V95.2.586; FATAH K, 1992, THROMB HAEMOSTASIS, V68, P130; Fatah K, 1996, THROMB HAEMOSTASIS, V76, P535; Franco RF, 2000, HAEMATOLOGICA, V85, P67; Gemmati D, 2001, AM J HEMATOL, V67, P183, DOI 10.1002/ajh.1104; Hunter KA, 2001, CLIN SCI, V100, P459, DOI 10.1042/CS20000228; Kohler HP, 1998, THROMB HAEMOSTASIS, V79, P8, DOI 10.1055/s-0037-1614250; Lane DA, 2000, BLOOD, V95, P1517, DOI 10.1182/blood.V95.5.1517.005k48_1517_1532; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; Tuut M, 2001, ANN EPIDEMIOL, V11, P232, DOI 10.1016/S1047-2797(00)00226-X; Warner D, 2001, THROMB HAEMOSTASIS, V85, P408; Wartiovaara U, 1999, ATHEROSCLEROSIS, V142, P295, DOI 10.1016/S0021-9150(98)00241-X; WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; Woodhead JL, 1996, J BIOL CHEM, V271, P4946	30	169	171	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2003	361	9367					1424	1431		10.1016/S0140-6736(03)13135-2	http://dx.doi.org/10.1016/S0140-6736(03)13135-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727396				2022-12-01	WOS:000182516300011
J	Murphy, CT; McCarroll, SA; Bargmann, CI; Fraser, A; Kamath, RS; Ahringer, J; Li, H; Kenyon, C				Murphy, CT; McCarroll, SA; Bargmann, CI; Fraser, A; Kamath, RS; Ahringer, J; Li, H; Kenyon, C			Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans	NATURE			English	Article							SUPEROXIDE-DISMUTASE; INSULIN-RECEPTOR; COMPUTATIONAL ANALYSIS; REGULATES LONGEVITY; STRESS RESISTANCE; OXIDATIVE STRESS; EXPRESSION; MEMBER; IDENTIFICATION; FAMILY	Ageing is a fundamental, unsolved mystery in biology. DAF-16, a FOXO-family transcription factor, influences the rate of ageing of Caenorhabditis elegans in response to insulin/insulin-like growth factor 1 (IGF-I) signalling. Using DNA microarray analysis, we have found that DAF-16 affects expression of a set of genes during early adulthood, the time at which this pathway is known to control ageing. Here we find that many of these genes influence the ageing process. The insulin/IGF-I pathway functions cell non-autonomously to regulate lifespan, and our findings suggest that it signals other cells, at least in part, by feedback regulation of an insulin/IGF-I homologue. Furthermore, our findings suggest that the insulin/IGF-I pathway ultimately exerts its effect on lifespan by upregulating a wide variety of genes, including cellular stress-response, antimicrobial and metabolic genes, and by downregulating specific life-shortening genes.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Cambridge; University of Cambridge	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu	McCarroll, Steven A/A-8433-2009	Ahringer, Julie/0000-0002-7074-4051; Murphy, Coleen/0000-0002-8257-984X; Kenyon, Cynthia/0000-0003-3446-2636; Bargmann, Cornelia/0000-0002-8484-0618; Fraser, Andrew/0000-0001-9939-6014; McCarroll, Steven/0000-0002-6954-8184	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Banyai L, 1998, BBA-PROTEIN STRUCT M, V1429, P259, DOI 10.1016/S0167-4838(98)00237-4; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; DAVIS WL, 1990, BIOCHIM BIOPHYS ACTA, V1051, P276, DOI 10.1016/0167-4889(90)90133-X; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; Gems D, 1998, GENETICS, V150, P129; Gregoire FM, 1998, BIOCHEM BIOPH RES CO, V249, P385, DOI 10.1006/bbrc.1998.9164; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Herndon LA, 2000, RES PRO CEL, V29, P113; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ookuma S, 2003, CURR BIOL, V13, P427, DOI 10.1016/S0960-9822(03)00108-8; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Riddle DL, 1997, C ELEGANS, P739; Ried K, 1998, HUM MOL GENET, V7, P1771, DOI 10.1093/hmg/7.11.1771; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sun JT, 2002, GENETICS, V161, P661; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Taub J, 2003, NATURE, V421, P764, DOI 10.1038/nature01425; Tissenbaum HA, 1998, GENETICS, V148, P703; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Wolkow Catherine A., 2000, Science (Washington D C), V290, P147, DOI 10.1126/science.290.5489.147; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	52	1595	1717	9	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					277	284		10.1038/nature01789	http://dx.doi.org/10.1038/nature01789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12845331				2022-12-01	WOS:000184183900032
J	Castrillon, DH; Miao, LL; Kollipara, R; Horner, JW; DePinho, RA				Castrillon, DH; Miao, LL; Kollipara, R; Horner, JW; DePinho, RA			Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; MOUSE; GROWTH; FAILURE; IDENTIFICATION; OOCYTES; PATHWAY; AGE-1; GENES; FKHR	Foxo transcription factors have been implicated in diverse biological processes, including metabolism, cellular stress responses, and aging. Here, we show that Foxo3a(-/-) female mice exhibit a distinctive ovarian phenotype of global follicular activation leading to oocyte death, early depletion of functional ovarian follicles, and secondary infertility. Foxo3a thus functions at the earliest stages of follicular growth as a suppressor of follicular activation. In addition to providing a molecular entry point for studying the regulation of follicular growth, these results raise the possibility that accelerated follicular initiation plays a role in premature ovarian failure, a common cause of infertility and premature aging in women.	Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol,Womens & Perinatal Pathol Div, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.			DePinho, Ronald/0000-0002-5625-577X	PHS HHS [K08] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; DORMAN JB, 1995, GENETICS, V141, P1399; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/ror.0.0030183; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Fortune JE, 2000, MOL CELL ENDOCRINOL, V163, P53, DOI 10.1016/S0303-7207(99)00240-3; FRASER IS, 1988, FERTIL STERIL, V50, P747; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gems D, 1998, GENETICS, V150, P129; Kaestner KH, 2000, GENE DEV, V14, P142; LINTERNMOORE S, 1979, BIOL REPROD, V20, P773, DOI 10.1095/biolreprod20.4.773; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; Prueitt RL, 2001, NAT GENET, V27, P132, DOI 10.1038/84735; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5	23	654	686	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					215	218		10.1126/science.1086336	http://dx.doi.org/10.1126/science.1086336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855809				2022-12-01	WOS:000184056200044
J	Munker, C; Pfander, JA; Weyer, S; Buchl, A; Kleine, T; Mezger, K				Munker, C; Pfander, JA; Weyer, S; Buchl, A; Kleine, T; Mezger, K			Evolution of planetary cores and the earth-moon system from Nb/Ta systematics	SCIENCE			English	Article							OCEANIC BASALTS; SOLAR-SYSTEM; MANTLE; ORIGIN; ZR/HF; FRACTIONATION; NIOBIUM; IMPACT; NB; DIFFERENTIATION	It has been assumed that Nb and Ta are not fractionated during differentiation processes on terrestrial planets and that both elements are lithophile. High-precision measurements of Nb/Ta and Zr/Hf reveal that Nb is moderately siderophile at high pressures. Nb/Ta values in the bulk silicate Earth (14.0 +/- 0.3) and the Moon (17.0 +/- 0.8) are below the chondritic ratio of 19.9 +/- 0.6, in contrast to Mars and asteroids. The lunar Nb/Ta constrains the mass fraction of impactor material in the Moon to less than 65%. Moreover, the Moon-forming impact can be linked in time with the final core-mantle equilibration on Earth 4.533 billion years ago.	Univ Munster, Inst Mineral, D-48149 Munster, Germany; Max Planck Inst Chem, D-55020 Mainz, Germany	University of Munster; Max Planck Society	Munker, C (corresponding author), Univ Munster, Inst Mineral, Corrensstr 24, D-48149 Munster, Germany.	muenker@nwz.uni-muenster.de	Mezger, Klaus/D-9502-2011; Munker, Carsten/O-7606-2015; Kleine, Thorsten/S-2792-2017; Weyer, Stefan/AAA-8827-2020	Mezger, Klaus/0000-0002-2443-8539; Kleine, Thorsten/0000-0003-4657-5961; Munker, Carsten/0000-0001-6406-559X				Barth MG, 2000, CHEM GEOL, V165, P197, DOI 10.1016/S0009-2541(99)00173-4; BENZ W, 1989, ICARUS, V81, P113, DOI 10.1016/0019-1035(89)90129-2; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Cameron AGW, 2001, METEORIT PLANET SCI, V36, P9, DOI 10.1111/j.1945-5100.2001.tb01806.x; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; David K, 2000, EARTH PLANET SC LETT, V178, P285, DOI 10.1016/S0012-821X(00)00088-1; El Goresy A, 2001, EARTH PLANET SC LETT, V192, P485, DOI 10.1016/S0012-821X(01)00480-0; HART SR, 1993, CONTRIB MINERAL PETR, V113, P1, DOI 10.1007/BF00320827; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; JOCHUM KP, 1986, GEOCHIM COSMOCHIM AC, V50, P1173, DOI 10.1016/0016-7037(86)90400-X; Jochum KP, 2000, METEORIT PLANET SCI, V35, P229, DOI 10.1111/j.1945-5100.2000.tb01771.x; Jochum KP, 2002, GEOCHIM COSMOCHIM AC, V66, pA368; JOCHUM KP, 1996, EOS S, V77, P785; Jones J. H., 2000, ORIGIN EARTH MOON, P197, DOI DOI 10.1016/0016-7037(83)90024-8.; Kamber BS, 2000, CHEM GEOL, V166, P241, DOI 10.1016/S0009-2541(99)00218-1; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Lee DC, 2002, EARTH PLANET SC LETT, V198, P267, DOI 10.1016/S0012-821X(02)00533-2; Munker C, 1998, CHEM GEOL, V144, P23, DOI 10.1016/S0009-2541(97)00105-8; Munker C, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2001GC000183; MUNKER C, 2001, EOS S, V82, P1173; Niu YL, 1997, EARTH PLANET SC LETT, V148, P471, DOI 10.1016/S0012-821X(97)00048-4; Pfander JA, 2002, GEOCHIM COSMOCHIM AC, V66, pA597; Rudnick RL, 2000, SCIENCE, V287, P278, DOI 10.1126/science.287.5451.278; Schoenberg R, 2002, GEOCHIM COSMOCHIM AC, V66, P3151, DOI 10.1016/S0016-7037(02)00911-0; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Stolz AJ, 1996, GEOLOGY, V24, P587, DOI 10.1130/0091-7613(1996)024<0587:FAMREI>2.3.CO;2; van Westrenen W, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000133; Wade J, 2001, NATURE, V409, P75, DOI 10.1038/35051064; WANKE H, 1975, P LUNAR PLANET SCI C, V6, P1313; Weyer S, 2003, EARTH PLANET SC LETT, V205, P309, DOI 10.1016/S0012-821X(02)01059-2; Weyer S, 2002, CHEM GEOL, V187, P295, DOI 10.1016/S0009-2541(02)00129-8; Yi W, 2000, J GEOPHYS RES-SOL EA, V105, P18927, DOI 10.1029/2000JB900152; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	33	319	348	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					84	87		10.1126/science.1084662	http://dx.doi.org/10.1126/science.1084662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843390				2022-12-01	WOS:000183914700037
J	Kim, J; Chung, YD; Park, DY; Choi, SK; Shin, DW; Soh, H; Lee, HW; Son, W; Yim, J; Park, CS; Kernan, MJ; Kim, C				Kim, J; Chung, YD; Park, DY; Choi, SK; Shin, DW; Soh, H; Lee, HW; Son, W; Yim, J; Park, CS; Kernan, MJ; Kim, C			A TRPV family ion channel required for hearing in Drosophila	NATURE			English	Article							REGULATORY FACTOR-X; CAPSAICIN-RECEPTOR; MECHANOSENSORY TRANSDUCTION; HEAT; EXPRESSION; MECHANISMS; ACTIVATION; ELEGANS; PROTEIN; GENOME	The many types of insect ear share a common sensory element, the chordotonal organ, in which sound-induced antennal or tympanal vibrations are transmitted to ciliated sensory neurons and transduced to receptor potentials(1,2). However, the molecular identity of the transducing ion channels in chordotonal neurons, or in any auditory system, is still unknown(3,4). Drosophila that are mutant for NOMPC, a transient receptor potential (TRP) superfamily ion channel, lack receptor potentials and currents in tactile bristles(5,6) but retain most of the antennal sound-evoked response(7), suggesting that a different channel is the primary transducer in chordotonal organs. Here we describe the Drosophila Nanchung (Nan) protein, an ion channel subunit similar to vanilloid-receptor-related (TRPV) channels of the TRP superfamily. Nan mediates hypo-osmotically activated calcium influx and cation currents in cultured cells. It is expressed in vivo exclusively in chordotonal neurons and is localized to their sensory cilia. Antennal sound-evoked potentials are completely absent in mutants lacking Nan, showing that it is an essential component of the chordotonal mechanotransducer.	Hanwha Chem Co R&D Ctr, Dept Genet, Taejon 305345, South Korea; Chungnam Natl Univ, Dept Microbiol, Taejon 305764, South Korea; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; K JIST, Dept Life Sci, Gwangju 500712, South Korea; Seoul Natl Univ, Natl Creat Res Inst Genet Reprogramming, Seoul 151742, South Korea	Chungnam National University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU)	Kim, C (corresponding author), Hanwha Chem Co R&D Ctr, Dept Genet, Taejon 305345, South Korea.		Kim, Janghwan/B-4522-2009	Son, Wonseok/0000-0003-1623-1236; Park, Chul-Seung/0000-0003-0209-1412; Kernan, Maurice/0000-0002-1546-6159	NIDCD NIH HHS [R01 DC002780] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002780] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Benham CD, 2002, NEUROPHARMACOLOGY, V42, P873, DOI 10.1016/S0028-3908(02)00047-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Eberl DF, 1999, CURR OPIN NEUROBIOL, V9, P389, DOI 10.1016/S0959-4388(99)80058-0; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Guler AD, 2002, J NEUROSCI, V22, P6408; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Strassmaier M, 2002, CURR OPIN NEUROBIOL, V12, P380, DOI 10.1016/S0959-4388(02)00344-6; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Vandaele C, 2001, MECH DEVELOP, V103, P159, DOI 10.1016/S0925-4773(01)00340-9; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	27	280	302	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					81	84		10.1038/nature01733	http://dx.doi.org/10.1038/nature01733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12819662				2022-12-01	WOS:000183912800044
J	Boulanger, MJ; Chow, DC; Brevnova, EE; Garcia, KC				Boulanger, MJ; Chow, DC; Brevnova, EE; Garcia, KC			Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex	SCIENCE			English	Article							PROXIMAL EXTRACELLULAR DOMAINS; RECEPTOR COMPLEXES; CRYSTAL-STRUCTURE; GP130; ACTIVATION; CYTOKINES; DISTINCT; PROGRAM; FAMILY; SITES	Interleukin-6 (IL-6) is an immunoregulatory cytokine that activates a cell-surface signaling assembly composed of IL-6, the IL-6 alpha-receptor (IL-6Ralpha), and the shared signaling receptor gp130. The 3.65 angstrom - resolution structure of the extracellular signaling complex reveals a hexameric, interlocking assembly mediated by a total of 10 symmetry-related, thermodynamically coupled interfaces. Assembly of the hexameric complex occurs sequentially: IL-6 is. rst engaged by IL-6Ralpha and then presented to gp130 in the proper geometry to facilitate a cooperative transition into the high-affinity, signaling-competent hexamer. The quaternary structures of other IL-6/IL-12 family signaling complexes are likely constructed by means of a similar topological blueprint.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321] Funding Source: NIH RePORTER; NIAID NIH HHS [AI51321] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; Benigni F, 1996, BLOOD, V87, P1851, DOI 10.1182/blood.V87.5.1851.bloodjournal8751851; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Chow DC, 2002, BBA-MOL CELL RES, V1592, P225, DOI 10.1016/S0167-4889(02)00317-8; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Chow DC, 2001, BIOCHEMISTRY-US, V40, P7593, DOI 10.1021/bi010192q; Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100; Grotzinger J, 1997, PROTEINS, V27, P96; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kalai M, 1997, BLOOD, V89, P1319, DOI 10.1182/blood.V89.4.1319; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; PAONESSA G, 1995, EMBO J, V14, P1942, DOI 10.1002/j.1460-2075.1995.tb07186.x; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Timmermann A, 2002, EUR J BIOCHEM, V269, P2716, DOI 10.1046/j.1432-1033.2002.02941.x; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; WARD LD, 1994, J BIOL CHEM, V269, P23286	22	441	488	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2101	2104		10.1126/science.1083901	http://dx.doi.org/10.1126/science.1083901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829785				2022-12-01	WOS:000183774900049
J	Zhou, ZY; Zheng, SL				Zhou, ZY; Zheng, SL			Palaeobiology: The missing link in Ginkgo evolution - The modern maidenhair tree has barely changed since the days of the dinosaurs.	NATURE			English	Editorial Material									Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China; Minist Natl Land & Resources, Shenyang Inst Geol & Mineral Resources, Shenyang 110032, Peoples R China	Chinese Academy of Sciences	Zhou, ZY (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China.							ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Chang M.M., 2001, JEHOL BIOTA; Crane P.R., 1990, FIELDIANA GEOLOGY, V20, P1, DOI [10.5962/bhl.title.100826, DOI 10.5962/BHL.TITLE.100826]; Fuji K, 1896, BOT MAG TOKYO, V10, P104; Harris T.M., 1974, YORKSHIRE JURASSIC F, V4; Rothwell G.W., 1997, GINKGO BILOBA GLOBAL, P223; Seward A.C., 1919, FOSSIL PLANTS, V4; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Zhou Z. Y., 1994, ACTA PALAEONTOL SIN, V33, P131; Zhou ZY, 1989, PALAEONTOGR ABT B, V211, P113	10	147	185	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					821	822		10.1038/423821a	http://dx.doi.org/10.1038/423821a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815417				2022-12-01	WOS:000183585300030
J	Kirkwood, T				Kirkwood, T			The most pressing problem of our age	BRITISH MEDICAL JOURNAL			English	Article									Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle General Hospital; Newcastle University - UK	Kirkwood, T (corresponding author), Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.								0	16	18	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1297	1299		10.1136/bmj.326.7402.1297	http://dx.doi.org/10.1136/bmj.326.7402.1297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805160	Green Published			2022-12-01	WOS:000183626500024
J	Anand, K; Ziebuhr, J; Wadhwani, P; Mesters, JR; Hilgenfeld, R				Anand, K; Ziebuhr, J; Wadhwani, P; Mesters, JR; Hilgenfeld, R			Coronavirus main proteinase (3CL(pro)) structure: Basis for design of anti-SARS drugs	SCIENCE			English	Article							VIRUS-ENCODED PROTEINASES; 229E 3C-LIKE PROTEINASE; PROTEASES	A novel coronavirus has been identified as the causative agent of severe acute respiratory syndrome (SARS). The viral main proteinase (M-pro, also called 3CL(pro)), which controls the activities of the coronavirus replication complex, is an attractive target for therapy. We determined crystal structures for human coronavirus (strain 229E) M-pro and for an inhibitor complex of porcine coronavirus [ transmissible gastroenteritis virus ( TGEV)] Mpro, and we constructed a homology model for SARS coronavirus (SARS-CoV) M-pro. The structures reveal a remarkable degree of conservation of the substrate-binding sites, which is further supported by recombinant SARS-CoV M-pro-mediated cleavage of a TGEV Mpro substrate. Molecular modeling suggests that available rhinovirus 3C(pro) inhibitors may be modified to make them useful for treating SARS.	Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Univ Wurzburg, Inst Virol & Immunol, D-97078 Wurzburg, Germany; Univ Jena, Inst Mol Biol, D-07745 Jena, Germany	University of Lubeck; University of Wurzburg; Friedrich Schiller University of Jena	Hilgenfeld, R (corresponding author), Univ Lubeck, Inst Biochem, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	hilgenfeld@biochem.uni-luebeck.de	Hilgenfeld, Rolf/C-9675-2011; Ziebuhr, John/G-7669-2015	Wadhwani, Parvesh/0000-0002-7290-5154; Mesters, Jeroen/0000-0001-8532-6699; Ziebuhr, John/0000-0002-5741-8825				Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Hegyi A, 2002, J GEN VIROL, V83, P581, DOI 10.1099/0022-1317-83-3-581; HEROLD J, 1993, VIROLOGY, V195, P680, DOI 10.1006/viro.1993.1419; KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; MARRA M, 2003, SCIENCE, V30, P1399, DOI DOI 10.1126/SC2ENCE.1085953; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Ryan MD, 1997, J GEN VIROL, V78, P699, DOI 10.1099/0022-1317-78-4-699; Siddell S.G., 1995, CORONAVIRIDAE, P1, DOI DOI 10.1007/978-1-4899-1531-3_1; Siddell S.G., 1995, CORONAVIRIDAE, P389; Thiel V, 2001, J VIROL, V75, P6676, DOI 10.1128/JVI.75.14.6676-6681.2001; Ziebuhr J, 1997, J VIROL, V71, P3992, DOI 10.1128/JVI.71.5.3992-3997.1997; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853; ZIEBUHR J, 1995, J VIROL, V69, P4331, DOI 10.1128/JVI.69.7.4331-4338.1995	18	1125	1220	20	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1763	1767		10.1126/science.1085658	http://dx.doi.org/10.1126/science.1085658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12746549				2022-12-01	WOS:000183459700056
J	Gao, HX; Sengupta, J; Valle, M; Korostelev, A; Eswar, N; Stagg, SM; Van Roey, P; Agrawal, RK; Harvey, SC; Sali, A; Chapman, MS; Frank, J				Gao, HX; Sengupta, J; Valle, M; Korostelev, A; Eswar, N; Stagg, SM; Van Roey, P; Agrawal, RK; Harvey, SC; Sali, A; Chapman, MS; Frank, J			Study of the structural dynamics of the E-coli 70S ribosome using real-space refinement	CELL			English	Article							AMINOACYL-TRANSFER-RNA; CRYOELECTRON MICROSCOPY; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ATOMIC MODELS; 80S RIBOSOME; PROTEIN S1; PSI-BLAST; SUBUNIT	Cryo-EM density maps showing the 70S ribosome of E. coli in two different functional states related by a ratchet-like motion were analyzed using real-space refinement. Comparison of the two resulting atomic models shows that the ribosome changes from a compact structure to a looser one, coupled with the rearrangement of many of the proteins. Furthermore, in contrast to the unchanged inter-subunit bridges formed wholly by RNA, the bridges involving proteins undergo large conformational changes following the ratchet-like motion, suggesting an important role of ribosomal proteins in facilitating the dynamics of translation.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Wadsworth Ctr Labs & Res, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA; Florida State Univ, Inst Mol Biophys, Kasha Lab, Tallahassee, FL 32306 USA; Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Georgia; Georgia Institute of Technology	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA.	joachim@wadsworth.org	Stagg, Scott/AAW-9294-2020; Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Korostelev, Andrei/0000-0003-1588-717X; Chapman, Michael/0000-0001-8525-8585	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054762, R37GM029169, P50GM062529, R01GM061576, R01GM053827, R01GM055440, P01GM064676] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061576, R01 GM55440, R01 GM54762, P01 GM64676, R01 GM61576, R37 GM29169, P50 GM62529, R01 GM53827] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; Chen LF, 2001, J STRUCT BIOL, V133, P221, DOI 10.1006/jsbi.2000.4321; Cooperman BS, 1995, BIOCHEM CELL BIOL, V73, P1087, DOI 10.1139/o95-117; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2001, COLD SPRING HARB SYM, V66, P67, DOI 10.1101/sqb.2001.66.67; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Frank J., 1996, 3 DIMENSIONAL ELECT; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LAUGHREA M, 1977, J MOL BIOL, V112, P399, DOI 10.1016/S0022-2836(77)80189-7; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Moore PB, 2002, NATURE, V418, P229, DOI 10.1038/418229a; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pieper U, 2002, NUCLEIC ACIDS RES, V30, P255, DOI 10.1093/nar/30.1.255; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; SERDYUK I, 1992, BIOCHIMIE, V74, P299, DOI 10.1016/0300-9084(92)90107-P; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Tung CS, 2002, NAT STRUCT BIOL, V9, P750, DOI 10.1038/nsb841; Uhlein M, 1998, BIOCHEM J, V331, P423; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	51	233	287	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					789	801		10.1016/S0092-8674(03)00427-6	http://dx.doi.org/10.1016/S0092-8674(03)00427-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809609	Bronze			2022-12-01	WOS:000183514400013
J	Lauber, K; Bohn, E; Krober, SM; Xiao, YJ; Blumenthal, SG; Lindemann, RK; Marini, P; Wiedig, C; Zobywalski, A; Baksh, S; Xu, Y; Autenrieth, IB; Schulze-Osthoff, K; Belka, C; Stuhler, G; Wesselborg, S				Lauber, K; Bohn, E; Krober, SM; Xiao, YJ; Blumenthal, SG; Lindemann, RK; Marini, P; Wiedig, C; Zobywalski, A; Baksh, S; Xu, Y; Autenrieth, IB; Schulze-Osthoff, K; Belka, C; Stuhler, G; Wesselborg, S			Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal	CELL			English	Article							RETRACTED ARTICLE. SEE; SECRETORY PHOSPHOLIPASE A(2); MORPHOLOGICAL-CHANGES; DISTINCT ROLES; ACID RELEASE; MEMBRANE; LYSOPHOSPHATIDYLCHOLINE; RECEPTOR; BINDING; SPHINGOSYLPHOSPHORYLCHOLINE	Efficient engulfment of the intact cell corpse is a critical end point of apoptosis, required to prevent secondary necrosis and inflammation. The presentation of "eat-me" signals on the dying cell is an important part of this process of recognition and engulfment by professional phagocytes. Here, we present evidence that apoptotic cells secrete chemotactic factor(s) that stimulate the attraction of monocytic cells and primary macrophages. The activation of caspase-3 in the apoptotic cell was found to be required for the release of this chemotactic factor(s). The putative chemoattractant was identified as the phospholipid, lysophosphatidylcholine. Further analysis showed that lysophosphatidylcholine was released from apoptotic cells due to the caspase-3 mediated activation of the calcium-independent phospholipase A(2). These data suggest that in addition to eat-me signals, apoptotic cells display attraction signals to ensure the efficient removal of apoptotic cells and prevent postapoptotic necrosis.	Univ Tubingen, Dept Internal Med 1, D-72074 Tubingen, Germany; Univ Tubingen, Inst Med Microbiol, D-72074 Tubingen, Germany; Univ Tubingen, Inst Pathol, D-72074 Tubingen, Germany; Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Gynecol & Obstet, Cleveland, OH 44195 USA; Univ Tubingen, Dept Radiat Oncol, D-72074 Tubingen, Germany; Univ Tubingen, Dept Internal Med 2, D-72074 Tubingen, Germany; Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Dept Med, Boston, MA 02115 USA; Univ Dusseldorf, Inst Mol Med, D-4000 Dusseldorf, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Heinrich Heine University Dusseldorf	Wesselborg, S (corresponding author), Univ Tubingen, Dept Internal Med 1, D-72074 Tubingen, Germany.	snwessel@med.uni-tuebingen.de	Schulze-Osthoff, Klaus/N-9025-2013	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Wesselborg, Sebastian/0000-0002-5236-942X				Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Binder RJ, 2000, J IMMUNOL, V165, P6029, DOI 10.4049/jimmunol.165.11.6029; Brown S, 2002, NATURE, V418, P200, DOI 10.1038/nature00811; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; HOFFMAN RD, 1982, P NATL ACAD SCI-BIOL, V79, P3285, DOI 10.1073/pnas.79.10.3285; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xiao YJ, 2000, ANN NY ACAD SCI, V905, P242; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200	34	662	692	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					717	730		10.1016/S0092-8674(03)00422-7	http://dx.doi.org/10.1016/S0092-8674(03)00422-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809603	Bronze			2022-12-01	WOS:000183514400007
J	Kanemaki, M; Sanchez-Diaz, A; Gambus, A; Labib, K				Kanemaki, M; Sanchez-Diaz, A; Gambus, A; Labib, K			Functional proteomic identification of DNA replication proteins by induced proteolysis in vivo	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PROTEOME; FIRING ORIGINS; BUDDING YEAST; S-PHASE; PURIFICATION; COMPLEXES; CDC7	Evolutionarily diverse eukaryotic cells share many conserved proteins of unknown function. Some are essential for cell viability(1,2), emphasising their importance for fundamental processes of cell biology but complicating their analysis. We have developed an approach to the large-scale characterization of such proteins, based on conditional and rapid degradation of the target protein in vivo, so that the immediate consequences of bulk protein depletion can be examined(3). Budding yeast strains have been constructed in which essential proteins of unknown function have been fused to a 'heat-inducible-degron' cassette that targets the protein for proteolysis at 37 degreesC (ref. 4). By screening the collection for defects in cell-cycle progression, here we identify three DNA replication factors that interact with each other and that have uncharacterized homologues in human cells. We have used the degron strains to show that these proteins are required for the establishment and normal progression of DNA replication forks. The degron collection could also be used to identify other, essential, proteins with roles in many other processes of eukaryotic cell biology.	Christie Hosp NHS Trust, Paterson Inst Canc Res, Canc Res UK, Manchester M20 4BX, Lancs, England	Cancer Research UK; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; University of Manchester	Labib, K (corresponding author), Christie Hosp NHS Trust, Paterson Inst Canc Res, Canc Res UK, Wilmslow Rd, Manchester M20 4BX, Lancs, England.		Kanemaki, Masato/Q-3246-2019; Sanchez-Diaz, Alberto/L-2320-2014; Gambus, Aga/AAK-4687-2021	Kanemaki, Masato/0000-0002-7657-1649; Sanchez-Diaz, Alberto/0000-0002-3308-4824; Gambus, Aga/0000-0002-4648-0332				Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Levy F, 1999, EUR J BIOCHEM, V259, P244, DOI 10.1046/j.1432-1327.1999.00024.x; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x	29	200	208	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					720	724		10.1038/nature01692	http://dx.doi.org/10.1038/nature01692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12768207				2022-12-01	WOS:000183443400035
J	Nemani, RR; Keeling, CD; Hashimoto, H; Jolly, WM; Piper, SC; Tucker, CJ; Myneni, RB; Running, SW				Nemani, RR; Keeling, CD; Hashimoto, H; Jolly, WM; Piper, SC; Tucker, CJ; Myneni, RB; Running, SW			Climate-driven increases in global terrestrial net primary production from 1982 to 1999	SCIENCE			English	Article							VARIABILITY; RESOLUTION; BUDGET; INDEX	Recent climatic changes have enhanced plant growth in northern mid-latitudes and high latitudes. However, a comprehensive analysis of the impact of global climatic changes on vegetation productivity has not before been expressed in the context of variable limiting factors to plant growth. We present a global investigation of vegetation responses to climatic changes by analyzing 18 years (1982 to 1999) of both climatic data and satellite observations of vegetation activity. Our results indicate that global changes in climate have eased several critical climatic constraints to plant growth, such that net primary production increased 6% (3.4 petagrams of carbon over 18 years) globally. The largest increase was in tropical ecosystems. Amazon rain forests accounted for 42% of the global increase in net primary production, owing mainly to decreased cloud cover and the resulting increase in solar radiation.	Univ Montana, Sch Forestry, Missoula, MT 59801 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 113, Japan; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Boston Univ, Dept Geog, Boston, MA 02215 USA	University of Montana System; University of Montana; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Tokyo; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Boston University	Nemani, RR (corresponding author), Univ Montana, Sch Forestry, Missoula, MT 59801 USA.		Myneni, Ranga B./AAU-6088-2021; Mitchard, Edward T A/C-6346-2009; Myneni, Ranga B/F-5129-2012; Noojipady, Praveen/B-2511-2010; Zhong, Hong Lin/C-2633-2012	Mitchard, Edward T A/0000-0002-5690-4055; Myneni, Ranga B/0000-0002-0234-6393; Hashimoto, Hirofumi/0000-0001-7706-1854				BARRETT DJ, 2002, GLOBAL BIOGEOCHEM CY, V16; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; Costa MH, 1999, J GEOPHYS RES-ATMOS, V104, P14189, DOI 10.1029/1998JD200126; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; De Fries RS, 1998, INT J REMOTE SENS, V19, P3141, DOI 10.1080/014311698214235; FAN SM, 1990, J GEOPHYS RES-ATMOS, V95, P16851, DOI 10.1029/JD095iD10p16851; FRIEDLINGSTEIN P, 1995, GLOBAL BIOGEOCHEM CY, V9, P541, DOI 10.1029/95GB02381; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Gu LH, 2003, SCIENCE, V299, P2035, DOI 10.1126/science.1078366; HICKE JA, 2002, GEOPHYS RES LETT, V29; Houghton J. T., 2001, CLIMATE CHANGE 2001; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; JAMES ME, 1994, INT J REMOTE SENS, V15, P3347, DOI 10.1080/01431169408954335; KEELING CD, 2001, SIO REFERENCE SERIES, V21; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Myneni RB, 1997, IEEE T GEOSCI REMOTE, V35, P1380, DOI 10.1109/36.649788; NEMANI RR, 2002, GEOPHYS RES LETT; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Potter C, 2001, J GEOPHYS RES-ATMOS, V106, P10423, DOI 10.1029/2000JD900563; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Trigo RM, 2002, CLIMATE RES, V20, P9, DOI 10.3354/cr020009; White M.A., 2000, EARTH INTERACT, V4, P1, DOI DOI 10.1175/1087-3562(2000)0042.0.CO;2; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	30	2379	2713	62	1130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1560	1563		10.1126/science.1082750	http://dx.doi.org/10.1126/science.1082750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791990				2022-12-01	WOS:000183333100052
J	Prag, G; Misra, S; Jones, EA; Ghirlando, R; Davies, BA; Horazdovsky, BF; Hurley, JH				Prag, G; Misra, S; Jones, EA; Ghirlando, R; Davies, BA; Horazdovsky, BF; Hurley, JH			Mechanism of ubiquitin recognition by the CUE domain of Vps9p	CELL			English	Article							INTERACTING MOTIF; UBA DOMAINS; BINDS UBIQUITIN; PROTEIN; SURFACE; DEGRADATION; PATHWAY; COMPLEX; REPAIR; RECEPTOR	Coupling of ubiquitin conjugation to ER degradation (CUE) domains are similar to50 amino acid monoubiquitin binding motifs found in proteins of trafficking and ubiquitination pathways. The 2.3 Angstrom structure of the Vps9p-CUE domain is a dimeric domain-swapped variant of the ubiquitin binding UBA domain. The 1.7 Angstrom structure of the CUE:ubiquitin complex shows that one CUE dimer binds one ubiquitin molecule. The bound CUE dimer is kinked relative to the unbound CUE dimer and wraps around ubiquitin. The CUE monomer contains two ubiquitin binding surfaces on opposite faces of the molecule that cannot bind simultaneously to a single ubiquitin molecule. Dimerization of the CUE domain allows both surfaces to contact a single ubiquitin molecule, providing a mechanism for high-affinity binding to monoubiquitin.	NIDDKD, Mol Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Mayo Clin & Mayo Fdn, Mayo Clin Canc Ctr, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Mayo Clinic; Mayo Clinic	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	james.hurley@nih.gov	Ghirlando, Rodolfo/A-8880-2009	Misra, Saurav/0000-0002-1385-8554	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55301] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; BONIFACINO JS, 2003, IN PRESS ANN REV BIO; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Burdon MA, 1996, CURR OPIN NEUROL, V9, P16, DOI 10.1097/00019052-199602000-00004; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; DAVIES BA, 2003, VPS9P CUE DOMAIN UBI; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	57	181	184	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2003	113	5					609	620		10.1016/S0092-8674(03)00364-7	http://dx.doi.org/10.1016/S0092-8674(03)00364-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787502	Bronze			2022-12-01	WOS:000183397600011
J	Li, DW; Zhao, R; Lilyestrom, W; Gai, DH; Zhang, RG; DeCaprio, JA; Fanning, E; Jochimiak, A; Szakonyi, G; Chen, XJS				Li, DW; Zhao, R; Lilyestrom, W; Gai, DH; Zhang, RG; DeCaprio, JA; Fanning, E; Jochimiak, A; Szakonyi, G; Chen, XJS			Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen	NATURE			English	Article							LARGE T-ANTIGEN; TEMPERATURE-SENSITIVE MUTANTS; ORIGIN DNA-BINDING; CRYSTAL-STRUCTURE; DOUBLE HEXAMERS; VIRAL ORIGIN; RAS ONCOGENE; IN-VITRO; SIMIAN-VIRUS-40; INITIATION	The oncoprotein large tumour antigen (LTag) is encoded by the DNA tumour virus simian virus 40. LTag transforms cells and induces tumours in animals by altering the functions of tumour suppressors (including pRB and p53) and other key cellular proteins. LTag is also a molecular machine that distorts/melts the replication origin of the viral genome and unwinds duplex DNA. LTag therefore seems to be a functional homologue of the eukaryotic minichromosome maintenance (MCM) complex. Here we present the X-ray structure of a hexameric LTag with DNA helicase activity. The structure identifies the p53-binding surface and reveals the structural basis of hexamerization. The hexamer contains a long, positively charged channel with an unusually large central chamber that binds both single-stranded and double-stranded DNA. The hexamer organizes into two tiers that can potentially rotate relative to each other through connecting alpha-helices to expand/constrict the channel, producing an 'iris' effect that could be used for distorting or melting the origin and unwinding DNA at the replication fork.	Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Argonne Natl Lab, Adv Photon Source, SBC, Argonne, IL 60439 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Vanderbilt Univ, VU Stn B 1634, Nashville, TN 37235 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; United States Department of Energy (DOE); Argonne National Laboratory; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University	Chen, XJS (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA.	xiaojiang.chen@uchsc.edu	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beachy TM, 2002, J VIROL, V76, P3145, DOI 10.1128/JVI.76.7.3145-3157.2002; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Bullock PA, 1997, CRIT REV BIOCHEM MOL, V32, P503, DOI 10.3109/10409239709082001; CAVENDER JF, 1995, J VIROL, V69, P923, DOI 10.1128/JVI.69.2.923-934.1995; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; FARBER JM, 1987, J VIROL, V61, P436, DOI 10.1128/JVI.61.2.436-445.1987; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Joo WS, 1998, MOL CELL BIOL, V18, P2677, DOI 10.1128/MCB.18.5.2677; KIERSTEAD TD, 1993, J VIROL, V67, P1817, DOI 10.1128/JVI.67.4.1817-1829.1993; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; LIN JY, 1991, J VIROL, V65, P6447, DOI 10.1128/JVI.65.12.6447-6453.1991; LIN JY, 1991, J VIROL, V65, P2066, DOI 10.1128/JVI.65.4.2066-2072.1991; LOEBER G, 1989, J VIROL, V63, P94, DOI 10.1128/JVI.63.1.94-100.1989; LOEBER G, 1989, J VIROL, V63, P4426, DOI 10.1128/JVI.63.10.4426-4430.1989; Luo XL, 1996, NAT STRUCT BIOL, V3, P1034, DOI 10.1038/nsb1296-1034; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEDEN KWC, 1989, VIROLOGY, V168, P13, DOI 10.1016/0042-6822(89)90398-X; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; RAY S, 1992, J VIROL, V66, P6509, DOI 10.1128/JVI.66.11.6509-6516.1992; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Simmons DT, 2000, ADV VIRUS RES, V55, P75, DOI 10.1016/S0065-3527(00)55002-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smelkova NV, 1998, J VIROL, V72, P8676, DOI 10.1128/JVI.72.11.8676-8681.1998; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; Valle M, 2000, MOL CELL BIOL, V20, P34, DOI 10.1128/MCB.20.1.34-41.2000; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; Wu CX, 1998, J VIROL, V72, P10256, DOI 10.1128/JVI.72.12.10256-10259.1998; Wu CX, 2001, J VIROL, V75, P2839, DOI 10.1128/JVI.75.6.2839-2847.2001; WUNKIM K, 1990, J VIROL, V64, P2014, DOI 10.1128/JVI.64.5.2014-2020.1990	50	240	247	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2003	423	6939					512	518		10.1038/nature01691	http://dx.doi.org/10.1038/nature01691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774115				2022-12-01	WOS:000183162900036
J	Hsu, AL; Murphy, CT; Kenyon, C				Hsu, AL; Murphy, CT; Kenyon, C			Regulation of aging and age-related disease by DAF-16 and heat-shock factor	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; EXTENDED LIFE; LONGEVITY; LONG; IDENTIFICATION; RESISTANCE; STRESS; MUTANT	The Caenorhabditis elegans transcription factor HSF-1, which regulates the heat-shock response, also influences aging. Reducing hsf-1 activity accelerates tissue aging and shortens life-span, and we show that hsf-1 overexpression extends life-span. We find that HSF-1, like the transcription factor DAF-16, is required for daf-2-insulin/IGF-1 receptor mutations to extend life-span. Our findings suggest this is because HSF-1 and DAF-16 together activate expression of specific genes, including genes encoding small heat-shock proteins, which in turn promote longevity. The small heat-shock proteins also delay the onset of polyglutamine-expansion protein aggregation, suggesting that these proteins couple the normal aging process to this type of age-related disease.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.		Hsu, Ao-Lin Allen/AAX-1856-2020	Hsu, Ao-Lin/0000-0002-2864-3134; Kenyon, Cynthia/0000-0003-3446-2636				Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; Gems D, 1998, GENETICS, V150, P129; GLESE KC, 2002, J BIOL CHEM, V277, P46310; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; MORIMOTO R, COMMUNICATION; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; MURPHY CT, IN PRESS NATURE; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Verbeke P, 2001, CELL BIOL INT, V25, P845, DOI 10.1006/cbir.2001.0789; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	29	1073	1132	5	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1142	1145		10.1126/science.1083701	http://dx.doi.org/10.1126/science.1083701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	678VC	12750521				2022-12-01	WOS:000182886500045
J	Brivanlou, AH; Gage, FH; Jaenisch, R; Jessell, T; Melton, D; Rossant, J				Brivanlou, AH; Gage, FH; Jaenisch, R; Jessell, T; Melton, D; Rossant, J			Setting standards for human embryonic stem cells	SCIENCE			English	Editorial Material							HUMAN BLASTOCYSTS; MOUSE EMBRYOS; IN-VITRO; DIFFERENTIATION; LINES; ESTABLISHMENT; CULTURE; GROWTH		Rockefeller Univ, New York, NY 10021 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Whitehead Inst, Cambridge, MA 02142 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Harvard Univ, Cambridge, MA 02138 USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	Rockefeller University; Salk Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Columbia University; Howard Hughes Medical Institute; Harvard University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Brivanlou, AH (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Lagasse E, 2001, IMMUNITY, V14, P425, DOI 10.1016/S1074-7613(01)00123-6; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MCKAY R, 2002, WORKSH SPONS NEW YOR; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	20	247	272	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					913	+		10.1126/science.1082940	http://dx.doi.org/10.1126/science.1082940			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738841				2022-12-01	WOS:000182719800033
J	Marmottant, P; Hilgenfeldt, S				Marmottant, P; Hilgenfeldt, S			Controlled vesicle deformation and lysis by single oscillating bubbles	NATURE			English	Article							SONOLUMINESCENCE; CAVITATION; ULTRASOUND; SONOPORATION; BOUNDARY; DYNAMICS; FLOW	The ability of collapsing (cavitating) bubbles to focus and concentrate energy, forces and stresses is at the root of phenomena such as cavitation damage, sonochemistry or sonoluminescence(1,2). In a biomedical context, ultrasound-driven microbubbles have been used to enhance contrast in ultrasonic images(3). The observation of bubble-enhanced sonoporation(4-6)-acoustically induced rupture of membranes-has also opened up intriguing possibilities for the therapeutic application of sonoporation as an alternative to cell-wall permeation techniques such as electroporation(7) and particle guns(8). However, these pioneering experiments have not been able to pinpoint the mechanism by which the violently collapsing bubble opens pores or larger holes in membranes. Here we present an experiment in which gentle (linear) bubble oscillations are sufficient to achieve rupture of lipid membranes. In this regime, the bubble dynamics and the ensuing sonoporation can be accurately controlled. The use of microbubbles as focusing agents makes acoustics on the micrometre scale (microacoustics) a viable tool, with possible applications in cell manipulation and cell-wall permeation as well as in microfluidic devices.	Univ Twente, Fac Appl Phys, NL-7500 AE Enschede, Netherlands	University of Twente	Marmottant, P (corresponding author), Univ Twente, Fac Appl Phys, POB 217, NL-7500 AE Enschede, Netherlands.		Marmottant, Philippe/D-6808-2012; Hilgenfeldt, Sascha/A-4593-2014; Hilgenfeldt, Sascha/B-7356-2009	Hilgenfeldt, Sascha/0000-0002-6799-2118; 				BLAKE JR, 1974, J ENG MATH, V8, P23, DOI 10.1007/BF02353701; Boal D., 2002, MECH CELL; Brujan EA, 2001, J FLUID MECH, V433, P251, DOI 10.1017/S0022112000003347; Chang D. C., 1992, GUIDE ELECTROPORATIO; CHANG DC, 1993, ADV ECHO IMAGING USI; DAVIDSON BJ, 1971, J SOUND VIB, V15, P217, DOI 10.1016/0022-460X(71)90536-0; DIMITROV DS, 1987, PROG COLLOID POLYM S, V73, P48; ELDER SA, 1959, J ACOUST SOC AM, V31, P54, DOI 10.1121/1.1907611; Greenleaf WJ, 1998, ULTRASOUND MED BIOL, V24, P587, DOI 10.1016/S0301-5629(98)00003-9; Hilgenfeldt S, 2000, J ACOUST SOC AM, V107, P3530, DOI 10.1121/1.429438; Hilgenfeldt S, 1999, NATURE, V398, P402, DOI 10.1038/18842; Leighton T., 2012, ACOUSTIC BUBBLE; LIGHTHILL J, 1978, J SOUND VIB, V61, P391, DOI 10.1016/0022-460X(78)90388-7; Longuet-Higgins MS, 1998, P ROY SOC A-MATH PHY, V454, P725, DOI 10.1098/rspa.1998.0183; MILLER DL, 1988, J ACOUST SOC AM, V84, P1378, DOI 10.1121/1.396636; MILLER DL, 1979, SCIENCE, V205, P505, DOI 10.1126/science.451616; Miller DL, 2000, ULTRASOUND MED BIOL, V26, P661, DOI 10.1016/S0301-5629(99)00170-2; PLESSET MS, 1977, ANNU REV FLUID MECH, V9, P145, DOI 10.1146/annurev.fl.09.010177.001045; Popinet S, 1999, INT J NUMER METH FL, V30, P775, DOI 10.1002/(SICI)1097-0363(19990730)30:6<775::AID-FLD864>3.0.CO;2-#; Pozrikidis C., 1992, BOUNDARY INTEGRAL SI; Prosperetti A, 1997, J ACOUST SOC AM, V101, P2003, DOI 10.1121/1.418133; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; RILEY N, 1966, Q J MECH APPL MATH, V19, P461, DOI 10.1093/qjmam/19.4.461; ROONEY JA, 1970, SCIENCE, V169, P869, DOI 10.1126/science.169.3948.869; Seifert U, 1999, EUR PHYS J B, V8, P405, DOI 10.1007/s100510050706; SEKI M, 1991, PLANT MOL BIOL, V17, P259, DOI 10.1007/BF00039501; SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Wang ZQ, 1999, PHYS REV E, V59, P1777, DOI 10.1103/PhysRevE.59.1777; Ward M, 2000, ULTRASOUND MED BIOL, V26, P1169, DOI 10.1016/S0301-5629(00)00260-X	30	624	643	10	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					153	156		10.1038/nature01613	http://dx.doi.org/10.1038/nature01613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736680	Bronze			2022-12-01	WOS:000182699600041
J	Palmer, LI				Palmer, LI			The legal and political future of physician-assisted suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OREGON		Univ Louisville, Louisville, KY 40292 USA	University of Louisville	Palmer, LI (corresponding author), Univ Louisville, Louisville, KY 40292 USA.							ASHCROFT J, 2001, COMMUNCIATION   1106; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Steinbrook R, 2002, NEW ENGL J MED, V346, P460, DOI 10.1056/NEJM200202073460624; 2001, FED REG         1109, V66, P56607	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2283	2283		10.1001/jama.289.17.2283	http://dx.doi.org/10.1001/jama.289.17.2283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	675ET	12734144	Bronze, Green Published			2022-12-01	WOS:000182680700035
J	Bingham, SA; Day, NE; Luben, R; Ferrari, P; Slimani, N; Norat, T; Clavel-Chapelon, F; Kesse, E; Nieters, A; Boeing, H; Tjonneland, A; Overvad, K; Martinez, C; Dorronsoro, M; Gonzalez, CA; Key, TJ; Trichopoulou, A; Naska, A; Vineis, P; Tumino, R; Krogh, V; Bueno-de-Mesquita, HB; Peeters, PHM; Berglund, G; Hallmans, G; Lund, E; Skeie, G; Kaaks, R; Riboli, E				Bingham, SA; Day, NE; Luben, R; Ferrari, P; Slimani, N; Norat, T; Clavel-Chapelon, F; Kesse, E; Nieters, A; Boeing, H; Tjonneland, A; Overvad, K; Martinez, C; Dorronsoro, M; Gonzalez, CA; Key, TJ; Trichopoulou, A; Naska, A; Vineis, P; Tumino, R; Krogh, V; Bueno-de-Mesquita, HB; Peeters, PHM; Berglund, G; Hallmans, G; Lund, E; Skeie, G; Kaaks, R; Riboli, E			Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study	LANCET			English	Article							RISK; RECURRENCE; CALIBRATION; VEGETABLES; ADENOMA; COHORT; FRUIT	Background Dietary fibre is thought to protect against colorectal cancer but this view has been challenged by recent prospective and intervention studies that showed no protective effect. Methods We prospectively examined the association between dietary fibre intake and incidence of colorectal cancer in 519 978 individuals aged 25-70 years taking part in the EPIC study, recruited from ten European countries. Participants completed a dietary questionnaire in 1992-98 and were followed up for cancer incidence. Relative risk estimates were obtained from fibre intake, categorised by sex-specific, cohort-wide quintiles, and from linear models relating the hazard ratio to fibre intake expressed as a continuous variable. Findings Follow-up consisted of 1939 011 person-years, and data for 1065 reported cases of colorectal cancer were included in the analysis. Dietary fibre in foods was inversely related to incidence of large bowel cancer (adjusted relative risk 0.75 [95% CI 0.59-0.95] for the highest versus lowest quintile of intake), the protective effect being greatest for the left side of the colon, and least for the rectum. After calibration with more detailed dietary data, the adjusted relative risk for the highest versus lowest quintile of fibre from food intake was 0.58 (0.41-0.85). No food source of fibre was significantly more protective than others, and non-food supplement sources of fibre were not investigated. Interpretation In populations with low average intake of dietary fibre, an approximate doubling of total fibre intake from foods could reduce the risk of colorectal cancer by 40%.	Int Agcy Res Canc, WHO, Unit Nutr & Canc, F-69372 Lyon 08, France; Univ Cambridge, Strangeways Res Lab, Cambridge CB2 1TN, England; MRC, Dunn Human Nutr Unit, Cambridge, England; Inst Gustave Roussy, INSERM, U521, F-94805 Villejuif, France; German Canc Res Ctr, D-6900 Heidelberg, Germany; German Inst Human Nutr, Potsdam, Germany; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; Aalborg Hosp, Dept Clin Epidemiol, Aalborg, Denmark; Univ Aarhus, Dept Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Andalusian Sch Publ Hlth, Granada, Spain; Dept Publ Hlth Guipuzkoa, San Sebastian, Spain; Catalan Inst Oncol, Barcelona, Spain; Radcliffe Infirm, Canc Res UK, Oxford OX2 6HE, England; Univ Athens, Sch Med, GR-10679 Athens, Greece; Univ Turin, Turin, Italy; CPO Piemonte, Turin, Italy; Ragusa Canc Registry, Ragusa, Sicily, Italy; Natl Canc Inst, Dept Epidemiol, I-20133 Milan, Italy; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; Lund Univ, Malmo Diet & Canc Study, Malmo, Sweden; Umea Univ, Dept Nutr Res, S-90187 Umea, Sweden; Univ Tromso, Inst Community Med, N-9001 Tromso, Norway	World Health Organization; International Agency for Research on Cancer (IARC); University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Danish Cancer Society; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Escuela Andaluza de Salud Publica; Catalan Institute of Oncology; Cancer Research UK; Radcliffe Infirmary; Athens Medical School; National & Kapodistrian University of Athens; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; Fondazione IRCCS Istituto Nazionale Tumori Milan; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Lund University; Umea University; UiT The Arctic University of Tromso	Riboli, E (corresponding author), Int Agcy Res Canc, WHO, Unit Nutr & Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	ntr@iarc.fr	Krogh, Vittorio/AAA-9171-2019; Luben, Robert N/H-5519-2015; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Kesse-Guyot, Emmanuelle/K-4689-2012; Kesse-Guyot, Emmanuelle/F-2692-2017; Krogh, Vittorio/K-2628-2016; Clavel-Chapelon, Francoise/G-6733-2014; Kesse-Guyot, Emmanuelle/ABH-7347-2020	Krogh, Vittorio/0000-0003-0122-8624; Luben, Robert N/0000-0002-5088-6343; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Krogh, Vittorio/0000-0003-0122-8624; tumino, rosario/0000-0003-2666-414X; Riboli, Elio/0000-0001-6795-6080; Tjonneland, Anne/0000-0003-4385-2097; Skeie, Guri/0000-0003-2476-4251; Overvad, Kim/0000-0001-6429-7921; Lund, Eiliv/0000-0002-8071-8711				Agudo A, 2002, PUBLIC HEALTH NUTR, V5, P1179, DOI 10.1079/PHN2002398; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; BINGHAM SA, 1990, P NUTR SOC, V49, P153, DOI 10.1079/PNS19900021; BOFFA LC, 1992, CANCER RES, V52, P5906; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; BRESLOW NE, 1987, IARC SCI PUBL, V82; Chai F, 2000, CARCINOGENESIS, V21, P7, DOI 10.1093/carcin/21.1.7; *COMA WORK GROUP D, 1998, 48 UK DEP HLTH COMA; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Deharveng G, 1999, EUR J CLIN NUTR, V53, P60, DOI 10.1038/sj.ejcn.1600677; *DEP HLTH, 1991, 41 UK DEP HLTH; Domon-Dell C, 2002, GUT, V50, P525, DOI 10.1136/gut.50.4.525; Fuchs CS, 1999, NEW ENGL J MED, V340, P169, DOI 10.1056/NEJM199901213400301; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; KAAKS R, 1995, AM J EPIDEMIOL, V142, P548, DOI 10.1093/oxfordjournals.aje.a117673; Key TJ, 1998, PUBLIC HEALTH NUTR, V1, P33, DOI 10.1079/PHN19980006; Kipnis V, 2001, AM J EPIDEMIOL, V153, P394, DOI 10.1093/aje/153.4.394; MCNEIL NI, 1981, DIS COLON RECTUM, V24, P596, DOI 10.1007/BF02605753; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rosner B, 2001, AM J EPIDEMIOL, V154, P827, DOI 10.1093/aje/154.9.827; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; WCRF/AICR, 1997, FOOD NUTR PREV CANC; Wirfalt E, 2002, PUBLIC HEALTH NUTR, V5, P1197, DOI 10.1079/PHN2002399	28	750	803	3	140	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2003	361	9368					1496	1501		10.1016/S0140-6736(03)13174-1	http://dx.doi.org/10.1016/S0140-6736(03)13174-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737858				2022-12-01	WOS:000182658900007
J	Cassman, M				Cassman, M			Counting on the neuron	SCIENCE			English	Editorial Material									Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94131 USA	University of California System; University of California San Francisco	Cassman, M (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94131 USA.	mcassman@research.ucsf.edu						[Anonymous], 2002, NATURE, V420, P703; *NY AC SCI, 2002, COMP MOD MAMM CELL N; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; NATL RESOURCE CELL A	4	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					756	757		10.1126/science.1082371	http://dx.doi.org/10.1126/science.1082371			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730591				2022-12-01	WOS:000182579800037
J	Spitz, F; Gonzalez, F; Duboule, D				Spitz, F; Gonzalez, F; Duboule, D			A global control region defines a chromosomal regulatory landscape containing the HoxD cluster	CELL			English	Article							GENE-EXPRESSION; TRANSGENIC ANALYSIS; SONIC-HEDGEHOG; LIMB BUD; COMPLEX; MOUSE; SEQUENCE; ULNALESS; DNA; GENOME	During limb development, coordinated expression of several Hoxd genes is required in presumptive digits. We searched for the underlying control sequences upstream from the cluster and found Lunapark (Lnp), a gene which shares limb and CNS expression specificities with both Hoxd genes and Evx2, another gene located nearby. We used a targeted enhancer-trap approach to identify a DNA segment capable of directing reporter gene expression in both digits and CNS, following Lnp, Evx2, and Hoxd-specific patterns. This DNA region showed an unusual interspecies conservation, including with its pufferfish counterpart. It contains a cluster of global enhancers capable of controlling transcription of several genes unrelated in structure or function, thus defining large regulatory domains. These domains were interrupted in the Ulna-less mutation, a balanced inversion that modified the topography of the locus. We discuss the heuristic value of these results in term of locus specific versus gene-specific regulation.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.			Gonzalez Grassi, Federico/0000-0002-7147-2246; duboule, denis/0000-0001-9961-2960; Spitz, Francois/0000-0002-1960-829X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Becker M, 1998, COMPUT PHYS, V12, P125; Beckers J, 1998, DEV DYNAM, V213, P1; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Carvajal JJ, 2001, DEVELOPMENT, V128, P1857; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DAVISSON MT, 1990, J HERED, V81, P151; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; DOLLE P, 1994, DEVELOPMENT, P143; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; GERARD M, 1993, EMBO J, V12, P3539, DOI 10.1002/j.1460-2075.1993.tb06028.x; Goodman FR, 2002, AM J HUM GENET, V70, P547, DOI 10.1086/338921; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Herault Y, 1997, DEVELOPMENT, V124, P3493; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Herault Y, 1996, EMBO J, V15, P6727, DOI 10.1002/j.1460-2075.1996.tb01062.x; JIN JR, 1995, DNA CELL BIOL, V14, P267, DOI 10.1089/dna.1995.14.267; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Monge I, 2003, DEV BIOL, V256, P212, DOI 10.1016/S0012-1606(02)00136-7; Morgan BA, 1996, P NATL ACAD SCI USA, V93, P2801, DOI 10.1073/pnas.93.7.2801; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Oliver Brian, 2002, J Biol, V1, P4; Orford M, 2000, Nucleic Acids Res, V28, pE84, DOI 10.1093/nar/28.18.e84; Peichel CL, 1997, DEVELOPMENT, V124, P3481; Peichel CL, 1996, GENETICS, V144, P1757; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIJL, 1997, CURR OPIN GENET DEV, V7, P481; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Zakany J, 1999, NATURE, V401, P761, DOI 10.1038/44511; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	55	358	373	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 2	2003	113	3					405	417		10.1016/S0092-8674(03)00310-6	http://dx.doi.org/10.1016/S0092-8674(03)00310-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732147	Bronze			2022-12-01	WOS:000182640800014
J	Taylor, JRA; Kier, WM				Taylor, JRA; Kier, WM			Switching skeletons: Hydrostatic support in molting crabs	SCIENCE			English	Article							HOMARUS-AMERICANUS; CYCLE; CRUSTACEAN; LOBSTER; MUSCLE; BEHAVIOR	Skeletal support systems are essential for support, movement, muscular antagonism, and locomotion. Crustaceans shed their rigid exoskeleton at each molt yet are still capable of forceful movement. We hypothesize that the soft water-inflated body of newly molted crabs may rely on a hydrostatic skeleton, similar to that of worms and polyps. We measured internal hydrostatic pressure and the force exerted during claw adduction and observed a strong correlation between force and hydrostatic pressure, consistent with hydrostatic skeletal support. This alternation between the two basic skeletal types may be widespread among arthropods.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Taylor, JRA (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							ADAMS ES, 1990, ANIM BEHAV, V39, P706, DOI 10.1016/S0003-3472(05)80382-3; Alexander R., 1983, ANIMAL MECH; CHAPMAN G, 1975, J EXP ZOOL, V194, P249, DOI 10.1002/jez.1401940118; CHAPMAN G, 1958, BIOL REV, V33, P338, DOI 10.1111/j.1469-185X.1958.tb01260.x; Clark R. B., 1964, DYNAMICS METAZOAN EV; CLARK RB, 1958, J EXP BIOL, V35, P731; CROMARTY SI, 1991, J EXP BIOL, V158, P565; Drach P., 1939, Ann Inst oceanogr Paris, V19, P103; GUTMANN WF, 1981, AM ZOOL, V21, P63; HARRIS JE, 1957, J EXP BIOL, V34, P116; Kelly DA, 1999, J EXP BIOL, V202, P253; LIPCIUS RN, 1982, MAR BIOL, V68, P241, DOI 10.1007/BF00409591; MYKLES DL, 1981, J ULTRA MOL STRUCT R, V75, P314, DOI 10.1016/S0022-5320(81)80088-3; MYKLES DL, 1980, J EXP BIOL, V84, P89; Olmsted JMD, 1923, J MORPHOL, V38, P279, DOI 10.1002/jmor.1050380203; Passano LM, 1960, PHYSIOL CRUSTACEA, V1, P472, DOI DOI 10.1016/B978-0-12-395628-6.50021-X; REAKA ML, 1975, J MORPHOL, V146, P55, DOI 10.1002/jmor.1051460104; Ryer CH, 1997, MAR ECOL PROG SER, V147, P77, DOI 10.3354/meps147077; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; SHAFER GD, 1923, STANFORD U PUBL, V3, P303; SKINNER D M, 1985, P43; SKINNER DM, 1966, J EXP ZOOL, V163, P115, DOI 10.1002/jez.1401630202; SMITH KK, 1989, AM SCI, V77, P29; STEGER R, 1983, SCIENCE, V221, P558, DOI 10.1126/science.221.4610.558; TAMM GR, 1978, SCIENCE, V200, P79, DOI 10.1126/science.200.4337.79; TAYLOR JD, UNPUB; TRAVIS DF, 1954, BIOL BULL, V107, P433, DOI 10.2307/1538591; Trueman E. R., 1975, LOCOMOTION SOFT BODI; Wainwright SA., 1982, COMPANION ANIMAL PHY, P325; Wainwright SA, 1982, MECH DESIGN ORGANISM	30	42	42	4	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					209	210		10.1126/science.1085987	http://dx.doi.org/10.1126/science.1085987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855806				2022-12-01	WOS:000184056200041
J	Gregg, JW; Jones, CG; Dawson, TE				Gregg, JW; Jones, CG; Dawson, TE			Urbanization effects on tree growth in the vicinity of New York City	NATURE			English	Article							ATMOSPHERIC DEPOSITION; RURAL GRADIENT; URBAN; OZONE; POPULUS; FORESTS; AREAS; CO2	Plants in urban ecosystems are exposed to many pollutants and higher temperatures, CO2 and nitrogen deposition than plants in rural areas(1-5). Although each factor has a detrimental or beneficial influence on plant growth(6), the net effect of all factors and the key driving variables are unknown. We grew the same cottonwood clone in urban and rural sites and found that urban plant biomass was double that of rural sites. Using soil transplants, nutrient budgets, chamber experiments and multiple regression analyses, we show that soils, temperature, CO2, nutrient deposition, urban air pollutants and microclimatic variables could not account for increased growth in the city. Rather, higher rural ozone (O-3) exposures reduced growth at rural sites. Urban precursors fuel the reactions of O-3 formation, but NOx scavenging reactions(7) resulted in lower cumulative urban O-3 exposures compared to agricultural and forested sites throughout the northeastern USA. Our study shows the overriding effect of O-3 despite a diversity of altered environmental factors, reveals 'footprints' of lower cumulative urban O-3 exposures amidst a background of higher regional exposures, and shows a greater adverse effect of urban pollutant emissions beyond the urban core.	Cornell Univ, Ithaca, NY 14853 USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA	Cornell University; Cary Institute of Ecosystem Studies	Gregg, JW (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.		Jones, Clive G/I-4603-2014	Jones, Clive G/0000-0001-7630-7285				COLEMAN JS, 1988, OECOLOGIA, V76, P57, DOI 10.1007/BF00379600; *FED LAND MAN AIR, 2000, PHAS 1 REP; Freedman B., 1995, ENV ECOLOGY ECOLOGIC; GATZ DF, 1991, ATMOS ENVIRON B-URB, V25, P1, DOI 10.1016/0957-1272(91)90036-E; GOLDMAN MB, 1995, SOIL BIOL BIOCHEM, V27, P281, DOI 10.1016/0038-0717(94)00185-4; GREGG JW, 1999, THESIS CORNELL U; *I EC STUD, 2002, ENV MON PROGR; Idso CD, 2001, ATMOS ENVIRON, V35, P995, DOI 10.1016/S1352-2310(00)00412-X; ISAKSEN ISA, 1978, ENVIRON SCI TECHNOL, V12, P1279, DOI 10.1021/es60147a011; Jacovides CP, 1997, AGR FOREST METEOROL, V87, P91, DOI 10.1016/S0168-1923(97)00031-2; Jones H, 1996, PLANTS MICROCLIMATE; LEFOHN AS, 1987, JAPCA J AIR WASTE MA, V37, P595, DOI 10.1080/08940630.1987.10466247; Lovett GM, 2000, ENVIRON SCI TECHNOL, V34, P4294, DOI 10.1021/es001077q; LOVETT GM, 1993, CAN J FOREST RES, V23, P1603, DOI 10.1139/x93-200; MAGNUSSEN S, 1985, Forest Tree Improvement, P1; Mooney HA, 1991, RESPONSE PLANTS MULT; *NEW YORK STAT DEP, 1995, DAR951 NYS DEC; PETERSON JT, 1969, NAPCA PUB; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Potvin C, 1988, FUNCT ECOL, V2, P123, DOI 10.2307/2389472; POUYAT RV, 1995, J ENVIRON QUAL, V24, P516, DOI 10.2134/jeq1995.00472425002400030019x; *US NAT RES COUNC, 1992, RETH OZ PROBL URB RE; *USDA FOR SERV, 1980, A134224C82 USDA FOR; *USDA FOR SERV FIA, 2002, FIELD METH PHAS 3 ME; Wait DA, 1999, OECOLOGIA, V121, P193, DOI 10.1007/s004420050921; Wait DA, 1996, TREE PHYSIOL, V16, P359; WEINSTEIN LH, 1990, USE NATIVE CULTIVATE, P117; Yun SC, 1999, NEW PHYTOL, V141, P411, DOI 10.1046/j.1469-8137.1999.00359.x; [No title captured]	29	272	306	17	254	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					183	187		10.1038/nature01728	http://dx.doi.org/10.1038/nature01728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853954				2022-12-01	WOS:000184032700039
J	Chew, MK; Laubichler, MD				Chew, MK; Laubichler, MD			Natural enemies - Metaphor or misconception?	SCIENCE			English	Editorial Material									Arizona State Univ, Sch Life Sci, Biol & Soc Program, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Laubichler, MD (corresponding author), Arizona State Univ, Sch Life Sci, Biol & Soc Program, Tempe, AZ 85287 USA.							Baumer A., 1990, NS BIOL; Huslin Anita, 2002, WASHINGTON POST 0723, pB03; Johnson M, 1980, METAPHORS WE LIVE; Kevles D., 1985, NAME EUGENICS; Lewontin R. C., 1984, NOT IN OUR GENES; Paul D. B., 1995, CONTROLLING HUMAN HE; Weindling P., 1989, HLTH RACE GERMAN POL; 1935, HORNADAYS AM NATURAL; 2002, NATURE, V418, P267; 2002, SCIENCE, V297, P2175	10	69	69	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					52	53		10.1126/science.1085274	http://dx.doi.org/10.1126/science.1085274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12846231				2022-12-01	WOS:000183914700024
J	Polesskaya, A; Seale, P; Rudnicki, MA				Polesskaya, A; Seale, P; Rudnicki, MA			Wnt signaling induces the myogenic specification of resident CD45(+) adult stem cells during muscle regeneration	CELL			English	Article							MURINE SKELETAL-MUSCLE; PARAXIAL MESODERM; PROGENITOR CELLS; SATELLITE CELLS; SONIC HEDGEHOG; BETA-CATENIN; IN-VITRO; EXPRESSION; MYOD; PATHWAY	The observation that CD45(+) stem cells injected into the circulation participate in muscle regeneration raised the question of whether CD45(+) stem cells resident in muscle play a physiological role during regeneration. We found that CD45(+) cells cultured from uninjured muscle were uniformly nonmyogenic. However, CD45(+) cells purified from regenerating muscle readily gave rise to determined myoblasts. The number of CD45(+) cells in muscle rapidly expanded following injury, and a high proportion entered the cell cycle. Investigation of candidate pathways involved in embryonic myogenesis revealed that Wnt signaling was sufficient to induce the myogenic specification of muscle-derived CD45(+) stem cells. Moreover, injection of the Wnt antagonists sFRP2/3 into regenerating muscle markedly reduced CD45(+) stem cell proliferation and myogenic specification. Our data therefore suggest that mobilization of resident CD45(+) stem cells is an important factor in regeneration after injury and highlight the Wnt pathway as a potential therapeutic target for degenerative neuromuscular disease.	Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	University of Ottawa; Ottawa Hospital Research Institute; McMaster University	Rudnicki, MA (corresponding author), Ottawa Hlth Res Inst, Program Mol Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.			Rudnicki, Michael/0000-0002-3866-5249				Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Baranski M, 2000, DEV BIOL, V217, P25, DOI 10.1006/dbio.1999.9516; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Borello U, 1999, DEVELOPMENT, V126, P4247; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Davies JA, 2002, EXP NEPHROL, V10, P102; Dell'Agnola C, 2002, EXP HEMATOL, V30, P905, DOI 10.1016/S0301-472X(02)00866-4; Dennis S, 1999, J CELL SCI, V112, P3815; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Heslop L, 2000, J CELL SCI, V113, P2299; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Howell JC, 2002, EXP HEMATOL, V30, P915, DOI 10.1016/S0301-472X(02)00872-X; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kablar B, 1997, DEVELOPMENT, V124, P4729; KOPAN R, 1994, DEVELOPMENT, V120, P2385; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Labus Marie B., 1998, Wound Repair and Regeneration, V6, P58, DOI 10.1046/j.1524-475X.1998.60109.x; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6; Levin JM, 2001, J MUSCLE RES CELL M, V22, P361, DOI 10.1023/A:1013129209062; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Mahmud N, 2002, EXP HEMATOL, V30, P925, DOI 10.1016/S0301-472X(02)00863-9; Malik TH, 2000, BIOCHEM J, V349, P829, DOI 10.1042/bj3490829; Marcelle C, 1997, DEVELOPMENT, V124, P3955; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Pagel CN, 1999, J NEUROL SCI, V164, P103, DOI 10.1016/S0022-510X(99)00061-1; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Reshef R, 1998, GENE DEV, V12, P290, DOI 10.1101/gad.12.3.290; Romero-Ramos M, 2002, J NEUROSCI RES, V69, P894, DOI 10.1002/jnr.10374; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sasaki T, 2001, INT J BIOCHEM CELL B, V33, P1041, DOI 10.1016/S1357-2725(01)00075-9; Schmidt M, 2000, DEVELOPMENT, V127, P4105; SCHULTZ E, 1986, J MUSCLE RES CELL M, V7, P361, DOI 10.1007/BF01753657; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Tajbakhsh S, 1995, DEVELOPMENT, V121, P4077; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Vainio SJ, 2000, PEDIATR NEPHROL, V15, P151, DOI 10.1007/s004670000404; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200	59	389	415	0	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 27	2003	113	7					841	852		10.1016/S0092-8674(03)00437-9	http://dx.doi.org/10.1016/S0092-8674(03)00437-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837243	Bronze			2022-12-01	WOS:000183817900009
J	Caulfield, M; Munroe, P; Pembroke, J; Samani, N; Dominiczak, A; Brown, M; Benjamin, N; Webster, J; Ratcliffe, P; O'Shea, S; Papp, J; Taylor, E; Dobson, R; Knight, J; Newhouse, S; Hooper, J; Lee, W; Brain, N; Clayton, D; Lathrop, GM; Farrall, M; Connell, J				Caulfield, M; Munroe, P; Pembroke, J; Samani, N; Dominiczak, A; Brown, M; Benjamin, N; Webster, J; Ratcliffe, P; O'Shea, S; Papp, J; Taylor, E; Dobson, R; Knight, J; Newhouse, S; Hooper, J; Lee, W; Brain, N; Clayton, D; Lathrop, GM; Farrall, M; Connell, J		MRC Brit Genetics Hypertension Stu	Genome-wide mapping of human loci for essential hypertension	LANCET			English	Article							SIB-PAIR LINKAGE; MATERNAL SUSCEPTIBILITY LOCUS; BLOOD-PRESSURE; COMPLEX TRAITS; SCANS; PREECLAMPSIA; CHROMOSOME-2	Background Blood pressure may contribute to 50% of the global cardiovascular disease epidemic. By understanding the genes predisposing to common disorders such as human essential hypertension we may gain insights into novel pathophysiological mechanisms and potential therapeutic targets. In the Medical Research Council BRItish Genetics of HyperTension (BRIGHT) study, we aim to identify these genetic factors by scanning the human genome for susceptibility genes for essential hypertension. We describe the results of a genome scan for hypertension in a large white European population. Methods We phenotyped 2010 affected sibling pairs drawn from 1599 severely hypertensive families, and completed a 10 centimorgan genome-wide scan. After rigorous quality control, we analysed the genotypic data by non-parametric linkage, which tests whether genes are shared in excess among the affected sibling pairs. Lod scores, calculated at regular points along each chromosome, were used to assess the support for linkage, Findings Linkage analysis identified a principle locus on chromosome 6q, with a lod score of 3.21 that attained genome-wide significance (p=0.042). The inclusion of three further loci with lod scores higher than 1.57 (2q, 5q, and 9q) also show genome-wide significance (p=0.017) when assessed under a locus-counting analysis. Interpretation These findings imply that human essential hypertension has an oligogenic element (a few genes may be involved in determination of the trait) possibly superimposed on more minor genetic effects, and that several genes may be tractable to a positional cloning strategy.	Queen Marys Sch Med, Barts & London, William Harvey Res Inst, Barts & London Genome Ctr, London EC1M 6BQ, England; Univ Leicester, Glenfield Hosp, Leicester, Leics, England; Univ Glasgow, Western Infirm, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; Aberdeen Royal Infirm, Aberdeen, Scotland; Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Clin Med, Oxford, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Ctr Natl Genotypage, Evry, France	University of London; Queen Mary University London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Aberdeen; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CEA; UDICE-French Research Universities; Universite Paris Saclay	Caulfield, M (corresponding author), Queen Marys Sch Med, Barts & London, William Harvey Res Inst, Barts & London Genome Ctr, Charterhouse Sq, London EC1M 6BQ, England.		Newhouse, Stephen J/C-9330-2011; Dominiczak, Anna F/D-2262-2009; Brown, Matthew A/E-5749-2010; Dobson, Richard j/C-9269-2011; Dominiczak, Anna F/P-9390-2017; Knight, Jo/F-4946-2011	Newhouse, Stephen J/0000-0002-1843-9842; Brown, Matthew A/0000-0003-0538-8211; Dobson, Richard j/0000-0003-4224-9245; Dominiczak, Anna F/0000-0003-4913-3608; Munroe, Patricia/0000-0002-4176-2947; Knight, Joanne/0000-0002-7148-1660; Ratcliffe, Peter/0000-0002-2853-806X; Caulfield, Mark/0000-0001-9295-3594; Lee, Wai Kwong/0000-0001-8560-8063				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Holmans P, 2002, HUM HERED, V53, P92, DOI 10.1159/000057987; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; Hunt SC, 2002, HYPERTENSION, V40, P1, DOI 10.1161/01.HYP.0000022660.28915.B1; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kardia SLR, 2003, AM J HYPERTENS, V16, P154, DOI 10.1016/S0895-7061(02)03249-1; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; Leal SM, 2000, AM J HUM GENET, V66, P567, DOI 10.1086/302748; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Luft FC, 2001, HYPERTENSION, V37, P350, DOI 10.1161/01.HYP.37.2.350; Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Province MA, 2003, AM J HYPERTENS, V16, P144, DOI 10.1016/S0895-7061(02)03248-X; Ranade K, 2003, AM J HYPERTENS, V16, P158, DOI 10.1016/S0895-7061(02)03245-4; Rao DC, 2003, AM J HYPERTENS, V16, P148, DOI 10.1016/S0895-7061(02)03247-8; Rice JP, 1999, GENET EPIDEMIOL, V17, pS691; RISCH N, 1990, AM J HUM GENET, V46, P229; Samani NJ, 2003, AM J HYPERTENS, V16, P167, DOI 10.1016/S0895-7061(02)03244-2; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Zhu DL, 2001, J HYPERTENS, V19, P55, DOI 10.1097/00004872-200101000-00008	27	208	214	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 21	2003	361	9375					2118	2123		10.1016/S0140-6736(03)13722-1	http://dx.doi.org/10.1016/S0140-6736(03)13722-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	692GY	12826435				2022-12-01	WOS:000183654200011
J	Irwig, L				Irwig, L			'This added to my multiple myopia'	BRITISH MEDICAL JOURNAL			English	Article									Univ Sydney, Sch Publ Hlth, Ecreening & Test Evaluat Program, Sydney, NSW 2006, Australia	University of Sydney	Irwig, L (corresponding author), Univ Sydney, Sch Publ Hlth, Ecreening & Test Evaluat Program, Sydney, NSW 2006, Australia.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1336	1336		10.1136/bmj.326.7402.1336	http://dx.doi.org/10.1136/bmj.326.7402.1336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805196	Green Published			2022-12-01	WOS:000183626500061
J	Bailes, E; Gao, F; Bibollet-Ruche, F; Courgnaud, V; Peeters, M; Marx, PA; Hahn, BH; Sharp, PM				Bailes, E; Gao, F; Bibollet-Ruche, F; Courgnaud, V; Peeters, M; Marx, PA; Hahn, BH; Sharp, PM			Hybrid origin of SIV in chimpanzees	SCIENCE			English	Article							TROGLODYTES		Univ Nottingham, Nottingham NG7 2UH, England; Univ Alabama, Birmingham, AL 35294 USA; Duke Univ, Durham, NC 27710 USA; Univ Montpellier 1, F-34032 Montpellier 1, France; Tulane Natl Primate Res Ctr, Covington, LA 70433 USA	University of Nottingham; University of Alabama System; University of Alabama Birmingham; Duke University; Universite de Montpellier; Tulane University	Sharp, PM (corresponding author), Univ Nottingham, Nottingham NG7 2UH, England.	paul@evol.nott.ac.uk	Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010; Sharp, Paul/Y-3787-2019	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Hahn, Beatrice/0000-0002-9400-9887	NIAID NIH HHS [N01 AI85338, R01 AI50529, R01 AI44596] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085338, R01AI044596, R01AI050529] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beer BE, 2001, J VIROL, V75, P12014, DOI 10.1128/JVI.75.24.12014-12027.2001; Courgnaud V, 2002, J VIROL, V76, P8298, DOI 10.1128/JVI.76.16.8298-8309.2002; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465	6	270	276	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1713	1713		10.1126/science.1080657	http://dx.doi.org/10.1126/science.1080657			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805540				2022-12-01	WOS:000183459700041
J	Burt, D; Pourquie, O				Burt, D; Pourquie, O			Chicken genome - Science nuggets to come soon	SCIENCE			English	Editorial Material									Roslin Inst Edinburgh, Roslin EH25 9PS, Midlothian, Scotland; Stowers Inst Med Res, Kansas City, MO 64110 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Stowers Institute for Medical Research	Burt, D (corresponding author), Roslin Inst Edinburgh, Roslin EH25 9PS, Midlothian, Scotland.	dave.burt@bbsrc.ac.uk; OLP@Stowers-Institute.org	Burt, David W/C-7802-2013; Pourquié, Olivier/CAJ-5443-2022	Burt, David W/0000-0002-9991-1028; Pourquié, Olivier/0000-0001-5189-1227				Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Burt DW, 2003, MOL VIS, V9, P164; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; de Koning DJ, 2003, J ANIM SCI, V81, P1158; Hu J, 2001, NUCLEIC ACIDS RES, V29, P106, DOI 10.1093/nar/29.1.106; HUBBARD S, COMMUNICATION; MCPHERSON J, COMMUNICATION; Morisson M, 2002, GENET SEL EVOL, V34, P521, DOI [10.1051/gse:2002021, 10.1186/1297-9686-34-4-521]; Neiman PE, 2003, ONCOGENE, V22, P1073, DOI 10.1038/sj.onc.1206070; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; Schmid M, 2000, CYTOGENET CELL GENET, V90, P169, DOI 10.1159/000056772; WILSON S, COMMUNICATION	12	41	44	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1669	1669		10.1126/science.1086231	http://dx.doi.org/10.1126/science.1086231			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805524	Green Submitted			2022-12-01	WOS:000183459700025
J	Nishii, I; Ogihara, S; Kirk, DL				Nishii, I; Ogihara, S; Kirk, DL			A kinesin, InvA, plays an essential role in Volvox morphogenesis	CELL			English	Article							CYTOPLASMIC BRIDGE SYSTEM; PROTEIN; CARTERI; INVERSION; PATTERNS; DIFFERENTIATION; MECHANISMS; ENCODES; CELLS; LIGHT	In Volvox carted adults, reproductive cells called gonidia are enclosed within a spherical monolayer of biflagellate somatic cells. Embryos must "invert" (turn inside out) to achieve this configuration, however, because at the end of cleavage the gonidia are on the outside and the flagellar ends of all somatic cells point inward. Generation of a bend region adequate to turn the embryo inside out involves a dramatic change in cell shape, plus cell movements. Here, we cloned a gene called invA that is essential for inversion and found that it codes for a kinesin localized in the cytoplasmic bridges that link all cells to their neighbors. In invA null mutants, cells change shape normally, but are unable to move relative to the cytoplasmic bridges. A normal bend region cannot be formed and inversion stops. We conclude that the InvA kinesin provides the motile force that normally drives inversion to completion.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 560, Japan	Washington University (WUSTL); Osaka University	Kirk, DL (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	kirk@biology.wustl.edu						ADAMS CR, 1990, CURR GENET, V18, P141, DOI 10.1007/BF00312602; Asamiziu E, 2000, DNA RES, V7, P305, DOI 10.1093/dnares/7.5.305; GREEN KJ, 1981, J CELL BIOL, V91, P743, DOI 10.1083/jcb.91.3.743; GREEN KJ, 1981, J CELL BIOL, V91, P756, DOI 10.1083/jcb.91.3.756; Hallmann A, 2000, J CELL SCI, V113, P4605; Hasson T, 2001, CURR OPIN CELL BIOL, V13, P29, DOI 10.1016/S0955-0674(00)00170-8; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; KELLAND JL, 1977, J PHYCOL, V13, P373, DOI 10.1111/j.0022-3646.1977.00373.x; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; KIRK DL, 1983, DEV BIOL, V96, P493, DOI 10.1016/0012-1606(83)90186-0; Kirk DL, 2001, DEV GROWTH DIFFER, V43, P621; Kirk DL, 1982, DEV ORDER ITS ORIGIN, P247; Kirk DL, 1998, VOLVOX MOL GENETIC O, V33, P275; Kirk MM, 1999, DEVELOPMENT, V126, P639; KIRK MM, 1985, CELL, V41, P419, DOI 10.1016/S0092-8674(85)80015-5; KUSCHAKEWITSCH S, 1923, B ACAD SC OUKRAINE, V1, P32; MILLER SM, 1993, PLANT CELL, V5, P1125, DOI 10.1105/tpc.5.9.1125; Miller SM, 1999, DEVELOPMENT, V126, P649; Nishii I, 1999, DEVELOPMENT, V126, P2117; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Sambrook JF., 2001, MOL CLONING LAB MANU; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; SESSOMS AH, 1973, P NATL ACAD SCI USA, V70, P1335, DOI 10.1073/pnas.70.5.1335; Starr R C, 1970, Symp Soc Dev Biol, V29, P59; Starr R. C., 1969, Archiv fuer Protistenkunde, V111, P204; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; TAM LW, 1991, DEVELOPMENT, V112, P571; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIAMONTES GI, 1977, J CELL BIOL, V75, P719, DOI 10.1083/jcb.75.3.719; VIAMONTES GI, 1979, CELL, V17, P537, DOI 10.1016/0092-8674(79)90262-9	31	53	55	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2003	113	6					743	753		10.1016/S0092-8674(03)00431-8	http://dx.doi.org/10.1016/S0092-8674(03)00431-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809605	Bronze			2022-12-01	WOS:000183514400009
J	Luck, S; Torny, M; d'Agapeyeff, K; Pitt, A; Heath, P; Breathnach, A; Russell, AB				Luck, S; Torny, M; d'Agapeyeff, K; Pitt, A; Heath, P; Breathnach, A; Russell, AB			Estimated early-onset group B streptococcal neonatal disease	LANCET			English	Article							INFECTION	Estimates of incidence of early-onset group B streptococcal (EOGBS) infection are based on blood or cerebrospinal fluid culture-proven cases, which can be falsely negative and hence underestimate the true burden of disease. Probable EOGBS infection can be defined as colonisation by group B streptococci accompanied by features of clinical sepsis. Data collected prospectively in the UK over 1 year for neonates who required a septic screen in the first 72 h of life indicated a combined rate of definite and probable EOGBS infection of 3.6 per 1000 livebirths. This estimate Indicates a much greater disease burden in the UK than that suggested by figures of culture-proven sepsis, and lends support to the need for prevention strategies.	Univ London St Georges Hosp, London, England	St Georges University London	Russell, AB (corresponding author), Chelsea & Westminster Hosp, Dept Neonatol, 369 Fulham Rd, London SW10 9NH, England.			Heath, Paul/0000-0002-7540-7433				Ahmet Z, 1999, MOL CELL PROBE, V13, P349, DOI 10.1006/mcpr.1999.0262; Beardsall K, 2001, ARCH DIS CHILD-FETAL, V84, pF77; Nicoll A, 2000, ARCH DIS CHILD-FETAL, V82, pF207; Russell ARB, 2001, ARCH DIS CHILD-FETAL, V84, pF140, DOI 10.1136/fn.84.2.F140b; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103	5	93	99	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1953	1954		10.1016/S0140-6736(03)13553-2	http://dx.doi.org/10.1016/S0140-6736(03)13553-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801740				2022-12-01	WOS:000183359700012
J	Wolffers, I; van Beelen, N				Wolffers, I; van Beelen, N			Public health and the human rights of sex workers	LANCET			English	Editorial Material							WOMEN		Free Univ Amsterdam, Med Ctr, Dept Hlth Care & Culture, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Wolffers, I (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Hlth Care & Culture, NL-1081 BT Amsterdam, Netherlands.	wolffers.social@med.vu.nl						Ahmad K, 2001, LANCET, V358, P643, DOI 10.1016/S0140-6736(01)05819-6; Day S, 1997, GENITOURIN MED, V73, P161; Liao SS, 2003, AIDS EDUC PREV, V15, P109, DOI 10.1521/aeap.15.3.109.23834; Nairne D, 2000, RES SEX WORK, V3, P3; Sacks V, 1996, SOC SCI MED, V42, P59, DOI 10.1016/0277-9536(95)00079-8; THOMPSON N, 2003, BOSTON GLOBE    0105; Vanwesenbeeck I, 2002, ANN REV SEX RES, V12, P242; Wawer MJ, 1996, SOC SCI MED, V42, P453, DOI 10.1016/0277-9536(95)00150-6	8	38	39	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2003	361	9373					1981	1981		10.1016/S0140-6736(03)13594-5	http://dx.doi.org/10.1016/S0140-6736(03)13594-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	687DB	12801755				2022-12-01	WOS:000183359700026
J	Dalton, R				Dalton, R			Legal row looms for gene-map firm	NATURE			English	News Item																		2001, NATURE, V412, P105	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					470	470		10.1038/423470b	http://dx.doi.org/10.1038/423470b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774085	Bronze			2022-12-01	WOS:000183162900010
J	Groet, J; McElwaine, S; Spinelli, M; Rinaldi, A; Burtscher, I; Mulligan, C; Mensah, A; Cavani, S; Dagna-Bricarelli, F; Basso, G; Cotter, FE; Nizetic, D				Groet, J; McElwaine, S; Spinelli, M; Rinaldi, A; Burtscher, I; Mulligan, C; Mensah, A; Cavani, S; Dagna-Bricarelli, F; Basso, G; Cotter, FE; Nizetic, D			Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder	LANCET			English	Editorial Material							LEUKEMIA	Transient myeloid disorder Is a unique self-regressing neoplasia specific to Down's syndrome. The transcription factor GATA1 is needed for normal growth and maturation of erythroid cells and megakaryocytes. Mutations in GATA1 have been reported in acute megakaryoblastic leukaemia In Down's syndrome. We aimed to investigate changes in GATA1 in patients with Down's syndrome and either transient myeloid disorder (n=10) or acute megakaryoblastic leukaemia (n=6). We recorded mutations eliminating exon 2 from GATA1 In all patients with transient myeloid disorder (age 0-24 days) and In all with acute megakaryoblastic leukaemia (age 14-38 months). The range of mutations did not differ between patients with each disorder. Patients with transient myeloid disorder with mutations in GATA1 can regress spontaneously to complete remission, and mutations do not necessarily predict later acute megakaryoblastic leukaemia.	Univ London, Queen Marys Sch Med, St Bartholomews & Royal London Hosp, Dept Haematol, London E1 2AD, England; Univ Padua, Fac Med, Dept Pediat, Italian Natl Assoc Pediat Haematooncol, Padua, Italy; Galliera Hosp, Inst Human Genet, Genoa, Italy	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Padua; Ente Ospedaliero Ospedali Galliera	Nizetic, D (corresponding author), Univ London, Queen Marys Sch Med, St Bartholomews & Royal London Hosp, Dept Haematol, Med Coll Bldg,Turner St, London E1 2AD, England.		Nizetic, Dean/F-9509-2015	Mensah, Afua Adjeiwaa/0000-0001-8113-3689; BASSO, GIUSEPPE/0000-0002-2634-9302; Nizetic, Dean/0000-0001-5486-5761	Telethon [C.51] Funding Source: Medline	Telethon(Fondazione Telethon)		Al-Kasim F, 2002, J PEDIAT HEMATOL ONC, V24, P9, DOI 10.1097/00043426-200201000-00004; GARNIS AS, 2002, J PEDIAT HEMATOL ONC, V24, P2; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Taub JW, 2002, J PEDIAT HEMATOL ONC, V24, P6, DOI 10.1097/00043426-200201000-00003; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955	5	126	131	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1617	1620		10.1016/S0140-6736(03)13266-7	http://dx.doi.org/10.1016/S0140-6736(03)13266-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747884				2022-12-01	WOS:000182746300014
J	Hall, WD; Mant, A; Mitchell, PB; Rendle, VA; Hickie, IB; McManus, P				Hall, WD; Mant, A; Mitchell, PB; Rendle, VA; Hickie, IB; McManus, P			Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis	BRITISH MEDICAL JOURNAL			English	Article							DEPRESSION; RATES	Objective To examine die association between trends in antidepressant prescribing and suicide rates in Australia for 1991-2000. Design Analysis of databases of suicide and rates of antidepressant prescribing according to age and sex. Setting Australian Bureau of Statistics data, sales data from the Australian pharmaceutical industry, prescribing data in general practice. Subjects Men and women aged 15 years and over in 10 year age groups. Main outcome measures Trends in suicide rates and trends in antidepressant prescribing. Association measured by Spearman's rank correlations. Results While overall national rates of suicide did not fall significantly, incidence decreased in older men and women and increased in younger adults. In both men (r(s)=-0.91; P<0.01) and women (r(s)=-.0.76; P<0.05) the higher the exposure to antidepressants the larger the decline in rate of suicide. Conclusions Changes in suicide rates and exposure to antidepressants in Australia for 1991-2000 are significantly associated. This effect is most apparent in older age groups, in which rates of suicide decreased substantially in association with exposure to antidepressants. The increase in antidepressant prescribing may be a proxy marker for improved overall management of depression. If so, increased prescribing of selective serotonin reuptake inhibitors in general practice may have produced a quantifiable benefit in population mental health.	Univ New S Wales, Sch Psychiat, Randwick, NSW 2031, Australia; Beyond Blue Natl Depress Initiat, Melbourne, Vic 3122, Australia; Dept Hlth & Ageing, Drug Utilisat Subcomm, Canberra, ACT 2601, Australia; Univ Queensland, Inst Mol Biosci, Off Publ Policy & Eth, Brisbane, Qld 4072, Australia; Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of Queensland; University of New South Wales Sydney	Mant, A (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.		Hickie, Ian B/K-8975-2015; anand, amit/A-7222-2009; Hall, Wayne D/A-3283-2008	Hickie, Ian B/0000-0001-8832-9895; Hall, Wayne D/0000-0003-1984-0096; Mitchell, Philip/0000-0002-7954-5235				*AUSTR BUR STAT, 2000, SUIC AUSTR; Australian Bureau of Statistics, AUSTR SOC TRENDS 200; Barbui C, 1999, SOC PSYCH PSYCH EPID, V34, P152, DOI 10.1007/s001270050127; Bridges-Webb C., 1992, MED J AUST S, V157, pS1; Bridges-Webb Charles, 1992, Medical Journal of Australia, V157, pS1; BRITT H, GEN PRACTICE SERIES, V8; BRITT H, 2001, GEN PRACTICE SERIES, V8; Britt H, 1999, GEN PRACTICE SERIES; Carlsten A, 2001, PHARMACOEPIDEM DR S, V10, P525, DOI 10.1002/pds.618; CATALANO P, 2001, NATL ALCOHOL INDICAT, V4; Cook T.D., 1979, QUASIEXPERIMENTATION; Headey B, 1999, AUSTRALAS J AGEING, V18, P32, DOI 10.1111/j.1741-6612.1999.tb00887.x; Hickie IB, 2002, MED J AUSTRALIA, V176, pS61; Hickie IB, 2001, MED J AUSTRALIA, V175, pS25; Isacsson G, 2000, ACTA PSYCHIAT SCAND, V102, P113, DOI 10.1034/j.1600-0447.2000.102002113.x; Isacsson G, 1996, J AFFECT DISORDERS, V41, P1, DOI 10.1016/0165-0327(96)00050-X; Jorm AF, 2000, AUST NZ J PSYCHIAT, V34, P619, DOI 10.1080/j.1440-1614.2000.00761.x; Mackay FR, 1999, BRIT J GEN PRACT, V49, P892; McManus P, 2000, MED J AUSTRALIA, V173, P458, DOI 10.5694/j.1326-5377.2000.tb139294.x; Morrell S, 2001, ECON LABOUR RELAT RE, V12, P4; Naismith SL, 2001, MED J AUSTRALIA, V175, pS42; PRESKORN SH, 1994, J CLIN PSYCHIAT, V55, P6; Rihmer Z, 2001, EUR PSYCHIAT, V16, P406, DOI 10.1016/S0924-9338(01)00598-3; Vagholkar S, 1996, Aust Fam Physician, V25, P370; Webb M., 2000, NATL ALCOHOL INDICAT, V2; *WHO COLL CTR DRUG, 1998, METH GUID ATC CLASS	26	215	222	1	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 10	2003	326	7397					1008	1011		10.1136/bmj.326.7397.1008	http://dx.doi.org/10.1136/bmj.326.7397.1008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	679KG	12742921	Bronze, Green Published			2022-12-01	WOS:000182920500015
J	Nizak, C; Monier, S; del Nery, E; Moutel, S; Goud, B; Perez, F				Nizak, C; Monier, S; del Nery, E; Moutel, S; Goud, B; Perez, F			Recombinant antibodies to the small GTPase Rab6 as conformation sensors	SCIENCE			English	Article							TO-TGN TRANSPORT; IN-VIVO; COMPLEX; CELLS; GOLGI; SELECTION; PROTEINS; PATHWAY	Here we report an approach, based on antibody phage display, to generate molecular conformation sensors. Recombinant antibodies specific to the guanosine triphosphate (GTP)-bound conformation of the small guanosine triphosphatase (GTPase) Rab6, a regulator of membrane traffic, were generated and used to locate Rab6.GTP in fixed cells, and, after green fluorescent protein (GFP) tagging and intracellular expression, to follow Rab6.GTP in vivo. Rab6 was in its GTP-bound conformation on the Golgi apparatus and transport intermediates, and the geometry of transport intermediates was modulated by Rab6 activity. More generally, the same approach could be applied to other molecules that can be locked in a particular conformation in vitro.	Inst Curie, CNRS, UMR144, F-75248 Paris 05, France; Inst Curie, Translat Dept, F-75248 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Perez, F (corresponding author), Inst Curie, CNRS, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.		Nizak, Clement/L-1334-2013; Tschöpe, Solange Monier/L-9120-2018; Goud, Bruno/GWC-4807-2022; Perez, Franck/A-1558-2014	Nizak, Clement/0000-0002-4591-8240; Perez, Franck/0000-0002-9129-9401; Moutel, Sandrine/0000-0002-9585-4855; DEL NERY, Elaine/0000-0002-9654-5202				BIOCCA S, 1995, TRENDS CELL BIOL, V5, P59; Cohen Pascale A, 2002, Methods Mol Biol, V178, P367; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; DEMAUR AA, 2002, J BIOL CHEM, V277, P45075; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; MONIER S, UNPUB; NISHIMURA N, 1994, J BIOL CHEM, V269, P14191; NIZAK C, UNPUB; Plafker K, 2002, J BIOL CHEM, V277, P30121, DOI 10.1074/jbc.M203006200; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Smothers JF, 2002, SCIENCE, V298, P621, DOI 10.1126/science.298.5593.621; STAHL B, 1994, J BIOL CHEM, V269, P24770; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265	24	101	110	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					984	987		10.1126/science.1083911	http://dx.doi.org/10.1126/science.1083911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738866				2022-12-01	WOS:000182719800058
J	Starzl, TE; Murase, N; Abu-Elmagd, K; Gray, EA; Shapiro, R; Eghtesad, B; Corry, RJ; Jordan, ML; Fontes, P; Gayowski, T; Bond, G; Scantlebury, VP; Potdar, S; Randhawa, P; Wu, T; Zeevi, A; Nalesnik, MA; Woodward, J; Marcos, A; Trucco, M; Demetris, AJ; Fung, JJ				Starzl, TE; Murase, N; Abu-Elmagd, K; Gray, EA; Shapiro, R; Eghtesad, B; Corry, RJ; Jordan, ML; Fontes, P; Gayowski, T; Bond, G; Scantlebury, VP; Potdar, S; Randhawa, P; Wu, T; Zeevi, A; Nalesnik, MA; Woodward, J; Marcos, A; Trucco, M; Demetris, AJ; Fung, JJ			Tolerogenic immunosuppression for organ transplantation	LANCET			English	Article							BONE-MARROW; ALLOGRAFT RECIPIENTS; GRAFT ACCEPTANCE; CELL-MIGRATION; LIVER; TOLERANCE; DONOR; CHIMERISM; REJECTION; KIDNEY	Background Insight into the mechanisms of organ engraftment and acquired tolerance has made it possible to facilitate these mechanisms, by tailoring the timing and dosage of immunosuppression in accordance with two therapeutic principles: recipient pretreatment, and minimum use of post-transplant immunosuppression. We aimed to apply these principles in recipients of renal and extrarenal organ transplants. Methods 82 patients awaiting kidney, liver, pancreas, or intestinal transplantation were pretreated with about 5 mg/kg of a broadly reacting rabbit antithymocyte globulin during several hours. Post-transplant immunosuppression was restricted to tacrolimus unless additional drugs were needed to treat breakthrough rejection. After 4 months, patients on tacrolimus monotherapy were considered for dose-spacing to every other day or longer intervals. Findings We frequently saw evidence of immune activation in graft biopsy samples, but unless this was associated with graft dysfunction or serious immune destruction, treatment usually was not intensified. Immunosuppression-related morbidity was virtually eliminated. 78 (95%) of 82 patients survived at 1 year and at 13-18 months. Graft survival was 73 (89%) of 82 at 1 year and 72 (88%) of 82 at 13-18 months. Of the 72 recipients with surviving grafts, 43 are on spaced doses of tacrolimus monotherapy: every other day (n=6), three times per week (11), twice per week (15), or once per week (11). Interpretation The striking ability to wean immunosuppression in these recipients indicates variable induction of tolerance. The simple therapeutic principles are neither drug-specific nor organ-specific. Systematic application of these principles should allow improvements in quality of life and long-term survival after organ transplantation.	Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Paediat, Div Immunogenet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Starzl, TE (corresponding author), UPMC Montefiore, Inst Transplantat, 7th Floor,S 3459 5th Ave, Pittsburgh, PA 15213 USA.		Randhawa, Parmjeet/H-4285-2019; FUNG, John Julian/A-2679-2012	FUNG, John Julian/0000-0002-3038-0441	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029961, R37DK029961] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 29961, R01 DK029961-19] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elmagd K, 2001, ANN SURG, V234, P404, DOI 10.1097/00000658-200109000-00014; BARBER WH, 1989, TRANSPLANTATION, V47, P66, DOI 10.1097/00007890-198901000-00015; CALNE R, 1994, LANCET, V343, P67, DOI 10.1016/S0140-6736(94)90809-5; Calne R, 1998, LANCET, V351, P1701, DOI 10.1016/S0140-6736(05)77739-4; Demetris AJ, 1997, HEPATOLOGY, V25, P658; FONTES P, 1994, LANCET, V344, P151, DOI 10.1016/S0140-6736(94)92756-1; Garcia-Morales R, 1998, TRANSPLANTATION, V65, P956, DOI 10.1097/00007890-199804150-00016; Ichikawa N, 2000, LIVER TRANSPLANT, V6, P686, DOI 10.1053/jlts.2000.19029; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; MURASE N, 1995, TRANSPLANTATION, V60, P158, DOI 10.1097/00007890-199507270-00009; MYBURGH JA, 1986, WORLD J SURG, V10, P369, DOI 10.1007/BF01655296; MYBURGH JA, 1991, PATHWAYS APPL IMMUNO, P87; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Sakamoto T, 1999, TRANSPLANTATION, V67, P833, DOI 10.1097/00007890-199903270-00009; Smiley ST, 2000, TRANSPLANTATION, V70, P415, DOI 10.1097/00007890-200008150-00005; STARZL TE, 1968, NEW ENGL J MED, V278, P642, DOI 10.1056/NEJM196803212781202; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P385; Starzl TE, 2002, J AM COLL SURGEONS, V195, P587, DOI 10.1016/S1072-7515(02)01498-9; STARZL TE, 1993, HEPATOLOGY, V17, P1127; Starzl TE, 2001, NAT REV IMMUNOL, V1, P233, DOI 10.1038/35105088; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; Starzl TE, 1998, NEW ENGL J MED, V339, P1905, DOI 10.1056/NEJM199812243392607; STARZL TE, 1985, CHRONIC RENAL DIS, P507; Takatsuki M, 2001, TRANSPLANTATION, V72, P449, DOI 10.1097/00007890-200108150-00016; Wang CM, 2001, TRANSPLANTATION, V72, P44, DOI 10.1097/00007890-200107150-00011	27	364	385	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 3	2003	361	9368					1502	1510		10.1016/S0140-6736(03)13175-3	http://dx.doi.org/10.1016/S0140-6736(03)13175-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737859	Green Accepted			2022-12-01	WOS:000182658900008
J	Richard, C; Balavoine, F; Schultz, P; Ebbesen, TW; Mioskowski, C				Richard, C; Balavoine, F; Schultz, P; Ebbesen, TW; Mioskowski, C			Supramolecular self-assembly of lipid derivatives on carbon nanotubes	SCIENCE			English	Article							PROTEINS; CRYSTALLIZATION; FLUORESCENCE; ORGANIZATION; SURFACTANTS; MICROSCOPY; ELECTRODE	Images of the assembly of surfactants and synthetic lipids on the surface of carbon nanotubes were obtained by transmission electron microscopy. Above the critical micellar concentration, sodium dodecyl sulfate (SDS) forms supramolecular structures made of rolled-up half-cylinders on the nanotube surface. Depending on the symmetry and the diameter of the carbon nanotube, we observed rings, helices, or double helices. Similar self-assemblies were also obtained with several synthetic single-chain lipids designed for the immobilization of histidine-tagged proteins. At the nanotube-water interface, permanent assemblies were produced from mixed micelles of SDS and different water-insoluble double-chain lipids after dialysis of the surfactant. Such arrangements could be further exploited for the development of new biosensors and bioelectronic nanomaterials.	CEA Saclay, Serv Marquage Mol & Chim Bioorgan, F-91191 Gif Sur Yvette, France; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Strasbourg 1, ISIS, F-67000 Strasbourg, France; Fac Pharm, CNRS, UMR 7514, F-67401 Illkirch Graffenstaden, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mioskowski, C (corresponding author), CEA Saclay, Serv Marquage Mol & Chim Bioorgan, Bat 547, F-91191 Gif Sur Yvette, France.		; Richard, Cyrille/O-6802-2017	schultz, patrick/0000-0002-7310-6186; Richard, Cyrille/0000-0003-4896-6675				Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g; Aksay IA, 1996, SCIENCE, V273, P892, DOI 10.1126/science.273.5277.892; Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s; Bonard JM, 1997, ADV MATER, V9, P827, DOI 10.1002/adma.19970091014; Burghard M, 1998, ADV MATER, V10, P584, DOI 10.1002/(SICI)1521-4095(199805)10:8<584::AID-ADMA584>3.3.CO;2-0; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x; Dorn IT, 1998, J AM CHEM SOC, V120, P2753, DOI 10.1021/ja9735620; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Journet C, 1997, NATURE, V388, P756, DOI 10.1038/41972; KUBALEK EW, 1994, J STRUCT BIOL, V113, P117, DOI 10.1006/jsbi.1994.1039; MANNE S, 1994, LANGMUIR, V10, P4409, DOI 10.1021/la00024a003; MANNE S, 1995, SCIENCE, V270, P1480, DOI 10.1126/science.270.5241.1480; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Paborsky LR, 1996, ANAL BIOCHEM, V234, P60, DOI 10.1006/abio.1996.0050; Patrick HN, 2000, COLLOID SURFACE A, V162, P149, DOI 10.1016/S0927-7757(99)00187-9; RICHARD C, 2000, THESIS U PARIS SUD O; Schmid EL, 1997, ANAL CHEM, V69, P1979, DOI 10.1021/ac9700033; Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023; Wanless EJ, 1996, J PHYS CHEM-US, V100, P3207, DOI 10.1021/jp952439x; Yakobson BI, 1997, AM SCI, V85, P324; ZETTLEMO.AC, 1968, J COLLOID INTERF SCI, V28, P343, DOI 10.1016/0021-9797(68)90066-0	24	694	717	4	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					775	778		10.1126/science.1080848	http://dx.doi.org/10.1126/science.1080848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730595				2022-12-01	WOS:000182579800043
J	Shergill, SS; Bays, PM; Frith, CD; Wolpert, DM				Shergill, SS; Bays, PM; Frith, CD; Wolpert, DM			Two eyes for an eye: The neuroscience of force escalation	SCIENCE			English	Article							MOVEMENT		UCL, Inst Neurol, London WC1N 3BG, England; Inst Psychiat, London, England	University of London; University College London; University of London; King's College London	Wolpert, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	wolpert@hera.ucl.ac.uk	Shergill, Sukhi S/G-7725-2011; Bays, Paul/B-3999-2009; Frith, Chris/A-2171-2009	shergill, sukhi/0000-0003-4928-9100; Bays, Paul/0000-0003-4684-4893; Frith, Chris/0000-0002-8665-0690				ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1998, J NEUROSCI, V18, P7511; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; CLAXTON G, 1975, PERCEPT MOTOR SKILL, V41, P335, DOI 10.2466/pms.1975.41.1.335; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; MILNE RJ, 1988, EXP BRAIN RES, V70, P569; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; von Holst E, 1954, BRIT J ANIM BEHAV, V2, P89, DOI DOI 10.1016/S0950-5601(54)80044-X; WEISKRANTZ L, 1971, NATURE, V230, P598, DOI 10.1038/230598a0; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	11	260	260	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					187	187		10.1126/science.1085327	http://dx.doi.org/10.1126/science.1085327			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855800	Green Submitted			2022-12-01	WOS:000184056200033
J	Nieuwenhuizen, WF; Pieters, RHH; Knippels, LMJ; Jansen, MCJF; Koppelman, SJ				Nieuwenhuizen, WF; Pieters, RHH; Knippels, LMJ; Jansen, MCJF; Koppelman, SJ			Is Candida albicans a trigger in the onset of coeliac disease?	LANCET			English	Article							CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; DERMATITIS-HERPETIFORMIS; MICE; GLIADIN; COLONIZATION; AUTOANTIGEN; SUBSTRATE; PROTEINS; PEPTIDES	Coeliac disease is a T-cell-mediated autoimmune disease of the small intestine that is induced by ingestion of gluten proteins from wheat, barley, or rye. We postulate that Candida albicans is a trigger in the onset of coeliac disease. The virulence factor of C albicans-hyphal wall protein 1 (HWP1)-contains aminoacid sequences that are identical or highly homologous to known coeliac disease-related a-gliadin and gamma-gliadin T-cell epitopes. HWP1 is a transglutaminase substrate, and is used by C albicans to adhere to the intestinal epithelium. Furthermore, tissue transglutaminase and endomysium components could become covalently linked to the yeast. Subsequently, C albicans might function as an adjuvant that stimulates antibody formation against HWP1 and gluten, and formation of autoreactive antibodies against tissue transglutaminase and endomysium.	TNO, NL-3700 AJ Zeist, Netherlands; Univ Utrecht, Dept Immunotoxicol, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands	Netherlands Organization Applied Science Research; Utrecht University	Nieuwenhuizen, WF (corresponding author), TNO, POB 360, NL-3700 AJ Zeist, Netherlands.							Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; ARRESE JE, 1995, DERMATOLOGY, V190, P119, DOI 10.1159/000246659; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; BRADWAY SD, 1993, CRIT REV ORAL BIOL M, V4, P293, DOI 10.1177/10454411930040030601; DEREPENTIGNY L, 1992, INFECT IMMUN, V60, P4907, DOI 10.1128/IAI.60.11.4907-4914.1992; Hervonen K, 2002, SCAND J GASTROENTERO, V37, P51, DOI 10.1080/003655202753387356; KAGNOFF MF, 1984, J EXP MED, V160, P1544, DOI 10.1084/jem.160.5.1544; Lacour M, 2002, INT J HYG ENVIR HEAL, V205, P257, DOI 10.1078/1438-4639-00159; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Seissler J, 2001, CLIN EXP IMMUNOL, V125, P216, DOI 10.1046/j.1365-2249.2001.01584.x; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stern M, 2000, J PEDIATR GASTR NUTR, V31, P513, DOI 10.1097/00005176-200011000-00012; Sundstrom P, 2002, J INFECT DIS, V185, P521, DOI 10.1086/338836; TlaskalovaHogenova H, 1997, ANN NY ACAD SCI, V815, P503, DOI 10.1111/j.1749-6632.1997.tb52115.x; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; VESY CJ, 1993, MODERN PATHOL, V6, P61	20	43	44	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 21	2003	361	9375					2152	2154		10.1016/S0140-6736(03)13695-1	http://dx.doi.org/10.1016/S0140-6736(03)13695-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	692GY	12826451				2022-12-01	WOS:000183654200026
J	Elf, J; Nilsson, D; Tenson, T; Ehrenberg, M				Elf, J; Nilsson, D; Tenson, T; Ehrenberg, M			Selective charging of tRNA isoacceptors explains patterns of codon usage	SCIENCE			English	Article							TRANSFER-RNA ABUNDANCE; ESCHERICHIA-COLI; SEQUENCE; TRANSLATION; ADAPTATION; ACCURACY; PPGPP	We modeled how the charged levels of different transfer RNAs (tRNAs) that carry the same amino acid ( isoacceptors) respond when this amino acid becomes growth-limiting. The charged levels will approach zero for some isoacceptors (such as tRNA(2)(Leu)) and remain high for others (such as tRNA(4)(Leu)), as determined by the concentrations of isoacceptors and how often their codons occur in protein synthesis. The theory accounts for ( synonymous) codons for the same amino acid that are used in ribosome-mediated transcriptional attenuation, the choices of synonymous codons in trans-translating transfer-messenger RNA, and the overrepresentation of rare codons in messenger RNAs for amino acid biosynthetic enzymes.	Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Uppsala University; Karolinska Institutet; University of Tartu	Ehrenberg, M (corresponding author), Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.	ehrenberg@xray.bmc.uu.se	Nilsson, Daniel/B-8365-2009; Tenson, Tanel/I-6431-2015	Nilsson, Daniel/0000-0001-5831-385X; Tenson, Tanel/0000-0002-0260-3601; elf, johan/0000-0001-5522-1810				Barak Z, 1996, J MOL BIOL, V256, P676, DOI 10.1006/jmbi.1996.0117; BJORK GR, 1996, CELLULAR MOL BIOL, P861; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOCK A, 1966, J BACTERIOL, V92, P1076; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; CASHEL M, 1996, CELLULAR MOL BIOL, P1458; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; EHRENBERG M, UNPUB; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; LANDICK R, 1987, CELLULAR MOL BIOL, P1276; MORRIS DW, 1965, J BACTERIOL, V90, P1624, DOI 10.1128/JB.90.6.1624-1631.1965; Nakamura Y, 1996, NUCLEIC ACIDS RES, V24, P214, DOI 10.1093/nar/24.1.214; NEIDHARDT FC, 1996, CELLULAR MOL BIOL; OFARRELL PH, 1978, CELL, V14, P545, DOI 10.1016/0092-8674(78)90241-6; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; POST LE, 1979, P NATL ACAD SCI USA, V76, P1697, DOI 10.1073/pnas.76.4.1697; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; YEGIAN CD, 1969, J MOL BIOL, V39, P45, DOI 10.1016/0022-2836(69)90332-5	27	182	187	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1718	1722		10.1126/science.1083811	http://dx.doi.org/10.1126/science.1083811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805541				2022-12-01	WOS:000183459700043
J	Bjedov, I; Tenaillon, O; Gerard, B; Souza, V; Denamur, E; Radman, M; Taddei, F; Matic, I				Bjedov, I; Tenaillon, O; Gerard, B; Souza, V; Denamur, E; Radman, M; Taddei, F; Matic, I			Stress-induced mutagenesis in bacteria	SCIENCE			English	Article							STATIONARY-PHASE MUTATION; DNA-POLYMERASE-II; ESCHERICHIA-COLI; ADAPTIVE MUTATION; MISMATCH REPAIR; GENE-EXPRESSION; POPULATIONS; MUTATORS; RPOS; RECOMBINATION	The evolutionary significance of stress-induced mutagenesis was evaluated by studying mutagenesis in aging colonies ( MAC) of Escherichia coli natural isolates. A large fraction of isolates exhibited a strong MAC, and the high MAC variability reflected the diversity of selective pressures in ecological niches. MAC depends on starvation, oxygen, and RpoS and adenosine 3',5'-monophosphate regulons; thus it may be a by-product of genetic strategies for improving survival under stress. MAC could also be selected through beneficial mutations that it generates, as shown by computer modeling and the patterns of stress-inducible and constitutive mutagenesis. We suggest that irrespective of the causes of their emergence, stress-induced mutations participate in adaptive evolution.	Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, U571, F-75730 Paris 15, France; Univ Paris 07, Fac Med Xavier Bichat, INSERM, EO339, F-75870 Paris, France; Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidad Nacional Autonoma de Mexico	Matic, I (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, U571, 156 Rue Vaugirard, F-75730 Paris 15, France.		Tenaillon, Olivier/L-9857-2017; Radman, Miroslav/HDM-5955-2022	Bjedov, Ivana/0000-0001-5894-6016; Radman, Miroslav/0000-0003-0216-3148; souza, valeria/0000-0002-2992-4229; Tenaillon, Olivier/0000-0002-3796-1601; Radman, Miroslav/0000-0002-7034-4365; Taddei, Francois/0000-0002-7894-0647				Bregeon D, 1999, J GENET, V78, P21, DOI 10.1007/BF02994699; Bridges BA, 1998, MUTAT RES-DNA REPAIR, V408, P1, DOI 10.1016/S0921-8777(98)00008-1; Chicurel M, 2001, SCIENCE, V292, P1824, DOI 10.1126/science.292.5523.1824; Courcelle J, 2001, GENETICS, V158, P41; CUPPLES CG, 1990, GENETICS, V125, P275; Denamur E, 2002, J BACTERIOL, V184, P605, DOI 10.1128/JB.184.2.605-609.2002; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; ESCARCELLER M, 1994, J BACTERIOL, V176, P6221, DOI 10.1128/jb.176.20.6221-6228.1994; Foster PL, 1999, ANNU REV GENET, V33, P57, DOI 10.1146/annurev.genet.33.1.57; Friedberg EC, 1995, DNA REPAIR MUTAGENES; Giraud A, 2001, CURR OPIN MICROBIOL, V4, P582, DOI 10.1016/S1369-5274(00)00254-X; HARRIS RS, 1994, SCIENCE, V264, P258, DOI 10.1126/science.8146657; Harris RS, 1997, GENE DEV, V11, P2426, DOI 10.1101/gad.11.18.2426; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Holliday R, 1995, UNDERSTANDING AGING; Karunakaran P, 2000, J BACTERIOL, V182, P3331, DOI 10.1128/JB.182.12.3331-3335.2000; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; LENSKI RE, 1995, SCIENCE, V269, P285, DOI 10.1126/science.7618089; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Miller JH, 1998, MUTAT RES-DNA REPAIR, V409, P99, DOI 10.1016/S0921-8777(98)00049-4; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; PETERS AC, 1987, J GEN MICROBIOL, V133, P1257; Runyen-Janecky LJ, 1999, INFECT IMMUN, V67, P1415, DOI 10.1128/IAI.67.3.1415-1423.1999; Saier MH, 1996, ESCHERICHIA COLI SAL, V1, P1325; Saumaa S, 2002, J BACTERIOL, V184, P6957, DOI 10.1128/JB.184.24.6957-6965.2002; SEDGWICK SG, 1985, P NATL ACAD SCI USA, V82, P4172, DOI 10.1073/pnas.82.12.4172; Sommer SS, 2001, MUTAT RES-DNA REPAIR, V487, P1, DOI 10.1016/S0921-8777(01)00108-2; STEELE DF, 1992, GENETICS, V132, P9; Taddei F, 1997, MOL GEN GENET, V256, P277, DOI 10.1007/s004380050570; TADDEI F, 1995, P NATL ACAD SCI USA, V92, P11736, DOI 10.1073/pnas.92.25.11736; Tenaillon O, 2000, P NATL ACAD SCI USA, V97, P10465, DOI 10.1073/pnas.180063397; Tenaillon O, 1999, GENETICS, V152, P485; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; TESSMAN I, 1994, GENETICS, V136, P439; Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997	38	405	417	5	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1404	1409		10.1126/science.1082240	http://dx.doi.org/10.1126/science.1082240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775833				2022-12-01	WOS:000183181800037
J	Marra, MA; Jones, SJM; Astell, CR; Holt, RA; Brooks-Wilson, A; Butterfield, YSN; Khattra, J; Asano, JK; Barber, SA; Chan, SY; Cloutier, A; Coughlin, SM; Freeman, D; Girn, N; Griffith, OL; Leach, SR; Mayo, M; McDonald, H; Montgomery, SB; Pandoh, PK; Petrescu, AS; Robertson, AG; Schein, JE; Siddiqui, A; Smailus, DE; Stott, JE; Yang, GS; Plummer, F; Andonov, A; Artsob, H; Bastien, N; Bernard, K; Booth, TF; Bowness, D; Czub, M; Drebot, M; Fernando, L; Flick, R; Garbutt, M; Gray, M; Grolla, A; Jones, S; Feldmann, H; Meyers, A; Kabani, A; Li, Y; Normand, S; Stroher, U; Tipples, GA; Tyler, S; Vogrig, R; Ward, D; Watson, B; Brunham, RC; Krajden, M; Petric, M; Skowronski, DM; Upton, C; Roper, RL				Marra, MA; Jones, SJM; Astell, CR; Holt, RA; Brooks-Wilson, A; Butterfield, YSN; Khattra, J; Asano, JK; Barber, SA; Chan, SY; Cloutier, A; Coughlin, SM; Freeman, D; Girn, N; Griffith, OL; Leach, SR; Mayo, M; McDonald, H; Montgomery, SB; Pandoh, PK; Petrescu, AS; Robertson, AG; Schein, JE; Siddiqui, A; Smailus, DE; Stott, JE; Yang, GS; Plummer, F; Andonov, A; Artsob, H; Bastien, N; Bernard, K; Booth, TF; Bowness, D; Czub, M; Drebot, M; Fernando, L; Flick, R; Garbutt, M; Gray, M; Grolla, A; Jones, S; Feldmann, H; Meyers, A; Kabani, A; Li, Y; Normand, S; Stroher, U; Tipples, GA; Tyler, S; Vogrig, R; Ward, D; Watson, B; Brunham, RC; Krajden, M; Petric, M; Skowronski, DM; Upton, C; Roper, RL			The genome sequence of the SARS-associated coronavirus	SCIENCE			English	Article							PROTEIN FAMILIES; VIRUS; TRANSCRIPTION; GENERATION; DATABASE	We sequenced the 29,751-base genome of the severe acute respiratory syndrome (SARS)-associated coronavirus known as the Tor2 isolate. The genome sequence reveals that this coronavirus is only moderately related to other known coronaviruses, including two human coronaviruses, HCoV-OC43 and HCoV-229E. Phylogenetic analysis of the predicted viral proteins indicates that the virus does not closely resemble any of the three previously known groups of coronaviruses. The genome sequence will aid in the diagnosis of SARS virus infection in humans and potential animal hosts (using polymerase chain reaction and immunological tests), in the development of antivirals (including neutralizing antibodies), and in the identification of putative epitopes for vaccine development.	British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	British Columbia Cancer Agency; University of British Columbia; University of Victoria	Marra, MA (corresponding author), British Columbia Canc Agcy, Genome Sci Ctr, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	mmarra@bccgsc.ca	Jones, Steven J/C-3621-2009; Roper, Rachel/A-7935-2013; Marra, Marco A/B-5987-2008; Schein, Jacquie E/G-3674-2015; Upton, Chris/A-4670-2008; Brooks-Wilson, Angela/E-9399-2012; Holt, Robert A/C-3303-2009; Griffith, Obi/P-1286-2014	Jones, Steven J/0000-0003-3394-2208; Roper, Rachel/0000-0001-6971-7745; Marra, Marco A/0000-0001-7146-7175; Brooks-Wilson, Angela/0000-0003-1009-6408; Holt, Robert A/0000-0002-7259-1247; Montgomery, Stephen/0000-0002-5200-3903; Griffith, Obi/0000-0002-0843-4271; Upton, Chris/0000-0002-9019-8967				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Cohen JISS., 2001, FIELDS VIROLOGY, P2707; DONNELLY CA, 2003, LANCET          0507; Fauquet C.M., 2000, VIRUS TAXONOMY CLASS, P835; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Hofmann K., 1993, BIOL CHEM, V374, P166; Jonassen CM, 1998, J GEN VIROL, V79, P715, DOI 10.1099/0022-1317-79-4-715; Krishnan R, 1996, VIROLOGY, V218, P400, DOI 10.1006/viro.1996.0210; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; KUO L, 2002, ANN M AM SOC VIR LEX; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; Munch R, 2003, MICROBES INFECT, V5, P69, DOI 10.1016/S1286-4579(02)00053-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ortego J, 2002, J VIROL, V76, P11518, DOI 10.1128/JVI.76.22.11518-11529.2002; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEIRIS JSM, 2003, LANCET          0408; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sawicki DL, 2001, J GEN VIROL, V82, P385, DOI 10.1099/0022-1317-82-2-385; Sawicki SG, 1998, ADV EXP MED BIOL, V440, P215; SAWICKI SG, 1990, J VIROL, V64, P1050, DOI 10.1128/JVI.64.3.1050-1056.1990; SCHAAD MC, 1994, J VIROL, V68, P8169, DOI 10.1128/JVI.68.12.8169-8179.1994; SETHNA PB, 1989, P NATL ACAD SCI USA, V86, P5626, DOI 10.1073/pnas.86.14.5626; Siddell S.G., 1995, CORONAVIRIDAE, P389; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai JC, 2003, J VIROL, V77, P841, DOI 10.1128/JVI.77.2.841-850.2003; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	32	1575	1911	8	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2003	300	5624					1399	1404		10.1126/science.1085953	http://dx.doi.org/10.1126/science.1085953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12730501				2022-12-01	WOS:000183181800036
J	Oldfield, TEE; Smith, RJ; Harrop, SR; Leader-Williams, N				Oldfield, TEE; Smith, RJ; Harrop, SR; Leader-Williams, N			Field sports and conservation in the United Kingdom	NATURE			English	Article							AGRI-ENVIRONMENT SCHEMES; PROTECTED AREAS; BIODIVERSITY; COUNTRYSIDE; FARMERS; ENGLAND	Many natural habitats exist on privately owned land outside protected areas(1), but few governments can afford to enforce or subsidize conservation of this biodiversity. Even in some developed countries, conservation subsidy schemes have only achieved limited success(2-4). Fortunately, some landowners may be willing to accept management costs in return for other benefits(5), although this remains controversial when it involves the killing of charismatic species. For example, participants in British field sports, such as fox hunting and game-bird shooting, may voluntarily conserve important habitats that are required by quarry species(6-8). Here we report results from a multidisciplinary study that addressed this issue by focusing on three sites across central England. We found that landowners participating in field sports maintained the most established woodland and planted more new woodland and hedgerows than those who did not, despite the equal availability of subsidies. Therefore, voluntary habitat management appears to be important for biodiversity conservation in Britain. Current debates on the future of field sports in Britain, and similar activities globally, may benefit from considering their utility as incentives to conserve additional habitat on private land.	Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NS, Kent, England	University of Kent	Leader-Williams, N (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NS, Kent, England.		Smith, Robert J/D-9660-2011	Smith, Robert J/0000-0003-1599-9171				Baker PJ, 2002, NATURE, V419, P34, DOI 10.1038/419034a; Barr C.J., 1990, COUNTRYSIDE SURVEY 1; Beedell JDC, 1999, J ENVIRON MANAGE, V57, P165, DOI 10.1006/jema.1999.0296; BENNETT AF, 1999, LINKAGE LANDSCAPE RO; BURNS L, 2000, REPORT COMMITTEE INQ; *ENGL NAT, 2002, ANN REP APR 1 2001 3; Garbutt RA, 2002, BIOL CONSERV, V106, P273, DOI 10.1016/S0006-3207(01)00253-1; GLOWKA L, 1994, GUID CONV BIOL DIV; Goodman P.S., 2002, MAINSTREAMING BIODIV, P21; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Langholz JA, 2001, BIOSCIENCE, V51, P1079, DOI 10.1641/0006-3568(2001)051[1079:PAPOPO]2.0.CO;2; Leader-Williams N, 2002, NATURE, V419, P878, DOI 10.1038/419878a; LEADERWILLIAMS N, 1990, SCI PROGRESS-UK, V74, P189; LOVELACE D, 2000, MONEY MAKES COUNTRY; Macdonald D. W, 1987, RUNNING FOX; Macdonald DW, 2000, BIOL CONSERV, V94, P221, DOI 10.1016/S0006-3207(99)00173-1; O'Connell M, 2002, BIOL CONSERV, V103, P115, DOI 10.1016/S0006-3207(01)00125-2; Ovenden GN, 1998, J APPL ECOL, V35, P955, DOI 10.1111/j.1365-2664.1998.tb00014.x; ROBERTSON PA, 1988, BIOL CONSERV, V45, P159, DOI 10.1016/0006-3207(88)90136-X; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Stoate C, 2002, BIODIVERS CONSERV, V11, P561, DOI 10.1023/A:1015564806990; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Tapper S. C., 1999, QUESTION BALANCE GAM; Thomas RC, 1997, BIOL CONSERV, V82, P243, DOI 10.1016/S0006-3207(97)00039-6; *UK GOV, 2001, ACH BETT QUAL LIF GO	26	50	55	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					531	533		10.1038/nature01678	http://dx.doi.org/10.1038/nature01678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774120	Bronze			2022-12-01	WOS:000183162900041
J	Lev-Maor, G; Sorek, R; Shomron, N; Ast, G				Lev-Maor, G; Sorek, R; Shomron, N; Ast, G			The birth of an alternatively spliced exon: 3 ' splice-site selection in Alu exons	SCIENCE			English	Article							MESSENGER-RNA; MEDIATED INSERTION; SEQUENCE; ELEMENTS; SUBUNIT; GENES; MUTATION; RECEPTOR; VARIANT; JUNK	Alu repetitive elements can be inserted into mature messenger RNAs via a splicing-mediated process termed exonization. To understand the molecular basis and the regulation of the process of turning intronic Alus into new exons, we compiled and analyzed a data set of human exonized Alus. We revealed a mechanism that governs 3' splice-site selection in these exons during alternative splicing. On the basis of these findings, we identified mutations that activated the exonization of a silent intronic Alu.	Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Mol Med, IL-69978 Ramat Aviv, Israel; Compugen, IL-69512 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Ast, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Mol Med, IL-69978 Ramat Aviv, Israel.	gilast@post.tau.ac.il						BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; CANCE WG, 1993, INT J CANCER, V54, P571, DOI 10.1002/ijc.2910540409; CARAS IW, 1987, NATURE, V325, P545, DOI 10.1038/325545a0; Chua K, 1999, NATURE, V402, P207, DOI 10.1038/46086; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KNEBELMANN B, 1995, HUM MOL GENET, V4, P675, DOI 10.1093/hmg/4.4.675; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVMAOR G, UNPUB; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; MANROW RE, 1993, J MOL BIOL, V234, P281, DOI 10.1006/jmbi.1993.1583; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; MIHOVILOVIC M, 1993, BIOCHEM BIOPH RES CO, V197, P137, DOI 10.1006/bbrc.1993.2452; Miller M, 1997, GENE, V190, P309, DOI 10.1016/S0378-1119(97)00022-X; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Rowold DJ, 2000, GENETICA, V108, P57, DOI 10.1023/A:1004099605261; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Schmid CW, 1996, PROG NUCLEIC ACID RE, V53, P283, DOI 10.1016/S0079-6603(08)60148-8; Slavov D, 2002, GENE, V299, P83, DOI 10.1016/S0378-1119(02)01016-8; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; SOREK R, UNPUB; Svineng G, 1998, BIOCHEM J, V330, P1255, DOI 10.1042/bj3301255; Vervoort R, 1998, HUM GENET, V103, P686, DOI 10.1007/PL00008709	26	338	362	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1288	1291		10.1126/science.1082588	http://dx.doi.org/10.1126/science.1082588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764196				2022-12-01	WOS:000183042400048
J	Petersen, KF; Befroy, D; Dufour, S; Dziura, J; Ariyan, C; Rothman, DL; DiPietro, L; Cline, GW; Shulman, GI				Petersen, KF; Befroy, D; Dufour, S; Dziura, J; Ariyan, C; Rothman, DL; DiPietro, L; Cline, GW; Shulman, GI			Mitochondrial dysfunction in the elderly: Possible role in insulin resistance	SCIENCE			English	Article							FREE FATTY-ACIDS; SKELETAL-MUSCLE; MECHANISM; ACCUMULATION; SPECTROSCOPY; ACTIVATION; MUTATIONS; HUMANS; LIVER	Insulin resistance is a major factor in the pathogenesis of type 2 diabetes in the elderly. To investigate how insulin resistance arises, we studied healthy, lean, elderly and young participants matched for lean body mass and fat mass. Elderly study participants were markedly insulin-resistant as compared with young controls, and this resistance was attributable to reduced insulin-stimulated muscle glucose metabolism. These changes were associated with increased fat accumulation in muscle and liver tissue assessed by H-1 nuclear magnetic resonance (NMR) spectroscopy, and with a similar to40% reduction in mitochondrial oxidative and phosphorylation activity, as assessed by in vivo C-13/P-31 NMR spectroscopy. These data support the hypothesis that an age-associated decline in mitochondrial function contributes to insulin resistance in the elderly.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; Howard Hughes Medical Institute; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Ariyan, Charlotte/0000-0003-0818-3895	NCRR NIH HHS [M01 RR000125, M01 RR-00125] Funding Source: Medline; NIA NIH HHS [P60 AG-10469, R01 AG-09872, R01 AG023686-01A1, R01 AG023686] Funding Source: Medline; NIDDK NIH HHS [K23 DK002734-04, R01 DK049230, K23 DK002734, K-23 DK-02347, P30 DK045735, R01 DK-49230, P30 DK-45735] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, K23DK002734, R01DK049230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686, R01AG009872, P60AG010469] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HUSE DM, 1989, JAMA-J AM MED ASSOC, V262, P2708, DOI 10.1001/jama.262.19.2708; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; JOHNSON AB, 1992, CLIN SCI, V82, P219, DOI 10.1042/cs0820219; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Luft R, 1993, Lakartidningen, V90, P2770; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI200215001, 10.1172/JCI0215001]; Petersen KF, 1998, DIABETES, V47, P381, DOI 10.2337/diabetes.47.3.381; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914; SAAD MF, 1989, LANCET, V1, P1356; SASAKI A, 1982, DIABETOLOGIA, V22, P154, DOI 10.1007/BF00283743; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	30	1521	1581	5	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1140	1142		10.1126/science.1082889	http://dx.doi.org/10.1126/science.1082889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750520	Green Accepted			2022-12-01	WOS:000182886500044
J	Cossart, R; Aronov, D; Yuste, R				Cossart, R; Aronov, D; Yuste, R			Attractor dynamics of network UP states in the neocortex	NATURE			English	Article							SPONTANEOUS FIRING PATTERNS; LESS-THAN-1 HZ OSCILLATION; CAT VISUAL-CORTEX; FUNCTIONAL ARCHITECTURE; PREFRONTAL CORTEX; NEURONS; PROJECTIONS; MEMORY	The cerebral cortex receives input from lower brain regions, and its function is traditionally considered to be processing that input through successive stages to reach an appropriate output(1,2). However, the cortical circuit contains many interconnections, including those feeding back from higher centres(3-6), and is continuously active even in the absence of sensory inputs(7-9). Such spontaneous firing has a structure that reflects the coordinated activity of specific groups of neurons(10-12). Moreover, the membrane potential of cortical neurons fluctuates spontaneously between a resting ( DOWN) and a depolarized (UP) state(11,13-16), which may also be coordinated. The elevated firing rate in the UP state follows sensory stimulation(16) and provides a substrate for persistent activity, a network state that might mediate working memory(17-21). Using two-photon calcium imaging, we reconstructed the dynamics of spontaneous activity of up to 1,400 neurons in slices of mouse visual cortex. Here we report the occurrence of synchronized UP state transitions ('cortical flashes') that occur in spatially organized ensembles involving small numbers of neurons. Because of their stereotyped spatiotemporal dynamics, we conclude that network UP states are circuit attractors-emergent features of feedback neural networks(22) that could implement memory states or solutions to computational problems.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Cossart, R (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	rcossart@biology.columbia.edu	Cossart, Rosa/AAT-7934-2020; Cossart, Rosa/E-7674-2014	Cossart, Rosa/0000-0003-2111-6638; Cossart, Rosa/0000-0003-2111-6638				Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Badea T, 2001, J NEUROBIOL, V48, P215, DOI 10.1002/neu.1052; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Creutzfeldt O., 1995, CORTEX CEREBRI; De No RL, 1938, J NEUROPHYSIOL, V1, P207; Douglas RJ, 1998, SYNAPTIC ORG BRAIN, P459; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hebb D.O., 2002, CLIN PSYCHOL; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Llinas R. R., 2002, I VORTEX NEURONS SEL; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0	28	458	471	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2003	423	6937					283	288		10.1038/nature01614	http://dx.doi.org/10.1038/nature01614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748641				2022-12-01	WOS:000182853100042
J	Alford, MH				Alford, MH			Redistribution of energy available for ocean mixing by long-range propagation of internal waves	NATURE			English	Article							INERTIAL CURRENTS; TIDAL ENERGY; DEEP-OCEAN; WIND; ALTIMETRY; TIDES	Ocean mixing, which affects pollutant dispersal, marine productivity and global climate(1), largely results from the breaking of internal gravity waves-disturbances propagating along the ocean's internal stratification. A global map of internal-wave dissipation would be useful in improving climate models, but would require knowledge of the sources of internal gravity waves and their propagation. Towards this goal, I present here computations of horizontal internal-wave propagation from 60 historical moorings and relate them to the source terms of internal waves as computed previously(2,3). Analysis of the two most energetic frequency ranges-near-inertial frequencies and semidiurnal tidal frequencies-reveals that the fluxes in both frequency bands are of the order of 1 kW m(-1) (that is, 15-50% of the energy input) and are directed away from their respective source regions. However, the energy flux due to near-inertial waves is stronger in winter, whereas the tidal fluxes are uniform throughout the year. Both varieties of internal waves can thus significantly affect the space-time distribution of energy available for global mixing.	Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; Univ Washington, Sch Oceanog, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Alford, MH (corresponding author), Univ Washington, Appl Phys Lab, 1013 NE 40th St, Seattle, WA 98105 USA.	malford@apl.washington.edu						Alford MH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016614; Alford MH, 2001, J GEOPHYS RES-OCEANS, V106, P16947, DOI 10.1029/2000JC000370; Alford MH, 2001, J PHYS OCEANOGR, V31, P2359, DOI 10.1175/1520-0485(2001)031<2359:ISGTSD>2.0.CO;2; DASARO EA, 1985, J PHYS OCEANOGR, V15, P943, DOI 10.1175/1520-0485(1985)015<0943:UOTSIC>2.0.CO;2; DASARO EA, 1995, J PHYS OCEANOGR, V25, P2909, DOI 10.1175/1520-0485(1995)025<2909:UOICFB>2.0.CO;2; DASARO EA, 1991, P DYN OC INT GRAV WA, V2, P451; Doherty KW, 1999, J ATMOS OCEAN TECH, V16, P1816, DOI 10.1175/1520-0426(1999)016<1816:AMPI>2.0.CO;2; DUSHAW BD, 1995, J PHYS OCEANOGR, V25, P631, DOI 10.1175/1520-0485(1995)025<0631:BABTIT>2.0.CO;2; Egbert GD, 2000, NATURE, V405, P775, DOI 10.1038/35015531; FU LL, 1981, REV GEOPHYS, V19, P141, DOI 10.1029/RG019i001p00141; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; GARRETT C, 1975, J GEOPHYS RES, V80, P291, DOI 10.1029/JC080i003p00291; Garrett C, 2001, J PHYS OCEANOGR, V31, P962, DOI 10.1175/1520-0485(2001)031<0962:WITNIB>2.0.CO;2; GILL AE, 1984, J PHYS OCEANOGR, V14, P1129, DOI 10.1175/1520-0485(1984)014<1129:OTBOIW>2.0.CO;2; GREGG MC, 1987, J GEOPHYS RES-OCEANS, V92, P5249, DOI 10.1029/JC092iC05p05249; Kunze E, 2002, J PHYS OCEANOGR, V32, P1890, DOI 10.1175/1520-0485(2002)032<1890:IWIMSC>2.0.CO;2; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Levitus S, 1994, WORLD OCEAN ATLAS 19; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Merrifield MA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000996; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; PINGREE RD, 1991, J PHYS OCEANOGR, V21, P28, DOI 10.1175/1520-0485(1991)021<0028:APABRO>2.0.CO;2; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; Ray RD, 2001, GEOPHYS RES LETT, V28, P1259, DOI 10.1029/2000GL012447; Ray RD, 1997, PROG OCEANOGR, V40, P135, DOI 10.1016/S0079-6611(97)00025-6; Samelson RM, 1998, J PHYS OCEANOGR, V28, P712, DOI 10.1175/1520-0485(1998)028<0712:LSCWLE>2.0.CO;2; St Laurent L, 2002, J PHYS OCEANOGR, V32, P2882, DOI 10.1175/1520-0485(2002)032<2882:TROITI>2.0.CO;2; Thorpe SA, 1999, J PHYS OCEANOGR, V29, P1085, DOI 10.1175/1520-0485(1999)029<1085:OIWG>2.0.CO;2; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171; Wunsch C, 1998, J PHYS OCEANOGR, V28, P2332, DOI 10.1175/1520-0485(1998)028<2332:TWDBTW>2.0.CO;2	30	277	283	7	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					159	162		10.1038/nature01628	http://dx.doi.org/10.1038/nature01628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736682				2022-12-01	WOS:000182699600043
J	Groemping, Y; Lapouge, K; Smerdon, SJ; Rittinger, K				Groemping, Y; Lapouge, K; Smerdon, SJ; Rittinger, K			Molecular basis of phosphorylation-induced activation of the NADPH oxidase	CELL			English	Article							RESPIRATORY BURST OXIDASE; SRC HOMOLOGY-3 DOMAINS; PROTEIN-KINASE-C; CELL-FREE SYSTEM; SH3 DOMAIN; CRYSTAL-STRUCTURE; PX DOMAIN; P47(PHOX); BINDING; RECOGNITION	The multi-subunit NADPH oxidase complex plays a crucial role in host defense against microbial infection through the production of reactive oxygen species. Activation of the NADPH oxidase requires the targeting of a cytoplasmic p40-p47-p67(phox) complex to the membrane bound heterodimeric p22-gp91(phox) flavocytochrome. This interaction is prevented in the resting state due to an auto-inhibited conformation of p47(phox). The X-ray structure of the auto-inhibited form of p47(phox) reveals that tandem SH3 domains function together to maintain the cytoplasmic complex in an inactive form. Further structural and biochemical data show that phosphorylation of p47(phox) activates a molecular switch that relieves the inhibitory intramolecular interaction. This permits p47phox to interact with the cytoplasmic tail of p22(phox) and initiate formation of the active, membrane bound enzyme complex.	Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England	MRC National Institute for Medical Research	Rittinger, K (corresponding author), Natl Inst Med Res, Div Prot Struct, Mill Hill, London NW7 1AA, England.	katrin.rittinger@nimr.mrc.ac.uk	Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Smerdon, Stephen/0000-0001-5688-8465; Lapouge, Karine/0000-0003-0620-9553	Medical Research Council [MC_U117565398] Funding Source: Medline; MRC [MC_U117565398] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benard V, 1999, TRENDS PHARMACOL SCI, V20, P365, DOI 10.1016/S0165-6147(99)01367-X; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; deMendez I, 1997, MOL CELL BIOL, V17, P2177, DOI 10.1128/MCB.17.4.2177; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; FINAN P, 1994, J BIOL CHEM, V269, P13752; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Hata K, 1998, J BIOL CHEM, V273, P4232, DOI 10.1074/jbc.273.7.4232; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Huang J, 1999, J BIOL CHEM, V274, P19731, DOI 10.1074/jbc.274.28.19731; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lambeth JD, 2000, J BIOCHEM MOL BIOL, V33, P427; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Leusen Jeanette H. W., 1996, Frontiers in Bioscience (online), V1, pD72; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; Lim WA, 1996, STRUCTURE, V4, P657; Mayer BJ, 2001, J CELL SCI, V114, P1253; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nauseef WM, 1999, P ASSOC AM PHYSICIAN, V111, P373, DOI 10.1111/paa.1999.111.5.373; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noack D, 2001, BLOOD, V97, P305, DOI 10.1182/blood.V97.1.305; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JW, 1997, J BIOL CHEM, V272, P11035; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Prehoda KE, 2001, NAT STRUCT BIOL, V8, P570, DOI 10.1038/89586; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilson L, 1997, INFLAMM RES, V46, P265, DOI 10.1007/s000110050185; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	53	302	313	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					343	355		10.1016/S0092-8674(03)00314-3	http://dx.doi.org/10.1016/S0092-8674(03)00314-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732142	Bronze			2022-12-01	WOS:000182640800009
J	Ishitani, R; Nureki, O; Nameki, N; Okada, N; Nishimura, S; Yokoyama, S				Ishitani, R; Nureki, O; Nameki, N; Okada, N; Nishimura, S; Yokoyama, S			Alternative tertiary structure of tRNA for recognition by a posttranscriptional modification enzyme	CELL			English	Article							PHENYLALANINE TRANSFER-RNA; ARCHAEAL TRANSFER-RNA; MINIMAL TRANSFER-RNA; PSEUDOURIDINE SYNTHASE; GUANINE TRANSGLYCOSYLASE; MITOCHONDRIAL GENOMES; THERMOPHILIC ARCHAEA; CRYSTAL-STRUCTURE; WILD-TYPE; SEQUENCES	Transfer RNA (tRNA) canonically has the clover-leaf secondary structure with the acceptor, D, anticodon, and T arms, which are folded into the L-shaped tertiary structure. To strengthen the L form, posttranscriptional modifications occur on nucleotides buried within the core, but the modification enzymes are paradoxically inaccessible to them in the L form. In this study, we determined the crystal structure of tRNA bound with archaeosine tRNA-guanine transglycosylase, which modifies G15 of the D arm in the core. The bound tRNA assumes an alternative conformation ("lambda form") drastically different from the L form. All of the D-arm secondary base pairs and the canonical tertiary interactions are disrupted. Furthermore, a helical structure is reorganized, while the rest of the D arm is single stranded and protruded. Consequently, the enzyme precisely locates the exposed G15 in the active site, by counting the nucleotide number from G1 to G15 in the lambda form.	Univ Tokyo, Dept Biochem & Biophys, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; SPring 8, Harima Inst, RIKEN, Sayo, Hyogo 6795148, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; JST, PRESTO, Yokohama, Kanagawa 2268501, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Banyu Tsukuba Res Inst Merck, Tsukuba, Ibaraki 3002611, Japan	University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN; RIKEN; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Merck & Company	Yokoyama, S (corresponding author), Univ Tokyo, Dept Biochem & Biophys, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Nameki, Nobukazu/H-1764-2013; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338				AEBI M, 1990, J BIOL CHEM, V265, P16216; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Bai Y, 2000, J BIOL CHEM, V275, P28731, DOI 10.1074/jbc.M002174200; Bjork GR, 1999, FEBS LETT, V452, P47, DOI 10.1016/S0014-5793(99)00528-1; Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charette M, 2000, IUBMB LIFE, V49, P341; Davis DR., 1998, MODIFICATION EDITING, P85; EDMONDS CG, 1991, J BACTERIOL, V173, P3138, DOI 10.1128/JB.173.10.3138-3148.1991; Ferre-D'Amare AR, 2003, CURR OPIN STRUC BIOL, V13, P49, DOI 10.1016/S0959-440X(02)00002-7; Green R, 1999, BIOCHEMISTRY-US, V38, P1772, DOI 10.1021/bi982246a; GREGSON JM, 1993, J BIOL CHEM, V268, P10076; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588; Gutgsell NS, 2001, RNA, V7, P990, DOI 10.1017/S1355838201000243; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; HORIE N, 1985, BIOCHEMISTRY-US, V24, P5711, DOI 10.1021/bi00342a004; Ishitani R, 2002, J MOL BIOL, V318, P665, DOI 10.1016/S0022-2836(02)00090-6; Ishitani R, 2001, ACTA CRYSTALLOGR D, V57, P1659, DOI 10.1107/S0907444901011994; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAWAI G, 1992, BIOCHEMISTRY-US, V31, P1040, DOI 10.1021/bi00119a012; Khaitovich P, 1999, BIOCHEMISTRY-US, V38, P1780, DOI 10.1021/bi9822473; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; McCloskey JA, 1998, NUCLEIC ACIDS RES, V26, P196, DOI 10.1093/nar/26.1.196; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Ohtsuki T, 2002, FEBS LETT, V514, P37, DOI 10.1016/S0014-5793(02)02328-1; OKIMOTO R, 1990, EMBO J, V9, P3405, DOI 10.1002/j.1460-2075.1990.tb07542.x; OKIMOTO R, 1992, GENETICS, V130, P471; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROE BA, 1985, J BIOL CHEM, V260, P9759; SANNER MF, 1995, P 11 ACM S COMP GEOM, P104; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Watanabe M, 1997, J BIOL CHEM, V272, P20146, DOI 10.1074/jbc.272.32.20146; Watanabe M, 2001, J BIOL CHEM, V276, P2387, DOI 10.1074/jbc.M005043200; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; Yokoyama Shigeyuki, 1995, P207	49	145	150	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					383	394		10.1016/S0092-8674(03)00280-0	http://dx.doi.org/10.1016/S0092-8674(03)00280-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732145	Bronze			2022-12-01	WOS:000182640800012
J	Miralles, F; Posern, G; Zaromytidou, AI; Treisman, R				Miralles, F; Posern, G; Zaromytidou, AI; Treisman, R			Actin dynamics control SRF activity by regulation of its coactivator MAL	CELL			English	Article							SERUM-RESPONSE-FACTOR; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; TERNARY COMPLEX; RHOA; FAMILY; SIGNAL; DIFFERENTIATION; POLYMERIZATION	Rho GTPases regulate the transcription factor SRF via their ability to induce actin polymerization. SRF activity responds to G actin, but the mechanism of this has remained unclear. We show that Rho-actin signaling regulates the subcellular localization of the myocardin-related SRF coactivator MAL, rearranged in t(1;22)(p13;q13) AML. The MAL-SRF interaction displays the predicted properties of a Rho-regulated SRF cofactor. MAL is predominantly cytoplasmic in serum-starved cells, but accumulates in the nucleus following serum stimulation. Activation of the Rho-actin signaling pathway is necessary and sufficient to promote MAL nuclear accumulation. MAL N-terminal sequences, including two RPEL motifs, are required for the response to signaling, while other regions mediate its nuclear export (or cytoplasmic retention) and nuclear import. MAL associates with unpolymerized actin through its RPEL motifs. Constitutively cytoplasmic MAL derivatives interfere with MAL redistribution and Rho-actin signaling to SRF. MAL associates with several SRF target promoters regulated via the Rho-actin pathway.	Canc Res UK London Res Inst, Transcript Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK	Treisman, R (corresponding author), Canc Res UK London Res Inst, Transcript Lab, Lincolns Inn Fields Labs, Room 401,44 Lincolns Inn Fields, London WC2A 3PX, England.			Treisman, Richard/0000-0002-9658-0067; Miralles, Francesc/0000-0003-3069-2725				Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; GROSSE R, 2003, IN PRESS EMBO J, V22; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Murai K, 2002, MOL CELL BIOL, V22, P7083, DOI 10.1128/MCB.22.20.7083-7092.2002; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Posern G, 2000, ONCOGENE, V19, P6361, DOI 10.1038/sj.onc.1204027; Psichari E, 2002, J BIOL CHEM, V277, P29490, DOI 10.1074/jbc.M112368200; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835	31	1011	1049	1	47	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 2	2003	113	3					329	342		10.1016/S0092-8674(03)00278-2	http://dx.doi.org/10.1016/S0092-8674(03)00278-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732141	Bronze			2022-12-01	WOS:000182640800008
J	Stickler, DJ; Jones, GL; Russell, AD				Stickler, DJ; Jones, GL; Russell, AD			Control of encrustation and blockage of Foley catheters	LANCET			English	Article								Urinary catheters often become encrusted and blocked by crystalline Proteus mirabilis biofilms. Results of experiments In a laboratory model of a Foley catheterised bladder Infected with P mirabilis showed that when retention balloons were inflated with a solution of triclosan (10 g/L), the catheters drained freely for at least 7 days. Triclosan became impregnated throughout the silicone catheter material and completely Inhibited the formation of crystalline biofilm, whereas catheters inflated with water became blocked in 24 h. Our observations suggest a way to control a common complication in patients with long-term indwelling bladder catheters.	Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales; Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Stickler, DJ (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales.							BIBBY JM, 1995, CELLS MAT, V2, P183; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Kunin CM, 1997, URINARY TRACT INFECT, V5th, P226; Morris NS, 1997, BRIT J UROL, V80, P58, DOI 10.1046/j.1464-410X.1997.00185.x; Stickler DJ, 2002, J APPL MICROBIOL, V92, p163S, DOI 10.1046/j.1365-2672.92.5s1.6.x	5	59	70	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 26	2003	361	9367					1435	1437		10.1016/S0140-6736(03)13104-2	http://dx.doi.org/10.1016/S0140-6736(03)13104-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727400				2022-12-01	WOS:000182516300015
J	Swingler, S; Brichacek, B; Jacque, JM; Ulich, C; Zhou, J; Stevenson, M				Swingler, S; Brichacek, B; Jacque, JM; Ulich, C; Zhou, J; Stevenson, M			HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection	NATURE			English	Article							T-CELLS; ACTIVATION; REPLICATION; VIRUS; LYMPHOCYTES; INHIBITION; EVASION; THERAPY	All primate lentiviruses (HIV-1, HIV-2, SIV) encode Nef proteins, which are important for viral replication and pathogenicity in vivo(1-3). It is not known how Nef regulates these processes. It has been suggested that Nef protects infected cells from apoptosis and recognition by cytotoxic T lymphocytes(4-6). Other studies suggest that Nef influences the activation state of the infected cell, thereby enhancing the ability of that cell to support viral replication(7-10). Here we show that macrophages that express Nef or are stimulated through the CD40 receptor release a paracrine factor that renders T lymphocytes permissive to HIV-1 infection. This activity requires the upregulation of B-cell receptors involved in the alternative pathway of T-lymphocyte stimulation. T lymphocytes stimulated through this pathway become susceptible to viral infection without progressing through the cell cycle. We identify two proteins, soluble CD23 and soluble ICAM, that are induced from macrophages by Nef and CD40L, and which mediate their effects on lymphocyte permissivity. Our results reveal a mechanism by which Nef expands the cellular reservoir of HIV-1 by permitting the infection of resting T lymphocytes.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Stevenson, M (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.		Jacque, Jean-Marc/B-6875-2008		NIAID NIH HHS [R01 AI037475, R01 AI032890] Funding Source: Medline; NIMH NIH HHS [R01 MH093306, R01 MH064411] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Davis SJ, 1996, SCIENCE, V273, P1241, DOI 10.1126/science.273.5279.1241; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; GRUBER MF, 1995, J IMMUNOL, V154, P5528; Jamieson BD, 1998, J VIROL, V72, P6520, DOI 10.1128/JVI.72.8.6520-6526.1998; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; KALTER DC, 1991, J IMMUNOL, V146, P298; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lisignoli G, 1996, EUR J IMMUNOL, V26, P17, DOI 10.1002/eji.1830260104; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	28	190	195	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					213	219		10.1038/nature01749	http://dx.doi.org/10.1038/nature01749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853962	Green Accepted			2022-12-01	WOS:000184032700047
J	Hajjar, I; Kotchen, TA				Hajjar, I; Kotchen, TA			Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE; NATIONAL-HEALTH; POPULATION	Context Prior analyses of National Health and Nutrition Examination Survey (NHANES) data through 1991 have suggested that hypertension prevalence is declining, but more recent self-reported rates of hypertension suggest that the rate is increasing. Objective To describe trends in the prevalence, awareness, treatment, and control of hypertension in the United States using NHANES data. Design, Setting, and Participants Survey using a stratified multistage probability sample of the civilian noninstitutionalized population. The most recent NHANES survey, conducted in 1999-2000 (n=5448), was compared with the 2 phases of NHANES III conducted in 1988-1991 (n=9901) and 1991-1994 (n =9717). Individuals aged 18 years or older were included in this analysis. Main Outcome Measures Hypertension, defined as a measured blood pressure of 140/90 mm Hg or greater or reported use of anti hypertensive medications. Hypertension awareness and treatment were assessed with standardized questions. Hypertension control was defined as treatment with anti hypertensive medication and a measured blood pressure of less than 140/90 mm Hg. Results In 1999-2000, 28.7% of NHANES participants had hypertension, an increase of 3.7% (95% confidence interval [CI], 0%-8.3%) from 1988-1991. Hypertension prevalence was highest in non-Hispanic blacks (33.5%), increased with age (65.4% among those aged greater than or equal to60 years), and tended to be higher in women (30.1%). In a multiple regression analysis, increasing age, increasing body mass index, and non-Hispanic black race/ethnicity were independently associated with increased rates of hypertension. Overall, in 1999-2000, 68.9% were aware of their hypertension (nonsignificant decline of -0.3%; 95% CI, -4.2% to 3.6%), 58.4% were treated (increase of 6.0%; 95% Cl, 1.2%-10.8%), and hypertension was controlled in 31.0% (increase of 6.4%; 95% Cl, 1.6%-11.2%). Women, Mexican Americans, and those aged 60 years or older had significantly lower rates of control compared with men, younger individuals, and non-Hispanic whites. Conclusions Contrary to earlier reports, hypertension prevalence is increasing in the United States. Hypertension control rates, although improving, continue to be low. Programs targeting hypertension prevention and treatment are of utmost importance.	Univ S Carolina, Palmetto Hlth Alliance, Dept Med, Div Geriatr, Columbia, SC 29203 USA; Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Epidemiol, Milwaukee, WI 53226 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical College of Wisconsin; Medical College of Wisconsin	Hajjar, I (corresponding author), Univ S Carolina, Palmetto Hlth Alliance, Dept Med, Div Geriatr, 9 Med Pk,Suite 230, Columbia, SC 29203 USA.	ihab.hajjar@palmettohealth.org						[Anonymous], 1991, JAMA, V265, P3255; [Anonymous], VITAL HLTH STAT; [Anonymous], 1996, ANAL REPORTING GUIDE; AYLA C, 2002, MMWR-MORBID MORTAL W, V51, P456; Baines LA, 2001, DIABETES, V50, P843; Barker WH, 1998, HYPERTENSION, V31, P552, DOI 10.1161/01.HYP.31.1.552; BERGLUND PA, 2002, P 27 ANN SAS US GROU; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Goff DC, 2001, ANN EPIDEMIOL, V11, P271, DOI 10.1016/S1047-2797(00)00224-6; Hansson L, 1999, BLOOD PRESSURE, V8, P196; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Kannel W B, 1995, Hypertens Res, V18, P181, DOI 10.1291/hypres.18.181; KANNEL WB, 1993, J CARDIOVASC PHARM, V21, pS27, DOI 10.1097/00005344-199321002-00006; Klein RJ, HLTH PEOPLE 2010 STA, V2001, P1, DOI DOI 10.1037/E583772012-001; Kotchen JM, 1998, AM J PUBLIC HEALTH, V88, P1696, DOI 10.2105/AJPH.88.11.1696; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; Lloyd-Jones DM, 2002, HYPERTENSION, V40, P640, DOI 10.1161/01.HYP.0000035855.44620.DA; *NAT AC AG SOC, 2000, HYP COMM COND OLD AM; *NAT HLTH NUTR EX, 1989, CYCL 2 BLOOD PRESS Q; Neal B, 2000, LANCET, V356, P1955; *NHANES, 2002, BLOOD PRESS SECT PHY; Rust K, 1985, J OFF STAT, V1, P381; Rust K F, 1996, Stat Methods Med Res, V5, P283, DOI 10.1177/096228029600500305; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; *US DEP HHS, 2000, HLTH PEOPL 2010 UND; Vargas CM, 1997, PREV MED, V26, P678, DOI 10.1006/pmed.1997.0190; Wassertheil-Smoller S, 2000, HYPERTENSION, V36, P780, DOI 10.1161/01.HYP.36.5.780; *WEST INC, 1996, NAT HLTH NUTR EX SUR; 1992, VITAL HLTH STAT, V2, P1; 1997, ARCH INTERN MED, V157, P2413; 1995, HLTH PEOPLE 2000 MID	36	1687	1829	4	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2003	290	2					199	206		10.1001/jama.290.2.199	http://dx.doi.org/10.1001/jama.290.2.199			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698GH	12851274	Bronze			2022-12-01	WOS:000183989800024
J	Masoudi, FA; Wang, YF; Inzucchi, SE; Setaro, JF; Havranek, EP; Foody, JM; Krumholz, HM				Masoudi, FA; Wang, YF; Inzucchi, SE; Setaro, JF; Havranek, EP; Foody, JM; Krumholz, HM			Metformin and thiazolidinedione use in medicare patients with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LACTIC-ACIDOSIS; THERAPY; CONTRAINDICATIONS	Context According to package inserts, metformin is contraindicated in diabetic patients receiving drug treatment for heart failure therapy, and thiazolidinediones are not recommended in diabetic patients with symptoms of advanced heart failure. Little is known about patterns of use of these anti hyperglycemic drugs in diabetic patients with heart failure. Objective To determine the proportions of patients hospitalized with heart failure and concomitant diabetes treated with metformin or thiazolidinediones. Design Serial cross-sectional measurements using data from retrospective medical record abstraction. Setting Nongovernmental acute care hospitals in the United States. Patients Two nationally representative samples of Medicare beneficiaries hospitalized with the primary diagnosis of heart failure and concomitant diabetes between April 1998 and March 1999 and between July 2000 and June 2001. Main Outcome Measures The prescription of either metformin or a thiazolidinedione at hospital discharge. Results In the 1998-1999 sample (n=12505), 7.1% of patients were discharged with a prescription for metformin, 7.2% with a prescription for a thiazolidinedione, and 13.5% with a prescription for either drug. In the 2000-2001 sample (n=13158), metformin use increased to 11.2%, thiazolidinedione use to 16.1%, And use of either drug to 24.4% (P<.001 for all comparisons). Similar increases were seen among patients of all age groups, all races, and both sexes. Conclusions The use of metformin and thiazolidinediones is common and has increased rapidly in Medicare beneficiaries with diabetes and heart failure in direct contrast with explicit warnings against this practice by the Food and Drug Administration. Further studies to establish the safety and effectiveness of this practice are needed to ensure optimal care of patients with diabetes and heart failure.	Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Endocrinol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Cardiol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Geriatr Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Dept Med,Div Cardiol, Denver, CO USA; Colorado Fdn Med Care, Aurora, CO USA	Yale University; Yale University; Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, 333 Cedar St,Room I-456 SHM,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Inzucchi, Silvio/ABF-4121-2021; Masoudi, Frederick/Q-7467-2019		NATIONAL INSTITUTE ON AGING [K08AG001011] Funding Source: NIH RePORTER; NCI NIH HHS [500-02-CO 01] Funding Source: Medline; NIA NIH HHS [K08-AG01011] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213; *BRIST MYERS SQUIB, GLUC GLUC XR PRESCR; CAMPBELL IW, 1985, HORM METAB RES, V15, P105; Emslie-Smith AM, 2001, DIABETIC MED, V18, P483, DOI 10.1046/j.1464-5491.2001.00509.x; Ghazzi MN, 1997, DIABETES, V46, P433, DOI 10.2337/diabetes.46.3.433; *GLAX PHARM, 2002, AV PRESCR INF; Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197; Holstein A, 1999, DIABETIC MED, V16, P692, DOI 10.1046/j.1464-5491.1999.00115.x; Horlen C, 2002, JAMA-J AM MED ASSOC, V287, P2504, DOI 10.1001/jama.287.19.2504-a; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; INZUCCHI SE, 2002, PRACT DIABETOL, V21, P7; LUFT D, 1978, DIABETOLOGIA, V14, P75, DOI 10.1007/BF01263444; *MED EC CO INC, 1998, PHYS DESK REF; *MED EC CO INC, 1999, PHYS DESK REF; Misbin RI, 1998, NEW ENGL J MED, V338, P265, DOI 10.1056/NEJM199801223380415; Parulkar AA, 2001, ANN INTERN MED, V134, P61, DOI 10.7326/0003-4819-134-1-200101020-00014; SALPETER S, 2002, COCHRANE DB SYST REV, V2, P2967; Stang M, 1999, DIABETES CARE, V22, P925, DOI 10.2337/diacare.22.6.925; *TAK PHARM, 2002, ACT PRESCR INF; Tang WHW, 2003, J AM COLL CARDIOL, V41, P1394, DOI 10.1016/S0735-1097(03)00159-1; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; *US FDA, SUMM ACT AV; WIHOLM BE, 1993, EUR J CLIN PHARMACOL, V44, P589, DOI 10.1007/BF02440866	23	95	96	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					81	85		10.1001/jama.290.1.81	http://dx.doi.org/10.1001/jama.290.1.81			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837715	Bronze			2022-12-01	WOS:000183868600023
J	Klausner, RD; Fauci, AS; Corey, L; Nabel, GJ; Gayle, H; Berkley, S; Haynes, BF; Baltimore, D; Collins, C; Douglas, RG; Esparza, J; Francis, DP; Ganguly, NK; Gerberding, JL; Johnston, MI; Kazatchkine, MD; McMichael, AJ; Makgoba, MW; Pantaleo, G; Piot, P; Shao, YM; Tramont, E; Varmus, H; Wasserheit, JN				Klausner, RD; Fauci, AS; Corey, L; Nabel, GJ; Gayle, H; Berkley, S; Haynes, BF; Baltimore, D; Collins, C; Douglas, RG; Esparza, J; Francis, DP; Ganguly, NK; Gerberding, JL; Johnston, MI; Kazatchkine, MD; McMichael, AJ; Makgoba, MW; Pantaleo, G; Piot, P; Shao, YM; Tramont, E; Varmus, H; Wasserheit, JN			The need for a global HIV vaccine enterprise	SCIENCE			English	Editorial Material									Bill & Melinda Gates Fdn, Seattle, WA 98102 USA; NIAID, Div AIDS, NIH, Vaccine & Prevent Res Program, Bethesda, MD 20892 USA; NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Program Infect Dis, Seattle, WA 98109 USA; Univ Washington, Dept Lab Med, Seattle, WA 98109 USA; Int AIDS Vaccine Initiat, New York, NY 10038 USA; Duke Univ, Sch Med, Durham, NC 27710 USA; CALTECH, Pasadena, CA 91125 USA; AIDS Vaccine Advocacy Coalit, New York, NY 10011 USA; Sequella Global TB Fdn, Rockville, MD 20850 USA; WHO, UNAIDS, Joint UN Programme HIV AIDS, HIV Vaccine Initiat, Geneva 27, Switzerland; VaxGen Inc, Brisbane, CA 94005 USA; Indian Council Med Res, New Delhi 110029, India; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; ANRS, F-75013 Paris, France; Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Natal, ZA-4041 Durban, South Africa; Univ Lausanne, CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Bill & Melinda Gates Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Duke University; California Institute of Technology; UNAIDS; World Health Organization; Indian Council of Medical Research (ICMR); Centers for Disease Control & Prevention - USA; University of Oxford; University of Kwazulu Natal; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Memorial Sloan Kettering Cancer Center	Klausner, RD (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98102 USA.		Corey, Lawrence/AAE-1796-2020; Pantaleo, Giuseppe/K-6163-2016	Corey, Lawrence/0000-0002-2179-2436; 				FRANCIS DW, COMMUNICATION; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X	2	156	167	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2036	2039		10.1126/science.1086916	http://dx.doi.org/10.1126/science.1086916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829768				2022-12-01	WOS:000183774900028
J	Paratcha, G; Ledda, F; Ibanez, CF				Paratcha, G; Ledda, F; Ibanez, CF			The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family Ligands	CELL			English	Article							MICE LACKING GDNF; C-RET PROTOONCOGENE; TYROSINE KINASE; N-CAM; SYNAPTIC PLASTICITY; FGF RECEPTOR; NERVOUS-SYSTEM; LIPID RAFTS; NEURONAL SURVIVAL; AXONAL GROWTH	Intercellular communication involves either direct cell-cell contact or release and uptake of diffusible signals, two strategies mediated by distinct and largely non-overlapping sets of molecules. Here, we show that the neural cell adhesion molecule NCAM can function as a signaling receptor for members of the GDNF ligand family. Association of NCAM with GFRalpha1, a GPI-anchored receptor for GDNF, downregulates NCAM-mediated cell adhesion and promotes high-affinity binding of GDNF to p140(NCAM), resulting in rapid activation of cytoplasmic protein tyrosine kinases Fyn and FAK in cells lacking RET, a known GDNF signaling receptor. GDNF stimulates Schwann cell migration and axonal growth in hippocampal and cortical neurons via binding to NCAM and activation of Fyn, but independently of RET. These results uncover an unexpected intersection between short- and long-range mechanisms of intercellular communication and reveal a pathway for GDNF signaling that does not require the RET receptor.	Karolinska Inst, Div Mol Neurobiol, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet	Ibanez, CF (corresponding author), Karolinska Inst, Div Mol Neurobiol, Dept Neurosci, Retzius Vag 8,A2-2, S-17177 Stockholm, Sweden.			Paratcha, Gustavo/0000-0002-0804-4433				Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chao CC, 2003, NEUROBIOL AGING, V24, P105, DOI 10.1016/S0197-4580(02)00047-7; Chazal G, 2000, J NEUROSCI, V20, P1446; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 2000, INT J DEV NEUROSCI, V18, P213, DOI 10.1016/S0736-5748(99)00090-8; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; KLINZ SG, 1995, J NEUROCHEM, V65, P84; Kokaia Z, 1999, EUR J NEUROSCI, V11, P1202, DOI 10.1046/j.1460-9568.1999.00513.x; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Maness PF, 1996, PERSPECT DEV NEUROBI, V4, P169; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nanobashvili A, 2000, P NATL ACAD SCI USA, V97, P12312, DOI 10.1073/pnas.97.22.12312; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Poteryaev D, 1999, FEBS LETT, V463, P63, DOI 10.1016/S0014-5793(99)01590-2; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; Saffell JL, 1995, MOL CELL NEUROSCI, V6, P521, DOI 10.1006/mcne.1995.0004; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Thomaidou D, 2001, J NEUROCHEM, V78, P767, DOI 10.1046/j.1471-4159.2001.00454.x; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yu T, 1998, J NEUROSCI, V18, P4684	50	448	480	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 27	2003	113	7					867	879		10.1016/S0092-8674(03)00435-5	http://dx.doi.org/10.1016/S0092-8674(03)00435-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837245	Bronze			2022-12-01	WOS:000183817900011
J	Missler, M; Zhang, WQ; Rohlmann, A; Kattenstroth, G; Hammer, RE; Gottmann, K; Sudhof, TC				Missler, M; Zhang, WQ; Rohlmann, A; Kattenstroth, G; Hammer, RE; Gottmann, K; Sudhof, TC			alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis	NATURE			English	Article							CALCIUM CHANNELS; TRANSMITTER RELEASE; MICE LACKING; NEOCORTICAL NEURONS; LATROTOXIN RECEPTOR; GABAERGIC SYNAPSES; NERVE-TERMINALS; PYRAMIDAL CELLS; RAT NEOCORTEX; BRAIN	Synapses are specialized intercellular junctions in which cell adhesion molecules connect the presynaptic machinery for neurotransmitter release to the postsynaptic machinery for receptor signalling. Neurotransmitter release requires the presynaptic co-assembly of Ca2+ channels with the secretory apparatus, but little is known about how synaptic components are organized. alpha-Neurexins, a family of > 1,000 presynaptic cell-surface proteins encoded by three genes, link the pre- and postsynaptic compartments of synapses by binding extracellularly to postsynaptic cell adhesion molecules and intracellularly to presynaptic PDZ domain proteins. Using triple-knockout mice, we show that alpha-neurexins are not required for synapse formation, but are essential for Ca2+-triggered neurotransmitter release. Neurotransmitter release is impaired because synaptic Ca2+ channel function is markedly reduced, although the number of cell-surface Ca2+ channels appears normal. These data suggest that alpha-neurexins organize presynaptic terminals by functionally coupling Ca2+ channels to the presynaptic machinery.	Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Ctr Basic Neurosci, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Gottingen, Zentrum Physiol & Pathophysiol, D-37073 Gottingen, Germany; Ruhr Univ Bochum, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Gottingen; Ruhr University Bochum	Missler, M (corresponding author), Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.			Rohlmann, Astrid/0000-0003-0869-6893; Missler, Markus/0000-0001-8008-984X				Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Geppert M, 1998, J BIOL CHEM, V273, P1705, DOI 10.1074/jbc.273.3.1705; Hata Y, 1996, J NEUROSCI, V16, P2488; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Katz B., 1969, RELEASE NEURAL TRANS; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Ludwig A, 1997, J NEUROSCI, V17, P1339; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mohrmann R, 1999, J NEUROSCI, V19, P10004; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muth JN, 2001, TRENDS PHARMACOL SCI, V22, P526, DOI 10.1016/S0165-6147(00)01797-1; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; Plitzko D, 2001, EUR J NEUROSCI, V14, P1412, DOI 10.1046/j.0953-816x.2001.01740.x; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Saegusa H, 2000, P NATL ACAD SCI USA, V97, P6132, DOI 10.1073/pnas.100124197; Sakmann B., 1995, SINGLE CHANNEL RECOR; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Singer JH, 1996, J NEUROPHYSIOL, V76, P799, DOI 10.1152/jn.1996.76.2.799; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Zhang W, 1999, EUR J NEUROSCI, V11, P2332, DOI 10.1046/j.1460-9568.1999.00655.x	50	480	494	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					939	948		10.1038/nature01755	http://dx.doi.org/10.1038/nature01755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827191				2022-12-01	WOS:000183753900039
J	Harrap, SB				Harrap, SB			Where are all the blood-pressure genes?	LANCET			English	Review							COMPLEX HUMAN-DISEASES; WIDE LINKAGE ANALYSIS; GENOME SCAN; SUSCEPTIBILITY; DISEQUILIBRIUM; HYPERTENSION; PATTERNS; FAMILY; TRAITS	Context The potential for discovery of underlying genetic causes for common conditions, such as hypertension, is a major justification for the human genome project. Hopes have been raised that personalised molecular prognostic and therapeutic strategies will result from genomic studies. Starting point The largest and most recent searches of the genome (Mark Caulfield and colleagues, Lancet 2003; 361: 2118-23; Michael Province and colleagues, Am J Hypertens 2003; 16: 144-47) have found limited evidence of genes that determine hypertension, and even less evidence for the existence of causative DNA variants (alleles) within these genes. Previous genomic studies did not reach a consensus on the likely location of blood-pressure genes. The difficulty in identifying genetic causes for common conditions might be because the causative alleles are numerous, with small individual impact, and are distributed unevenly between populations. Where next? Without comprehensive and reliable description of the alleles associated with hypertension, using genetics for diagnosis remains tenuous. However, the discovery of a single allele proven to be associated with control of blood pressure could lead to the discovery of relevant and hovel physiological targets for the prevention and treatment of hypertension.	Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia	University of Melbourne	Harrap, SB (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia.			Harrap, Stephen/0000-0003-2907-6714				Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Bashyam MD, 2003, J HUM GENET, V48, P55, DOI 10.1007/s100380300007; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harrap SB, 2000, AM J EPIDEMIOL, V152, P704, DOI 10.1093/aje/152.8.704; Harrap SB, 2002, PHYSIOL GENOMICS, V8, P99, DOI 10.1152/physiolgenomics.00069.2001; HARRAP SB, 1986, HYPERTENSION, V8, P572, DOI 10.1161/01.HYP.8.7.572; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaplan N, 2001, GENET EPIDEMIOL, V20, P432, DOI 10.1002/gepi.1012; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Phillips PC, 1999, TRENDS GENET, V15, P6, DOI 10.1016/S0168-9525(98)01622-9; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Province MA, 2003, AM J HYPERTENS, V16, P144, DOI 10.1016/S0895-7061(02)03248-X; Ranade K, 2003, AM J HYPERTENS, V16, P158, DOI 10.1016/S0895-7061(02)03245-4; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Thiel BA, 2003, AM J HYPERTENS, V16, P151, DOI 10.1016/S0895-7061(02)03246-6; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405; Zhu DL, 2001, J HYPERTENS, V19, P55, DOI 10.1097/00004872-200101000-00008	30	56	65	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 21	2003	361	9375					2149	2151		10.1016/S0140-6736(03)13694-X	http://dx.doi.org/10.1016/S0140-6736(03)13694-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	692GY	12826450				2022-12-01	WOS:000183654200025
J	Kuo, AL; Gulbis, JM; Antcliff, JF; Rahman, T; Lowe, ED; Zimmer, J; Cuthbertson, J; Ashcroft, FM; Ezaki, T; Doyle, DA				Kuo, AL; Gulbis, JM; Antcliff, JF; Rahman, T; Lowe, ED; Zimmer, J; Cuthbertson, J; Ashcroft, FM; Ezaki, T; Doyle, DA			Crystal structure of the potassium channel KirBac1.1 in the closed state	SCIENCE			English	Article							RECTIFIER K+ CHANNEL; ACETYLCHOLINE-RECEPTOR; RECTIFICATION; PERMEATION; PORE; RESOLUTION; MECHANISM; DYNAMICS; SPERMINE; DOMAINS	The KirBac1.1 channel belongs to the inward-rectifier family of potassium channels. Here we report the structure of the entire prokaryotic Kir channel assembly, in the closed state, refined to a resolution of 3.65 angstroms. We identify the main activation gate and structural elements involved in gating. On the basis of structural evidence presented here, we suggest that gating involves coupling between the intracellular and membrane domains. This further suggests that initiation of gating by membrane or intracellular signals represents different entry points to a common mechanistic pathway.	Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England; Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3050, Australia; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Gifu Univ, Grad Sch Med Regenerat & Adv Med Sci, Dept Microbiol & Bioinformat, Gifu 5008705, Japan	University of Oxford; Walter & Eliza Hall Institute; University of Oxford; Gifu University	Doyle, DA (corresponding author), Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England.		Lowe, Edward/AAP-5381-2021	Lowe, Edward/0000-0002-1757-0208; Zimmer, Jochen/0000-0002-8423-2882				Ashcroft F. M., 2000, ION CHANNELS DIS; Beckstein O, 2001, J PHYS CHEM B, V105, P12902, DOI 10.1021/jp012233y; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Hille B., 2001, IONIC CHANNELS EXCIT, P814; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TAM SC, 1984, J CHEM SOC FARAD T 1, V80, P2255, DOI 10.1039/f19848002255; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	27	631	649	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1922	1926		10.1126/science.1085028	http://dx.doi.org/10.1126/science.1085028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12738871				2022-12-01	WOS:000183619400039
J	Abbott, A				Abbott, A			British panel bans use of antidepressant to treat children	NATURE			English	News Item																			0	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					792	792		10.1038/423792a	http://dx.doi.org/10.1038/423792a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815392	Bronze			2022-12-01	WOS:000183585300009
J	Ohtake, F; Takeyama, K; Matsumoto, T; Kitagawa, H; Yamamoto, Y; Nohara, K; Tohyama, C; Krust, A; Mimura, J; Chambon, P; Yanagisawa, J; Fujii-Kuriyama, Y; Kato, S				Ohtake, F; Takeyama, K; Matsumoto, T; Kitagawa, H; Yamamoto, Y; Nohara, K; Tohyama, C; Krust, A; Mimura, J; Chambon, P; Yanagisawa, J; Fujii-Kuriyama, Y; Kato, S			Modulation of oestrogen receptor signalling by association with the activated dioxin receptor	NATURE			English	Article							ESTROGEN-RECEPTOR; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TRANSCRIPTION FACTOR; GENE-EXPRESSION; C-FOS; NUCLEAR RECEPTORS; AH RECEPTOR; ENDOMETRIOSIS; ALPHA; INHIBITION	Environmental contaminants affect a wide variety of biological events in many species. Dioxins are typical environmental contaminants that exert adverse oestrogen-related effects(1). Although their anti-oestrogenic actions(2,3) are well described, dioxins can also induce endometriosis(4-7) and oestrogen-dependent tumours(8,9), implying possible oestrogenic effects. However, the molecular mechanism underlying oestrogen-related actions of dioxins remains largely unknown. A heterodimer of the dioxin receptor (AhR) and Arnt, which are basic helix-loop-helix/PAS-family transcription factors, mediates most of the toxic effects of dioxins(10,11). Here we show that the agonist-activated AhR/Arnt heterodimer directly associates with oestrogen receptors ER-alpha and ER-beta. This association results in the recruitment of unliganded ER and the co-activator p300 to oestrogen-responsive gene promoters, leading to activation of transcription and oestrogenic effects. The function of liganded ER is attenuated. Oestrogenic actions of AhR agonists were detected in wild-type ovariectomized mouse uteri, but were absent in AhR(-/-) or ER-alpha(-/-) ovariectomized mice. Our findings suggest a novel mechanism by which ER-mediated oestrogen signalling is modulated by a co-regulatory-like function of activated AhR/Arnt, giving rise to adverse oestrogen-related actions of dioxin-type environmental contaminants.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol, SORST, Kawaguchi, Saitama 3320012, Japan; Taiho Pharmaceut Co Ltd, Canc Res Lab, Hanno Res Ctr, Hanno, Saitama 3578527, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan; Univ Strasbourg 1, Coll France, CNRS,INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058577, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Taiho Pharmaceutical; National Institute for Environmental Studies - Japan; Japan Science & Technology Agency (JST); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Tsukuba	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Mimura, Junsei/E-7893-2013; Tohyama, Chiharu/AAI-5598-2020	Tohyama, Chiharu/0000-0003-1061-6872				ASTROFF B, 1991, TOXICOL LETT, V56, P305, DOI 10.1016/0378-4274(91)90159-4; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; Bock K W, 1994, Rev Physiol Biochem Pharmacol, V125, P1, DOI 10.1007/BFb0030908; Brown NM, 1998, CARCINOGENESIS, V19, P1623, DOI 10.1093/carcin/19.9.1623; Cummings AM, 1996, TOXICOL APPL PHARM, V138, P131, DOI 10.1006/taap.1996.0106; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Davis BJ, 2000, CANCER RES, V60, P5414; Dupont S, 2000, DEVELOPMENT, V127, P4277; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; GIBBONS A, 1993, SCIENCE, V262, P1373, DOI 10.1126/science.8248776; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; KRISHNAN V, 1995, MOL CELL BIOL, V15, P6710; Kuchenhoff A, 1999, FERTIL STERIL, V71, P354, DOI 10.1016/S0015-0282(98)00437-3; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mayani A, 1997, HUM REPROD, V12, P373, DOI 10.1093/humrep/12.2.373; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; PUGA A, 1992, DNA CELL BIOL, V11, P269, DOI 10.1089/dna.1992.11.269; RIER SE, 1993, FUND APPL TOXICOL, V21, P433, DOI 10.1006/faat.1993.1119; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Sogawa K, 1997, J BIOCHEM, V122, P1075; Tian Y, 1998, J STEROID BIOCHEM, V67, P17, DOI 10.1016/S0960-0760(98)00067-3; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1	30	592	630	2	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					545	550		10.1038/nature01606	http://dx.doi.org/10.1038/nature01606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774124				2022-12-01	WOS:000183162900045
J	Osborn, DPJ; King, MB; Nazareth, I				Osborn, DPJ; King, MB; Nazareth, I			Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice	BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL HEALTH		UCL, Dept Psychiat & Behav Sci, London NW3 2PF, England; UCL, Dept Primary Care & Populat, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Osborn, DPJ (corresponding author), UCL, Dept Psychiat & Behav Sci, London NW3 2PF, England.	dosborn@rfc.ucl.ac.uk	King, Michael B/D-7477-2011; Osborn, David/B-8165-2009	King, Michael B/0000-0003-4715-7171; Osborn, David/0000-0003-2519-1539; Nazareth, Irwin/0000-0003-2146-9628				National Institute for Clinical Excellence, 2002, SCHIZ COR INT TREATM; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; Osborn DPJ, 2001, WESTERN J MED, V175, P329, DOI 10.1136/ewjm.175.5.329; Phelan M, 2001, BRIT MED J, V322, P443, DOI 10.1136/bmj.322.7284.443; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	5	49	49	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 24	2003	326	7399					1122	1123		10.1136/bmj.326.7399.1122	http://dx.doi.org/10.1136/bmj.326.7399.1122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	685DF	12763984	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000183245000020
J	Enstrom, JE; Kabat, GC				Enstrom, JE; Kabat, GC			Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PASSIVE SMOKING; LUNG-CANCER; METAANALYSIS; EXPOSURE; TRENDS	Objective To measure the relation between environmental tobacco smoke, as estimated by smoking in Spouses, and long term mortality from tobacco related disease. Design Prospective Cohort Study covering 39 years. Setting Adult population of California, United States. Participants 118 094 adults enrolled in late 1959 in the American Cancer Society cancer prevention study, who were followed until 1998. Particular focus is on the 35 561 never smokers who had a spouse in the study with known smoking habits. Main outcome measures Relative risks and 95% confidence intervals for deaths from coronary heart disease, lung cancer, and chronic obstructive pulmonary disease related to smoking in spouses and active cigarette smoking. Results For participants followed from 1960 until 1998 the age adjusted relative risk (95% confidence interval) for never smokers married to ever smokers compared with never smokers married to never smokers was 0.94 (0.85 to 1.05) for coronary heart disease, 0.75 (0.42 to 135) for lung cancer, and 1.27 (0.78 to 2.08) for chronic obstructive pulmonary disease among 9619 men, mid 1.01 (0.94 to 1.08), 0.99 (0.72 to 1.37), mid 1.13 (0.80 to 1.58), respectively, among 25 942 women. No significant associations were found for current or former exposure to environmental tobacco smoke before or after adjusting for seven confounders and before or after excluding participants with pre-existing disease. No significant associations were found during tire shorter follow tip periods of 1960-5, 1966-72, 1973-85 mid 1973-98. Conclusions The results do not support a causal relation between environmental tobacco smoke and tobacco related mortality, although they do not rule out a small effect. The association between exposure to environmental tobacco smoke and coronary heart disease and lung, cancer may be considerably weaker than generally believed.	Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA	University of California System; University of California Los Angeles; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Enstrom, JE (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA.	jenstrom@ucla.edu						Bailar JC, 1999, NEW ENGL J MED, V340, P958, DOI 10.1056/NEJM199903253401211; BURNS DM, 1997, SMOKING TOBACCO CONT, V8, P113; Enstrom JE, 1999, EPIDEMIOLOGY, V10, P500, DOI 10.1097/00001648-199909000-00007; ENSTROM JE, 1980, J NATL CANCER I, V65, P1175; FLEISS JL, 1991, J CLIN EPIDEMIOL, V44, P127, DOI 10.1016/0895-4356(91)90261-7; GARFINKEL L, 1981, JNCI-J NATL CANCER I, V66, P1061, DOI 10.1093/jnci/66.6.1061; GORI GB, 1999, PASSIVE SMOKE EPAS B; Green CR, 1997, J HEALTH POLIT POLIC, V22, P1279, DOI 10.1215/03616878-22-5-1279; Hackshaw AK, 1997, BMJ-BRIT MED J, V315, P980, DOI 10.1136/bmj.315.7114.980; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; LEE PN, 1992, ENV TOBACCO SMOKE MO; LEVOIS ME, 1995, REGUL TOXICOL PHARM, V21, P184, DOI 10.1006/rtph.1995.1023; LeVois ME, 1998, BRIT MED J, V317, P344, DOI 10.1136/bmj.317.7154.344; *NAT CANC I, 1999, NIH PUBL; *NAT CANC I, 1999, SMOK TOB CONTR MON, V10; SCHAAD UB, 1995, PEDIATR INFECT DIS J, V14, P1, DOI 10.1097/00006454-199501000-00001; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schall LC, 2001, ANN EPIDEMIOL, V11, P292, DOI 10.1016/S1047-2797(00)00217-9; SO Y, 1992, SAS STAT SOFTWARE; TAYLOR AE, 1992, CIRCULATION, V86, P1; Thun M, 1999, ENVIRON HEALTH PERSP, V107, P841, DOI 10.2307/3434563; *US DEP HHS, 2001, WOM SMOK REP SURG GE, P343; *US EPA, 1992, 600690006F EPA; *US EPA, 1992, NIH PUBL	27	125	130	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2003	326	7398					1057	+		10.1136/bmj.326.7398.1057	http://dx.doi.org/10.1136/bmj.326.7398.1057			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681ZD	12750205	Bronze, Green Published			2022-12-01	WOS:000183064700013
J	Hay, SI; Were, EC; Renshaw, M; Noor, AM; Ochola, SA; Olusanmi, L; Alipui, N; Snow, RW				Hay, SI; Were, EC; Renshaw, M; Noor, AM; Ochola, SA; Olusanmi, L; Alipui, N; Snow, RW			Forecasting, warning, and detection of malaria epidemics: a case study	LANCET			English	Article							HIGHLANDS; KENYA	Our aim was to assess whether a combination of seasonal climate forecasts, monitoring of meteorological conditions, and early detection of cases could have helped to prevent the 2002 malaria emergency In the highlands of western Kenya. Seasonal climate forecasts did not anticipate the heavy rainfall. Rainfall data gave timely and reliable early warnings; but monthly surveillance of malaria out-patients gave no effective alarm, though it did help to confirm that normal rainfall conditions in Kisii Central and Gucha led to typical resurgent outbreaks whereas exceptional rainfall in Nandi and Kericho led to true malaria epidemics. Management of malaria in the highlands, including improved planning for the annual resurgent outbreak, augmented by simple central nationwide early warning, represents a feasible strategy for increasing epidemic preparedness in Kenya.	Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Minist Hlth, Div Malaria Control, Nairobi, Kenya; UNICEF, ESARO, Nairobi, Kenya; UNICEF, KCO, Nairobi, Kenya; UN Complex Gigiri, Nairobi, Kenya; Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England	University of Oxford; Kenya Medical Research Institute; University of Oxford	Hay, SI (corresponding author), Univ Oxford, Dept Zool, TALA Res Grp, S Parks Rd, Oxford OX1 3PS, England.	simon.hay@zoo.ox.ac.uk	Snow, Robert William/AFR-1436-2022; Hay, Simon I/F-8967-2015	Snow, Robert William/0000-0003-3725-6088; Hay, Simon I/0000-0002-0611-7272	Wellcome Trust [056642, 081829] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Hay SI, 2002, EMERG INFECT DIS, V8, P555, DOI 10.3201/eid0806.010310; NAJERA JA, 1998, MALARIA EPIDEMICS DE, P81; ROBERTS JMD, 1964, J TROP MED HYG, V67, P230; *WHO, 2001, MAL EARL WARN SYST C, P80	5	78	83	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2003	361	9370					1705	1706		10.1016/S0140-6736(03)13366-1	http://dx.doi.org/10.1016/S0140-6736(03)13366-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KB	12767739	Green Accepted			2022-12-01	WOS:000182919700014
J	Fredrick, K; Noller, HF				Fredrick, K; Noller, HF			Catalysis of ribosomal translocation by sparsomycin	SCIENCE			English	Article							ANTITUMOR ANTIBIOTIC SPARSOMYCIN; PEPTIDYL TRANSFERASE CENTER; TRANSFER-RNA; PROTEIN-SYNTHESIS; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; STRUCTURAL BASIS; P-SITE; BINDING; INTERMEDIATE	During protein synthesis, transfer RNAs (tRNAs) are translocated from the aminoacyl to peptidyl to exit sites of the ribosome, coupled to the movement of messenger RNA ( mRNA), in a reaction catalyzed by elongation factor G (EF-G) and guanosine triphosphate (GTP). Here, we show that the peptidyl transferase inhibitor sparsomycin triggers accurate translocation in vitro in the absence of EF-G and GTP. Our results provide evidence that translocation is a function inherent to the ribosome and that the energy to drive this process is stored in the tRNA-mRNA-ribosome complex after peptide-bond formation. These findings directly implicate the peptidyl transferase center of the 50S subunit in the mechanism of translocation, a process involving large-scale movement of tRNA and mRNA in the 30S subunit, some 70 angstroms away.	Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.				NIGMS NIH HHS [GM17129] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017129, R37GM017129] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; BILGIN N, 1990, EMBO J, V9, P735, DOI 10.1002/j.1460-2075.1990.tb08167.x; CABANAS MJ, 1978, BIOCHEM BIOPH RES CO, V83, P991; CUNDLIFFE E, 1990, RIBOSOME, P479; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; FREDRICK K, UNPUB; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; GAVRILOV.LP, 1972, FEBS LETT, V22, P91, DOI 10.1016/0014-5793(72)80227-8; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; HISHIZAW.T, 1970, P NATL ACAD SCI USA, V66, P523, DOI 10.1073/pnas.66.2.523; Jerinic O, 2000, J MOL BIOL, V304, P707, DOI 10.1006/jmbi.2000.4269; LAZARO E, 1991, BIOCHEMISTRY-US, V30, P9642, DOI 10.1021/bi00104a011; LAZARO E, 1991, ANTIMICROB AGENTS CH, V35, P10, DOI 10.1128/AAC.35.1.10; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MONRO RE, 1969, NATURE, V222, P356, DOI 10.1038/222356a0; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; PESTKA S, 1969, J BIOL CHEM, V244, P1533; PESTKA S, 1971, J BIOL CHEM, V246, P7715; PESTKA S, 1969, P NATL ACAD SCI USA, V64, P709, DOI 10.1073/pnas.64.2.709; Porse BT, 1999, P NATL ACAD SCI USA, V96, P9003, DOI 10.1073/pnas.96.16.9003; ROSENDAHL G, 1994, NUCLEIC ACIDS RES, V22, P357, DOI 10.1093/nar/22.3.357; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; Southworth DR, 2002, J MOL BIOL, V324, P611, DOI 10.1016/S0022-2836(02)01196-8; THEOCHARIS DA, 1992, BIOCHEMISTRY-US, V31, P5861, DOI 10.1021/bi00140a023; THOMPSON J, 1991, BIOCHIMIE, V73, P1131, DOI 10.1016/0300-9084(91)90156-U; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	35	113	116	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1159	1162		10.1126/science.1084571	http://dx.doi.org/10.1126/science.1084571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750524				2022-12-01	WOS:000182886500050
J	Garcia-Barros, M; Paris, F; Cordon-Cardo, C; Lyden, D; Rafii, S; Haimovitz-Friedman, A; Fuks, Z; Kolesnick, R				Garcia-Barros, M; Paris, F; Cordon-Cardo, C; Lyden, D; Rafii, S; Haimovitz-Friedman, A; Fuks, Z; Kolesnick, R			Tumor response to radiotherapy regulated by endothelial cell apoptosis	SCIENCE			English	Article							IONIZING-RADIATION; STEM-CELLS; IN-VITRO; SPHINGOMYELINASE; CERAMIDE; CANCER; GROWTH; DEATH; MICE; ANGIOGENESIS	About 50% of cancer patients receive radiation therapy. Here we investigated the hypothesis that tumor response to radiation is determined not only by tumor cell phenotype but also by microvascular sensitivity. MCA/129 fibrosarcomas and B16F1 melanomas grown in apoptosis-resistant acid sphingomyelinase (asmase) -deficient or Bax-deficient mice displayed markedly reduced baseline microvascular endothelial apoptosis and grew 200 to 400% faster than tumors on wild-type microvasculature. Thus, endothelial apoptosis is a homeostatic factor regulating angiogenesis-dependent tumor growth. Moreover, these tumors exhibited reduced endothelial apoptosis upon irradiation and, unlike tumors in wild-type mice, they were resistant to single-dose radiation up to 20 grays (Gy). These studies indicate that microvascular damage regulates tumor cell response to radiation at the clinically relevant dose range.	Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; Cornell Univ, Coll Med, Dept Hematol Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.		Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348	NCI NIH HHS [CA 52462, CA 85704] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085704] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chavakis E, 2002, ARTERIOSCL THROM VAS, V22, P887, DOI 10.1161/01.ATV.0000017728.55907.A9; ELLIS F, 1969, Clinical Radiology, V20, P1, DOI 10.1016/S0009-9260(69)80043-7; Folkman J, 2000, NAT REV MOL CELL BIO, V1, P76, DOI 10.1038/35036100; Folkman J, 2002, CANCER CELL, V1, P113, DOI 10.1016/S1535-6108(02)00038-7; FUKS Z, 1994, CANCER RES, V54, P2582; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HENDRY JH, 1994, RADIOTHER ONCOL, V30, P11, DOI 10.1016/0167-8140(94)90004-3; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KIM JH, 1986, CANCER RES, V46, P1120; Kozin SV, 2001, CANCER RES, V61, P39; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; MUNRO TR, 1961, BRIT J RADIOL, V34, P246, DOI 10.1259/0007-1285-34-400-246; Ning SC, 2002, RADIAT RES, V157, P45, DOI 10.1667/0033-7587(2002)157[0045:TAASAS]2.0.CO;2; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Platt J, 2000, EUR J CANCER, V36, P2397, DOI 10.1016/S0959-8049(00)00336-1; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; St Croix B, 2000, SCIENCE, V289, P1197; Stewart FM, 2001, BLOOD, V98, P1246, DOI 10.1182/blood.V98.4.1246; TEICHER BA, 1992, CANCER RES, V52, P6702; TROTT KR, 1994, RADIOTHER ONCOL, V30, P1, DOI 10.1016/0167-8140(94)90002-7; WHELDON TE, 1977, BRIT J RADIOL, V50, P843, DOI 10.1259/0007-1285-50-599-843; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291	31	1189	1264	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1155	1159		10.1126/science.1082504	http://dx.doi.org/10.1126/science.1082504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750523				2022-12-01	WOS:000182886500049
J	Weill, M; Lutfalla, G; Mogensen, K; Chandre, F; Berthomieu, A; Berticat, C; Pasteur, N; Philips, A; Fort, P; Raymond, M				Weill, M; Lutfalla, G; Mogensen, K; Chandre, F; Berthomieu, A; Berticat, C; Pasteur, N; Philips, A; Fort, P; Raymond, M			Insecticide resistance in mosquito vectors	NATURE			English	Article							ACETYLCHOLINESTERASE		Univ Montpellier 2, Inst Sci Evolut, UMR 5554, F-34095 Montpellier, France; CNRS, Def Antivirales & Tumorales UMR 5124, F-34293 Montpellier, France; CNRS, Ctr Rech Biochim Macromol, UPR1086, F-34293 Montpellier, France; IRD, LIN, F-34394 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Weill, M (corresponding author), Univ Montpellier 2, Inst Sci Evolut, UMR 5554, CC 065, F-34095 Montpellier, France.	weill@isem.univ-montp2.fr	Fort, Philippe/M-9498-2015; Raymond, Michel/C-9049-2015; Lutfalla, Georges/AAW-9386-2021; Chandre, Fabrice/Q-3429-2019; PHILIPS, Alexandre/AAB-6047-2020	Fort, Philippe/0000-0001-5997-8722; Chandre, Fabrice/0000-0002-1994-9705; Weill, Mylene/0000-0002-4043-1601; Raymond, Michel/0000-0002-1714-6984; LUTFALLA, Georges/0000-0002-6591-7894				Bourguet D, 1996, PESTIC BIOCHEM PHYS, V55, P122, DOI 10.1006/pest.1996.0041; MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122	5	343	371	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					136	137		10.1038/423136b	http://dx.doi.org/10.1038/423136b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736674				2022-12-01	WOS:000182699600035
J	Hafezparast, M; Klocke, R; Ruhrberg, C; Marquardt, A; Ahmad-Annuar, A; Bowen, S; Lalli, G; Witherden, AS; Hummerich, H; Nicholson, S; Morgan, PJ; Oozageer, R; Priestley, JV; Averill, S; King, VR; Ball, S; Peters, J; Toda, T; Yamamoto, A; Hiraoka, Y; Augustin, M; Korthaus, D; Wattler, S; Wabnitz, P; Dickneite, C; Lampel, S; Boehme, F; Peraus, G; Popp, A; Rudelius, M; Schlegel, J; Fuchs, H; de Angelis, MH; Schiavo, G; Shima, DT; Russ, AP; Stumm, G; Martin, JE; Fisher, EMC				Hafezparast, M; Klocke, R; Ruhrberg, C; Marquardt, A; Ahmad-Annuar, A; Bowen, S; Lalli, G; Witherden, AS; Hummerich, H; Nicholson, S; Morgan, PJ; Oozageer, R; Priestley, JV; Averill, S; King, VR; Ball, S; Peters, J; Toda, T; Yamamoto, A; Hiraoka, Y; Augustin, M; Korthaus, D; Wattler, S; Wabnitz, P; Dickneite, C; Lampel, S; Boehme, F; Peraus, G; Popp, A; Rudelius, M; Schlegel, J; Fuchs, H; de Angelis, MH; Schiavo, G; Shima, DT; Russ, AP; Stumm, G; Martin, JE; Fisher, EMC			Mutations in dynein link motor neuron degeneration to defects in retrograde transport	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INTERMEDIATE-CHAIN BINDING; AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; HEAVY-CHAIN; MICE; GENE; DYNACTIN; DISEASE; SOD1	Degenerative disorders of motor neurons include a range of progressive fatal diseases such as amyotrophic lateral sclerosis (ALS), spinal-bulbar muscular atrophy (SBMA), and spinal muscular atrophy (SMA). Although the causative genetic alterations are known for some cases, the molecular basis of many SMA and SBMA-like syndromes and most ALS cases is unknown. Here we show that missense point mutations in the cytoplasmic dynein heavy chain result in progressive motor neuron degeneration in heterozygous mice, and in homozygotes this is accompanied by the formation of Lewy-like inclusion bodies, thus resembling key features of human pathology. These mutations exclusively perturb neuron-specific functions of dynein.	Ingenium Pharmaceut AG, D-82152 Martinsried, Germany; UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Canc Res UK, Lab Endothelial Cell Biol, London WC2A 3PX, England; Canc Res UK, Lab Cell Regulat, London WC2A 3PX, England; Canc Res UK, Lab Mol Neuropathobiol, London WC2A 3PX, England; Queen Mary Univ London, Royal London Hosp, Dept Histopathol, London E1 1BB, England; Queen Mary Univ London, Barts & London, Dept Neurosci, London E1 4NS, England; MRC, Mammalian Genet Unit, Harwell OX11 0RD, Berks, England; Commun Res Labs, Kansai Adv Res Ctr, CREST Res Project, Cell Biol Grp, Kobe, Hyogo 6512492, Japan; Tech Univ Munich, Inst Pathol, Div Neuropathol, D-81675 Munich, Germany; Gesell Strahlenforsch Natl Res Ctr Environm & Hlt, Inst Expt Genet, D-85764 Neuherberg, Germany	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Cancer Research UK; Cancer Research UK; Cancer Research UK; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of London; Queen Mary University London; Japan Science & Technology Agency (JST); National Institute of Information & Communications Technology (NICT) - Japan; Technical University of Munich	Stumm, G (corresponding author), Ingenium Pharmaceut AG, Fraunhoferstr 13, D-82152 Martinsried, Germany.	e.fisher@prion.ucl.ac.uk	Fisher, Elizabeth MC/C-2168-2008; Ruhrberg, Christiana/C-6404-2009; Yamamoto, Ayumu/AAN-4565-2021; Hafezparast, Majid/H-6728-2018; Hiraoka, Yasushi/B-5111-2009; Hafezparast, Majid/N-8292-2019; AHMAD ANNUAR, AZLINA/B-8305-2010; de Angelis, Martin Hrabe/F-5531-2012	Fisher, Elizabeth MC/0000-0003-2850-9936; Ruhrberg, Christiana/0000-0002-3212-9381; Yamamoto, Ayumu/0000-0001-6960-9461; Hiraoka, Yasushi/0000-0001-9407-8228; Hafezparast, Majid/0000-0002-5262-7150; de Angelis, Martin Hrabe/0000-0002-7898-2353; Schiavo, Giampietro/0000-0002-4319-8745; Schlegel, Jurgen/0000-0002-5544-2717				Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; HAFEZPARAST M, UNPUB; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; King SM, 2000, J CELL SCI, V113, P2521; LA SA, 1991, NATURE, V352, P77; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Murakami T, 2001, NEUROSCI LETT, V308, P149, DOI 10.1016/S0304-3940(01)02036-5; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Shah JV, 2002, CURR OPIN CELL BIOL, V14, P58, DOI 10.1016/S0955-0674(01)00294-0; Stieber A, 2000, J NEUROL SCI, V173, P63, DOI 10.1016/S0022-510X(99)00301-9; Terada S, 2000, CURR OPIN NEUROBIOL, V10, P566, DOI 10.1016/S0959-4388(00)00129-X; Tsuchiya K, 2000, ACTA NEUROPATHOL, V100, P603, DOI 10.1007/s004010000237; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Witherden AS, 2002, GENE, V283, P71, DOI 10.1016/S0378-1119(01)00853-8; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	30	530	548	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					808	812		10.1126/science.1083129	http://dx.doi.org/10.1126/science.1083129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730604				2022-12-01	WOS:000182579800054
J	Dumas, JJ; Kumar, R; Seehra, J; Somers, WS; Mosyak, L				Dumas, JJ; Kumar, R; Seehra, J; Somers, WS; Mosyak, L			Crystal structure of the GpIb alpha-thrombin complex essential for platelet aggregation	SCIENCE			English	Article							GLYCOPROTEIN-IB-ALPHA; VON-WILLEBRAND-FACTOR; BINDING-SITE; IDENTIFICATION; RECEPTOR; ADHESION; GLYCOCALICIN; RESIDUES; DOMAIN; LOCALIZATION	Direct interaction between platelet receptor glycoprotein Ibalpha (GpIbalpha) and thrombin is required for platelet aggregation and activation at sites of vascular injury. Abnormal GpIbalpha-thrombin binding is associated with many pathological conditions, including occlusive arterial thrombosis and bleeding disorders. The crystal structure of the GpIbalpha-thrombin complex at 2.6 angstrom resolution reveals simultaneous interactions of GpIbalpha with exosite I of one thrombin molecule, and with exosite II of a second thrombin molecule. In the crystal lattice, the periodic arrangement of GpIbalpha-thrombin complexes mirrors a scaffold that could serve as a driving force for tight platelet adhesion. The details of these interactions reconcile GpIbalpha-thrombin binding modes that are presently controversial, highlighting two distinct interfaces that are potential targets for development of novel antithrombotic drugs.	Wyeth, Dept Chem & Screening Sci, Cambridge, MA 02140 USA	Pfizer	Mosyak, L (corresponding author), Wyeth, Dept Chem & Screening Sci, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	wsomers@wyeth.com; lmosyak@wyeth.com						Andrews RK, 1997, INT J BIOCHEM CELL B, V29, P91, DOI 10.1016/S1357-2725(96)00122-7; Andrews RK, 1999, THROMB HAEMOSTASIS, V82, P357, DOI 10.1055/s-0037-1615854; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178; Bouton MC, 1998, THROMB HAEMOSTASIS, V80, P310, DOI 10.1055/s-0037-1615193; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; de Cristofaro R, 1998, BIOCHEM J, V332, P643, DOI 10.1042/bj3320643; De Cristofaro R, 2000, J BIOL CHEM, V275, P3887, DOI 10.1074/jbc.275.6.3887; De Cristofaro R, 2001, BIOCHEMISTRY-US, V40, P13268, DOI 10.1021/bi010491f; DeCandia E, 1997, THROMB HAEMOSTASIS, V77, P735; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; DONG JF, 1994, BIOCHEMISTRY-US, V33, P13946, DOI 10.1021/bi00250a050; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; DUMAS JC, UNPUB; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; GAN ZR, 1994, J BIOL CHEM, V269, P1301; GRALNICK HR, 1994, P NATL ACAD SCI USA, V91, P6334, DOI 10.1073/pnas.91.14.6334; HARMON JT, 1986, J BIOL CHEM, V261, P3224; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; JANDROTPERRUS M, 1992, BLOOD, V80, P2781; JANDROTPERRUS M, 1991, THROMB HAEMOSTASIS, V66, P300; JANDROTPERRUS M, 1992, SEMIN THROMB HEMOST, V18, P261, DOI 10.1055/s-2007-1002433; KATAGIRI Y, 1990, THROMB HAEMOSTASIS, V63, P122; Li CQ, 2001, J BIOL CHEM, V276, P6161, DOI 10.1074/jbc.M004164200; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; NICHOLLS A, 1993, GRASP; NURDEN AT, 1975, NATURE, V255, P720, DOI 10.1038/255720a0; OKUMURA T, 1978, J BIOL CHEM, V253, P3435; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; Ravanat C, 2000, THROMB HAEMOSTASIS, V83, P327; Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Soslau G, 2001, J BIOL CHEM, V276, P21173, DOI 10.1074/jbc.M008249200; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Wang JH, 2002, TRENDS BIOCHEM SCI, V27, P122, DOI 10.1016/S0968-0004(01)02038-2; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; WORKMAN EF, 1977, J BIOL CHEM, V252, P7118	42	134	137	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					222	226		10.1126/science.1083917	http://dx.doi.org/10.1126/science.1083917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855811				2022-12-01	WOS:000184056200046
J	Matsumoto, K; Suzuki, W; Tanaka, K				Matsumoto, K; Suzuki, W; Tanaka, K			Neuronal correlates of goal-based motor selection in the prefrontal cortex	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; ORBITOFRONTAL CORTEX; REWARD EXPECTANCY; COGNITIVE CONTROL; UNIT-ACTIVITY; HUMAN BRAIN; BEHAVIOR; SIGNALS; MACAQUE; MONKEY	Choosing an action that leads to a desired goal requires an understanding of the linkages between actions and their outcomes. We investigated neural mechanisms of such goal-based action selection. We trained monkeys on a task in which the relation between visual cues, action types, and reward conditions changed regularly, such that the monkeys selected their actions based on anticipated reward conditions. A significant number of neurons in the medial prefrontal cortex were activated, after cue presentation and before motor execution, only by particular action-reward combinations. This prefrontal activity is likely to underlie goal-based action selection.	RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan	RIKEN	Matsumoto, K (corresponding author), RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsumot@postman.riken.go.jp	Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427; Matsumoto, Kenji/0000-0003-0883-4280				Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Duncan John, 1995, P721; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Overmier JB, 2001, INTEGR PHYS BEH SCI, V36, P173, DOI 10.1007/BF02734091; PETERSON GB, 1980, LEARN MOTIV, V11, P267, DOI 10.1016/0023-9690(80)90001-6; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Savage LM, 2001, INTEGR PHYS BEH SCI, V36, P182, DOI 10.1007/BF02734092; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; WATANABE M, 1990, EXP BRAIN RES, V80, P296; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	28	302	306	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					229	232		10.1126/science.1084204	http://dx.doi.org/10.1126/science.1084204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	699KN	12855813				2022-12-01	WOS:000184056200048
J	Anderson, GG; Palermo, JJ; Schilling, JD; Roth, R; Heuser, J; Hultgren, SJ				Anderson, GG; Palermo, JJ; Schilling, JD; Roth, R; Heuser, J; Hultgren, SJ			Intracellular bacterial biofilm-like pods in urinary tract infections	SCIENCE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; COMPLETE GENOME SEQUENCE; HOST DEFENSES; OUTER-MEMBRANE; BLADDER; PROTEIN; RESISTANCE; INVASION; CELLS; MICE	Escherichia coli entry into the bladder is met with potent innate defenses, including neutrophil influx and epithelial exfoliation. Bacterial subversion of innate responses involves invasion into bladder superficial cells. We discovered that the intracellular bacteria matured into biofilms, creating pod-like bulges on the bladder surface. Pods contained bacteria encased in a polysaccharide-rich matrix surrounded by a protective shell of uroplakin. Within the biofilm, bacterial structures interacted extensively with the surrounding matrix, and biofilm associated factors had regional variation in expression. The discovery of intracellular biofilm-like pods explains how bladder infections can persist in the face of robust host defenses.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	hultgren@borcim.wustl.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029549, R01AI048689, R01AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540, R01DK051406] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48689, AI29549] Funding Source: Medline; NIDDK NIH HHS [DK64540, DK51406] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2002, AM J MED, V113, p5S; Fulcher TP, 2001, OPHTHALMOLOGY, V108, P1088, DOI 10.1016/S0161-6420(01)00561-9; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; HEUSER JE, 1987, J MUSCLE RES CELL M, V8, P303, DOI 10.1007/BF01568887; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; JUSTICE S, UNPUB; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Olsson LE, 1998, J PHARMACOL EXP THER, V284, P1203; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; OWEN P, 1987, J BACTERIOL, V169, P3770, DOI 10.1128/jb.169.8.3770-3777.1987; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WU XR, 1990, J BIOL CHEM, V265, P19170	31	733	769	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					105	107		10.1126/science.1084550	http://dx.doi.org/10.1126/science.1084550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843396				2022-12-01	WOS:000183914700044
J	Ashraf, H				Ashraf, H			UK ethicists say GM foods could help poor - Group back the controversial crops as government warily tests public opinion	LANCET			English	News Item																			0	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2051	2051						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814720				2022-12-01	WOS:000183488900016
J	van Montfort, RLM; Congreve, M; Tisi, D; Carr, R; Jhoti, H				van Montfort, RLM; Congreve, M; Tisi, D; Carr, R; Jhoti, H			Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B	NATURE			English	Article							REVERSIBLE INACTIVATION; SUBSTRATE-SPECIFICITY; INSULIN SENSITIVITY; HYDROGEN-PEROXIDE; ENZYME CATALYSIS; INTERMEDIATE; ROLES	Protein tyrosine phosphatases regulate signal transduction pathways involving tyrosine phosphorylation(1) and have been implicated in the development of cancer, diabetes, rheumatoid arthritis and hypertension(2). Increasing evidence suggests that the cellular redox state is involved in regulating tyrosine phosphatase activity through the reversible oxidization of the catalytic cysteine to sulphenic acid (Cys-SOH)(3-6). But how further oxidation to the irreversible sulphinic (Cys-SO2H) and sulphonic (Cys-SO3H) forms is prevented remains unclear. Here we report the crystal structures of the regulatory sulphenic and irreversible sulphinic and sulphonic acids of protein tyrosine phosphatase 1B (PTP1B), an important enzyme in the negative regulation of the insulin receptor(7,8) and a therapeutic target in type II diabetes and obesity(9). We also identify a sulphenyl-amide species that is formed through oxidation of its catalytic cysteine. Formation of the sulphenyl-amide causes large changes in the PTP1B active site, which are reversible by reduction with the cellular reducing agent glutathione. The sulphenyl-amide is a protective intermediate in the oxidative inhibition of PTP1B. In addition, it may facilitate reactivation of PTP1B by biological thiols and signal a unique state of the protein.	Astex Technol Ltd, Cambridge CB4 0QA, England		Jhoti, H (corresponding author), Astex Technol Ltd, 436 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0QA, England.	h.jhoti@astex-technology.com	van Montfort, Rob/D-3248-2009					BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barford D, 1995, CURR OPIN STRUC BIOL, V5, P728, DOI 10.1016/0959-440X(95)80004-2; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163; HARTSHORN MJ, IN PRESS J COMPUT AI; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Scapin G, 2001, PROTEIN SCI, V10, P1596, DOI 10.1110/ps.11001; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	23	492	505	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2003	423	6941					773	777		10.1038/nature01681	http://dx.doi.org/10.1038/nature01681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802339				2022-12-01	WOS:000183443400048
J	Wikelski, M; Tarlow, EM; Raim, A; Diehl, RH; Larkin, RP; Visser, GH				Wikelski, M; Tarlow, EM; Raim, A; Diehl, RH; Larkin, RP; Visser, GH			Costs of migration in free-flying songbirds	NATURE			English	Article							BIRD MIGRATION		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; Illinois Nat Hist Survey, Champaign, IL 61820 USA; Univ Groningen, Ctr Isotope Res, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zool Lab, NL-9750 AA Haren, Netherlands	Princeton University; University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Groningen; University of Groningen	Wikelski, M (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.							Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; COCHRAN WW, 1987, ANIM BEHAV, V35, P927, DOI 10.1016/S0003-3472(87)80132-X; Cochran WW, 1972, ANIMAL ORIENTATION N, P39; Faaborg John, 1995, P357; GRABER RR, 1971, BIOL NOTES ILLINOIS, V75; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Klaassen M, 1996, J EXP BIOL, V199, P57; MASMAN D, 1987, AUK, V104, P603, DOI 10.1093/auk/104.4.603; Pennycuick CJ, 1998, J THEOR BIOL, V191, P47, DOI 10.1006/jtbi.1997.0572; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; Speakman JR, 1997, DOUBLY LABELED WATER; [No title captured]	13	316	327	0	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					704	704		10.1038/423704a	http://dx.doi.org/10.1038/423704a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802324	Bronze			2022-12-01	WOS:000183443400032
J	Hansen, L				Hansen, L			Commentary: We need to determine who benefits most from flu treatments	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Edinburgh, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh	Hansen, L (corresponding author), Univ Edinburgh, Edinburgh EH9 1QH, Midlothian, Scotland.							*ADV COMM IMM PRAC, 2002, MMWR, V51; *APPR COMM NAT I C, 2003, FULL GUID US ZAN OS; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x	3	1	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1239	1240		10.1136/bmj.326.7401.1239	http://dx.doi.org/10.1136/bmj.326.7401.1239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791736	Green Published			2022-12-01	WOS:000183480700013
J	Tian, PF; Keusters, D; Suzaki, Y; Warren, WS				Tian, PF; Keusters, D; Suzaki, Y; Warren, WS			Femtosecond phase-coherent two-dimensional spectroscopy	SCIENCE			English	Article							PEPTIDES; SEQUENCES; DYNAMICS; ECHO	Femtosecond phase-coherent two-dimensional (2D) spectroscopy has been experimentally demonstrated as the direct optical analog of 2D nuclear magnetic resonance. An acousto-optic pulse shaper created a collinear three-pulse sequence with well-controlled and variable interpulse delays and phases, which interacted with a model atomic system of rubidium vapor. The desired nonlinear polarization was selected by phase cycling (coadding experimental results obtained with different interpulse phases). This method may enhance our ability to probe the femtosecond structural dynamics of macromolecules.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Ctr Ultrafast Laser Applicat, Dept Chem, Princeton, NJ 08544 USA; Kagawa Univ, Fac Engn, Dept Adv Mat Sci, Kagawa 7610396, Japan	Princeton University; Princeton University; Kagawa University	Tian, PF (corresponding author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.							Asplund MC, 2000, P NATL ACAD SCI USA, V97, P8219, DOI 10.1073/pnas.140227997; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; de Boeij WP, 1998, CHEM PHYS, V233, P287, DOI 10.1016/S0301-0104(98)00084-6; Ernst R.R., 1987, PRINCIPLES NUCL MAGN; Ge NH, 2002, PHYSCHEMCOMM, V5, P17, DOI 10.1039/b109935c; Golonzka O, 2001, PHYS REV LETT, V86, P2154, DOI 10.1103/PhysRevLett.86.2154; Hamm P, 1998, J PHYS CHEM B, V102, P6123, DOI 10.1021/jp9813286; Hybl JD, 2001, J CHEM PHYS, V115, P6606, DOI 10.1063/1.1398579; Keusters D, 2001, SPRINGER SERIES CHEM, V66, P165; Keusters D, 1999, J PHYS CHEM A, V103, P10369, DOI 10.1021/jp99235b; KHALIL M, IN PRESS J PHYS CH A; Merchant KA, 2001, PHYS REV LETT, V86, P3899, DOI 10.1103/PhysRevLett.86.3899; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Mukamel S., 1995, PRINCIPLES NONLINEAR; SCHERER NF, 1991, J CHEM PHYS, V95, P1487, DOI 10.1063/1.461064; Scheurer C, 2001, J CHEM PHYS, V115, P4989, DOI 10.1063/1.1391266; TAN HS, UNPUB; TAN HW, COMMUNICATION, P37401; WARREN WS, 1981, J CHEM PHYS, V75, P5956, DOI 10.1063/1.442051; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Woutersen S, 2002, J PHYS-CONDENS MAT, V14, pR1035, DOI 10.1088/0953-8984/14/39/202; Woutersen S, 2001, P NATL ACAD SCI USA, V98, P11254, DOI 10.1073/pnas.201169498; Yang WG, 1998, OPT LETT, V23, P1843, DOI 10.1364/OL.23.001843; Zanni MT, 2001, P NATL ACAD SCI USA, V98, P11265, DOI 10.1073/pnas.201412998; 2001, CHEM PHYS, V266, P135	25	370	388	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1553	1555		10.1126/science.1083433	http://dx.doi.org/10.1126/science.1083433			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791987	Green Submitted			2022-12-01	WOS:000183333100049
J	Wirth, S; Yanike, M; Frank, LM; Smith, AC; Brown, EN; Suzuki, WA				Wirth, S; Yanike, M; Frank, LM; Smith, AC; Brown, EN; Suzuki, WA			Single neurons in the monkey hippocampus and learning of new associations	SCIENCE			English	Article							CONDITIONAL OCULOMOTOR ASSOCIATIONS; SUPPLEMENTARY EYE FIELD; PERIRHINAL NEURONS; CORTEX; MEMORY; ACQUISITION; RESPONSES; TASK	The medial temporal lobe is crucial for the ability to learn and retain new declarative memories. This form of memory includes the ability to quickly establish novel associations between unrelated items. To better understand the patterns of neural activity during associative memory formation, we recorded the activity of hippocampal neurons of macaque monkeys as they learned new associations. Hippocampal neurons signaled learning by changing their stimulus-selective response properties. This change in the pattern of selective neural activity occurred before, at the same time as, or after learning, which suggests that these neurons are involved in the initial formation of new associative memories.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Anesthesia & Crit Care, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02114 USA	New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Suzuki, WA (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.		Wirth, Sylvia/M-4752-2017	Frank, Loren/0000-0002-1752-5677; Wirth, Sylvia/0000-0001-7002-329X				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; CAHUSAC PMB, 1993, HIPPOCAMPUS, V3, P29, DOI 10.1002/hipo.450030104; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Erickson CA, 1999, J NEUROSCI, V19, P10404; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; McEchron MD, 1999, HIPPOCAMPUS, V9, P385, DOI 10.1002/(SICI)1098-1063(1999)9:4<385::AID-HIPO5>3.0.CO;2-K; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MITZ AR, 1991, J NEUROSCI, V11, P1855; Moody SL, 1998, J NEUROSCI, V18, P399; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515	18	251	255	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1578	1581		10.1126/science.1084324	http://dx.doi.org/10.1126/science.1084324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791995				2022-12-01	WOS:000183333100057
J	McQuibban, GA; Saurya, S; Freeman, M				McQuibban, GA; Saurya, S; Freeman, M			Mitochondrial membrane remodelling regulated by a conserved rhomboid protease	NATURE			English	Article							CYTOCHROME-C PEROXIDASE; DROSOPHILA EGF RECEPTOR; DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED GTPASE; INTERMEMBRANE SPACE; OUTER-MEMBRANE; YEAST; SEQUENCE; FAMILY; GENE	Rhomboid proteins are intramembrane serine proteases that activate epidermal growth factor receptor (EGFR) signalling in Drosophila(1). Rhomboids are conserved throughout evolution(2-5), and even in eukaryotes their existence in species with no EGFRs implies that they must have additional roles. Here we report that Saccharomyces cerevisiae has two rhomboids, which we have named Rbd1p and Rbd2p. RBD1 deletion results in a respiratory defect; consistent with this, Rbd1p is localized in the inner mitochondrial membrane and mutant cells have disrupted mitochondria. We have identified two substrates of Rbd1p: cytochrome c peroxidase (Ccp1p); and a dynamin-like GTPase (Mgm1p), which is involved in mitochondrial membrane fusion(6-10). Rbd1p mutants are indistinguishable from Mgm1p mutants, indicating that Mgm1p is a key substrate of Rbd1p and explaining the rbd1Delta mitochondrial phenotype. Our data indicate that mitochondrial membrane remodelling is regulated by cleavage of Mgm1p and show that intramembrane proteolysis by rhomboids controls cellular processes other than signalling. In addition, mitochondrial rhomboids are conserved throughout eukaryotes and the mammalian homologue, PARL(11), rescues the yeast mutant, suggesting that these proteins represent a functionally conserved subclass of rhomboid proteases.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451				Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Church C, 1996, J BIOL CHEM, V271, P18499, DOI 10.1074/jbc.271.31.18499; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DAUM G, 1982, J BIOL CHEM, V257, P3028; Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Ghiglione C, 2002, DEVELOPMENT, V129, P175; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; Guthrie C., 2002, GUIDE YEAST GENETICS; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; JONES BA, 1992, GENE DEV, V6, P380, DOI 10.1101/gad.6.3.380; KAPUT J, 1982, J BIOL CHEM, V257, P5054; Klambt C, 2002, CURR BIOL, V12, pR21, DOI 10.1016/S0960-9822(01)00642-X; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Muratsubaki H, 1998, ARCH BIOCHEM BIOPHYS, V352, P175, DOI 10.1006/abbi.1998.0583; Pascall JC, 1998, FEBS LETT, V429, P337, DOI 10.1016/S0014-5793(98)00622-X; Pellegrini L, 2001, J ALZHEIMERS DIS, V3, P181; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; Tsruya R, 2002, GENE DEV, V16, P222, DOI 10.1101/gad.214202; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; URBAN S, IN PRESS MOL CELL; Wasserman JD, 2000, GENE DEV, V14, P1651; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101	30	309	323	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					537	541		10.1038/nature01633	http://dx.doi.org/10.1038/nature01633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774122				2022-12-01	WOS:000183162900043
J	Cho, GY; Wu, YT; Ackerman, JL				Cho, GY; Wu, YT; Ackerman, JL			Detection of hydroxyl ions in bone mineral by solid-state NMR spectroscopy	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CALCIUM PHOSPHATES; HYDROXYAPATITE; TEMPERATURE; CARBONATE; CRYSTALS; PHASES; ENAMEL	Previous measurements of the hydroxyl (OH-) ion content of the calcium phosphate crystals of bone mineral have indicated a substantial depletion or near-absence of OH-, despite its presumed status as a constituent of the hydroxyapatite lattice. Analytical methods for determining bone crystal OH content have depended on procedures or assumptions that may have biased the results, such as chemical pretreatment to eliminate interference from the organic matrix. We demonstrate a two-dimensional solid-state nuclear magnetic resonance (NMR) spectroscopy technique that detects the proton spectrum of bone crystals while suppressing the interfering matrix signals, eliminating the need for specimen pretreatment other than cryogenic grinding. Results on fresh-frozen and ground whole bone of several mammalian species show that the bone crystal OH- is readily detectable; a rough estimate yields an OH- content of human cortical bone of about 20% of the amount expected in stoichiometric hydroxyapatite. This finding sheds light on the biochemical processes underlying normal and abnormal bone mineral metabolism.	Massachusetts Gen Hosp, Dept Radiol, NMR Ctr, Biomat Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Hosp, Dept Orthopaed Surg, Lab Study Skeletal Disorders & Rehabil, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Ackerman, JL (corresponding author), Massachusetts Gen Hosp, Dept Radiol, NMR Ctr, Biomat Lab, Room 2301,149 13th St, Charlestown, MA 02129 USA.		Ackerman, Jerome L./E-2646-2015	Ackerman, Jerome L./0000-0001-5176-7496	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042258] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03264] Funding Source: Medline; NIAMS NIH HHS [AR42258] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3; AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032; BERRY EE, 1967, J INORG NUCL CHEM, V29, P317, DOI 10.1016/0022-1902(67)80033-2; BESHAH K, 1990, J SOLID STATE CHEM, V84, P71, DOI 10.1016/0022-4596(90)90185-Z; BILTZ RM, 1971, CALC TISS RES, V7, P259, DOI 10.1007/BF02062614; BLUMENTHAL NC, 1973, CALC TISS RES, V13, P235, DOI 10.1007/BF02015413; Elliott J. C., 1994, STRUCTURE CHEM APATI; Glimcher M. J, 1998, METABOLIC BONE DIS C, P23, DOI [DOI 10.1007/S10641-010-9735-5, 10.1021/cr60164a001, DOI 10.1016/B978-012068700-8/50003-7]; KIM HM, 1995, J BONE MINER RES, V10, P1589; Loong CK, 2000, BONE, V26, P599, DOI 10.1016/S8756-3282(00)00273-8; Ramanathan C, 1999, MAGNET RESON MED, V41, P1214, DOI 10.1002/(SICI)1522-2594(199906)41:6<1214::AID-MRM18>3.0.CO;2-H; REY C, 1995, BONE, V16, P583, DOI 10.1016/8756-3282(95)00101-I; ROTHWELL WP, 1980, J AM CHEM SOC, V102, P2637, DOI 10.1021/ja00528a020; SANTOS RA, 1994, J MAGN RESON SER B, V105, P183, DOI 10.1006/jmrb.1994.1120; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723; TOMAZIC BB, 1993, J BIOMED MATER RES, V27, P217, DOI 10.1002/jbm.820270211; VATASSER.GT, 1970, CALC TISS RES, V5, P183, DOI 10.1007/BF02017547; WU Y, IN PRESS CALCIF TISS; WU YT, 1994, J MOL BIOL, V244, P423, DOI 10.1006/jmbi.1994.1740; Wu YT, 2002, J BONE MINER RES, V17, P472, DOI 10.1359/jbmr.2002.17.3.472; YESINOWSKI JP, 1987, J AM CHEM SOC, V109, P6274, DOI 10.1021/ja00255a009	22	234	243	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1123	1127		10.1126/science.1078470	http://dx.doi.org/10.1126/science.1078470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750514				2022-12-01	WOS:000182886500038
J	Schwarz-Linek, U; Werner, JM; Pickford, AR; Gurusiddappa, S; Kim, JH; Pilka, ES; Briggs, JAG; Gough, TS; Hook, M; Campbell, ID; Potts, JR				Schwarz-Linek, U; Werner, JM; Pickford, AR; Gurusiddappa, S; Kim, JH; Pilka, ES; Briggs, JAG; Gough, TS; Hook, M; Campbell, ID; Potts, JR			Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper	NATURE			English	Article							F1 MODULE PAIR; STAPHYLOCOCCUS-AUREUS; BINDING-PROTEIN; STREPTOCOCCUS-PYOGENES; MEDIATE ADHERENCE; CHEMICAL-SHIFT; NMR; SEQUENCE; DYSGALACTIAE; RESIDUES	Staphylococcus aureus and Streptococcus pyogenes, two important human pathogens, target host fibronectin (Fn) in their adhesion to and invasion of host cells(1,2). Fibronectin-binding proteins (FnBPs), anchored in the bacterial cell wall, have multiple Fn-binding repeats(3) in an unfolded(4,5) region of the protein. The bacterium-binding site in the amino-terminal domain ((1-5)F1) of Fn contains five sequential Fn type 1 (F1) modules. Here we show the structure of a streptococcal (S. dysgalactiae) FnBP peptide (B3)(6,7) in complex with the module pair (1)F1(2)F1. This identifies (1)F1-and (2)F1-binding motifs in B3 that form additional antiparallel beta-strands on sequential F1 modules-the first example of a tandem beta-zipper. Sequence analyses of larger regions of FnBPs from S. pyogenes and S. aureus reveal a repeating pattern of F1-binding motifs that match the pattern of F1 modules in (1-5)F1 of Fn. In the process of Fn-mediated invasion of host cells, therefore, the bacterial proteins seem to exploit the modular structure of Fn by forming extended tandem beta-zippers. This work is a vital step forward in explaining the full mechanism of the integrin-dependent(2,8) FnBP-mediated invasion of host cells.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; Univ Oxford, Cent Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QH, England	University of Oxford; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Oxford	Potts, JR (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	jennifer.potts@bioch.ox.ac.uk	Briggs, John/J-3096-2012; Werner, Joern/E-1148-2013; Pickford, Andy/AGB-6901-2022	Pickford, Andy/0000-0002-7237-0030; Briggs, John/0000-0003-3990-6910; Schwarz-Linek, Ulrich/0000-0003-0526-223X; Werner, Jorn/0000-0002-4712-1833				Brunger AT, 1993, X PLOR VERSION 3 1 S; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Hashimoto Y, 2000, J BIOMOL NMR, V17, P203, DOI 10.1023/A:1008341609461; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; HUFF S, 1994, J BIOL CHEM, V269, P15563; Ing M, 1997, STAPHYLOCOCCI HUMAN, P331; Jaffe J, 1996, MOL MICROBIOL, V21, P373, DOI 10.1046/j.1365-2958.1996.6331356.x; Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x; Knodler LA, 2001, NAT REV MOL CELL BIO, V2, P578, DOI 10.1038/35085062; Massey RC, 2001, CELL MICROBIOL, V3, P839, DOI 10.1046/j.1462-5822.2001.00157.x; MCGAVIN MJ, 1993, J BIOL CHEM, V268, P23946; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Penkett CJ, 2000, BIOCHEMISTRY-US, V39, P2887, DOI 10.1021/bi992267k; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Potts JR, 1999, BIOCHEMISTRY-US, V38, P8304, DOI 10.1021/bi990202b; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Schwarz-Linek U, 2001, FEBS LETT, V497, P137, DOI 10.1016/S0014-5793(01)02418-8; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; TALAY SR, 1994, MOL MICROBIOL, V13, P531, DOI 10.1111/j.1365-2958.1994.tb00448.x; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; Tjandra N, 1997, NAT STRUCT BIOL, V4, P443, DOI 10.1038/nsb0697-443; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010	30	294	306	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					177	181		10.1038/nature01589	http://dx.doi.org/10.1038/nature01589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736686				2022-12-01	WOS:000182699600048
J	Leventhal, AG; Wang, YC; Pu, ML; Zhou, YF; Ma, YY				Leventhal, AG; Wang, YC; Pu, ML; Zhou, YF; Ma, YY			GABA and its agonists improved visual cortical function in senescent monkeys	SCIENCE			English	Article							CONTRAST SENSITIVITY; AGE; PERCEPTION; NEURONS; CORTEX	Human cerebral cortical function degrades during old age. Much of this change may result from a degradation of intracortical inhibition during senescence. We used multibarreled microelectrodes to study the effects of electrophoretic application of gamma-aminobutyric acid (GABA), the GABA type a (GABAa) receptor agonist muscimol, and the GABAa receptor antagonist bicuculline, respectively, on the properties of individual V1 cells in old monkeys. Bicuculline exerted a much weaker effect on neuronal responses in old than in young animals, confirming a degradation of GABA-mediated inhibition. On the other hand, the administration of GABA and muscimol resulted in improved visual function. Many treated cells in area V1 of old animals displayed responses typical of young cells. The present results have important implications for the treatment of the sensory, motor, and cognitive declines that accompany old age.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Lab Primate Cognit Neurosci, Kunming 650223, Yunnan, Peoples R China	Utah System of Higher Education; University of Utah; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Leventhal, AG (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.	audie.leventhal@m.cc.utah.edu			NATIONAL INSTITUTE ON AGING [R01AG017922] Funding Source: NIH RePORTER; NIA NIH HHS [AG-17922] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Caspary DM, 1999, NEUROSCIENCE, V93, P307, DOI 10.1016/S0306-4522(99)00121-9; CASPARY DM, 1995, EXP GERONTOL, V30, P349, DOI 10.1016/0531-5565(94)00052-5; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; KASAMATSU T, 1982, EXP BRAIN RES, V45, P317, DOI 10.1007/BF01208591; KLINE DW, 1983, J GERONTOL, V38, P211, DOI 10.1093/geronj/38.2.211; KLINE DW, 1991, VISION VISUAL DYSFUN, V16, P150; KLINE DW, 1985, HDB PSYCHOL AGING, P296; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; MATSUMURA M, 1990, NEUROSCI RES, V8, P138, DOI 10.1016/0168-0102(90)90066-N; Ordy J. M., 1991, EFFECTS AGING ENV VI, P1; OWSLEY C, 1987, BRIT J OPHTHALMOL, V71, P791, DOI 10.1136/bjo.71.10.791; OWSLEY C, 1981, INVEST OPHTH VIS SCI, V21, P362; Porciatti V, 1999, VISION RES, V39, P2157, DOI 10.1016/S0042-6989(98)00288-0; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; SPEAR PD, 1993, VISION RES, V33, P2589, DOI 10.1016/0042-6989(93)90218-L; Tran DB, 1998, GRAEF ARCH CLIN EXP, V236, P269, DOI 10.1007/s004170050076; WESTON HC, 1948, BRIT J OPHTHALMOL, V32, P645, DOI 10.1136/bjo.32.9.645	20	409	476	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					812	815		10.1126/science.1082874	http://dx.doi.org/10.1126/science.1082874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730605				2022-12-01	WOS:000182579800055
J	Li, RH; Mitra, N; Gratkowski, H; Vilaire, G; Litvinov, R; Nagasami, C; Weisel, JW; Lear, JD; DeGrado, WF; Bennett, JS				Li, RH; Mitra, N; Gratkowski, H; Vilaire, G; Litvinov, R; Nagasami, C; Weisel, JW; Lear, JD; DeGrado, WF; Bennett, JS			Activation of integrin alpha IIb beta 3 by modulation of transmembrane helix associations	SCIENCE			English	Article							IIB-IIIA COMPLEX; INSIDE-OUT ACTIVATION; FIBRINOGEN BINDING; ELECTRON-MICROSCOPY; PLATELETS; MODEL; ALPHA(IIB)BETA(3); REARRANGEMENTS; TRANSDUCTION; PEPTIDES	Transmembrane helices of integrin alpha and beta subunits have been implicated in the regulation of integrin activity. Two mutations, glycine-708 to asparagine-708 (G708N) and methionine-701 to asparagine-701, in the transmembrane helix of the beta3 subunit enabled integrin alphaIIbbeta3 to constitutively bind soluble fibrinogen. Further characterization of the G708N mutant revealed that it induced alphaIIbbeta3 clustering and constitutive phosphorylation of focal adhesion kinase. This mutation also enhanced the tendency of the transmembrane helix to form homotrimers. These results suggest that homomeric associations involving transmembrane domains provide a driving force for integrin activation. They also suggest a structural basis for the coincidence of integrin activation and clustering.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	DeGrado, WF (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.		Litvinov, Rustem/E-5291-2011; Li, Renhao/B-1257-2012	Litvinov, Rustem/0000-0003-0643-1496; Li, Renhao/0000-0002-5806-5080	NCI NIH HHS [K01 CA096706] Funding Source: Medline; NHLBI NIH HHS [HL40387, HL54500] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA096706] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL054500] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; [Anonymous], UNPUB; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; BENNETT JS, 1983, P NATL ACAD SCI-BIOL, V80, P2417, DOI 10.1073/pnas.80.9.2417; Bennett JS, 2001, BLOOD, V97, P3093, DOI 10.1182/blood.V97.10.3093; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Calzada MJ, 2002, J BIOL CHEM, V277, P39899, DOI 10.1074/jbc.M205886200; Choma C, 2000, NAT STRUCT BIOL, V7, P161; FITZGERALD LA, 1985, J BIOL CHEM, V260, P1366; GARTNER TK, 1985, J BIOL CHEM, V260, P1891; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; LUKASHEV ME, 1994, J BIOL CHEM, V269, P18311; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; SHATTIL SJ, 1985, BLOOD, V66, P92; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	30	242	250	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					795	798		10.1126/science.1079441	http://dx.doi.org/10.1126/science.1079441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730600				2022-12-01	WOS:000182579800050
J	Verburg, P; Hecky, RE; Kling, H				Verburg, P; Hecky, RE; Kling, H			Ecological consequences of a century of warming in Lake Tanganyika	SCIENCE			English	Article							PHYTOPLANKTON; RIVER	Deep tropical lakes are excellent climate monitors because annual mixing is shallow and flushing rates are low, allowing heat to accumulate during climatic warming. We describe effects of warming on Lake Tanganyika: A sharpened density gradient has slowed vertical mixing and reduced primary production. Increased warming rates during the coming century may continue to slow mixing and further reduce productivity in Lake Tanganyika and other deep tropical lakes.	Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; Fisheries & Oceans Canada, Inst Freshwater, Algal Taxon & Ecol, Winnipeg, MB R3T 2N6, Canada	University of Waterloo; Fisheries & Oceans Canada	Verburg, P (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	pverburg@scimail.uwaterloo.ca		verburg, piet/0000-0001-7574-9161				BEAUCHAMP R. S. A., 1939, INTERNAL REV GES HYDROBIOL U HYDROGR, V39, P316, DOI 10.1002/iroh.19390390303; Brooks J. L., 1950, Quarterly Review of Biology, V25, P131, DOI 10.1086/397539; CAPART A, 1952, I R SCI NAT BELG, V1, P3; COULTER GW, 1963, LIMNOL OCEANOGR, V8, P463, DOI 10.4319/lo.1963.8.4.0463; CRAIG H, 1974, LAKE TANGANYIKA GEOC, P1; Davies-Colley R. J, 1993, COLOUR CLARITY NATUR; DUBOIS J. T., 1958, HYDROBIOLOGIA, V10, P215, DOI 10.1007/BF00142188; EDMOND JM, 1993, LIMNOL OCEANOGR, V38, P725, DOI 10.4319/lo.1993.38.4.0725; Hecky R.E., 1991, P90; HECKY RE, 1981, LIMNOL OCEANOGR, V26, P548, DOI 10.4319/lo.1981.26.3.0548; Hutchinson G. E., 1957, TREATISE LIMNOLOGY, VI; Jarvinen M, 1999, HYDROBIOLOGIA, V407, P81, DOI 10.1023/A:1003706002126; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Kimbadi S, 1999, HYDROBIOLOGIA, V407, P75, DOI 10.1023/A:1003749817147; KUFFERATH J, 1952, MILIEU BIOCH, V1, P31; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Millero FJ, 2000, AQUAT GEOCHEM, V6, P1, DOI 10.1023/A:1009626325650; PLISNIER PD, 1996, GCPRAF271FINTD56 FAO; Quayle WC, 2002, SCIENCE, V295, P645, DOI 10.1126/science.1064074; STAPPERS L, 1913, MISSION STAPPERS 191; Vandelannoote A, 1999, HYDROBIOLOGIA, V407, P65, DOI 10.1023/A:1003701901217; VANMEEL L, 1954, PHYTOPLANCTON, V4; Vollmer MK, 2002, ADV GLOB CHANGE RES, V12, P209	23	263	284	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					505	507		10.1126/science.1084846	http://dx.doi.org/10.1126/science.1084846			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12829786				2022-12-01	WOS:000184340500039
J	MacCarthy, PA; Kearney, MT; Nolan, J; Lee, AJ; Prescott, RJ; Shah, AM; Brooksby, WP; Fox, KAA				MacCarthy, PA; Kearney, MT; Nolan, J; Lee, AJ; Prescott, RJ; Shah, AM; Brooksby, WP; Fox, KAA			Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							VARIABILITY		Guys Kings & St Thomass Sch Med, Dept Cardiol, London SE5 9PJ, England; N Staffordshire Cardiac Ctr, Stoke On Trent ST4 6QG, Staffs, England; Univ Edinburgh, Med Stat Unit, Edinburgh EH3 9YW, Midlothian, Scotland; Pontefract Hosp, Pontefract WF8 1PL, England; Wakefield Hosp, Pontefract WF8 1PL, England; Univ Edinburgh, Dept Cardiol, Edinburgh EH8 9YL, Midlothian, Scotland	University of London; King's College London; University of Edinburgh; University of Edinburgh	Kearney, MT (corresponding author), Guys Kings & St Thomass Sch Med, Dept Cardiol, London SE5 9PJ, England.		Lee, Andrew/GVU-2817-2022; Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752; Shah, Ajay/0000-0002-6547-0631				BIGGER JT, 1995, CIRCULATION, V91, P1936, DOI 10.1161/01.CIR.91.7.1936; Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9	5	45	45	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2003	327	7406					78	79		10.1136/bmj.327.7406.78	http://dx.doi.org/10.1136/bmj.327.7406.78			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702NF	12855525	Green Published, Bronze			2022-12-01	WOS:000184229400018
J	Petersson, P; Waldenstrom, A; Fahraeus, C; Schouenborg, J				Petersson, P; Waldenstrom, A; Fahraeus, C; Schouenborg, J			Spontaneous muscle twitches during sleep guide spinal self-organization	NATURE			English	Article							NOCICEPTIVE WITHDRAWAL REFLEXES; SENSORIMOTOR TRANSFORMATION; DEVELOPMENTAL ADAPTATION; SUBSTANTIA-GELATINOSA; POSTNATAL-DEVELOPMENT; DORSAL-HORN; RAT; NEURONS; SYSTEM; NETWORK	During development, information about the three-dimensional shape and mechanical properties of the body is laid down in the synaptic connectivity of sensorimotor systems through unknown adaptive mechanisms. In spinal reflex systems, this enables the fast transformation of complex sensory information into adequate correction of movements. Here we use a computer simulation to show that an unsupervised correlation-based learning mechanism, using spontaneous muscle twitches, can account for the functional adaptation of the withdrawal reflex system. We also show that tactile feedback resulting from spontaneous muscle twitches during sleep(1-3) does indeed modify sensorimotor transformation in young rats in a predictable manner. The results indicate that these twitches, corresponding to human fetal movements(4), are important in spinal self-organization.	Lund Univ, Dept Physiol Sci, Sect Neurophysiol, S-22184 Lund, Sweden	Lund University	Petersson, P (corresponding author), Lund Univ, Dept Physiol Sci, Sect Neurophysiol, BMC F10, S-22184 Lund, Sweden.	per.petersson@mphy.lu.se	Petersson, Per/A-5740-2010; Petersson, Per/P-1878-2019	Petersson, Per/0000-0001-6697-0171; Petersson, Per/0000-0001-6697-0171; Schouenborg, Jens/0000-0002-2815-6918				BLUMBERG MS, 1994, BEHAV NEUROSCI, V108, P1196, DOI 10.1037/0735-7044.108.6.1196; Blumberg MS, 1996, DEV PSYCHOBIOL, V29, P1, DOI 10.1002/(SICI)1098-2302(199601)29:1<1::AID-DEV1>3.0.CO;2-Y; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; DELISI L, 1932, RIV PATOL NERV MENT, V29, P481; FITZGERALD M, 1986, DEV BRAIN RES, V24, P261, DOI 10.1016/0165-3806(86)90194-X; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Fregnac Y, 1998, DAHLEM WORK, P113; Gardner R., 1975, ADV SLEEP RES, P67; HADDERSALGRA M, 1993, EARLY HUM DEV, V35, P63, DOI 10.1016/0378-3782(93)90140-P; Holmberg H, 1996, J PHYSIOL-LONDON, V493, P239, DOI 10.1113/jphysiol.1996.sp021379; Holmberg H, 1996, J PHYSIOL-LONDON, V495, P399, DOI 10.1113/jphysiol.1996.sp021602; Holmberg H, 1997, J NEUROSCI, V17, P2071; Johansson R., 1993, SYSTEM MODELING IDEN; Karlsson KAE, 2002, BEHAV NEUROSCI, V116, P912, DOI 10.1037//0735-7044.116.5.912; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Levinsson A, 2002, J NEUROSCI, V22, P8170; Levinsson A, 1999, J NEUROSCI, V19, P10397; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8779, DOI 10.1073/pnas.83.22.8779; Morisset V, 1998, EUR J NEUROSCI, V10, P3642, DOI 10.1046/j.1460-9568.1998.00370.x; Nakatsuka T, 2000, NEUROSCIENCE, V99, P549, DOI 10.1016/S0306-4522(00)00224-4; Nicolelis MAL, 1996, J NEUROPHYSIOL, V75, P2192, DOI 10.1152/jn.1996.75.5.2192; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; SCHOUENBORG J, 1994, EXP BRAIN RES, V100, P170; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WALDENSTROM A, 2002, IASP ABSTR, V1558, pP106; WALDENSTROM A, 2001, SOC NEUR ABSTR, V30, P1623	30	133	133	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					72	75		10.1038/nature01719	http://dx.doi.org/10.1038/nature01719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840761				2022-12-01	WOS:000183912800042
J	Naleway, AL; Belongia, EA; Greenlee, RT; Kieke, BA; Chen, RT; Shay, DK				Naleway, AL; Belongia, EA; Greenlee, RT; Kieke, BA; Chen, RT; Shay, DK			Eczematous skin disease and recall of past diagnoses: Implications for smallpox vaccination	ANNALS OF INTERNAL MEDICINE			English	Article							ATOPIC-DERMATITIS; PREVALENCE; COMPLICATIONS; UK	Background: Persons with atopic dermatitis or eczema, regardless of disease severity or activity, may develop eczema vaccinatum if they or their close contacts receive the smallpox vaccine. According to current recommendations, a preexposure vaccination program should identify these persons and exclude them from participating. Objective: To determine the prevalence of diagnosed atopic dermatitis and eczema in a defined population and assess the sensitivity of screening questions to identify patients who have received these diagnoses. Design: Population-based prevalence survey and telephone interview. Setting: 14 ZIP code regions in Wisconsin. Patients: Persons given a diagnosis of atopic dermatitis or eczema in 2000 and 2001 were identified from a population-based cohort. Persons with a history of atopic dermatitis diagnosed since 1979 were eligible for the telephone survey. Measurements: Prevalence of diagnosed atopic dermatitis or eczema; proportions of respondents able to recall a past diagnosis of atopic dermatitis, eczema, or recurrent rash. Results: The prevalence of atopic dermatitis or eczema diagnosis in 2000 or 2001 was 0.8%. At least 2.4% of the cohort would be ineligible for smallpox vaccination because of active skin disease in themselves or household members. Among 94 adult respondents with atopic dermatitis, 55 (59%) correctly self-reported skin disease. Seventy-nine (60%) of 133 household contacts of adults with atopic dermatitis correctly reported the presence of skin disease in a household member. Parental recall of skin disease in children with atopic dermatitis was 70% (123 of 177). Conclusions: Identifying dermatologic contraindications to smallpox vaccination by relying only on a self-reported history of rash illnesses is likely to miss a substantial proportion of individuals who should not receive smallpox vaccine in a preexposure vaccination campaign.	Marshfield Med Res Fdn, Epidemiol Res Ctr, Marshfield, WI 54449 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Belongia, EA (corresponding author), Marshfield Med Res Fdn, Epidemiol Res Ctr, 1000 N Oak Ave,Mailstop ML2, Marshfield, WI 54449 USA.	belongia.edward@mcrf.mfldclin.edu		Shay, David/0000-0001-9619-4820; Belongia, Edward/0000-0001-7478-0415; Naleway, Allison/0000-0001-5747-4643	PHS HHS [200-95-0957] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM AC DERM, 2003, ECZ AT DERM; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bicknell WJ, 2002, NEW ENGL J MED, V347, P691; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Breslow NE, 1987, STAT METHODS CANC RE, VII; *CDCP, 2003, SMALLP VACC REP STAT; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; *DEP DEF, 2003, SMALLP SAF SUMM; DeStefano F, 1996, J CLIN EPIDEMIOL, V49, P643, DOI 10.1016/0895-4356(96)00008-X; Ellis CN, 2002, J AM ACAD DERMATOL, V46, P361, DOI 10.1067/mjd.2002.120528; GOLDSTEIN JA, 1975, PEDIATRICS, V55, P342; GREENBERG M, 1948, AM J DIS CHILD, V76, P492; Hanifin JM., 1980, ACTA DERM-VENEREOL, V92, P44; Hastie TJ, 1990, GEN ADDITIVE MODELS; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Herd RM, 1996, BRIT J DERMATOL, V135, P18; KAY J, 1994, J AM ACAD DERMATOL, V30, P35, DOI 10.1016/S0190-9622(94)70004-4; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; Lane JM, 2002, NEW ENGL J MED, V347, P691; Larsen FS, 1996, J AM ACAD DERMATOL, V34, P760, DOI 10.1016/S0190-9622(96)90009-2; Laughter D, 2000, J AM ACAD DERMATOL, V43, P649, DOI 10.1067/mjd.2000.107773; McNally NJ, 2000, BRIT J DERMATOL, V142, P712, DOI 10.1046/j.1365-2133.2000.03416.x; NEAME RL, 1995, BRIT J DERMATOL, V132, P772; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; WADDINGTON E, 1964, ANN REPORT T LONDON, V50, P22; Williams H, 2001, J AM ACAD DERMATOL, V45, pS33, DOI 10.1067/mjd.2001.117019; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; 2003, MMWR MORB MORTAL WKL, V52, P278; 2003, MMWR DISPATCH, V52, P1	33	33	35	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2003	139	1					1	7		10.7326/0003-4819-139-1-200307010-00006	http://dx.doi.org/10.7326/0003-4819-139-1-200307010-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	695GR	12834312				2022-12-01	WOS:000183823200001
J	Bunch, TJ; White, RD; Gersh, BJ; Meverden, RA; Hodge, DO; Ballman, KV; Hammill, SC; Shen, WK; Packer, DL				Bunch, TJ; White, RD; Gersh, BJ; Meverden, RA; Hodge, DO; Ballman, KV; Hammill, SC; Shen, WK; Packer, DL			Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL-SERVICES SYSTEM; VENTRICULAR-FIBRILLATION; RAPID DEFIBRILLATION; HEALTH-STATUS; PRIMARY-CARE; SURVIVORS; LIFE; RESUSCITATION; TECHNICIANS; PARAMEDICS	BACKGROUND: Mortality after out-of-hospital cardiac arrest from ventricular fibrillation is high. Programs focusing on early defibrillation have improved the rate of survival to hospital discharge. We conducted a population-based analysis of the long-term outcome and quality of life of survivors. METHODS: All patients who had an out-of-hospital cardiac arrest between November 1990 and January 2001 who received early defibrillation for ventricular fibrillation in Olmsted County, Minnesota, were included. The survival rate was compared with that of an age-, sex-, and disease-matched (2:1) control population of residents who had not had an out-of-hospital cardiac arrest and with that of age- and sex-matched controls from the general U.S. population. The quality of life was assessed with use of the Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36) and compared with U.S. population norms. RESULTS: Of 200 patients who presented with an out-of-hospital cardiac arrest with ventricular fibrillation, 145 (72 percent) survived to hospital admission (7 died in the emergency department) and 79 (40 percent) were neurologically intact (good overall capability or moderate overall disability) at discharge. The mean (+/-SD) length of follow-up was 4.8+/-3.0 years. Nineteen patients died after discharge from the hospital. The expected five-year survival rate (79 percent) was identical to that among age-, sex-, and disease-matched controls (P=0.68) but lower than that among the age- and sex-matched U.S. population (86 percent, P=0.02). Fifty patients completed SF-36 surveys at the end of follow-up, and the majority had a nearly normal quality of life, with the exception of reduced vitality. CONCLUSIONS: Long-term survival among patients who have undergone rapid defibrillation after out-of-hospital cardiac arrest is similar to that among age-, sex-, and disease-matched patients who did not have out-of-hospital cardiac arrest. The quality of life among the majority of survivors is similar to that of the general population.	Mayo Clin & Mayo Fdn, Dept Anesthesiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Div Biostat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	White, RD (corresponding author), Mayo Clin & Mayo Fdn, Dept Anesthesiol, 200 1St St SW, Rochester, MN 55905 USA.			Ballman, Karla/0000-0002-4492-0357				American Heart Association, 2000, 2001 HEART STROK STA; BERGNER L, 1985, AM J PUBLIC HEALTH, V75, P1321, DOI 10.2105/AJPH.75.11.1321; Bergner L, 1983, Am J Emerg Med, V1, P259, DOI 10.1016/0735-6757(83)90101-8; BERGNER L, 1984, AM J PUBLIC HEALTH, V74, P508, DOI 10.2105/AJPH.74.5.508; BERTINI G, 1990, Journal of Emergency Medicine, V8, P407, DOI 10.1016/0736-4679(90)90166-S; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; EISENBERG MS, 1980, NEW ENGL J MED, V302, P1379, DOI 10.1056/NEJM198006193022502; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Graves JR, 1997, RESUSCITATION, V35, P117; Herbst JH, 1999, PACE, V22, P915, DOI 10.1111/j.1540-8159.1999.tb06816.x; HOLMES DR, 1986, CIRCULATION, V73, P1254, DOI 10.1161/01.CIR.73.6.1254; Hsu JWY, 1996, ANN EMERG MED, V28, P597, DOI 10.1016/S0196-0644(96)70080-X; JENNETT B, 1975, LANCET, V1, P480; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1708, DOI 10.1001/jama.270.14.1708; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Kuilman M, 1999, RESUSCITATION, V41, P25, DOI 10.1016/S0300-9572(99)00016-7; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; PARADIS NA, 1996, CARDIAC ARREST SCI P, P867; Smith HJ, 2000, HEART, V84, P390, DOI 10.1136/heart.84.4.390; Stratton S, 1998, ANN EMERG MED, V31, P471, DOI 10.1016/S0196-0644(98)70256-2; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; Sunnerhagen KS, 1996, RESUSCITATION, V31, P135, DOI 10.1016/0300-9572(95)00903-5; SWOR RA, 1995, ANN EMERG MED, V25, P780, DOI 10.1016/S0196-0644(95)70207-5; VALENZUELA TD, 1993, ANN EMERG MED, V22, P1678, DOI 10.1016/S0196-0644(05)81305-8; Ware J.E., 1993, SCORING SF 36 SF 36, DOI DOI 10.6-10.7; White R D, 2001, Curr Opin Crit Care, V7, P145, DOI 10.1097/00075198-200106000-00002; White RD, 1996, ANN EMERG MED, V28, P480, DOI 10.1016/S0196-0644(96)70109-9; White RD, 1998, RESUSCITATION, V39, P145, DOI 10.1016/S0300-9572(98)00135-X; White RD, 2001, RESUSCITATION, V49, P9, DOI 10.1016/S0300-9572(00)00338-5; 1994, JAMA, V271, P984; [No title captured]	35	270	278	0	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2003	348	26					2626	2633		10.1056/NEJMoa023053	http://dx.doi.org/10.1056/NEJMoa023053			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693PN	12826637				2022-12-01	WOS:000183726400006
J	Nishiyama, M; Hoshino, A; Tsai, L; Henley, JR; Goshima, Y; Tessier-Lavigne, M; Poo, MM; Hong, KS				Nishiyama, M; Hoshino, A; Tsai, L; Henley, JR; Goshima, Y; Tessier-Lavigne, M; Poo, MM; Hong, KS			Cyclic AMP/GMP-dependent modulation of Ca2+ channels sets the polarity of nerve growth-cone turning	NATURE			English	Article							ARACHIDONATE 12-LIPOXYGENASE; CALCIUM TRANSIENTS; CANINE BRAIN; NETRIN-1; GUIDANCE; CELLS; ACID; ORIENTATION; SPECIFICITY; ACTIVATION	Signalling by intracellular second messengers such as cyclic nucleotides and Ca2+ is known to regulate attractive and repulsive guidance of axons by extracellular factors(1,2). However, the mechanism of interaction among these second messengers in determining the polarity of the guidance response is largely unknown. Here, we report that the ratio of cyclic AMP to cyclic GMP activities sets the polarity of netrin-1-induced axon guidance: high ratios favour attraction, whereas low ratios favour repulsion. Whole-cell recordings of Ca2+ currents at Xenopus spinal neuron growth cones indicate that cyclic nucleotide signalling directly modulates the activity of L-type Ca2+ channels LCCs) in axonal growth cones. Furthermore, cGMP signalling activated by an arachidonate 12-lipoxygenase metabolite(3) suppresses LCC activity triggered by netrin-1, and is required for growth-cone repulsion mediated by the DCC-UNC5 receptor complex(4). By linking cAMP and cGMP signalling and modulation of Ca2+ channel activity in growth cones, these findings delineate an early membrane-associated event responsible for signal transduction during bi-directional axon guidance.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, Div Neurobiol, Berkeley, CA 94720 USA; Yokohama City Univ, Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA	New York University; University of California System; University of California Berkeley; Yokohama City University; Howard Hughes Medical Institute; Stanford University	Hong, KS (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.		Henley, John/D-7171-2011	Henley, John/0000-0003-1846-5941				Baldridge WH, 2001, VISUAL NEUROSCI, V18, P849, DOI 10.1017/S0952523801186013; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BRUNE B, 1991, MOL PHARMACOL, V39, P671; Carabelli V, 2002, J PHYSIOL-LONDON, V541, P351, DOI 10.1113/jphysiol.2002.017749; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; HAWKINS DJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P447, DOI 10.1016/0003-9861(89)90312-3; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; Mikule K, 2002, J NEUROSCI, V22, P4932, DOI 10.1523/JNEUROSCI.22-12-04932.2002; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; NISHIYAMA M, 1993, J HISTOCHEM CYTOCHEM, V41, P111, DOI 10.1177/41.1.8417106; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nishiyama M, 1998, EUR J PHARMACOL, V341, P57, DOI 10.1016/S0014-2999(97)01353-8; NISHIYAMA M, 1992, J NEUROCHEM, V58, P1395, DOI 10.1111/j.1471-4159.1992.tb11355.x; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; Ruiz-Velasco V, 1998, CIRC RES, V82, P557, DOI 10.1161/01.RES.82.5.557; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Spitzer NC, 2000, BIOESSAYS, V22, P811; Tabti N., 1991, CULTURING NERVE CELL, P137	30	312	324	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					990	995		10.1038/nature01751	http://dx.doi.org/10.1038/nature01751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827203				2022-12-01	WOS:000183753900051
J	Sinervo, B; Clobert, J				Sinervo, B; Clobert, J			Morphs, dispersal behavior, genetic similarity, and the evolution of cooperation	SCIENCE			English	Article							ALTERNATIVE MALE; CORRELATIONAL SELECTION; KIN SELECTION; ALTRUISM; FITNESS; DRIVEN; CYCLES; GAME	Genetic similarity owing to kin relationship is often invoked to explain the evolution of social cooperation. In this study, male color morphs of side-blotched lizards settle nonrandomly with respect to genetic similarity. Blue morphs tend to settle in close proximity to other blue morphs with high genetic similarity. Blue neighbors have three times the average fitness of blue males lacking such neighbors. Conversely, genetically similar males depress fitness of the orange morph. Moreover, orange males are hyperdispersed with respect to genetic similarity. Pedigree and dispersal data show that genetically similar blue neighbors are not kin. Instead, conditions for the evolution of dispersal and cooperation are promoted by an emergent property of the morph locus that increases genetic similarity within morphs: genome-wide correlational selection links many traits to the morph locus, including settlement behavior.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; CNRS, UMR 7625, Ecol Lab, F-75252 Paris 05, France	University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Sinervo, B (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Earth & Marine Sci Bldg,A316, Santa Cruz, CA 95064 USA.	sinervo@biology.ucsc.edu						AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Calsbeek R, 2002, OECOLOGIA, V132, P468, DOI 10.1007/s00442-002-0975-8; Dawkins R., 1976, SELFISH GENE; DOUGHTY P, 1994, J HERPETOL, V28, P485, DOI 10.2307/1564962; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Koella JC, 2000, P ROY SOC B-BIOL SCI, V267, P1979, DOI 10.1098/rspb.2000.1239; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P919, DOI 10.1098/rspb.1996.0136; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; Le Galliard JF, 2003, EVOLUTION, V57, P1; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; PFENNIG DW, 1993, NATURE, V362, P836, DOI 10.1038/362836a0; PFENNIG DW, 1993, ANIM BEHAV, V46, P87, DOI 10.1006/anbe.1993.1164; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; SHERMAN PW, 1997, COOPERATIVE BREEDING, P267; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2000, HORM BEHAV, V38, P222, DOI 10.1006/hbeh.2000.1622; Sinervo B, 2001, GENETICA, V112, P417, DOI 10.1023/A:1013360426789; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Sinervo B, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P41; Svensson E, 2001, P NATL ACAD SCI USA, V98, P12561, DOI 10.1073/pnas.211071298; Svensson E, 2001, EVOLUTION, V55, P2053; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998	29	123	126	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1949	1951		10.1126/science.1083109	http://dx.doi.org/10.1126/science.1083109			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817150				2022-12-01	WOS:000183619400048
J	Tremblay, S; Shiller, DM; Ostry, DJ				Tremblay, S; Shiller, DM; Ostry, DJ			Somatosensory basis of speech production	NATURE			English	Article							VOWEL-U; PERTURBATION; COMPENSATION; VARIABILITY; ADAPTATION; MODEL	The hypothesis that speech goals are defined acoustically and maintained by auditory feedback is a central idea in speech production research(1-6). An alternative proposal is that speech production is organized in terms of control signals that subserve movements and associated vocal-tract configurations(7-9). Indeed, the capacity for intelligible speech by deaf speakers suggests that somatosensory inputs related to movement play a role in speech production-but studies that might have documented a somatosensory component have been equivocal. For example, mechanical perturbations that have altered somatosensory feedback have simultaneously altered acoustics(10-14). Hence, any adaptation observed under these conditions may have been a consequence of acoustic change. Here we show that somatosensory information on its own is fundamental to the achievement of speech movements. This demonstration involves a dissociation of somatosensory and auditory feedback during speech production. Over time, subjects correct for the effects of a complex mechanical load that alters jaw movements (and hence somatosensory feedback), but which has no measurable or perceptible effect on acoustic output. The findings indicate that the positions of speech articulators and associated somatosensory inputs constitute a goal of speech movements that is wholly separate from the sounds produced.	McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; Haskins Labs Inc, New Haven, CT 06511 USA	McGill University; Yale University; Haskins Laboratories	Ostry, DJ (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Galantucci, Bruno/E-5770-2010					BERNSTEIN LR, 1982, J ACOUST SOC AM, V71, P147, DOI 10.1121/1.387254; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; GUENTHER FH, 1995, PSYCHOL REV, V102, P594, DOI 10.1037/0033-295X.102.3.594; Guenther FH, 1999, J ACOUST SOC AM, V105, P2854, DOI 10.1121/1.426900; Hamlet S. L, 1976, J PHONETICS, V4, P199; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; LINDBLOM B, 1979, J PHONETICS, V7, P147, DOI 10.1016/S0095-4470(19)31046-0; MCFARLAND DH, 1995, J ACOUST SOC AM, V97, P1865, DOI 10.1121/1.412060; McFarland DH, 1996, J ACOUST SOC AM, V100, P1093, DOI 10.1121/1.416286; PERKELL JS, 1993, J ACOUST SOC AM, V93, P2948, DOI 10.1121/1.405814; PERKELL JS, 1985, J ACOUST SOC AM, V77, P1889, DOI 10.1121/1.391940; Saltzman E. L., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969cco0104_2, DOI 10.1207/S15326969ECO0104_2, 10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; SAVARIAUX C, 1995, J ACOUST SOC AM, V98, P2428, DOI 10.1121/1.413277; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588	20	207	210	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					866	869		10.1038/nature01710	http://dx.doi.org/10.1038/nature01710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	691BQ	12815431				2022-12-01	WOS:000183585300045
J	Eisen, JA; Fraser, CM				Eisen, JA; Fraser, CM			Phylogenomics: Intersection of evolution and genomics	SCIENCE			English	Editorial Material							SEQUENCE; GENES; BACTERIAL; PROTEIN	Much has been gained from genomic and evolutionary studies of species. Combining the perspectives of these different approaches suggests that an integrated phylogenomic approach will be beneficial.	Inst Genome Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Eisen, JA (corresponding author), Inst Genome Res, Rockville, MD 20850 USA.	jeisen@tigr.org	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Fraser, Claire/0000-0003-1462-2428				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; DOOLITTLE WF, 1999, TRENDS CELL BIOL, V9, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 2002, NATURE, V415, P845, DOI 10.1038/nature725; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Eisen JA, 1997, NAT MED, V3, P1076, DOI 10.1038/nm1097-1076; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Eisen JA, 2000, GENOME BIOL, V1; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HUENHOLTZ P, 2002, GENOME BIOL, V3; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Roelofs J, 2001, NATURE, V411, P1013, DOI 10.1038/35082627; Rujan T, 2001, TRENDS GENET, V17, P113, DOI 10.1016/S0168-9525(00)02209-5; Salzberg SL, 2001, SCIENCE, V293, P1048; Stanhope MJ, 2001, NATURE, V411, P940, DOI 10.1038/35082058; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	30	212	229	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1706	1707		10.1126/science.1086292	http://dx.doi.org/10.1126/science.1086292			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805538				2022-12-01	WOS:000183459700039
J	Sanfey, AG; Rilling, JK; Aronson, JA; Nystrom, LE; Cohen, JD				Sanfey, AG; Rilling, JK; Aronson, JA; Nystrom, LE; Cohen, JD			The neural basis of economic decision-making in the ultimatum game	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COMPETITION; COOPERATION; SATIATION; FAIRNESS; DISGUST; PAIN	The nascent field of neuroeconomics seeks to ground economic decision-making in the biological substrate of the brain. We used functional magnetic resonance imaging of Ultimatum Game players to investigate neural substrates of cognitive and emotional processes involved in economic decision-making. In this game, two players split a sum of money; one player proposes a division and the other can accept or reject this. We scanned players as they responded to fair and unfair proposals. Unfair offers elicited activity in brain areas related to both emotion ( anterior insula) and cognition ( dorsolateral prefrontal cortex). Further, significantly heightened activity in anterior insula for rejected unfair offers suggests an important role for emotions in decision-making.	Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Hlth & Well Being, Princeton, NJ 08544 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sanfey, AG (corresponding author), Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA.		Sanfey, Alan G/D-2350-2010; sarinopoulos, isidoros/B-5453-2010	Sanfey, Alan/0000-0002-7421-8294				Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Bonetti S, 1998, J ECON PSYCHOL, V19, P377, DOI 10.1016/S0167-4870(98)00012-9; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; CAMERER C, IN PRESS ADV BEHAV E; Critchley HD, 2000, J NEUROSCI, V20, P3033; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Denton D, 1999, P NATL ACAD SCI USA, V96, P5304, DOI 10.1073/pnas.96.9.5304; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hertwig R, 2001, BEHAV BRAIN SCI, V24, P383, DOI 10.1017/S0140525X01004149; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; Loewenstein G., 2003, HDB AFFECTIVE SCI; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Roth A.E., 1995, HDB EXPT EC; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; THALER RH, 1988, J ECON PERSPECT, V2, P195, DOI 10.1257/jep.2.4.195; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; [No title captured]	28	1967	2031	22	555	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1755	1758		10.1126/science.1082976	http://dx.doi.org/10.1126/science.1082976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805551				2022-12-01	WOS:000183459700054
J	Yamamoto, Y; Verma, UN; Prajapati, S; Kwak, YT; Gaynor, RB				Yamamoto, Y; Verma, UN; Prajapati, S; Kwak, YT; Gaynor, RB			Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression	NATURE			English	Article							NF-KAPPA-B; KINASE COMPLEX; MICE LACKING; P65 SUBUNIT; ACTIVATION; PROTEINS; CBP/P300; GROWTH; ACETYLATION; PATHWAY	Cytokine-induced activation of the IkappaB kinases (IKK) IKK-alpha and IKK-beta is a key step involved in the activation of the NF-kappaB pathway(1-4). Gene-disruption studies of the murine IKK genes have shown that IKK-beta, but not IKK-alpha, is critical for cytokine-induced IkappaB degradation(5-7). Nevertheless, mouse embryo fibroblasts deficient in IKK- a are defective in the induction of NF-kappaB-dependent transcription(7-9). These observations raised the question of whether IKK-alpha might regulate a previously undescribed step to activate the NF-kappaB pathway that is independent of its previously described cytoplasmic role in the phosphorylation of IkappaBalpha. Here we show that IKK-alpha functions in the nucleus to activate the expression of NF-kappaB-responsive genes after stimulation with cytokines. IKK-alpha interacts with CREB-binding protein and in conjunction with Rel A is recruited to NF-kappaB-responsive promoters and mediates the cytokine-induced phosphorylation and subsequent acetylation of specific residues in histone H3. These results define a new nuclear role of IKK-alpha in modifying histone function that is critical for the activation of NF-kappaB-directed gene expression.	Univ Texas, SW Med Ctr, Harold Simmons Canc Ctr, Dept Med,Div Hematol Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gaynor, RB (corresponding author), Univ Texas, SW Med Ctr, Harold Simmons Canc Ctr, Dept Med,Div Hematol Oncol, Dallas, TX 75390 USA.							Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goodman RH, 2000, GENE DEV, V14, P1553; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; VAN AD, 1996, SCIENCE, V274, P787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	29	503	524	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					655	659		10.1038/nature01576	http://dx.doi.org/10.1038/nature01576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789342				2022-12-01	WOS:000183301200044
J	Bazzano, LA; He, J; Muntner, P; Vupputuri, S; Whelton, PK				Bazzano, LA; He, J; Muntner, P; Vupputuri, S; Whelton, PK			Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; APPARENTLY HEALTHY-MEN; PLASMA HOMOCYSTEINE; LIQUID-CHROMATOGRAPHY; HEART-DISEASE; FIBRINOGEN; INFLAMMATION; ASSOCIATION; SMOKERS	Background: Few studies have examined the relationship between cigarette smoking and novel risk factors for cardiovascular disease in a general population or have included a biochemical marker of current smoking. Objective: To examine the relationship between cigarette smoking and serum C-reactive protein, fibrinogen, and homocysteine levels. Design: Cross-sectional study. Setting: The U.S. general population. Patients: 4187 current smokers, 4791 former smokers, and 8375 never-smokers 18 years of age or older who participated in the Third National Health and Nutrition Examination Survey conducted between 1988 and 1994. Measurements: serum C-reactive protein levels were categorized as detectable (2.2 to 9.9 mg/L) or clinically elevated (greater than or equal to10 mg/L), and fibrinogen and homocysteine levels were defined as elevated if in the 85th percentile or greater (11.1 mumol/L and 12.7 mmol/L, respectively). Results: After adjustment for traditional cardiovascular disease risk factors, cigarette smoking was related to elevated levels of C-reactive protein, fibrinogen, and homocysteine. Compared with never smoking cigarettes, self-reported current cigarette smoking was associated with a C-reactive protein level in the detectable (odds ratio, 1.66 [95% CI, 1.40 to 1.97]; P < 0.001) or clinically elevated (odds ratio, 1.98 [CI, 1.57 to 2.51]; P < 0.001) ranges, with elevated levels of fibrinogen (odds ratio, 2.15 [CI, 1.65 to 2.80]; P < 0.001) and homocysteine (odds ratio, 2.10 [CI, 1.62 to 2.74]; P < 0.001). There were positive and significant dose-response relationships between measures of cigarette smoking (cigarettes per day, pack-years, and serum cotinine levels) and elevated levels of novel risk factors. Conclusions: These findings suggest that inflammation and hyperhomocysteinemia may be important mechanisms by which smoking promotes atherosclerotic disease.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, New Orleans, LA 70112 USA; Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA	Tulane University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave SL18, New Orleans, LA 70112 USA.				NHLBI NIH HHS [R01 HL60300] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060300] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 2001, 2002 HEART STROK STA; Anderson JL, 2000, CIRCULATION, V102, P1227, DOI 10.1161/01.CIR.102.11.1227; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Azar RR, 2000, AM J CARDIOL, V86, P205, DOI 10.1016/S0002-9149(00)00856-0; Bermudez EA, 2002, AM J CARDIOL, V89, P1117, DOI 10.1016/S0002-9149(02)02284-1; Bernert JT, 1997, CLIN CHEM, V43, P2281; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Campisi R, 1998, CIRCULATION, V98, P119, DOI 10.1161/01.CIR.98.2.119; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DAS I, 1985, CLIN CHIM ACTA, V153, P9, DOI 10.1016/0009-8981(85)90133-0; de Bree A, 2001, AM J EPIDEMIOL, V154, P150, DOI 10.1093/aje/154.2.150; Erlinger TP, 2001, ARCH INTERN MED, V161, P1903, DOI 10.1001/archinte.161.15.1903; Fusegawa Y, 1999, THROMB RES, V93, P271, DOI 10.1016/S0049-3848(98)00184-4; GREEN D, 1994, ARTERIOSCLER THROMB, V14, P686, DOI 10.1161/01.ATV.14.5.686; Gunter E.W., 1996, LAB PROCEDURES USED; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; HUNG J, 1995, CIRCULATION, V92, P2432, DOI 10.1161/01.CIR.92.9.2432; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9; KROBOT K, 1992, ARTERIOSCLER THROMB, V12, P780, DOI 10.1161/01.ATV.12.7.780; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; MUSCAT JE, 1991, AM HEART J, V121, P141, DOI 10.1016/0002-8703(91)90967-M; Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; SHAW ST, 1977, CRC CR REV CL LAB SC, V8, P145, DOI 10.3109/10408367709151695; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; US Department of Health and Human Services [Internet], 1990, HLTH BEN SMOK CESS R; [No title captured]	32	273	284	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2003	138	11					891	897		10.7326/0003-4819-138-11-200306030-00010	http://dx.doi.org/10.7326/0003-4819-138-11-200306030-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	686AB	12779299				2022-12-01	WOS:000183296400004
J	Chambers, I; Colby, D; Robertson, M; Nichols, J; Lee, S; Tweedie, S; Smith, A				Chambers, I; Colby, D; Robertson, M; Nichols, J; Lee, S; Tweedie, S; Smith, A			Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells	CELL			English	Article							LEUKEMIA INHIBITORY FACTOR; PRIMORDIAL GERM-CELLS; SELF-RENEWAL; DIFFERENTIATION; GENE; RECEPTOR; MAINTENANCE; ACTIVATION; STAT3; GP130	Embryonic stem (ES) cells undergo extended proliferation while remaining poised for multilineage differentiation. A unique network of transcription factors may characterize self-renewal and simultaneously suppress differentiation. We applied expression cloning in mouse ES cells to isolate a self-renewal determinant. Nanog is a divergent homeodomain protein that directs propagation of undifferentiated ES cells. Nanog mRNA is present in pluripotent mouse and human cell lines, and absent from differentiated cells. In preimplantation embryos, Nanog is restricted to founder cells from which ES cells can be derived. Endogenous Nanog acts in parallel with cytokine stimulation of Stat3 to drive ES cell self-renewal. Elevated Nanog expression from transgene constructs is sufficient for clonal expansion of ES cells, bypassing Stat3 and maintaining Oct4 levels. Cytokine dependence, multilineage differentiation, and embryo colonization capacity are fully restored upon transgene excision. These findings establish a central role for Nanog in the transcription factor hierarchy that defines ES cell identity.	Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh	Chambers, I (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	ichambers@ed.ac.uk	Tweedie, Susan/B-3695-2019; Chambers, Ian/H-5416-2011	Tweedie, Susan/0000-0003-1818-8243; Chambers, Ian/0000-0003-2605-1597; Smith, Austin/0000-0002-3029-4682; Nichols, Jennifer/0000-0002-8650-1388				ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 1997, BIOCHEM J, V328, P879, DOI 10.1042/bj3280879; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; PERA MF, 1989, DIFFERENTIATION, V42, P10, DOI 10.1111/j.1432-0436.1989.tb00602.x; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; RYSKOV AP, 1983, NUCLEIC ACIDS RES, V11, P6541, DOI 10.1093/nar/11.18.6541; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG., 1991, J TISSUE CULTURE MET, V13, P89, DOI [DOI 10.1007/BF01666137, 10.1007/BF01666137, 10.1007/bf01666137]; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; Wang SH, 2003, GENE EXPR PATTERNS, V3, P99, DOI 10.1016/S1567-133X(03)00005-X; Yoshida A, 1996, ASSIST REPROD REV, V67, P93; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2	48	2466	2779	4	272	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2003	113	5					643	655		10.1016/S0092-8674(03)00392-1	http://dx.doi.org/10.1016/S0092-8674(03)00392-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787505	Green Submitted, Bronze			2022-12-01	WOS:000183397600014
J	Graef, IA; Wang, F; Charron, F; Chen, L; Neilson, J; Tessier-Lavigne, M; Crabtree, GR				Graef, IA; Wang, F; Charron, F; Chen, L; Neilson, J; Tessier-Lavigne, M; Crabtree, GR			Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons	CELL			English	Article							LYMPHOCYTE-T ACTIVATION; MOTOR-NEURON POOLS; LIM HOMEOBOX GENES; NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; CYCLOSPORINE-A; GROWTH; GUIDANCE; DROSOPHILA; PROTEIN	Axon outgrowth is the first step in the formation of neuronal connections, but the pathways that regulate axon extension are still poorly understood. We find that mice deficient in calcineurin-NFAT signaling have dramatic defects in axonal outgrowth, yet have little or no defect in neuronal differentiation or survival. In vitro, sensory and commissural neurons lacking calcineurin function or NFATc2, c3, and c4 are unable to respond to neurotrophins or netrin-1 with efficient axonal outgrowth. Neurotrophins and netrins stimulate calcineurin-dependent nuclear localization of NFATc4 and activation of NFAT-mediated gene transcription in cultured primary neurons. These data indicate that the ability of these embryonic axons to respond to growth factors with rapid outgrowth requires activation of calcineurin/NFAT signaling by these factors. The precise parsing of signals for elongation turning and survival could allow independent control of these processes during development.	Stanford Univ, Sch Med, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tessier-Lavigne, M (corresponding author), Stanford Univ, Sch Med, Dept Biol Sci, 300 Pasteur Dr, Stanford, CA 94305 USA.		Charron, Frederic/O-8017-2019; Charron, Frederic/D-2140-2009	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Neilson, Joel R./0000-0002-3408-608X	NATIONAL CANCER INSTITUTE [R01CA039612, R37CA039612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008973] Funding Source: NIH RePORTER; NCI NIH HHS [CA 39612] Funding Source: Medline; NIDCR NIH HHS [P01 DE 08973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Giger RJ, 2001, CELL, V105, P1, DOI 10.1016/S0092-8674(01)00290-2; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; LANKFORD KL, 1989, J CELL BIOL, V109, P1229, DOI 10.1083/jcb.109.3.1229; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; Senti KA, 2000, DEVELOPMENT, V127, P2291; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	52	303	314	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					657	670		10.1016/S0092-8674(03)00390-8	http://dx.doi.org/10.1016/S0092-8674(03)00390-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787506	Bronze			2022-12-01	WOS:000183397600015
J	Takahashi, K; Mitsui, K; Yamanaka, S				Takahashi, K; Mitsui, K; Yamanaka, S			Role of ERas in promoting tumour-like properties in mouse embryonic stem cells	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN; KINASE; TRANSFORMATION; GENE; AKT; ESTABLISHMENT; SUPPRESSION; PTEN; LINE	Embryonic stem (ES) cells are pluripotent cells derived from early mammalian embryos(1,2). Their immortality and rapid growth make them attractive sources for stem cell therapies(3); however, they produce tumours (teratomas) when transplanted, which could preclude their therapeutic usage(4). Why ES cells, which lack chromosomal abnormalities, possess tumour-like properties is largely unknown. Here we show that mouse ES cells specifically express a Ras-like gene, which we have named ERas. We show that human HRasp, which is a recognized pseudogene, does not contain reported base substitutions and instead encodes the human orthologue of ERas. This protein contains amino-acid residues identical to those present in active mutants of Ras(5) and causes oncogenic transformation in NIH 3T3 cells. ERas interacts with phosphatidylinositol-3-OH kinase(6) but not with Raf(7,8). ERas-null ES cells maintain pluripotency but show significantly reduced growth and tumorigenicity, which are rescued by expression of ERas complementary DNA or by activated phosphatidylinositol-3-OH kinase. We conclude that the transforming oncogene ERas is important in the tumour-like growth properties of ES cells.	Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Lab Anim Mol Technol, Nara 6300192, Japan	Nara Institute of Science & Technology	Yamanaka, S (corresponding author), Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Lab Anim Mol Technol, Nara 6300192, Japan.		Takahashi, Kazutoshi/ABE-5504-2020; Mitsui, Kaoru/E-1464-2011	Takahashi, Kazutoshi/0000-0002-5329-8395; Mitsui, Kaoru/0000-0003-0534-9845				Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHEN ZQ, 1985, J VIROL, V56, P607, DOI 10.1128/JVI.56.2.607-612.1985; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Freed CR, 2002, P NATL ACAD SCI USA, V99, P1755, DOI 10.1073/pnas.062039699; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Klippel A, 1996, MOL CELL BIOL, V16, P4117; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; MIYOSHI J, 1984, NUCLEIC ACIDS RES, V12, P1821, DOI 10.1093/nar/12.4.1821; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rosario M, 1999, EMBO J, V18, P1270, DOI 10.1093/emboj/18.5.1270; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	30	272	305	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					541	545		10.1038/nature01646	http://dx.doi.org/10.1038/nature01646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774123	Bronze			2022-12-01	WOS:000183162900044
J	Shu, YS; Hasenstaub, A; McCormick, DA				Shu, YS; Hasenstaub, A; McCormick, DA			Turning on and off recurrent balanced cortical activity	NATURE			English	Article							VISUAL-CORTEX; NEOCORTICAL NEURONS; PERSISTENT ACTIVITY; CAT; INHIBITION; INPUT; RAT; EXCITATION; MECHANISMS; COMPONENTS	The vast majority of synaptic connections onto neurons in the cerebral cortex arise from other cortical neurons, both excitatory and inhibitory, forming local and distant 'recurrent' networks. Although this is a basic theme of cortical organization, its study has been limited largely to theoretical investigations, which predict that local recurrent networks show a proportionality or balance between recurrent excitation and inhibition, allowing the generation of stable periods of activity(1-5). This recurrent activity might underlie such diverse operations as short-term memory(4,6,7), the modulation of neuronal excitability with attention(8,9), and the generation of spontaneous activity during sleep(5,10-14). Here we show that local cortical circuits do indeed operate through a proportional balance of excitation and inhibition generated through local recurrent connections, and that the operation of such circuits can generate self-sustaining activity that can be turned on and off by synaptic inputs. These results confirm the long-hypothesized role of recurrent activity as a basic operation of the cerebral cortex.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.		Kobelt, Liza/F-5926-2011; Shu, Yousheng/AAC-3881-2020	Shu, Yousheng/0000-0002-2834-2876				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; COMPTE A, UNPUB J NEUROPHYSIOL; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J.M., 1995, MEMORY CEREBRAL CORT; Gutkin BS, 2001, J COMPUT NEUROSCI, V11, P121, DOI 10.1023/A:1012837415096; Hahnloser RHR, 2002, NEURAL COMPUT, V14, P1669, DOI 10.1162/08997660260028665; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STERN P, 1992, J PHYSIOL-LONDON, V449, P247, DOI 10.1113/jphysiol.1992.sp019085; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3	30	753	764	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					288	293		10.1038/nature01616	http://dx.doi.org/10.1038/nature01616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748642				2022-12-01	WOS:000182853100043
J	McVernon, J; Andrews, N; Slack, MPE; Ramsay, ME				McVernon, J; Andrews, N; Slack, MPE; Ramsay, ME			Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis	LANCET			English	Article							CAPSULAR POLYSACCHARIDE	An increase in invasive Hib disease incidence in the UK has coincided with the distribution of combination vaccines that contain acellular pertussis (DTaP-Hib). These vaccines have been associated with reduced Immunogenicity of the Hib component, although there is little agreement on the clinical relevance of this finding. We retrospectively compared vaccine formulations given to fully vaccinated Hib cases with those administered to fully immunised age-matched controls Using conditional logistic regression. More cases than controls received all three doses of their infant primary course as DTaP-Hib, compared with two or three doses of another Hib vaccine (conditional odds ratio 6.77 [95% CI 3.26-14.07]).	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England; Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; Hlth Protect Agcy, Haemophilus Reference Unit, Oxford, England	Health Protection Agency; University of Oxford; Health Protection Agency	McVernon, J (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England.		; Ramsay, Mary Elizabeth/S-8281-2016	McVernon, Jodie/0000-0001-9774-1961; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Anderson P, 2000, PEDIATR INFECT DIS J, V19, P589, DOI 10.1097/00006454-200007000-00001; Daum RS, 2001, J INFECT DIS, V184, P1293, DOI 10.1086/324007; Eskola J, 1999, LANCET, V354, P2063, DOI 10.1016/S0140-6736(99)04377-9; RAMSAY ME, IN PRESS J INFECT DI; *UK CHIEF MED OFF, PLANN HIB VACC CATCH	5	133	137	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 3	2003	361	9368					1521	1523		10.1016/S0140-6736(03)13171-6	http://dx.doi.org/10.1016/S0140-6736(03)13171-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737866				2022-12-01	WOS:000182658900014
J	Sheth, U; Parker, R				Sheth, U; Parker, R			Decapping and decay of messenger RNA occur in cytoplasmic processing bodies	SCIENCE			English	Article							YEAST; PROTEINS; COMPLEX; DEADENYLATION; TRANSLATION; HELICASE; DEGRADATION; MECHANISMS; PARTICLES; MUTATIONS	A major pathway of eukaryotic messenger RNA ( mRNA) turnover begins with deadenylation, followed by decapping and 5' to 3' exonucleolytic decay. We provide evidence that mRNA decapping and 5' to 3' degradation occur in discrete cytoplasmic foci in yeast, which we call processing bodies ( P bodies). First, proteins that activate or catalyze decapping are concentrated in P bodies. Second, inhibiting mRNA turnover before decapping leads to loss of P bodies; however, inhibiting turnover at, or after, decapping, increases the abundance and size of P bodies. Finally, mRNA degradation intermediates are localized to P bodies. These results de. ne the flux of mRNAs between polysomes and P bodies as a critical aspect of cytoplasmic mRNA metabolism and a possible site for regulation of mRNA degradation.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM045443, GM45443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson P, 2002, J CELL SCI, V115, P3227; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; BRENGUES M, UNPUB; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; SHETH U, UNPUB; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000	33	964	1002	4	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					805	808		10.1126/science.1082320	http://dx.doi.org/10.1126/science.1082320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730603	Green Accepted			2022-12-01	WOS:000182579800053
J	Garg, V; Kathiriyra, IS; Barnes, R; Schluterman, MK; King, IN; Butler, CA; Rothrock, CR; Eapen, RS; Hirayama-Yamada, K; Joo, K; Matsuoka, R; Cohen, JC; Srivastava, D				Garg, V; Kathiriyra, IS; Barnes, R; Schluterman, MK; King, IN; Butler, CA; Rothrock, CR; Eapen, RS; Hirayama-Yamada, K; Joo, K; Matsuoka, R; Cohen, JC; Srivastava, D			GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5	NATURE			English	Article								Congenital heart defects (CHDs) are the most common developmental anomaly and are the leading non-infectious cause of mortality in newborns(1). Only one causative gene, NKX2-5, has been identified through genetic linkage analysis of pedigrees with non-syndromic CHDs(2,3). Here, we show that isolated cardiac septal defects in a large pedigree were linked to chromosome 8p22-23. A heterozygous G296S missense mutation of GATA4, a transcription factor essential for heart formation(4-7), was found in all available affected family members but not in any control individuals. This mutation resulted in diminished DNA-binding affinity and transcriptional activity of Gata4. Furthermore, the Gata4 mutation abrogated a physical interaction between Gata4 and TBX5, a T-box protein responsible for a subset of syndromic cardiac septal defects(8,9). Conversely, interaction of Gata4 and TBX5 was disrupted by specific human TBX5 missense mutations that cause similar cardiac septal defects. In a second family, we identified a frame-shift mutation of GATA4 (E359del) that was transcriptionally inactive and segregated with cardiac septal defects. These results implicate GATA4 as a genetic cause of human cardiac septal defects, perhaps through its interaction with TBX5.	Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Div Genom Med, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Heart Inst Japan, Tokyo 1628666, Japan; Kyusyu Kosei Nenkin Hosp, Dept Pediat, Fukuoka 8068501, Japan	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Women's Medical University; Tokyo Women's Medical University	Garg, V (corresponding author), Univ Texas, SW Med Ctr, Dept Pediat, 6000 Harry Hines Blvd,Rm NA8-124, Dallas, TX 75390 USA.	Vidu.Garg@UTSouthwestern.edu; Deepak.Srivastava@UTSouthwestern.edu	Garg, Vidu/E-3101-2011; Burdine, Marie Schluterman/GLU-1812-2022; Garg, Vidu/D-8240-2012	Burdine, Marie Schluterman/0000-0002-3940-5748; Garg, Vidu/0000-0002-3778-5927	NHLBI NIH HHS [L40 HL078465-02, L40 HL078465] Funding Source: Medline; NICHD NIH HHS [K08 HD001382] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cross SJ, 2000, J MED GENET, V37, P785, DOI 10.1136/jmg.37.10.785; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P103, DOI 10.1007/BF00801907; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Li QY, 1997, NAT GENET, V15, P21; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.0.CO;2-V; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yang JF, 2000, AM J MED GENET, V92, P237, DOI 10.1002/(SICI)1096-8628(20000605)92:4<237::AID-AJMG2>3.0.CO;2-G	30	883	933	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					443	447		10.1038/nature01827	http://dx.doi.org/10.1038/nature01827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12845333				2022-12-01	WOS:000184318400047
J	Celikel, R; McClintock, RA; Roberts, JR; Mendolicchio, GL; Ware, J; Varughese, KI; Ruggeri, ZM				Celikel, R; McClintock, RA; Roberts, JR; Mendolicchio, GL; Ware, J; Varughese, KI; Ruggeri, ZM			Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ib-alpha	SCIENCE			English	Article							SITE-DIRECTED MUTAGENESIS; VON-WILLEBRAND-FACTOR; PROCOAGULANT ACTIVITY; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; BINDING SITE; ACTIVATION; COMPLEX; IDENTIFICATION; RESIDUES	Thrombin bound to platelets contributes to stop bleeding and, in pathological conditions, may cause vascular thrombosis. We have determined the structure of platelet glycoprotein Ibalpha (GpIbalpha) bound to thrombin at 2.3 angstrom resolution and defined two sites in GpIbalpha that bind to exosite II and exosite I of two distinct alpha-thrombin molecules, respectively. GpIbalpha occupancy may be sequential, as the site binding to alpha-thrombin exosite I appears to be cryptic in the unoccupied receptor but exposed when a first thrombin molecule is bound through exosite II. These interactions may modulate alpha-thrombin function by mediating GpIbalpha clustering and cleavage of protease-activated receptors, which promote platelet activation, while limiting fibrinogen clotting through blockade of exosite I.	Scripps Res Inst, Roon Res Ctr Arteriosclerosis & Thrombosis, Div Expt Thrombosis & Hemostasis, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, Div Cellular Pathol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Varughese, KI (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Cellular Pathol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, R01HL042846, R01HL055375, P01HL048728, R37HL042846] Funding Source: NIH RePORTER; NCRR NIH HHS [RR0833] Funding Source: Medline; NHLBI NIH HHS [HL-31950, HL-48728, HL-42846, HL-55375, R01 HL042846] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrews RK, 1999, THROMB HAEMOSTASIS, V82, P357, DOI 10.1055/s-0037-1615854; BEVERS EM, 1991, BLOOD REV, V5, P146, DOI 10.1016/0268-960X(91)90031-7; BODE W, 1992, PROTEIN SCI, V1, P426; Bouton MC, 1998, THROMB HAEMOSTASIS, V80, P310, DOI 10.1055/s-0037-1615193; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; De Cristofaro R, 2001, BIOCHEMISTRY-US, V40, P13268, DOI 10.1021/bi010491f; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; GRALNICK HR, 1994, P NATL ACAD SCI USA, V91, P6334, DOI 10.1073/pnas.91.14.6334; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li CQ, 2001, J BIOL CHEM, V276, P6161, DOI 10.1074/jbc.M004164200; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; Marchese P, 1999, P NATL ACAD SCI USA, V96, P7837, DOI 10.1073/pnas.96.14.7837; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; Mazzucato M, 1998, J BIOL CHEM, V273, P1880, DOI 10.1074/jbc.273.4.1880; MURATA M, 1991, J BIOL CHEM, V266, P15474; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Soslau G, 2001, J BIOL CHEM, V276, P21173, DOI 10.1074/jbc.M008249200; Tait AS, 2002, BLOOD, V99, P4422, DOI 10.1182/blood.V99.12.4422; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200	28	155	162	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					218	221		10.1126/science.1084183	http://dx.doi.org/10.1126/science.1084183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855810				2022-12-01	WOS:000184056200045
J	Day, M; Langston, R; Morris, RGM				Day, M; Langston, R; Morris, RGM			Glutamate-receptor-mediated encoding and retrieval of paired-associate learning	NATURE			English	Article							HIPPOCAMPAL CIRCUITRY; SYNAPTIC PLASTICITY; PLACE CELLS; MEMORY; POTENTIATION; TRANSMISSION; IMPAIRMENT; EXPERIENCE; SEQUENCES; AMNESIA	Paired-associate learning is often used to examine episodic memory in humans(1). Animal models include the recall of food-cache locations by scrub jays(2) and sequential memory(3,4). Here we report a model in which rats encode, during successive sample trials, two paired associates ( flavours of food and their spatial locations) and display better-than-chance recall of one item when cued by the other. In a first study, pairings of a particular foodstuff and its location were never repeated, so ensuring unique 'what-where' attributes. Blocking N-methyl-D-aspartate receptors in the hippocampus - crucial for the induction of certain forms of activity-dependent synaptic plasticity(5,6) impaired memory encoding but had no effect on recall. Inactivating hippocampal neural activity by blocking alpha-amino-3-hydroxy- 5-methyl-4-isoxazole propionic acid ( AMPA) receptors impaired both encoding and recall. In a second study, two paired associates were trained repeatedly over 8 weeks in new pairs, but blocking of hippocampal AMPA receptors did not affect their recall. Thus we conclude that unique what - where paired associates depend on encoding and retrieval within a hippocampal memory space(7,8), with consolidation of the memory traces representing repeated paired associates in circuits elsewhere.	Univ Edinburgh, Div Neurosci, Cognit Neurosci Lab, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Ctr Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Morris, RGM (corresponding author), Univ Edinburgh, Div Neurosci, Cognit Neurosci Lab, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Morris, Richard G M/C-9982-2013	Langston, Rosamund/0000-0002-4668-3105				[Anonymous], 1983, CANADIAN PSYCHOL; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; COWAN WM, 2001, SYNAPSES; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; Gardiner JM, 2001, EPISODIC MEMORY NEW, P11; Gilbert PE, 2002, BEHAV NEUROSCI, V116, P63, DOI 10.1037//0735-7044.116.1.63; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MISHKIN M, 1975, J EXP PSYCHOL-ANIM B, V1, P326, DOI 10.1037/0097-7403.1.4.326; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775; ZOLAMORGAN S, 1985, BEHAV NEUROSCI, V99, P22, DOI 10.1037/0735-7044.99.1.22	25	196	200	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2003	424	6945					205	209		10.1038/nature01769	http://dx.doi.org/10.1038/nature01769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853960	Green Published			2022-12-01	WOS:000184032700045
J	Salomon, JA; Weinstein, MC; Hammitt, JK; Goldie, SJ				Salomon, JA; Weinstein, MC; Hammitt, JK; Goldie, SJ			Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERFERON-ALPHA-2B PLUS RIBAVIRIN; LIVER FIBROSIS PROGRESSION; TERM-FOLLOW-UP; INITIAL TREATMENT; VIRUS-INFECTION; NON-A; NON-B; COMBINATION THERAPY; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA	Context Approximately 2.7 million US individuals are chronically infected with the hepatitis C virus (HCV). As public health campaigns are pursued, a growing number of treatment candidates are likely to have minimal evidence of liver damage. Objective To examine the clinical benefits and cost-effectiveness of newer treatments for chronic hepatitis C infection in a population of asymptomatic, HCV seropositive but otherwise healthy individuals. Design and Setting Cost-effectiveness analysis using a Markov model of the natural history of HCV infection and impact of treatment. We used an epidemiologic model to derive a range of natural history parameters that were empirically calibrated to provide a good fit to observed data on both prevalence of HCV seropositivity and time trends in outcomes related to HCV infection. Patients Cohorts of 40-year-old men and women with elevated levels of alanine aminotransferase, positive results on quantitative HCV RNA assays and serologic tests for antibody to HCV, and no histological evidence of fibrosis on liver biopsy. Interventions Monotherapy with standard or pegylated interferon alfa-2b; combination therapy with standard or pegylated interferon plus ribavirin. Main Outcome Measures Lifetime costs, life expectancy, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results The probability of patients with chronic HCV developing cirrhosis over a 30-year period ranged from 13% to 46% for men and from 1% to 29% for women. The incremental cost-effectiveness of combination therapy with pegylated interferon for men ranged from $26000 to $64000 per QALY for genotype 1 and from $10000 to $28000 per QALY for other genotypes; and for women ranged from $32000 to $90000 for genotype 1 and from $12000 to $42000 for other genotypes. Because the benefits of treatment were realized largely in the form of improvements in health-related quality of life, rather than prolonged survivorship, cost-effectiveness ratios expressed as dollars per year of life were substantially higher. Results were most sensitive to assumptions about the gains and decrements in health-related quality of life associated with treatment. Conclusions While newer treatment options for hepatitis C appear to be reasonably cost-effective on average, these results vary widely across different patient subgroups and depend critically on quality-of-life assumptions. As the pool of persons eligible for treatment for HCV infection expands to the more general population, it will be imperative for patients and their physicians to consider these assumptions in making individual-level treatment decisions.	Harvard Univ, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva, Switzerland; Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA	Harvard University; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Salomon, JA (corresponding author), Harvard Univ, Ctr Populat & Dev Studies, 9 Bow St, Cambridge, MA 02138 USA.	jsalomon@hsph.harvard.edu	Salomon, Joshua A/D-3898-2009; Salomon, Joshua/S-1929-2019	Salomon, Joshua A/0000-0003-3929-5515; Salomon, Joshua/0000-0003-3929-5515	OHS HRSA HHS [ST32HS00055-03] Funding Source: Medline	OHS HRSA HHS		Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; [Anonymous], COMMUNICATION; Barbaro G, 2000, J HEPATOL, V33, P448, DOI 10.1016/S0168-8278(00)80281-0; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Buti M, 2000, J HEPATOL, V33, P651, DOI 10.1034/j.1600-0641.2000.033004651.x; Camma C, 1998, J HEPATOL, V28, P531, DOI 10.1016/S0168-8278(98)80274-2; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; CHRISTENSEN E, 1989, SCAND J GASTROENTERO, V24, P999, DOI 10.3109/00365528909089247; COLCHER MD, 1994, HEPATOLOGY, V20, P618; Cotler SJ, 2001, AM J GASTROENTEROL, V96, P2730, DOI 10.1111/j.1572-0241.2001.04132.x; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; Dore GJ, 2002, J GASTROEN HEPATOL, V17, P423, DOI 10.1046/j.1440-1746.2002.02730.x; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Dusheiko GM, 1995, HEPATOLOGY, V22, P1863, DOI 10.1016/0270-9139(95)90216-3; Edlin BR, 2002, HEPATOLOGY, V36, pS210, DOI 10.1053/jhep.2002.36809; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gold MR., 1996, COST EFFECTIVENESS H; GORDON SC, 1993, HEPATOLOGY, V18, P1338, DOI 10.1002/hep.1840180609; HOPF U, 1990, J HEPATOL, V10, P69, DOI 10.1016/0168-8278(90)90075-3; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kim WR, 1997, ANN INTERN MED, V127, P866, DOI 10.7326/0003-4819-127-10-199711150-00002; KIYOSAWA K, 1994, INTERVIROLOGY, V37, P101, DOI 10.1159/000150363; KORETZ RL, 1993, ANN INTERN MED, V119, P110, DOI 10.7326/0003-4819-119-2-199307150-00003; Kuehne FC, 2002, ARCH INTERN MED, V162, P2545, DOI 10.1001/archinte.162.22.2545; Lau DTY, 1998, HEPATOLOGY, V28, P1121, DOI 10.1002/hep.510280430; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; Matsumura H, 2000, J VIRAL HEPATITIS, V7, P268; MATTSON L, 1993, LIVER, V13, P274; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; *MED EC, 2001, DRUG TOP RED BOOK; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Okanoue T, 1999, J HEPATOL, V30, P653, DOI 10.1016/S0168-8278(99)80196-2; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; REICHARD O, 1995, HEPATOLOGY, V21, P918, DOI 10.1016/0270-9139(95)90234-1; ROBERTS JM, 1993, GASTROENTEROL JPN, V28, P37, DOI 10.1007/BF02989202; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Russo MW, 2000, HEPATOLOGY, V31, P358, DOI 10.1002/hep.510310215; Sagmeister M, 2001, EUR J GASTROEN HEPAT, V13, P483, DOI 10.1097/00042737-200105000-00004; SALERNO F, 1993, AM J GASTROENTEROL, V88, P514; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Seeff LB, 2001, HEPATOLOGY, V33, P455, DOI 10.1053/jhep.2001.21905; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Seeff Leonard B., 1999, American Journal of Medicine, V107, p10S; Sennfalt K, 2001, SCAND J GASTROENTERO, V36, P870, DOI 10.1080/003655201750313414; Shiell A, 1999, MED J AUSTRALIA, V171, P189, DOI 10.5694/j.1326-5377.1999.tb123595.x; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Sinha M, 2000, PEDIATR INFECT DIS J, V19, P23, DOI 10.1097/00006454-200001000-00006; Sobesky R, 1999, GASTROENTEROLOGY, V116, P378, DOI 10.1016/S0016-5085(99)70135-6; Stein K, 2002, GUT, V50, P253, DOI 10.1136/gut.50.2.253; Stinnett AA, 1997, MED DECIS MAKING, V17, P483, DOI 10.1177/0272989X9701700414; TAKAHASHI M, 1993, AM J GASTROENTEROL, V88, P240; Thomas DL, 2002, HEPATOLOGY, V36, pS201, DOI 10.1053/jhep.2002.36380; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; TREMOLADA F, 1992, J HEPATOL, V16, P273, DOI 10.1016/S0168-8278(05)80657-9; *US DEP HHS, 2001, HEP C EM THREAT PUBL; Wiese M, 2000, HEPATOLOGY, V32, P91, DOI 10.1053/jhep.2000.8169; Wong J B, 1999, Am J Med, V107, p74S; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 2000, AM J MED, V108, P366, DOI 10.1016/S0002-9343(00)00303-X; Wong JB, 2000, AM J GASTROENTEROL, V95, P1524; Wong JB, 2002, ACTA GASTRO-ENT BELG, V65, P110; Wong JB, 1998, JAMA-J AM MED ASSOC, V280, P2088, DOI 10.1001/jama.280.24.2088; Wong LL, 1997, ARCH INTERN MED, V157, P1429, DOI 10.1001/archinte.157.13.1429; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; YANO M, 1993, GUT, V34, pS13, DOI 10.1136/gut.34.2_Suppl.S13; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Younossi ZM, 1999, HEPATOLOGY, V30, P1318, DOI 10.1002/hep.510300518; Zaman A, 2000, AM J GASTROENTEROL, V95, P1323	78	192	198	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2003	290	2					228	237		10.1001/jama.290.2.228	http://dx.doi.org/10.1001/jama.290.2.228			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	698GH	12851278	Bronze			2022-12-01	WOS:000183989800028
J	Gardner, TS; di Bernardo, D; Lorenz, D; Collins, JJ				Gardner, TS; di Bernardo, D; Lorenz, D; Collins, JJ			Inferring genetic networks and identifying compound mode of action via expression profiling	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; SIMULATION	The complexity of cellular gene, protein, and metabolite networks can hinder attempts to elucidate their structure and function. To address this problem, we used systematic transcriptional perturbations to construct a first-order model of regulatory interactions in a nine-gene subnetwork of the SOS pathway in Escherichia coli. The model correctly identified the major regulatory genes and the transcriptional targets of mitomycin C activity in the subnetwork. This approach, which is experimentally and computationally scalable, provides a framework for elucidating the functional properties of genetic networks and identifying molecular targets of pharmacological compounds.	Boston Univ, Ctr Biodynam, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Telethon Inst Genet & Med, I-80131 Naples, Italy	Boston University; Boston University; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Collins, JJ (corresponding author), Boston Univ, Ctr Biodynam, 44 Cummington St, Boston, MA 02215 USA.	jcollins@bu.edu	di Bernardo, Diego/I-9440-2012; di Bernardo, Diego/AAF-5881-2021	di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Lorenz, David/0000-0001-8732-3627	Telethon [TGM03P17, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Courcelle J, 2001, GENETICS, V158, P41; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Koch WH, 1998, CONT CANC RES, P107; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Liang S, 1998, Pac Symp Biocomput, P18; Ljung L., 1999, SYSTEM IDENTIFICATIO; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; Montgomery DC., 2006, INTRO LINEAR REGRESS; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; VANSOMEREN EP, 2001, P 2 INT C SYST BIOL, P222; WALKER GC, 1996, CELLULAR MOL BIOL, P1400	27	841	875	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					102	105		10.1126/science.1081900	http://dx.doi.org/10.1126/science.1081900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843395				2022-12-01	WOS:000183914700043
J	Garrido, JJ; Giraud, P; Carlier, E; Fernandes, F; Moussif, A; Fache, MP; Debanne, D; Dargent, B				Garrido, JJ; Giraud, P; Carlier, E; Fernandes, F; Moussif, A; Fache, MP; Debanne, D; Dargent, B			A targeting motif involved in sodium channel clustering at the axonal initial segment	SCIENCE			English	Article							BETA-IV-SPECTRIN; POLARIZED NEURONS; ANKYRIN-G; RANVIER; NODES; LOCALIZATION; EXPRESSION; NA(V)1.6; DOMAINS; BARRIER	The sorting of sodium channels to axons and the formation of clusters are of primary importance for neuronal electrogenesis. Here, we showed that the cytoplasmic loop connecting domains II and III of the Na-v 1 subunit contains a determinant conferring compartmentalization in the axonal initial segment of rat hippocampal neurons. Expression of a soluble Na-v 1.2 II- III linker protein led to the disorganization of endogenous sodium channels. The motif was sufficient to redirect a somatodendritic potassium channel to the axonal initial segment, a process involving association with ankyrin G. Thus, this motif may play a fundamental role in controlling electrical excitability during development and plasticity.	Univ Mediterranee, Fac Med Secteur Nord, Inst Jean Roche, INSERM,U464, F-13916 Marseille 20, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Dargent, B (corresponding author), Univ Mediterranee, Fac Med Secteur Nord, Inst Jean Roche, INSERM,U464, Blvd P Dramard, F-13916 Marseille 20, France.		Debanne, Dominique/O-4673-2016; Garrido, Juan Jose/E-6782-2012	Debanne, Dominique/0000-0001-8581-5695; Garrido, Juan Jose/0000-0002-4499-4487				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Alessandri-Haber N, 1999, J PHYSIOL-LONDON, V518, P203, DOI 10.1111/j.1469-7793.1999.0203r.x; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Bouzidi M, 2002, J BIOL CHEM, V277, P28996, DOI 10.1074/jbc.M201760200; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; DARGENT B, UNPUB; Fernandes F. M., UNPUB; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; LEMAILLET G, 2003, J BIOL CHEM; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; MALHOTRA JD, 2002, J BIOL CHEM, V7, P7; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	31	270	301	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2091	2094		10.1126/science.1085167	http://dx.doi.org/10.1126/science.1085167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829783				2022-12-01	WOS:000183774900046
J	Aravanis, AM; Pyle, JL; Tsien, RW				Aravanis, AM; Pyle, JL; Tsien, RW			Single synaptic vesicles fusing transiently and successively without loss of identity	NATURE			English	Article							FROG NEUROMUSCULAR JUNCTION; READILY RELEASABLE POOL; RETINAL BIPOLAR CELLS; HIPPOCAMPAL SYNAPSES; NERVE-TERMINALS; ENDOCYTOSIS; MEMBRANE; EXOCYTOSIS; TRANSMITTER; TURNOVER	Vesicle fusion and recycling are particularly critical for ongoing neurotransmitter release(1-4) in the small nerve terminals of the brain, which typically contain about 30 functional vesicles(4,5). However, the modes of exocytosis and endocytosis that operate at synapses of the central nervous system are incompletely understood. Here we show real-time visualization of a single vesicle fusing at a small synapse of the central nervous system, made possible by highly intensified charge-coupled device imaging of hippocampal synaptic terminals, in which a single vesicle was labelled with the fluorescent membrane marker FM1-43 (ref. 6). In a small number of cases, full loss of fluorescent membrane dye was elicited by a single action potential, consistent with classical complete collapse(1). In most cases, however, action potentials triggered only partial loss of fluorescence, suggesting vesicular retention of membrane marker, consistent with 'kiss-and-run' vesicle cycling(3,4,7-9). An alternative hypothesis of independent fusion of partially stained vesicles arising from endosomal splitting could be excluded by observations on the size and timing of successive fusion events. Thus, our experimental evidence supports a predominance of kiss-and-run fusion events(10-12) and rapid vesicular re-use(11).	Stanford Univ, Beckman Ctr, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Tsien, RW (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Stevens CF, 1999, NEURON, V24, P1017, DOI 10.1016/S0896-6273(00)81047-8; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	23	309	316	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					643	647		10.1038/nature01686	http://dx.doi.org/10.1038/nature01686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789339				2022-12-01	WOS:000183301200041
J	Cyranoski, D				Cyranoski, D			Japanese team makes stem cells	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					577	577		10.1038/423577b	http://dx.doi.org/10.1038/423577b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789307	Bronze			2022-12-01	WOS:000183301200012
J	Herr, AB; Ballister, ER; Bjorkman, PJ				Herr, AB; Ballister, ER; Bjorkman, PJ			Insights into IgA-mediated immune responses from the crystal structures of human Fc alpha RI and its complex with IgA1-Fc	NATURE			English	Article							INHIBITORY RECEPTOR; LIGAND-BINDING; IMMUNOGLOBULIN; DOMAIN; FRAGMENT; ACTIVATION; REVEALS; CD89; IDENTIFICATION; REFINEMENT	Immunoglobulin-alpha (IgA)-bound antigens induce immune effector responses by activating the IgA-specific receptor FcalphaRI (CD89) on immune cells. Here we present crystal structures of human FcalphaRI alone and in a complex with the Fcalpha region of IgA1 (Fcalpha). FcalphaRI has two immunoglobulin-like domains that are oriented at approximately right angles to each other. Fcalpha resembles the Fcs of immunoglobulins IgG and IgE, but has differently located interchain disulphide bonds and external rather than interdomain N-linked carbohydrates. Unlike 1:1 FcgammaRIII:IgG and FcepsilonRI:IgE complexes, two FcalphaRI molecules bind each Fcalpha dimer, one at each Calpha2-Calpha3 junction. The FcalphaRI-binding site on IgA1 overlaps the reported polymeric immunoglobulin receptor (pIgR)-binding site, which might explain why secretory IgA cannot initiate phagocytosis or bind to FcalphaRI-expressing cells in the absence of an integrin co-receptor.	CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; La Salle High Sch, Pasadena, CA 91107 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399; Ballister, Edward/0000-0002-4478-2513				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bracke M, 2001, BLOOD, V97, P3478, DOI 10.1182/blood.V97.11.3478; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carayannopoulos L, 1996, J EXP MED, V183, P1579, DOI 10.1084/jem.183.4.1579; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 2001, J MOL BIOL, V311, P1049, DOI 10.1006/jmbi.2001.4929; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Hexham JM, 1999, J EXP MED, V189, P747, DOI 10.1084/jem.189.4.747; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Iikura M, 1998, J IMMUNOL, V161, P1510; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Morton HC, 1999, J EXP MED, V189, P1715; Motegi Y, 1998, J IMMUNOL, V161, P4340; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Norderhaug IN, 1999, CRIT REV IMMUNOL, V19, P481; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pleass RJ, 1999, J BIOL CHEM, V274, P23508, DOI 10.1074/jbc.274.33.23508; PUTNAM FW, 1979, J BIOL CHEM, V254, P2865; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; SHOGREN R, 1989, BIOCHEMISTRY-US, V28, P5525, DOI 10.1021/bi00439a029; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; van Spriel AB, 2001, BLOOD, V97, P2478, DOI 10.1182/blood.V97.8.2478; Vidarsson G, 2001, J IMMUNOL, V166, P6250, DOI 10.4049/jimmunol.166.10.6250; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; WEISBART RH, 1988, NATURE, V332, P647, DOI 10.1038/332647a0; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; White KD, 2002, J EXP MED, V196, P551, DOI 10.1084/jem.20020581; Wines BD, 1999, J IMMUNOL, V162, P2146; Wines BD, 2001, J IMMUNOL, V166, P1781, DOI 10.4049/jimmunol.166.3.1781; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; YANG CY, 1979, H-S Z PHYSIOL CHEM, V360, P1919	50	209	226	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					614	620		10.1038/nature01685	http://dx.doi.org/10.1038/nature01685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12768205	Bronze			2022-12-01	WOS:000183301200033
J	Sobngwi, E; Boudou, P; Mauvais-Jarvis, F; Leblanc, H; Velho, G; Vexiau, P; Porcher, R; Hadjadj, S; Pratley, R; Tataranni, PA; Calvo, F; Gautier, JF				Sobngwi, E; Boudou, P; Mauvais-Jarvis, F; Leblanc, H; Velho, G; Vexiau, P; Porcher, R; Hadjadj, S; Pratley, R; Tataranni, PA; Calvo, F; Gautier, JF			Effect of a diabetic environment in utero on predisposition to type 2 diabetes	LANCET			English	Article							INSULIN SECRETORY DYSFUNCTION; IMPAIRED GLUCOSE-TOLERANCE; PIMA-INDIANS; LIFE-STYLE; MELLITUS; RESISTANCE; MOTHERS; PRECURSORS; NIDDM; RATS	Background Type 2 diabetes is affected by genetics and environmental factors. We aimed to assess the effect of an in-utero diabetic environment independently of the genetic background for type 2 diabetes. Methods We measured insulin sensitivity and insulin secretion in response to oral and intravenous glucose in 15 non-diabetic adult offspring of mothers with type 1 diabetes (exposed participants) and 16 offspring of type 1 diabetic fathers (controls). No participants had type 1 diabetes-associated autoantibodies. We also measured pancreatic polypeptide, a marker of parasympathetic drive to the pancreas. Findings There was no difference between the groups with respect to percent body fat and insulin sensitivity. Five of the 15 exposed participants, but none of the controls had impaired glucose tolerance (p=0.02). Early insulin secretion after an oral glucose tolerance test was lower in exposed participants than in controls: 8.6 IU/mmol (SD 5.4) in exposed participants with impaired glucose tolerance, 14.2 IU/mmol (6.5) in those with normal glucose tolerance and 17.7 IU/mmol (10.9) in controls (p=0.04). Mean insulin secretion rate during glucose infusion study was 4.7 pmol/kg per min (3.6) in people with impaired glucose tolerance, 5.5 pmol/kg per min (4.5) in exposed participants with normal glucose tolerance and 7.5 pmol/kg per min (6.1) in controls (p<0.0001). The area under the curve of pancreatic polypeptide 120 min after oral glucose ingestion was 1007 (429) in people with impaired glucose tolerance, 2829 (1701) in those with normal glucose tolerance, and 3224 (1352) in controls (p=0.04). Interpretation Exposure to a diabetic environment in utero is associated with increased occurence of impaired glucose tolerance and a defective insulin secretory response in adult offspring, independent of genetic predisposition to type 2 diabetes. This insulin secretory defect could be related to low parasympathetic tone. Epidemiological studies are needed to confirm our observations before therapeutic strategies can be devised.	Univ Paris 07, St Louis Hosp, Assistance Pub Hop Paris,Sch Med, Dept Endocrinol & Diabet, Paris, France; Univ Paris 07, St Louis Hosp, Assistance Pub Hop Paris,Sch Med, Clin Invest Ctr,INSERM CIC9504, Paris, France; Univ Paris 07, St Louis Hosp, Assistance Pub Hop Paris,Sch Med, Dept Biostat & Med Informat, Paris, France; Hop St Vincent de Paul, INSERM, U561, F-75674 Paris, France; Ctr Hosp Reg & Univ Poitiers, Dept Endocrinol & Diabet, Poitiers, France; NIDDKD, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gautier, JF (corresponding author), Hop St Louis, INSERM, Dept Endocrinol & Diabet, Ave Claude Vellefaux, F-75010 Paris, France.		Velho, Gilberto/Q-6724-2017	Velho, Gilberto/0000-0001-8811-363X; calvo, fabien/0000-0002-0298-7633; Porcher, Raphael/0000-0002-5277-4679	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069015, Z01DK069015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; De Fronzo RA, 1979, AM J PHYSIOL, V237, P214; EATON RP, 1980, J CLIN ENDOCR METAB, V51, P520, DOI 10.1210/jcem-51-3-520; Gautier JF, 2001, DIABETES, V50, P1828, DOI 10.2337/diabetes.50.8.1828; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; HANSON RL, 1995, AM J HUM GENET, V57, P160; Harder T, 2001, NEUROSCI LETT, V299, P85, DOI 10.1016/S0304-3940(01)01495-1; Hovorka R, 1996, COMPUT METH PROG BIO, V50, P253, DOI 10.1016/0169-2607(96)01755-5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Plagemann A, 1999, DEV NEUROSCI-BASEL, V21, P58, DOI 10.1159/000017367; Plagemann A, 1997, DIABETOLOGIA, V40, P1094, DOI 10.1007/s001250050792; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Teixeira AS, 1999, LIFE SCI, V64, P655, DOI 10.1016/S0024-3205(98)00607-9; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Van Assche FA, 2001, BRIT MED BULL, V60, P173, DOI 10.1093/bmb/60.1.173; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Weiss PAM, 2000, DIABETES CARE, V23, P905, DOI 10.2337/diacare.23.7.905; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; *WHO, 1985, DIAB MELL REP STUD G	23	205	208	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1861	1865		10.1016/S0140-6736(03)13505-2	http://dx.doi.org/10.1016/S0140-6736(03)13505-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788573				2022-12-01	WOS:000183205800011
J	McDonald, D; Wu, L; Bohks, SM; KewalRamani, VN; Unutmaz, D; Hope, TJ				McDonald, D; Wu, L; Bohks, SM; KewalRamani, VN; Unutmaz, D; Hope, TJ			Recruitment of HIV and its receptors to dendritic cell-T cell junctions	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DC-SIGN; IMMUNOLOGICAL SYNAPSE; ANTIGEN	Monocyte-derived dendritic cells (MDDCs) can efficiently bind and transfer HIV infectivity without themselves becoming infected. Using live-cell microscopy, we found that HIV was recruited to sites of cell contact in MDDCs. Analysis of conjugates between MDDCs and T cells revealed that, in the absence of antigen-specific signaling, the HIV receptors CD4, CCR5, and CXCR4 on the T cell were recruited to the interface while the MDDCs concentrated HIV to the same region. We propose that contact between dendritic cells and T cells facilitates transmission of HIV by locally concentrating virus, receptor, and coreceptor during the formation of an infectious synapse.	Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Hope, TJ (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	thope@uic.edu	Wu, Li/E-4330-2011; KewalRamani, Vineet/V-5084-2019; Wu, Li/ABB-2813-2020	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487	NATIONAL CANCER INSTITUTE [Z01BC010485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052051, R01AI049131, R01AI047770] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI49131, R01-AI47770, R01 AI052051, R01-AI52051] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LOZACH PY, J BIOL CHEM     0227; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; MCDONALD D, UNPUB; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841	19	559	578	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1295	1297		10.1126/science.1084238	http://dx.doi.org/10.1126/science.1084238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12730499				2022-12-01	WOS:000183042400050
J	Cheung, WL; Ajiro, K; Samejima, K; Kloc, M; Cheung, P; Mizzen, CA; Beeser, A; Etkin, LD; Chernoff, J; Earnshaw, WC; Allis, CD				Cheung, WL; Ajiro, K; Samejima, K; Kloc, M; Cheung, P; Mizzen, CA; Beeser, A; Etkin, LD; Chernoff, J; Earnshaw, WC; Allis, CD			Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase	CELL			English	Article							PROGRAMMED CELL-DEATH; STE20-LIKE PROTEIN-KINASE; HP1 CHROMO DOMAIN; DNA FRAGMENTATION; SACCHAROMYCES-CEREVISIAE; N-TERMINUS; LYSINE 9; H3; CONDENSATION; ACTIVATION	DNA in eukaryotic cells is associated with histone proteins; hence, hallmark properties of apoptosis, such as chromatin condensation, may be regulated by post-translational histone modifications. Here we report that phosphorylation of histone H2B at serine 14 (S14) correlates with cells undergoing programmed cell death in vertebrates. We identify a 34 kDa apoptosis-induced H2B kinase as caspase-cleaved Mst1 (mammalian sterile twenty) kinase. Mst1 can phosphorylate H2B at S14 in vitro and in vivo, and the onset of H2B S14 phosphorylation is dependent upon cleavage of Mst1 by caspase-3. These data reveal a histone modification that is uniquely associated with apoptotic chromatin in species ranging from frogs to humans and provide insights into a previously unrecognized physiological substrate for Mst1 kinase. Our data provide evidence for a potential apoptotic "histone code.".	Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University of Virginia; University of Virginia; University of Edinburgh; University of Texas System; UTMD Anderson Cancer Center; Fox Chase Cancer Center	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, 1230 York Ave, New York, NY 10021 USA.	alliscd@mail.rockefeller.edu	Chernoff, Jonathan/I-7631-2014; Kloc, Malgorzata/AAF-6982-2020; Earnshaw, William/AAY-7438-2020	Chernoff, Jonathan/0000-0002-4803-7836; Earnshaw, William/0000-0002-7191-0621	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054168, R01GM040922] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54168, GM40922] Funding Source: Medline; Wellcome Trust [073915] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; de la Barre AE, 2001, EMBO J, V20, P6383, DOI 10.1093/emboj/20.22.6383; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Haunstetter A, 2000, CARDIOVASC RES, V45, P795, DOI 10.1016/S0008-6363(99)00264-3; Hendzel MJ, 1998, J BIOL CHEM, V273, P24470, DOI 10.1074/jbc.273.38.24470; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jason LJM, 2001, J BIOL CHEM, V276, P14597, DOI 10.1074/jbc.M011153200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERR JFR, 1974, J CELL SCI, V14, P571; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Loetscher H, 2001, DRUG DISCOV TODAY, V6, P671, DOI 10.1016/S1359-6446(01)01826-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Martin LJ, 2001, INT J MOL MED, V7, P455; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Robertson JD, 2000, J STRUCT BIOL, V129, P346, DOI 10.1006/jsbi.2000.4254; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Th'ng JPH, 2001, BIOCHEM CELL BIOL, V79, P305, DOI 10.1139/bcb-79-3-305; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; USUKU G, 1965, DEV BIOL, V11, P352, DOI 10.1016/0012-1606(65)90044-8; VANHOLDE KE, 1988, CHROMATIN, P111; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YOSHIZATO K, 1989, INT REV CYTOL, V119, P97; Yun DJ, 1998, MOL CELL, V1, P807, DOI 10.1016/S1097-2765(00)80080-5	55	368	412	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2003	113	4					507	517		10.1016/S0092-8674(03)00355-6	http://dx.doi.org/10.1016/S0092-8674(03)00355-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757711	Bronze			2022-12-01	WOS:000182981500012
J	Alavi, A; Hood, JD; Frausto, R; Stupack, DG; Cheresh, DA				Alavi, A; Hood, JD; Frausto, R; Stupack, DG; Cheresh, DA			Role of Raf in vascular protection from distinct apoptotic stimuli	SCIENCE			English	Article							KINASE-ACTIVITY; B-RAF; PROTEIN; SRC; PHOSPHORYLATION; REQUIREMENT; PATHWAYS; SERINE	Raf kinases have been linked to endothelial cell survival. Here, we show that basic fibroblast growth factor ( bFGF) and vascular endothelial growth factor ( VEGF) differentially activate Raf, resulting in protection from distinct pathways of apoptosis in human endothelial cells and chick embryo vasculature. bFGF activated Raf-1 via p21-activated protein kinase-1 (PAK-1) phosphorylation of serines 338 and 339, resulting in Raf-1 mitochondrial translocation and endothelial cell protection from the intrinsic pathway of apoptosis, independent of the mitogen-activated protein kinase kinase-1 (MEK1). In contrast, VEGF activated Raf-1 via Src kinase, leading to phosphorylation of tyrosines 340 and 341 and MEK1-dependent protection from extrinsic-mediated apoptosis. These findings implicate Raf-1 as a pivotal regulator of endothelial cell survival during angiogenesis.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Cheresh, DA (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cheresh@scripps.edu	Frausto, Ricardo/AAE-3146-2021	Frausto, Ricardo/0000-0003-3064-6745; Alavi, Alireza/0000-0002-5502-2616	NATIONAL CANCER INSTITUTE [R37CA050286, P01CA078045, R01CA050286, T32CA075924, R01CA045726] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA78045, CA45726, CA50286, CA75924] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Hood J, 1998, J BIOL CHEM, V273, P23504, DOI 10.1074/jbc.273.36.23504; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	22	275	299	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					94	96		10.1126/science.1082015	http://dx.doi.org/10.1126/science.1082015			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843393				2022-12-01	WOS:000183914700040
J	Hoffmann, AA; Hallas, RJ; Dean, JA; Schiffer, M				Hoffmann, AA; Hallas, RJ; Dean, JA; Schiffer, M			Low potential for climatic stress adaptation in a rainforest Drosophila species	SCIENCE			English	Article							OPPOSITE LATITUDINAL CLINES; DESICCATION RESISTANCE; CORRELATED RESPONSES; LABORATORY CULTURE; GENETIC-VARIATION; LIFE-HISTORY; MELANOGASTER; TOLERANCE; SELECTION; POPULATIONS	The ability of sensitive rainforest species to evolve in response to climate change is largely unknown. We show that the Australian tropical rainforest fly Drosophila birchii exhibits clinal variation in desiccation resistance, but the most resistant population lacks the ability to evolve further resistance even after intense selection for over 30 generations. Parent-offspring comparisons indicate low heritable variation for this trait but high levels of genetic variation for morphology. D. birchii also exhibits abundant genetic variation at microsatellite loci. The low potential for resistance evolution highlights the importance of assessing evolutionary potential in targeted ecological traits and species from threatened habitats.	La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia	La Trobe University	Hoffmann, AA (corresponding author), La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia.		Hoffmann, Ary/C-2961-2011; Schiffer, Michele/AAN-1478-2020; Hoffmann, Ary/R-2972-2019	Schiffer, Michele/0000-0002-5203-2480; Hoffmann, Ary/0000-0001-9497-7645				Addo-Bediako A, 2001, J INSECT PHYSIOL, V47, P1377, DOI 10.1016/S0022-1910(01)00128-7; AYALA FJ, 1965, EVOLUTION, V19, P538, DOI 10.1111/j.1558-5646.1965.tb03329.x; Baer CF, 2000, EVOLUTION, V54, P238, DOI 10.1111/j.0014-3820.2000.tb00024.x; BLOWS MW, 1993, EVOLUTION, V47, P1255, DOI [10.2307/2409990, 10.1111/j.1558-5646.1993.tb02151.x]; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Frankham R., 2010, INTRO CONSERVATION G; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Harshman LG, 2000, TRENDS ECOL EVOL, V15, P32, DOI 10.1016/S0169-5347(99)01756-5; Hercus MJ, 1999, GENETICS, V151, P1493; HOFFMANN AA, 1993, J EVOLUTION BIOL, V6, P643, DOI 10.1046/j.1420-9101.1993.6050643.x; Hoffmann AA, 2001, EVOLUTION, V55, P436, DOI 10.1111/j.0014-3820.2001.tb01305.x; HOFFMANN AA, 1989, BIOL J LINN SOC, V37, P117, DOI 10.1111/j.1095-8312.1989.tb02098.x; Hoffmann AA, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P200; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jenkins NL, 2001, AUST J ENTOMOL, V40, P41, DOI 10.1046/j.1440-6055.2001.00197.x; Karan D, 1998, ECOL ENTOMOL, V23, P391, DOI 10.1046/j.1365-2311.1998.00157.x; Karan D, 1998, EVOLUTION, V52, P825, DOI [10.1111/j.1558-5646.1998.tb03706.x, 10.2307/2411276]; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Lovejoy T.E., 1986, P257; PARSONS PA, 1982, EVOL BIOL, V14, P297; Partridge L, 1999, P ROY SOC B-BIOL SCI, V266, P255, DOI 10.1098/rspb.1999.0630; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Roff D.A., 2012, EVOLUTIONARY QUANTIT; Sgro CM, 2000, AM NAT, V156, P341, DOI 10.1086/303394; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	26	267	271	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					100	102		10.1126/science.1084296	http://dx.doi.org/10.1126/science.1084296			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843394				2022-12-01	WOS:000183914700042
J	Mou, Z; Fan, WH; Dong, XN				Mou, Z; Fan, WH; Dong, XN			Inducers of plant systemic acquired resistance regulate NPR1 function through redox changes	CELL			English	Article							SALICYLIC-ACID; GLUTATHIONE HOMEOSTASIS; TRANSCRIPTION FACTORS; NUCLEAR-LOCALIZATION; DISEASE-RESISTANCE; NITRIC-OXIDE; ARABIDOPSIS; GENE; INDUCTION; ACTIVATION	NPR1 is an essential regulator of plant systemic acquired resistance (SAR), which confers immunity to a broad-spectrum of pathogens. SAR induction results in accumulation of the signal molecule salicylic acid (SA), which induces defense gene expression via activation of NPR1. We found that in an uninduced state, NPR1 is present as an oligomer formed through intermolecular disulfide bonds. Upon SAR induction, a biphasic change in cellular reduction potential occurs, resulting in reduction of NPR1 to a monomeric form. Monomeric NPR1 accumulates in the nucleus and activates gene expression. Inhibition of NPR1 reduction prevents defense gene expression, whereas mutation of Cys82 or Cys216 in NPR1 leads to constitutive monomerization, nuclear localization of the mutant proteins, and defense gene expression. These data provide a missing link between accumulation of SA and activation of NPR1 in the SAR signaling pathway.	Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA	Duke University	Dong, XN (corresponding author), Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, POB 91000, Durham, NC 27708 USA.	xdong@duke.edu						Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chamnongpol S, 1998, P NATL ACAD SCI USA, V95, P5818, DOI 10.1073/pnas.95.10.5818; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chern MS, 2001, PLANT J, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; DURNER J, 1995, P NATL ACAD SCI USA, V92, P11312, DOI 10.1073/pnas.92.24.11312; Garlick AP, 2002, PLANTA, V216, P265, DOI 10.1007/s00425-002-0842-1; Glazebrook J, 1996, GENETICS, V143, P973; Gupte SA, 2002, J PHARMACOL EXP THER, V301, P299, DOI 10.1124/jpet.301.1.299; Hothersall JS, 1998, FEBS LETT, V434, P97, DOI 10.1016/S0014-5793(98)00959-4; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kvaratskhelia M, 1997, J BIOL CHEM, V272, P20998, DOI 10.1074/jbc.272.34.20998; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; Murphy DM, 2002, J BIOL CHEM, V277, P6162, DOI 10.1074/jbc.M110105200; Noctor G, 2002, J EXP BOT, V53, P1283, DOI 10.1093/jexbot/53.372.1283; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; RAO MV, 1995, PHOTOCHEM PHOTOBIOL, V61, P71, DOI 10.1111/j.1751-1097.1995.tb09245.x; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Vanacker H, 2000, PLANT PHYSIOL, V123, P1289, DOI 10.1104/pp.123.4.1289; WINGATE VPM, 1988, PLANT PHYSIOL, V87, P206, DOI 10.1104/pp.87.1.206; Wu GS, 1997, PLANT PHYSIOL, V115, P427, DOI 10.1104/pp.115.2.427; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	44	1004	1086	13	183	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2003	113	7					935	944		10.1016/S0092-8674(03)00429-X	http://dx.doi.org/10.1016/S0092-8674(03)00429-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837250	Bronze			2022-12-01	WOS:000183817900016
J	Yildiz, A; Forkey, JN; McKinney, SA; Ha, T; Goldman, YE; Selvin, PR				Yildiz, A; Forkey, JN; McKinney, SA; Ha, T; Goldman, YE; Selvin, PR			Myosin V walks hand-over-hand: Single fluorophore imaging with 1.5-nm localization	SCIENCE			English	Article							FLUORESCENT-PROBES; MOLECULES; MOTOR; ROTATION; MOVEMENT; TRACKING; ACTIN; RESOLUTION; MODEL	Myosin V is a dimeric molecular motor that moves processively on actin, with the center of mass moving similar to37 nanometers for each adenosine triphosphate hydrolyzed. We have labeled myosin V with a single fluorophore at different positions in the light-chain domain and measured the step size with a standard deviation of <1.5 nanometers, with 0.5-second temporal resolution, and observation times of minutes. The step size alternates between 37 + 2x nm and 37 - 2x, where x is the distance along the direction of motion between the dye and the midpoint between the two heads. These results strongly support a hand-over-hand model of motility, not an inchworm model.	Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania	Selvin, PR (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	selvin@uiuc.edu	Yildiz, Ahmet/E-6167-2015; Ha, Taekjip/B-9506-2009	Yildiz, Ahmet/0000-0003-4792-174X; Ha, Taekjip/0000-0003-2195-6258; McKinney, Sean/0000-0002-9740-6247	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044420, R01AR044420, R01AR026846, R37AR026846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44420, AR26846] Funding Source: Medline; NIGMS NIH HHS [GM65367, R01 GM065367] Funding Source: Medline; PHPPO CDC HHS [PHS 5 T32 GM08276] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHPPO CDC HHS		Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; Bartko AP, 1999, J PHYS CHEM B, V103, P3053, DOI 10.1021/jp9846330; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; Mehta A, 2001, J CELL SCI, V114, P1981; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592	30	1425	1486	12	374	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2061	2065		10.1126/science.1084398	http://dx.doi.org/10.1126/science.1084398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12791999				2022-12-01	WOS:000183774900037
J	Schotte, F; Lim, MH; Jackson, TA; Smirnov, AV; Soman, J; Olson, JS; Phillips, GN; Wulff, M; Anfinrud, PA				Schotte, F; Lim, MH; Jackson, TA; Smirnov, AV; Soman, J; Olson, JS; Phillips, GN; Wulff, M; Anfinrud, PA			Watching a protein as it functions with 150-ps time-resolved X-ray crystallography	SCIENCE			English	Article							LIGAND-BINDING; CARBONMONOXY-MYOGLOBIN; CONFORMATIONAL RELAXATION; CRYSTAL-STRUCTURE; PHOTODISSOCIATION; DYNAMICS; CO; INTERMEDIATE; CAVITIES; MOTIONS	We report picosecond time-resolved x-ray diffraction from the myoglobin (Mb) mutant in which Leu(29) is replaced by Phe (L29F mutant). The frame-by-frame structural evolution, resolved to 1.8 angstroms, allows one to literally "watch" the protein as it executes its function. Time-resolved mid-infrared spectroscopy of flash-photolyzed L29F MbCO revealed a short-lived CO intermediate whose 140-ps lifetime is shorter than that found in wild-type protein by a factor of 1000. The electron density maps of the protein unveil transient conformational changes far more dramatic than the structural differences between the carboxy and deoxy states and depict the correlated side-chain motion responsible for rapidly sweeping CO away from its primary docking site.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; Pusan Natl Univ, Dept Chem, Pusan 609735, South Korea; Harvard Univ, Sch Med, Boston, MA 02115 USA; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; European Synchrotron Radiat Facil, F-38043 Grenoble, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pusan National University; Harvard University; Harvard Medical School; Rice University; University of Wisconsin System; University of Wisconsin Madison; European Synchrotron Radiation Facility (ESRF)	Schotte, F (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.		Smirnov, Alexey/AAB-2521-2020	Smirnov, Alexey/0000-0001-5361-8232; Olson, John/0000-0002-0760-5403	NHLBI NIH HHS [HL47020] Funding Source: Medline; NIAMS NIH HHS [AR40252] Funding Source: Medline; NIGMS NIH HHS [GM35649] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029031, Z01DK029031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANSARI A, 1994, BIOCHEMISTRY-US, V33, P5128, DOI 10.1021/bi00183a017; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunori M, 2000, P NATL ACAD SCI USA, V97, P2058, DOI 10.1073/pnas.040459697; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Cho A, 2002, SCIENCE, V296, P1008, DOI 10.1126/science.296.5570.1008; Chu K, 2000, NATURE, V403, P921, DOI 10.1038/35002641; FRAUENFELDER H, 1991, BER BUNSEN PHYS CHEM, V95, P272, DOI 10.1002/bbpc.19910950310; Goodno GD, 1999, J PHYS CHEM A, V103, P10630, DOI 10.1021/jp993559y; JACKSON TA, 1994, CHEM PHYS, V180, P131, DOI 10.1016/0301-0104(93)E0414-Q; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; LIM MH, 1995, J CHEM PHYS, V102, P4355, DOI 10.1063/1.469484; LIM MH, 1993, P NATL ACAD SCI USA, V90, P5801, DOI 10.1073/pnas.90.12.5801; Ostermann A, 2000, NATURE, V404, P205, DOI 10.1038/35004622; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; TENG TY, 1994, NAT STRUCT BIOL, V1, P701, DOI 10.1038/nsb1094-701; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Vitkup D, 1997, NAT STRUCT BIOL, V4, P202, DOI 10.1038/nsb0397-202; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n	22	648	657	3	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1944	1947		10.1126/science.1078797	http://dx.doi.org/10.1126/science.1078797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817148				2022-12-01	WOS:000183619400046
J	Skaletsky, H; Kuroda-Kawaguchi, T; Minx, PJ; Cordum, HS; Hillier, L; Brown, LG; Repping, S; Pyntikova, T; Ali, J; Bieri, T; Chinwalla, A; Delehaunty, A; Delehaunty, K; Du, H; Fewell, G; Fulton, L; Fulton, R; Graves, T; Hou, SF; Latrielle, P; Leonard, S; Mardis, E; Maupin, R; McPherson, J; Miner, T; Nash, W; Nguyen, C; Ozersky, P; Pepin, K; Rock, S; Rohlfing, T; Scott, K; Schultz, B; Strong, C; Tin-Wollam, A; Yang, SP; Waterston, RH; Wilson, RK; Rozen, S; Page, DC				Skaletsky, H; Kuroda-Kawaguchi, T; Minx, PJ; Cordum, HS; Hillier, L; Brown, LG; Repping, S; Pyntikova, T; Ali, J; Bieri, T; Chinwalla, A; Delehaunty, A; Delehaunty, K; Du, H; Fewell, G; Fulton, L; Fulton, R; Graves, T; Hou, SF; Latrielle, P; Leonard, S; Mardis, E; Maupin, R; McPherson, J; Miner, T; Nash, W; Nguyen, C; Ozersky, P; Pepin, K; Rock, S; Rohlfing, T; Scott, K; Schultz, B; Strong, C; Tin-Wollam, A; Yang, SP; Waterston, RH; Wilson, RK; Rozen, S; Page, DC			The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes	NATURE			English	Article							HUMAN X-CHROMOSOME; HUMAN GENOME; SEX-CHROMOSOME; INTRACHROMOSOMAL RECOMBINATION; DROSOPHILA-MELANOGASTER; HUMAN CENTROMERE; GENE CONVERSION; TURNER SYNDROME; SHORT ARM; MAP	The male-specific region of the Y chromosome, the MSY, differentiates the sexes and comprises 95% of the chromosome's length. Here, we report that the MSY is a mosaic of heterochromatic sequences and three classes of euchromatic sequences: X-transposed, X-degenerate and ampliconic. These classes contain all 156 known transcription units, which include 78 protein-coding genes that collectively encode 27 distinct proteins. The X-transposed sequences exhibit 99% identity to the X chromosome. The X-degenerate sequences are remnants of ancient autosomes from which the modern X and Y chromosomes evolved. The ampliconic class includes large regions (about 30% of the MSY euchromatin) where sequence pairs show greater than 99.9% identity, which is maintained by frequent gene conversion (non-reciprocal transfer). The most prominent features here are eight massive palindromes, at least six of which contain testis genes.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of Amsterdam; Academic Medical Center Amsterdam	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	Mardis, Elaine/W-2202-2019; McPherson, John D/D-2633-2017; Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	McPherson, John D/0000-0001-8049-9347; Wilson, Richard K./0000-0002-1992-1358; Schultz, Brian/0000-0003-4964-976X; Chinwalla, Asif/0000-0001-7831-3996; Repping, Sjoerd/0000-0002-6959-149X; Rozen, Steven G./0000-0002-4288-0056				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; Delbridge ML, 1999, NAT GENET, V22, P223, DOI 10.1038/10279; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; FORD CE, 1959, LANCET, V1, P711; Graves JAM, 1992, CURR OPIN GENET DEV, V2, P890, DOI 10.1016/S0959-437X(05)80112-1; JACKSON JA, 1981, NATURE, V292, P306, DOI 10.1038/292306a0; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mazeyrat S, 1999, NAT GENET, V22, P224, DOI 10.1038/10282; Mumm S, 1997, GENOME RES, V7, P307, DOI 10.1101/gr.7.4.307; Ohno S., 1967, SEX CHROMOSOMES SEX; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Painter TS, 1921, SCIENCE, V53, P503, DOI 10.1126/science.53.1378.503; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Schweitzer F., 1998, ADV COMPLEX SYST, V1, P11, DOI DOI 10.1142/S021952599800003X; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; STERN C, 1957, AM J HUM GENET, V9, P147; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; TYLERSMITH C, 1988, J MOL BIOL, V203, P837, DOI 10.1016/0022-2836(88)90110-6; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogt PH, 1997, CYTOGENET CELL GENET, V79, P2; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WATSON JM, 1991, P NATL ACAD SCI USA, V88, P11256, DOI 10.1073/pnas.88.24.11256; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zhao S, 2000, GENOMICS, V63, P321, DOI 10.1006/geno.1999.6082; ZINN AR, 1993, TRENDS GENET, V9, P90, DOI 10.1016/0168-9525(93)90230-F	50	1436	1572	4	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2003	423	6942					825	U2		10.1038/nature01722	http://dx.doi.org/10.1038/nature01722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815422	Bronze			2022-12-01	WOS:000183585300035
J	Tsubuki, S; Takaki, Y; Saido, TC				Tsubuki, S; Takaki, Y; Saido, TC			Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of A beta to physiologically relevant proteolytic degradation	LANCET			English	Article							PROTEIN; DISEASE	The Dutch, Flemish, Italian, and Arctic mutations in the amyloid precursor protein (APP) gene encode changes within the sequence of the amyloid beta peptide (Abeta) and cause presenile cerebral amyloid angiopathy, cerebral parenchymal amyloidosis, or both. These disorders are caused by accumulation of Abeta, with no evidence of increased Abeta production. Our results showed that these mutations in Abeta make it resistant to proteolytic degradation by neprilysin, the peptidase with the most important role in catabolism of Abeta in the brain. These mutations in Abeta could thus be pathogenic not only by facilitating fibrillogenesis but also by extending the half-life of Abeta in the brain.	RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan	RIKEN	Saido, TC (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903				Kumar-Singh S, 2000, NEUROBIOL DIS, V7, P9, DOI 10.1006/nbdi.1999.0272; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; SAITO T, 2003, SCI SAAGE KE    0122; Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869	5	115	126	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1957	1958		10.1016/S0140-6736(03)13555-6	http://dx.doi.org/10.1016/S0140-6736(03)13555-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801742				2022-12-01	WOS:000183359700014
J	Wang, HY; Malbon, CC				Wang, HY; Malbon, CC			Wnt signaling, Ca2+, and cyclic GMP: Visualizing frizzled functions	SCIENCE			English	Editorial Material							BETA-CATENIN; G-PROTEINS; XENOPUS; PATHWAY; KINASE; RECEPTOR; HOMOLOGS; FAMILY; CELLS	Wnts control the specification of cell fate, cell adhesion, migration, polarity, and proliferation. Their roles in development have been probed in fruit flies, nematodes, zebrafish, frogs, and mice. Some Wnts inhibit the degradation of beta-catenin, which can regulate transcription of specific genes. Other Wnts exert their influences in other ways, such as increasing intracellular concentrations of Ca2+ and decreasing intracellular concentrations of cyclic guanosine monophosphate (cGMP). Heterotrimeric guanine nucleotide-binding proteins (G proteins) and RGS proteins have been implicated in Wnt signaling. Wnt regulation of intracellular Ca2+ and cGMP levels requires the G protein transducin and a cGMP-specific phosphodiesterase, which are major elements in signaling of the visual pathway.	SUNY Stony Brook, Hlth Sci Ctr, Dept Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Malbon, CC (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Pharmacol, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020					Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; IRVINE RF, 2002, SCI STKE; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Kume S, 2000, DEV BIOL, V226, P88, DOI 10.1006/dbio.2000.9849; Li H, 2002, BIOCHEM PHARMACOL, V64, P1325, DOI 10.1016/S0006-2952(02)01345-X; Li H, 2002, CANCER BIOL THER, V1, P621, DOI 10.4161/cbt.309; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; WANG HY, 2003, SCI STKE; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu CL, 2000, DEVELOPMENT, V127, P2773	22	115	119	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1529	1530		10.1126/science.1085259	http://dx.doi.org/10.1126/science.1085259			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791979				2022-12-01	WOS:000183333100039
J	Jodar, L; LaForce, FM; Ceccarini, C; Aguado, T; Granoff, DM				Jodar, L; LaForce, FM; Ceccarini, C; Aguado, T; Granoff, DM			Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries	LANCET			English	Editorial Material									WHO, CH-1211 Geneva, Switzerland; Programme Appropriate Technol Hlth, Ferney Voltaire, France; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	World Health Organization; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Jodar, L (corresponding author), Int Vaccine Inst, Bldg 81,SNU Campus, Seoul 151600, South Korea.				NIAID NIH HHS [AI46464, R01 AI 45642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046464, R01AI045642] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; LEVINE MM, 1997, NEW GENERATION VACCI, P489; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Sanchez JL, 1997, LANCET, V349, P1825, DOI 10.1016/S0140-6736(97)04486-3; Wenger J, 2001, VACCINE, V19, P1588, DOI 10.1016/S0264-410X(00)00356-X; *WHO, WHOV B0134; Wittet S, 2000, VACCINE, V19, P385, DOI 10.1016/S0264-410X(00)00196-1; 2002, WKLY EPIDEMIOL REC, V18, P152; 2001, WYETH ANN REPORTS; 1997, WKLY EPIDEMIOL REC, V72, P313; 2000, WYETH ANN REPORTS	11	72	73	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1902	1904		10.1016/S0140-6736(03)13494-0	http://dx.doi.org/10.1016/S0140-6736(03)13494-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788589				2022-12-01	WOS:000183205800026
J	Mitsui, K; Tokuzawa, Y; Itoh, H; Segawa, K; Murakami, M; Takahashi, K; Maruyama, M; Maeda, M; Yamanaka, S				Mitsui, K; Tokuzawa, Y; Itoh, H; Segawa, K; Murakami, M; Takahashi, K; Maruyama, M; Maeda, M; Yamanaka, S			The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells	CELL			English	Article							EMBRYONIC STEM-CELLS; LEUKEMIA INHIBITORY FACTOR; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; SELF-RENEWAL; HUMAN BLASTOCYSTS; GENE; DIFFERENTIATION; EXPRESSION; STAT3	Embryonic stem (ES) cells derived from the inner cell mass (ICM) of blastocysts grow infinitely while maintaining pluripotency. Leukemia inhibitory factor (LIF) can maintain self-renewal of mouse ES cells through activation of Stat3. However, LIF/Stat3 is dispensable for maintenance of ICM and human ES cells, suggesting that the pathway is not fundamental for pluripotency. In search of a critical factor(s) that underlies pluripotency in both ICM and ES cells, we performed in silico differential display and identified several genes specifically expressed in mouse ES cells and preimplantation embryos. We found that one of them, encoding the homeoprotein Nanog, was capable of maintaining ES cell self-renewal independently of LIF/Stat3. nanog-deficient ICM failed to generate epiblast and only produced parietal endoderm-like cells. nanog-deficient ES cells lost pluripotency and differentiated into extraembryonic endoderm lineage. These data demonstrate that Nanog is a critical factor underlying pluripotency in both ICM and ES cells.	Nara Inst Sci & Technol, Lab Anim Mol Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan; Osaka City Univ, Sch Med, Dept Anat 1, Osaka 5458585, Japan	Nara Institute of Science & Technology; Osaka Metropolitan University	Yamanaka, S (corresponding author), Nara Inst Sci & Technol, Lab Anim Mol Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan.	shinyay@gtc.aist-nara-ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Mitsui, Kaoru/E-1464-2011	Takahashi, Kazutoshi/0000-0002-5329-8395; Mitsui, Kaoru/0000-0003-0534-9845				Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Berger CN, 1997, GROWTH FACTORS, V14, P145, DOI 10.3109/08977199709021517; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Colman A, 2001, EMBO REP, V2, P2, DOI 10.1093/embo-reports/kve017; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Ernst M, 1999, J BIOL CHEM, V274, P9729, DOI 10.1074/jbc.274.14.9729; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fan Y, 1999, DEV BIOL, V210, P481, DOI 10.1006/dbio.1999.9279; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Guo Y, 2002, P NATL ACAD SCI USA, V99, P3663, DOI 10.1073/pnas.062041099; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jackson M, 2002, J BIOL CHEM, V277, P38683, DOI 10.1074/jbc.M203459200; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lachmann P, 2001, EMBO REP, V2, P165, DOI 10.1093/embo-reports/kve053; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mieth D, 2000, EMBO REP, V1, P4, DOI 10.1093/embo-reports/kvd020; Molkentin JD, 2000, DEV BIOL, V217, P301, DOI 10.1006/dbio.1999.9544; Morrison B, 1998, SWINE HEALTH PROD, V6, P4; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; ROGERS MB, 1991, DEVELOPMENT, V113, P815; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Smith A, 1998, CURR BIOL, V8, pR802, DOI 10.1016/S0960-9822(07)00504-0; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun-Wada GH, 2000, J BIOCHEM-TOKYO, V127, P703, DOI 10.1093/oxfordjournals.jbchem.a022660; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Wang SH, 2003, GENE EXPR PATTERNS, V3, P99, DOI 10.1016/S1567-133X(03)00005-X; WARE CB, 1995, DEVELOPMENT, V121, P1283; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yamanaka S, 1998, GENOMICS, V54, P191, DOI 10.1006/geno.1998.5561; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	60	2381	2659	12	287	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2003	113	5					631	642		10.1016/S0092-8674(03)00393-3	http://dx.doi.org/10.1016/S0092-8674(03)00393-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787504	Bronze			2022-12-01	WOS:000183397600013
J	Turner-Stokes, L				Turner-Stokes, L			Poststroke depression: getting the full picture	LANCET			English	Editorial Material							LESION LOCATION; STROKE PATIENTS; MOOD DISORDERS; BRAIN INJURY		Northwick Pk Hosp & Clin Res Ctr, Acad Dept Rehabil, Reg Rehabil Unit, Harrow HA1 3UJ, Middx, England; Univ London Kings Coll, Harrow HA1 3UJ, Middx, England	Imperial College London; University of London; King's College London	Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Acad Dept Rehabil, Reg Rehabil Unit, Harrow HA1 3UJ, Middx, England.		Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462				Aben I, 2003, J NEUROL NEUROSUR PS, V74, P581, DOI 10.1136/jnnp.74.5.581; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; Gainotti G, 1997, STROKE, V28, P2145, DOI 10.1161/01.STR.28.11.2145; Gordon A, 2001, HOSP PRACT, V36, P71, DOI 10.3810/hp.2001.03.232; Hassan N, 2002, CLIN REHABIL, V16, P534, DOI 10.1191/0269215502cr523oa; HERRMANN M, 1995, STROKE, V26, P850, DOI 10.1161/01.STR.26.5.850; HOUSE A, 1990, BRAIN, V113, P1113, DOI 10.1093/brain/113.4.1113; ROBINS AH, 1976, J CHRON DIS, V29, P479, DOI 10.1016/0021-9681(76)90088-6; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; SHARPE M, 1990, PSYCHOL MED, V20, P815, DOI 10.1017/S0033291700036503; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; Staley JK, 1998, BIOL PSYCHIAT, V44, P534, DOI 10.1016/S0006-3223(98)00185-1; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; STARKSTEIN SE, 1988, ARCH NEUROL-CHICAGO, V45, P725, DOI 10.1001/archneur.1988.00520310031013; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; Turner-Stokes L, 2003, CLIN REHABIL, V17, P150, DOI 10.1191/0269215503cr595oa	16	18	20	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1757	1758						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781530				2022-12-01	WOS:000183074800003
J	Rathore, SS; Foody, JM; Wang, YF; Smith, GL; Herrin, J; Masoudi, FA; Wolfe, P; Havranek, EP; Ordin, DL; Krumholz, HM				Rathore, SS; Foody, JM; Wang, YF; Smith, GL; Herrin, J; Masoudi, FA; Wolfe, P; Havranek, EP; Ordin, DL; Krumholz, HM			Race, quality of care, and outcomes of elderly patients hospitalized with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; PATIENTS GREATER-THAN-OR-EQUAL-TO-65 YEARS; ENZYME-INHIBITOR THERAPY; RACIAL-DIFFERENCES; UNITED-STATES; HEALTH-CARE; MEDICARE; READMISSION; MORTALITY; SURVIVAL	Context Black patients hospitalized with heart failure reportedly receive poorer quality of care and have worse outcomes than white patients. Because previous studies have been based on selected patient populations treated more than a decade ago, it is unclear if racial differences in quality of care and outcomes currently exist in the United States. Objective To evaluate differences in quality of care and patient outcomes between black and white Medicare beneficiaries hospitalized with heart failure. Design Retrospective analysis of medical record data systematically collected for the National Heart Failure Project. Setting and Patients Nationwide US sample of 29732 fee-for-service Medicare beneficiaries hospitalized with heart failure in 1998 and 1999. Main Outcome Measures Prescription of angiotensin-converting enzyme (ACE) inhibitors, measurement of left ventricular ejection fraction (LVEF), readmission within 1 year of discharge, and mortality within 30 days and 1 year of admission. Results Black patients and white patients had similar crude rates of LVEF assessment (67.8% black vs 66.6% white; P=.29). Among patients classified as ideal for ACE inhibitor use, black patients had higher crude rates of ACE inhibitor use than white patients (81.0% vs 73.8% white; P<.001) but had similar rates of ACE inhibitor or angiotensin receptor blocker (ARB) use (85.7% black vs 82.5% white; P=.08). After multivariable adjustment, black patients had comparable rates of LVEF assessment (risk ratio [RR], 0.99; 95% confidence interval [CI], 0.95-1.03). Black patients remained more likely to be prescribed ACE inhibitors (RR, 1.22; 95% CI, 1.14-1.28) than were white patients in an adjusted analysis, but there were no significant racial differences in the prescription of ACE inhibitors or ARBs (black vs white, RR, 1.03; 95% CI, 0.97-1.07). Black patients had higher rates of readmission within 1 year of discharge (68.2% vs 63.0%; P<.001) but had lower crude 30-day (6.3% vs 10.7%; P<.001) and 1-year (31.5% vs 40.1%; P<.001) mortality rates than white patients. After multivariable adjustment, black patients had a slightly higher rate of readmission than white patients (RR, 1.09; 95% CI, 1.06-1.13) but remained at lower risk of 30-day mortality (RR, 0.78; 95% CI, 0.68-0.91) and 1-year mortality (RR, 0.93; 95% CI, 0.88-0.98). Conclusions Black Medicare patients hospitalized with heart failure received comparable quality of care and had slightly higher rates of readmission but had lower mortality rates up to 1 year after hospitalization than did white patients.	Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; Flying Buttress Associates, Charlottesville, VA USA; Denver Hlth Med Ctr, Dept Med, Div Cardiol, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Geriatr Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Cardiol, Denver, CO 80262 USA; Colorado Fdn Med Care, Aurora, CO USA; Ctr Medicare & Medicaid Serv, Boston, MA USA	Yale University; Yale University; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centers for Medicare & Medicaid Services	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 333 Cedar St,Room I-456 SHM,POB 208025, New Haven, CT 06520 USA.		Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020	Smith, Grace/0000-0002-3171-2911	NIA NIH HHS [K08-AG01011] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG001011] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Afzal A, 1999, CLIN CARDIOL, V22, P791, DOI 10.1002/clc.4960221207; *AG HEALTHC RES QU, PROGR BRIEF EXC CTR; ALEXANDER M, 1995, JAMA-J AM MED ASSOC, V274, P1037, DOI 10.1001/jama.274.13.1037; Alexander M, 1999, AM HEART J, V137, P919, DOI 10.1016/S0002-8703(99)70417-5; *AM HEART ASS, 2001, 2002 HEART STROK STA; *AM HOSP ASS, 2000, CIRCULATION, V101, pE122; Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; BOURASSA MG, 1993, J AM COLL CARDIOL, V22, pA14, DOI 10.1016/0735-1097(93)90456-B; Chin MH, 1997, AM J CARDIOL, V79, P1640, DOI 10.1016/S0002-9149(97)00214-2; Croft JB, 1999, ARCH INTERN MED, V159, P505, DOI 10.1001/archinte.159.5.505; Croft JB, 1997, J AM GERIATR SOC, V45, P270, DOI 10.1111/j.1532-5415.1997.tb00939.x; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Evangelista LS, 2002, J CARD FAIL, V8, P381, DOI 10.1054/jcaf.2002.129234; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; GATSONIS CA, 1995, MED CARE, V33, P625, DOI 10.1097/00005650-199506000-00005; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; GILLUM RF, 1987, AM HEART J, V113, P1043, DOI 10.1016/0002-8703(87)90077-9; GILLUM RF, 1993, AM HEART J, V126, P1042, DOI 10.1016/0002-8703(93)90738-U; GOLDBERG KC, 1992, JAMA-J AM MED ASSOC, V267, P1473, DOI 10.1001/jama.267.11.1473; Gordon HS, 1996, JAMA-J AM MED ASSOC, V276, P1639, DOI 10.1001/jama.276.20.1639; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; *I MED, 2002, UN TREATM CONFR RAC; Ibrahim SA, 2003, J GERONTOL A-BIOL, V58, P56; Iglehart JK, 2001, NEW ENGL J MED, V345, P1920, DOI 10.1056/NEJM200112273452617; Jha AK, 2001, JAMA-J AM MED ASSOC, V285, P297, DOI 10.1001/jama.285.3.297; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; Kenward K, 1996, AM J PUBLIC HEALTH, V86, P1481, DOI 10.2105/AJPH.86.10.1481; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Luthi JC, 2002, INT J QUAL HEALTH C, V14, P15, DOI 10.1093/intqhc/14.1.15; Masoudi F A, 2000, Congest Heart Fail, V6, P337, DOI 10.1111/j.1527-5299.2000.80175.x; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Philbin EF, 1998, AM J CARDIOL, V82, P76, DOI 10.1016/S0002-9149(98)00233-1; Philbin EF, 2001, AM J CARDIOL, V87, P1367, DOI 10.1016/S0002-9149(01)01554-5; *PRACT MAN INF COR, 1998, INT CLASS DIS 9 REV; Rathore SS, 2003, J AM COLL CARDIOL, V41, p518A; Stafford RS, 1997, ARCH INTERN MED, V157, P2460, DOI 10.1001/archinte.157.21.2460; Sueta CA, 2000, AM J CARDIOL, V86, P1151, DOI 10.1016/S0002-9149(00)01180-2; Sueta CA, 2003, AM J CARDIOL, V91, P363, DOI 10.1016/S0002-9149(02)03173-9; Vaccarino V, 1999, AM HEART J, V138, P835, DOI 10.1016/S0002-8703(99)70007-4; Vaccarino V, 2002, AM HEART J, V143, P1058, DOI 10.1067/mhj.2002.122123; Ventura HO, 2001, J AM COLL CARDIOL, V37, p209A; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; Wolinsky FD, 1997, MED CARE, V35, P1031, DOI 10.1097/00005650-199710000-00005; Yancy CW, 2001, NEW ENGL J MED, V344, P1358, DOI 10.1056/NEJM200105033441803; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	49	184	185	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2003	289	19					2517	2524		10.1001/jama.289.19.2517	http://dx.doi.org/10.1001/jama.289.19.2517			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680KL	12759323	Bronze			2022-12-01	WOS:000182976500020
J	Cordenonsi, M; Dupont, S; Maretto, S; Insinga, A; Imbriano, C; Piccolo, S				Cordenonsi, M; Dupont, S; Maretto, S; Insinga, A; Imbriano, C; Piccolo, S			Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads	CELL			English	Article							GROWTH-FACTOR-BETA; P63; EXPRESSION; BINDING; PROTEIN; P73; DIFFERENTIATION; MECHANISM; INDUCER; FORMS	The p53 tumor suppressor belongs to a family of proteins that sense multiple cellular inputs to regulate Cell proliferation, apoptosis, and differentiation. Whether and how these functions of p53 intersect with the activity of extracellular growth factors is not understood. Here, we report that key cellular responses to TGF-beta signals rely on p53 family members. During Xenopus embryonic development, p53 promotes the activation of multiple TGF-beta target genes. Moreover, mesoderm differentiation is inhibited in p53-depleted embryos. In mammalian cells, the full transcriptional activation of the CDK inhibitor p21(WAF1) by TGF-beta requires p53. p53-deficient cells display an impaired cytostatic response to TGF-beta signals. Smad and p53 protein complexes converge on separate cis binding elements on a target promoter and synergistically activate TGF-beta induced transcription. p53 can physically interact in vivo with Smad2 in a TGF-beta-dependent fashion. The results unveil a previously unrecognized link between two primary tumor suppressor pathways in vertebrates.	Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, I-35121 Padua, Italy; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ Modena & Reggio Emilia, Dept Biol, I-41100 Modena, Italy	University of Padua; IRCCS European Institute of Oncology (IEO); Universita di Modena e Reggio Emilia	Piccolo, S (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, Viale Colombo 3, I-35121 Padua, Italy.	piccolo@civ.bio.unipd.it	Dupont, Sirio/AAP-8133-2021; Cordenonsi, Michelangelo/K-7692-2016; Imbriano, Carol/C-9376-2015; Imbriano, Carol/ABD-8204-2021; Insinga, Alessandra/AAR-9551-2020	Cordenonsi, Michelangelo/0000-0002-8253-5724; Imbriano, Carol/0000-0003-2864-4820; Imbriano, Carol/0000-0003-2864-4820; Insinga, Alessandra/0000-0002-6060-8339; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004	Telethon [E.0815] Funding Source: Medline	Telethon(Fondazione Telethon)		Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Candia AF, 1997, DEVELOPMENT, V124, P4467; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; COX LS, 1994, ONCOGENE, V9, P2951; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Fortunel NO, 2000, BLOOD, V96, P2022; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hall PA, 2000, CARCINOGENESIS, V21, P153, DOI 10.1093/carcin/21.2.153; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Liu B, 2003, BLOOD, V101, P124, DOI 10.1182/blood-2002-02-0398; Lu PF, 2001, MECH DEVELOP, V102, P275, DOI 10.1016/S0925-4773(01)00315-X; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Prunier C, 2001, MOL CELL BIOL, V21, P3302, DOI 10.1128/MCB.21.10.3302-3313.2001; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Sun BI, 1999, DEVELOPMENT, V126, P1467; Vairapandi M, 1996, ONCOGENE, V12, P2579; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; WOLKOWICZ R, 1995, P NATL ACAD SCI USA, V92, P6842, DOI 10.1073/pnas.92.15.6842; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127	32	316	327	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					301	314		10.1016/S0092-8674(03)00308-8	http://dx.doi.org/10.1016/S0092-8674(03)00308-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732139	Green Published, Bronze			2022-12-01	WOS:000182640800006
J	Meyer, AS; Gillespie, JR; Walther, D; Millet, IS; Doniach, S; Frydman, J				Meyer, AS; Gillespie, JR; Walther, D; Millet, IS; Doniach, S; Frydman, J			Closing the folding chamber of the eukaryotic chaperonin requires the transition state of ATP hydrolysis	CELL			English	Article							GROUP-II CHAPERONIN; CYTOPLASMIC CHAPERONIN; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; IN-VIVO; PROTEIN; BINDING; THERMOSOME; GROEL; RECONSTRUCTION	Chaperonins use ATPase cycling to promote conformational changes leading to protein folding. The prokaryotic chaperonin GroEL requires a cofactor, GroES, which serves as a "lid" enclosing substrates in the central cavity and confers an asymmetry on GroEL required for cooperative transitions driving the reaction. The eukaryotic chaperonin TRiC/CCT does not have such a cofactor but appears to have a "built-in" lid. Whether this seemingly symmetric chaperonin also operates through an asymmetric cycle is unclear. We show that unlike GroEL, TRiC does not close its lid upon nucleotide binding, but instead responds to the trigonal-bipyramidal transition state of ATP hydrolysis. Further, nucleotide analogs inducing this transition state confer an asymmetric conformation on TRiC. Similar to GroEL, lid closure in TRiC confines the substrates in the cavity and is essential for folding. Understanding the distinct mechanisms governing eukaryotic and bacterial chaperonin function may reveal how TRiC has evolved to fold specific eukaryotic proteins.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Incyte Genom Inc, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Incyte	Frydman, J (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Gillespie, Joel/GXW-0158-2022	, judith/0000-0003-2302-6943; Gillespie, Joel/0000-0002-5075-1609; Walther, Dirk/0000-0002-5755-9265; Meyer, Anne S./0000-0002-4164-0122	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433, R37GM056433] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56433] Funding Source: Medline; NINR NIH HHS [NRSA 10965] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Bada M, 2000, J MOL BIOL, V300, P563, DOI 10.1006/jmbi.2000.3854; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Ferreyra RG, 2000, METH MOL B, V140, P153; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Guinier A., 1955, SMALL ANGLE SCATTERI; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Gutsche I, 2001, J STRUCT BIOL, V135, P139, DOI 10.1006/jsbi.2001.4373; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horst M, 1996, PROTEIN SCI, V5, P759; Horwich AL, 1998, NAT STRUCT BIOL, V5, P333, DOI 10.1038/nsb0598-333; Kafri G, 2001, PROTEIN SCI, V10, P445, DOI 10.1110/ps.44401; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Llorca O, 1998, J BIOL CHEM, V273, P10091, DOI 10.1074/jbc.273.17.10091; MELKI R, 1994, MOL CELL BIOL, V14, P2895, DOI 10.1128/MCB.14.5.2895; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; MORNET D, 1984, P NATL ACAD SCI-BIOL, V81, P3680, DOI 10.1073/pnas.81.12.3680; Nitsch M, 1998, NAT STRUCT BIOL, V5, P855, DOI 10.1038/2296; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PENNINGROTH SM, 1980, J BIOL CHEM, V255, P9545; Rayment I, 1996, ANNU REV PHYSIOL, V58, P671; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SHLOMAI J, 1980, J BIOL CHEM, V255, P6789; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Szpikowska BK, 1998, PROTEIN SCI, V7, P1524, DOI 10.1002/pro.5560070705; Walther D, 2000, J APPL CRYSTALLOGR, V33, P350, DOI 10.1107/S0021889899015976; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yoshida T, 2002, J MOL BIOL, V315, P73, DOI 10.1006/jmbi.2001.5220; YOUNT RG, 1975, ADV ENZYMOL RAMB, V43, P1	39	142	146	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					369	381		10.1016/S0092-8674(03)00307-6	http://dx.doi.org/10.1016/S0092-8674(03)00307-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732144	Bronze			2022-12-01	WOS:000182640800011
J	Sharp, D				Sharp, D			Chateau resveratrol	LANCET			English	Editorial Material							FRENCH PARADOX; WINE; MORTALITY; DISEASE		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							de Lorgeril M, 2002, CARDIOVASC RES, V54, P503, DOI 10.1016/S0008-6363(01)00545-4; Klatsky AL, 2003, SCI AM, V288, P74, DOI 10.1038/scientificamerican0203-74; Laatikainen T, 2003, J EPIDEMIOL COMMUN H, V57, P379, DOI 10.1136/jech.57.5.379; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; MCMICHAEL J, 1979, LANCET, V1, P1186; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Rosenkranz S, 2002, FASEB J, V16, P1958, DOI 10.1096/fj.02-0207fje; Simini B, 2000, LANCET, V355, P48, DOI 10.1016/S0140-6736(05)71990-5; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; 2003, WINE SCI EXPLORATION, P320	11	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2003	361	9367					1404	1404		10.1016/S0140-6736(03)13149-2	http://dx.doi.org/10.1016/S0140-6736(03)13149-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727391				2022-12-01	WOS:000182516300006
J	Stillman, JH				Stillman, JH			Acclimation capacity underlies susceptibility to climate change	SCIENCE			English	Article							IMPACTS		Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	Stanford University	Stillman, JH (corresponding author), Stanford Univ, Hopkins Marine Stn, Oceanview Blvd, Pacific Grove, CA 93950 USA.			Stillman, Jonathon/0000-0002-4783-3830				Jensen MN, 2003, SCIENCE, V299, P38, DOI 10.1126/science.299.5603.38; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790	5	578	587	6	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					65	65		10.1126/science.1083073	http://dx.doi.org/10.1126/science.1083073			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843385				2022-12-01	WOS:000183914700031
J	Royer, DL; Osborne, CP; Beerling, DJ				Royer, DL; Osborne, CP; Beerling, DJ			Carbon loss by deciduous trees in a CO2-rich ancient polar environment	NATURE			English	Article							CLIMATE-CHANGE; FORESTS; ISLAND; FLORAS; CO2; VERTEBRATES; ANTARCTICA; VEGETATION; RESPONSES; TERTIARY	Fossils demonstrate that deciduous forests covered the polar regions for much of the past 250 million years(1) when the climate was warm and atmospheric CO2 high(2). But the evolutionary significance of their deciduous character has remained a matter of conjecture for almost a century(3). The leading hypothesis(1,4-7) argues that it was an adaptation to photoperiod, allowing the avoidance of carbon losses by respiration from a canopy of leaves unable to photosynthesize in the darkness of warm polar winters(8-11). Here we test this proposal with experiments using 'living fossil' tree species grown in a simulated polar climate with and without CO2 enrichment. We show that the quantity of carbon lost annually by shedding a deciduous canopy is significantly greater than that lost by evergreen trees through wintertime respiration and leaf litter production, irrespective of growth CO2 concentration. Scaling up our experimental observations indicates that the greater expense of being deciduous persists in mature forests, even up to latitudes of 83 degreesN, where the duration of the polar winter exceeds five months. We therefore reject the carbon-loss hypothesis as an explanation for the deciduous nature of polar forests.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Beerling, DJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Beerling, David J/C-2840-2009	Beerling, David J/0000-0003-1869-4314; Royer, Dana/0000-0003-0976-953X				AXELROD DI, 1966, EVOLUTION, V20, P1, DOI [10.2307/2406145, 10.1111/j.1558-5646.1966.tb03339.x]; Beerling DJ, 1998, PHILOS T R SOC B, V353, P131, DOI 10.1098/rstb.1998.0196; Beerling DJ, 2002, ANN BOT-LONDON, V89, P329, DOI 10.1093/aob/mcf045; CHANEY RW, 1947, ECOL MONOGR, V17, P139, DOI 10.2307/1943260; CREBER GT, 1985, PALAEOGEOGR PALAEOCL, V52, P35, DOI 10.1016/0031-0182(85)90030-6; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Dutton AL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000593; ESTES R, 1980, PALAEOGEOGR PALAEOCL, V30, P325, DOI 10.1016/0031-0182(80)90064-4; Falcon-Lang HJ, 2000, PALAEOGEOGR PALAEOCL, V160, P317, DOI 10.1016/S0031-0182(00)00079-1; Falcon-Lang HJ, 2001, GEOL MAG, V138, P39, DOI 10.1017/S0016756801004927; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; HICKEY LJ, 1984, DISCOVERY, V17, P17; MULLER MJ, 1981, SELECTED CLIMATIC DA; Osborne CP, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001467; Parrish JT, 1998, PALAIOS, V13, P149, DOI 10.2307/3515486; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; READ J, 1992, PALAEOGEOGR PALAEOCL, V99, P271, DOI 10.1016/0031-0182(92)90019-2; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; SEWARD A.C., 1914, BR MUS NAT HIST GEOL, V1, P1; Sokal R., 2000, BIOMETRY, V3rd ed., P451; SPICER RA, 1990, TRENDS ECOL EVOL, V5, P279, DOI 10.1016/0169-5347(90)90081-N; Tarduno JA, 1998, SCIENCE, V282, P2241, DOI 10.1126/science.282.5397.2241; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Tripati A, 2001, PALAEOGEOGR PALAEOCL, V170, P101, DOI 10.1016/S0031-0182(01)00230-9; Upchurch G.R., 1990, ANTARCTIC J US, V24, P7; Valdes P.J., 1996, PALAEOCLIMATES, V2, P139, DOI DOI 10.1016/J.ECOLMODEL.2005.03.026; Villar R, 2001, NEW PHYTOL, V151, P213, DOI 10.1046/j.1469-8137.2001.00147.x; Wolfe J.A., 1985, GEOPHYS MONOGR SER, V32, P357, DOI DOI 10.1029/GM032P0357; WOLFE JA, 1987, PALEOBIOLOGY, V13, P215; Yin XW, 2002, GLOBAL CHANGE BIOL, V8, P631, DOI 10.1046/j.1365-2486.2002.00497.x	30	48	51	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					60	62		10.1038/nature01737	http://dx.doi.org/10.1038/nature01737			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840757	Green Accepted			2022-12-01	WOS:000183912800038
J	Nilsson, M; Johnsen, R; Ye, WM; Hveem, K; Lagergren, J				Nilsson, M; Johnsen, R; Ye, WM; Hveem, K; Lagergren, J			Obesity and estrogen as risk factors for gastroesophageal reflux symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER ESOPHAGEAL SPHINCTER; NITRIC-OXIDE SYNTHASE; BODY-MASS; GASTRIC CARDIA; DISEASE; PREVALENCE; POPULATION; WOMEN; ADENOCARCINOMAS; PERISTALSIS	Context Gastroesophageal reflux and obesity are both increasing in prevalence. The scientific evidence for an association between these conditions is sparse and contradictory. A difference between sexes concerning this relation has been proposed. Objective To evaluate the relation between body mass and gastroesophageal reflux symptoms and determine how this relation is influenced by female sex hormones. Design Population-based, cross-sectional, case-control study. Setting Two consecutive public health surveys within the county of Nord-Trondelag, Norway, conducted in 1984-1986 and 1995-1997. Participants Among 65363 adult participants in the second survey, 3113 individuals who reported severe heartburn or regurgitation during the last 12 months were defined as cases, whereas 39872 persons without reflux symptoms were defined as controls. Main Outcome Measure Risk of reflux, estimated using multivariate logistic regression, with odds ratios (ORs) and 95% confidence intervals (Cls) as measures of association. Results There was a dose-response association between increasing body mass index (BMI) and reflux symptoms in both sexes (P for trend <.001), with a significantly stronger association in women (P<.001). Compared with those with a BMI less than 25, the risk of reflux was increased significantly among severely obese (BMI >35) men (OR, 3.3; 95% Cl, 2.4-4.7) and women (OR, 6.3; 95% Cl, 4.9-8.0). The association between BMI and reflux symptoms was stronger among premenopausal women compared with postmenopausal women (P<.001), although use of postmenopausal hormone therapy increased the strength of the association (P<.001). Reduction in BMI was associated with decreased risk of reflux symptoms. Conclusions There is a significant association between body mass and symptoms of gastroesophageal reflux. The association is stronger among women, especially premenopausally, and use of hormone therapy strengthens the association, suggesting that estrogens may play an important role in the etiology of reflux disease.	Karolinska Inst, Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden; Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Norwegian Univ Sci & Technol, Dept Community Med & Gen Practice, N-7034 Trondheim, Norway; Levanger Hosp, Dept Med, Levanger, Norway; HUNT Res Ctr, Verdal, Norway	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Norwegian University of Science & Technology (NTNU)	Nilsson, M (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden.	magnus.nilsson@ks.se	Hveem, Kristian/AFV-4683-2022; Ye, Weimin/A-5939-2008	Lagergren, Jesper/0000-0002-5143-5448; Nilsson, Magnus/0000-0002-6215-8132				Bray George A., 1997, Human Reproduction (Oxford), V12, P26; Breslow NE, 1980, STAT METHODS CANC RE; CASTRO LDP, 1967, AM J OBSTET GYNECOL, V98, P1; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; DAY JP, 1990, GASTROENTEROL CLIN N, V19, P587; DEMAN JG, 1991, BRIT J PHARMACOL, V103, P1092; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; Eloubeidi MA, 2000, AM J GASTROENTEROL, V95, P1881; GARROW JS, 1985, INT J OBESITY, V9, P147; HANSSON LE, 1993, INT J CANCER, V54, P402, DOI 10.1002/ijc.2910540309; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; HEY VMF, 1977, ANAESTHESIA, V32, P372, DOI 10.1111/j.1365-2044.1977.tb11643.x; Hirsch DP, 1998, GASTROENTEROLOGY, V115, P1374, DOI 10.1016/S0016-5085(98)70015-0; ISOLAURI J, 1995, ANN MED, V27, P67, DOI 10.3109/07853899509031939; *JOINT FAO WHO UNU, 1985, WHO TECHN REP SER, P724; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Konturek JW, 1997, J PHYSIOL PHARMACOL, V48, P201; KUSKOWSKAWOLK A, 1993, J EPIDEMIOL COMMUN H, V47, P103, DOI 10.1136/jech.47.2.103; KUSZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lagergren J, 2000, GUT, V47, P26, DOI 10.1136/gut.47.1.26; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; LOCKE GR, 1994, MAYO CLIN PROC, V69, P539, DOI 10.1016/S0025-6196(12)62245-9; Locke GR, 1999, AM J MED, V106, P642, DOI 10.1016/S0002-9343(99)00121-7; Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813; Nilsson M, 2002, SCAND J GASTROENTERO, V37, P626, DOI 10.1080/00365520212502; Nuedling S, 1999, CARDIOVASC RES, V43, P666, DOI 10.1016/S0008-6363(99)00093-0; Piccinini F, 2000, GYNECOL ENDOCRINOL, V14, P142, DOI 10.3109/09513590009167673; Revicki DA, 1998, QUAL LIFE RES, V7, P75; Rothacker DQ, 2000, J AM DIET ASSOC, V100, P784, DOI 10.1016/S0002-8223(00)00229-7; Ruhl CE, 1999, ANN EPIDEMIOL, V9, P424, DOI 10.1016/S1047-2797(99)00020-4; RUTH M, 1991, SCAND J GASTROENTERO, V26, P73, DOI 10.3109/00365529108996486; SIITERI PK, 1981, J ENDOCRINOL, V89, pP119; Ter RB, 1997, GASTROENTEROL CLIN N, V26, P549, DOI 10.1016/S0889-8553(05)70313-7; TOTTRUP A, 1991, AM J PHYSIOL, V260, pG385, DOI 10.1152/ajpgi.1991.260.3.G385; VANTHIEL DH, 1976, GASTROENTEROLOGY, V71, P232; VANTHIEL DH, 1977, GASTROENTEROLOGY, V72, P666; Xue SW, 1996, CAN J PHYSIOL PHARM, V74, P1249, DOI 10.1139/cjpp-74-11-1249; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569; Zervou S, 1999, MOL HUM REPROD, V5, P1048, DOI 10.1093/molehr/5.11.1048	42	333	343	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					66	72		10.1001/jama.290.1.66	http://dx.doi.org/10.1001/jama.290.1.66			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837713	Bronze			2022-12-01	WOS:000183868600021
J	Schoen, RE; Pinsky, PF; Weissfeld, JL; Bresalier, RS; Church, T; Prorok, P; Gohagan, JK				Schoen, RE; Pinsky, PF; Weissfeld, JL; Bresalier, RS; Church, T; Prorok, P; Gohagan, JK		Prostate Lung Colorectal Ovarian C	Results of repeat sigmoidoscopy 3 years after a negative examination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCREENING FLEXIBLE SIGMOIDOSCOPY; COLORECTAL-CANCER; ASYMPTOMATIC ADULTS; COLONOSCOPY; RISK; ADENOMAS; YIELD; SURVEILLANCE; PREVENTION; GUIDELINES	Context The necessary frequency of endoscopic colorectal cancer screening after a negative examination is uncertain. Objective To examine the yield of adenomas and cancer in the distal colon found by repeat flexible sigmoidoscopy (FSG) 3 years after a negative examination. Design, Setting, and Participants Participants were drawn from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), a randomized, controlled community-based study of cancer screening. The mean (SD) age was 65.7 (4.0) years at study entry (1993-1995) and 61.6% were men. individuals underwent screening FSG at baseline and at 3 years as part of the protocol and were referred to their personal physicians for further evaluation of screen-detected abnormalities. Results from subsequent diagnostic evaluations were tracked in a standardized fashion. Of 11583 eligible for repeat screening FSG 3 years after an initial negative examination, 9317 (80.4%) returned. Main Outcome Measures Polyp or mass detection in distal colon at year 3 repeat FSG; incidence of adenoma or cancer in distal colon at year 3 examination; determination of reason for detection (increased depth of insertion or improved preparation at the year 3 examination or detection in a previously examined area). Results A total of 1292 returning participants (13.9%) had a polyp or mass detected by FSG 3 years after the initial examination. In the distal colon, 3.1% (292/ 9317) were found to have an adenoma or cancer. The incidence of advanced adenoma (n=72) or cancer (n=6) in the distal colon was 78 (0.8%)of 9317. Of individuals with advanced distal adenomas detected at the year 3 examination, 80.6% (58/72) had lesions found in a portion of the colon that had been adequately examined at the initial sigmoidoscopy. Conclusions Repeat FSG 3 years after a negative examination will detect advanced adenomas and distal colon cancer. Although the overall percentage with detected abnormalities is modest, these data raise concern about the impact of a prolonged screening interval after a negative examination.	Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; NCI, Div Canc Prevent, Bethesda, MD 20892 USA; Univ Texas, MD Anderson Canc Ctr, Div Gastrointestinal Med & Nutr, Houston, TX 77030 USA; Univ Minnesota, Div Environm & Occupat Hlth, Minneapolis, MN USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities	Schoen, RE (corresponding author), Presbyterian Univ Hosp, Div Gastroenterol & Hepatol, Mezzanine Level,C Wing,200 Lothrop St, Pittsburgh, PA 15213 USA.	rschoen@pitt.edu	Church, Timothy/AAH-7017-2020	Church, Timothy/0000-0003-3292-5035; Bresalier, Robert/0000-0002-9740-281X	NCI NIH HHS [N01-CN2551] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkin WS, 2001, GASTROENTEROLOGY, V120, pA66; Bresalier RS, 2002, GASTROENTEROLOGY, V122, pA479; BRINT SL, 1993, AM J GASTROENTEROL, V88, P2019; COOPER GS, 1995, CANCER, V75, P775, DOI 10.1002/1097-0142(19950201)75:3<775::AID-CNCR2820750305>3.0.CO;2-D; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Fenlon HM, 1999, NEW ENGL J MED, V341, P1496, DOI 10.1056/NEJM199911113412003; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KREVSKY B, 1994, AM J GASTROENTEROL, V89, P1165; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Marshall JR, 1996, GASTROENTEROLOGY, V111, P1411, DOI 10.1016/S0016-5085(96)70001-X; MAULE WF, 1994, NEW ENGL J MED, V330, P183, DOI 10.1056/NEJM199401203300307; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; NEUGUT AI, 1995, GASTROENTEROLOGY, V108, P402, DOI 10.1016/0016-5085(95)90066-7; Pinsky PF, 2003, CLIN GASTROENTEROL H, V1, P103, DOI 10.1053/cgh.2003.50017; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; REX DK, 1994, GASTROENTEROLOGY, V106, P593, DOI 10.1016/0016-5085(94)90690-4; Rex DK, 1996, GASTROENTEROLOGY, V111, P1178, DOI 10.1053/gast.1996.v111.pm8898630; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; REX DK, 1990, FLEXIBLE SIGMOIDOSCO, P185; RIFF ER, 1990, CLEV CLIN J MED, V57, P131, DOI 10.3949/ccjm.57.2.131; Schoen RE, 2000, ARCH INTERN MED, V160, P1790, DOI 10.1001/archinte.160.12.1790; SCHOEN RE, IN PRESS AM J GASTRO; Schoenfeld P, 1999, GASTROENTEROLOGY, V117, P312, DOI 10.1053/gast.1999.0029900312; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Slattery ML, 1996, CANCER, V78, P1666, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1666::AID-CNCR5>3.0.CO;2-C; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Smith RA, 2001, CA-CANCER J CLIN, V51, P150; SQUILLACE S, 1994, AM J GASTROENTEROL, V89, P1156; Stallings FL, 2000, CONTROL CLIN TRIALS, V21, p379S, DOI 10.1016/S0197-2456(00)00093-3; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Weissfeld JL, 2002, CANCER, V94, P2569, DOI 10.1002/cncr.10538; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	35	73	75	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					41	48		10.1001/jama.290.1.41	http://dx.doi.org/10.1001/jama.290.1.41			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696CR	12837710	Bronze			2022-12-01	WOS:000183868600018
J	Reimold, WU				Reimold, WU			Impact cratering comes of age	SCIENCE			English	Editorial Material									Univ Witwatersrand, Sch Geosci, Impact Cratering Res Grp, ZA-2050 Johannesburg, South Africa	University of Witwatersrand	Reimold, WU (corresponding author), Univ Witwatersrand, Sch Geosci, Impact Cratering Res Grp, ZA-2050 Johannesburg, South Africa.		Reimold, Wolf Uwe/AAI-6226-2021	Hauser, Natalia/0000-0002-6975-6186				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Baldwin RB, 1949, THE FACE OF THE MOON; Courtillot V., 2002, EVOLUTIONARY CATASTR; de Pater I, 2001, PLANETARY SCI; French B. M., 1998, TRACES CATASTROPHE; GIBSON RL, 2001, VREDEFORT IMPACT STR; Hess H H., 1962, PETROLOGIC STUDIES V, P599, DOI DOI 10.1130/PETROLOGIC.1962.599; Melosh H.J., 1989, IMPACT CRATERING GEO; Milani A, 2003, SCIENCE, V300, P1882, DOI 10.1126/science.1077708; Montanari A., 2000, IMPACT STRATIGRAPHY; NICOLAYSEN LO, 1990, TECTONOPHYSICS, V171; PATRIDGE TC, 1999, INVESTIGATIONS ORIGI; TAYLOR SR, 2001, SOLAR SYSTEM EVOLUTI; Wegener A., 1915, ENTSTEHUNG KONTINENT, V23; Wilson M., 1989, IGNEOUS PETROGENESIS, P1, DOI 10.1007/978-1-4020-6788-4	15	7	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1889	1890		10.1126/science.1080687	http://dx.doi.org/10.1126/science.1080687			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817133				2022-12-01	WOS:000183619400028
J	Riley, S; Fraser, C; Donnelly, CA; Ghani, AC; Abu-Raddad, LJ; Hedley, AJ; Leung, GM; Ho, LM; Lam, TH; Thach, TQ; Chau, P; Chan, KP; Leung, PY; Tsang, T; Ho, W; Lee, KH; Lau, EMC; Ferguson, NM; Anderson, RM				Riley, S; Fraser, C; Donnelly, CA; Ghani, AC; Abu-Raddad, LJ; Hedley, AJ; Leung, GM; Ho, LM; Lam, TH; Thach, TQ; Chau, P; Chan, KP; Leung, PY; Tsang, T; Ho, W; Lee, KH; Lau, EMC; Ferguson, NM; Anderson, RM			Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions	SCIENCE			English	Article							ACUTE RESPIRATORY SYNDROME; CORONAVIRUS	We present an analysis of the first 10 weeks of the severe acute respiratory syndrome (SARS) epidemic in Hong Kong. The epidemic to date has been characterized by two large clusters - initiated by two separate "super-spread" events (SSEs) - and by ongoing community transmission. By fitting a stochastic model to data on 1512 cases, including these clusters, we show that the etiological agent of SARS is moderately transmissible. Excluding SSEs, we estimate that 2.7 secondary infections were generated per case on average at the start of the epidemic, with a substantial contribution from hospital transmission. Transmission rates fell during the epidemic, primarily as a result of reductions in population contact rates and improved hospital infection control, but also because of more rapid hospital attendance by symptomatic individuals. As a result, the epidemic is now in decline, although continued vigilance is necessary for this to be maintained. Restrictions on longer range population movement are shown to be a potentially useful additional control measure in some contexts. We estimate that most currently infected persons are now hospitalized, which highlights the importance of control of nosocomial transmission.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England; Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; Govt Hong Kong Special Adm Reg, Hlth Welf & Food Bur, Res Off, Hong Kong, Hong Kong, Peoples R China; Govt Hong Kong Special Adm Reg, Dept Hlth, Wanchai, Hong Kong, Peoples R China; Hong Kong Hosp Author, Kowloon, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Sch Publ Hlth, Prince Wales Hosp, Dept Community & Family Med, Shatin, Hong Kong, Peoples R China	Imperial College London; University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Riley, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, Exhibit Rd, London SW7 2AZ, England.	s.riley@imperial.ac.uk	Leung, Gabriel Matthew/C-4336-2009; Ghani, Azra/B-8560-2009; Thach, Thuan-Quoc/C-4416-2009; Abu-Raddad, Laith J/AAY-1441-2020; Chan, King Pan/C-4523-2009; Hedley, Anthony J/A-9113-2013; Ferguson, Neil/B-8578-2008; Fraser, Christophe/A-8109-2008; Hedley, Anthony/C-4305-2009; Lam, Tai Hing/C-4317-2009	Thach, Thuan-Quoc/0000-0003-3404-3888; Abu-Raddad, Laith J/0000-0003-0790-0506; Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; Leung, Gabriel/0000-0002-2503-6283; Riley, Steven/0000-0001-7904-4804; Anderson, Roy/0000-0002-9528-3175; Ghani, Azra/0000-0002-0007-4910; ho, lm/0000-0002-2709-927X; Donnelly, Christl/0000-0002-0195-2463; Lam, Tai Hing/0000-0002-2033-9971				ANDERSON R M, 1991; DIEKMANN O, 2002, MATH EPIDEMIOLOGY IN; DONNELLY CA, 2003, LANCET          0507; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; *HONG KONG DEP HLT, 2003, OUTBR SEV AC RESP SY; *HONG KONG POL DEC, UNPUB SEL DAIL REP S; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; PEIRIS JSM, 2003, LANCET          0509; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634	12	740	803	13	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1961	1966		10.1126/science.1086478	http://dx.doi.org/10.1126/science.1086478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12766206				2022-12-01	WOS:000183619400052
J	Au, WWL; Benoit-Bird, KJ				Au, WWL; Benoit-Bird, KJ			Automatic gain control in the echolocation system of dolphins	NATURE			English	Article							SIGNALS	In bats(1) and technological sonars(2), the gain of the receiver is progressively increased with time after the transmission of a signal to compensate for acoustic propagation loss. The current understanding of dolphin echolocation indicates that automatic gain control is not a part of their sonar system(3). In order to test this understanding, we have performed field measurements of free-ranging echolocating dolphins. Here we show that dolphins do possess an automatic gain control mechanism, but that it is implemented in the transmission phase rather than the receiving phase of a sonar cycle. We find that the amplitude of the dolphins' echolocation signals are highly range dependent; this amplitude increases with increasing target range, R, in a 20 log(R) fashion to compensate for propagation loss. If the echolocation target is a fish school with many sound scatterers, the echoes from the school will remain nearly constant(4) with range as the dolphin closes in on it. This characteristic has the same effect as time-varying gain in bats and technological sonar when considered from a sonar system perspective.	Univ Hawaii, Hawaii Inst Marine Biol, Kailua, HI 96734 USA	University of Hawaii System	Au, WWL (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, POB 1106, Kailua, HI 96734 USA.	wau@hawaii.edu						Au W. W., 1993, SONAR DOLPHINS; Au WWL, 2003, J ACOUST SOC AM, V113, P598, DOI 10.1121/1.1518980; AU WWL, 2002, J ACOUST SOC AM, V111, P2343; Cranford T. W, 1988, ANIMAL SONAR PROCESS, P67; Cranford TW, 2000, SPR HDB AUD, V12, P109; EVANS WE, 1967, ANIMAL SONAR SYSTEMS, P363; HEITHAUS MR, 2002, ENCY MARINE MAMMALS, P411; HENSON OW, 1965, J PHYSIOL-LONDON, V180, P871, DOI 10.1113/jphysiol.1965.sp007737; Ketten DR, 2000, SPR HDB AUD, V12, P43; Medwin H., 1998, FUNDAMENTALS ACOUSTI; MOROZOV VP, 1972, BIOFIZIKA+, V17, P139; PENNER RH, 1988, ANIMAL SONAR PROCESS, P707; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; Ridgway SH, 2001, J EXP BIOL, V204, P3829; SIMMONS JA, 1992, J ACOUST SOC AM, V91, P1150, DOI 10.1121/1.402641; SUGA N, 1975, J EXP BIOL, V62, P277; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3	17	134	143	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2003	423	6942					861	863		10.1038/nature01727	http://dx.doi.org/10.1038/nature01727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815429				2022-12-01	WOS:000183585300043
J	Bignall, J				Bignall, J			Monkeying with Shakespeare	LANCET			English	Editorial Material																		Bignall J, 1999, LANCET, V353, P610, DOI 10.1016/S0140-6736(99)00058-6; Bignall J, 2002, LANCET, V360, P504, DOI 10.1016/S0140-6736(02)09761-1; HUXLEY TH, 1862, LANCET, V1, P166; LISTER S, 2003, TIMES           0509, P3; SHAPIRO RD, 1986, ORIGINS SKEPTICS GUI, P169	5	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2004	2004						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814709				2022-12-01	WOS:000183488900006
J	Ford, N				Ford, N			Public health and company wealth	BRITISH MEDICAL JOURNAL			English	Article									Med Sans Frontieres, London EC1N 8QX, England	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, London EC1N 8QX, England.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1296	1296		10.1136/bmj.326.7402.1296	http://dx.doi.org/10.1136/bmj.326.7402.1296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805159	Green Published			2022-12-01	WOS:000183626500023
J	Mann, E				Mann, E			Managing pain	BRITISH MEDICAL JOURNAL			English	Article									Poole Hosp NHS Trust, Poole BH21 2JB, Dorset, England; Bournemouth Univ, IHCS, Poole BH21 2JB, Dorset, England	Bournemouth University	Mann, E (corresponding author), Poole Hosp NHS Trust, Poole BH21 2JB, Dorset, England.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1320	1321		10.1136/bmj.326.7402.1320	http://dx.doi.org/10.1136/bmj.326.7402.1320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805176	Green Published			2022-12-01	WOS:000183626500039
J	Chothia, C; Gough, J; Vogel, C; Teichmann, SA				Chothia, C; Gough, J; Vogel, C; Teichmann, SA			Evolution of the protein repertoire	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; ENZYMES; PERSPECTIVE; GENOMICS; METABOLISM; BEHAVIOR; FAMILY	Most proteins have been formed by gene duplication, recombination, and divergence. Proteins of known structure can be matched to about 50% of genome sequences, and these data provide a quantitative description and can suggest hypotheses about the origins of these processes.	MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 2QH, England; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	MRC Laboratory Molecular Biology; Stanford University	Chothia, C (corresponding author), MRC, Mol Biol Lab, Struct Studies Div, Hills Rd, Cambridge CB2 2QH, England.			Teichmann, Sarah/0000-0002-6294-6366				Alves R, 2002, J MOL BIOL, V320, P751, DOI 10.1016/S0022-2836(02)00546-6; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; APIC G, IN PRESS J STRUCT FU; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; COUGH J, 2001, J MOL BIOL, V313, P903; Dandekar T, 1999, BIOCHEM J, V343, P115, DOI 10.1042/0264-6021:3430115; HOROWITZ N. H., 1965, P15; Huynen MA, 1998, MOL BIOL EVOL, V15, P583, DOI 10.1093/oxfordjournals.molbev.a025959; Jardine O, 2002, GENOME RES, V12, P916, DOI 10.1101/gr.228002; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Koonin EV., 2003, SEQUENCE EVOLUTION F; Kuznetsov VA, 2002, J BIOL SYST, V10, P381, DOI 10.1142/S0218339002000767; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Muller A, 2002, GENOME RES, V12, P1625, DOI 10.1101/gr.221202; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; PERUTZ MF, 1965, J MOL BIOL, V13, P669, DOI 10.1016/S0022-2836(65)80134-6; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Riley M, 2000, ANNU REV MICROBIOL, V54, P341, DOI 10.1146/annurev.micro.54.1.341; Rison SCG, 2002, J MOL BIOL, V318, P911, DOI 10.1016/S0022-2836(02)00140-7; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; Teichmann SA, 2001, J MOL BIOL, V311, P693, DOI 10.1006/jmbi.2001.4912; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; VOGEL C, UNPUB; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Wolf YI, 1999, GENOME RES, V9, P17; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957	31	383	400	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1701	1703		10.1126/science.1085371	http://dx.doi.org/10.1126/science.1085371			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805536				2022-12-01	WOS:000183459700037
J	Vaudry, D; Falluel-Morel, A; Leuillet, S; Vaudry, H; Gonzalez, BJ				Vaudry, D; Falluel-Morel, A; Leuillet, S; Vaudry, H; Gonzalez, BJ			Regulators of cerebellar granule cell development act through specific signaling pathways	SCIENCE			English	Editorial Material							GROWTH-FACTOR-I; APOPTOSIS; NEURONS; DEATH; DEPOLARIZATION; INVOLVEMENT; INDUCTION; POTASSIUM; SURVIVAL; MANNER	The proper development of the central nervous system depends upon a finely tuned balance between cell proliferation and programmed cell death (PCD). Although PCD was initially believed to depend solely on the inability of certain neurons to obtain access to a limited supply of trophic factors, it has become apparent that the local production of death signals is also critical. In this Viewpoint, we discuss several pathways implicated in the survival of cerebellar granule cells-both pathways that protect from apoptosis and pathways that promote apoptosis-and describe how these disparate pathways converge on the final common mediators of PCD. Information on other important pathways implicated in granule cell survival may be found in the Connections Maps.	Univ Rouen, INSERM,U413, European Inst Peptide Res IFRMP 23, Lab Cellular & Mol Neuroendocrinol, F-76821 Mont St Aignan, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Vaudry, D (corresponding author), Univ Rouen, INSERM,U413, European Inst Peptide Res IFRMP 23, Lab Cellular & Mol Neuroendocrinol, F-76821 Mont St Aignan, France.		VAUDRY, David/M-1454-2018; Gonzalez, Bruno/E-6103-2016	VAUDRY, David/0000-0003-3567-7452; Gonzalez, Bruno/0000-0002-7176-1320; Anthony, FALLUEL-MOREL/0000-0002-4081-6704				ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Armstrong RC, 1997, J NEUROSCI, V17, P553; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Chen RW, 1999, J NEUROSCI, V19, P9654; Chen RW, 2003, J NEUROCHEM, V84, P566, DOI 10.1046/j.1471-4159.2003.01548.x; Chrysis D, 2001, J NEUROSCI, V21, P1481, DOI 10.1523/JNEUROSCI.21-05-01481.2001; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; deLuca A, 1996, J NEUROSCI, V16, P4174; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lafon-Cazal M, 2002, EUR J NEUROSCI, V16, P575, DOI 10.1046/j.1460-9568.2002.02124.x; LEUILLET S, 2003, SCI STKE; Linseman DA, 2002, J NEUROSCI, V22, P9287; Luo J, 2003, J BIOL CHEM, V278, P4542, DOI 10.1074/jbc.M208295200; Marx J, 2001, SCIENCE, V293, P2192, DOI 10.1126/science.293.5538.2192; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; PEARSON H, 1992, EUR J NEUROSCI, V4, P1369, DOI 10.1111/j.1460-9568.1992.tb00162.x; Persengiev SP, 2001, J STEROID BIOCHEM, V77, P151, DOI 10.1016/S0960-0760(01)00037-1; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Skaper SD, 1998, J NEUROCHEM, V70, P1859, DOI 10.1046/j.1471-4159.1998.70051859.x	20	51	52	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1532	1534		10.1126/science.1085260	http://dx.doi.org/10.1126/science.1085260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791981				2022-12-01	WOS:000183333100041
J	Amieva, MR; Vogelmann, R; Covacci, A; Tompkins, LS; Nelson, WJ; Falkow, S				Amieva, MR; Vogelmann, R; Covacci, A; Tompkins, LS; Nelson, WJ; Falkow, S			Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA	SCIENCE			English	Article							TYROSINE PHOSPHORYLATION; PATHOGENICITY ISLAND; IN-VIVO; CELLS; PROTEIN; TRANSLOCATION; PHOSPHATASE; INFECTION; INDUCTION; STRAINS	Helicobacter pylori translocates the protein CagA into gastric epithelial cells and has been linked to peptic ulcer disease and gastric carcinoma. We show that injected CagA associates with the epithelial tight-junction scaffolding protein ZO-1 and the transmembrane protein junctional adhesion molecule, causing an ectopic assembly of tight-junction components at sites of bacterial attachment, and altering the composition and function of the apical-junctional complex. Long-term CagA delivery to polarized epithelia caused a disruption of the epithelial barrier function and dysplastic alterations in epithelial cell morphology. CagA appears to target H. pylori to host cell intercellular junctions and to disrupt junction-mediated functions.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Ist Ric Immunobiol Siena Chiron Vaccines, I-53100 Siena, Italy	Stanford University; Stanford University; Stanford University; Stanford University; Novartis	Amieva, MR (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.		Amieva, Manuel/U-2581-2017	Amieva, Manuel/0000-0002-5601-4490	NATIONAL CANCER INSTITUTE [R01CA092229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA092229, CA92229] Funding Source: Medline; NIAID NIH HHS [R01 AI038459, AI38459] Funding Source: Medline; NIDCD NIH HHS [DDC DK56339] Funding Source: Medline; NIDDK NIH HHS [P30 DK056339] Funding Source: Medline; NIGMS NIH HHS [R01GM35227, R01 GM035527] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMIEVA MR, UNPUB; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BLASER MJ, 1995, CANCER RES, V55, P2111; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Collares-Buzato CB, 1998, EUR J CELL BIOL, V76, P85, DOI 10.1016/S0171-9335(98)80020-4; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Papini E, 1998, J CLIN INVEST, V102, P813, DOI 10.1172/JCI2764; Peek RM, 1995, LAB INVEST, V73, P760; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; STEER HW, 1984, GUT, V25, P1203, DOI 10.1136/gut.25.11.1203; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088	22	569	598	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1430	1434		10.1126/science.1081919	http://dx.doi.org/10.1126/science.1081919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775840	Green Accepted			2022-12-01	WOS:000183181800045
J	Ohashi, Y; Oka, A; Rodrigues-Pousada, R; Possenti, M; Ruberti, I; Morelli, G; Aoyama, T				Ohashi, Y; Oka, A; Rodrigues-Pousada, R; Possenti, M; Ruberti, I; Morelli, G; Aoyama, T			Modulation of phospholipid signaling by GLABRA2 in root-hair pattern formation	SCIENCE			English	Article							CELL-DIFFERENTIATION; TRANSGENIC PLANTS; ARABIDOPSIS ROOT; GENE-EXPRESSION; EPIDERMIS; PROTEIN; FAMILY	The root-hair pattern of Arabidopsis is determined through a regulatory circuit composed of transcription factor genes. The homeobox gene GLABRA2 (GL2) has been considered a key component, acting farthest downstream in this regulation. GL2 modified to include a transactivating function caused epidermal cells to develop ectopic root hairs or root hair-like structures. With this system, the phospholipase Dzeta1 gene (AtPLDzeta1) was identified as a direct target of GL2. Inducible expression of AtPLDzeta1 promoted ectopic root-hair initiation. We conclude that GL2 exerts its regulatory effect on root-hair development through modulation of phospholipid signaling.	Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; Ist Nazl Ric Alimenti & Nutr, I-00178 Rome, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Ctr Studio Acidi Nucl, I-00185 Rome, Italy	Kyoto University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sapienza University Rome	Aoyama, T (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.		Morelli, Giorgio/A-5559-2016; Morelli, Giorgio/P-3334-2019; Ohashi, Yohei/AAT-4006-2021	Morelli, Giorgio/0000-0002-8994-4838; Morelli, Giorgio/0000-0002-8994-4838; Ohashi, Yohei/0000-0002-2288-130X; Possenti, Marco/0000-0001-6707-3245; RODRIGUES POUSADA, Renato Alberto/0000-0003-2551-4705				Abe M, 2001, PLANT J, V26, P487, DOI 10.1046/j.1365-313x.2001.01047.x; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Dolan L, 2001, CURR OPIN PLANT BIOL, V4, P550, DOI 10.1016/S1369-5266(00)00214-4; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Hung CY, 1998, PLANT PHYSIOL, V117, P73, DOI 10.1104/pp.117.1.73; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; RODRIGUESPOUSAD.R, UNPUB; Schiefelbein JW, 2000, PLANT PHYSIOL, V124, P1525, DOI 10.1104/pp.124.4.1525; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wang XM, 2000, PROG LIPID RES, V39, P109, DOI 10.1016/S0163-7827(00)00002-3; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	20	211	235	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1427	1430		10.1126/science.1083695	http://dx.doi.org/10.1126/science.1083695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775839				2022-12-01	WOS:000183181800044
J	Rota, PA; Oberste, MS; Monroe, SS; Nix, WA; Campagnoli, R; Icenogle, JP; Penaranda, S; Bankamp, B; Maher, K; Chen, MH; Tong, SX; Tamin, A; Lowe, L; Frace, M; DeRisi, JL; Chen, Q; Wang, D; Erdman, DD; Peret, TCT; Burns, C; Ksiazek, TG; Rollin, PE; Sanchez, A; Liffick, S; Holloway, B; Limor, J; McCaustland, K; Olsen-Rasmussen, M; Fouchier, R; Gunther, S; Osterhaus, ADME; Drosten, C; Pallansch, MA; Anderson, LJ; Bellini, WJ				Rota, PA; Oberste, MS; Monroe, SS; Nix, WA; Campagnoli, R; Icenogle, JP; Penaranda, S; Bankamp, B; Maher, K; Chen, MH; Tong, SX; Tamin, A; Lowe, L; Frace, M; DeRisi, JL; Chen, Q; Wang, D; Erdman, DD; Peret, TCT; Burns, C; Ksiazek, TG; Rollin, PE; Sanchez, A; Liffick, S; Holloway, B; Limor, J; McCaustland, K; Olsen-Rasmussen, M; Fouchier, R; Gunther, S; Osterhaus, ADME; Drosten, C; Pallansch, MA; Anderson, LJ; Bellini, WJ			Characterization of a novel coronavirus associated with severe acute respiratory syndrome	SCIENCE			English	Article							TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS; TARGETED RECOMBINATION; SPIKE GENE; VIRUS; DETERMINANT; ENTRY	In March 2003, a novel coronavirus (SARS-CoV) was discovered in association with cases of severe acute respiratory syndrome (SARS). The sequence of the complete genome of SARS-CoV was determined, and the initial characterization of the viral genome is presented in this report. The genome of SARS-CoV is 29,727 nucleotides in length and has 11 open reading frames, and its genome organization is similar to that of other coronaviruses. Phylogenetic analyses and sequence comparisons showed that SARS-CoV is not closely related to any of the previously characterized coronaviruses.	Ctr Dis Control, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA; Erasmus Univ, Dept Virol, NL-3000 DR Rotterdam, Netherlands; Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Erasmus University Rotterdam; Bernhard Nocht Institut fur Tropenmedizin	Rota, PA (corresponding author), Ctr Dis Control, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.	prota@cdc.gov	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Campagnoli, Ray/0000-0003-0531-3893; Guan, Yi/0000-0001-6057-9243; Gunther, Stephan/0000-0002-6562-0230; Monroe, Stephan/0000-0002-5424-716X; Rollin, Pierre/0000-0002-4608-2641; Osterhaus, Albert/0000-0002-6074-1172				Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V52, P357; de Haan CAM, 2002, VIRUS RES, V82, P77; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; DROSTEN C, 2003, N ENGL J MED    0417; Escors D, 2001, J VIROL, V75, P1312, DOI 10.1128/JVI.75.3.1312-1324.2001; Fauquet C.M., 2000, VIRUS TAXONOMY CLASS, P835; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; HOLMES KV, 2001, FIELDS VIROLOGY, pCH36; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LAI MMC, 2001, FIELDS VIROLOGY, pCH35; LEE N, 2003, N ENGL J MED    0417; Leparc-Goffart I, 1998, J VIROL, V72, P9628, DOI 10.1128/JVI.72.12.9628-9636.1998; LIU DX, 1992, J VIROL, V66, P6143, DOI 10.1128/JVI.66.10.6143-6154.1992; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POUTANEN SM, 2003, N ENGL J MED    0417; Sanchez CM, 1999, J VIROL, V73, P7607; Sawicki SG, 1998, ADV EXP MED BIOL, V440, P215; Siddell S, 1995, CORONAVIRIDAE; THIEL V, 1994, J GEN VIROL, V75, P3041, DOI 10.1099/0022-1317-75-11-3041; TSANG KW, 2003, N ENGL J MED    0417; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	23	1875	2201	4	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2003	300	5624					1394	1399		10.1126/science.1085952	http://dx.doi.org/10.1126/science.1085952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12730500				2022-12-01	WOS:000183181800035
J	Zavialov, AV; Berglund, J; Pudney, AF; Fooks, LJ; Ibrahim, TM; MacIntyre, S; Knight, SD				Zavialov, AV; Berglund, J; Pudney, AF; Fooks, LJ; Ibrahim, TM; MacIntyre, S; Knight, SD			Structure and biogenesis of the capsular F1 antigen from Yersinia pestis: Preserved folding energy drives fiber formation	CELL			English	Article							PILUS BIOGENESIS; MACROMOLECULAR STRUCTURES; CHAPERONE FUNCTION; ESCHERICHIA-COLI; CAF1M; CRYSTALLOGRAPHY; REFINEMENT; PROTEINS; SURFACE; BINDING	Most gram-negative pathogens express fibrous adhesive virulence organelles that mediate targeting to the sites of infection. The F1 capsular antigen from the plague pathogen Yersinia pestis consists of linear fibers of a single subunit (Caf1) and serves as a prototype for nonpilus organelles assembled via the chaperone/usher pathway. Genetic data together with high-resolution X-ray structures corresponding to snapshots of the assembly process reveal the structural basis of fiber formation. Comparison of chaperone bound Caf1 subunit with the subunit in the fiber reveals a novel type of conformational change involving the entire hydrophobic core of the protein. The observed conformational change suggests that the chaperone traps a high-energy folding intermediate of Caf1. A model is proposed in which release of the subunit allows folding to be completed, driving fiber formation.	Univ Reading, Sch Anim & Microbial Sci, Div Microbiol, Reading RG6 6AJ, Berks, England; Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biosci Struct Biol, SE-75124 Uppsala, Sweden	University of Reading; Swedish University of Agricultural Sciences	MacIntyre, S (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Div Microbiol, Reading RG6 6AJ, Berks, England.		Zavialov, Anton V./C-7664-2015; Knight, Stefan/D-4315-2015	Zavialov, Anton V./0000-0001-6191-5931; Knight, Stefan/0000-0002-7180-8758				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCP4, 1994, ACTA CRYSTALLOGR D, V50, P780; Chapman DAG, 1999, J BACTERIOL, V181, P2422, DOI 10.1128/JB.181.8.2422-2429.1999; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; ESHDAT Y, 1981, J BACTERIOL, V148, P308, DOI 10.1128/JB.148.1.308-314.1981; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Hung DL, 1996, EMBO J, V15, P3792, DOI 10.1002/j.1460-2075.1996.tb00753.x; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Knight SD, 2000, CURR OPIN CHEM BIOL, V4, P653, DOI 10.1016/S1367-5931(00)00144-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; MacIntyre S, 2001, MOL MICROBIOL, V39, P12, DOI 10.1046/j.1365-2958.2001.02199.x; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Soto GE, 1998, EMBO J, V17, P6155, DOI 10.1093/emboj/17.21.6155; Thanassi DG, 1998, CURR OPIN MICROBIOL, V1, P223, DOI 10.1016/S1369-5274(98)80015-5; Thanassi DG, 2002, J BACTERIOL, V184, P6260, DOI 10.1128/JB.184.22.6260-6269.2002; Titball RW, 2001, VACCINE, V19, P4175, DOI 10.1016/S0264-410X(01)00163-3; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Zavialov A, 2003, ACTA CRYSTALLOGR D, V59, P359, DOI 10.1107/S0907444902021054; Zavialov AV, 2002, MOL MICROBIOL, V45, P983, DOI 10.1046/j.1365-2958.2002.03066.x; ZavYalov VP, 1997, BIOCHEM J, V324, P571, DOI 10.1042/bj3240571	33	213	229	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					587	596		10.1016/S0092-8674(03)00351-9	http://dx.doi.org/10.1016/S0092-8674(03)00351-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787500	Bronze			2022-12-01	WOS:000183397600009
J	Puigserver, P; Rhee, J; Donovan, J; Walkey, CJ; Yoon, JC; Oriente, F; Kitamura, Y; Altomonte, J; Dong, HJ; Accili, D; Spiegelman, BM				Puigserver, P; Rhee, J; Donovan, J; Walkey, CJ; Yoon, JC; Oriente, F; Kitamura, Y; Altomonte, J; Dong, HJ; Accili, D; Spiegelman, BM			Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1 alpha interaction	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; CARBOXYKINASE GTP GENE; PROTEIN-KINASE-B; PHOSPHOENOLPYRUVATE CARBOXYKINASE; COACTIVATOR PGC-1; FACTOR FOXO1; FACTOR FKHR; EXPRESSION; BETA; PHOSPHORYLATION	Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis(1-3). Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Mt Sinai Sch Med, Inst Human Gene Therapy & Mol Med, New York, NY 10029 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Rhee, James/V-9973-2019; ORIENTE, Francesco/J-6652-2018	Dong, H. Henry/0000-0003-0279-5241; Altomonte, Jennifer/0000-0003-1079-3633; ORIENTE, Francesco/0000-0003-4375-4526				Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Becard D, 2001, DIABETES, V50, P2425, DOI 10.2337/diabetes.50.11.2425; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rossetti L, 1996, J BIOL CHEM, V271, P203, DOI 10.1074/jbc.271.1.203; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313	22	1103	1152	8	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					550	555		10.1038/nature01667	http://dx.doi.org/10.1038/nature01667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12754525	Bronze			2022-12-01	WOS:000183162900046
J	Lodowski, DT; Pitcher, JA; Capel, WD; Lefkowitz, RJ; Tesmer, JJG				Lodowski, DT; Pitcher, JA; Capel, WD; Lefkowitz, RJ; Tesmer, JJG			Keeping G proteins at bay: A complex between G protein-coupled receptor kinase 2 and G beta gamma	SCIENCE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GTPASE-ACTIVATING PROTEINS; HETEROTRIMERIC G-PROTEINS; PHOSPHOLIPASE-C-BETA; CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; G(BETA-GAMMA) SUBUNITS; STRUCTURAL BASIS; ALPHA-SUBUNITS; BINDING	The phosphorylation of heptahelical receptors by heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor kinases (GRKs) is a universal regulatory mechanism that leads to desensitization of G protein signaling and to the activation of alternative signaling pathways. We determined the crystallographic structure of bovine GRK2 in complex with G protein beta(1)gamma(2) subunits. Our results show how the three domains of GRK2-the RGS (regulator of G protein signaling) homology, protein kinase, and pleckstrin homology domains-integrate their respective activities and recruit the enzyme to the cell membrane in an orientation that not only facilitates receptor phosphorylation, but also allows for the simultaneous inhibition of signaling by Galpha and Gbetagamma subunits.	Univ Texas, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; UCL, Dept Pharmacol, MRC, Lab Mol & Cell Biol, London WC1E 6BT, England; UCL, Dept Pharmacol, Cell Biol Unit, London WC1E 6BT, England; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of Texas System; University of Texas Austin; University of London; University College London; University of London; University College London; Duke University; Duke University	Tesmer, JJG (corresponding author), Univ Texas, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	tesmer@mail.utexas.edu	Lefkowitz, Robert/AAW-2649-2021; Pitcher, Julie/ABH-2078-2020	Tesmer, John/0000-0003-1125-3727	NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; Chestukhin A, 1996, J BIOL CHEM, V271, P10175, DOI 10.1074/jbc.271.17.10175; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; DebBurman SK, 1996, J BIOL CHEM, V271, P22552, DOI 10.1074/jbc.271.37.22552; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fushman D, 1998, J BIOL CHEM, V273, P2835, DOI 10.1074/jbc.273.5.2835; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iaccarino G, 1999, P ASSOC AM PHYSICIAN, V111, P399, DOI 10.1111/paa.1999.111.5.399; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Lodowski DT, 2003, ACTA CRYSTALLOGR D, V59, P936, DOI 10.1107/S0907444903002622; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; MAHADEVAN D, 1995, BIOCHEMISTRY-US, V34, P9111, DOI 10.1021/bi00028a021; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; PAO CS, 2002, SCI STKE, pPE42; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Razzini G, 2000, J BIOL CHEM, V275, P14873, DOI 10.1074/jbc.275.20.14873; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; SHI W, 1995, J BIOL CHEM, V270, P2112, DOI 10.1074/jbc.270.5.2112; Shiina T, 2001, J BIOL CHEM, V276, P33019, DOI 10.1074/jbc.M100140200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Touhara K, 1997, FEBS LETT, V417, P243, DOI 10.1016/S0014-5793(97)01294-5; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837	58	306	318	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1256	1262		10.1126/science.1082348	http://dx.doi.org/10.1126/science.1082348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764189				2022-12-01	WOS:000183042400039
J	Yaman, I; Fernandez, J; Liu, HY; Caprara, M; Komar, AA; Koromilas, AE; Zhou, LY; Snider, MD; Scheuner, D; Kaufman, RJ; Hatzoglou, M				Yaman, I; Fernandez, J; Liu, HY; Caprara, M; Komar, AA; Koromilas, AE; Zhou, LY; Snider, MD; Scheuner, D; Kaufman, RJ; Hatzoglou, M			The zipper model of translational control: A small upstream ORF is the switch that controls structural remodeling of an mRNA leader	CELL			English	Article							RIBOSOME ENTRY SITE; MEDIATED TRANSLATION; INTERNAL INITIATION; REGION; ATTENUATION; PSEUDOKNOT; IRES	Transport of the essential amino acids arginine and lysine is critical for the survival of mammalian cells. The adaptive response to nutritional stress involves increased translation of the arginine/lysine transporter (cat-1) mRNA via an internal ribosome entry site (IRES) within the mRNA leader. Induction of cat-1 IRES activity requires both translation of a small upstream open reading frame (uORF) within the IRES and phosphorylation of the translation initiation factor eIF2alpha. We show here that translation of the upstream ORF unfolds an inhibitory structure in the mRNA leader, eliciting a conformational change that yields an active IRES. The IRES, whose activity is induced by amino acid starvation, is created by RNA-RNA interactions between the 5' end of the leader and downstream sequences. This study suggests that the structure of the IRES is dynamic and regulation of this RNA structure is a mechanism of translational control.	Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; McGill Univ, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Lady Davis Institute; McGill University; McGill University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA.	mxh8@po.cwru.edu	yaman, ibrahim/A-7192-2016	yaman, ibrahim/0000-0002-3987-1984; Komar, Anton/0000-0003-4188-0633	NIAID NIH HHS [AI42394] Funding Source: Medline; NIDDK NIH HHS [R01 DK60596-01] Funding Source: Medline; NIGMS NIH HHS [GM26796, GM62853] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026796, R01GM062853] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonnal S, 2003, NUCLEIC ACIDS RES, V31, P427, DOI 10.1093/nar/gkg003; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Fletcher SP, 2002, J VIROL, V76, P5024, DOI 10.1128/JVI.76.10.5024-5033.2002; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Garlapati S, 2002, RNA, V8, P601, DOI 10.1017/S135583820202071X; HAHN J, 1982, MOL GEN GENET, V186, P204, DOI 10.1007/BF00331851; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hyatt SL, 1997, J BIOL CHEM, V272, P19951, DOI 10.1074/jbc.272.32.19951; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; PAIN VM, 1994, BIOCHIMIE, V76, P718, DOI 10.1016/0300-9084(94)90076-0; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Rijnbrand RCA, 1996, VIROLOGY, V226, P47, DOI 10.1006/viro.1996.0626; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schlax PJ, 2001, J BIOL CHEM, V276, P38494, DOI 10.1074/jbc.M106934200; Schlegl J, 1997, RNA, V3, P1159; Vos S, 2002, BIOCHEMISTRY-US, V41, P5383, DOI 10.1021/bi0156310; WANG CY, 1995, RNA, V1, P526; Yanofsky C, 2000, J BACTERIOL, V182, P1, DOI 10.1128/JB.182.1.1-8.2000	23	167	177	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2003	113	4					519	531		10.1016/S0092-8674(03)00345-3	http://dx.doi.org/10.1016/S0092-8674(03)00345-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757712	Bronze			2022-12-01	WOS:000182981500013
J	Bansal, D; Miyake, K; Vogel, SS; Groh, S; Chen, CC; Williamson, R; McNeil, PL; Campbell, KP				Bansal, D; Miyake, K; Vogel, SS; Groh, S; Chen, CC; Williamson, R; McNeil, PL; Campbell, KP			Defective membrane repair in dysferlin-deficient muscular dystrophy	NATURE			English	Article							MIYOSHI MYOPATHY; SKELETAL-MUSCLE; GENE; EXOCYTOSIS; EXPRESSION; COMPLEX; ACCUMULATION; DISRUPTIONS; MECHANISM; PROTEINS	Muscular dystrophy includes a diverse group of inherited muscle diseases characterized by wasting and weakness of skeletal muscle(1). Mutations in dysferlin are linked to two clinically distinct muscle diseases, limb-girdle muscular dystrophy type 2B and Miyoshi myopathy, but the mechanism that leads to muscle degeneration is unknown(2,3). Dysferlin is a homologue of the Caenorhabditis elegans fer-1 gene, which mediates vesicle fusion to the plasma membrane in spermatids(4). Here we show that dysferlin-null mice maintain a functional dystrophin glycoprotein complex but nevertheless develop a progressive muscular dystrophy. In normal muscle, membrane patches enriched in dysferlin can be detected in response to sarcolemma injuries. In contrast, there are sub-sarcolemmal accumulations of vesicles in dysferlin-null muscle. Membrane repair assays with a two-photon laser-scanning microscope demonstrated that wildtype muscle fibres efficiently reseal their sarcolemma in the presence of Ca2+. Interestingly, dysferlin-deficient muscle fibres are defective in Ca2+-dependent sarcolemma resealing. Membrane repair is therefore an active process in skeletal muscle fibres, and dysferlin has an essential role in this process. Our findings show that disruption of the muscle membrane repair machinery is responsible for dysferlin-deficient muscle degeneration, and highlight the importance of this basic cellular mechanism of membrane resealing in human disease.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; NIAAA, Lab Mol Physiol, NIH, Rockville, MD 20852 USA; Univ Iowa, Coll Med, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Vogel, Steven/A-3585-2012; Chen, Chien-Chang/D-2023-2015	Chen, Chien-Chang/0000-0001-8850-4278; Vogel, Steven/0000-0002-3005-2667; Campbell, Kevin/0000-0003-2066-5889	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000452, Z01AA000452] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Achanzar WE, 1997, J CELL SCI, V110, P1073; Anderson LVB, 2000, NEUROMUSCULAR DISORD, V10, P553, DOI 10.1016/S0960-8966(00)00143-7; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; CLARKE MSF, 1993, J CELL SCI, V106, P121; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.3.CO;2-K; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; McNeil PL, 2000, J CELL SCI, V113, P1891; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375	27	701	727	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					168	172		10.1038/nature01573	http://dx.doi.org/10.1038/nature01573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736685				2022-12-01	WOS:000182699600046
J	Yang, WY; Gruebele, M				Yang, WY; Gruebele, M			Folding at the speed limit	NATURE			English	Article							UNFOLDED CYTOCHROME-C; MICROSCOPIC THEORY; CONTACT FORMATION; LAMBDA-REPRESSOR; KINETICS; DYNAMICS; DIFFUSION; PROTEINS; RATES	Many small proteins seem to fold by a simple process explicable by conventional chemical kinetics and transition-state theory. This assumes an instant equilibrium between reactants and a high-energy activated state(1). In reality, equilibration occurs on timescales dependent on the molecules involved, below which such analyses break down(1). The molecular timescale, normally too short to be seen in experiments, can be of a significant length for proteins. To probe it directly, we studied very rapidly folding mutants of the five-helix bundle protein lambda(6-85), whose activated state is significantly populated during folding. A time-dependent rate coefficient below 2 mus signals the onset of the molecular timescale, and hence the ultimate speed limit for folding(2). A simple model shows that the molecular timescale represents the natural pre-factor for transition state models of folding.	Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gruebele, M (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.		Yang, Wei Yuan/B-4474-2011					Berne B. J., 1993, ACTIVATED BARRIER CR, P82; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Burton RE, 1997, NAT STRUCT BIOL, V4, P305, DOI 10.1038/nsb0497-305; Chang IJ, 2003, P NATL ACAD SCI USA, V100, P3838, DOI 10.1073/pnas.0637283100; Ervin J, 2000, J PHOTOCH PHOTOBIO B, V54, P1, DOI 10.1016/S1011-1344(00)00002-6; Garcia-Mira MM, 2002, SCIENCE, V298, P2191, DOI 10.1126/science.1077809; Ghaemmaghami S, 1998, BIOCHEMISTRY-US, V37, P9179, DOI 10.1021/bi980356b; Gruebele M, 1998, ACCOUNTS CHEM RES, V31, P699, DOI 10.1021/ar970083x; Hagen SJ, 1997, J PHYS CHEM B, V101, P2352, DOI 10.1021/jp9622997; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Metzler R, 1999, P NATL ACAD SCI USA, V96, P11085, DOI 10.1073/pnas.96.20.11085; Myers JK, 1999, BIOCHEMISTRY-US, V38, P6761, DOI 10.1021/bi990088x; Pappenberger G, 2000, P NATL ACAD SCI USA, V97, P17, DOI 10.1073/pnas.97.1.17; Portman JJ, 2001, J CHEM PHYS, V114, P5082, DOI 10.1063/1.1334663; Portman JJ, 2001, J CHEM PHYS, V114, P5069, DOI 10.1063/1.1334662; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Silow M, 1997, BIOCHEMISTRY-US, V36, P7633, DOI 10.1021/bi970210x; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Thirumalai D, 1999, J PHYS CHEM B, V103, P608, DOI 10.1021/jp982362n; Yeh IC, 2002, J AM CHEM SOC, V124, P6563, DOI 10.1021/ja025789n	24	360	364	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					193	197		10.1038/nature01609	http://dx.doi.org/10.1038/nature01609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736690				2022-12-01	WOS:000182699600052
J	Tabar, L; Yen, MF; Vitak, B; Chen, HHT; Smith, RA; Duffy, SW				Tabar, L; Yen, MF; Vitak, B; Chen, HHT; Smith, RA; Duffy, SW			Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening	LANCET			English	Article							ALL-CAUSE MORTALITY; SWEDISH RANDOMIZED TRIALS; AGED 40-49 YEARS; CARCINOMA MORTALITY; 2 COUNTY; PROGRAM; UPDATE	Background The long term effect of mammographic service screening is not well established. We aimed to assess the long-term effect of mammographic screening on death from breast cancer, taking into account potential biases from self-selection, changes in breast cancer incidence, and classification of cause of death. Methods We compared deaths from breast cancer diagnosed in the 20 years before screening was introduced (1958-77) with those from breast cancer diagnosed in the 20 years after the introduction of screening (1978-97) in two Swedish counties, in 210 000 women aged 20-69 years. We also compared deaths from all cancers and from all causes in patients diagnosed with breast cancer in the 20 years before and after screening was introduced. In the analysis, data were stratified into age-groups invited for screening (40-69 years) and not invited (20-39 years), and by whether or not the women had actually received screening. We also analysed mortality for the 40-49-year age-group separately. Findings The unadjusted risk of death from breast cancer dropped significantly in the second screening period compared with the first in women aged 40-69 years (relative risk [RR] 0.77 [95% Cl 0.7-0.85]; p<0.0001). No such decline was seen in 20-39 year olds. After adjustment for age, self-selection bias, and changes in breast-cancer incidence in the 40-69 years age-group, breast-cancer mortality was reduced in women who were screened (0.56; 0.49-0.64 p<0.0001), in those who were not screened (0.84 [0.71-0.09]; p=0.03), and in screened and unscreened women combined (0.59 [0.53-0.66]; p<0.0001). After adjustment for age, self-selection bias, and changes in incidence in the 40-49-year age-group, deaths from breast cancer fell significantly in those who were screened (0.52 [0.4-0.67]; p<0.0001); and in all women, screened and unscreened combined (0.55 [0.44-0.7] p<0.0001) but not in unscreened women (p=0.2). In both 40-69-year and 40-49-year age-groups, reductions in deaths from all cancers and from all-causes in women with breast cancer were consistent with these results. Interpretation Taking account of potential biases, changes in clinical practice and changes in the incidence of breast cancer, mammography screening is contributing to substantial reductions in breast cancer mortality in these two Swedish counties.	Queen Mary Univ London, Wolfson Inst Prevent Med, Canc Res UK Dept Epidemiol Math & Stat, London EC1M 6BQ, England; Cent Hosp Falun, Dept Mammog, Falun, Sweden; UCL, Dept Stat Sci, London WC1E 6BT, England; Linkoping Univ Hosp, Dept Med Radiol, S-58185 Linkoping, Sweden; Natl Taiwan Univ, Grad Inst Prevent Med, Taipei 10764, Taiwan; Amer Canc Soc, Atlanta, GA 30329 USA	Cancer Research UK; University of London; Queen Mary University London; Falun Hospital; University of London; University College London; Linkoping University; National Taiwan University; American Cancer Society	Duffy, SW (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Canc Res UK Dept Epidemiol Math & Stat, Charterhouse Sq, London EC1M 6BQ, England.	stephen.duffy@cancer.org.uk	Tabar, Laszlo Kornel/AGT-3287-2022	Chen, Hsiu-Hsi/0000-0002-5799-6705				Andersson I, 1997, J Natl Cancer Inst Monogr, P63; Antman K, 1999, JAMA-J AM MED ASSOC, V281, P1470, DOI 10.1001/jama.281.16.1470; Berry DA, 1998, BREAST IMAGING, P23, DOI 10.3233/BD-1998-103-405; Bjurstam N, 1997, CANCER, V80, P2091, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.3.CO;2-F; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Breslow NE, 1987, STAT METHODS CANC RE; Chen HH, 1997, J EPIDEMIOL BIOSTAT, V2, P25; Chen T., 1997, J EPIDEMIOL BIOSTAT, P9; Church TR, 2002, J NATL CANCER I, V94, P861, DOI 10.1093/jnci/94.11.861; Dickersin K, 1999, LANCET, V353, P1896, DOI 10.1016/S0140-6736(99)90074-0; DUFFY SW, 1991, BRIT J CANCER, V64, P1133, DOI 10.1038/bjc.1991.477; Duffy SW, 2002, CANCER-AM CANCER SOC, V95, P458, DOI 10.1002/cncr.10765; Duffy SW, 2002, APPL STAT, V51, P234; Gail MH, 2002, J NATL CANCER I, V94, P862, DOI 10.1093/jnci/94.11.862; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Jonsson H, 2001, J MED SCREEN, V8, P152, DOI 10.1136/jms.8.3.152; Lagerlund M, 2000, EUR J CANCER PREV, V9, P25, DOI 10.1097/00008469-200002000-00004; Lenner P, 1997, J Med Screen, V4, P6; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Paci E, 2002, BRIT J CANCER, V87, P65, DOI 10.1038/sj.bjc.6600301; RINGASH J, 2001, CMAJ, V16, P469; Rostgaard K, 2001, STAT MED, V20, P47, DOI 10.1002/1097-0258(20010115)20:1<47::AID-SIM613>3.0.CO;2-5; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; Tabar L, 2002, J MED SCREEN, V9, P159, DOI 10.1136/jms.9.4.159; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; Tabar L, 2001, CANCER-AM CANCER SOC, V91, P1724, DOI 10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V; Tornberg S, 1994, J Med Screen, V1, P184	32	498	515	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2003	361	9367					1405	1410		10.1016/S0140-6736(03)13143-1	http://dx.doi.org/10.1016/S0140-6736(03)13143-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727392				2022-12-01	WOS:000182516300007
J	Calarese, DA; Scanlan, CN; Zwick, MB; Deechongkit, S; Mimura, Y; Kunert, R; Zhu, P; Wormald, MR; Stanfield, RL; Roux, KH; Kelly, JW; Rudd, PM; Dwek, RA; Katinger, H; Burton, DR; Wilson, IA				Calarese, DA; Scanlan, CN; Zwick, MB; Deechongkit, S; Mimura, Y; Kunert, R; Zhu, P; Wormald, MR; Stanfield, RL; Roux, KH; Kelly, JW; Rudd, PM; Dwek, RA; Katinger, H; Burton, DR; Wilson, IA			Antibody domain exchange is an immunological solution to carbohydrate cluster recognition	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; HIV-INACTIVATING PROTEIN; CD4 BINDING-SITE; CYANOVIRIN-N; CRYSTAL-STRUCTURE; DC-SIGN; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; STRUCTURAL BASIS	Human antibody 2G12 neutralizes a broad range of human immunodeficiency virus type 1( HIV-1) isolates by binding an unusually dense cluster of carbohydrate moieties on the "silent" face of the gp120 envelope glycoprotein. Crystal structures of Fab 2G12 and its complexes with the disaccharide Manalpha1-2Man and with the oligosaccharide Man 9 GlcNAc 2 revealed that two Fabs assemble into an interlocked V-H domain-swapped dimer. Further biochemical, biophysical, and mutagenesis data strongly support a Fab-dimerized antibody as the prevalent form that recognizes gp120. The extraordinary configuration of this antibody provides an extended surface, with newly described binding sites, for multivalent interaction with a conserved cluster of oligomannose type sugars on the surface of gp120. The unique interdigitation of Fab domains within an antibody uncovers a previously unappreciated mechanism for high-affinity recognition of carbohydrate or other repeating epitopes on cell or microbial surfaces.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England; Univ Bodenkultur Wien, Inst Appl Microbiol, A-1180 Vienna, Austria; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Oxford; University of Natural Resources & Life Sciences, Vienna; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	burton@scripps.edu; wilson@scripps.edu	Stanfield, Robyn/AAH-3190-2019; Wormald, Mark R/G-2785-2011; Kunert, Renate E/B-9185-2018	Wormald, Mark R/0000-0002-4853-2773; Kunert, Renate E/0000-0002-3397-3621	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R37AI033292] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33292] Funding Source: Medline; NIGMS NIH HHS [GM46192] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrientos LG, 2002, BIOCHEM BIOPH RES CO, V298, P598, DOI 10.1016/S0006-291X(02)02489-0; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Carrasco B, 2001, BIOPHYS CHEM, V93, P181, DOI 10.1016/S0301-4622(01)00220-4; Chang LC, 2002, J MOL BIOL, V318, P1, DOI 10.1016/S0022-2836(02)00045-1; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Ferrantelli F, 2002, CURR OPIN IMMUNOL, V14, P495, DOI 10.1016/S0952-7915(02)00362-X; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; Hong PWP, 2002, J VIROL, V76, P12855, DOI 10.1128/JVI.76.24.12855-12865.2002; Kabat EA, 1991, SEQUENCES PROTEINS I, V5th; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; O'Keefe BR, 2000, MOL PHARMACOL, V58, P982, DOI 10.1124/mol.58.5.982; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; PETRESCU AJ, UNPUB; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; Ragupathi G, 2002, P NATL ACAD SCI USA, V99, P13699, DOI 10.1073/pnas.202427599; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; SCANLON CN, UNPUB; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Thomas R, 2002, J BIOL CHEM, V277, P2059, DOI 10.1074/jbc.M104364200; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Weis WI, 1997, CURR OPIN STRUC BIOL, V7, P624, DOI 10.1016/S0959-440X(97)80070-X; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; WILSON IA, 1995, NAT STRUCT BIOL, V2, P433, DOI 10.1038/nsb0695-433; Woods RJ, 1998, EUR J BIOCHEM, V258, P372, DOI 10.1046/j.1432-1327.1998.2580372.x; Wormald MR, 2002, CHEM REV, V102, P371, DOI 10.1021/cr990368i; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Zinkernagel RM, 2001, ADV IMMUNOL, V79, P1, DOI 10.1016/S0065-2776(01)79001-3; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	58	639	724	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2065	2071		10.1126/science.1083182	http://dx.doi.org/10.1126/science.1083182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829775				2022-12-01	WOS:000183774900038
J	Mitrofanov, IG; Zuber, MT; Litvak, ML; Boynton, WV; Smith, DE; Drake, D; Hamara, D; Kozyrev, AS; Sanin, AB; Shinohara, C; Saunders, RS; Tretyakov, V				Mitrofanov, IG; Zuber, MT; Litvak, ML; Boynton, WV; Smith, DE; Drake, D; Hamara, D; Kozyrev, AS; Sanin, AB; Shinohara, C; Saunders, RS; Tretyakov, V			CO2 snow depth and subsurface water-ice abundance in the northern hemisphere of Mars	SCIENCE			English	Article							SUMMER TEMPERATURES; ORBITER CAMERA; POLAR-CAP; EVOLUTION; FROST; HYDROGEN; NEUTRONS; BEHAVIOR; DETECTOR; SURFACE	Observations of seasonal variations of neutron flux from the high-energy neutron detector (HEND) on Mars Odyssey combined with direct measurements of the thickness of condensed carbon dioxide by the Mars Orbiter Laser Altimeter (MOLA) on Mars Global Surveyor show a latitudinal dependence of northern winter deposition of carbon dioxide. The observations are also consistent with a shallow substrate consisting of a layer with water ice overlain by a layer of drier soil. The lower ice-rich layer contains between 50 and 75 weight % water, indicating that the shallow subsurface at northern polar latitudes on Mars is even more water rich than that in the south.	Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; NASA, Terr Phys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Tech Source, Santa Fe, NM 87505 USA; NASA Headquarters, Washington, DC 20514 USA	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Massachusetts Institute of Technology (MIT); University of Arizona; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA)	Mitrofanov, IG (corresponding author), Russian Acad Sci, Space Res Inst, Moscow 117997, Russia.		Litvak, Maxim/C-6453-2017; Sanin, Anton/T-9393-2017	Mitrofanov, Igor/0000-0001-7204-2101				BIEMANN K, 1979, J MOL EVOL, V14, P65, DOI 10.1007/BF01732368; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; BOYNTON WV, IN PRESS SPACE SCI R; Carr M.H, 1996, WATER MARS; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; DRAKE DM, 1988, J GEOPHYS RES-SOLID, V93, P6353, DOI 10.1029/JB093iB06p06353; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; FELDMAN WC, 1993, J GEOPHYS RES-PLANET, V98, P20855, DOI 10.1029/93JE02325; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Jakosky B. M., 1992, MARS, P969; JAKOSKY BM, 1982, J GEOPHYS RES, V87, P2999, DOI 10.1029/JB087iB04p02999; James P.B., 1992, MARS, P934; James PB, 2001, ICARUS, V154, P131, DOI 10.1006/icar.2001.6653; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Masarik J, 1996, J GEOPHYS RES-PLANET, V101, P18891, DOI 10.1029/96JE01563; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Smith DE, 2001, SCIENCE, V294, P2141, DOI 10.1126/science.1066556; Squyres S. W., 1992, MARS, P523; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; WATERS L, 1999, LAUR996058 LOS AL NA; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341	28	60	60	4	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2081	2084		10.1126/science.1084350	http://dx.doi.org/10.1126/science.1084350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829779				2022-12-01	WOS:000183774900042
J	Noh, B; Bandyopadhyay, A; Peer, WA; Spalding, EP; Murphy, AS				Noh, B; Bandyopadhyay, A; Peer, WA; Spalding, EP; Murphy, AS			Enhanced gravi- and phototropism in plant mdr mutants mislocalizing the auxin efflux protein PIN1	NATURE			English	Article							ARABIDOPSIS; TRANSPORT; LIGHT	Many aspects of plant growth and development are dependent on the flow of the hormone auxin down the plant from the growing shoot tip where it is synthesized(1,2). The direction of auxin transport in stems is believed to result from the basal localization within cells of the PIN1 membrane protein, which controls the efflux of the auxin anion(3). Mutations in two genes homologous to those encoding the P-glycoprotein ABC transporters that are especially abundant in multidrug-resistant tumour cells in animals(4) were recently shown to block polar auxin transport in the hypocotyls of Arabidopsis seedlings(5). Here we show that the mdr mutants display faster and greater gravitropism and enhanced phototropism instead of the impaired curvature development expected in mutants lacking polar auxin transport. We find that these phenotypes result from a disruption of the normal accumulation of PIN1 protein along the basal end of hypocotyl cells associated with basipetal auxin flow. Lateral auxin conductance becomes relatively larger as a result, enhancing the growth differentials responsible for tropic responses.	Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Spalding, EP (corresponding author), Univ Wisconsin, Dept Bot, 430 Lincoln Dr, Madison, WI 53706 USA.		Spalding, Edgar P/A-9034-2008; Spalding, Edgar P/ABF-3253-2021; Peer, Wendy/H-2970-2013; Spalding, Edgar P/GWC-1811-2022	Spalding, Edgar P/0000-0002-6890-4765; Peer, Wendy/0000-0003-0046-7324; Spalding, Edgar P/0000-0002-6890-4765				Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Harper JDI, 1996, CYTOBIOS, V87, P71; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Muday GK, 2001, TRENDS PLANT SCI, V6, P535, DOI 10.1016/S1360-1385(01)02101-X; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sidler M, 1998, PLANT CELL, V10, P1623, DOI 10.1105/tpc.10.10.1623	14	203	222	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					999	1002		10.1038/nature01716	http://dx.doi.org/10.1038/nature01716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827205				2022-12-01	WOS:000183753900053
J	Kovalchuk, I; Kovalchuk, O; Kalck, V; Boyko, V; Filkowski, J; Heinlein, M; Hohn, B				Kovalchuk, I; Kovalchuk, O; Kalck, V; Boyko, V; Filkowski, J; Heinlein, M; Hohn, B			Pathogen-induced systemic plant signal triggers DNA rearrangements	NATURE			English	Article							TOBACCO MOSAIC-VIRUS; HOMOLOGOUS RECOMBINATION; TRANSPOSABLE ELEMENTS; MAIZE; ARABIDOPSIS; RESISTANCE; INFECTION; INDUCTION; RADIATION	Plant genome stability is known to be affected by various abiotic environmental conditions(1-7), but little is known about the effect of pathogens. For example, exposure of maize plants to barley stripe mosaic virus seems to activate transposable elements(8,9) and to cause mutations in the non-infected progeny of infected plants(10). The induction by barley stripe mosaic virus of an inherited effect may mean that the virus has a non-cell-autonomous influence on genome stability. Infection with Peronospora parasitica results in an increase in the frequency of somatic recombination in Arabidopsis thaliana(11); however, it is unclear whether effects on recombination require the presence of the pathogen or represent a systemic plant response. It is also not clear whether the changes in the frequency of somatic recombination can be inherited. Here we report a threefold increase in homologous recombination frequency in both infected and noninfected tissue of tobacco plants infected with either tobacco mosaic virus(12) or oilseed rape mosaic virus(13). These results indicate the existence of a systemic recombination signal that also results in an increased frequency of meiotic and/or inherited late somatic recombination.	Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	University of Lethbridge; Friedrich Miescher Institute for Biomedical Research	Kovalchuk, I (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.							Aguilar I, 1996, PLANT MOL BIOL, V30, P191, DOI 10.1007/BF00017814; Boyko V, 2000, NAT CELL BIOL, V2, P826, DOI 10.1038/35041072; BRAKKE MK, 1984, ANNU REV PHYTOPATHOL, V22, P77, DOI 10.1146/annurev.py.22.090184.000453; BURK L. G., 1964, TOBACCO SCI, V8, P101; DELLAPORTA SL, 1984, COLD SPRING HARB SYM, V49, P321, DOI 10.1101/SQB.1984.049.01.038; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Dong XN, 2001, CURR OPIN PLANT BIOL, V4, P309, DOI 10.1016/S1369-5266(00)00178-3; Gorbunova V, 2000, PLANT J, V24, P601, DOI 10.1046/j.1365-313x.2000.00905.x; Harrison BD, 1999, PHILOS T ROY SOC B, V354, P521, DOI 10.1098/rstb.1999.0403; JOHNS MA, 1985, EMBO J, V4, P1093, DOI 10.1002/j.1460-2075.1985.tb03745.x; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Kovalchuk I, 1998, NAT BIOTECHNOL, V16, P1054, DOI 10.1038/3505; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PUCHTA H, 1995, PLANT J, V7, P203, DOI 10.1046/j.1365-313X.1995.7020203.x; Ries G, 2000, P NATL ACAD SCI USA, V97, P13425, DOI 10.1073/pnas.230251897; Ries G, 2000, NATURE, V406, P98, DOI 10.1038/35017595; Shalev G, 1999, P NATL ACAD SCI USA, V96, P7398, DOI 10.1073/pnas.96.13.7398; WALBOT V, 1992, MOL GEN GENET, V234, P353, DOI 10.1007/BF00538694; Walbot V, 1999, NATURE, V397, P398, DOI 10.1038/17043; Waterhouse PM, 2001, TRENDS PLANT SCI, V6, P297, DOI 10.1016/S1360-1385(01)01989-6; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6	23	209	227	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					760	762		10.1038/nature01683	http://dx.doi.org/10.1038/nature01683			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802336				2022-12-01	WOS:000183443400045
J	Yamauchi, T; Kamon, J; Ito, Y; Tsuchida, A; Yokomizo, T; Kita, S; Sugiyama, T; Miyagishi, M; Hara, K; Tsunoda, M; Murakami, K; Ohteki, T; Uchida, S; Takekawa, S; Waki, H; Tsuno, NH; Shibata, Y; Terauchi, Y; Froguel, P; Tobe, K; Koyasu, S; Taira, K; Kitamura, T; Shimizu, T; Nagai, R; Kadowaki, T				Yamauchi, T; Kamon, J; Ito, Y; Tsuchida, A; Yokomizo, T; Kita, S; Sugiyama, T; Miyagishi, M; Hara, K; Tsunoda, M; Murakami, K; Ohteki, T; Uchida, S; Takekawa, S; Waki, H; Tsuno, NH; Shibata, Y; Terauchi, Y; Froguel, P; Tobe, K; Koyasu, S; Taira, K; Kitamura, T; Shimizu, T; Nagai, R; Kadowaki, T			Cloning of adiponectin receptors that mediate antidiabetic metabolic effects	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; EXPRESSION; EFFICIENT; ADIPOSE; OBESITY; MICE	Adiponectin (also known as 30-kDa adipocyte complement-related protein; Acrp30)(1-4) is a hormone secreted by adipocytes that acts as an antidiabetic(5-12) and anti-atherogenic(8,12,13) adipokine. Levels of adiponectin in the blood are decreased under conditions of obesity, insulin resistance and type 2 diabetes(2). Administration of adiponectin causes glucose-lowering effects and ameliorates insulin resistance in mice(5-7). Conversely, adiponectin-deficient mice exhibit insulin resistance and diabetes(8,9). This insulin-sensitizing effect of adiponectin seems to be mediated by an increase in fatty-acid oxidation through activation of AMP kinase(10,11) and PPAR-alpha(5,6,12). Here we report the cloning of complementary DNAs encoding adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2) by expression cloning(14-16). AdipoR1 is abundantly expressed in skeletal muscle, whereas AdipoR2 is predominantly expressed in the liver. These two adiponectin receptors are predicted to contain seven transmembrane domains, but to be structurally and functionally distinct from G-protein-coupled receptors(17-19). Expression of AdipoR1/R2 or suppression of AdipoR1/R2 expression by small-interfering RNA 20 supports our conclusion that they serve as receptors for globular and full-length adiponectin, and that they mediate increased AMP kinase(10,11) and PPAR-alpha ligand activities(12), as well as fatty-acid oxidation and glucose uptake by adiponectin.	Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Nissan Chem Ind Co Ltd, Biol Res Labs, Saitama 3490294, Japan; Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; JST, PRESTO, Kawaguchi, Japan; Univ Tokyo, Inst Med Sci, Div Hematopoiet Factors, Tokyo 1088639, Japan; Univ Tokyo, Sch English, Dept Chem & Biotechnol, Tokyo 1138656, Japan; Natl Inst AIST, Gene Funct Res Ctr, Tsukuba, Ibaraki 3058562, Japan; Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; Univ Tokyo, Grad Sch Med, Dept Transfus Med, Tokyo 1138655, Japan; Inst Pasteur, CNRS, Inst Biol, UPRES A8090, F-59000 Lille, France	University of Tokyo; Japan Science & Technology Agency (JST); Nissan Chemical Corporation; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Keio University; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan.		FROGUEL, Philippe/O-6799-2017; Waki, Hironori/AAE-3942-2020; Adiels, Martin/C-9278-2011; Yokomizo, Takehiko/P-5673-2016; Miyagishi, Makoto/L-8174-2016; sheng, jian/E-9474-2012; Koyasu, Shigeo/J-5583-2015; Terauchi, Yasuo/AAO-4347-2020	FROGUEL, Philippe/0000-0003-2972-0784; Waki, Hironori/0000-0002-5302-9793; Yokomizo, Takehiko/0000-0002-5219-1553; Miyagishi, Makoto/0000-0001-7654-3616; Koyasu, Shigeo/0000-0001-9585-3038; 	Medical Research Council [G0000477] Funding Source: Medline; MRC [G0000477] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Karpichev IV, 2002, J BIOL CHEM, V277, P19609, DOI 10.1074/jbc.M202045200; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Michael I, 1998, EUR MASS SPECTROM, V4, P1; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P802; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	27	2421	2693	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					762	769		10.1038/nature01705	http://dx.doi.org/10.1038/nature01705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802337				2022-12-01	WOS:000183443400046
J	Riddler, SA; Smit, E; Cole, SR; Li, R; Chmiel, JS; Dobs, A; Palella, F; Visscher, B; Evans, R; Kingsley, LA				Riddler, SA; Smit, E; Cole, SR; Li, R; Chmiel, JS; Dobs, A; Palella, F; Visscher, B; Evans, R; Kingsley, LA			Impact of HIV infection and HAART on serum lipids in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	10th Conference on Retroviruses and Opportunistic Infections	FEB 10-14, 2003	BOSTON, MA				INSULIN-RESISTANCE; PROTEASE; HYPERLIPIDEMIA; THERAPY; LIPODYSTROPHY; LIPOPROTEINS	Context Alterations in serum lipid values have been widely reported among persons infected with human immunodeficiency virus (HIV) type 1 treated with highly active antiretroviral therapy (HAART), but no data have yet been reported on changes from preseroconversion lipid values. Objective To describe changes in serum cholesterol levels associated with HIV infection and antiretroviral medication exposure, and 1-time assessment of triglyceride levels post-HAART initiation. Design, Setting, and Participants The Multicenter AIDS Cohort Study, a prospective study in which homosexual and bisexual men were enrolled and from which 50 of 517 HIV seroconverters were drawn for the analysis herein, who later initiated HAART, involving measurements of stored serum samples obtained between 1984 and 2002. Main Outcome Measures Changes in levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) at 6 time points during an average of 12 years; 1-time assessment of triglyceride levels from the third post-HAART clinic visit. Results Among the 50 men, notable declines in mean serum TC (-30 mg/dL [-0.78 mmol/L]) HDL-C (-12 mg/dL [-0.31 mmol/L]), and LDL-C values (-22 mg/dL [-0.57 mmol/L]) were observed after HIV infection. Following HAART initiation, there were large increases in mean TC and LDL-C values (50 and 21 mg/dL [1.30 and 0.54 mmol/L], respectively); however, the mean changes from the preseroconversion values were 20 mg/dL (0.52 mmol/L) (95% confidence interval [CI], -1 to 41) and -1 mg/dL <LF>(-0.03 mmol/L) (95% Cl, -25 to 22), respectively. Mean HDL-C remained below baseline levels throughout follow-up. The median value (interquartile range) of triglycerides was 225 mg/dL (2.54 mmol/L) (147-331 mg/dL). Conclusions Before treatment, HIV infection results in substantial decreases in serum TC, HDL-C, and LDL-C levels. Subsequent HAART initiation is associated with increases in TC and LDL-C but little change in HDL-C. Increases in TC and LDL-C observed after about 3 years of HAART possibly represent a return to preinfection serum lipid levels after accounting for expected age-related changes.	Univ Pittsburgh, Pittsburgh, PA USA; SUNY Buffalo, Buffalo, NY 14260 USA; Johns Hopkins Univ, Baltimore, MD USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Calif Los Angeles, Los Angeles, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Johns Hopkins University; Northwestern University; University of California System; University of California Los Angeles	Riddler, SA (corresponding author), 613 Falk Bldg,3601 5th Ave, Pittsburgh, PA 15213 USA.	riddler@msx.dept-med.pitt.edu		Kingsley, Lawrence/0000-0002-7000-8556	NIAID NIH HHS [U01 AI 46383, U01-AI-35039, P01 AI 43664, U01 AI 35041] Funding Source: Medline; NIDCR NIH HHS [DE 15166] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041, U01AI035039, P01AI043664, U01AI046383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015166] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Berthold HK, 1999, J INTERN MED, V246, P567, DOI 10.1046/j.1365-2796.1999.00615.x; Bonnet F, 2000, J ACQ IMMUN DEF SYND, V25, P199, DOI 10.1097/00126334-200010010-00017; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; FRIISMOLLER F, 2003, 10 C RETR OPP INF FE; GIORGI JV, 1990, CLIN IMMUNOL IMMUNOP, V55, P173, DOI 10.1016/0090-1229(90)90096-9; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; GRUNFELD C, 1991, AM J MED, V90, P154, DOI 10.1016/0002-9343(91)80154-E; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Henry K, 1998, LANCET, V352, P1031, DOI 10.1016/S0140-6736(98)00022-1; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Periard D, 1999, CIRCULATION, V100, P700, DOI 10.1161/01.CIR.100.7.700; Rifai N, 1998, CLIN CHEM, V44, P1242; Roberts AD, 1999, CLIN INFECT DIS, V29, P441, DOI 10.1086/520231; SHORPOSNER G, 1993, AM J MED, V94, P515, DOI 10.1016/0002-9343(93)90087-6; STASZEWSKI S, 2003, 10 C RETR OPP INF FE; *US DEP HHS, 1996, 3RD NAT HLTH NUTR EX; WARNICK GR, 1978, J LIPID RES, V19, P65	25	435	447	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2003	289	22					2978	2982		10.1001/jama.289.22.2978	http://dx.doi.org/10.1001/jama.289.22.2978			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	687XZ	12799406	Bronze, Green Published			2022-12-01	WOS:000183403400021
J	Barton, GM; Medzhitov, R				Barton, GM; Medzhitov, R			Toll-like receptor signaling pathways	SCIENCE			English	Editorial Material							TIRAP	Members of the Toll-like receptor (TLR) family recognize conserved microbial structures, such as bacterial lipopolysaccharide and viral double-stranded RNA, and activate signaling pathways that result in immune responses against microbial infections. All TLRs activate MyD88-dependent pathways to induce a core set of stereotyped responses, such as inflammation. However, individual TLRs can also induce immune responses that are tailored to a given microbial infection. Thus, these receptors are involved in both innate and adaptive immune responses. The mechanisms and components of these varied responses are only partly understood. Given the importance of TLRs in host defense, dissection of the pathways they activate has become an important emerging research focus. TLRs and their pathways are numerous; Science's Signal Transduction Knowledge Environment's TLR Connections Map provides an immediate, clear overview of the known components and relations of this complex system.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 300 Cedar St,CAB S660, New Haven, CT 06520 USA.			Barton, Gregory/0000-0002-3793-0100				BARTON G, 2003, SCI STKE; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	9	1017	1081	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1524	1525		10.1126/science.1085536	http://dx.doi.org/10.1126/science.1085536			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791976				2022-12-01	WOS:000183333100036
J	Anest, V; Hanson, JL; Cogswell, PC; Steinbrecher, KA; Strahl, BD; Baldwin, AS				Anest, V; Hanson, JL; Cogswell, PC; Steinbrecher, KA; Strahl, BD; Baldwin, AS			A nucleosomal function for I kappa B kinase-alpha in NF-kappa B-dependent gene expression	NATURE			English	Article							HISTONE H3; NEMO/IKK-GAMMA; IKK-ALPHA; PHOSPHORYLATION; ACETYLATION; INDUCTION; ACTIVATION; PATHWAY; BETA	NF-kappaB is a principal transcriptional regulator of diverse cytokine-mediated processes and is tightly controlled by the IkappaB kinase complex (IKK-alpha/beta/gamma). IKK-beta and IKK-gamma are critical for cytokine-induced NF-kappaB function, whereas IKK-alpha is thought to be involved in other regulatory pathways(1-4). However, recent data suggest a role for IKK-alpha in NF-kappaB-dependent gene expression in response to cytokine treatment(1,5-7). Here we demonstrate nuclear accumulation of IKK-alpha after cytokine exposure, suggesting a nuclear function for this protein. Consistent with this, chromatin immunoprecipitation (ChIP) assays reveal that IKK-alpha was recruited to the promoter regions of NF-kappaB-regulated genes on stimulation with tumour-necrosis factor-alpha. Notably, NF-kappaB-regulated gene expression is suppressed by the loss of IKK-alpha and this correlates with a complete loss of gene-specific phosphorylation of histone H3 on serine 10, a modification previously associated with positive gene expression. Furthermore, we show that IKK-alpha can directly phosphorylate histone H3 in vitro, suggesting a new substrate for this kinase. We propose that IKK-alpha is an essential regulator of NF-kappaB-dependent gene expression through control of promoter-associated histone phosphorylation after cytokine exposure. These findings provide additional insight into the role of the IKK complex in NF-kappaB-regulated gene expression.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.		Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259				Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Berger SL, 2001, ONCOGENE, V20, P3007, DOI 10.1038/sj.onc.1204324; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Courtois G, 2001, TRENDS MOL MED, V7, P427, DOI 10.1016/S1471-4914(01)02154-2; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Prajapati S, 2002, J BIOL CHEM, V277, P24331, DOI 10.1074/jbc.M201393200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	22	454	476	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					659	663		10.1038/nature01648	http://dx.doi.org/10.1038/nature01648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789343	Green Submitted			2022-12-01	WOS:000183301200045
J	Mandal, M; Boese, B; Barrick, JE; Winkler, WC; Breaker, RR				Mandal, M; Boese, B; Barrick, JE; Winkler, WC; Breaker, RR			Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria	CELL			English	Article							GENE-EXPRESSION; SMALL MOLECULES; MESSENGER-RNA; BINDING; OPERON; TRANSCRIPTION; BIOSYNTHESIS; ATTENUATION; METABOLISM; PROTEIN	Riboswitches are metabolite binding domains within certain messenger RNAs that serve as precision sensors for their corresponding targets. Allosteric rearrangement of mRNA structure is mediated by ligand binding, and this results in modulation of gene expression. We have identified a class of riboswitches that selectively recognizes guanine and becomes saturated at concentrations as low as 5 nM. In Bacillus subtilis, this mRNA motif is located on at least five separate transcriptional units that together encode 17 genes that are mostly involved in purine transport and purine nucleotide biosynthesis. Our findings provide further examples of mRNAs that sense metabolites and that control gene expression without the need for protein factors. Furthermore, it is now apparent that riboswitches contribute to the regulation of numerous fundamental metabolic pathways in certain bacteria.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Chem Engn, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.		Barrick, Jeffrey/A-3046-2012; Breaker, Ronald/E-9679-2010	Barrick, Jeffrey/0000-0003-0888-7358; Breaker, Ronald/0000-0002-2165-536X	NIGMS NIH HHS [GM 559343] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auger S, 2002, MICROBIOL-SGM, V148, P507, DOI 10.1099/00221287-148-2-507; Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; Christiansen LC, 1997, J BACTERIOL, V179, P2540, DOI 10.1128/jb.179.8.2540-2550.1997; EBBOLE DJ, 1987, J BIOL CHEM, V262, P8274; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gold L, 1997, P NATL ACAD SCI USA, V94, P59, DOI 10.1073/pnas.94.1.59; Grundy FJ, 1998, MOL MICROBIOL, V30, P737, DOI 10.1046/j.1365-2958.1998.01105.x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Jadhav VR, 2002, BIOCHIMIE, V84, P877, DOI 10.1016/S0300-9084(02)01404-9; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Kiga D, 1998, NUCLEIC ACIDS RES, V26, P1755, DOI 10.1093/nar/26.7.1755; Matthews KS, 1998, PROG NUCLEIC ACID RE, V58, P127; MCCONNELL TS, 1993, P NATL ACAD SCI USA, V90, P8362, DOI 10.1073/pnas.90.18.8362; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; MOSZER I, 1995, MICROBIOL-SGM, V141, P261, DOI 10.1099/13500872-141-2-261; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Ptashne M., 2002, GENES SIGNALS; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Shu D, 2003, J BIOL CHEM, V278, P7119, DOI 10.1074/jbc.M209895200; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; Stormo GD, 2001, P NATL ACAD SCI USA, V98, P9465, DOI 10.1073/pnas.181334498; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Switzer R.L., 2002, BACILLUS SUBTILIS IT, P255; Switzer RL, 1999, PROG NUCLEIC ACID RE, V62, P329; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; WENG ML, 1995, P NATL ACAD SCI USA, V92, P7455, DOI 10.1073/pnas.92.16.7455; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899	35	534	575	2	82	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					577	586		10.1016/S0092-8674(03)00391-X	http://dx.doi.org/10.1016/S0092-8674(03)00391-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787499	Bronze			2022-12-01	WOS:000183397600008
J	Korner, C				Korner, C			Slow in, rapid out - Carbon flux studies and Kyoto targets	SCIENCE			English	Editorial Material							TERRESTRIAL BIOSPHERE; DECIDUOUS FOREST; CO2 ENRICHMENT; BALANCE; EXCHANGE; VARIABILITY; ECOSYSTEMS		Univ Basel, Inst Bot, CH-4056 Basel, Switzerland	University of Basel	Korner, C (corresponding author), Univ Basel, Inst Bot, Schonbeinstr 6, CH-4056 Basel, Switzerland.		Korner, Christian C/B-6592-2014					Canadell JG, 2000, ECOSYSTEMS, V3, P115, DOI 10.1007/s100210000014; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Ehman JL, 2002, GLOBAL CHANGE BIOL, V8, P575, DOI 10.1046/j.1365-2486.2002.00492.x; Frolking S, 1996, GLOBAL CHANGE BIOL, V2, P343, DOI 10.1111/j.1365-2486.1996.tb00086.x; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Granados J, 2002, GLOBAL CHANGE BIOL, V8, P1109, DOI 10.1046/j.1365-2486.2002.00533.x; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; Prentice IC, 2000, ECOL APPL, V10, P1553, DOI 10.1890/1051-0761(2000)010[1553:TCBOTT]2.0.CO;2; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084	13	173	182	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1242	1243		10.1126/science.1084460	http://dx.doi.org/10.1126/science.1084460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764181				2022-12-01	WOS:000183042400030
J	Myers, GJ; Davidson, PW; Cox, C; Shamlaye, CF; Palumbo, D; Cernichiari, E; Sloane-Reeves, J; Wilding, GE; Kost, J; Huang, LS; Clarkson, TW				Myers, GJ; Davidson, PW; Cox, C; Shamlaye, CF; Palumbo, D; Cernichiari, E; Sloane-Reeves, J; Wilding, GE; Kost, J; Huang, LS; Clarkson, TW			Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study	LANCET			English	Article							IN-UTERO EXPOSURE; MATERNAL HAIR; OUTCOMES; MERCURY; DIET; AGE	Introduction Exposure to methylmercury (MeHg) before birth can adversely affect children's neurodevelopment. The most common form of prenatal exposure is maternal fish consumption, but whether such exposure harms the fetus is unknown. We aimed to identify adverse neurodevelopmental effects in a fish-consuming population. Methods We investigated 779 mother-infant pairs residing in the Republic of Seychelles. Mothers reported consuming fish on average 12 meals per week. Fish in Seychelles contain much the same concentrations of MeHg as commercial ocean fish elsewhere. Prenatal MeHg exposure was determined from maternal hair growing during pregnancy. We assessed neurocognitive, language, memory, motor, perceptual-motor, and behavioural functions in children at age 9 years. The association between prenatal MeHg exposure and the primary endpoints was investigated with multiple linear regression with adjustment for covariates that affect child development. Findings Mean prenatal MeHg exposure was 6.9 parts per million (SD 4.5ppm). Only two endpoints were associated with prenatal MeHg exposure. Increased exposure was associated with decreased performance in the grooved pegboard using the non-dominant hand in males and improved scores in the hyperactivity index of the Conner's teacher rating scale. Covariates affecting child development were appropriately associated with endpoints. Interpretation These data do not support the hypothesis that there is a neurodevelopmental risk from prenatal MeHg exposure resulting solely from ocean fish consumption.	Univ Rochester, Med Ctr, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14620 USA; Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14620 USA; NICHD, Dept Neurol, NIH, US Dept HHS, Bethesda, MD USA; NICHD, Dept Pediat, NIH, US Dept HHS, Bethesda, MD USA; NICHD, Dept Epidemiol Stat & Prevent, NIH, US Dept HHS, Bethesda, MD USA; Minist Hlth, Victoria, Seychelles	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Myers, GJ (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, Dept Biostat & Computat Biol, 601 Elmwood Ave,Box 631, Rochester, NY 14620 USA.		Myers, Gary J/I-4901-2013	Myers, Gary J/0000-0003-4317-015X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010219, P30ES001247] Funding Source: NIH RePORTER; NIEHS NIH HHS [T32 ES-007, R01-ES10219, ES-01247] Funding Source: Medline; PHS HHS [R01-08442] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Axtell CD, 1998, ENVIRON HEALTH PERSP, V106, P559, DOI 10.2307/3434230; AXTELL CD, 2000, ENV RES A, V84, P12; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; CHOI BH, 1978, J NEUROPATH EXP NEUR, V37, P719, DOI 10.1097/00005072-197811000-00001; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Cox C, 1989, ENV RES, V31, P640; DAVIDSON P, 1974, PERCEPT PSYCHOPHYS, V14, P539; Davidson PW, 1999, JAMA-J AM MED ASSOC, V281, P897; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Davidson PW, 1995, NEUROTOXICOLOGY, V16, P677; Davidson PW, 2000, ENVIRON RES, V84, P1, DOI 10.1006/enrs.2000.4084; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; Dourson ML, 2001, NEUROTOXICOLOGY, V22, P677, DOI 10.1016/S0161-813X(01)00060-2; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Harada Y., 1968, MINAMATA DISEASE, P93; JULSHAMN K, 1987, SCI TOTAL ENVIRON, V65, P53, DOI 10.1016/0048-9697(87)90160-4; KJELLSTROM T, 1986, 3080 NAT SWED ENV BO; KJELLSTROM T, 1989, 3642 NAT SWED ENV BO; Lapham LW, 1995, NEUROTOXICOLOGY, V16, P689; Marsh DO, 1995, NEUROTOXICOLOGY, V16, P583; MARSH DO, 1987, ARCH NEUROL-CHICAGO, V44, P1017, DOI 10.1001/archneur.1987.00520220023010; MCKEOWNEYSSEN GE, 1983, AM J EPIDEMIOL, V118, P470, DOI 10.1093/oxfordjournals.aje.a113652; MITCHELL JW, 1982, NEW ZEAL MED J, V95, P112; Myers GJ, 1995, NEUROTOXICOLOGY, V16, P653; *NAT I ENV HLTH SC, 1998, WORKSH REP SCI ISS R; National Research Council (U.S.) Committee on the Toxicological Effects of Methylmercury, 2000, TOXICOLOGICAL EFFECT, P1; PHELPS RW, 1980, ARCH ENVIRON HEALTH, V35, P161, DOI 10.1080/00039896.1980.10667486; SAGER PR, 1984, DEV BRAIN RES, V12, P1, DOI 10.1016/0165-3806(84)90170-6; WHO, 1990, ENV HLTH CRIT, V101	30	416	426	6	70	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 17	2003	361	9370					1686	1692		10.1016/S0140-6736(03)13371-5	http://dx.doi.org/10.1016/S0140-6736(03)13371-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KB	12767734				2022-12-01	WOS:000182919700009
J	Kitajima, TS; Yokobayashi, S; Yamamoto, M; Watanabe, Y				Kitajima, TS; Yokobayashi, S; Yamamoto, M; Watanabe, Y			Distinct cohesin complexes organize meiotic chromosome domains	SCIENCE			English	Article							SISTER-CHROMATID COHESION; FISSION YEAST; RECOMBINATION; PROTEIN; HETEROCHROMATIN; SEGREGATION; REQUIREMENT; REC8	Meiotic cohesin complexes at centromeres behave differently from those along chromosome arms, but the basis for these differences has remained elusive. The fission yeast cohesin molecule Rec8 largely replaces its mitotic counterpart, Rad21/Scc1, along the entire chromosome during meiosis. Here we show that Rec8 complexes along chromosome arms contain Rec11, whereas those in the vicinity of centromeres have a different partner subunit, Psc3. The arm-associated Rec8-Rec11 complexes are critical for meiotic recombination. The Rec8-Psc3 complexes comprise two different types of assemblies. First, pericentromeric Rec8-Psc3 complexes depend on histone methylation-directed heterochromatin for their localization and are required for cohesion during meiosis II. Second, central core Rec8-Psc3 complexes form independently of heterochromatin and are presumably required for establishing monopolar attachment at meiosis I. These findings define distinct modes of assembly and functions for cohesin complexes at different regions along chromosomes.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan; Japan Sci & Technol Corp, SORST, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan.	ywatanab@ims.u-tokyo.ac.jp	Kitajima, Tomoya/A-7049-2016	Kitajima, Tomoya/0000-0002-6486-7143; Watanabe, Yoshinori/0000-0002-5488-4812				Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernard P, 2002, TRENDS CELL BIOL, V12, P419, DOI 10.1016/S0962-8924(02)02344-9; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; DEVEAUX LC, 1994, GENE DEV, V8, P203, DOI 10.1101/gad.8.2.203; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Krawchuk MD, 1999, GENETICS, V153, P57; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Li YF, 1997, MOL MICROBIOL, V23, P869, DOI 10.1046/j.1365-2958.1997.2691632.x; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; MCKEE B, COMMUNICATION; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Orr-Weaver TL, 1999, CELL, V99, P1, DOI 10.1016/S0092-8674(00)80055-0; Parisi S, 1999, MOL CELL BIOL, V19, P3515; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Watanabe Y., UNPUB; YOKOBAYASHI S, IN PRESS MOL CELL BI	27	124	131	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1152	1155		10.1126/science.1083634	http://dx.doi.org/10.1126/science.1083634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750522				2022-12-01	WOS:000182886500048
J	Priola, SA; Chesebro, B; Caughey, B				Priola, SA; Chesebro, B; Caughey, B			A view from the top - Prion diseases from 10,000 feet	SCIENCE			English	Editorial Material									NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Priola, SA (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000752, Z01AI000752, ZIAAI000580, Z01AI000580] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; 2003, KEYST S MOL ASP TRAN	2	24	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					917	+		10.1126/science.1085920	http://dx.doi.org/10.1126/science.1085920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738843	Green Submitted			2022-12-01	WOS:000182719800035
J	Zeitlinger, J; Simon, I; Harbison, CT; Hannett, NM; Volkert, TL; Fink, GR; Young, RA				Zeitlinger, J; Simon, I; Harbison, CT; Hannett, NM; Volkert, TL; Fink, GR; Young, RA			Program-specific distribution of a transcription factor dependent on partner transcription factor and MAPK signaling	CELL			English	Article							YEAST STE12 PROTEIN; PHEROMONE RESPONSE PATHWAY; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; FILAMENTOUS-GROWTH; INVASIVE GROWTH; GENE-EXPRESSION; KINASE CASCADE; DNA-BINDING; TRANSDUCTION	Specialized gene expression programs are induced by signaling pathways that act on transcription factors. Whether these transcription factors can function in multiple developmental programs through a global switch in promoter selection is not known. We have used genome-wide location analysis to show that the yeast Ste12 transcription factor, which regulates mating and filamentous growth, is bound to distinct program-specific target genes dependent on the developmental condition. This condition-dependent distribution of Ste12 requires concurrent binding of the transcription factor Tec1 during filamentation and is differentially regulated by the MAP kinases Fus3 and Kss1. Program-specific distribution across the genome may be a general mechanism by which transcription factors regulate distinct gene expression programs in response to signaling.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Zeitlinger, J (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Simon, Itamar/0000-0002-8517-1903				ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Breitkreutz A, 2002, TRENDS CELL BIOL, V12, P254, DOI 10.1016/S0962-8924(02)02284-5; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Crosby JA, 2000, YEAST, V16, P1365, DOI 10.1002/1097-0061(200011)16:15<1365::AID-YEA630>3.3.CO;2-J; Dickinson JR, 1996, MICROBIOL-UK, V142, P1391, DOI 10.1099/13500872-142-6-1391; DOLAN JW, 1989, P NATL ACAD SCI USA, V86, P5703, DOI 10.1073/pnas.86.15.5703; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; ELION EA, 1991, COLD SH Q B, V56, P41; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; Farley FW, 1999, GENETICS, V151, P1425; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; HAGEN DC, 1991, MOL CELL BIOL, V11, P2952, DOI 10.1128/MCB.11.6.2952; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; KIRKMANCORREIA C, 1993, MOL CELL BIOL, V13, P3765, DOI 10.1128/MCB.13.6.3765; Kohler T, 2002, EUKARYOT CELL, V1, P673, DOI 10.1128/EC.1.5.673-686.2002; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Michelson AM, 2002, P NATL ACAD SCI USA, V99, P546, DOI 10.1073/pnas.032685999; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Pi HW, 1997, MOL CELL BIOL, V17, P6410, DOI 10.1128/MCB.17.11.6410; PRIMIG M, 1991, EMBO J, V10, P4209, DOI 10.1002/j.1460-2075.1991.tb04999.x; Pryciak PM, 2001, DEV CELL, V1, P449, DOI 10.1016/S1534-5807(01)00066-1; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rua D, 2001, CURR OPIN MICROBIOL, V4, P720, DOI 10.1016/S1369-5274(01)00274-0; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; SONG OK, 1991, GENE DEV, V5, P741, DOI 10.1101/gad.5.5.741; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; van Drogen F, 2002, CURR BIOL, V12, pR53, DOI 10.1016/S0960-9822(01)00672-8; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; White LJ, 2001, SOFTW TEST VERIF REL, V11, P1, DOI 10.1002/stvr.220; Wisdom R, 1999, EXP CELL RES, V253, P180, DOI 10.1006/excr.1999.4685	58	184	193	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 2	2003	113	3					395	404		10.1016/S0092-8674(03)00301-5	http://dx.doi.org/10.1016/S0092-8674(03)00301-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732146	Bronze			2022-12-01	WOS:000182640800013
J	Martin, OY; Hosken, DJ				Martin, OY; Hosken, DJ			The evolution of reproductive isolation through sexual conflict	NATURE			English	Article							FLY SEPSIS-CYNIPSEA; SERIALLY BOTTLENECKED LINES; RAPID EVOLUTION; SPECIATION; SELECTION; BEHAVIOR; COSTS; SIZE	Classical population-genetics theory suggests that reproductive isolation will evolve fastest in small isolated populations(1). In contrast, recent theory suggests that divergence should occur fastest in larger allopatric populations(2). The rationale behind this is that sexual conflict, potentially the strongest driver of speciation, is greater in larger, higher-density populations. This idea is highly controversial(3) and has little experimental support(4,5). Here we show, using replicate fly populations with varying levels of sexual conflict, that larger, more dense populations with more sexual conflict diverged to a greater degree than small populations with relaxed conflict. This result strongly suggests that speciation can occur rapidly in large populations through increased sexual conflict.	Univ Zurich, Museum Zool, CH-8057 Zurich, Switzerland	University of Zurich	Martin, OY (corresponding author), Univ Zurich, Museum Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		MARTIN, OLIVER Y/A-4534-2009	MARTIN, OLIVER Y/0000-0002-8601-7131				Andres JA, 2003, J EVOLUTION BIOL, V16, P219, DOI 10.1046/j.1420-9101.2003.00525.x; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Blanckenhorn WU, 2000, ETHOLOGY, V106, P577, DOI 10.1046/j.1439-0310.2000.00573.x; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Ding A, 2002, EVOL ECOL RES, V4, P259; Gage MJG, 2002, P ROY SOC B-BIOL SCI, V269, P2309, DOI 10.1098/rspb.2002.2154; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Hosken DJ, 2003, J EVOLUTION BIOL, V16, P485, DOI 10.1046/j.1420-9101.2003.00537.x; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Martin OY, 2003, EVOL ECOL RES, V5, P119; Martin OY, 2002, ANIM BEHAV, V63, P541, DOI 10.1006/anbe.2001.1929; MEFFERT LM, 1992, EVOLUTION, V46, P1399, DOI 10.1111/j.1558-5646.1992.tb01132.x; MEFFERT LM, 1991, EVOLUTION, V45, P293, DOI 10.1111/j.1558-5646.1991.tb04404.x; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Parker G.A., 1979, P123; PARKER GA, 1972, BEHAVIOUR, V41, P242, DOI 10.1163/156853972X00031; PARKER GA, 1972, BEHAVIOUR, V41, P172, DOI 10.1163/156853972X00257; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SHARP PM, 1984, GENETICS, V106, P601; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tregenza T, 2000, NATURE, V407, P149, DOI 10.1038/35025138; WARD PI, 1992, FUNCT ECOL, V6, P649, DOI 10.2307/2389959	28	195	202	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					979	982		10.1038/nature01752	http://dx.doi.org/10.1038/nature01752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827200				2022-12-01	WOS:000183753900048
J	Colombo, K; Grill, SW; Kimple, RJ; Willard, FS; Siderovski, DP; Gonczy, P				Colombo, K; Grill, SW; Kimple, RJ; Willard, FS; Siderovski, DP; Gonczy, P			Translation of polarity cues into asymmetric spindle positioning in Caenorhabditis elegans embryos	SCIENCE			English	Article							C-ELEGANS; CELL-DIVISION; G-ALPHA; DISSOCIATION INHIBITOR; BINDING PROTEIN; GERM-LINE; DROSOPHILA; LOCALIZATION; ORIENTATION; SEGREGATION	Asymmetric divisions are crucial for generating cell diversity; they rely on coupling between polarity cues and spindle positioning, but how this coupling is achieved is poorly understood. In one-cell stage Caenorhabditis elegans embryos, polarity cues set by the PAR proteins mediate asymmetric spindle positioning by governing an imbalance of net pulling forces acting on spindle poles. We found that the GoLoco-containing proteins GPR-1 and GPR-2, as well as the Galpha subunits GOA-1 and GPA-16, were essential for generation of proper pulling forces. GPR-1/2 interacted with guanosine diphosphate-bound GOA-1 and were enriched on the posterior cortex in a par-3- and par-2-dependent manner. Thus, the extent of net pulling forces may depend on cortical Galpha activity, which is regulated by anterior-posterior polarity cues through GPR-1/2.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Swiss Institute Experimental Cancer Research; Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill	Gonczy, P (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.		Kimple, Randall/L-6460-2019; Grill, Stephan/D-9427-2012; Siderovski, David Peter/AAA-9603-2019	Kimple, Randall/0000-0001-8336-8000; Siderovski, David Peter/0000-0002-0688-8210; Gonczy, Pierre/0000-0002-6305-6883	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62338] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boyd L, 1996, DEVELOPMENT, V122, P3075; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; COLOMBO K, UNPUB; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; GRILL SW, UNPUB; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hung TJ, 1999, DEVELOPMENT, V126, P127; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Miller KG, 2000, GENETICS, V156, P1649; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rose LS, 1998, DEVELOPMENT, V125, P1337; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tsou MFB, 2002, DEVELOPMENT, V129, P4469; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	26	225	235	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1957	1961		10.1126/science.1084146	http://dx.doi.org/10.1126/science.1084146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12750478				2022-12-01	WOS:000183619400051
J	Lipsitch, M; Cohen, T; Cooper, B; Robins, JM; Ma, S; James, L; Gopalakrishna, G; Chew, SK; Tan, CC; Samore, MH; Fisman, D; Murray, M				Lipsitch, M; Cohen, T; Cooper, B; Robins, JM; Ma, S; James, L; Gopalakrishna, G; Chew, SK; Tan, CC; Samore, MH; Fisman, D; Murray, M			Transmission dynamics and control of severe acute respiratory syndrome	SCIENCE			English	Article							CORONAVIRUS	Severe acute respiratory syndrome (SARS) is a recently described illness of humans that has spread widely over the past 6 months. With the use of detailed epidemiologic data from Singapore and epidemic curves from other settings, we estimated the reproductive number for SARS in the absence of interventions and in the presence of control efforts. We estimate that a single infectious case of SARS will infect about three secondary cases in a population that has not yet instituted control measures. Public-health efforts to reduce transmission are expected to have a substantial impact on reducing the size of the epidemic.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Minist Hlth, Epidemiol & Dis Control Div, Singapore 169854, Singapore; Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; City Hamilton Publ Hlth & Community Serv Dept, Hamilton, ON L8R 3L5, Canada; Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Ministry of Health-Singapore; Utah System of Higher Education; University of Utah; McMaster University; Harvard University; Massachusetts General Hospital	Murray, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mmurray@hsph.harvard.edu	Cohen, Ted/G-8101-2011	Cooper, Ben/0000-0002-9445-7217; Cohen, Ted/0000-0002-8091-7198; Lipsitch, Marc/0000-0003-1504-9213	NIAID NIH HHS [T32 AI07433, R01 AI 46669, K08 AI055985, K08 AI055985-01A1, R21 AI 55825, R01 AI 48935, R01 AI 32475] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055985, T32AI007433, R21AI055825, R01AI046669, R01AI048935, R01AI032475] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON R M, 1991; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; DONNELLY CA, 2003, LANCET, V361; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LIPSITCH M, UNPUB; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; *US CDCP, 2003, MMWR-MORBID MORTAL W, V52, P405	11	920	996	2	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1966	1970		10.1126/science.1086616	http://dx.doi.org/10.1126/science.1086616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12766207	Green Submitted, Green Accepted			2022-12-01	WOS:000183619400053
J	Goldman, DP; Berry, SH; McCabe, MS; Kilgore, ML; Potosky, AL; Schoenbaum, ML; Schonlau, M; Weeks, JC; Kaplan, R; Escarce, JJ				Goldman, DP; Berry, SH; McCabe, MS; Kilgore, ML; Potosky, AL; Schoenbaum, ML; Schonlau, M; Weeks, JC; Kaplan, R; Escarce, JJ			Incremental treatment costs in National Cancer Institute-sponsored clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; MEDICAL ONCOLOGISTS; BARRIERS; CARE; CHEMOTHERAPY; MULTICENTER; KNOWLEDGE; ATTITUDES	Context Concern about additional costs for direct patient care impedes efforts to enroll patients in clinical trials. But generalizable evidence substantiating these concerns is lacking. Objective To assess the additional cost of treating cancer patients in the National Cancer Institute (NCI)-sponsored clinical trials in the United States across a range of trial phases, treatment modalities, and patient care settings. Design Retrospective cost study using a multistage, stratified, random sample of patients enrolled in 1 of 35 active phase 3 trials or phase 1 or any phase 2 trials between October 1, 1998, and December 31, 1999. Unadjusted and adjusted costs were compared and related to trial phase, institution type, and vital status. Setting and Participants A representative sample of 932 cancer patients enrolled in nonpediatric, NCI-sponsored clinical trials and 696 nonparticipants with a similar stage of disease not enrolled in a research protocol from 83 cancer clinical research institutions across the United States. Main Outcome Measures Direct treatment costs as measured using a combination of medical records, telephone survey, and Medicare claims data. Administrative and other research costs were excluded. Results The incremental costs of direct care in trials were modest. Over approximately a 2.5-year period, adjusted costs were 6.5% higher for trial participants than nonparticipants ($35418 vs $33248; P=.11). Cost differences for phase 3 studies were 3.5% (P=.22), lower than for phase 1 or 2 trials (12.8%; P=.20). Trial participants who died had higher costs than nonparticipants who died (17.9%; $39420 vs $33432, respectively; P=15). Conclusions Treatment costs for nonpediatric clinical trial participants are on average 6.5% higher than what they would be if patients did not enroll. This implies total incremental treatment costs for NCI-sponsored trials of $16 million in 1999. Incremental costs were higher for patients who died and who were in early phase studies although these findings deserve further scrutiny. Overall, the additional treatment costs of an open reimbursement policy for government-sponsored cancer clinical trials appear minimal.	RAND Corp, Hlth, Santa Monica, CA 90407 USA; RAND Corp, Stat, Santa Monica, CA 90407 USA; NCI, Off Educ & Special Initiat, Div Canc Control & Populat Sci, Washington, DC USA; NCI, Clin Invest Branch, Natl Canc Therapy Evaluat Program, Washington, DC USA; Univ Alabama, Dept Hlth Care Org & Policy, Birmingham, AL USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA	RAND Corporation; RAND Corporation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Birmingham; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goldman, DP (corresponding author), RAND Corp, Hlth, 1700 Main St, Santa Monica, CA 90407 USA.		Schoenbaum, Michael/GRR-3988-2022; Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396; Kaplan, Richard S./0000-0002-0189-8348				Aaron HJ., 2000, EXTENDING MEDICARE R; BENSON AB, 1991, J CLIN ONCOL, V9, P2067, DOI 10.1200/JCO.1991.9.11.2067; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Brown ML, 2002, MED CARE, V40, P104; Brown ML, 1999, J NATL CANCER I, V91, P818, DOI 10.1093/jnci/91.10.818; Chirikos TN, 2001, MED CARE, V39, P373, DOI 10.1097/00005650-200104000-00008; Cochran W.G., 1963, SAMPLING TECHNIQUES; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; FISHER B, 1989, NEW ENGL J MED, V320, P822, DOI 10.1056/NEJM198903303201302; FLEMING ID, 1994, CANCER, V74, P2662, DOI 10.1002/1097-0142(19941101)74:9+<2662::AID-CNCR2820741813>3.0.CO;2-3; GLICKSMAN AS, 1996, STRATEGIES EVALUATIN; Goldman DP, 2001, J CLIN ONCOL, V19, P105, DOI 10.1200/JCO.2001.19.1.105; GOLDMAN DP, 2000, RAND PUBLICATION; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Lara PN, 2001, J CLIN ONCOL, V19, P1728, DOI 10.1200/JCO.2001.19.6.1728; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; MANSOUR EG, 1994, CANCER, V74, P2672, DOI 10.1002/1097-0142(19941101)74:9+<2672::AID-CNCR2820741815>3.0.CO;2-X; Martin Joseph B, 2002, Trans Am Clin Climatol Assoc, V113, P227; Paller MS, 2002, ACAD MED, V77, P1201, DOI 10.1097/00001888-200212000-00008; Perez EA, 1998, J CLIN ONCOL, V16, P754, DOI 10.1200/JCO.1998.16.2.754; POTOSKY AL, 1993, MED CARE, V31, P732; QUIRK J, 2000, ANN M AM SOC CLIN ON; Roche K, 2002, J CLIN ONCOL, V20, P545, DOI 10.1200/JCO.20.2.545; SCHAIN WS, 1994, CANCER, V74, P2666, DOI 10.1002/1097-0142(19941101)74:9+<2666::AID-CNCR2820741814>3.0.CO;2-P; SCHOENBAUM M, 2001, HLTH SERV OUTCOMES R, V2, P67; Siminoff LA, 2000, MED CARE, V38, P696, DOI 10.1097/00005650-200007000-00002; Siminoff LA, 2000, J CLIN ONCOL, V18, P1203, DOI 10.1200/JCO.2000.18.6.1203; Simon MS, 1999, AM J CLIN ONCOL-CANC, V22, P42, DOI 10.1097/00000421-199902000-00011; STINSON TJ, 2000, ANN M AM SOC CLIN ON; US General Accounting Office, 1999, US GEN ACC OFF PUBL; Wagner JL, 1999, JNCI-J NATL CANCER I, V91, P847, DOI 10.1093/jnci/91.10.847; 2002, FED REG          DEC, V76, P236	34	56	56	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2003	289	22					2970	2977		10.1001/jama.289.22.2970	http://dx.doi.org/10.1001/jama.289.22.2970			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687XZ	12799405	Bronze			2022-12-01	WOS:000183403400020
J	Girardin, SE; Boneca, IG; Carneiro, LAM; Antignac, A; Jehanno, M; Viala, J; Tedin, K; Taha, MK; Labigne, A; Zahringer, U; Coyle, AJ; Bertin, J; Sansonetti, PJ; Philpott, DJ				Girardin, SE; Boneca, IG; Carneiro, LAM; Antignac, A; Jehanno, M; Viala, J; Tedin, K; Taha, MK; Labigne, A; Zahringer, U; Coyle, AJ; Bertin, J; Sansonetti, PJ; Philpott, DJ			Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan	SCIENCE			English	Article							NF-KAPPA-B; RECOGNITION PROTEIN; IMMUNE-RESPONSES; ESCHERICHIA-COLI; CROHNS-DISEASE; FAMILY MEMBER; DROSOPHILA; INNATE; TOLL; ACTIVATION	Although the role of Toll-like receptors in extracellular bacterial sensing has been investigated intensively, intracellular detection of bacteria through Nod molecules remains largely uncharacterized. Here, we show that human Nod1 specifically detects a unique diaminopimelate-containing N-acetylglucosamine-N-acetylmuramic acid (GlcNAc-MurNAc) tripeptide motif found in Gram-negative bacterial peptidoglycan, resulting in activation of the transcription factor NF-kappaB pathway. Moreover, we show that in epithelial cells (which represent the first line of defense against invasive pathogens), Nod1 is indispensable for intracellular Gram-negative bacterial sensing.	Inst Pasteur, Unite Neisseria, F-75724 Paris 15, France; Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne Mol, F-75724 Paris, France; Inst Pasteur, Unite Pathogenie Bacterienne Muqueuses, F-75724 Paris 15, France; Inst Pasteur, Grp Immunite Innee & Signalisat, F-75724 Paris 15, France; Free Univ Berlin, Inst Mikrobiol & Tierseuchen, D-10115 Berlin, Germany; Res Ctr Borstel, Div Immunochem, Ctr Med & Biosci, D-23845 Borstel, Germany; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Free University of Berlin; Forschungszentrum Borstel; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Philpott, DJ (corresponding author), Inst Pasteur, Unite Neisseria, 28 Rue Dr Roux, F-75724 Paris 15, France.		Carneiro, Leticia/T-8978-2019; Boneca, Ivo G/H-1677-2014	Carneiro, Leticia/0000-0001-5870-8288; Boneca, Ivo G/0000-0001-8122-509X; Tedin, Karsten/0000-0003-2109-0730				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Eckmann L, 2000, J BIOL CHEM, V275, P14084, DOI 10.1074/jbc.275.19.14084; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HOLTJE J, 1988, MICROBIOL MOL BIOL R, V62, P181; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; McLaughlan AM, 1998, MICROBIOL-SGM, V144, P1359, DOI 10.1099/00221287-144-5-1359; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PEDRON T, UNPUB; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735	30	1156	1214	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1584	1587		10.1126/science.1084677	http://dx.doi.org/10.1126/science.1084677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791997				2022-12-01	WOS:000183333100059
J	Booth, CM; Matukas, LM; Tomlinson, GA; Rachlis, AR; Rose, DB; Dwosh, HA; Walmsley, SL; Mazzulli, T; Avendano, M; Derkach, P; Ephtimios, IE; Kitai, I; Mederski, BD; Shadowitz, SB; Gold, WL; Hawryluck, LA; Rea, E; Chenkin, JS; Cescon, DW; Poutanen, SM; Detsky, AS				Booth, CM; Matukas, LM; Tomlinson, GA; Rachlis, AR; Rose, DB; Dwosh, HA; Walmsley, SL; Mazzulli, T; Avendano, M; Derkach, P; Ephtimios, IE; Kitai, I; Mederski, BD; Shadowitz, SB; Gold, WL; Hawryluck, LA; Rea, E; Chenkin, JS; Cescon, DW; Poutanen, SM; Detsky, AS			Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Severe acute respiratory syndrome (SARS) is an emerging infectious disease that first manifested in humans in China in November 2002 and has subsequently spread worldwide. Objectives To describe the clinical characteristics and short-term outcomes of SARS in the first large group of patients in North America; to describe how these patients were treated and the variables associated with poor outcome. Design, Setting, and Patients Retrospective case series involving 144 adult patients admitted to 10 academic and community hospitals in the greater Toronto, Ontario, area between March 7 and April 10, 2003, with a diagnosis of suspected or probable SARS. Patients were included if they had fever, a known exposure to SARS, and respiratory symptoms or infiltrates observed on chest radiograph. Patients were excluded if an alternative diagnosis was determined. Main Outcome Measures Location of exposure to SARS; features of the history, physical examination, and laboratory tests at admission to the hospital; and 21-day outcomes such as death or intensive care unit (ICU) admission with or without mechanical ventilation. Results Of the 144 patients, 111 (77%) were exposed to SARS in the hospital setting. Features of the clinical examination most commonly found in these patients at admission were self-reported fever (99%), documented elevated temperature (85%), nonproductive cough (69%), myalgia (49%), and dyspnea (42%). Common laboratory features included elevated lactate dehydrogenase (87%), hypocalcemia (60%), and lymphopenia,(54%). Only 2% of patients had rhinorrhea. A total of 126 patients (88%) were treated with ribavirin, although its use was associated with significant toxicity, including hemolysis (in 76%) and decrease in hemoglobin of 2 g/dL (in 49%). Twenty-nine patients (20%) were admitted to the ICU with or without mechanical ventilation, and 8 patients died (21-day mortality, 6.5%; 95% confidence interval [CI], 1.9%-11.8%). Multivariable analysis showed that the presence of diabetes (relative risk [RR], 3.1; 95% CI, 1.4-7.2; P=.01) or other comorbid conditions (RR, 2.5; 95% CI, 1.1-5.8; P=.03) were independently associated with poor outcome (death, ICU admission, or mechanical ventilation). Conclusions The majority of cases in the SARS outbreak in the greater Toronto area were related to hospital exposure. In the event that contact history becomes unreliable, several features of the clinical presentation will be useful in raising the suspicion of SARS. Although SARS is associated with significant morbidity and mortality, especially in patients with diabetes or other comorbid conditions, the vast majority (93.5%) of patients in our cohort survived.	Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; Scarborough Gen Hosp, Toronto, ON, Canada; York Cent Hosp, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada; Westpk Healthcare Ctr, Toronto, ON, Canada; Markham Stouffville Hosp, Toronto, ON, Canada; RougeValley Hlth Syst, Toronto, ON, Canada; N York Gen Hosp, Toronto, ON, Canada; Toronto Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Scarborough Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; North York General Hospital	Detsky, AS (corresponding author), Mt Sinai Hosp, Suite 427,600 Univ Ave, Toronto, ON M5G 1X5, Canada.	allan.detsky@uhn.on.ca	Poutanen, Susan M/F-9640-2012; Poutanen, Susan M./N-8066-2019; Tomlinson, George A/L-5432-2016	Poutanen, Susan M/0000-0003-4747-2550; Poutanen, Susan M./0000-0003-4747-2550; Tomlinson, George A/0000-0002-9328-6399; Walmsley, Sharon/0000-0002-3959-5692				Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; *BRIT COL GEN SCI, SARS ASS COR; *CDCP, 2003, SEV AC RESP SYNDR CO; *CDCP, SARS COR SEQ; Centers for Disease Control and Prevention, 2003, UPD OUTBR SEV AC RES; CONOVER WJ, 1980, PRACTICAL NON PARAME; Cox DR., 1984, ANAL SURVIVAL DATA; DROSTEN C, N ENGL J MED; DWOSH HA, IN PRESS CMAJ; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; *HLTH CAN, SEV AC RESP SYNDR CA; KSIAZEK TG, N ENGL J MED; LEE N, N ENGL J MED; Mandell LA, 2000, CLIN INFECT DIS, V31, P422, DOI 10.1086/313965; *ONT MIN HLTH LONG, 2003, SEV AC RESP SYNDR; POUTANEN SM, N ENGL J MED; TSANG KW, N ENGL J MED; Tukey John W., 1990, STAT SCI, V5, P327, DOI [10.1214/ss/1177012101, DOI 10.1214/SS/1177012101]; WHO, WHO ISS GLOB AL CAS; WHO, CUM NUMB REP PROB CA; *WHO, CAS DEF SURV SEV AC	22	916	1003	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2003	289	21					2801	2809		10.1001/jama.289.21.JOC30885	http://dx.doi.org/10.1001/jama.289.21.JOC30885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KH	12734147	Bronze			2022-12-01	WOS:000183205500028
J	Transue, ER				Transue, ER			What I have seen	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2003	289	20					2619	2620		10.1001/jama.289.20.2619	http://dx.doi.org/10.1001/jama.289.20.2619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682DG	12771095	Bronze			2022-12-01	WOS:000183075600001
J	McKay, L; Clery, H; Carrick-Anderson, K; Hollis, S; Scott, G				McKay, L; Clery, H; Carrick-Anderson, K; Hollis, S; Scott, G			Genital Chlamydia trachomatis infection in a subgroup of young men in the UK	LANCET			English	Article							PREVALENCE	The frequency of genital Chlamydia trachomads infection in young men in the UK has been found to be consistently lower than that in young women, but studies In such populations might have been affected by selection bias. We tested 798 male military recruits for chlamydia as part of their routine medical examination at Glencorse barracks in Scotland. 78 (9.8%) men were infected with chlamydia; rates of infection were similar in all age-groups. 69 (88%) chlamydia-positive men were asymptomatic. This rate is higher than those usually cited, showing the importance of opportunistic testing for chlamydia in men as well as in women.	Royal Infirm, Dept Genitourinary Med, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Scott, G (corresponding author), Royal Infirm, Dept Genitourinary Med, Lauriston Pl, Edinburgh EH3 9YW, Midlothian, Scotland.							Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Pierpoint T, 2000, SEX TRANSM INFECT, V76, P273, DOI 10.1136/sti.76.4.273; Rogstad KE, 2001, SEX TRANSM INFECT, V77, P111, DOI 10.1136/sti.77.2.111; *UK DEP HLTH, 1998, SUMM CONCL CMOS EXP; Van der Pol B, 2000, J CLIN MICROBIOL, V38, P1105, DOI 10.1128/JCM.38.3.1105-1112.2000	5	27	27	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1792	1792		10.1016/S0140-6736(03)13398-3	http://dx.doi.org/10.1016/S0140-6736(03)13398-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781541				2022-12-01	WOS:000183074800014
J	Froy, O; Gotter, AL; Casselman, AL; Reppert, SM				Froy, O; Gotter, AL; Casselman, AL; Reppert, SM			Illuminating the circadian clock in monarch butterfly migration	SCIENCE			English	Article								Migratory monarch butterflies use a time-compensated Sun compass to navigate to their overwintering grounds in Mexico. Here, we report that constant light, which disrupts circadian clock function at both the behavioral and molecular levels in monarchs, also disrupts the time-compensated component of flight navigation. We further show that ultraviolet light is important for flight navigation but is not required for photic entrainment of circadian rhythms. Tracing these distinct light-input pathways into the brain should aid our understanding of the clock-compass mechanisms necessary for successful migration.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, LRB-728,364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Froy, Oren/C-3550-2009					Brower LP, 1996, J EXP BIOL, V199, P93; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; FROY O, UNPUB; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Saunders DS, 1982, INSECT CLOCKS; URQUHART F, 1960, MONARCH BUTTERLY; Wehner R, 2001, J EXP BIOL, V204, P2589; White R.C., UNPUB; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	12	128	138	6	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1303	1305		10.1126/science.1084874	http://dx.doi.org/10.1126/science.1084874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764200				2022-12-01	WOS:000183042400053
J	Guo, B; Zhai, DY; Cabezas, E; Welsh, K; Nouraini, S; Satterthwait, AC; Reed, JC				Guo, B; Zhai, DY; Cabezas, E; Welsh, K; Nouraini, S; Satterthwait, AC; Reed, JC			Humanin peptide suppresses apoptosis by interfering with Bax activation	NATURE			English	Article							CELL-DEATH; PROTEINS	Bax (Bcl2-associated X protein) is an apoptosis-inducing protein that participates in cell death during normal development and in various diseases(1). Bax resides in an inactive state in the cytosol of many cells. In response to death stimuli, Bax protein undergoes conformational changes that expose membrane-targeting domains, resulting in its translocation to mitochondrial membranes, where Bax inserts and causes release of cytochrome c and other apoptogenic proteins(2). It is unknown what controls conversion of Bax from the inactive to active conformation. Here we show that Bax interacts with humanin (HN), an anti-apoptotic peptide of 24 amino acids encoded in mammalian genomes(3,4). HN prevents the translocation of Bax from cytosol to mitochondria. Conversely, reducing HN expression by small interfering RNAs sensitizes cells to Bax and increases Bax translocation to membranes. HN peptides also block Bax association with isolated mitochondria, and suppress cytochrome c release in vitro. Notably, the mitochondrial genome contains an identical open reading frame, and the mitochondrial version of HN can also bind and suppress Bax. We speculate therefore that HN arose from mitochondria and transferred to the nuclear genome, providing a mechanism for protecting these organelles from Bax.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham.org						Atherton E., 1989, SOLID PHASE SYNTHESI; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Gray MW, 2001, GENOME BIOL, V2; Guo B, 2001, J BIOL CHEM, V276, P2780, DOI 10.1074/jbc.M005889200; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kermer P, 2002, CELL DEATH DIFFER, V9, P405, DOI 10.1038/sj.cdd.4400972; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nouraini S, 2000, MOL CELL BIOL, V20, P1604, DOI 10.1128/MCB.20.5.1604-1615.2000; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Stroud RM, 1998, CURR OPIN STRUC BIOL, V8, P525, DOI 10.1016/S0959-440X(98)80132-2; STRYER L, 1988, BIOCHEMISTRY; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu QL, 2000, METHOD ENZYMOL, V322, P283; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	23	444	501	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2003	423	6938					456	461		10.1038/nature01627	http://dx.doi.org/10.1038/nature01627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12732850				2022-12-01	WOS:000183012000046
J	Kawakami, R; Shinohara, Y; Kato, Y; Sugiyama, H; Shigemoto, R; Ito, I				Kawakami, R; Shinohara, Y; Kato, Y; Sugiyama, H; Shigemoto, R; Ito, I			Asymmetrical allocation of NMDA receptor epsilon 2 subunits in hippocampal circuitry	SCIENCE			English	Article							RAT-BRAIN; LOCALIZATION; EXPRESSION; DIVERSITY; SUBTYPES; POTENT	Despite its implications for higher order functions of the brain, little is currently known about the molecular basis of left-right asymmetry of the brain. Here we report that synaptic distribution of N-methyl-D-aspartate (NMDA) receptor GluRepsilon2 (NR2B) subunits in the adult mouse hippocampus is asymmetrical between the left and right and between the apical and basal dendrites of single neurons. These asymmetrical allocations of epsilon2 subunits differentiate the properties of NMDA receptors and synaptic plasticity between the left and right hippocampus. These results provide a molecular basis for the structural and functional asymmetry of the mature brain.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; Grad Univ Adv Studies, Sch Life Sci, Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan	Kyushu University; Kyushu University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Ito, I (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	isitoscb@mbox.nc.kyushu-u.ac.jp	Shigemoto, Ryuichi/E-3628-2013; Kawakami, Ryosuke/AAU-6087-2020; 良介, 川上/E-2029-2012	Shigemoto, Ryuichi/0000-0001-8761-9444; 				Amaral David G., 1995, P443; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Corballis MC, 1998, TRENDS COGN SCI, V2, P152, DOI 10.1016/S1364-6613(98)01156-5; COTMAN CW, 1974, J CELL BIOL, V62, P236, DOI 10.1083/jcb.62.1.236; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Gottmann K, 1997, J NEUROSCI, V17, P2766; Hollmann M, 1999, HANDB EXP PHARM, V141, P3; Ito I, 1996, NEUROSCI LETT, V203, P69, DOI 10.1016/0304-3940(95)12258-3; Ito I, 2000, NEUROPHARMACOLOGY, V39, P943, DOI 10.1016/S0028-3908(99)00217-8; Kilbride J, 1998, EUR J PHARMACOL, V356, P149, DOI 10.1016/S0014-2999(98)00526-3; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Mutel V, 1998, J NEUROCHEM, V70, P2147; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Rogers L.J., 2002, COMP VERTEBRATE LATE; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Springer SP, 1997, LEFT BRAIN RIGHT BRA; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K	26	172	173	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2003	300	5621					990	994		10.1126/science.1082609	http://dx.doi.org/10.1126/science.1082609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738868	Green Accepted			2022-12-01	WOS:000182719800060
J	Marshall, BT; Long, M; Piper, JW; Yago, T; McEver, RP; Zhu, C				Marshall, BT; Long, M; Piper, JW; Yago, T; McEver, RP; Zhu, C			Direct observation of catch bonds involving cell-adhesion molecules	NATURE			English	Article							RECEPTOR-LIGAND BONDS; P-SELECTIN; HUMAN NEUTROPHILS; FORCE; KINETICS; LEUKOCYTES; TRANSIENT; LIFETIME; REQUIRES; BINDING	Bonds between adhesion molecules are often mechanically stressed. A striking example is the tensile force applied to selectin-ligand bonds, which mediate the tethering and rolling of flowing leukocytes on vascular surfaces(1-3). It has been suggested that force could either shorten bond lifetimes, because work done by the force could lower the energy barrier between the bound and free states(4) ('slip'), or prolong bond lifetimes by deforming the molecules such that they lock more tightly(5,6) ('catch'). Whereas slip bonds have been widely observed(7-14), catch bonds have not been demonstrated experimentally. Here, using atomic force microscopy and flow-chamber experiments, we show that increasing force first prolonged and then shortened the lifetimes of P-selectin complexes with P-selectin glycoprotein ligand-1, revealing both catch and slip bond behaviour. Transitions between catch and slip bonds might explain why leukocyte rolling on selectins first increases and then decreases as wall shear stress increases(,)(9,15)(16). This dual response to force provides a mechanism for regulating cell adhesion under conditions of variable mechanical stress.	Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA; Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, C (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	cheng.zhu@me.gatech.edu	Zhu, Cheng/A-5724-2011					Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Chen SQ, 1997, P NATL ACAD SCI USA, V94, P3172, DOI 10.1073/pnas.94.7.3172; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dembo Micah, 1994, V24, P51; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; MOORE KL, 1991, J CELL BIOL, V112, P491, DOI 10.1083/jcb.112.3.491; MOORE KL, 1994, J BIOL CHEM, V269, P23318; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Pierres A, 1996, P NATL ACAD SCI USA, V93, P15114, DOI 10.1073/pnas.93.26.15114; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Smith MJ, 1999, BIOPHYS J, V77, P3371, DOI 10.1016/S0006-3495(99)77169-9; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wong JY, 1999, BIOPHYS J, V77, P1445, DOI 10.1016/S0006-3495(99)76992-4; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041	30	723	751	10	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					190	193		10.1038/nature01605	http://dx.doi.org/10.1038/nature01605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736689	Green Published			2022-12-01	WOS:000182699600051
J	Batlle, JC				Batlle, JC			Legal status of physician-assisted suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EUTHANASIA; CONSULTATION; OREGON; DEATH		Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Batlle, JC (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							BAILE WF, 1993, CANCER, V72, P2786, DOI 10.1002/1097-0142(19931101)72:9<2786::AID-CNCR2820720942>3.0.CO;2-2; Cantor NL, 2001, J LAW MED ETHICS, V29, P182; Cohen-Almagor R, 2002, J LAW MED ETHICS, V30, P95, DOI 10.1111/j.1748-720X.2002.tb00725.x; *DEP JUST OFF ATT, 2001, 25342001 AG DEP JUST; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2002, ARCH INTERN MED, V162, P142, DOI 10.1001/archinte.162.2.142; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Hamerly JP, 1998, AM J HEALTH-SYST PH, V55, P543, DOI 10.1093/ajhp/55.6.543; Lindsay RA, 2002, J LAW MED ETHICS, V30, P6, DOI 10.1111/j.1748-720X.2002.tb00714.x; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; New York State Task Force on Life and the Law, 1994, DEATH IS SOUGHT ASS; Onwuteaka-Philipsen BD, 2001, J MED ETHICS, V27, P331; PRETTY D, RIGHT DIE CASE EUROP; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811	14	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2279	2281		10.1001/jama.289.17.2279	http://dx.doi.org/10.1001/jama.289.17.2279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	675ET	12734142				2022-12-01	WOS:000182680700033
J	McCarthy, EP; Burns, RB; Ngo-Metzger, Q; Davis, RB; Phillips, RS				McCarthy, EP; Burns, RB; Ngo-Metzger, Q; Davis, RB; Phillips, RS			Hospice use among Medicare managed care and fee-for-service patients dying with cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	25th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 02-04, 2002	ATLANTA, GEORGIA	Soc Gen Internal Med			ILL PATIENTS; PALLIATIVE CARE; LIFE; HMO; REIMBURSEMENT; OUTCOMES; SYSTEMS; DEATH; END	Context For most patients aged 65 years or older with cancer, hospice services are uniformly covered by Medicare. Hospice care is believed to improve care for patients at the end of life. However, few patients use hospice and others enroll too late to maximize the benefits of hospice services. Objectives Because type of insurance may affect use, we examined whether patients with Medicare managed care insurance enrolled in hospice earlier and had longer hospice stays than patients with Medicare fee-for-service (FFS) insurance. Design and Setting Retrospective analysis of the last year of life using the Linked Medicare-Tumor Registry Database in 1 of 9 Surveillance, Epidemiology, and End Results program coverage areas. Patients A total of 260090 Medicare beneficiaries aged 66 years or older diagnosed with first primary lung (n=62 117), colorectal (n=57 260), prostate (n=59 826), female breast (n =37 609), bladder (n =19 598), pancreatic (n =11 378), gastric (n =9599), or liver (n=2703) cancer between January 1, 1973, and December 31, 1996, and who died between January 1, 1988, and December 31, 1998. Main Outcome Measures Time from diagnosis to hospice entry and hospice length of stay for patients enrolled in FFS vs managed care plans after adjusting for patient demographics, tumor registry, year of hospice entry, and type and cancer stage. Results Of the 260090 patients, most were men (59%), white (85%), and enrolled in FFS (89.7%). Only 54937 patients (21.1%) received hospice care before death. Hospice use varied by type of primary cancer ranging from 31.8% of patients with pancreatic cancer to 15.6% with bladder cancer. Managed care patients were more likely to use hospice than FFS patients (32.4% vs 19.8%, P<.001). Among hospice patients, median (interquartile range) length of stay was longer for managed care vs FFS patients (32 days [11-82] vs 25 days [9-66], P<.001). After adjustment, managed care patients had higher rates of hospice enrollment (adjusted hazard ratio [HR], 1.38; 95% CI, 1.35-1.42) and had a longer length of stay (adjusted HR, 0.91; 95% CI, 0.88-0.94) vs FFS patients. Managed care patients were less likely to enroll in hospice within 7 days of their death (18.6% vs 22.6%, P<.001) and somewhat more likely to enroll in hospice more than 180 days before death (7.8% vs 6.1 %, P<.001); the results for each of the 8 cancer diagnoses were similar. Hospice enrollment and length of stay among managed care vs FFS patients differed significantly by region. Conclusion Medicare beneficiaries enrolled in managed care had consistently higher rates of hospice use and significantly longer hospice stays than those enrolled in FFS. Although these differences may reflect patient and family preferences, our findings raise the possibility that some managed care plans are more successful at facilitating or encouraging hospice use for patients dying with cancer.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	McCarthy, EP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, 330 Brookline Ave,Rose 139, Boston, MA 02215 USA.				NCI NIH HHS [5R29 CA79052] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA079052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM CANC SOC, 2002, CANC FACTS FIG 2002; BULKIN W, 1988, NEW ENGL J MED, V318, P376, DOI 10.1056/NEJM198802113180609; Cher DJ, 1997, JAMA-J AM MED ASSOC, V278, P1001, DOI 10.1001/jama.278.12.1001; CHRISTAKIS NA, 1994, J GEN INTERN MED, V9, P314, DOI 10.1007/BF02599178; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Cleary JF, 1997, CANCER, V80, P1335, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1335::AID-CNCR21>3.3.CO;2-5; CLEMENT DG, 1994, JAMA-J AM MED ASSOC, V271, P1487, DOI 10.1001/jama.271.19.1487; *CTR MED MED SERV, 2002, FACT SHEET PROT MED; *CTR MED MED SERV, 2002, US DEP HLTH HUM SERV; *CTR MED MED SERV, 2000, US DEP HLTH HUM SERV; Curtis JR, 1997, JAMA-J AM MED ASSOC, V278, P1025, DOI 10.1001/jama.278.12.1025; Emanuel EJ, 2002, ARCH INTERN MED, V162, P1722, DOI 10.1001/archinte.162.15.1722; *GEN ACC OFF, 2000, MED MOR BEN US HOSP; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; Kinzbrunner B M, 1998, J Palliat Med, V1, P127, DOI 10.1089/jpm.1998.1.127; Lamont EB, 2002, CANCER, V94, P2733, DOI 10.1002/cncr.10530; Lee E, 2013, STAT METHODS SURVIVA; LEVY MH, 1993, J NATL CANCER I, V85, P1283, DOI 10.1093/jnci/85.16.1283; McCarthy EP, 2003, J CLIN ONCOL, V21, P728, DOI 10.1200/JCO.2003.06.142; MILES SH, 1995, WESTERN J MED, V163, P302; Morgan RO, 1997, NEW ENGL J MED, V337, P169, DOI 10.1056/NEJM199707173370306; *NAT HOSP PALL CAR, 2002, DEV QUAL CAR COST EF; Neuman P, 1998, HEALTH AFFAIR, V17, P132, DOI 10.1377/hlthaff.17.4.132; POTOSKY AL, 1993, MED CARE, V31, P732; Randal J, 1996, J NATL CANCER I, V88, P860, DOI 10.1093/jnci/88.13.860; Riley G, 1996, HEALTH CARE FINANC R, V17, P65; Steinberg S M, 1998, J Palliat Med, V1, P387, DOI 10.1089/jpm.1998.1.387; SULMASY DP, 1995, ARCH INTERN MED, V155, P133, DOI 10.1001/archinte.155.2.133; Virnig B A, 1999, Hosp J, V14, P1; Virnig BA, 2001, AM J MANAG CARE, V7, P777; WALLSTON KA, 1988, MED CARE, V26, P177, DOI 10.1097/00005650-198802000-00008; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027	32	107	108	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2238	2245		10.1001/jama.289.17.2238	http://dx.doi.org/10.1001/jama.289.17.2238			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	675ET	12734135	Bronze			2022-12-01	WOS:000182680700026
J	Woods, GL; White, KL; Vanderwall, DK; Li, GP; Aston, KI; Bunch, TD; Meerdo, LN; Pate, BJ				Woods, GL; White, KL; Vanderwall, DK; Li, GP; Aston, KI; Bunch, TD; Meerdo, LN; Pate, BJ			A mule cloned from fetal cells by nuclear transfer	SCIENCE			English	Article									Univ Idaho, Dept Vet & Anim Sci, NW Equine Reprod Lab, Moscow, ID 83844 USA; Utah State Univ, Ctr Dev & Mol Biol, Ctr Biotechnol, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA	Idaho; University of Idaho; Utah System of Higher Education; Utah State University	Woods, GL (corresponding author), Univ Idaho, Dept Vet & Anim Sci, NW Equine Reprod Lab, Moscow, ID 83844 USA.		Migliaccio, Kati/AAC-8451-2020					ALLEN WR, 1993, EQUINE REPROD, pCH63; Hinrichs K, 1998, THERIOGENOLOGY, V49, P13, DOI 10.1016/S0093-691X(97)00398-1; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; WOODS G, UNPUB; Woods GL, 2002, THERIOGENOLOGY, V58, P779	5	213	265	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1063	1063		10.1126/science.1086743	http://dx.doi.org/10.1126/science.1086743			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12775846				2022-12-01	WOS:000184872400030
J	Johansson, LC; Norberg, RA				Johansson, LC; Norberg, RA			Delta-wing function of webbed feet gives hydrodynamic lift for swimming propulsion in birds	NATURE			English	Article							LEADING-EDGE; FLIGHT	Most foot-propelled swimming birds sweep their webbed feet backwards in a curved path that lies in a plane aligned with the swimming direction. When the foot passes the most outward position, near the beginning of the power stroke, a tangent to the foot trajectory is parallel with the line of swimming and the foot web is perpendicular to it. But later in the stroke the foot takes an increasingly transverse direction, swinging towards the longitudinal axis of the body. Here we show that, early in the power stroke, propulsion is achieved mostly by hydrodynamic drag on the foot, whereas there is a gradual transition into lift-based propulsion later in the stroke. At the shift to lift mode, the attached vortices of the drag-based phase turn into a starting vortex, shed at the trailing edge, and into spiralling leading-edge vortices along the sides of the foot. Because of their delta shape, webbed feet can generate propulsive forces continuously through two successive modes, from drag at the beginning of the stroke, all the way through the transition to predominantly lift later in the stroke.	Univ Gothenburg, Dept Zool, SE-40530 Gothenburg, Sweden; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Gothenburg; Harvard University	Norberg, RA (corresponding author), Univ Gothenburg, Dept Zool, Box 463, SE-40530 Gothenburg, Sweden.		Johansson, Christoffer/B-2189-2013	Johansson, Christoffer/0000-0002-1851-3635				Blake R. W., 1981, S ZOOL SOC LONDON, V48, P29; Braun J., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P307; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Johansson LC, 2000, NATURE, V407, P582, DOI 10.1038/35036689; Johansson LC, 2001, J EXP BIOL, V204, P1687; Katz J., 1991, LOW SPEED AERODYNAMI; Lee M., 1990, APPL MECH REV, V43, P209, DOI [10.1115/1.3119169, DOI 10.1115/1.3119169]; NORBERG RA, 1994, P ROY SOC B-BIOL SCI, V257, P227, DOI 10.1098/rspb.1994.0119; THOMAS ALR, 1993, PHILOS T ROY SOC B, V340, P361, DOI 10.1098/rstb.1993.0079; WALKER JA, 1997, QUICKSAND QUICK SMOO	10	42	43	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					65	68		10.1038/nature01695	http://dx.doi.org/10.1038/nature01695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840759				2022-12-01	WOS:000183912800040
J	Mitchell, SL; Teno, JM; Roy, J; Kabumoto, G; Mor, V				Mitchell, SL; Teno, JM; Roy, J; Kabumoto, G; Mor, V			Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVANCED DEMENTIA; PREFERENCES; DIRECTIVES; ATTITUDES; FACILITY; RISK	Context Empiric data and expert opinion suggest that use of feeding tubes is not beneficial for older persons with advanced dementia. Previous research has shown a 10-fold variation in this practice across the United States. Objective To identify the facility and resident characteristics associated with feeding tube use among US nursing homes residents with severe cognitive impairment. Design, Setting, and Participants Cross-sectional study of all residents with advanced cognitive impairment who had Minimum Data Set assessments within 60 days of April 1, 1999, (N = 186835) and who resided in Medicare- or Medicaid-certified US nursing homes. Main Outcomes Measures Facility and resident characteristics described in the 1999 On-line Survey Certification of Automated Records and the 1999 Minimum Data Set. Multivariate analysis using generalized estimating equations determined the facility and resident factors independently associated with feeding tube use. Results Thirty-four percent of residents with advanced cognitive impairment had feeding tubes (N = 63 101). Resident characteristics associated with a greater likelihood of feeding tube use included younger age, nonwhite race, male sex, divorced marital status, lack of advance directives, a recent decline in functional status, and no diagnosis of Alzheimer disease. Controlling for these patient factors, residents living in facilities that were for profit (adjusted odds ratio (OR], 1.09; 95% confidence interval [Cl], 1.06-1.12); located in an urban area (OR, 1.14; 95% Cl, 1.11-1.16); having more than 100 beds (OR, 1.04; 95% Cl, 1.01-1.07); and lacking a special dementia care unit (OR, 1.11; 95% Cl, 1.07-1.15) had a higher likelihood of having a feeding tube. Additionally, feeding tube use was more likely among residents living in facilities that had a smaller proportion of residents with do-not-resuscitate orders, had a higher prevalence of non-white residents, and lacked a nurse practitioner or physician assistant on staff. Conclusions More than one third of severely cognitively impaired residents in US nursing homes have feeding tubes. Feeding tube use is independently associated with both the residents' clinical characteristics and the nursing homes' fiscal, organizational, and demographic features.	Beth Israel Deaconess Med Ctr, Hebrew Rehabil Ctr Aged, Res & Training Inst, Dept Med, Boston, MA 02131 USA; Harvard Univ, Sch Med, Div Aging, Boston, MA 02115 USA; Brown Univ, Sch Med, Dept Community Hlth, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Brown University	Mitchell, SL (corresponding author), Beth Israel Deaconess Med Ctr, Hebrew Rehabil Ctr Aged, Res & Training Inst, Dept Med, 1200 Ctr St, Boston, MA 02131 USA.				NIA NIH HHS [K23AG20054-01, AG-11624] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG011624, K23AG020054] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahronheim JC, 2001, J AM GERIATR SOC, V49, P148, DOI 10.1046/j.1532-5415.2001.49035.x; BATCHELOR AJ, 1992, J AM GERIATR SOC, V40, P679, DOI 10.1111/j.1532-5415.1992.tb01959.x; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; FRIES BE, 1994, MED CARE, V32, P668, DOI 10.1097/00005650-199407000-00002; Gessert CE, 2000, J AM GERIATR SOC, V48, P1593, DOI 10.1111/j.1532-5415.2000.tb03869.x; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; GRADY D, 2000, NY TIMES        0120, pA13; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; Intrator O, 1999, MED CARE, V37, P228, DOI 10.1097/00005650-199903000-00003; Kayser-Jones J, 1999, J AM GERIATR SOC, V47, P1187, DOI 10.1111/j.1532-5415.1999.tb05198.x; Kiely DK, 2001, J AM GERIATR SOC, V49, P1346, DOI 10.1046/j.1532-5415.2001.49263.x; Mebane EW, 1999, J AM GERIATR SOC, V47, P579, DOI 10.1111/j.1532-5415.1999.tb02573.x; Meier DE, 2002, NEW ENGL J MED, V346, P1087, DOI 10.1056/NEJM200204043461413; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Mitchell S L, 2001, J Am Med Dir Assoc, V2, P10, DOI 10.1097/00130535-200101000-00003; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 2003, J AM GERIATR SOC, V51, P75, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell SL, 2003, J AM GERIATR SOC, V51, P129, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell Susan L, 2003, J Am Med Dir Assoc, V4, P27, DOI 10.1097/00130535-200301000-00005; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; *SAS I INC, 1997, SAS STAT SOFTW CHANG; Teno JM, 2002, JAMA-J AM MED ASSOC, V287, P3211, DOI 10.1001/jama.287.24.3211; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	26	235	239	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2003	290	1					73	80		10.1001/jama.290.1.73	http://dx.doi.org/10.1001/jama.290.1.73			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696CR	12837714	Bronze			2022-12-01	WOS:000183868600022
J	Lowe, CJ; Wu, M; Salic, A; Evans, L; Lander, E; Stange-Thomann, N; Gruber, CE; Gerhart, J; Kirschner, M				Lowe, CJ; Wu, M; Salic, A; Evans, L; Lander, E; Stange-Thomann, N; Gruber, CE; Gerhart, J; Kirschner, M			Anteroposterior patterning in hemichordates and the origins of the chordate nervous system	CELL			English	Article							HOMEOBOX GENES; DEVELOPMENTAL EXPRESSION; ANIMAL PHYLOGENY; NEURAL PLATE; HOX CLUSTER; SEA-URCHIN; BODY PLAN; DROSOPHILA; EVOLUTION; BRAIN	The chordate central nervous system has been hypothesized to originate from either a dorsal centralized, or a ventral centralized, or a noncentralized nervous system of a deuterostome ancestor. In an effort to resolve these issues, we examined the hemichordate Saccoglossus kowalevskii and studied the expression of orthologs of genes that are involved in patterning the chordate central nervous system. All 22 orthologs studied are expressed in the ectoderm in an anteroposterior arrangement nearly identical to that found in chordates. Domain topography is conserved between hemichordates and chordates despite the fact that hemichordates have a diffuse nerve net, whereas chordates have a centralized system. We propose that the deuterostome ancestor may have had a diffuse nervous system, which was later centralized during the evolution of the chordate lineage.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02142 USA; Express Genom Inc, Frederick, MD 21701 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lowe, CJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	clowe@uclink4.berkeley.edu	Salic, Adrian/GXG-1611-2022	Lowe, Christopher/0000-0002-7789-8643	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042724] Funding Source: NIH RePORTER; NICHD NIH HHS [1-R01-HD42724] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Arendt D, 1996, BIOESSAYS, V18, P255, DOI 10.1002/bies.950180314; BALSER EJ, 1990, ACTA ZOOL-STOCKHOLM, V71, P235, DOI 10.1111/j.1463-6395.1990.tb01082.x; Bateson W., 1886, Q J MICROSC SCI, V26, P511; Bateson W., 1884, Q J MICROSC SCI, Vs2-24, P208; Bateson W., 1885, Q J MICROSC SCI, V25, P81; BATESON W, 1886, Q J MICROSC SCI, V26, P535; Brusca R.C., 1990, INVERTEBRATES; BULLOCK TH, 1945, Q J MICROSC SCI, V86, P55; Bullock TH, 1965, STRUCTURE FUNCTION N, P1567; BURDONJONES C, 1952, PHILOS T ROY SOC B, V236, P553, DOI 10.1098/rstb.1952.0010; Cameron CB, 1996, CAN J ZOOL, V74, P15, DOI 10.1139/z96-003; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; COLWIN AL, 1950, J EXP ZOOL, V115, P263, DOI 10.1002/jez.1401150204; COLWIN AL, 1953, J MORPHOL, V92, P401, DOI 10.1002/jmor.1050920302; COLWIN LH, 1962, BIOL BULL, V123, P493; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; GARSTANG W, 1894, ZOOL ANT, V17, P122; GARSTANG WALTER, 1928, QUART JOUR MICROS SCI, V72, P51; Gee H., 1996, BACKBONE VIEWS ORIGI; Geoffroy Saint-Hilaire E., 1822, MEM HIST NAT, V9, P89; Glavic A, 2002, DEVELOPMENT, V129, P1609; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438; Jan Yuh Nung, 1993, P1207; Jefferies RPS, 1996, ACTA ZOOL-STOCKHOLM, V77, P101, DOI 10.1111/j.1463-6395.1996.tb01256.x; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; KARR TL, 1989, DEVELOPMENT, V105, P605; KIM YJ, 1993, J NEUROSCI, V13, P1045; KNIGHTJONES EW, 1952, PHILOS T ROY SOC B, V236, P315, DOI 10.1098/rstb.1952.0004; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; LACALLI TC, 1994, AM ZOOL, V34, P533; Lilly B, 1999, MECH DEVELOP, V88, P195, DOI 10.1016/S0925-4773(99)00189-6; LOWE CJ, IN PRESS METHODS CEL; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mendez AT, 2000, MAR BIOTECHNOL, V2, P231, DOI 10.1007/s101269900027; Morgan T., 1894, J MORPHOL, V9, P1, DOI DOI 10.1002/JMOR.1050090102; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Nielsen C, 1999, DEV GENES EVOL, V209, P198, DOI 10.1007/s004270050244; Nubler-Jung K, 1999, J ZOOL SYST EVOL RES, V37, P93; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Papillon D, 2003, DEV GENES EVOL, V213, P142, DOI 10.1007/s00427-003-0306-z; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Popodi E, 1996, MOL BIOL EVOL, V13, P1078, DOI 10.1093/oxfordjournals.molbev.a025670; Raikova OI, 2000, ZOOMORPHOLOGY, V120, P107, DOI 10.1007/s004350000028; Reichert H, 2001, PHILOS T R SOC B, V356, P1533, DOI 10.1098/rstb.2001.0972; Reuter M, 1998, TISSUE CELL, V30, P57, DOI 10.1016/S0040-8166(98)80006-2; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Rubenstein JLR, 1997, MOL CELLULAR APPROAC, P356; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Salic AN, 1997, DEVELOPMENT, V124, P4739; Sasai Y, 2001, INT J DEV BIOL, V45, P321; SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Suda Y, 1999, DEVELOPMENT, V126, P743; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takacs CM, 2002, EVOL DEV, V4, P405, DOI 10.1046/j.1525-142X.2002.02029.x; Tallafuss A, 2002, GENE, V287, P23, DOI 10.1016/S0378-1119(01)00829-0	67	354	361	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2003	113	7					853	865		10.1016/S0092-8674(03)00469-0	http://dx.doi.org/10.1016/S0092-8674(03)00469-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837244	Bronze			2022-12-01	WOS:000183817900010
J	Tyree, MT				Tyree, MT			The ascent of water	NATURE			English	Article									US Forest Serv, USDA, NE Expt Stn, Burlington, VT 05402 USA	United States Department of Agriculture (USDA); United States Forest Service	Tyree, MT (corresponding author), US Forest Serv, USDA, NE Expt Stn, POB 968, Burlington, VT 05402 USA.							Tyree MT, 2003, TREES-STRUCT FUNCT, V17, P95, DOI 10.1007/s00468-002-0227-x; Tyree MT, 2002, XYLEM STRUCTURE ASCE; Wei CF, 1999, PLANT PHYSIOL, V121, P1191, DOI 10.1104/pp.121.4.1191	3	107	115	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					923	923		10.1038/423923a	http://dx.doi.org/10.1038/423923a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827177	Bronze			2022-12-01	WOS:000183753900026
J	Halsell, JS; Riddle, JR; Atwood, JE; Gardner, P; Shope, R; Poland, GA; Gray, GC; Ostroff, S; Eckart, RE; Hospenthal, DR; Gibson, RL; Grabenstein, JD; Arness, MK; Tornberg, DN				Halsell, JS; Riddle, JR; Atwood, JE; Gardner, P; Shope, R; Poland, GA; Gray, GC; Ostroff, S; Eckart, RE; Hospenthal, DR; Gibson, RL; Grabenstein, JD; Arness, MK; Tornberg, DN		Dept Def Smallpox Vaccination Clin	Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS; MYOCARDITIS; PERICARDITIS; SURVEILLANCE	Context In the United States, the annual incidence of myocarditis is estimated at 1 to 10 per 100000 population. As many as 1% to 5% of patients with acute viral infections involve the myocardium. Although many viruses have been reported to cause myopencarditis, it has been a rare or unrecognized event after vaccination with the currently used strain of vaccinia virus (New York City Board of Health). Objective To describe a series of probable cases of myopericarditis following smallpox vaccination among US military service members reported since the reintroduction of vaccinia vaccine. Design, Setting, Participants Surveillance case definitions are presented. The cases were identified either through sentinel reporting to US military headquarters surveillance using the Defense Medical Surveillance System or reports to the Vaccine Adverse Event Reporting System using International Classification of Diseases, Ninth Revision. The cases occurred among individuals vaccinated from mid-December 2002 to March 14, 2003. Main Outcome Measure Elevated serum levels of creatine kinase (MB isoenzyme), troponin 1, and troponin T, usually in the presence of ST-segment elevation on electrocardiogram and wall motion abnormalities on echocardiogram. Results Among 230734 primary, vaccinees, 18 cases of probable myopericarditis after smallpox vaccination were reported (an incidence of 7.8 per 100000 over 30 days). No cases of myopericarditis following smallpox vaccination were reported among 95 622 vaccinees who were previously vaccinated. All cases were white men aged 21 years to 33 years (mean age, 26.5 years), who presented with acute myopericarditis 7 to 19 days following vaccination. A causal relationship is supported by the close temporal clustering (7-19 days; mean, 10.5 days following vaccination), wide geographic and temporal distribution, occurrence in only primary vaccinees, and lack of evidence for alternative etiologies or other diseases associated with myopericarditis. Additional supporting evidence is the observation that the observed rate of myopericarditis among primary vaccinees is 3.6-fold (95% confidence interval, 3.33-4.11) higher than the expected rate among personnel who were not vaccinated. The background incidence of myopericarditis did not show statistical significance when stratified by age (20-34 years: 2.18 expected cases per 100000; 95% confidence interval [CI], 1.90-2.34), race (whites: 1.82 per 100000; 95% Cl, 1.50-2.01), and sex (males: 2.28 per 100000; 95% Cl, 2.04-2.54). Conclusion Among US military personnel vaccinated against smallpox, myopericarditis occurred at a rate of 1 per 12819 primary vaccinees. Myopericarditis should be considered an expected adverse event associated with smallpox vaccination. Clinicians should consider myopericarditis in the differential diagnosis of patients presenting with chest pain 4 to 30 days following smallpox vaccination and be aware of the implications as well as the need to report this potential adverse advent.	Armed Forces Epidemiol Board, Falls Church, VA 22041 USA		Riddle, JR (corresponding author), Armed Forces Epidemiol Board, Skyline 6,Suite 682,5111 Leesburg Pike, Falls Church, VA 22041 USA.	James.Riddle@otsg.amedd.army.mil	Grabenstein, John/Y-7322-2019; Gray, Gregory C./ABF-1298-2020	Gray, Gregory/0000-0002-4628-5908				AHLBORG B, 1966, ACTA MED SCAND, VS, P127; BENGTSSON ELIAS, 1966, ACTA MED SCAND SUPPL, V464, P113; BENGTSSON ELLAS, 1957, CARDIOLOGIA, V30, P1, DOI 10.1159/000165631; CANGEMI VF, 1958, NEW ENGL J MED, V258, P1257, DOI 10.1056/NEJM195806192582507; *CDCP, TEMP DEF REC HEART P; *CDCP, INT SMALLP FACT SHEE; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P278; DOLGOPOL VB, 1955, ARCH NEURO PSYCHIATR, V73, P216, DOI 10.1001/archneurpsyc.1955.02330080094018; DONADON W, 1974, MINERVA CARDIOANGIOL, V22, P642; Drucker N A, 1997, Adv Pediatr, V44, P141; FEERY BJ, 1977, MED J AUSTRALIA, V2, P180, DOI 10.5694/j.1326-5377.1977.tb114544.x; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fenner F., 1988, SMALLPOX ITS ERADICA; FINLAYJONES LR, 1964, NEW ENGL J MED, V270, P41, DOI 10.1056/NEJM196401022700108; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; HALLETT P, 1969, MED J AUSTRALIA, V1, P898, DOI 10.5694/j.1326-5377.1969.tb49779.x; HEIKKILA J, 1982, BRIT HEART J, V47, P381; HELLE EPJ, 1978, ANN CLIN RES, V10, P280; *INF MED CLIN GREN, 1974, PEDIATRIE, V29, P179; KARJALAINEN J, 1983, ACTA MED SCAND, V213, P65; Karjalainen J, 1999, EUR HEART J, V20, P1120, DOI 10.1053/euhj.1998.1444; Klein RM, 1998, AM HEART J, V136, P389, DOI 10.1016/S0002-8703(98)70211-X; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; MACADAM D, 1962, BRIT MED J, V2, P1099; MARTINO TA, 1994, CIRC RES, V74, P182, DOI 10.1161/01.RES.74.2.182; MATHIEU L, 1953, ARCH MAL COEUR VAISS, V48, P802; MATTHEWS AW, 1974, BRIT HEART J, V36, P1043; MEAD J, 1966, J AM GERIATR SOC, V14, P754, DOI 10.1111/j.1532-5415.1966.tb02902.x; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; NEFF JM, 1967, PEDIATRICS, V39, P916; PHILLIPS M, 1986, JAMA-J AM MED ASSOC, V256, P2696, DOI 10.1001/jama.256.19.2696; PRICE M. A., 1968, Papua New Guinea Medical Journal, V11, P30; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; SOLE MJ, 1993, J AM COLL CARDIOL, V22, pA99, DOI 10.1016/0735-1097(93)90470-L; Towbin J A, 2001, Adolesc Med, V12, P47; WOODRUFF JF, 1980, AM J PATHOL, V101, P425; World Health Organisation, 1977, INT CLASS DIS 9 REV; WYNNE J, 2001, CARDIOMYOPATHIES MYO, P1783; 2003, MORB MORTAL WKLY REP, V52, P492	40	201	211	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2003	289	24					3283	3289		10.1001/jama.289.24.3283	http://dx.doi.org/10.1001/jama.289.24.3283			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	693EX	12824210	Bronze			2022-12-01	WOS:000183704600022
J	Schmidt, R; Enzinger, C; Ropele, S; Schmidt, H; Fazekas, F				Schmidt, R; Enzinger, C; Ropele, S; Schmidt, H; Fazekas, F			Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study	LANCET			English	Article							HYPERINTENSITIES; MRI	More than half of all elderly people have some degree of cerebral white matter lesions. However, the rate of progression of these lesions is uncertain. We aimed to assess the progression of lesions in community-dwelling volunteers aged 50-75 years without neuropsychiatric disease. We used MRI to grade and measure the total volume of white matter lesions in 296 volunteers at baseline, 3 years, and 6 years. 58 participants with no lesions and 123 with punctate abnormalities at baseline had a low tendency for lesion progression, whereas 14 participants with early confluent and nine with confluent lesions underwent median increases of 2.7 cm(3) (IQR 0.5-5.9) and 9.3 cm(3) (7.1-21.0), respectively, in lesion volume at 6 years. Lesion grade at baseline was the only significant predictor of lesion progression (p<0.0001). Punctate white matter lesions are not progressive and are thus benign, whereas early confluent and confluent white matter abnormalities are progressive, and thus malignant.	Karl Franzens Univ Graz, Dept Neurol, A-8036 Graz, Austria; Karl Franzens Univ Graz, MRI Ctr, A-8036 Graz, Austria; Karl Franzens Univ Graz, Inst Med Biochem & Med Mol Biol, A-8036 Graz, Austria	University of Graz; University of Graz; University of Graz	Schmidt, R (corresponding author), Karl Franzens Univ Graz, Dept Neurol, A-8036 Graz, Austria.							FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132; van Gijn J, 2000, LANCET, V356, P612, DOI 10.1016/S0140-6736(00)02599-X; Veldink JH, 1998, NEUROLOGY, V51, P319, DOI 10.1212/WNL.51.1.319; Whitman GT, 2001, NEUROLOGY, V57, P990, DOI 10.1212/WNL.57.6.990	5	224	233	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2046	2048		10.1016/S0140-6736(03)13616-1	http://dx.doi.org/10.1016/S0140-6736(03)13616-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814718				2022-12-01	WOS:000183488900014
J	Wandinger, KP; Lunemann, JD; Wengert, O; Bellmann-Strobl, J; Aktas, O; Weber, A; Grundstrom, E; Ehrlich, S; Wernecke, KD; Volk, HD; Zipp, F				Wandinger, KP; Lunemann, JD; Wengert, O; Bellmann-Strobl, J; Aktas, O; Weber, A; Grundstrom, E; Ehrlich, S; Wernecke, KD; Volk, HD; Zipp, F			TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis	LANCET			English	Article							BLOOD MONONUCLEAR-CELLS; HUMAN T-CELLS; I INTERFERONS; MS PATIENTS; GUIDELINES; LYMPHOCYTE; MECHANISM; LINES	Background Many patients with multiple sclerosis do not respond to interferon beta, which is widely used as an immunomodulatory treatment in this disease. We aimed to assess the functional relevance of tumour necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL), which is upregulated on incubation with interferon beta, for clinical treatment response. Methods We quantified gene expression longitudinally by realtime-PCR of the peripheral immune cells of 82 patients with multiple sclerosis. In a first cohort of 62 patients, 20 were classified as first-year responders since they did not have relapses during treatment with interferon beta la; 19 were classified as first-year non-responders; and 23 developed neutralising antibodies to interferon beta. A second cohort, also characterised by MRI, consisted of 11 patients on interferon beta la and nine patients who,were not treated. Concentrations of soluble TRAIL were determined by ELISA in serum samples of nine non-treated patients, 49 patients before treatment (29 responders, 20 non-responders), as well as longitudinally in a subset of 23 patients. Findings In both patient cohorts, drug-responders could be distinguished from non-responders by early and sustained induction of TRAIL (p<0.0001, each). In the presence of neutralising antibodies, initial upregulation of TRAIL expression was subsequently abrogated. Raised concentrations of soluble TRAIL in patients' serum samples before the start of treatment allowed prediction of the treatment response in the first year (ROC analysis with area under the curve 0.879 [0.785-0.974]). Interpretation Our data suggest that TRAIL expression is a candidate for pretreatment assessment and might thus be used as a prognostic marker of treatment response to interferon beta in multiple sclerosis. Furthermore, our observations have implications for the development of future immunoregulatory strategies in multiple sclerosis therapy.	Charite Univ Hosp, Neurosci Res Ctr, Inst Neuroimmunol, NWFZ 2680, D-10117 Berlin, Germany; Charite Univ Hosp, Dept Neurol, D-10117 Berlin, Germany; Charite Univ Hosp, Inst Med Biometry, D-10117 Berlin, Germany; Charite Univ Hosp, Inst Med Immunol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zipp, F (corresponding author), Charite Univ Hosp, Neurosci Res Ctr, Inst Neuroimmunol, NWFZ 2680, Schumannstr 20-21, D-10117 Berlin, Germany.		Aktas, Orhan/B-7623-2009; Zipp, Frauke/C-9968-2015; Lunemann, Jan D/G-8729-2011; volk, hans-dieter/AAV-8053-2021; Ehrlich, Stefan/ABB-4650-2020	Aktas, Orhan/0000-0002-2020-9210; Zipp, Frauke/0000-0002-1231-1928; Lunemann, Jan D/0000-0002-3007-708X; volk, hans-dieter/0000-0002-7743-6668; Ehrlich, Stefan/0000-0003-2132-4445; Bellmann-Strobl, Judith/0000-0003-2615-1643				Brunner E., 2002, NONPARAMETRIC ANAL L; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Deisenhammer F, 1999, NEUROLOGY, V52, P1239, DOI 10.1212/WNL.52.6.1239; Duquette P, 1996, NEUROLOGY, V47, P889; Ebers G, 1999, NEUROLOGY, V53, P679; Francis G, 2001, NEUROLOGY, V56, P1628; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Hilliard B, 2001, J IMMUNOL, V166, P1314, DOI 10.4049/jimmunol.166.2.1314; Huang WX, 2000, NEUROLOGY, V55, P928, DOI 10.1212/WNL.55.7.928; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kracke A, 2000, NEUROLOGY, V54, P193, DOI 10.1212/WNL.54.1.193; Kumar-Sinha C, 2002, J BIOL CHEM, V277, P575, DOI 10.1074/jbc.M107795200; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Mariani SM, 1998, EUR J IMMUNOL, V28, P973, DOI 10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T; Markovic-Plese S, 2001, J CLIN INVEST, V108, P1185, DOI 10.1172/JCI12516; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; STONE LA, 1995, ANN NEUROL, V37, P611, DOI 10.1002/ana.410370511; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wandinger KP, 2001, ANN NEUROL, V50, P349, DOI 10.1002/ana.1096; Wandinger KP, 1997, J NEUROL SCI, V149, P87, DOI 10.1016/S0022-510X(97)05383-5; Wang X, 2000, J IMMUNOL, V165, P548, DOI 10.4049/jimmunol.165.1.548; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	30	173	186	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2036	2043		10.1016/S0140-6736(03)13641-0	http://dx.doi.org/10.1016/S0140-6736(03)13641-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814715				2022-12-01	WOS:000183488900011
J	Baldauf, SL				Baldauf, SL			The deep roots of eukaryotes	SCIENCE			English	Editorial Material							OSTREOCOCCUS-TAURI CHLOROPHYTA; UNIVERSAL TREE; DIVERSITY; EVOLUTION; GENOME; SEQUENCES; PLASTIDS; ANCIENT; ORIGIN	Most cultivated and characterized eukaryotes can be confidently assigned to one of eight major groups. After a few false starts, we are beginning to resolve relationships among these major groups as well. However, recent developments are radically revising this picture again, particularly (i) the discovery of the likely antiquity and taxonomic diversity of ultrasmall eukaryotes, and (ii) a fundamental rethinking of the position of the root. Together these data suggest major gaps in our understanding simply of what eukaryotes are or, when it comes to the tree, even which end is up.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of York - UK	Baldauf, SL (corresponding author), Univ York, Dept Biol, Box 373, York YO10 5YW, N Yorkshire, England.	slb14@york.ac.uk		Baldauf, Sandra/0000-0003-4485-6671				Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; AMARALZETTLER LA, 2001, J EUKARYOT MICROBIOL, V48, P293; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baldauf SL, 1996, P NATL ACAD SCI USA, V93, P7749, DOI 10.1073/pnas.93.15.7749; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Courties C, 1998, J PHYCOL, V34, P844, DOI 10.1046/j.1529-8817.1998.340844.x; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/10635150118513; Derelle E, 2002, J PHYCOL, V38, P1150, DOI 10.1046/j.1529-8817.2002.02021.x; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Hausmann K., 1996, PROTOZOOLOGY; Hilario E, 1998, J MOL EVOL, V46, P703, DOI 10.1007/PL00006351; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Keeling PJ, 1996, EMBO J, V15, P2285, DOI 10.1002/j.1460-2075.1996.tb00581.x; Klobutcher LA, 2002, CELL, V111, P763, DOI 10.1016/S0092-8674(02)01138-8; LEE JJ, 2000, ILLUTRATED GUIDE PRO; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2002, MOL BIOL EVOL, V19, P118, DOI 10.1093/oxfordjournals.molbev.a003976; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; PATTERSON DJ, 2000, FLAGELLATES UNITY DI, P269; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; RIZZO PJ, 1977, SCIENCE, V198, P1258, DOI 10.1126/science.563104; Simpson AGB, 2002, CURR BIOL, V12, pR691, DOI 10.1016/S0960-9822(02)01207-1; SOGIN ML, 1993, NATURE, V362, P795, DOI 10.1038/362795a0; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; YANAI I, 2002, CURR BIOL, V3, P24; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799	34	572	613	4	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1703	1706		10.1126/science.1085544	http://dx.doi.org/10.1126/science.1085544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805537				2022-12-01	WOS:000183459700038
J	Zazula, GD; Froese, DG; Schweger, CE; Mathewes, RW; Beaudoin, AB; Telka, AM; Harington, CR; Westgate, JA				Zazula, GD; Froese, DG; Schweger, CE; Mathewes, RW; Beaudoin, AB; Telka, AM; Harington, CR; Westgate, JA			Ice-age steppe vegetation in east Beringia - Tiny plant fossils indicate how this frozen region once sustained huge herds of mammals	NATURE			English	Article							ALASKA; TUNDRA		Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; Simon Fraser Univ, Dept Earth Sci, Burnaby, BC V5A 1S6, Canada; Prov Museum Alberta, Edmonton, AB T5N 0M6, Canada; Univ Alberta, Dept Anthropol, Edmonton, AB T6G 2H4, Canada; PALEOTEC Serv, W Ottawa, ON K1R 5K2, Canada; Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada	Simon Fraser University; Simon Fraser University; University of Alberta; University of Toronto	Zazula, GD (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.		Froese, Duane G/B-6038-2009; Beaudoin, Alwynne B./H-3873-2011	Beaudoin, Alwynne B./0000-0002-8895-4567; MATHEWES, ROLF/0000-0001-7637-199X				ANDERSON PM, 1994, QUATERNARY SCI REV, V13, P71, DOI 10.1016/0277-3791(94)90125-2; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; CWYNAR LC, 1980, SCIENCE, V208, P1375, DOI 10.1126/science.208.4450.1375; EDWARDS ME, 1989, ARCTIC ALPINE RES, V21, P296, DOI 10.2307/1551569; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Froese D, 2002, QUATERNARY SCI REV, V21, P2137, DOI 10.1016/S0277-3791(02)00038-0; Goetcheus VG, 2001, QUATERNARY SCI REV, V20, P135, DOI 10.1016/S0277-3791(00)00127-X; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Harington C.R., 1996, Current Research in the Pleistocene, V13, P105; Vetter MA, 2000, ARCTIC, V53, P165	10	77	79	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					603	603		10.1038/423603a	http://dx.doi.org/10.1038/423603a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789326	Bronze			2022-12-01	WOS:000183301200027
J	Arlt, W; Allolio, B				Arlt, W; Allolio, B			Adrenal insufficiency	LANCET			English	Review							GLUCOCORTICOID REPLACEMENT THERAPY; DAILY CORTISOL PRODUCTION; BONE-MINERAL DENSITY; ADRENOCORTICOTROPIN STIMULATION TEST; CORTICOTROPIN-RELEASING-HORMONE; INSULIN-INDUCED HYPOGLYCEMIA; AUTOIMMUNE ADDISONS-DISEASE; STEROID-PRODUCING CELLS; KEARNS-SAYRE-SYNDROME; DOSE METYRAPONE TEST	Adrenal insufficiency is caused by either primary adrenal failure (mostly due to autoimmune adrenalitis) or by hypothalamic-pituitary impairment of the corticotropic axis (predominantly due to pituitary disease). It is a rare disease, but is life threatening when overlooked. Main presenting symptoms such as fatigue, anorexia, and weight loss are nonspecific, thus diagnosis is often delayed. The diagnostic work-up is well established but some pitfalls remain, particularly in the identification of secondary adrenal insufficiency. Despite optimised life-saving glucocorticoid-replacement and mineralocorticoid-replacement therapy, health-related quality of life in adrenal insufficiency is more severely impaired than previously thought. Dehydroeplandrosterone-replacement therapy has been introduced that could help to restore quality of life. Monitoring of glucocorticoid-replacement quality is hampered by lack of objective methods of assessment, and is therefore largely based on clinical grounds. Thus, long-term management of patients with adrenal insufficiency remains a challenge, requiring an experienced specialist. However, all doctors should know how to diagnose and manage suspected acute adrenal failure.	Univ Wurzburg, Dept Med, Endocrine & Diabet Unit, D-97080 Wurzburg, Germany; Univ Birmingham, Div Med Sci, Birmingham, W Midlands, England	University of Wurzburg; University of Birmingham	Allolio, B (corresponding author), Univ Wurzburg, Dept Med, Endocrine & Diabet Unit, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	allolio_b@klinik.uni.wuerzburg.de	Arlt, Wiebke/B-6310-2009	Arlt, Wiebke/0000-0001-5106-9719				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; ALLOLIO B, 1990, CLIN ENDOCRINOL, V33, P279, DOI 10.1111/j.1365-2265.1990.tb00492.x; ALLOLIO B, 1983, LANCET, V2, P626; Allolio B, 2002, TRENDS ENDOCRIN MET, V13, P288, DOI 10.1016/S1043-2760(02)00617-3; ALLOLIO B, 1994, CLIN ENDOCRINOL, V40, P769, DOI 10.1111/j.1365-2265.1994.tb02511.x; Allolio B, 1985, AKT ENDOKR STOFFW, V6, P35; ALSHOUMER KAS, 1995, CLIN ENDOCRINOL, V42, P85, DOI 10.1111/j.1365-2265.1995.tb02602.x; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Auchus RJ, 1997, CLIN ENDOCRINOL, V46, P21, DOI 10.1046/j.1365-2265.1997.d01-1748.x; BARBATO AL, 1977, ACTA ENDOCRINOL-COP, V84, P600, DOI 10.1530/acta.0.0840600; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Beishuizen A, 2001, BEST PRACT RES CL EN, V15, P513, DOI 10.1053/beem.2001.0167; Betterle C, 1999, J CLIN ENDOCR METAB, V84, P618, DOI 10.1210/jc.84.2.618; Betterle C, 2002, ENDOCR REV, V23, P327, DOI 10.1210/er.23.3.327; Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902; BORST GC, 1982, NEW ENGL J MED, V306, P1462, DOI 10.1056/NEJM198206173062405; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; BRAATVEDT GD, 1990, BRIT MED J, V301, P1312, DOI 10.1136/bmj.301.6764.1312; Braatvedt GD, 1999, OSTEOPOROSIS INT, V10, P435, DOI 10.1007/s001980050251; Brandon DD, 1999, STEROIDS, V64, P372, DOI 10.1016/S0039-128X(98)00112-3; BRIEGEL J, 1992, INTENS CARE MED, V18, P318, DOI 10.1007/BF01706486; BROIDE J, 1995, J CLIN ENDOCR METAB, V80, P1243, DOI 10.1210/jc.80.4.1243; BURCH WM, 1982, JAMA-J AM MED ASSOC, V247, P2002, DOI 10.1001/jama.247.14.2002; Clark PM, 1998, CLIN ENDOCRINOL, V49, P287; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P309; CUNNINGHAM SK, 1983, ARCH INTERN MED, V143, P2276, DOI 10.1001/archinte.143.12.2276; De Vroede M, 1998, ARCH DIS CHILD, V78, P544, DOI 10.1136/adc.78.6.544; DICKSTEIN G, 1986, ACTA ENDOCRINOL-COP, V112, P28, DOI 10.1530/acta.0.1120028; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; DIEDERICH S, 1994, DEUT MED WOCHENSCHR, V119, P595, DOI 10.1055/s-2008-1058735; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; DRUCKER D, 1986, CRIT CARE MED, V14, P789, DOI 10.1097/00003246-198609000-00006; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; Fallo F, 1999, EUR J ENDOCRINOL, V140, P425, DOI 10.1530/eje.0.1400425; FALLO F, 1994, AM J HYPERTENS, V7, P1105, DOI 10.1093/ajh/7.12.1105; FEEK CM, 1981, CLIN ENDOCRINOL, V14, P451, DOI 10.1111/j.1365-2265.1981.tb00634.x; FEEK CM, 1981, CLIN ENDOCRINOL, V15, P75, DOI 10.1111/j.1365-2265.1981.tb02750.x; FIAD TM, 1994, CLIN ENDOCRINOL, V40, P603, DOI 10.1111/j.1365-2265.1994.tb03011.x; FINDLING JW, 1994, J CLIN ENDOCR METAB, V79, P1091, DOI 10.1210/jc.79.4.1091; FINDLING JW, 1987, J CLIN ENDOCR METAB, V64, P592, DOI 10.1210/jcem-64-3-592; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Flemming TG, 1999, J INTERN MED, V246, P497, DOI 10.1046/j.1365-2796.1999.00538.x; FLORKOWSKI CM, 1994, NEW ZEAL MED J, V107, P52; FRANCKE U, 1987, AM J HUM GENET, V40, P212; Glowniak JV, 1997, SURGERY, V121, P123, DOI 10.1016/S0039-6060(97)90280-4; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; GROVES RW, 1988, J ROY SOC MED, V81, P514, DOI 10.1177/014107688808100906; HAGG E, 1987, CLIN ENDOCRINOL, V26, P221, DOI 10.1111/j.1365-2265.1987.tb00780.x; Handschug K, 2001, HUM MOL GENET, V10, P283, DOI 10.1093/hmg/10.3.283; Hangaard J, 1996, J CLIN ENDOCR METAB, V81, P2502, DOI 10.1210/jc.81.7.2502; HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x; Henzen C, 2000, LANCET, V355, P542, DOI 10.1016/S0140-6736(99)06290-X; Howlett TA, 1997, CLIN ENDOCRINOL, V46, P263, DOI 10.1046/j.1365-2265.1997.1340955.x; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Inder WJ, 2002, J CLIN ENDOCR METAB, V87, P2745, DOI 10.1210/jc.87.6.2745; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P2046, DOI 10.1210/jc.87.5.2046; JURNEY TH, 1987, CHEST, V92, P292, DOI 10.1378/chest.92.2.292; Kannisto S, 2000, J CLIN ENDOCR METAB, V85, P652, DOI 10.1210/jc.85.2.652; Kasperlik-Zaluska AA, 1998, CLIN ENDOCRINOL, V49, P779, DOI 10.1046/j.1365-2265.1998.00611.x; Kawashima A, 1998, RADIOGRAPHICS, V18, P393, DOI 10.1148/radiographics.18.2.9536486; KEHLET H, 1976, CLIN ENDOCRINOL, V5, P37, DOI 10.1111/j.1365-2265.1976.tb03801.x; Kemp EH, 1998, CLIN ENDOCRINOL, V49, P609; KERRIGAN JR, 1993, J CLIN ENDOCR METAB, V76, P1505, DOI 10.1210/jc.76.6.1505; Knapen MH, 1993, ADDISON PATIENTS NET; KONG MF, 1994, CLIN ENDOCRINOL, V41, P757, DOI 10.1111/j.1365-2265.1994.tb02790.x; Kraan GPB, 1998, J CLIN ENDOCR METAB, V83, P1247, DOI 10.1210/jc.83.4.1247; Krasner AS, 1999, JAMA-J AM MED ASSOC, V282, P671, DOI 10.1001/jama.282.7.671; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lam KY, 2001, CLIN ENDOCRINOL, V54, P633, DOI 10.1046/j.1365-2265.2001.01266.x; Lamberts SWJ, 1997, NEW ENGL J MED, V337, P1285, DOI 10.1056/NEJM199710303371807; LANDON J, 1966, J CLIN INVEST, V45, P437, DOI 10.1172/JCI105358; Lange M, 2002, EUR J ENDOCRINOL, V147, P41, DOI 10.1530/eje.0.1470041; Laureti S, 1999, J CLIN ENDOCR METAB, V84, P1762, DOI 10.1210/jc.84.5.1762; LEBRETHON MC, 1994, J CLIN INVEST, V93, P1828, DOI 10.1172/JCI117168; LEDINGHAM IM, 1983, LANCET, V1, P1270; Lindholm J, 2001, CLIN ENDOCRINOL, V54, P283, DOI 10.1046/j.1365-2265.2001.01163.x; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; Lovas K, 2002, CLIN ENDOCRINOL, V56, P581, DOI 10.1046/j.1365-2265.2002.01466.x; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; Lutz A, 2000, EUR J ENDOCRINOL, V143, P91, DOI 10.1530/eje.0.1430091; MAISEY DN, 1974, LANCET, V2, P896; MASON AS, 1968, LANCET, V2, P744; Mayenknecht J, 1998, J CLIN ENDOCR METAB, V83, P1558, DOI 10.1210/jc.83.5.1558; Monson JP, 1997, CLIN ENDOCRINOL, V46, P269, DOI 10.1046/j.1365-2265.1997.87897.x; Moser HW, 1997, BRAIN, V120, P1485, DOI 10.1093/brain/120.8.1485; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Murphy H, 1998, J CLIN ENDOCR METAB, V83, P712; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NELSON JC, 1978, AM J MED SCI, V275, P165, DOI 10.1097/00000441-197803000-00006; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; NEUFELD M, 1981, MEDICINE, V60, P355, DOI 10.1097/00005792-198109000-00003; Nilsson B, 2000, J CLIN ENDOCR METAB, V85, P1420, DOI 10.1210/jc.85.4.1420; NUSSEY SS, 1993, CLIN ENDOCRINOL, V39, P381, DOI 10.1111/j.1365-2265.1993.tb02381.x; OELKERS W, 1989, NEW ENGL J MED, V321, P492, DOI 10.1056/NEJM198908243210802; OELKERS W, 1992, J CLIN ENDOCR METAB, V75, P259, DOI 10.1210/jc.75.1.259; Oelkers W, 1998, EUR J ENDOCRINOL, V139, P567, DOI 10.1530/eje.0.1390567; Peacey SR, 1997, CLIN ENDOCRINOL, V46, P255, DOI 10.1046/j.1365-2265.1997.780907.x; POWRIE JK, 1995, CLIN ENDOCRINOL, V42, P315, DOI 10.1111/j.1365-2265.1995.tb01881.x; Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; REINCKE M, 1993, J CLIN ENDOCR METAB, V77, P151, DOI 10.1210/jc.77.1.151; RHEAUME E, 1992, NAT GENET, V1, P239, DOI 10.1038/ng0792-239; RIEDEL M, 1993, EXP CLIN ENDOCRINOL, V101, P106, DOI 10.1055/s-0029-1211215; ROBINSON BG, 1987, CLIN ENDOCRINOL, V27, P437, DOI 10.1111/j.1365-2265.1987.tb01171.x; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; SALEM M, 1994, ANN SURG, V219, P416, DOI 10.1097/00000658-199404000-00013; Satta MA, 2000, CLIN ENDOCRINOL, V52, P123; SAWCZUK IS, 1986, UROL RADIOL, V8, P44, DOI 10.1007/BF02924072; SCHULTE HM, 1987, CLIN ENDOCRINOL, V27, P655, DOI 10.1111/j.1365-2265.1987.tb02948.x; SCOTT RS, 1978, CLIN ENDOCRINOL, V9, P571, DOI 10.1111/j.1365-2265.1978.tb01516.x; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; STEIN CA, 1986, ANN INTERN MED, V104, P286, DOI 10.7326/0003-4819-104-2-286_2; STEWART PM, 1988, LANCET, V1, P1208; Stewart PM, 1998, CLIN ENDOCRINOL, V48, P124, DOI 10.1046/j.1365-2265.1998.0429d.x; Streeten DHP, 1996, J CLIN ENDOCR METAB, V81, P285, DOI 10.1210/jc.81.1.285; Tajima T, 2001, J CLIN ENDOCR METAB, V86, P3820, DOI 10.1210/jc.86.8.3820; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; Thomas PQ, 2001, HUM MOL GENET, V10, P39, DOI 10.1093/hmg/10.1.39; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; TORDJMAN K, 1995, J CLIN ENDOCR METAB, V80, P1301, DOI 10.1210/jc.80.4.1301; Tordjman K, 2000, CLIN ENDOCRINOL, V52, P633, DOI 10.1046/j.1365-2265.2000.00984.x; TSATSOULIS A, 1988, CLIN ENDOCRINOL, V28, P225, DOI 10.1111/j.1365-2265.1988.tb03659.x; TSIGOS C, 1993, J CLIN INVEST, V92, P2458, DOI 10.1172/JCI116853; Tuchelt H, 2000, CLIN ENDOCRINOL, V53, P301, DOI 10.1046/j.1365-2265.2000.01089.x; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; VASIKARAN SD, 1994, CLIN ENDOCRINOL, V41, P261, DOI 10.1111/j.1365-2265.1994.tb02540.x; Vilain E, 1999, J CLIN ENDOCR METAB, V84, P4335, DOI 10.1210/jc.84.12.4335; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; WATTS NB, 1988, JAMA-J AM MED ASSOC, V259, P708, DOI 10.1001/jama.259.5.708; WEBER A, 1994, HUM MOL GENET, V3, P585, DOI 10.1093/hmg/3.4.585; WEETMAN AP, 1995, BAILLIERE CLIN ENDOC, V9, P157, DOI 10.1016/S0950-351X(95)80899-X; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182; Wichers M, 1999, CLIN ENDOCRINOL, V50, P759, DOI 10.1046/j.1365-2265.1999.00723.x; Willis AC, 1997, POSTGRAD MED J, V73, P286, DOI 10.1136/pgmj.73.859.286; WINQVIST O, 1992, LANCET, V339, P1559, DOI 10.1016/0140-6736(92)91829-W; WOOD JB, 1965, LANCET, V1, P243; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zelissen P, 1994, ADDISON PATIENTS NET; ZELISSEN PMJ, 1994, ANN INTERN MED, V120, P207, DOI 10.7326/0003-4819-120-3-199402010-00005	146	602	630	0	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2003	361	9372					1881	1893		10.1016/S0140-6736(03)13492-7	http://dx.doi.org/10.1016/S0140-6736(03)13492-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788587				2022-12-01	WOS:000183205800024
J	Wilson, JF				Wilson, JF			The vaccine crossroads	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2003	138	10					857	860		10.7326/0003-4819-138-10-200305200-00037	http://dx.doi.org/10.7326/0003-4819-138-10-200305200-00037			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KH	12755580				2022-12-01	WOS:000182920700029
J	Cosma, MP; Pepe, S; Annunziata, I; Newbold, RF; Grompe, M; Parenti, G; Ballabio, A				Cosma, MP; Pepe, S; Annunziata, I; Newbold, RF; Grompe, M; Parenti, G; Ballabio, A			The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases	CELL			English	Article							ENZYME REPLACEMENT THERAPY; METACHROMATIC LEUKODYSTROPHY; ARYLSULFATASE-A; STEROID SULFATASE; FELINE MODEL; COMPLEMENTATION; FORMYLGLYCINE; FIBROBLASTS; EXPRESSION; SYSTEM	In multiple sulfatase deficiency (MSD), a human inherited disorder, the activities of all sulfatases are impaired due to a defect in posttranslational modification. Here we report the identification, by functional complementation using microcell-mediated chromosome transfer, of a gene that is mutated in MSD and is able to rescue the enzymatic deficiency in patients' cell lines. Functional conservation of this gene was observed among distantly related species, suggesting a critical biological role. Coexpression of SUMF1 with sulfatases results in a strikingly synergistic increase of enzymatic activity, indicating that SUMF1 is both an essential and a limiting factor for sulfatases. These data have profound implications on the feasibility of enzyme replacement therapy for eight distinct inborn errors of metabolism.	Telethon Inst Genet & Med, I-80131 Naples, Italy; Univ Naples Federico 2, Dept Pediat, I-80131 Naples, Italy; Brunel Univ, Brunel Inst Canc Genet & Pharmacogenom, Uxbridge UB8 4SP, Middx, England; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Univ Naples 2, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Brunel University; Oregon Health & Science University; Universita della Campania Vanvitelli	Ballabio, A (corresponding author), Telethon Inst Genet & Med, I-80131 Naples, Italy.	ballabio@tigem.it	BALLABIO, Andrea/AAL-2672-2020; Cosma, Maria Pia/E-8731-2015	BALLABIO, Andrea/0000-0003-1381-4604; Cosma, Maria Pia/0000-0003-4207-5097; Grompe, Markus/0000-0002-6616-4345; parenti, giancarlo/0000-0002-6287-5748	Telethon [TGM03S01, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		BALLABIO A, 1985, HUM GENET, V70, P315, DOI 10.1007/BF00295367; BALLABIO A, 2001, METABOLIC MOL BASIS, P4241; BISCHEL M, 1966, ARCH NEUROL-CHICAGO, V15, P13, DOI 10.1001/archneur.1966.00470130017002; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BURCH M, 1986, CLIN GENET, V30, P409; BURK R, 1981, AM J HUM GENET, V33, pA72; Byers S, 2000, PEDIATR RES, V47, P743, DOI 10.1203/00006450-200006000-00010; CHANG PL, 1980, P NATL ACAD SCI-BIOL, V77, P6166, DOI 10.1073/pnas.77.10.6166; CONARY JT, 1988, BIOL CHEM H-S, V369, P297, DOI 10.1515/bchm3.1988.369.1.297; Consiglio A, 2001, NAT MED, V7, P310, DOI 10.1038/85454; COUCHOT J, 1974, ARCH FR PEDIATR, V31, P775; Crawley AC, 1997, J CLIN INVEST, V99, P651, DOI 10.1172/JCI119208; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; FRANCA JRD, 1995, J ATMOS CHEM, V22, P81; Ho TT, 2002, J GENE MED, V4, P613, DOI 10.1002/jgm.302; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; HORWITZ AL, 1979, P NATL ACAD SCI USA, V76, P6496, DOI 10.1073/pnas.76.12.6496; Hunt JD, 1996, ANAL BIOCHEM, V238, P107, DOI 10.1006/abio.1996.0263; Imreh S, 1997, GENE CHROMOSOME CANC, V20, P224; Kolodny E.H., 1995, METABOLIC MOL BASES, V7th, P2693; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Matzner U, 2000, GENE THER, V7, P1250, DOI 10.1038/sj.gt.3301232; Matzner U, 2002, GENE THER, V9, P53, DOI 10.1038/sj.gt.3301593; Meroni G, 1996, HUM MOL GENET, V5, P423, DOI 10.1093/hmg/5.4.423; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, V3, DOI DOI 10.1036/OMMBID.165; Parenti G, 1997, CURR OPIN GENET DEV, V7, P386, DOI 10.1016/S0959-437X(97)80153-0; Saeki Y, 2001, MOL THER, V3, P591, DOI 10.1006/mthe.2001.0294; Schiller NG, 1998, IDENTITIES-GLOB STUD, V5, P1; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; STEIN C, 1989, J BIOL CHEM, V264, P1252; Toietta G, 2001, HUM GENE THER, V12, P2007, DOI 10.1089/104303401753204571; von Figura K., 2001, METABOLIC MOL BASES, V8th ed., P3695; Wade-Martins R, 2001, NAT BIOTECHNOL, V19, P1067, DOI 10.1038/nbt1101-1067; ZENGER J L, 1989, American Journal of Human Genetics, V45, pA70	40	257	291	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					445	456		10.1016/S0092-8674(03)00348-9	http://dx.doi.org/10.1016/S0092-8674(03)00348-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757706	Bronze			2022-12-01	WOS:000182981500007
J	Dierks, T; Schmidt, B; Borissenko, LV; Peng, JH; Preusser, A; Mariappan, M; von Figura, K				Dierks, T; Schmidt, B; Borissenko, LV; Peng, JH; Preusser, A; Mariappan, M; von Figura, K			Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C-alpha-formylglycine generating enzyme	CELL			English	Article							HUMAN ARYLSULFATASE-A; ENDOPLASMIC-RETICULUM; POSTTRANSLATIONAL FORMATION; EUKARYOTIC SULFATASES; PROTEIN MODIFICATION; CRYSTAL-STRUCTURE; CYSTEINE; CONVERSION; FIBROBLASTS; MECHANISM	C-alpha-formylglycine (FGly) is the catalytic residue in the active site of eukaryotic sulfatases. It is posttranslationally generated from a cysteine in the endoplasmic reticulum. The genetic defect of FGly formation causes multiple sulfatase deficiency (MSD), a lysosomal storage disorder. We purified the FGly generating enzyme (FGE) and identified its gene and nine mutations in seven MSD patients. In patient fibroblasts, the activity of sulfatases is partially restored by transduction of FGE encoding cDNA, but not by cDNA carrying an MSD mutation. The gene encoding FGE is highly conserved among pro- and eukaryotes and has a paralog of unknown function in vertebrates. FGE is localized in the endoplasmic reticulum and is predicted to have a tripartite domain structure.	Univ Gottingen, D-37073 Gottingen, Germany	University of Gottingen	von Figura, K (corresponding author), Univ Gottingen, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.	kfigura@gwdg.de	mariappan, malaiyalam/K-9024-2012; Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANSON DS, 1993, BIOCHEM J, V294, P657, DOI 10.1042/bj2940657; ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; BASNER R, 1979, PEDIATR RES, V13, P1316, DOI 10.1203/00006450-197912000-00002; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; BURCH M, 1986, CLIN GENET, V30, P409; BURK RD, 1984, J PEDIATR-US, V104, P574, DOI 10.1016/S0022-3476(84)80550-8; CHANG PL, 1983, J INHERIT METAB DIS, V6, P167, DOI 10.1007/BF02310875; CONARY JT, 1988, BIOL CHEM H-S, V369, P297, DOI 10.1515/bchm3.1988.369.1.297; COUCHOT J, 1974, ARCH FR PEDIATR, V31, P775; Dierks T, 1998, FEBS LETT, V423, P61, DOI 10.1016/S0014-5793(98)00065-9; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; FLUHARTY AL, 1979, AM J HUM GENET, V31, P574; FLUHARTY AL, 1978, AM J HUM GENET, V30, P249; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; KRESSE H, 1980, BIOCHEM BIOPH RES CO, V97, P41, DOI 10.1016/S0006-291X(80)80131-8; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, V3, DOI DOI 10.1036/OMMBID.165; Peng JH, 2003, J MASS SPECTROM, V38, P80, DOI 10.1002/jms.404; Rampini S, 1970, Helv Paediatr Acta, V25, P436; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROMMERSKIRCH W, 1992, P NATL ACAD SCI USA, V89, P2561, DOI 10.1073/pnas.89.7.2561; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; STECKEL F, 1985, EUR J BIOCHEM, V151, P141, DOI 10.1111/j.1432-1033.1985.tb09078.x; Szameit C, 1999, J BIOL CHEM, V274, P15375, DOI 10.1074/jbc.274.22.15375; Thiel C, 2002, BIOCHEM J, V367, P195, DOI 10.1042/BJ20020794; VAMOS E, 1981, J INHERIT METAB DIS, V4, P103, DOI 10.1007/BF02263612; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; YUTAKA T, 1981, CLIN GENET, V20, P296	44	269	304	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2003	113	4					435	444		10.1016/S0092-8674(03)00347-7	http://dx.doi.org/10.1016/S0092-8674(03)00347-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757705	Bronze			2022-12-01	WOS:000182981500006
J	Garfield, CF; Chung, PJ; Rathouz, PJ				Garfield, CF; Chung, PJ; Rathouz, PJ			Alcohol advertising in magazines and adolescent readership	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRINKING; SCHOOL	Context Adolescent drinking is a major public health concern. The federal government does not restrict alcohol advertising to adolescents, but relies on the alcohol industry for self-regulation. Objectives To investigate recent alcohol advertising in magazines and to determine whether advertising frequency is associated with adolescent readership. Design, Setting, and Subjects All alcohol advertisements were counted that appeared from 1997-2001 in 35 of 48 major US magazines, which tracked their adolescent readership (3 refused all alcohol advertisements; and advertisement counts were unavailable for 10). Variation was assessed in the advertisement placement frequency for each major category of alcohol (beer, wine and wine coolers, and distilled liquor) by a magazine's adolescent readership (age 12-19 years), young adult readership (age 20-24 years), and older adult readership (age greater than or equal to25 years); readership demographics (sex, race, and income); year; frequency of publication; and cost per advertisement. Main Outcome Measure Variation in alcohol advertising frequency by adolescent readership. Results Adolescent readership ranged from 1.0 to 7.1 million. The alcohol industry placed 9148 advertisements at a cost of $696 million. Of the 9148 advertisements, 1201 (13%) were for beer, 443 (5%) for wine, and 7504 (82%) for liquor. After adjustment for other magazine characteristics, the advertisement rate ratio was 1.6 times more for beer (95% confidence interval [CI], 1.0-2.6; P=.05) and liquor (95% CI, 1.1-2.3; P=.01) for every additional million adolescent readers. Wine industry advertising was not associated with adolescent readership. Conclusions Magazine advertising by the beer and liquor industries is associated with adolescent readership. industry and federal policymakers should examine ways to regulate advertising that reaches large numbers of adolescents.	Evanston NW Healthcare Res Inst, Dept Pediat, Evanston, IL 60202 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago	Garfield, CF (corresponding author), Evanston NW Healthcare Res Inst, Dept Pediat, 2650 Ridge Ave, Evanston, IL 60202 USA.	c-garfield@northwestern.edu	Garfield, Craig/AAE-2525-2020	Garfield, Craig/0000-0002-6512-6005				*AM COLL EM PHYS, 2001, ANN EMERG MED, V37, P557; [Anonymous], 1999, Pediatrics, V104, P341; Atkin, 1993, Adolesc Med, V4, P527; ATKIN CK, 1990, J ADOLESCENT HEALTH, V11, P10, DOI 10.1016/0197-0070(90)90125-L; ATKIN CK, 1984, J COMMUN, V28, P71; Chung PJ, 2002, HEALTH AFFAIR, V21, P254, DOI 10.1377/hlthaff.21.2.254; *COMP MED REP, 2001, TARG 2 CONS MAG OCC; *FED TRAD COMM, SELF REG ALC IND REV; Foster SE, 2003, JAMA-J AM MED ASSOC, V289, P989, DOI 10.1001/jama.289.8.989; *GEORG U CTR ALC M, 2002, OV YOUTH TARG ALC AD; GRUBE JW, 1994, AM J PUBLIC HEALTH, V84, P254, DOI 10.2105/AJPH.84.2.254; Grube JW, 1995, EFFECTS MASS MEDIA U, V28, P105; IACOBUCCI D, 2001, KELLOGG MARKETING; Jacobs EA, 2001, PEDIATRICS, V108, P185, DOI 10.1542/peds.108.1.185; Johnston L, 2003, MONITORING FUTURE NA; JOHNSTON LD, 1996, NIH PUBLICATION, V1; MADDEN PA, 1994, AM J PUBLIC HEALTH, V84, P297, DOI 10.2105/AJPH.84.2.297; Martin SE, 2002, ALCOHOL CLIN EXP RES, V26, P900, DOI 10.1097/00000374-200206000-00021; *MED RES INC, 2000, MED REP; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS 1997; *NAT I ALC AB ALC, 1997, YOUTH DRINK RISK FAC; *NAT I ALC AB ALC, 1996, ALC AL 31 DRINK DRIV; *OFF INSP GEN, 1992, YOUTH ALC DANG DEADL; SHELOV S, 1995, PEDIATRICS, V95, P295; Snyder LB, 2000, J STUD ALCOHOL, V61, P896, DOI 10.15288/jsa.2000.61.896; Strasburger, 1993, Adolesc Med, V4, P391; Strasburger VC, 2002, PEDIATR CLIN N AM, V49, P353, DOI 10.1016/S0031-3955(01)00009-8; STRUNIN L, 1992, INT J ADDICT, V27, P129, DOI 10.3109/10826089209068734; *US DEP HHS, 2000, HLTH PEOPL 2010 UND; *US DEP HHS, 1997, 9 SPEC REP US C ALC; Valois RF, 1999, J ADOLESCENT HEALTH, V25, P328, DOI 10.1016/S1054-139X(99)00051-8; Wechsler H, 1998, J AM COLL HEALTH, V47, P57, DOI 10.1080/07448489809595621; 1991, MMWR MORB MORTAL WKL, V40, P178; 2001, US WINE MARKET IMPAC; 2002, US BEER MARKET IMPAC; 2001, US SPIRITS MARKET IM	36	48	49	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2003	289	18					2424	2429		10.1001/jama.289.18.2424	http://dx.doi.org/10.1001/jama.289.18.2424			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	677WF	12746369				2022-12-01	WOS:000182831200035
J	Wardle, DA; Hornberg, G; Zackrisson, O; Kalela-Brundin, M; Coomes, DA				Wardle, DA; Hornberg, G; Zackrisson, O; Kalela-Brundin, M; Coomes, DA			Long-term effects of wildfire on ecosystem properties across an island area gradient	SCIENCE			English	Article							TERRESTRIAL ECOSYSTEMS; CARBON STORAGE; BOREAL FOREST; FIRE; GRASSLAND; BUDGET; SINK	Boreal forest soils play an important role in the global carbon cycle by functioning as a large terrestrial carbon sink or source, and the alteration of fire regime through global change phenomena may influence this role. We studied a system of forested lake islands in the boreal zone of Sweden for which fire frequency increases with increasing island size. Large islands supported higher plant productivity and litter decomposition rates than did smaller ones, and, with increasing time since fire, litter decomposition rates were suppressed sooner than was ecosystem productivity. This contributes to greater carbon storage with increasing time since fire; for every century without a major fire, an additional 0.5 kilograms per square meter of carbon becomes stored in the humus.	Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden; Landcare Res, Lincoln, New Zealand; Museum Forestry, SE-92123 Lycksele, Sweden; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	Swedish University of Agricultural Sciences; Landcare Research - New Zealand; University of Cambridge	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden.		Coomes, David/H-5630-2011; Wardle, David A./F-6031-2011	Wardle, David A./0000-0002-0476-7335				ANDERSON JM, 1991, ECOL APPL, V1, P326, DOI 10.2307/1941761; BONAN GB, 1989, ANNU REV ECOL SYST, V20, P1, DOI 10.1146/annurev.es.20.110189.000245; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; FLANNIGAN MD, 1991, CANADIAN J FOREST RE, V21, P61; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.1890/1051-0761(2002)012[0891:FCSITN]2.0.CO;2; HAAPASAARI M, 1998, ACTA FOR FENN, V135, P1; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P145, DOI 10.1046/j.1365-2699.2000.00164.x; Hurtt GC, 2002, P NATL ACAD SCI USA, V99, P1389, DOI 10.1073/pnas.012249999; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Larsen CPS, 1997, J BIOGEOGR, V24, P663, DOI 10.1111/j.1365-2699.1997.tb00076.x; OJIMA DS, 1994, BIOGEOCHEMISTRY, V24, P67, DOI 10.1007/BF02390180; PAYETTE S, 1992, P144, DOI 10.1017/CBO9780511565489.006; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; SIREN GUSTAF, 1955, ACTA FOREST FENNICA, V62, P1; Tilman D, 2000, ECOLOGY, V81, P2680, DOI 10.1890/0012-9658(2000)081[2680:FSAECS]2.0.CO;2; Wardle DA, 2002, J BIOGEOGR, V29, P583, DOI 10.1046/j.1365-2699.2002.00708.x; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; ZACKRISSON O, 1977, OIKOS, V29, P22, DOI 10.2307/3543289	22	223	232	9	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					972	975		10.1126/science.1082709	http://dx.doi.org/10.1126/science.1082709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738863				2022-12-01	WOS:000182719800055
J	Hillier, LW; Fulton, RS; Fulton, LA; Graves, TA; Pepin, KH; Wagner-McPherson, C; Layman, D; Maas, J; Jaeger, S; Walker, R; Wylie, K; Sekhon, M; Becker, MC; O'Laughlin, MD; Schaller, ME; Fewell, GA; Delehaunty, KD; Miner, TL; Nash, WE; Cordes, M; Du, H; Sun, H; Edwards, J; Bradshaw-Cordum, H; Ali, J; Andrews, S; Isak, A; VanBrunt, A; Nguyen, C; Du, FY; Lamar, B; Courtney, L; Kalicki, J; Ozersky, P; Bielicki, L; Scott, K; Holmes, A; Harkins, R; Harris, A; Strong, CM; Hou, SF; Tomlinson, C; Dauphin-Kohlberg, S; Kozlowicz-Reilly, A; Leonard, S; Rohlfing, T; Rock, SM; Tin-Wollam, AM; Abbott, A; Minx, P; Maupin, R; Strowmatt, C; Latreille, P; Miller, N; Johnson, D; Murray, J; Woessner, JP; Wendl, MC; Yang, SP; Schultz, BR; Wallis, JW; Spieth, J; Bieri, TA; Nelson, JO; Berkowicz, N; Wohldmann, PE; Cook, LL; Hickenbotham, MT; Eldred, J; Williams, D; Bedell, JA; Mardis, ER; Clifton, SW; Chissoe, SL; Marra, MA; Raymond, C; Haugen, E; Gillett, W; Zhou, Y; James, R; Phelps, K; Iadanoto, S; Bubb, K; Simms, E; Levy, R; Clendenning, J; Kaul, R; Kent, WJ; Furey, TS; Baertsch, RA; Brent, MR; Keibler, E; Flicek, P; Bork, P; Suyama, M; Bailey, JA; Portnoy, ME; Torrents, D; Chinwalla, AT; Gish, WR; Eddy, SR; McPherson, JD; Olson, MV; Eichler, EE; Green, ED; Waterston, RH; Wilson, RK				Hillier, LW; Fulton, RS; Fulton, LA; Graves, TA; Pepin, KH; Wagner-McPherson, C; Layman, D; Maas, J; Jaeger, S; Walker, R; Wylie, K; Sekhon, M; Becker, MC; O'Laughlin, MD; Schaller, ME; Fewell, GA; Delehaunty, KD; Miner, TL; Nash, WE; Cordes, M; Du, H; Sun, H; Edwards, J; Bradshaw-Cordum, H; Ali, J; Andrews, S; Isak, A; VanBrunt, A; Nguyen, C; Du, FY; Lamar, B; Courtney, L; Kalicki, J; Ozersky, P; Bielicki, L; Scott, K; Holmes, A; Harkins, R; Harris, A; Strong, CM; Hou, SF; Tomlinson, C; Dauphin-Kohlberg, S; Kozlowicz-Reilly, A; Leonard, S; Rohlfing, T; Rock, SM; Tin-Wollam, AM; Abbott, A; Minx, P; Maupin, R; Strowmatt, C; Latreille, P; Miller, N; Johnson, D; Murray, J; Woessner, JP; Wendl, MC; Yang, SP; Schultz, BR; Wallis, JW; Spieth, J; Bieri, TA; Nelson, JO; Berkowicz, N; Wohldmann, PE; Cook, LL; Hickenbotham, MT; Eldred, J; Williams, D; Bedell, JA; Mardis, ER; Clifton, SW; Chissoe, SL; Marra, MA; Raymond, C; Haugen, E; Gillett, W; Zhou, Y; James, R; Phelps, K; Iadanoto, S; Bubb, K; Simms, E; Levy, R; Clendenning, J; Kaul, R; Kent, WJ; Furey, TS; Baertsch, RA; Brent, MR; Keibler, E; Flicek, P; Bork, P; Suyama, M; Bailey, JA; Portnoy, ME; Torrents, D; Chinwalla, AT; Gish, WR; Eddy, SR; McPherson, JD; Olson, MV; Eichler, EE; Green, ED; Waterston, RH; Wilson, RK			The DNA sequence of human chromosome 7	NATURE			English	Article							HUMAN-CHROMOSOME 7; HUMAN-GENOME; GENE; MAP; IDENTIFICATION; DUPLICATION; INTEGRATION; ANNOTATION; EVOLUTION	Human chromosome 7 has historically received prominent attention in the human genetics community, primarily related to the search for the cystic fibrosis gene and the frequent cytogenetic changes associated with various forms of cancer. Here we present more than 153 million base pairs representing 99.4% of the euchromatic sequence of chromosome 7, the first metacentric chromosome completed so far. The sequence has excellent concordance with previously established physical and genetic maps, and it exhibits an unusual amount of segmentally duplicated sequence (8.2%), with marked differences between the two arms. Our initial analyses have identified 1,150 protein-coding genes, 605 of which have been confirmed by complementary DNA sequences, and an additional 941 pseudogenes. Of genes confirmed by transcript sequences, some are polymorphic for mutations that disrupt the reading frame.	Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Washington, Genome Ctr, Seattle, WA 98195 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Washington Univ, Dept Comp Sci, St Louis, MO 63130 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Case Western Reserve Univ, Sch Med, Ctr Computat Genome, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; Washington University (WUSTL); European Molecular Biology Laboratory (EMBL); Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	rwilson@watson.wustl.edu	Brent, Michael/AAK-3702-2020; McPherson, John D/D-2633-2017; Wendl, Michael C/A-2741-2008; Wilson, Richard K./AAF-4139-2019; Marra, Marco A/B-5987-2008; Mardis, Elaine/W-2202-2019; Sekhon, Mandeep/L-4665-2018; Bork, Peer/F-1813-2013; Torrents, David/G-5785-2015	Brent, Michael/0000-0002-8689-0299; McPherson, John D/0000-0001-8049-9347; Wilson, Richard K./0000-0002-1992-1358; Marra, Marco A/0000-0001-7146-7175; Sekhon, Mandeep/0000-0002-9993-6938; Bork, Peer/0000-0002-2627-833X; Suyama, Mikita/0000-0001-9526-3193; Schultz, Brian/0000-0003-4964-976X; Furey, Terry/0000-0001-5546-9672; Haugen, Eric/0000-0001-7444-8981; Eddy, Sean/0000-0001-6676-4706; Kaul, Rajinder/0000-0002-7895-9284; Chinwalla, Asif/0000-0001-7831-3996; Torrents, David/0000-0002-6086-9037; Flicek, Paul/0000-0002-3897-7955				ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Ashburner M, 2001, GENOME RES, V11, P1425; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; DeSilva U, 1999, GENOME RES, V9, P428; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Eichler EE, 1999, GENOME RES, V9, P1048, DOI 10.1101/gr.9.11.1048; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Felsenfeld A, 1999, GENOME RES, V9, P1; Flicek P, 2003, GENOME RES, V13, P46, DOI 10.1101/gr.830003; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; *HUM GEN MAPP CONS, 2001, NATURE, V409, P934; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MARAIA RJ, 1994, NUCLEIC ACIDS RES, V22, P3045, DOI 10.1093/nar/22.15.3045; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nadezhdin EV, 2001, MOL GENET GENOMICS, V265, P820; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohta T, 1995, J MOL EVOL, V41, P717, DOI 10.1007/BF00173150; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SOLOVYEV VV, 2001, STAT APPROACHES EUKA; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	49	198	992	1	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					157	U2		10.1038/nature01782	http://dx.doi.org/10.1038/nature01782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853948	Bronze			2022-12-01	WOS:000184032700033
J	Christensen, PR; Bandfield, JL; Bell, JF; Gorelick, N; Hamilton, VE; Ivanov, A; Jakosky, BM; Kieffer, HH; Lane, MD; Jakosky, BM; Kieffer, HH; Lane, MD; Malin, MC; McConnochie, T; McEwen, AS; McSween, HY; Mehall, GL; Moersch, JE; Nealson, KH; Rice, JW; Richardson, MI; Ruff, SW; Smith, MD; Titus, TN; Wyatt, MB				Christensen, PR; Bandfield, JL; Bell, JF; Gorelick, N; Hamilton, VE; Ivanov, A; Jakosky, BM; Kieffer, HH; Lane, MD; Jakosky, BM; Kieffer, HH; Lane, MD; Malin, MC; McConnochie, T; McEwen, AS; McSween, HY; Mehall, GL; Moersch, JE; Nealson, KH; Rice, JW; Richardson, MI; Ruff, SW; Smith, MD; Titus, TN; Wyatt, MB			Morphology and composition of the surface of Mars: Mars Odyssey THEMIS results	SCIENCE			English	Article							THERMAL INERTIA; MARTIAN SURFACE; WHITE ROCK; ORIGIN; SOIL	The Thermal Emission Imaging System (THEMIS) on Mars Odyssey has produced infrared to visible wavelength images of the martian surface that show lithologically distinct layers with variable thickness, implying temporal changes in the processes or environments during or after their formation. Kilometer-scale exposures of bedrockare observed; elsewhere airfall dust completely mantles the surface over thousands of square kilometers. Mars has compositional variations at 100-meter scales, for example, an exposure of olivine-rich basalt in the walls of Ganges Chasma. Thermally distinct ejecta facies occur around some craters with variations associated with crater age. Polar observations have identified temporal patches of water frost in the north polar cap. No thermal signatures associated with endogenic heat sources have been identified.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Colorado, LASP, Boulder, CO 80309 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Planetary Sci Inst, Phoenix, AZ 85032 USA; Malin Space Sci Syst, San Diego, CA 92191 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA; Univ So Calif, Los Angeles, CA 90089 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Arizona State University; Arizona State University-Tempe; Cornell University; University of Hawaii System; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Tennessee System; University of Tennessee Knoxville; University of Southern California; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	phil.christensen@asu.edu	Ivanov, Anton B/C-8944-2014; Smith, Michael/C-8875-2012; Moersch, Jeffrey E/F-7189-2010	Ivanov, Anton B/0000-0001-8376-8581; Moersch, Jeffrey E/0000-0003-3433-9419; Richardson, Mark/0000-0001-9633-4141; Bandfield, Joshua/0000-0003-3571-3716; Gorelick, Noel/0000-0002-5548-2436				ARVIDSON RE, IN PRESS J GEOPHYS R; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; Burr DM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013345; CARR MH, 1977, J GEOPHYS RES, V91, P3533; Christensen P., 1992, MARS SPACE SCI SERIE, P686; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; CHRISTENSEN PR, 1986, ICARUS, V68, P217, DOI 10.1016/0019-1035(86)90020-5; CHRISTENSEN PR, IN PRESS SPACE SCI R; GILLESPIE AR, 1986, REMOTE SENS ENVIRON, V20, P209, DOI 10.1016/0034-4257(86)90044-1; Jakosky BM, 2000, J GEOPHYS RES-PLANET, V105, P9643, DOI 10.1029/1999JE001088; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1976, SCIENCE, V194, P1344, DOI 10.1126/science.194.4271.1344; Lane MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001832; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; MOUGINISMARK P, 1979, J GEOPHYS RES, V84, P8011, DOI 10.1029/JB084iB14p08011; PALLUCONI FD, 1981, ICARUS, V45, P415, DOI 10.1016/0019-1035(81)90044-0; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6551, DOI 10.1029/96JE03303; Ruff SW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001580; Ruff SW, 2001, J GEOPHYS RES-PLANET, V106, P23921, DOI 10.1029/2000JE001329; Shorthill R. W., 1973, Moon, V7, P22, DOI 10.1007/BF00578805; Sullivan R, 2001, J GEOPHYS RES-PLANET, V106, P23607, DOI 10.1029/2000JE001296; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; Treiman AH, 1997, J GEOPHYS RES-PLANET, V102, P9153, DOI 10.1029/96JE03884; WILLIAMS SH, 1994, GEOLOGY, V22, P107, DOI 10.1130/0091-7613(1994)022<0107:WRAEML>2.3.CO;2	30	285	288	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2056	2061		10.1126/science.1080885	http://dx.doi.org/10.1126/science.1080885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12791998				2022-12-01	WOS:000183774900036
J	Fulton, JE; Delany, ME				Fulton, JE; Delany, ME			Poultry genetic resources - Operation rescue needed	SCIENCE			English	Editorial Material							FUTURE		Hy Line Int, Dallas Ctr, Dallas Ctr, IA 50063 USA; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Fulton, JE (corresponding author), Hy Line Int, Dallas Ctr, Dallas Ctr, IA 50063 USA.	medelany@ucdavis.edu						ABPLANALP H, 1990, IMMUNOGENETICS, V31, P291, DOI 10.1007/BF02115002; AUSTIN LM, 1995, AM J PATHOL, V146, P1529; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; Beck MM, 1998, POULTRY SCI, V77, P226, DOI 10.1093/ps/77.2.226; BRILLARD JP, COMMUNICATION; Chalah T, 1999, CRYOBIOLOGY, V39, P185, DOI 10.1006/cryo.1999.2201; Chang Il-Kuk, 1998, Japanese Poultry Science, V35, P321; Cheng K. S., COMMUNICATION; CHENG KM, 2003, STRATEGIC OPERATIONA; COEHLO CND, 1991, DEVELOPMENT, V113, P1487; Delany ME, 1998, POULT AVIAN BIOL REV, V9, P25; DELANY ME, 2003, POULTRY GENETICS BRE; ERF GF, 2002, MODERN CONCEPTS IMMU, P316; *FAO UN, WORLD WATCH LIST DOM; FITE KV, 1989, CURR EYE RES, V8, P1039, DOI 10.3109/02713688908997396; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Li ZD, 2002, POULTRY SCI, V81, P1360, DOI 10.1093/ps/81.9.1360; PETITTE JN, 2003, POULTRY GENETICS BRE; PISENTI JM, 1999, AVIAN GENETIC RESOUR; Punnett R. C, 1923, HEREDITY POULTRY HEREDITY POULTRY; SOMES RG, 1988, B STORRS AGR EXPT ST, V476; Weigend S, 2002, WORLD POULTRY SCI J, V58, P411, DOI 10.1079/WPS20020031; Wentworth AL, 2000, AVIAN POULT BIOL REV, V11, P173	23	48	50	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1667	1668		10.1126/science.1085407	http://dx.doi.org/10.1126/science.1085407			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805523				2022-12-01	WOS:000183459700024
J	Simpson, GG; Dijkwel, PP; Quesada, V; Henderson, I; Dean, C				Simpson, GG; Dijkwel, PP; Quesada, V; Henderson, I; Dean, C			FY is an RNA 3 ' end-processing factor that interacts with FCA to control the Arabidopsis floral transition	CELL			English	Article							LATE-FLOWERING MUTANTS; DROSOPHILA-MELANOGASTER; REPEAT PROTEIN; DOMAIN; GENE; RECOGNITION; COMPLEX; TIME; MECHANISM; THALIANA	The nuclear RNA binding protein, FCA, promotes Arabidopsis reproductive development. FCA contains a WW protein interaction domain that is essential for FCA function. We have identified FY as a protein partner for this domain. FY belongs to a highly conserved group of eukaryotic proteins represented in Saccharomyces cerevisiae by the RNA 3' end-processing factor, Pfs2p. FY regulates RNA 3' end processing in Arabidopsis as evidenced through its role in FCA regulation. FCA expression is autoregulated through the use of different polyadenylation sites within the FCA pre-mRNA, and the FCA/FY interaction is required for efficient selection of the promoter-proximal polyadenylation site. The FCA/FY interaction is also required for the downregulation of the floral repressor FLC. We propose that FCA controls 3' end formation of specific transcripts and that in higher eukaryotes, proteins homologous to FY may have evolved as sites of association for regulators of RNA 3' end processing.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.		Dijkwel, P/J-5515-2013	Dijkwel, P/0000-0002-1432-2209; Henderson, Ian/0000-0001-5066-1489; quesada, victor/0000-0002-0965-8680				Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; Braun DM, 1997, PLANT J, V12, P83, DOI 10.1046/j.1365-313X.1997.12010083.x; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Harlow E LD, 1988, ANTIBODIES LAB MANUA, V1st; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Ito S, 2001, BIOCHEM BIOPH RES CO, V280, P656, DOI 10.1006/bbrc.2000.4163; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Juge F, 2000, RNA, V6, P1529, DOI 10.1017/S1355838200001266; Koepf EK, 1999, BIOCHEMISTRY-US, V38, P14338, DOI 10.1021/bi991105l; KOORNNEEF M, 1994, PLANT J, V6, P911, DOI 10.1046/j.1365-313X.1994.6060911.x; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; MITCHELSON A, 1993, GENE DEV, V7, P241, DOI 10.1101/gad.7.2.241; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Mylne J, 1998, PLANT MOL BIOL REP, V16, P257, DOI 10.1023/A:1007520410190; Ohnacker M, 2000, EMBO J, V19, P37, DOI 10.1093/emboj/19.1.37; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; TAKAGAKI Y, 1992, J BIOL CHEM, V267, P23471; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	39	308	343	3	51	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 13	2003	113	6					777	787		10.1016/S0092-8674(03)00425-2	http://dx.doi.org/10.1016/S0092-8674(03)00425-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809608	Bronze			2022-12-01	WOS:000183514400012
J	Murkofsky, RL; Phillips, RS; McCarthy, EP; Davis, RB; Hamel, MB				Murkofsky, RL; Phillips, RS; McCarthy, EP; Davis, RB; Hamel, MB			Length of stay in home care before and after the 1997 Balanced Budget Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSPECTIVE PAYMENT; FOR-PROFIT; OWNERSHIP; QUALITY; FACILITIES; MORTALITY; SERVICES	Context Prior to 1997, home health agencies (HHAs) were reimbursed on a fee-for-service basis and had incentives to provide more services. The 1997 Balanced Budget Act (BBA) reduced payments for home care services to help control Medicare spending. Objective To examine the length of stay in home care before and after the 1997 BBA. Design and Setting Cross-sectional study of home care patients in the 1996 and 1998 National Home and Hospice Care Surveys, which surveyed 1053 HHAs in 1996 and 1088 HHAs in 1998. Patients Nationally representative random sample of home care patients with Medicare coverage in 1996 (4127 patients) and 1998 (4051 patients). Main Outcome Measure Length of stay in home care (based on the number of days a patient was enrolled in home care services). Results From 1996 to 1998, unadjusted median length of stay decreased by 16 days for all home care patients (60-44 days, P=.002). The decrease affected for-profit HHAs more than not-for-profit HHAs (111-55 days [51% decrease, P=.002] vs 46-36 days [22% decrease, P=.042]). In a Cox proportional hazards model of time to discharge from home care, post-BBA year (1,998) was associated with a shorter length of stay in home care (adjusted hazard ratio [aHR] for home care discharge, 1.39 [95% confidence interval {CI}, 1.19-1.61]), and for-profit status was associated with a longer length of stay in home care (aHR, 0.82 [95% CI, 0.71-0.94]) after adjusting for patient demographics, diagnoses, and functional status. Conclusion After the 1997 BBA, length of stay in home care decreased among Medicare patients, particularly among those receiving care from for-profit HHAs.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gerontol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gen Med & Primary Care, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Murkofsky, RL (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gerontol, 1 Deaconess Rd,Palmer 119, Boston, MA 02215 USA.	rmurkofs@bidmc.harvard.edu			NIA NIH HHS [5K12AG00294] Funding Source: Medline; BHP HRSA HHS [5T32PE11001] Funding Source: Medline; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K12AG000294] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BHP HRSA HHS; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Devereaux PJ, 2002, CAN MED ASSOC J, V166, P1399; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; FREEMAN L, 1995, MON LABOR REV, V118, P3; Furth SL, 1999, PEDIATRICS, V104, P519, DOI 10.1542/peds.104.3.519; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; Harrington C, 2001, AM J PUBLIC HEALTH, V91, P1452, DOI 10.2105/AJPH.91.9.1452; Himmelstein DU, 1999, JAMA-J AM MED ASSOC, V282, P159, DOI 10.1001/jama.282.2.159; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kominski G F, 1993, Health Care Financ Rev, V15, P121; McCall N, 2003, HEALTH SERV RES, V38, P85, DOI 10.1111/1475-6773.00106; MENKE T, 1990, INQUIRY-J HEALTH CAR, V27, P114; MULLER A, 1993, MED CARE, V31, P296, DOI 10.1097/00005650-199304000-00002; MUSHLIN AI, 1988, MED CARE, V26, P1081, DOI 10.1097/00005650-198811000-00006; *NAT CTR HLTH STAT, 1998, NAT HOM HOSP CAR SUR; *NAT CTR HLTH STAT, 1996, NAT HOM HOSP CAR SUR; *NAT CTR HLTH STAT, 2002, NAT HOM HOSP CAR SUR; *NAT CTR HLTH STAT, NAT HLTH CAR SURV; SCHEFFLER RM, 1994, MED CARE, V32, P471, DOI 10.1097/00005650-199405000-00006; SCHLESINGER M, 1989, MED CARE, V27, P244, DOI 10.1097/00005650-198903000-00003; Schlesinger M, 1997, MED CARE, V35, P974, DOI 10.1097/00005650-199709000-00009; Shah BV, 1996, SUDAAN USERS MANUAL; Thomas EJ, 2000, J GEN INTERN MED, V15, P211, DOI 10.1046/j.1525-1497.2000.015004211.x; Tu HT, 2002, NEW ENGL J MED, V346, P1288, DOI 10.1056/NEJMsa011250; *US DEP HHS, 1995, OEI049300260 US DEP; *US DEP HHS, 1995, OEI049300262 US DEP; *US DEP HHS, 1997, PUBL US DEP HHS; *US DEP HHS, 2000, PUBL US DEP HHS; *US DEP HHS, 1999, OEI029900530 US DEP; *US GAO, 1997, GAOHEHS97139R US GAO; *US GAO, 1998, MED HOM HLTH BEN IMP; *US GAO, 1996, GAOHEHS9616 US GAO; *US GAO, 2000, GAOHEHS00176 US GAO; *US GAO, 1998, SUBC HLTH COMM WAYS, P1; Yuan Z, 2000, MED CARE, V38, P231, DOI 10.1097/00005650-200002000-00012; 2002, FED REG         0628, V67, P43616; 1995, FED REG         0810, V60, P40847	37	34	34	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2003	289	21					2841	2848		10.1001/jama.289.21.2841	http://dx.doi.org/10.1001/jama.289.21.2841			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684KH	12783915	Bronze			2022-12-01	WOS:000183205500033
J	Bogaty, P; Brophy, J				Bogaty, P; Brophy, J			Increasing burden of treatment in the acute coronary syndromes: is it justified?	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; CONSERVATIVE STRATEGIES; THROMBOLYSIS; MORTALITY; ASPIRIN		Univ Laval, Quebec Heart Inst, Quebec City, PQ, Canada; McGill Univ, Ctr Hlth, Montreal, PQ, Canada	Laval University; McGill University	Bogaty, P (corresponding author), Hop Laval, Quebec Heart Inst, 2725 Chemin St Foy, Ste Foy, PQ G1V 4G5, Canada.	Peter.Bogaty@med.ulaval.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				ANDERSON HV, 1995, J AM COLL CARDIOL, V26, P1643, DOI 10.1016/0735-1097(95)00404-1; Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; BRAUNWALD E, ACC AHA 2002 GUIDELI; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Heidenreich PA, 2001, J AM COLL CARDIOL, V38, P478, DOI 10.1016/S0735-1097(01)01388-2; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Liem AH, 2002, EUR HEART J, V23, P1931, DOI 10.1053/euhj.2002.3291; McPherson K, 2001, QUAL HEALTH CARE, V10, pI61; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Simoons ML, 2001, LANCET, V357, P1915; Topol E, 1998, NEW ENGL J MED, V339, P436; VOLPI A, 1993, CIRCULATION, V88, P416, DOI 10.1161/01.CIR.88.2.416; Wallentin L, 1999, LANCET, V354, P708; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2000, NEW ENGL J MED, V342, P145	26	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2003	361	9371					1813	1816		10.1016/S0140-6736(03)13407-1	http://dx.doi.org/10.1016/S0140-6736(03)13407-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781554				2022-12-01	WOS:000183074800024
J	Fletcher, CV				Fletcher, CV			Enfuvirtide, a new drug for HIV infection	LANCET			English	Editorial Material							PEPTIDE INHIBITOR; VIRUS; PHARMACOKINETICS; FUSION; T-20		Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Fletcher, CV (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, 4200 E 9th Ave, Denver, CO 80262 USA.							CLOTET B, 2002, 14 INT AIDS C BARC S; Kilby JM, 2002, AIDS RES HUM RETROV, V18, P685, DOI 10.1089/088922202760072294; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; LaBranche CC, 2001, ANTIVIR RES, V50, P95, DOI 10.1016/S0166-3542(01)00130-9; LALEZARI JP, 2003, N ENGL J MED; *ROCH PHARM, 2003, FUZEONTM PACK INS; Zhang XP, 2002, CLIN PHARMACOL THER, V72, P10, DOI 10.1067/mcp.2002.125945	7	35	37	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1577	1578		10.1016/S0140-6736(03)13323-5	http://dx.doi.org/10.1016/S0140-6736(03)13323-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747873				2022-12-01	WOS:000182746300003
J	Dror, I; Amitay, T; Yaron, B; Berkowitz, B				Dror, I; Amitay, T; Yaron, B; Berkowitz, B			Salt-pump mechanism for contaminant intrusion into coastal aquifers	SCIENCE			English	Article									Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Berkowitz, B (corresponding author), Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel.		BERKOWITZ, BRIAN/K-1497-2012	BERKOWITZ, BRIAN/0000-0003-3078-1859				Brendel ML, 1999, FLUID PHASE EQUILIBR, V165, P87, DOI 10.1016/S0378-3812(99)00267-8; Lipiatou E, 1997, DEEP-SEA RES PT II, V44, P881, DOI 10.1016/S0967-0645(96)00093-8; SETSCHENOW J, 1889, Z PHYS CHEM, V4, P117, DOI DOI 10.1515/ZPCH-1889-0109; Tkalich P, 2002, MAR POLLUT BULL, V44, P1219, DOI 10.1016/S0025-326X(02)00178-9; Xie WH, 1997, MAR ENVIRON RES, V44, P429, DOI 10.1016/S0141-1136(97)00017-2; Zhang Q, 2001, J CONTAM HYDROL, V49, P201, DOI 10.1016/S0169-7722(00)00194-7	6	17	17	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					950	950		10.1126/science.1080075	http://dx.doi.org/10.1126/science.1080075			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738855				2022-12-01	WOS:000182719800047
J	Zerhouni, E				Zerhouni, E			Embryonic stem cells - Stem cell programs	SCIENCE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Zerhouni, E (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.								0	4	5	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					911	912		10.1126/science.1084819	http://dx.doi.org/10.1126/science.1084819			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738840				2022-12-01	WOS:000182719800032
J	Bagri, A; Cheng, HJ; Yaron, A; Pleasure, SJ; Tessier-Lavigne, M				Bagri, A; Cheng, HJ; Yaron, A; Pleasure, SJ; Tessier-Lavigne, M			Stereotyped pruning of long hippocampal axon branches triggered by retraction inducers of the semaphorin family	CELL			English	Article							PROJECTION; CELLS; NEURONS	Like naturally occurring neuronal cell death, stereotyped pruning of long axon branches to temporary targets is a widespread regressive phenomenon in the developing mammalian brain that helps sculpt the pattern of neuronal connections. The mechanisms controlling stereotyped pruning are, however, poorly understood. Here, we provide evidence that semaphorins, activating the Plexin-A3 receptor, function as retraction inducers to trigger-stereotyped pruning of specific hippocampal mossy fiber and pyramidal axon branches. Both pruning events are defective in Plexin-A3 mutants, reflecting a cell-autonomous requirement for Plexin-A3. The distribution of mRNAs for Sema3F and Sema3A makes them candidates for triggering the pruning. In vitro, hippocampal neurons respond to semaphorins by retracting axon branches. These results implicate semaphorins as retraction inducers controlling stereotyped pruning in the mammalian brain.	Univ Calif San Francisco, Dept Neurol, Program Neurosci, San Francisco, CA 94143 USA; Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University	Pleasure, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, Program Neurosci, San Francisco, CA 94143 USA.	samuelp@itsa.ucsf.edu; marctl@stanford.edu	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567				Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; HERRMANN K, 1995, P NATL ACAD SCI USA, V92, P11244, DOI 10.1073/pnas.92.24.11244; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; LINKE R, 1995, J COMP NEUROL, V351, P602, DOI 10.1002/cne.903510409; Martin LA, 2002, J NEUROSCI, V22, P3520; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; OLEARY DDM, 1986, DEV BRAIN RES, V27, P87, DOI 10.1016/0165-3806(86)90235-X; OLEARY DDM, 1990, COLD SH Q B, V55, P453; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; STANFIELD BB, 1985, J COMP NEUROL, V238, P236, DOI 10.1002/cne.902380210; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2	26	246	248	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					285	299		10.1016/S0092-8674(03)00267-8	http://dx.doi.org/10.1016/S0092-8674(03)00267-8			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732138	Bronze			2022-12-01	WOS:000182640800005
J	Naber, N; Minehardt, TJ; Rice, S; Chen, XR; Grammer, J; Matuska, M; Vale, RD; Kollman, PA; Car, R; Yount, RG; Cooke, R; Pate, E				Naber, N; Minehardt, TJ; Rice, S; Chen, XR; Grammer, J; Matuska, M; Vale, RD; Kollman, PA; Car, R; Yount, RG; Cooke, R; Pate, E			Closing of the nucleotide pocket of kinesin-family motors upon binding to microtubules	SCIENCE			English	Article							CRYSTAL-STRUCTURE; G-PROTEINS; MOLECULAR MOTORS; MECHANISM; MYOSIN; DOMAIN; ATPASE; ACTIVATION; SWITCHES; REVEALS	We have used adenosine diphosphate analogs containing electron paramagnetic resonance (EPR) spin moieties and EPR spectroscopy to show that the nucleotide-binding site of kinesin-family motors closes when the motor.diphosphate complex binds to microtubules. Structural analyses demonstrate that a domain movement in the switch 1 region at the nucleotide site, homologous to domain movements in the switch 1 region in the G proteins [heterotrimeric guanine nucleotide-binding proteins], explains the EPR data. The switch movement primes the motor both for the free energy-yielding nucleotide hydrolysis reaction and for subsequent conformational changes that are crucial for the generation of force and directed motion along the microtubule.	Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Washington State Univ, Dept Chem, Pullman, WA 99164 USA; Washington State Univ, Dept Math, Pullman, WA 99164 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Princeton University; Washington State University; Washington State University; Washington State University	Naber, N (corresponding author), Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA.		Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir I/0000-0002-6361-2798	NCRR NIH HHS [RR1081] Funding Source: Medline; NIAMS NIH HHS [AR42895, AR39643] Funding Source: Medline; NIDDK NIH HHS [DK05915] Funding Source: Medline; NIGMS NIH HHS [GM29072] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039643, P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029072] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CROWDER MS, 1987, BIOPHYS J, V51, P323, DOI 10.1016/S0006-3495(87)83338-6; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Griffith O.H., 1976, SPIN LABELING THEORY, P454; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; KOZIELSKI F, 1997, CELL, V7, P1407; Kull FJ, 2002, J CELL SCI, V115, P15; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Ma YZ, 1997, J BIOL CHEM, V272, P717, DOI 10.1074/jbc.272.2.717; Minehardt TJ, 2001, BIOPHYS J, V80, P1151, DOI 10.1016/S0006-3495(01)76092-4; Naber N, 2003, BIOPHYS J, V84, P3190, DOI 10.1016/S0006-3495(03)70043-5; Pate E, 1997, BIOCHEMISTRY-US, V36, P12155, DOI 10.1021/bi970996z; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 2001, CURR OPIN STRUC BIOL, V11, P716, DOI 10.1016/S0959-440X(01)00265-2; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; Schief WR, 2001, CURR OPIN CELL BIOL, V13, P19, DOI 10.1016/S0955-0674(00)00169-1; Song YH, 2001, EMBO J, V20, P6213, DOI 10.1093/emboj/20.22.6213; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; THOMAS DD, 1987, ANNU REV PHYSIOL, V49, P691, DOI 10.1146/annurev.ph.49.030187.003355; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; YOUNT RG, 1995, BIOPHYS J, V68, pS44; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	27	49	50	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					798	801		10.1126/science.1082374	http://dx.doi.org/10.1126/science.1082374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730601				2022-12-01	WOS:000182579800051
J	Bivona, TG; Perez de Castro, I; Ahearn, IM; Grana, TM; Chiu, VK; Lockyer, PJ; Cullen, PJ; Pellicer, A; Cox, AD; Philips, MR				Bivona, TG; Perez de Castro, I; Ahearn, IM; Grana, TM; Chiu, VK; Lockyer, PJ; Cullen, PJ; Pellicer, A; Cox, AD; Philips, MR			Phospholipase C gamma activates Ras on the Golgi apparatus by means of RasGRP1	NATURE			English	Article							CALCIUM; DIACYLGLYCEROL; RECRUITMENT; PROTEIN	Ras proteins regulate cellular growth and differentiation, and are mutated in 30% of cancers. We have shown recently that Ras is activated on and transmits signals from the Golgi apparatus as well as the plasma membrane(1,2) but the mechanism of compartmentalized signalling was not determined. Here we show that, in response to Src-dependent activation of phospholipase Cgamma1, the Ras guanine nucleotide exchange factor RasGRP1 translocated to the Golgi where it activated Ras. Whereas Ca2+ positively regulated Ras on the Golgi apparatus through RasGRP1, the same second messenger negatively regulated Ras on the plasma membrane by means of the Ras GTPase-activating protein CAPRI(3). Ras activation after T-cell receptor stimulation in Jurkat cells, rich in RasGRP1, was limited to the Golgi apparatus through the action of CAPRI, demonstrating unambiguously a physiological role for Ras on Golgi. Activation of Ras on Golgi also induced differentiation of PC12 cells, transformed fibroblasts and mediated radioresistance. Thus, activation of Ras on Golgi has important biological consequences and proceeds through a pathway distinct from the one that activates Ras on the plasma membrane.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; Babraham Inst, Cambridge CB2 4AT, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	New York University; New York University; New York University; New York University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Bristol	Philips, MR (corresponding author), NYU, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.	philim01@med.nyu.edu	MARTINEZ, ANTONIO PELLICER/C-4832-2015; de Castro, Ignacio Pérez/A-6260-2012	de Castro, Ignacio Pérez/0000-0002-8822-8274; Cullen, Peter/0000-0002-9070-8349; Cox, Adrienne D./0000-0002-4901-2454; Ahearn, Ian/0000-0002-2275-137X; Mark, Philips/0000-0002-1179-8156; Pellicer, Angel/0000-0002-5062-0692				Bankaitis VA, 2002, SCIENCE, V295, P290, DOI 10.1126/science.1068446; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Ji GS, 1998, MOL BIOL CELL, V9, P749, DOI 10.1091/mbc.9.4.749; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Park WM, 1997, ONCOGENE, V14, P831, DOI 10.1038/sj.onc.1200893; Peppelenbosch MP, 1996, J BIOL CHEM, V271, P7883, DOI 10.1074/jbc.271.14.7883; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596	19	344	360	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					694	698		10.1038/nature01806	http://dx.doi.org/10.1038/nature01806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12845332				2022-12-01	WOS:000184578800050
J	Dudley, CA; Erbel-Sieler, C; Estill, SJ; Reick, M; Franken, P; Pitts, S; McKnight, SL				Dudley, CA; Erbel-Sieler, C; Estill, SJ; Reick, M; Franken, P; Pitts, S; McKnight, SL			Altered patterns of sleep and behavioral adaptability in NPAS2-defficient mice	SCIENCE			English	Article							CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; PHASE-SHIFT; RHYTHM; MOUSE; PERIOD; LIGHT; LOOP; PHOTORECEPTION	Animal behavior is synchronized to the 24-hour light:dark (LD) cycle by regulatory programs that produce circadian fluctuations in gene expression throughout the body. In mammals, the transcription factor CLOCK controls circadian oscillation in the suprachiasmatic nucleus of the brain; its paralog, neuronal PAS domain protein 2 (NPAS2), performs a similar function in other forebrain sites. To investigate the role of NPAS2 in behavioral manifestations of circadian rhythm, we studied locomotor activity, sleep patterns, and adaptability to both light- and restricted food-driven entrainment in NPAS2-deficient mice. Our results indicate that NPAS2 plays a substantive role in maintaining circadian behaviors in normal LD and feeding conditions and that NPAS2 is critical for adaptability to food restriction.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Columbia Univ, Dept Psychol, New York, NY 10027 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Stanford University; Columbia University	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	smckni@biochem.swmed.edu	Jansen, Heiko T./A-5770-2008; Franken, Paul/A-9633-2018	Jansen, Heiko T./0000-0003-0178-396X; Franken, Paul/0000-0002-2500-2921	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059388] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 64148] Funding Source: Medline; NIDDK NIH HHS [5T3DK07328] Funding Source: Medline; NIMH NIH HHS [4R37 MH59388] Funding Source: Medline; PHS HHS [37919] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abe H, 2001, EUR J NEUROSCI, V14, P1121, DOI 10.1046/j.0953-816x.2001.01732.x; Abe H, 2001, MOL BRAIN RES, V87, P92, DOI 10.1016/S0169-328X(00)00295-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Challet E, 2001, BRAIN RES, V909, P81, DOI 10.1016/S0006-8993(01)02625-7; DAAN S, 1975, P NATL ACAD SCI USA, V72, P3744, DOI 10.1073/pnas.72.9.3744; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Franken P, 1999, SLEEP, V22, P155; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mayeda AR, 1999, BEHAV GENET, V29, P171, DOI 10.1023/A:1021639901679; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SCHWARTZ WJ, 1980, J COMP NEUROL, V189, P157, DOI 10.1002/cne.901890109; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tankersley CG, 2002, J APPL PHYSIOL, V92, P870, DOI 10.1152/japplphysiol.00904.2001; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	48	304	314	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					379	383		10.1126/science.1082795	http://dx.doi.org/10.1126/science.1082795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12843397				2022-12-01	WOS:000184207300048
J	Wolfe, JT; Wang, HG; Howard, J; Garrison, JC; Barrett, PQ				Wolfe, JT; Wang, HG; Howard, J; Garrison, JC; Barrett, PQ			T-type calcium channel regulation by specific G-protein beta gamma subunits	NATURE			English	Article							CA2+ CHANNEL; DOPAMINE-RECEPTORS; INHIBITION; CURRENTS; MODULATION; EXPRESSION; BINDING; CELLS; K+	Low-voltage-activated (LVA) T-type calcium channels have a wide tissue distribution and have well-documented roles in the control of action potential burst generation and hormone secretion(1). In neurons of the central nervous system and secretory cells of the adrenal and pituitary, LVA channels are inhibited by activation of G-protein-coupled receptors that generate membrane-delimited signals(2-5), yet these signals have not been identified. Here we show that the inhibition of alpha(1H) (Ca(v)3.2), but not alpha(1G) (Ca(v)3.1) LVA Ca2+ channels is mediated selectively by beta(2)gamma(2) subunits that bind to the intracellular loop connecting channel transmembrane domains II and III. This region of the alpha(1H) channel is crucial for inhibition, because its replacement abrogates inhibition and its transfer to non-modulated alpha(1G) channels confers beta(2)gamma(2)-dependent inhibition. betagamma reduces channel activity independent of voltage, a mechanism distinct from the established betagamma-dependent inhibition of non-L-type high-voltage-activated channels of the Ca(v)2 family(6,7). These studies identify the alpha(1H) channel as a new effector for G-protein betagamma subunits, and highlight the selective signalling roles available for particular betagamma combinations.	Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Barrett, PQ (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	pqb4b@virginia.edu	Wolfe, Joshua/H-3821-2013; Barrett, Paula/AAY-1056-2021		NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; BIRD IM, 1993, ENDOCRINOLOGY, V133, P1555, DOI 10.1210/en.133.4.1555; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Cooper CB, 2000, J BIOL CHEM, V275, P40777, DOI 10.1074/jbc.C000673200; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992; Drolet P, 1997, MOL ENDOCRINOL, V11, P503, DOI 10.1210/me.11.4.503; FISHMAN MC, 1981, P NATL ACAD SCI-BIOL, V78, P5245, DOI 10.1073/pnas.78.8.5245; GRABER SG, 1996, METH NEUROSCI, V29, P207; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOZASA T, 1999, CRC METH SIG TRANS, P23; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; LLEDO PM, 1992, NEURON, V8, P455, DOI 10.1016/0896-6273(92)90273-G; LLEDO PM, 1990, ENDOCRINOLOGY, V127, P990, DOI 10.1210/endo-127-3-990; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Safa P, 2001, J BIOL CHEM, V276, P38727, DOI 10.1074/jbc.M103724200; Schrier AD, 2001, AM J PHYSIOL-CELL PH, V280, pC265, DOI 10.1152/ajpcell.2001.280.2.C265; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; WILLIAMS PJ, 1990, J NEUROSCI, V10, P757; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9	30	113	120	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					209	213		10.1038/nature01772	http://dx.doi.org/10.1038/nature01772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853961				2022-12-01	WOS:000184032700046
J	Heintz, N				Heintz, N			Ataxin-1 regulators in the spotlight	SCIENCE			English	Editorial Material							BULBAR MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; 14-3-3 PROTEINS; DISEASE BRAINS		Rockefeller Univ, Dept Mol Biol, New York, NY 10021 USA	Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Dept Mol Biol, 1230 York Ave, New York, NY 10021 USA.							Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401	8	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2003	301	5629					59	60		10.1126/science.1086311	http://dx.doi.org/10.1126/science.1086311			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843383				2022-12-01	WOS:000183914700029
J	Pinyopich, A; Ditta, GS; Savidge, B; Liljegren, SJ; Baumann, E; Wisman, E; Yanofsky, MF				Pinyopich, A; Ditta, GS; Savidge, B; Liljegren, SJ; Baumann, E; Wisman, E; Yanofsky, MF			Assessing the redundancy of MADS-box genes during carpel and ovule development	NATURE			English	Article							FLORAL ORGAN IDENTITY; ARABIDOPSIS-THALIANA; EXPRESSION; TRANSCRIPTION; DETERMINES; SPATULA; PETUNIA; PROTEIN; PLANTS	Carpels are essential for sexual plant reproduction because they house the ovules and subsequently develop into fruits that protect, nourish and ultimately disperse the seeds. The AGAMOUS (AG) gene is necessary for plant sexual reproduction because stamens and carpels are absent from ag mutant flowers(1),(2). However, the fact that sepals are converted into carpelloid organs in certain mutant backgrounds even in the absence of AG activity indicates that an AG-independent carpel-development pathway exists(2). AG is a member of a monophyletic clade of MADS-box genes that includes SHATTERPROOF1 (SHP1), SHP2 and SEEDSTICK (STK)(3), indicating that these four genes might share partly redundant activities. Here we show that the SHP genes are responsible for AG-independent carpel development. We also show that the STK gene is required for normal development of the funiculus, an umbilical-cord-like structure that connects the developing seed to the fruit, and for dispersal of the seeds when the fruit matures. We further show that all four members of the AG clade are required for specifying the identity of ovules, the landmark invention during the course of vascular plant evolution that enabled seed plants to become the most successful group of land plants(4).	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	University of California System; University of California San Diego; Max Planck Society	Yanofsky, MF (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.							Alvarez J, 1999, DEVELOPMENT, V126, P2377; ANGENENT GC, 1995, PLANT CELL, V7, P1569, DOI 10.1105/tpc.7.10.1569; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; COLOMBO L, 1995, PLANT CELL, V7, P1859, DOI 10.1105/tpc.7.11.1859; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Heisler MGB, 2001, DEVELOPMENT, V128, P1089; Kempin SA, 1997, NATURE, V389, P802, DOI 10.1038/39770; KUNST L, 1989, PLANT CELL, V1, P1195, DOI 10.1105/tpc.1.12.1195; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Stewart W.N., 1993, PALEOBOTANY EVOLUTIO; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Western TL, 1999, PLANT J, V18, P329, DOI 10.1046/j.1365-313X.1999.00448.x; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	22	529	607	11	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					85	88		10.1038/nature01741	http://dx.doi.org/10.1038/nature01741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840762				2022-12-01	WOS:000183912800045
J	Potts, M; Walsh, J				Potts, M; Walsh, J			Tackling India's HIV epidemic: lessons from Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MALE CIRCUMCISION; INTERVENTIONS; TRANSMISSION; IMPACT; CORE	India stands on the brink of a major HIV epidemic. However, by examining where public health initiatives went wrong in Africa, die international community may be able to help India avoid the devastating effects seen in Africa.	Univ Calif Berkeley, Sch Publ Hlth, Bay Area Int Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst Human Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Potts, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Bay Area Int Grp, Berkeley, CA 94720 USA.	pottsmalcolm@yahoo.com						Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Chen SY, 2002, AM J PUBLIC HEALTH, V92, P1387, DOI 10.2105/AJPH.92.9.1387-a; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; GREEN R, 2001, INT HLTH EC ASS 3 IN; Hawkes S, 2002, SEX TRANSM INFECT, V78, pI31, DOI 10.1136/sti.78.suppl_1.i31; *INT LESB GAY ASS, SIT HOM IND REP SWED; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; LAZARO FD, AIDS CHALLENGE THAIL; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; MASAKI E, COST EFFECTIVENESS H; MCNEIL D, 2002, NY TIMES        1009; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; National Intelligence Council, 2002, NEXT WAV HIV AIDS NI; Parkhurst JO, 2002, LANCET, V360, P78, DOI 10.1016/S0140-6736(02)09340-6; *ROCK FDN, 2002, MICR IN MOB MICR DEC; Shelton JD, 2001, BRIT MED J, V323, P139, DOI 10.1136/bmj.323.7305.139; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; *UN POP FUND, 2003, SEC ESS SUPPL; *UNAIDS, 2000, REP GLOB HIV AIDS EP; LEMONAIDS	24	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2003	326	7403					1389	1392		10.1136/bmj.326.7403.1389	http://dx.doi.org/10.1136/bmj.326.7403.1389			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694CN	12816832	Green Published			2022-12-01	WOS:000183756400030
J	Wong, RSM; Wu, A; To, KF; Lee, N; Lam, CWK; Wong, CK; Chan, PKS; Ng, MHL; Yu, LM; Hui, DS; Tam, JS; Cheng, G; Sung, JJY				Wong, RSM; Wu, A; To, KF; Lee, N; Lam, CWK; Wong, CK; Chan, PKS; Ng, MHL; Yu, LM; Hui, DS; Tam, JS; Cheng, G; Sung, JJY			Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis	BRITISH MEDICAL JOURNAL			English	Article							CYTOMEGALOVIRUS-INDUCED THROMBOCYTOPENIA; IMMUNODEFICIENCY-VIRUS INFECTION; IMMUNOCOMPETENT ADULT; MEGAKARYOCYTES	Objectives To evaluate the haematological findings of patients with severe acute respiratory syndrome (SARS). Design Analysis of the demographic, clinical, and laboratory characteristics of patients with SARS. Setting Prince of Wales Hospital, Hong Kong. Subjects All patients with a diagnosis of SARS between 11 March and 29 March 2003 who had no pre-existing haematological disorders. Main outcome measures Clinical end points included the need for intensive care and death. Univariate and multivariate analyses were performed to examine factors associated with adverse outcome. Results 64 male and 93 female patients were included in this study. The most common findings included lymphopenia in 153 (98%) of the 157 patients, neutrophilia in 129 (82% thrombocytopenia in 87 patients (55%), followed by thrombocytosis in 77 (49%), and isolated prolonged activated partial thromboplastin time in 96 patients (63%). The haemoglobin count dropped by more than 20 g/l from baseline in 95 (61%) patients. Four patients (2.5%) developed disseminated intravascular coagulation. Lymphopenia was shown in haemato-lymphoid organs at postmortem examination. Multivariate analysis showed that advanced age and a high concentration of lactate dehydrogenase at presentation were independent predictors of an adverse outcome. Subsets of peripheral blood lymphocytes were analysed in 31 patients. The counts of CD4 positive and CD8 positive T cells fell early in the course of illness. Low counts of CD4 and CD8 cells at presentation were associated with adverse outcomes. Conclusions Abnormal haematological variables were common among patients with SARS. Lymphopenia and the depletion of T lymphocyte subsets may be associated with disease activity.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Ctr Clin Trials & Epidemiol Res, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Sung, JJY (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.		Chan, Paul KS/J-9360-2013; Hui, David Shu-Cheong/O-2754-2015; Lee, Nelson/B-6418-2008; Wong, CK/H-3256-2016; Wong, Raymond S. M./H-9644-2016; Sung, Joseph J. Y./R-3203-2018	Chan, Paul KS/0000-0002-6360-4608; Hui, David Shu-Cheong/0000-0003-4382-2445; Lee, Nelson/0000-0002-0783-6607; Wong, CK/0000-0002-5637-8331; Wong, Raymond S. M./0000-0002-9011-4268; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Ly-Mee/0000-0003-0331-7364				[Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P226; BALLEM PJ, 1992, NEW ENGL J MED, V327, P1779, DOI 10.1056/NEJM199212173272503; CHESNEY PJ, 1978, J PEDIATR-US, V92, P957, DOI 10.1016/S0022-3476(78)80375-8; EISENBERG MJ, 1993, WESTERN J MED, V158, P525; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; MAURY CPJ, 1990, J INTERN MED, V227, P253, DOI 10.1111/j.1365-2796.1990.tb00154.x; MCCROMICK JB, 1986, NEW ENGL J MED, V314, P20; NINOMIYA N, 1977, HELV PAEDIATR ACTA, V32, P87; OSKI FA, 1966, NEW ENGL J MED, V275, P352, DOI 10.1056/NEJM196608182750703; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; ROBERTS RB, 1987, CLIN PHARMACOL THER, V42, P365, DOI 10.1038/clpt.1987.165; VANCAMPEN H, 1989, J GEN VIROL, V70, P467, DOI 10.1099/0022-1317-70-2-467; vanSpronsen DJ, 1996, BRIT J HAEMATOL, V92, P218; ZUCKERFRANKLIN D, 1994, SEMIN HEMATOL, V31, P329	16	395	428	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2003	326	7403					1358	1362		10.1136/bmj.326.7403.1358	http://dx.doi.org/10.1136/bmj.326.7403.1358			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694CN	12816821	Green Published, Bronze			2022-12-01	WOS:000183756400017
J	Stollewerk, A; Schoppmeier, M; Damen, WGM				Stollewerk, A; Schoppmeier, M; Damen, WGM			Involvement of Notch and Delta genes in spider segmentation	NATURE			English	Article							SIGNALING PATHWAY; CUPIENNIUS-SALEI; EXPRESSION; OSCILLATOR; SOMITE; HAIRY; PATTERN; FRINGE; HER1	It is currently debated whether segmentation in different animal phyla has a common origin and shares a common genetic mechanism(1,2). The apparent use of different genetic networks in arthropods and vertebrates has become a strong argument against a common origin of segmentation. Our knowledge of arthropod segmentation is based mainly on the insect Drosophila, in which a hierarchical cascade of transcription factors controls segmentation(3,4). The function of some of these genes seems to be conserved among arthropods, including spiders(5,6), but not vertebrates(1,6-8). The Notch pathway has a key role in vertebrate segmentation (somitogenesis) but is not involved in Drosophila body segmentation(1,7,9). Here we show that Notch and Delta genes are involved in segmentation of another arthropod, the spider Cupiennius salei. Expression patterns of Notch and Delta, coupled with RNA interference experiments, identify many similarities between spider segmentation and vertebrate somitogenesis. Our data indicate that formation of the segments in arthropods and vertebrates may have shared a genetic programme in a common ancestor and that parts of this programme have been lost in particular descendant lineages.	Univ Cologne, Inst Genet Evolutionary Genet, D-50931 Cologne, Germany	University of Cologne	Damen, WGM (corresponding author), Univ Cologne, Inst Genet Evolutionary Genet, Weyertal 121, D-50931 Cologne, Germany.	damen@uni-koeln.de						Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Anderson D. T., 1973, EMBRYOLOGY PHYLOGENY, P365, DOI [10.1016/B978-0-08-017069-5.50014-7, DOI 10.1016/B978-0-08-017069-5.50014-7]; Baonza A, 2001, DEVELOPMENT, V128, P3889; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Damen WGM, 2000, P NATL ACAD SCI USA, V97, P4515, DOI 10.1073/pnas.97.9.4515; Damen WGM, 2002, DEVELOPMENT, V129, P1239; Davis G.K., 1999, TRENDS GENET, V9, pM68; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; de Celis JF, 1998, DEVELOPMENT, V125, P4617; Dearden P, 2000, DEV GENES EVOL, V210, P329, DOI 10.1007/s004270000072; DeRobertis EM, 1997, NATURE, V387, P25, DOI 10.1038/387025a0; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pankratz Michael J., 1993, P467; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Pourquie O, 1999, CURR OPIN GENET DEV, V9, P559, DOI 10.1016/S0959-437X(99)00011-8; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Schoppmeier M, 2001, DEV GENES EVOL, V211, P76, DOI 10.1007/s004270000121; Seitz K. H., 1966, Zoologische Jahrbuecher (Anatomie), V83, P327; STJOHNSTON D, 1992, CELL, V68, P201; Stollewerk A, 2002, DEVELOPMENT, V129, P5339, DOI 10.1242/dev.00109; Wiellette EL, 1999, DEVELOPMENT, V126, P1985	30	174	184	2	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2003	423	6942					863	865		10.1038/nature01682	http://dx.doi.org/10.1038/nature01682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815430				2022-12-01	WOS:000183585300044
J	Reddy, MM; Quinton, PM				Reddy, MM; Quinton, PM			Control of dynamic CFTR selectivity by glutamate and ATP in epithelial cells	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DEPENDENT HCO3 TRANSPORT; CYSTIC-FIBROSIS; CHLORIDE CONDUCTANCE; CHANNEL; RECEPTORS; DELTA-F508; ACTIVATION; MUTATIONS; BINDING	Cystic fibrosis is caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel(1). Phosphorylation and ATP hydrolysis are generally believed to be indispensable for activating CFTR2. Here we report phosphorylation- and ATP-independent activation of CFTR by cytoplasmic glutamate that exclusively elicits Cl-, but not HCO3-, conductance in the human sweat duct. We also report that the anion selectivity of glutamate-activated CFTR is not intrinsically fixed, but can undergo a dynamic shift to conduct HCO3- by a process involving ATP hydrolysis. Duct cells from patients with DeltaF508 mutant CFTR showed no glutamate/ATP activated Cl- or HCO3- conductance. In contrast, duct cells from heterozygous patients with R117H/DeltaF508 mutant CFTR also lost most of the Cl- conductance, yet retained significant HCO3- conductance. Hence, not only does glutamate control neuronal ion channels, as is well known, but it can also regulate anion conductance and selectivity of CFTR in native epithelial cells. The loss of this uniquely regulated HCO3- conductance is most probably responsible for the more severe forms of cystic fibrosis pathology.	Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California San Diego; University of California System; University of California Riverside	Reddy, MM (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.							ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Cavalheiro EA, 2001, P NATL ACAD SCI USA, V98, P5947, DOI 10.1073/pnas.121179198; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DalL'Asta V, 1999, AM J PHYSIOL-CELL PH, V276, pC865, DOI 10.1152/ajpcell.1999.276.4.C865; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Duan SM, 2000, J NEUROPHYSIOL, V83, P31, DOI 10.1152/jn.2000.83.1.31; Durie PR, 1999, CYSTIC FIBROSIS IN ADULTS, P261; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; LEW TS, 1991, PEDIATR PULM, V6, P251; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton MP., 1999, PHYSIOL REV, V79, P3; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; RAJ D, 2001, AM J PHYSIOL-RENAL, V280, pF214; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Reddy MM, 2001, AM J PHYSIOL-CELL PH, V280, pC604, DOI 10.1152/ajpcell.2001.280.3.C604; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; RIORDAN JR, 1989, SCIENCE, V245, P1066; Santana LF, 1998, SCIENCE, V279, P1027, DOI 10.1126/science.279.5353.1027; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Sohma Y, 2000, J MEMBRANE BIOL, V176, P77, DOI 10.1007/s002320001077; Welbourne T, 2001, AM J PHYSIOL-CELL PH, V280, pC1151, DOI 10.1152/ajpcell.2001.280.5.C1151; WOLLHEIM C, 2002, DIABETOLOGIA, V43, P265	30	88	91	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					756	760		10.1038/nature01694	http://dx.doi.org/10.1038/nature01694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802335				2022-12-01	WOS:000183443400044
J	Hoag, H				Hoag, H			BSE case rattles Canadian officials	NATURE			English	News Item																			0	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					467	467		10.1038/423467b	http://dx.doi.org/10.1038/423467b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774079	Bronze			2022-12-01	WOS:000183162900004
J	Rands, SA; Cowlishaw, G; Pettifor, RA; Rowcliffe, JM; Johnstone, RA				Rands, SA; Cowlishaw, G; Pettifor, RA; Rowcliffe, JM; Johnstone, RA			Spontaneous emergence of leaders and followers in foraging pairs	NATURE			English	Article							DECISION-MAKING; PREDATION; RISK; BEHAVIOR; SEGREGATION; STRATEGIES; POSITION; RUTILUS; MODEL	Animals that forage socially(1) often stand to gain from coordination of their behaviour(2-5). Yet it is not known how group members reach a consensus on the timing of foraging bouts. Here we demonstrate a simple process by which this may occur. We develop a state-dependent, dynamic game model(6) of foraging by a pair of animals, in which each individual chooses between resting or foraging during a series of consecutive periods, so as to maximize its own individual chances of survival(6,7). We find that, if there is an advantage to foraging together(1,2,8), the equilibrium behaviour of both individuals becomes highly synchronized. As a result of this synchronization, differences in the energetic reserves of the two players spontaneously develop, leading them to adopt different behavioural roles. The individual with lower reserves emerges as the 'pace-maker' who determines when the pair should forage, providing a straightforward resolution to the problem of group coordination. Moreover, the strategy that gives rise to this behaviour can be implemented by a simple 'rule of thumb'(9) that requires no detailed knowledge of the state of other individuals.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Zool Soc London, Inst Zool, London NW1 4RY, England	University of Cambridge; Zoological Society of London	Rands, SA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	s.rands@zoo.cam.ac.uk	Rowcliffe, Marcus/G-3713-2018; Rands, Sean A/B-2243-2008	Rowcliffe, Marcus/0000-0002-4286-6887; Rands, Sean A/0000-0002-7400-005X				Bednekoff PA, 1997, AM NAT, V150, P373, DOI 10.1086/286070; Camazine S., 2001, SELF ORG BIOL SYSTEM; CLARK CW, 1995, OIKOS, V72, P205, DOI 10.2307/3546222; CLARK CW, 1987, ANIM BEHAV, V35, P361, DOI 10.1016/S0003-3472(87)80259-2; Conradt L, 1998, P ROY SOC B-BIOL SCI, V265, P1359, DOI 10.1098/rspb.1998.0442; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Cuthill Innes C., 1997, P97; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; GIRALDEAU LA, 2000, MG BEH ECOL, P3; GOTCEITAS V, 1991, BEHAV ECOL SOCIOBIOL, V29, P255, DOI 10.1007/BF00163982; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HOUSTON A, 1988, NATURE, V332, P29, DOI 10.1038/332029a0; Houston AI., 1999, MODELS ADAPTIVE BEHA; Krause J, 1998, BEHAVIOUR, V135, P1031, DOI 10.1163/156853998792913519; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J., 2002, LIVING GROUPS; LEWONTIN RC, 1964, GENETICS, V49, P49; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MANGEL M, 1990, ANIM BEHAV, V39, P1163, DOI 10.1016/S0003-3472(05)80788-2; Mangel M., 1988, DYNAMIC MODELING BEH; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; McNamara JM, 1997, J THEOR BIOL, V189, P211, DOI 10.1006/jtbi.1997.0511; Richards SA, 2002, BEHAV ECOL, V13, P427, DOI 10.1093/beheco/13.3.427; ROOK AJ, 1991, APPL ANIM BEHAV SCI, V32, P157, DOI 10.1016/S0168-1591(05)80039-5; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Stephens D.W., 1986, pi; SZEKELY T, 1991, BEHAV ECOL SOCIOBIOL, V28, P203	30	235	237	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2003	423	6938					432	434		10.1038/nature01630	http://dx.doi.org/10.1038/nature01630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761547				2022-12-01	WOS:000183012000040
J	Jablonski, D; Roy, K; Valentine, JW; Price, RM; Anderson, PS				Jablonski, D; Roy, K; Valentine, JW; Price, RM; Anderson, PS			The impact of the pull of the recent on the history of marine diversity	SCIENCE			English	Article							BIODIVERSITY; ORIGINATION; EXTINCTION	Up to 50% of the increase in marine animal biodiversity through the Cenozoic at the genus level has been attributed to a sampling bias termed "the Pull of the Recent," the extension of stratigraphic ranges of fossil taxa by the relatively complete sampling of the Recent biota. However, 906 of 958 living genera and subgenera of bivalve mollusks having a fossil record occur in the Pliocene or Pleistocene. The Pull of the Recent thus accounts for only 5% of the Cenozoic increase in bivalve diversity, a major component of the marine record, suggesting that the diversity increase is likely to be a genuine biological pattern.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92903 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Chicago; University of California System; University of California San Diego; University of California System; University of California Berkeley	Jablonski, D (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	d-jablonski@uchicago.edu						Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; Benton MJ, 2001, GEOL J, V36, P211, DOI 10.1002/gj.877.abs; Best MMR, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)026<0103:BTITMS>2.0.CO;2; Crame JA, 2002, GEOL SOC SPEC PUBL, V194, P153, DOI 10.1144/GSL.SP.2002.194.01.12; DARRAGH TA, 1985, ALCHERINGA, V9, P83, DOI 10.1080/03115518508618960; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gage JD, 1991, DEEP SEA BIOL; GLOVER CP, 1993, J GEOL, V101, P729, DOI 10.1086/648271; Harper EM, 1998, ADEQUACY OF THE FOSSIL RECORD, P243; JABLONSKI D, 1995, SCIENCE, V268, P389, DOI 10.1126/science.11536722; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; MARKOV AV, 2000, PALEONTOLOG J, V36, P121; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; MOORE RC, 1969, TREATISE INVERTEBRAT, VN; PEASE CM, 1992, PALEOBIOLOGY, V18, P89, DOI 10.1017/S0094837300012239; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; RAUP D M, 1979, Bulletin of Carnegie Museum of Natural History, P85; Sepkoski, 2002, B AM PALEONTOL, V363, P1; Sepkoski J. J., 1996, GLOBAL EVENTS EVENT, DOI DOI 10.1007/978-3-642-79634-0_4; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Smith Andrew B., 2000, Special Papers in Palaeontology, V63, P1; Valentine J. W., 1969, Palaeontology, V12, P684; VALENTINE JW, 1978, PALEOBIOLOGY, V4, P55, DOI 10.1017/S0094837300005686; VALENTINE JW, 1989, PALEOBIOLOGY, V15, P83, DOI 10.1017/S0094837300009295	30	125	130	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1133	1135		10.1126/science.1083246	http://dx.doi.org/10.1126/science.1083246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750517				2022-12-01	WOS:000182886500041
J	Krejci, L; Van Komen, S; Li, Y; Villemain, J; Reddy, MS; Klein, H; Ellenberger, T; Sung, P				Krejci, L; Van Komen, S; Li, Y; Villemain, J; Reddy, MS; Klein, H; Ellenberger, T; Sung, P			DNA helicase Srs2 disrupts the Rad51 presynaptic filament	NATURE			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; YEAST RAD51; STRAND EXCHANGE; REPAIR; RECOMBINATION; MUTATIONS; GENE; RECA; SGS1	Mutations in the Saccharomyces cerevisiae gene SRS2 result in the yeast's sensitivity to genotoxic agents, failure to recover or adapt from DNA damage checkpoint-mediated cell cycle arrest, slow growth, chromosome loss, and hyper-recombination(1,2). Furthermore, double mutant strains, with mutations in DNA helicase genes SRS2 and SGS1, show low viability that can be overcome by inactivating recombination, implying that untimely recombination is the cause of growth impairment(1,3,4). Here we clarify the role of SRS2 in recombination modulation by purifying its encoded product and examining its interactions with the Rad51 recombinase. Srs2 has a robust ATPase activity that is dependent on single-stranded DNA ( ssDNA) and binds Rad51, but the addition of a catalytic quantity of Srs2 to Rad51-mediated recombination reactions causes severe inhibition of these reactions. We show that Srs2 acts by dislodging Rad51 from ssDNA. Thus, the attenuation of recombination efficiency by Srs2 stems primarily from its ability to dismantle the Rad51 presynaptic filament efficiently. Our findings have implications for the basis of Bloom's and Werner's syndromes, which are caused by mutations in DNA helicases and are characterized by increased frequencies of recombination and a predisposition to cancers and accelerated ageing(5).	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX 78245 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Harvard University; Harvard Medical School; New York University	Krejci, L (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, 15355 Lambda Dr, San Antonio, TX 78245 USA.		Krejci, Lumir/B-7842-2009	Krejci, Lumir/0000-0002-4732-1405; Klein, Hannah/0000-0003-4228-8535				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Klein HL, 2000, NAT GENET, V25, P132, DOI 10.1038/75957; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Mankouri HW, 2002, NUCLEIC ACIDS RES, V30, P1103, DOI 10.1093/nar/30.5.1103; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; MILNE GT, 1995, GENETICS, V139, P1189; Oakley TJ, 2002, DNA REPAIR, V1, P175, DOI 10.1016/S1568-7864(02)00002-2; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; PALLADINO F, 1992, GENETICS, V132, P23; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; RONG L, 1993, J BIOL CHEM, V268, P1252; SCHILD D, 1995, GENETICS, V140, P115; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200	30	485	493	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					305	309		10.1038/nature01577	http://dx.doi.org/10.1038/nature01577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748644				2022-12-01	WOS:000182853100047
J	Lunney, JR; Lynn, J; Foley, DJ; Lipson, S; Guralnik, JM				Lunney, JR; Lynn, J; Foley, DJ; Lipson, S; Guralnik, JM			Patterns of functional decline at the end of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OLDER PERSONS; DISABILITY; SERVICES; HOSPICE; DISEASE; HEALTH; ADULTS; HEART	Context Clinicians have observed various patterns of functional decline at the end of life, but few empirical data have tested these patterns in large populations. Objective To determine if functional decline differs among 4 types of illness trajectories: sudden death, cancer death, death from organ failure, and frailty. Design, Setting, and Participants Cohort analysis of data from 4 US regions in the prospective, longitudinal Established Populations for Epidemiologic Studies of the Elderly (EPESE) study. Of the 14456 participants aged 65 years or older who provided interviews at baseline (1981-1987), 4871 died during the first 6 years of follow-up; 4190 (86%) of these provided interviews within 1 year before dying. These decedents were evenly distributed in 12 cohorts based on the number of months between the final interview and death. Main Outcome Measures Self-or proxy-reported physical function (performance of 7 activities of daily living [ADLs]) within 1 year prior to death; predicted ADL dependency prior to death. Results Mean function declined across the 12 cohorts, simulating individual decline in the final year of life. Sudden death decedents were highly functional even in the last month before death (mean [95% confidence interval {CI}] numbers of ADL dependencies: 0.69 [0.19-1.19] at 12 months before death vs 1.22 [0.59-1.85] at the final month of life, P=.20); cancer decedents were highly functional early in their final year but markedly more disabled 3-months prior to death (0.77 [0.30-1.24] vs 4.09 [3.37-4.81], P<.001); organ failure decedents experienced a fluctuating. pattern of decline, with substantially poorer function during the last 3 months before death (2.10 [1.49-2.70] vs 3.66 [2.94-4.38], P<.001); and frail decedents were relatively more disabled in the final year and especially dependent during the last month (2.92 [2.24-3.60] vs 5.84 [5.33-6.35], P<.001). After controlling for age, sex, race, education, marital status, interval between final interview and death, and other demographic differences, frail decedents were more than 8 times more likely than sudden death decedents to be ADL dependent (OR, 8.32 [95% CI, 6.46-10.73); cancer decedents, one and a half times more likely (OR, 1.57 [95% CI, 1.25-1.96]); and organ failure decedents, 3 times more likely (OR, 3.00 [95% CI, 2.39-3.77]). Conclusions Trajectories of functional decline at the end of life are quite variable. Differentiating among expected trajectories and related needs would help shape tailored strategies and better programs of care prior to death.	NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; Washington Home Ctr Palliat Care Studies, Washington, DC USA; Hebrew Home Greater Washington, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lunney, JR (corresponding author), NIA, Lab Epidemiol Demog & Biometry, NIH, Gateway Bldg,Suite 3C-309, Bethesda, MD 20892 USA.		Ram, Prem/K-4511-2012		NATIONAL INSTITUTE OF NURSING RESEARCH [K22NR007967] Funding Source: NIH RePORTER; NINR NIH HHS [K22-NR07967] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		CORNONIHUNTLEY J, 1986, NIH PUBLICATION; CORNONIHUNTLEY J, NIH PUBLICATION, V2; *FED INT FOR AG RE, 2000, OLD AM 2000 KEY IND; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; Ferrucci L, 1996, J GERONTOL A-BIOL, V51, pM123, DOI 10.1093/gerona/51A.3.M123; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Glaser B., 1968, TIME DYING, DOI DOI 10.1097/00000446-196812000-00048; GURALNIK JM, 1991, AM J PUBLIC HEALTH, V81, P443, DOI 10.2105/AJPH.81.4.443; Guralnik JM, 2001, J AM GERIATR SOC, V49, pS12; Haan MN, 1997, J AM GERIATR SOC, V45, P667, DOI 10.1111/j.1532-5415.1997.tb01468.x; *I MED, 1997, APPR DEATH IMPR CAR; LAWTON MP, 1990, MILBANK Q, V68, P1, DOI 10.2307/3350075; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; MCNEIL J, 2001, AM DISABILITIES 1997; Minino A M, 2001, Natl Vital Stat Rep, V49, P1; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; VERBRUGGE LM, 1994, J HEALTH SOC BEHAV, V35, P97, DOI 10.2307/2137359; Visser M, 1998, AM J CLIN NUTR, V68, P584, DOI 10.1093/ajcn/68.3.584; Wolinsky FD, 1997, MED CARE, V35, P1031, DOI 10.1097/00005650-199710000-00005; Wolinsky FD, 1998, J GERONTOL B-PSYCHOL, V53, pS336, DOI 10.1093/geronb/53B.6.S336; Wolinsky FD, 1996, J AGING HEALTH, V8, P155, DOI 10.1177/089826439600800201	23	817	825	1	61	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2003	289	18					2387	2392		10.1001/jama.289.18.2387	http://dx.doi.org/10.1001/jama.289.18.2387			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	677WF	12746362	Bronze			2022-12-01	WOS:000182831200028
J	Golas, MM; Sander, B; Will, CL; Luhrmann, R; Stark, H				Golas, MM; Sander, B; Will, CL; Luhrmann, R; Stark, H			Molecular architecture of the multiprotein splicing factor SF3b	SCIENCE			English	Article							U2 SNRNP PROTEINS; BRANCH-SITE; CRYSTAL-STRUCTURE; ELECTRON CRYOMICROSCOPY; ANGSTROM RESOLUTION; RNA; DOMAIN; COMPLEX; BINDING; MICROSCOPY	The splicing factor SF3b is a multiprotein complex essential for the accurate excision of introns from pre-messenger RNA. As an integral component of the U2 small nuclear ribonucleoprotein (snRNP) and the U11/U12 di-snRNP, SF3b is involved in the recognition of the pre-messenger RNA's branch site within the major and minor spliceosomes. We have determined the three-dimensional structure of the human SF3b complex by single-particle electron cryomicroscopy at a resolution of less than 10 angstroms, allowing identification of protein domains with known structural folds. The best fit of a modeled RNA-recognition motif indicates that the protein p14 is located in the central cavity of the complex. The 22 tandem helical repeats of the protein SF3b155 are located in the outer shell of the complex enclosing p14.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	holger.stark@mpibpc.mpg.de	Sander, Bjoern/AAO-9021-2021	Sander, Bjoern/0000-0001-8495-2321; Holger, Stark/0000-0002-6161-1118				Bottcher C, 1999, FEBS LETT, V463, P255, DOI 10.1016/S0014-5793(99)01475-1; Burge C.B., 1999, RNA WORLD, V37, P525; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Das BK, 1999, MOL CELL BIOL, V19, P6796; De Carlo S, 2002, J STRUCT BIOL, V138, P216, DOI 10.1016/S1047-8477(02)00035-7; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; MACMILLAN AM, 1994, GENE DEV, V8, P3008, DOI 10.1101/gad.8.24.3008; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x; Shamoo Y, 1997, NAT STRUCT BIOL, V4, P215, DOI 10.1038/nsb0397-215; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; TISCHENDORF GW, 1974, MOL GEN GENET, V134, P187, DOI 10.1007/BF00267715; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Will CL, 1999, SCIENCE, V284, P2003, DOI 10.1126/science.284.5422.2003; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Xu RM, 1997, STRUCTURE, V5, P559, DOI 10.1016/S0969-2126(97)00211-6	30	201	217	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2003	300	5621					980	984		10.1126/science.1084155	http://dx.doi.org/10.1126/science.1084155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738865				2022-12-01	WOS:000182719800057
J	Huberman, AD; Wang, GY; Liets, LC; Collins, OA; Chapman, B; Chalupa, LM				Huberman, AD; Wang, GY; Liets, LC; Collins, OA; Chapman, B; Chalupa, LM			Eye-specific retinogeniculate segregation independent of normal neuronal activity	SCIENCE			English	Article								The segregation of initially intermingled left and right eye inputs to the dorsal lateral geniculate nucleus (DLGN) during development is thought to be in response to precise spatial and temporal patterns of spontaneous ganglion cell activity. To test this hypothesis, we disrupted the correlated activity of neighboring ganglion cells in the developing ferret retina through immunotoxin depletion of starburst amacrine cells. Despite the absence of this type of correlated activity, left and right eye inputs segregated normally in the DLGN. By contrast, when all spontaneous activity was blocked, the projections from the two eyes remained intermingled. Thus, certain features of normal neural activity patterns are not required for the formation of eye-specific projections to the DLGN.	Univ Calif Davis, Sch Med, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Dept Ophthalmol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chapman, B (corresponding author), Univ Calif Davis, Sch Med, Ctr Neurosci, Davis, CA 95616 USA.	bxchapman@ucdavis.edu; lmchalupa@ucdavis.edu			NEI NIH HHS [EY13301, EY03991, EY11369, R01 EY011369-11, R01 EY011369, EY12576] Funding Source: Medline; NIMH NIH HHS [P20 MH6095] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011369, R01EY013301, P30EY012576, R01EY003991] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		COOK PM, 1999, VISUAL NEUROSCI, V16, P3; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Hahm JO, 1999, J COMP NEUROL, V412, P705, DOI 10.1002/(SICI)1096-9861(19991004)412:4<705::AID-CNE11>3.0.CO;2-D; Huberman AD, 2002, J NEUROSCI, V22, P9419; Jones EG., 2003, THALAMUS, V1st; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P7; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAKIC P, 1979, NATURE, V261, P5560; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SKALIORA I, 1993, J NEUROSCI, V13, P313; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Wang L, 1997, J NEUROPHYSIOL, V78, P689, DOI 10.1152/jn.1997.78.2.689; WONG RO, 1993, NEURON, V11, P5; WONG ROL, 1999, ANN REV NEUROSCI, V22; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	26	92	96	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2003	300	5621					994	998		10.1126/science.1080694	http://dx.doi.org/10.1126/science.1080694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738869	Green Accepted			2022-12-01	WOS:000182719800061
J	Lenski, RE; Ofria, C; Pennock, RT; Adami, C				Lenski, RE; Ofria, C; Pennock, RT; Adami, C			The evolutionary origin of complex features	NATURE			English	Article							DESIGN; RATES; GENE	A long-standing challenge to evolutionary theory has been whether it can explain the origin of complex organismal features. We examined this issue using digital organisms-computer programs that self-replicate, mutate, compete and evolve. Populations of digital organisms often evolved the ability to perform complex logic functions requiring the coordinated execution of many genomic instructions. Complex functions evolved by building on simpler functions that had evolved earlier, provided that these were also selectively favoured. However, no particular intermediate stage was essential for evolving complex functions. The first genotypes able to perform complex functions differed from their non-performing parents by only one or two mutations, but differed from the ancestor by many mutations that were also crucial to the new functions. In some cases, mutations that were deleterious when they appeared served as stepping-stones in the evolution of complex features. These findings show how complex functions can originate by random mutation and natural selection.	Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; Michigan State Univ, Lyman Briggs Sch, E Lansing, MI 48824 USA; Michigan State Univ, Dept Philosophy, E Lansing, MI 48824 USA; CALTECH, Digital Life Lab, Pasadena, CA 91125 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; California Institute of Technology	Lenski, RE (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	lenski@msu.edu	Adami, Christoph/A-5181-2009; Adami, Chris/A-9675-2011	Adami, Chris/0000-0002-2915-9504; Lenski, Richard/0000-0002-1064-8375; Ofria, Charles/0000-0003-2924-1732				Adami C., 1998, INTRO ARTIFICIAL LIF; Bedau MA, 1997, FROM ANIM ANIMAT, P125; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Darwin C., 1859, ORIGIN SPECIES MEANS; Dawkins R., 1986, LONGMAN, V32, P361; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; Dennett D., 2002, ENCY EVOLUTION, pE83; Dennett DC., 1995, DARWINS DANGEROUS ID; Drake JW, 1998, GENETICS, V148, P1667; Foster JA, 2001, NAT REV GENET, V2, P428, DOI 10.1038/35076523; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Henry, 1992, ADAPTATION NATURAL A; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Koza J.R, 1997, GENETIC PROGRAMMING; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; MelendezHevia E, 1996, J MOL EVOL, V43, P293, DOI 10.1007/PL00006089; Miller K., 1999, FINDING DARWINS GOD; Mortlock RP, 1984, MICROORGANISMS MODEL; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Ofria C, 2002, IEEE T EVOLUT COMPUT, V6, P420, DOI 10.1109/TEVC.2002.802442; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; RAY T., 1992, ARTIF LIFE, P371, DOI DOI 10.1016/S0040-4039(01)97473-8; SALVINIPLAWEN LV, 1977, EVOLUTIONARY BIOL, V10, P207; Wagenaar D, 2000, FROM ANIM ANIMAT, P216; Wilke CO, 2002, TRENDS ECOL EVOL, V17, P528, DOI 10.1016/S0169-5347(02)02612-5; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Yedid G, 2002, NATURE, V420, P810, DOI 10.1038/nature01151; Yedid G, 2001, AM NAT, V157, P465, DOI 10.1086/319928; Yokoyama S, 2001, GENETICS, V158, P1697	33	403	409	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					139	144		10.1038/nature01568	http://dx.doi.org/10.1038/nature01568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736677				2022-12-01	WOS:000182699600038
J	Tomlinson, B; Cockram, C				Tomlinson, B; Cockram, C			SARS: experience at Prince of Wales Hospital, Hong Kong	LANCET			English	Editorial Material							CORONAVIRUS; VIRUS		Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Tomlinson, B (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	btomlinson@cuhk.edu.hk	Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019	Tomlinson, Brian/0000-0001-6717-5444				Buckingham SC, 2002, J INFECT DIS, V185, P1222, DOI 10.1086/340024; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P241; *CDCP, 2003, CDC LAB AN SUGG NEW; *HONG KONG DEP HLT, MAIN FIND INV OUTBR; LEE N, 2003, N ENGL J MED; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POUTANEN SM, 2003, N ENGL J MED; Storz J, 2000, J CLIN MICROBIOL, V38, P3291, DOI 10.1128/JCM.38.9.3291-3298.2000; TSANG KW, 2003, N ENGL J MED; *WHO, CAS DEF SURV SEV AC; World Health Organization, 2003, SEV AC RESP SYNDR SA; Yu M, 2000, AVIAN DIS, V44, P297, DOI 10.2307/1592543	12	114	116	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2003	361	9368					1486	1487		10.1016/S0140-6736(03)13218-7	http://dx.doi.org/10.1016/S0140-6736(03)13218-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737853	Bronze, Green Published			2022-12-01	WOS:000182658900002
J	Bergthorsson, U; Adams, KL; Thomason, B; Palmer, JD				Bergthorsson, U; Adams, KL; Thomason, B; Palmer, JD			Widespread horizontal transfer of mitochondrial genes in flowering plants	NATURE			English	Article							PHYLOGENETIC ANALYSES; LATERAL TRANSFER; EVOLUTION; NUCLEUS; PROKARYOTES; ANGIOSPERMS; INVASION; DIVERSE; RATES	Horizontal gene transfer - the exchange of genes across mating barriers - is recognized as a major force in bacterial evolution(1,2). However, in eukaryotes it is prevalent only in certain phagotrophic protists and limited largely to the ancient acquisition of bacterial genes(3-5). Although the human genome was initially reported(6) to contain over 100 genes acquired during vertebrate evolution from bacteria, this claim was immediately and repeatedly rebutted(7,8). Moreover, horizontal transfer is unknown within the evolution of animals, plants and fungi except in the special context of mobile genetic elements(9-12). Here we show, however, that standard mitochondrial genes, encoding ribosomal and respiratory proteins, are subject to evolutionarily frequent horizontal transfer between distantly related flowering plants. These transfers have created a variety of genomic outcomes, including gene duplication, recapture of genes lost through transfer to the nucleus, and chimaeric, half-monocot, half-dicot genes. These results imply the existence of mechanisms for the delivery of DNA between unrelated plants, indicate that horizontal transfer is also a force in plant nuclear genomes, and are discussed in the contexts of plant molecular phylogeny and genetically modified plants.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Iowa State Univ, Dept Bot, Ames, IA 50011 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Indiana University System; Indiana University Bloomington; Iowa State University; University of Michigan System; University of Michigan	Palmer, JD (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jpalmer@bio.indiana.edu	Palmer, Jeffrey/P-6747-2014	Palmer, Jeffrey/0000-0002-4626-2220				Adams J L, 1999, Curr Opin Drug Discov Devel, V2, P96; Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Barkman TJ, 2000, P NATL ACAD SCI USA, V97, P13166, DOI 10.1073/pnas.220427497; BLANCHARD JL, 1995, J MOL EVOL, V41, P397, DOI 10.1007/BF00160310; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Eickbush TH, 2002, MOBILE DNA, P1111, DOI [10.1128/9781555817954.ch49, DOI 10.1128/9781555817954.CH49]; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Intrieri MC, 2001, MOL PHYLOGENET EVOL, V20, P100, DOI 10.1006/mpev.2001.0927; Kadowaki KI, 1996, EMBO J, V15, P6652, DOI 10.1002/j.1460-2075.1996.tb01055.x; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; Nixon JEJ, 2002, EUKARYOT CELL, V1, P181, DOI 10.1128/EC.1.2.181-190.2002; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Robertson Hugh M., 2002, P1093; Salzberg SL, 2001, SCIENCE, V292, P1903, DOI 10.1126/science.1061036; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SMITH JM, 1992, J MOL EVOL, V34, P126; Stanhope MJ, 2001, NATURE, V411, P940, DOI 10.1038/35082058; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zardoya R, 2002, P NATL ACAD SCI USA, V99, P14893, DOI 10.1073/pnas.192573799	30	321	343	4	92	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2003	424	6945					197	201		10.1038/nature01743	http://dx.doi.org/10.1038/nature01743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699AA	12853958	Green Published			2022-12-01	WOS:000184032700043
J	Raymond, PA; Cole, JJ				Raymond, PA; Cole, JJ			Increase in the export of alkalinity from North America's largest river	SCIENCE			English	Article							WEATHERING RATES; CARBON; CHEMISTRY; EROSION; STREAMFLOW; NITROGEN; TRENDS; IMPACT; FLUX	Chemical weathering and the subsequent export of carbonate alkalinity (HCO3- + CO3-2) from soils to rivers account for significant amounts of terrestrially sequestered atmospheric CO2. We show here that during the past half-century, the export of this alkalinity has increased dramatically from North America's largest river, the Mississippi. This increased export is in part the result of increased flow resulting from higher rainfall in the Mississippi basin. Subcatchment data from the Mississippi suggest that the increase in the export of alkalinity is also linked to amount and type of land cover. These observations have important implications for the potential management of carbon sequestration in the United States.	Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA	Yale University; Cary Institute of Ecosystem Studies	Raymond, PA (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 205 Prospect St, New Haven, CT 06511 USA.	peter.raymond@yale.edu	Cole, Jonathan Jay/G-4566-2011; Raymond, Peter A/C-4087-2009	Cole, Jonathan Jay/0000-0003-4633-7402; Raymond, Peter A/0000-0002-8564-7860				Baldwin CK, 1999, WATER RESOUR RES, V35, P1143, DOI 10.1029/1998WR900070; Banfield JF, 1999, P NATL ACAD SCI USA, V96, P3404, DOI 10.1073/pnas.96.7.3404; BERNER RA, 1984, AM J SCI, V284, P1183, DOI 10.2475/ajs.284.10.1183; Cochran MF, 1996, CHEM GEOL, V132, P71; Dai A, 1997, J CLIMATE, V10, P2943, DOI 10.1175/1520-0442(1997)010<2943:SOGLPV>2.0.CO;2; Dijkstra FA, 2003, BIOGEOCHEMISTRY, V62, P253, DOI 10.1023/A:1021132132199; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Goolsby DA, 2001, HYDROL PROCESS, V15, P1209, DOI 10.1002/hyp.210; Hicke JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013578; HODELL DA, 1991, GEOLOGY, V19, P24, DOI 10.1130/0091-7613(1991)019<0024:VITSIC>2.3.CO;2; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; HOWARTH RW, 1991, ECOL APPL, V1, P27, DOI 10.2307/1941845; Johnson LB, 1997, FRESHWATER BIOL, V37, P193, DOI 10.1046/j.1365-2427.1997.d01-539.x; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Jongmans AG, 1997, NATURE, V389, P682, DOI 10.1038/39493; LASAGA AC, 1994, GEOCHIM COSMOCHIM AC, V58, P2361, DOI 10.1016/0016-7037(94)90016-7; Lins HF, 1999, GEOPHYS RES LETT, V26, P227, DOI 10.1029/1998GL900291; Liu Z, 2000, ENVIRON GEOL, V39, P1053, DOI 10.1007/s002549900072; LYNCH JA, 1995, ATMOS ENVIRON, V29, P1231, DOI 10.1016/1352-2310(94)00371-Q; Markewitz D, 2001, NATURE, V410, P802, DOI 10.1038/35071052; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Millot R, 2002, EARTH PLANET SC LETT, V196, P83, DOI 10.1016/S0012-821X(01)00599-4; Morgan J.J., 1996, AQUATIC CHEM, V3; Moulton KL, 2000, AM J SCI, V300, P539, DOI 10.2475/ajs.300.7.539; Nemani R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014867; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Rothman DH, 2002, P NATL ACAD SCI USA, V99, P4167, DOI 10.1073/pnas.022055499; Rothman DH, 2001, P NATL ACAD SCI USA, V98, P4305, DOI 10.1073/pnas.071047798; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; SCHWARTZMAN DW, 1989, NATURE, V340, P457, DOI 10.1038/340457a0; Semhi K, 2000, APPL GEOCHEM, V15, P865, DOI 10.1016/S0883-2927(99)00076-1; SKIBA U, 1992, ATMOS ENVIRON A-GEN, V26, P2477, DOI 10.1016/0960-1686(92)90100-Y; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Strakhov N.M., 1967, PRINCIPLES LITHOGENE, V1; SUNDQUIST ET, 1993, SCIENCE, V259, P934, DOI 10.1126/science.259.5097.934; SUNDQUIST ET, 1991, QUATERNARY SCI REV, V10, P283, DOI 10.1016/0277-3791(91)90026-Q; TURNER RE, 1994, NATURE, V368, P619, DOI 10.1038/368619a0; WHITE AF, 1995, GEOCHIM COSMOCHIM AC, V59, P1729, DOI 10.1016/0016-7037(95)00078-E; White AF, 1999, GEOCHIM COSMOCHIM AC, V63, P3277, DOI 10.1016/S0016-7037(99)00250-1	42	256	272	3	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2003	301	5629					88	91		10.1126/science.1083788	http://dx.doi.org/10.1126/science.1083788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696YG	12843391				2022-12-01	WOS:000183914700038
J	Mangeat, B; Turelli, P; Caron, G; Friedli, M; Perrin, L; Trono, D				Mangeat, B; Turelli, P; Caron, G; Friedli, M; Perrin, L; Trono, D			Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ARTHRITIS-ENCEPHALITIS VIRUS; G->A HYPERMUTATION; IN-VIVO; LENTIVIRAL VECTOR; DNA-SYNTHESIS; VIF PROTEIN; GENE; REPLICATION; SUBSTITUTIONS	Viral replication usually requires that innate intracellular lines of defence be overcome, a task usually accomplished by specialized viral gene products. The virion infectivity factor (Vif) protein of human immunodeficiency virus (HIV) is required during the late stages of viral production to counter the antiviral activity of APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G; also known as CEM15), a protein expressed notably in human T lymphocytes(1-4). When produced in the presence of APOBEC3G, vif-defective virus is non-infectious. APOBEC3G is closely related to APOBEC1, the central component of an RNA-editing complex that deaminates a cytosine residue in apoB messenger RNA(5-7). APOBEC family members also have potent DNA mutator activity through dC deamination(8); however, whether the editing potential of APOBEC3G has any relevance to HIV inhibition is unknown. Here, we demonstrate that it does, as APOBEC3G exerts its antiviral effect during reverse transcription to trigger G-to-A hypermutation in the nascent retroviral DNA. We also find that APOBEC3G can act on a broad range of retroviruses in addition to HIV, suggesting that hypermutation by editing is a general innate defence mechanism against this important group of pathogens.	Univ Geneva, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Med, CH-1211 Geneva, Switzerland; Univ Geneva, Frontiers Genet Res Program, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Trono, D (corresponding author), Univ Geneva, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland.			Mangeat, Bastien/0000-0003-2592-0236				BORMAN AM, 1995, VIROLOGY, V208, P601, DOI 10.1006/viro.1995.1191; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CHARNIAUX-COTTON HELENE, 1962, GEN AND COMP ENDOCRINOL SUPPL, V1, P241, DOI 10.1016/0016-6480(62)90095-3; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gunther S, 1997, VIROLOGY, V235, P104, DOI 10.1006/viro.1997.8676; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; JAYANTA C, 2003, NATURE, V422, P726; JOHNSON PR, 1991, VIROLOGY, V185, P217, DOI 10.1016/0042-6822(91)90769-8; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; Mansky LM, 2000, J VIROL, V74, P9525, DOI 10.1128/JVI.74.20.9525-9531.2000; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Turelli P, 1997, J VIROL, V71, P4522, DOI 10.1128/JVI.71.6.4522-4530.1997; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; WAINHOBSON S, 1995, VIROLOGY, V209, P297, DOI 10.1006/viro.1995.1261; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	28	1184	1232	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					99	103		10.1038/nature01709	http://dx.doi.org/10.1038/nature01709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12808466				2022-12-01	WOS:000183912800048
J	Zhang, H; Yang, B; Pomerantz, RJ; Zhang, CM; Arunachalam, SC; Gao, L				Zhang, H; Yang, B; Pomerantz, RJ; Zhang, CM; Arunachalam, SC; Gao, L			The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; B MESSENGER-RNA; TYPE-1 VIF PROTEIN; REVERSE TRANSCRIPTION; G->A HYPERMUTATION; NONPERMISSIVE CELLS; EDITING ENZYME; SOR GENE; INFECTION; REPLICATION	High mutation frequency during reverse transcription has a principal role in the genetic variation of primate lentiviral populations. It is the main driving force for the generation of drug resistance and the escape from immune surveillance. G to A hypermutation is one of the characteristics of primate lentiviruses, as well as other retroviruses, during replication in vivo and in cell culture(1-6). The molecular mechanisms of this process, however, remain to be clarified. Here, we demonstrate that CEM15 (also known as apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G; APOBEC3G)(7,8), an endogenous inhibitor of human immunodeficiency virus type 1 (HIV-1) replication, is a cytidine deaminase and is able to induce G to A hypermutation in newly synthesized viral DNA. This effect can be counteracted by the HIV-1 virion infectivity factor (Vif). It seems that this viral DNA mutator is a viral defence mechanism in host cells that may induce either lethal hypermutation or instability of the incoming nascent viral reverse transcripts, which could account for the Vif-defective phenotype. Importantly, the accumulation of CEM15-mediated non-lethal hypermutation in the replicating viral genome could potently contribute to the genetic variation of primate lentiviral populations.	Thomas Jefferson Univ, Dept Med, Div Infect Dis & Environm Med, Ctr Human Virol & Biodef,Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA	Jefferson University	Zhang, H (corresponding author), Thomas Jefferson Univ, Dept Med, Div Infect Dis & Environm Med, Ctr Human Virol & Biodef,Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA.		Yang, Bin/J-4044-2015; Yang, Bin/W-7014-2019	Yang, Bin/0000-0003-4110-1513; Yang, Bin/0000-0003-1180-6184	NIAID NIH HHS [R01 AI047720] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047720] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Chester A, 2000, BBA-GENE STRUCT EXPR, V1494, P1, DOI 10.1016/S0167-4781(00)00219-0; Dettenhofer M, 2000, J VIROL, V74, P8938, DOI 10.1128/JVI.74.19.8938-8945.2000; Dornadula G, 2000, J VIROL, V74, P2594, DOI 10.1128/JVI.74.6.2594-2602.2000; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; FITZGIBBON JE, 1993, AIDS RES HUM RETROV, V9, P833, DOI 10.1089/aid.1993.9.833; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kao S, 2003, J VIROL, V77, P1131, DOI 10.1128/JVI.77.2.1131-1140.2003; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; MARTINEZ MA, 1994, P NATL ACAD SCI USA, V91, P11787, DOI 10.1073/pnas.91.25.11787; Mehta A, 1996, J BIOL CHEM, V271, P28294, DOI 10.1074/jbc.271.45.28294; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; SOVA P, 1993, J VIROL, V67, P6322, DOI 10.1128/JVI.67.10.6322-6326.1993; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Vartanian JP, 1997, J MOL BIOL, V270, P139, DOI 10.1006/jmbi.1997.1104; Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000; ZHANG L, 1996, TERRA NOVA ABSTR S, V1, P70	30	879	905	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2003	424	6944					94	98		10.1038/nature01707	http://dx.doi.org/10.1038/nature01707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12808465	Green Accepted			2022-12-01	WOS:000183912800047
J	Maiato, H; Fairley, EAL; Rieder, CL; Swedlow, JR; Sunkel, CE; Earnshaw, WC				Maiato, H; Fairley, EAL; Rieder, CL; Swedlow, JR; Sunkel, CE; Earnshaw, WC			Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics	CELL			English	Article							KINESIN-RELATED PROTEIN; NEWT LUNG-CELLS; MITOTIC SPINDLE; CENP-E; IN-VITRO; CHROMOSOME ALIGNMENT; INSTABILITY; ATTACHMENT; MITOSIS; INVITRO	One of the most intriguing aspects of mitosis is the ability of kinetochores to hold onto plus ends of microtubules that are actively gaining or losing tubulin subunits. Here, we show that CLASP1, a microtubule-associated protein, localizes preferentially near the plus ends of growing spindle microtubules and is also a component of a kinetochore region that we term the outer corona. A truncated form of CLASP1 lacking the kinetochore binding domain behaves as a dominant negative, leading to the formation of radial arrays of microtubule bundles that are highly resistant to depolymerization. Microinjection of CLASP1-specific antibodies suppresses microtubule dynamics at kinetochores and throughout the spindle, resulting in the formation of monopolar asters with chromosomes buried in the interior. Incubation with microtubule-stabilizing drugs rescues the kinetochore association with microtubule plus ends at the periphery of the asters. Our data suggest that CLASP1 is required at kinetochores for attached microtubules to exhibit normal dynamic behavior.	Univ Edinburgh, Inst Cell & Mol Biol, Chromosome Struct Grp, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Porto, Inst Biol Mol & Celular, Genet Mol Lab, P-4150180 Oporto, Portugal; Wadsworth Ctr, Lab Cell Regulat, Div Mol Med, Albany, NY 12201 USA; Univ Dundee, Div Gene Regulat & Express, MSI, WTB Complex, Dundee DD1 5EH, Scotland; Univ Porto, Inst Ciencias Biomed Abel Alazar, P-4099003 Oporto, Portugal	University of Edinburgh; Universidade do Porto; Wadsworth Center; University of Dundee; Universidade do Porto	Earnshaw, WC (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Chromosome Struct Grp, Wellcome Trust Ctr Cell Biol, Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.		Earnshaw, William/AAY-7438-2020; Sunkel, Claudio E/J-3352-2013; Maiato, Helder/J-9466-2013	Sunkel, Claudio E/0000-0002-2963-9380; Maiato, Helder/0000-0002-6200-9997; Swedlow, Jason/0000-0002-2198-1958; Earnshaw, William/0000-0002-7191-0621	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040198, R37GM040198] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 40198, R37 GM040198, R37 GM040198-20] Funding Source: Medline; Wellcome Trust [073915] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; AIZAWA H, 1991, J BIOL CHEM, V266, P9841; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; CARPENTER ATC, 1991, CELL, V64, P885, DOI 10.1016/0092-8674(91)90313-N; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; COOKE CA, 1990, J CELL BIOL, V110, P1475, DOI 10.1083/jcb.110.5.1475; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; HYMAN AA, 1990, J CELL BIOL, V110, P1607, DOI 10.1083/jcb.110.5.1607; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; JOKELAINEN PT, 1967, J ULTRA MOL STRUCT R, V19, P19, DOI 10.1016/S0022-5320(67)80058-3; Jordan MA, 1999, METHOD CELL BIOL, V61, P267; JORDAN MA, 1992, J CELL SCI, V102, P401; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LaFountain JR, 2001, MOL BIOL CELL, V12, P4054, DOI 10.1091/mbc.12.12.4054; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Mastronarde D. N., 1997, Molecular Biology of the Cell, V8, p171A; McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; PASQUALONE D, 1994, J CELL BIOL, V127, P849; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.E02-04-0236; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yin HW, 2002, MOL BIOL CELL, V13, P1881, DOI 10.1091/mbc.01-09-0458	56	164	169	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 27	2003	113	7					891	904		10.1016/S0092-8674(03)00465-3	http://dx.doi.org/10.1016/S0092-8674(03)00465-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	695EJ	12837247	Green Submitted, Bronze			2022-12-01	WOS:000183817900013
J	Morris, MC; Kaiser, P; Rudyak, S; Baskerville, C; Watson, MH; Reed, SI				Morris, MC; Kaiser, P; Rudyak, S; Baskerville, C; Watson, MH; Reed, SI			Cks1-dependent proteasome recruitment and activation of CDC20 transcription in budding yeast	NATURE			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DEPENDENT PROTEOLYSIS; PROTEIN-KINASE; M-PHASE; GENE; ELONGATION; COMPLEX; PDS1; CLB2	Cks proteins are small evolutionarily conserved proteins that interact genetically and physically with cyclin-dependent kinases. However, in spite of a large body of genetic, biochemical and structural research, no compelling unifying model of their functions has emerged(1,2). Here we show, by investigating the essential role of Cks1 in Saccharomyces cerevisiae, that the protein is primarily involved in promoting mitosis by modulating the transcriptional activation of the APC/C protein-ubiquitin ligase activator Cdc20. Cks1 is required for both the periodic dissociation of Cdc28 kinase from the CDC20 promoter and the periodic association of the proteasome with the promoter. We propose that the essential role of Cks1 is to recruit the proteasome to, and/or dissociate the Cdc28 kinase from, the CDC20 promoter, thus facilitating transcription by remodelling transcriptional complexes or chromatin associated with the CDC20 gene.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Reed, SI (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Rudyak, Stanislav/U-1781-2017; MORRIS, May/ABB-2629-2021; MORRIS, May C/J-5940-2016	MORRIS, May/0000-0001-8106-9728; MORRIS, May C/0000-0001-8106-9728				AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; COLLART MA, 1993, CURRENT PROTOCOLS MO, V2; ENDICOTT JA, 1995, STRUCTURE, V3, P321, DOI 10.1016/S0969-2126(01)00162-9; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; HILT W, 1993, J BIOL CHEM, V268, P3479; Jensen S, 2001, J CELL BIOL, V152, P27, DOI 10.1083/jcb.152.1.27; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser P, 1999, GENE DEV, V13, P1190, DOI 10.1101/gad.13.9.1190; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; MAHER M, 1995, MOL CELL BIOL, V15, P3129; Nasmyth K, 1993, CURR OPIN CELL BIOL, V5, P166, DOI 10.1016/0955-0674(93)90099-C; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pines J, 1996, CURR BIOL, V6, P1399, DOI 10.1016/S0960-9822(96)00741-5; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; TANG Y, 1993, GENE DEV, V7, P822, DOI 10.1101/gad.7.5.822; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	23	103	107	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					1009	1013		10.1038/nature01720	http://dx.doi.org/10.1038/nature01720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827207				2022-12-01	WOS:000183753900055
J	Siddall, M; Rohling, EJ; Almogi-Labin, A; Hemleben, C; Meischner, D; Schmelzer, I; Smeed, DA				Siddall, M; Rohling, EJ; Almogi-Labin, A; Hemleben, C; Meischner, D; Schmelzer, I; Smeed, DA			Sea-level fluctuations during the last glacial cycle	NATURE			English	Article							BAH AL MANDAB; RED-SEA; CLIMATE-CHANGE; GREENLAND; ISOTOPE; RECORDS; CORALS; AGES; FORAMINIFERA; TEMPERATURE	The last glacial cycle was characterized by substantial millennial-scale climate fluctuations(1-5), but the extent of any associated changes in global sea level (or, equivalently, ice volume) remains elusive. Highstands of sea level can be reconstructed from dated fossil coral reef terraces(6,7), and these data are complemented by a compilation of global sea-level estimates based on deep-sea oxygen isotope ratios at millennial-scale resolution(8) or higher(1). Records based on oxygen isotopes, however, contain uncertainties in the range of +/-30 m, or +/-1degreesC in deep sea temperature(9,10). Here we analyse oxygen isotope records from Red Sea sediment cores to reconstruct the history of water residence times in the Red Sea. We then use a hydraulic model of the water exchange between the Red Sea and the world ocean to derive the sill depth and hence global sea level-over the past 470,000 years (470 kyr). Our reconstruction is accurate to within +/-12 m, and gives a centennial-scale resolution from 70 to 25 kyr before present. We find that sea-level changes of up to 35 m, at rates of up to 2 cm yr(-1), occurred, coincident with abrupt changes in climate.	Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Geol Survey Israel, IL-95501 Jerusalem, Israel; Univ Tubingen, Dept Geol & Paleontol, D-7400 Tubingen, Germany; Univ Gottingen, Inst Geol & Palaeontol, Dept Sedimentary Geol, D-37073 Gottingen, Germany	NERC National Oceanography Centre; University of Southampton; Geological Survey Israel; Eberhard Karls University of Tubingen; University of Gottingen	Siddall, M (corresponding author), Southampton Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.		Rohling, Eelco J/B-9736-2008; Smeed, David/B-4726-2012	Rohling, Eelco J/0000-0001-5349-2158; Smeed, David/0000-0003-1740-1778; Almogi-Labin, Ahuva/0000-0002-4082-7120				Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Almogi-Labina A, 2000, MAR MICROPALEONTOL, V40, P295, DOI 10.1016/S0377-8398(00)00043-8; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Edwards F.J., 1987, KEY ENV RED SEA, P45; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Fairbanks RG, 1990, PALEOCEANOGRAPHY, V5, P937, DOI 10.1029/PA005i006p00937; Fenton M, 2000, MAR MICROPALEONTOL, V40, P277, DOI 10.1016/S0377-8398(00)00042-6; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; GRIFFITHS RW, 1984, DEEP-SEA RES, V31, P245, DOI 10.1016/0198-0149(84)90104-3; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hemleben C, 1996, PALEOCEANOGRAPHY, V11, P147, DOI 10.1029/95PA03838; PIRAZZOLI PA, 1993, MAR GEOL, V109, P221, DOI 10.1016/0025-3227(93)90062-Z; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rohling EJ, 1999, PALEOCEANOGRAPHY, V14, P706, DOI 10.1029/1999PA900042; SCHMELZER I, 1998, HIGH FREQUENCY EVENT; SHACKLETON NJ, 1987, QUATERNARY SCI REV, V6, P183, DOI 10.1016/0277-3791(87)90003-5; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Siddall M, 2002, DEEP-SEA RES PT I, V49, P1551, DOI 10.1016/S0967-0637(02)00043-2; Smeed D, 1997, OCEANOL ACTA, V20, P773; Smeed DA, 2000, J PHYS OCEANOGR, V30, P2574, DOI 10.1175/1520-0485(2000)030<2574:HCOTLE>2.0.CO;2; Sofianos SS, 2002, DEEP-SEA RES PT II, V49, P1323, DOI 10.1016/S0967-0645(01)00164-3; Voelker AHL, 1998, RADIOCARBON, V40, P517; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9	29	1155	1200	5	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					853	858		10.1038/nature01690	http://dx.doi.org/10.1038/nature01690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815427				2022-12-01	WOS:000183585300041
J	Presgraves, DC; Balagopalan, L; Abmayr, SM; Orr, HA				Presgraves, DC; Balagopalan, L; Abmayr, SM; Orr, HA			Adaptive evolution drives divergence of a hybrid inviability gene between two species of Drosophila	NATURE			English	Article							NUCLEAR-PORE COMPLEX; POPULATION-GENETICS; NUCLEOPORIN; PROTEIN; NUP98; MELANOGASTER; HITCHHIKING; SITE; ARCHITECTURE; SPECIATION	Speciation-the splitting of one species into two-occurs by the evolution of any of several forms of reproductive isolation between taxa, including the intrinsic sterility and inviability of hybrids. Abundant evidence shows that these hybrid fitness problems are caused by incompatible interactions between loci: new alleles that become established in one species are sometimes functionally incompatible with alleles at interacting loci from another species. However, almost nothing is known about the genes involved in such hybrid incompatibilities or the evolutionary forces that drive their divergence. Here we identify a gene that causes epistatic inviability in hybrids between two fruitfly species, Drosophila melanogaster and D. simulans. Our population genetic analysis reveals that this gene-which encodes a nuclear pore protein-evolved by positive natural selection in both species' lineages. These results show that a lethal hybrid incompatibility has evolved as a by-product of adaptive protein evolution.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Presgraves, DC (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	dvnp@mail.rochester.edu						Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Davis AW, 1996, NATURE, V380, P157, DOI 10.1038/380157a0; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; Emtage JLT, 1997, J CELL SCI, V110, P911; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fay JC, 2000, GENETICS, V155, P1405; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; HEY J, 1993, MOL BIOL EVOL, V10, P804; KAPLAN NL, 1989, GENETICS, V123, P887; Keller CA, 1998, DEV BIOL, V202, P157, DOI 10.1006/dbio.1998.9009; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; LACHAISE D, 1986, EVOLUTION, V40, P262, DOI 10.1111/j.1558-5646.1986.tb00468.x; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MULLER H. J., 1942, GENETICS, V27, P157; Naveira HF, 1998, ENDLESS FORMS, P330; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Presgraves DC, 2003, GENETICS, V163, P955; ROSE MR, 1983, SCIENCE, V220, P157, DOI 10.1126/science.220.4593.157; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Sawamura K, 2000, P NATL ACAD SCI USA, V97, P2652, DOI 10.1073/pnas.050558597; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sturtevant AH, 1920, GENETICS, V5, P488; STURTEVANT AH, 1929, PUBL CARNEG I WASH, V399, P1; TAJIMA F, 1989, GENETICS, V123, P585; Teixeira MT, 1999, J BIOL CHEM, V274, P32439, DOI 10.1074/jbc.274.45.32439; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Turelli M, 2000, GENETICS, V154, P1663; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Wall JD, 2002, GENETICS, V162, P203; WATANABE TK, 1979, JPN J GENET, V54, P325, DOI 10.1266/jjg.54.325; Wilson A.S., 1976, MOL EVOLUTION, P225; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Wu CI, 1998, ENDLESS FORMS, P339; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	48	312	315	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2003	423	6941					715	719		10.1038/nature01679	http://dx.doi.org/10.1038/nature01679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12802326				2022-12-01	WOS:000183443400034
J	Reynolds, EH				Reynolds, EH			Brain and mind: a challenge for WHO	LANCET			English	Editorial Material							ILLNESS		Kings Coll London, Inst Epileptol, London SE5 9PJ, England	University of London; King's College London	Reynolds, EH (corresponding author), Kings Coll London, Inst Epileptol, Denmark Hill Campus, London SE5 9PJ, England.	reynolds@buckles.u-net.com						Baker M, 2001, BRIT MED J, V322, P937, DOI 10.1136/bmj.322.7291.937; Bogousslavsky J, 2003, LANCET NEUROL, V2, P212, DOI 10.1016/S1474-4422(03)00347-8; Crisp AH, 2000, BRIT J PSYCHIAT, V177, P4, DOI 10.1192/bjp.177.1.4; EISENBERG L, 1995, AM J PSYCHIAT, V152, P1563, DOI 10.1176/ajp.152.11.1563; Health organization, 2001, WORLD HLTH REPORT 20; Kendell RE, 2001, BRIT J PSYCHIAT, V178, P490, DOI 10.1192/bjp.178.6.490; Ramachandran VS, 2003, REITH LECT, V3; Reynolds E. H., 1989, BRIDGE NEUROLOGY PSY; REYNOLDS EH, 1990, BRIT J PSYCHIAT, V157, P481, DOI 10.1192/bjp.157.4.481; 2002, ICD10 INT STAT CLASS	10	44	45	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 7	2003	361	9373					1924	1925		10.1016/S0140-6736(03)13600-8	http://dx.doi.org/10.1016/S0140-6736(03)13600-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801732				2022-12-01	WOS:000183359700004
J	Coursol, S; Fan, LM; Le Stunff, H; Spiegel, S; Gilroy, S; Assmann, SM				Coursol, S; Fan, LM; Le Stunff, H; Spiegel, S; Gilroy, S; Assmann, SM			Sphingolipid signalling in Arabidopsis guard cells involves heterotrimeric G proteins	NATURE			English	Article							SPHINGOSINE 1-PHOSPHATE; COUPLED RECEPTOR; KINASE; SPHINGOSINE-1-PHOSPHATE; PLANTS; THALIANA; CHANNELS; LYSOPHOSPHOLIPIDS; PROLIFERATION; ACTIVATION	In animals, the sphingolipid metabolite sphingosine-1-phosphate (S1P) functions as both an intracellular messenger and an extracellular ligand for G-protein-coupled receptors of the S1P receptor family, regulating diverse biological processes ranging from cell proliferation to apoptosis(1-3). Recently, it was discovered in plants that S1P is a signalling molecule involved in abscisic acid (ABA) regulation of guard cell turgor(4). Here we report that the enzyme responsible for S1P production, sphingosine kinase (SphK), is activated by ABA in Arabidopsis thaliana, and is involved in both ABA inhibition of stomatal opening and promotion of stomatal closure. Consistent with this observation, inhibition of SphK attenuates ABA regulation of guard cell inward K+ channels and slow anion channels, which are involved in the regulation of stomatal pore size. Surprisingly, S1P regulates stomatal apertures and guard cell ion channel activities in wild-type plants, but not in knockout lines of the sole prototypical heterotrimeric G-protein alpha-subunit gene, GPA1 (refs 5-8). Our results implicate heterotrimeric G proteins as downstream elements in the S1P signalling pathway that mediates ABA regulation of stomatal function, and suggest that the interplay between S1P and heterotrimeric G proteins represents an evolutionarily conserved signalling mechanism.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem, Richmond, VA 23298 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Commonwealth University	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.		LE STUNFF, Hervé/AAA-6882-2019	Gilroy, Simon/0000-0001-9597-6839				Assmann SM, 2001, CURR OPIN PLANT BIOL, V4, P421, DOI 10.1016/S1369-5266(00)00195-3; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Blatt MR, 2000, ANNU REV CELL DEV BI, V16, P221, DOI 10.1146/annurev.cellbio.16.1.221; Brownlee C, 2001, CURR BIOL, V11, pR535, DOI 10.1016/S0960-9822(01)00313-X; Cismowski MJ, 2001, LIFE SCI, V68, P2301, DOI 10.1016/S0024-3205(01)01019-0; Colucci G, 2002, P NATL ACAD SCI USA, V99, P4736, DOI 10.1073/pnas.072087699; Crowther GJ, 1997, ARCH BIOCHEM BIOPHYS, V337, P284, DOI 10.1006/abbi.1996.9799; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Heringdorf DMZ, 1998, EMBO J, V17, P2830, DOI 10.1093/emboj/17.10.2830; Himmel HM, 2000, MOL PHARMACOL, V58, P449, DOI 10.1124/mol.58.2.449; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Jones AM, 2002, CURR OPIN PLANT BIOL, V5, P402, DOI 10.1016/S1369-5266(02)00288-1; Josefsson LG, 1997, EUR J BIOCHEM, V249, P415, DOI 10.1111/j.1432-1033.1997.t01-1-00415.x; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Ng CKY, 2001, ANN BOT-LONDON, V88, P957, DOI 10.1006/anbo.2001.1543; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Nishiura H, 2000, BIOCHEM SOC T, V28, P747, DOI 10.1042/BST0280747; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Pandey S, 2002, NEW PHYTOL, V153, P517, DOI 10.1046/j.0028-646X.2001.00329.x; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Schilling T, 2002, NEUROSCIENCE, V109, P827, DOI 10.1016/S0306-4522(01)00534-6; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046	29	263	287	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					651	654		10.1038/nature01643	http://dx.doi.org/10.1038/nature01643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789341	Bronze			2022-12-01	WOS:000183301200043
J	Perkins, BA; Ficociello, LH; Silva, KH; Finkelstein, DM; Warram, JH; Krolewski, AS				Perkins, BA; Ficociello, LH; Silva, KH; Finkelstein, DM; Warram, JH; Krolewski, AS			Regression of microalbuminuria in type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FILTRATION-RATE; NEPHROPATHY; RISK; PREVALENCE; ALBUMIN; COMPLICATIONS; PROTEINURIA; PROGRESSION; PREDICTORS; REMISSION	BACKGROUND: In the present study, we aimed to determine the frequency of a significant reduction in urinary albumin excretion and factors affecting such reduction in patients with type 1 diabetes and microalbuminuria. METHODS: The study included 386 patients with persistent microalbuminuria, indicated by repeated measurements of urinary albumin excretion (estimated on the basis of albumin-to-creatinine ratios) in the range of 30 to 299 microg per minute during an initial two-year evaluation period. Subsequent measurements during the next six years were grouped into two-year periods, averaged, and analyzed for regression of microalbuminuria, which was defined as a 50 percent reduction in urinary albumin excretion from one two-year period to the next. RESULTS: Regression of microalbuminuria was frequent, with a six-year cumulative incidence of 58 percent (95 percent confidence interval, 52 to 64 percent). The use of angiotensin-converting-enzyme inhibitors was not associated with the regression of microalbuminuria. However, microalbuminuria of short duration, salutary levels of glycosylated hemoglobin (less than 8 percent), low systolic blood pressure (less than 115 mm Hg), and low levels of both cholesterol and triglycerides (less than 198 mg per deciliter [5.12 mmol per liter] and 145 mg per deciliter [1.64 mmol per liter], respectively) were independently associated with the regression of microalbuminuria. Patients with salutary levels of all modifiable factors had a hazard ratio for regression of 3.0 (95 percent confidence interval, 1.5 to 6.0), as compared with patients with no salutary levels of any modifiable factor. CONCLUSIONS: Frequent regression of microalbuminuria in patients with type 1 diabetes indicates that elevated urinary albumin excretion does not imply inexorably progressive nephropathy. Identification of the multiple determinants of the regression of microalbuminuria has implications for current theories about the mechanisms of early diabetic nephropathy.	Joslin Diabet Ctr, Sect Genet & Epidemiol, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Krolewski, AS (corresponding author), Joslin Diabet Ctr, Sect Genet & Epidemiol, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	andrzej.krolewski@joslin.harvard.edu		Ficociello, Linda/0000-0003-3523-0028	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041526] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK41526] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1999, Diabet Med, V16, P918; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; Chaturvedi N, 1996, BMJ-BRIT MED J, V312, P253; Chaturvedi N, 2001, KIDNEY INT, V60, P219, DOI 10.1046/j.1523-1755.2001.00789.x; CLOSE CF, 1995, BMJ-BRIT MED J, V311, P973; COONROD BA, 1993, DIABETES CARE, V16, P1376, DOI 10.2337/diacare.16.10.1376; COOPER ME, 1988, DIABETIC MED, V5, P361, DOI 10.1111/j.1464-5491.1988.tb01006.x; COOPER ME, 1988, DIABETIC MED, V5, P422; DCCT Res Grp, 1987, DIABETES CARE, V10, P1; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Ellis D, 1996, AM J KIDNEY DIS, V27, P809, DOI 10.1016/S0272-6386(96)90518-1; FELDTRASMUSSEN B, 1991, DIABETOLOGIA, V34, P164, DOI 10.1007/BF00418270; FORSBLOM CM, 1992, BRIT MED J, V305, P1051, DOI 10.1136/bmj.305.6861.1051; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Hovind P, 2001, DIABETES CARE, V24, P1972, DOI 10.2337/diacare.24.11.1972; HUMES HD, 1989, AM J PHYSIOL, V256, pF688, DOI 10.1152/ajprenal.1989.256.4.F688; Kitamura M, 1999, KIDNEY INT, V55, P1639, DOI 10.1046/j.1523-1755.1999.00425.x; Krolewski AS, 1999, KIDNEY INT, V55, P1582, DOI 10.1046/j.1523-1755.1999.00371.x; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; MATHIESEN ER, 1995, DIABETIC MED, V12, P482, DOI 10.1111/j.1464-5491.1995.tb00528.x; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Oldfield MD, 2001, J CLIN INVEST, V108, P1853; ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116; Osicka TM, 1997, CLIN SCI, V93, P65, DOI 10.1042/cs0930065; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Raptis AE, 2001, EXP CLIN ENDOCR DIAB, V109, pS424, DOI 10.1055/s-2001-18600; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; RUDBERG S, 1992, KIDNEY INT, V41, P822, DOI 10.1038/ki.1992.126; Schreiner G F, 1995, Curr Opin Nephrol Hypertens, V4, P369; Scott LJ, 2001, DIABETES, V50, P2842, DOI 10.2337/diabetes.50.12.2842; Stockand JD, 1997, AM J KIDNEY DIS, V29, P971, DOI 10.1016/S0272-6386(97)90476-5; VIBERTI GC, 1982, LANCET, V1, P1430; WANG PH, 1993, LANCET, V341, P1306, DOI 10.1016/0140-6736(93)90816-Y; Warram JH, 2000, DIABETES, V49, P94, DOI 10.2337/diabetes.49.1.94; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; Wilmer WA, 1999, AM J KIDNEY DIS, V34, P308, DOI 10.1016/S0272-6386(99)70360-4; Wong T, 1999, J Am Pharm Assoc (Wash), V39, P785; Zoja C, 1995, AM J KIDNEY DIS, V26, P934, DOI 10.1016/0272-6386(95)90058-6	42	551	580	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2003	348	23					2285	2293		10.1056/NEJMoa021835	http://dx.doi.org/10.1056/NEJMoa021835			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	686AA	12788992				2022-12-01	WOS:000183296300003
J	Brugarolas, J; Clark, JW; Chabner, B				Brugarolas, J; Clark, JW; Chabner, B			Using "rationally designed drugs" rationally	LANCET			English	Editorial Material							CHRONIC MYELOGENOUS LEUKEMIA; ABL TYROSINE KINASE; INHIBITOR; BCR/ABL; CELLS; MICE; INDUCTION		Dana Farber Canc Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Brugarolas, J (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							Brugarolas J, 2001, LANCET, V357, P249, DOI 10.1016/S0140-6736(00)03608-4; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Demetri GD, 2002, EUR J CANCER, V38, pS52, DOI 10.1016/S0959-8049(02)80603-7; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Rothenberg ML, 2003, NAT REV CANCER, V3, P303, DOI 10.1038/nrc1047; SZCZYLIK C, 1991, SCIENCE, V253, P562, DOI 10.1126/science.1857987	13	5	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1758	1759		10.1016/S0140-6736(03)13446-0	http://dx.doi.org/10.1016/S0140-6736(03)13446-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781531				2022-12-01	WOS:000183074800004
J	Peiris, JSM; Chu, CM; Cheng, VCC; Chan, KS; Hung, IFN; Poon, LLM; Law, KI; Tang, BSF; Hon, TYW; Chan, CS; Chan, KH; Ng, JSC; Zheng, BJ; Ng, WL; Lai, RWM; Guan, Y; Yuen, KY				Peiris, JSM; Chu, CM; Cheng, VCC; Chan, KS; Hung, IFN; Poon, LLM; Law, KI; Tang, BSF; Hon, TYW; Chan, CS; Chan, KH; Ng, JSC; Zheng, BJ; Ng, WL; Lai, RWM; Guan, Y; Yuen, KY		HKU UCH SARS Study Grp	Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study	LANCET			English	Article							VIRUS	Background We investigated the temporal progression of the clinical, radiological, and virological changes in a community outbreak of severe acute respiratory syndrome (SARS). Methods We followed up 75 patients for 3 weeks managed with a standard treatment protocol of ribavirin and corticosteroids, and assessed the, pattern of clinical disease, viral load, risk factors for poor clinical outcome, and the usefulness of virological diagnostic methods. Findings Fever and pneumonia initially improved but 64 (85%) patients developed recurrent fever after a mean of 8-9 (SD 3.1) days, 55 (73%) had watery diarrhoea after 7.5 (2.3) days, 60 (80%) had radiological worsening after 7.4 (2.2) days, and respiratory symptoms worsened in 34 (45%) after 8.6 (3.0) days. In 34 (45%) patients, improvement of initial pulmonary lesions was associated with appearance of new radiological lesions at other sites. Nine (12%) patients developed spontaneous pneumomediastinum and 15 (20%) developed acute respiratory distress syndrome (ARDS) in week 3. Quantitative reverse-transcriptase (RT) PCR of nasopharyngeal aspirates in 14 patients (four with ARDS) showed peak viral load at day 10, and at day 15 a load lower than at admission. Age and chronic hepatitis B virus infection treated with lamivudine were independent significant risk factors for progression to ARDS (p=0.001). SARS-associated coronavirus in faeces was seen on RT-PCR in 65 (97%) of 67 patients at day 14. The mean time to seroconversion was 20 days. Interpretation The consistent clinical progression, shifting radiological infiltrates, and an inverted V viral-load profile suggest that worsening in week 2 is unrelated to uncontrolled viral replication but may be related to immunopathological damage.	Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; United Christian Hosp, Dept Med Intens Care Radiol & Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; United Christian Hospital	Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Yuen, Kwok Yung/C-4465-2009; Poon, Leo Lit Man/C-4382-2009; Chan, Chung Sing/C-4577-2009; Poon, Leo/AAP-6887-2020; Hung, Ivan FN/ABD-5916-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Hung, Ivan FN/0000-0002-1556-2538; Guan, Yi/0000-0001-6057-9243; Yuen, Kwok-yung/0000-0002-2083-1552; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; CHENG, Vincent Chi-Chung/0000-0003-1765-7706; Chu, Chung Ming/0000-0002-9959-1271	PHS HHS [A195357] Funding Source: Medline; Wellcome Trust Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; *CDCP, SARS COR SEQ; *HA, HA GUID SEV AC RESP; Ho W, 2003, LANCET, V361, P1313, DOI 10.1016/S0140-6736(03)13085-1; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KSIAZEK TG, NOVEL CORONAVIRUS AS; LEE N, MAJOR OUTBREAK SEVER; Majeski EI, 2003, AM J RESP CELL MOL, V28, P208, DOI 10.1165/rcmb.4891; Ning Q, 1998, J IMMUNOL, V160, P3487; OLLIFF JFC, 1989, CLIN RADIOL, V40, P463, DOI 10.1016/S0009-9260(89)80245-4; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POON LLM, RAPID DIAGNOSIS CORO; POUTANEN SM, IDENTIFICATION SEVER; *SEV AC RESP SYNDR, MULT COUNTR OUTBR; TSANG KW, CLUSTER CASES SEVERE; TURNER RB, 1986, J INFECT DIS, V154, P443, DOI 10.1093/infdis/154.3.443; TUTOR JD, 1995, PEDIATR PULM, V19, P393, DOI 10.1002/ppul.1950190614; ATYPICAL PNEUMONIA	18	1635	1793	3	209	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1767	1772		10.1016/S0140-6736(03)13412-5	http://dx.doi.org/10.1016/S0140-6736(03)13412-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781535	Green Published, Bronze			2022-12-01	WOS:000183074800008
J	Burke, JM; Rieseberg, LH				Burke, JM; Rieseberg, LH			Fitness effects of transgenic disease resistance in sunflowers	SCIENCE			English	Article							GENE FLOW; INTROGRESSION		Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Vanderbilt University; Indiana University System; Indiana University Bloomington	Burke, JM (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.		Burke, John M/A-3502-2013; Rieseberg, Loren H/B-3591-2013	Burke, John M/0000-0002-1412-5539; Rieseberg, Loren H/0000-0002-2712-2417				Burke JM, 2002, AM J BOT, V89, P1550, DOI 10.3732/ajb.89.9.1550; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; NOYES RD, 1981, PHYSIOL PLANT PATHOL, V18, P123; Rieseberg LH, 2001, TAXON, V50, P47, DOI 10.2307/1224511	5	107	122	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1250	1250		10.1126/science.1084960	http://dx.doi.org/10.1126/science.1084960			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764188	Green Submitted			2022-12-01	WOS:000183042400037
J	Fouchier, RAM; Kuiken, T; Schutten, M; van Amerongen, G; van Doornum, J; van den Hoogen, BG; Peiris, M; Lim, W; Stohr, K; Osterhaus, ADME				Fouchier, RAM; Kuiken, T; Schutten, M; van Amerongen, G; van Doornum, J; van den Hoogen, BG; Peiris, M; Lim, W; Stohr, K; Osterhaus, ADME			Aetiology - Koch's postulates fulfilled for SARS virus	NATURE			English	Article									Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; 9F Publ Hlth Lab Ctr, Govt Virus Unit, Kowloon, Hong Kong, Peoples R China	Erasmus University Rotterdam; Erasmus MC; University of Hong Kong	Fouchier, RAM (corresponding author), Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands.		van den Hoogen, Bernadette/J-5461-2013; Fouchier, Ron A/A-1911-2014; Peiris, Joseph Sriyal Malik/C-4380-2009	Fouchier, Ron A/0000-0001-8095-2869; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Osterhaus, Albert/0000-0002-6074-1172				[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P81; DROSTEN C, IN PRESS N ENGL J ME; KSIAZEK TG, IN PRESS N ENGL J ME; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POUTANEN SM, IN PRESS N ENGL J ME; Rivers TM, 1937, J BACTERIOL, V33, P1; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098	7	545	609	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					240	240		10.1038/423240a	http://dx.doi.org/10.1038/423240a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748632	Green Published, Bronze			2022-12-01	WOS:000182853100032
J	Wolf-Maier, K; Cooper, RS; Banegas, JR; Giampaoli, S; Hense, HW; Joffres, M; Kastarinen, M; Poulter, N; Primatesta, P; Rodriguez-Artalejo, F; Stegmayr, B; Thamm, M; Tuomilehto, J; Vanuzzo, D; Vescio, F				Wolf-Maier, K; Cooper, RS; Banegas, JR; Giampaoli, S; Hense, HW; Joffres, M; Kastarinen, M; Poulter, N; Primatesta, P; Rodriguez-Artalejo, F; Stegmayr, B; Thamm, M; Tuomilehto, J; Vanuzzo, D; Vescio, F			Hypertension, prevalence and blood pressure levels in 6 European countries, Canada, and the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MONICA PROJECT; CARDIOVASCULAR-DISEASE; REGIONAL-VARIATIONS; CASE-FATALITY; HEALTH SURVEY; RISK-FACTORS; TRENDS; MORTALITY; STROKE	Context Geographic variations in cardiovascular disease (CVD) and associated risk factors have been recognized worldwide. However, little attention has been directed to potential differences in hypertension between Europe and North America. Objective To determine whether higher blood pressure (BP) levels and hypertension are more prevalent in Europe than in the United States and Canada. Design, Setting, and Participants Sample surveys that were national in scope and conducted in the 1990s were identified in Germany, Finland, Sweden,, England, Spain, Italy, Canada, and the United States. Collaborating investigators provided tabular data in a consistent format by age and sex for persons at least 35 years of age. Population registries were the main basis for sampling. Survey sizes ranged from 1800 to 23 100, with response rates of 61% to 87.5%. The data were analyzed to provide age-specific and age-adjusted estimates of BP and hypertension prevalence by country and region (eg, European vs North American). Main Outcome Measures Blood pressure levels and prevalence of hypertension in Europe, the United States, and Canada. Results Average BP was 136/83 mm Hg in the European countries and 127/77 mm Hg in Canada and the United States among men and women combined who were 35 to 74 years of age. This difference already existed among younger persons (35-39 years) in whom treatment was uncommon (ie, 124/78 mm Hg and 115/75 mm Hg, respectively), and the slope with age was,steeper in the European countries. For all age groups, BP measurements were lowest in the United States,and highest in Germany. The age- and sex-adjusted prevalence of hypertension was 28% in the North American countries and 44% in the European countries at the 140/90 mm Hg threshold. The findings for men and women by region were similar. Hypertension prevalence was strongly correlated with stroke mortality (r=0.78) and more modestly with total CVD (r=0.44). Conclusions Despite extensive research on geographic patterns of CVD, the 60% higher prevalence of hypertension in Europe compared with the United States and Canada has not been generally appreciated. The implication of this finding for national prevention strategies should be vigorously explored.	Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Univ Autonoma Madrid, Fac Med, Dept Med Prevent & Salud Publ, Madrid, Spain; Ist Super Sanita, Epidemiol & Biostat Lab, I-00161 Rome, Italy; Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; Dalhousie Univ, Fac Med, Dept Epidemiol & Community Hlth, Halifax, NS, Canada; Kuopio Univ Hosp, Dept Internal Med, SF-70210 Kuopio, Finland; Univ London Imperial Coll Sci Technol & Med, Cardiovasc Studies Unit, London, England; UCL, Sch Med, Dept Epidemiol & Publ Hlth, London W1N 8AA, England; Univ Umea Hosp, Dept Med, S-90185 Umea, Sweden; Robert Koch Inst, D-1000 Berlin, Germany; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Agenzia Reg Friuli Venezia Giulia, Udine, Italy	Loyola University Chicago; Autonomous University of Madrid; Istituto Superiore di Sanita (ISS); University of Munster; Dalhousie University; Kuopio University Hospital; University of Eastern Finland; Imperial College London; University of London; University College London; UCL Medical School; Umea University; Robert Koch Institute; University of Helsinki; Finland National Institute for Health & Welfare	Cooper, RS (corresponding author), Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	rcooper@lumc.edu	Vescio, Fenicia/N-5776-2017	Vescio, Fenicia/0000-0002-3285-919X				Ataman SL, 1996, J CLIN EPIDEMIOL, V49, P869, DOI 10.1016/0895-4356(96)00111-4; Banegas JR, 1998, HYPERTENSION, V32, P998, DOI 10.1161/01.HYP.32.6.998; Banegas JR, 2002, J HYPERTENS, V20, P2157, DOI 10.1097/00004872-200211000-00014; Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88; Beer-Borst S, 2000, J EPIDEMIOL COMMUN H, V54, P424, DOI 10.1136/jech.54.6.424; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper R, 2000, CIRCULATION, V102, P3137; ELLIOTT P, 1988, BRIT MED J, V297, P319; Gasse C, 2001, J HUM HYPERTENS, V15, P27, DOI 10.1038/sj.jhh.1001120; Giampaoli S, 2001, Ital Heart J Suppl, V2, P294; Hajjar I, 2003, J NUTR, V133, P211, DOI 10.1093/jn/133.1.211; Joffres MR, 1997, AM J HYPERTENS, V10, P1097; Joffres MR, 2001, AM J HYPERTENS, V14, P1099, DOI 10.1016/S0895-7061(01)02211-7; Kastarinen MJ, 1998, J HYPERTENS, V16, P1379, DOI 10.1097/00004872-199816090-00019; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; KING H, 1991, B WORLD HEALTH ORGAN, V69, P643; Kotchen TA, 1997, CIRCULATION, V96, P1071, DOI 10.1161/01.CIR.96.4.1071; O'Brien, 1997, Blood Press Monit, V2, P31; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; Primatesta P, 2001, HYPERTENSION, V38, P827, DOI 10.1161/hyp.38.4.827; Primatesta P, 2001, HYPERTENSION, V37, P187, DOI 10.1161/01.HYP.37.2.187; *PROD GED DMAK, 1999, WORLD DRINK TRENDS; Rehm J, 2000, EUR J EPIDEMIOL, V16, P669, DOI 10.1023/A:1007693009604; Rywik SL, 1998, ANN EPIDEMIOL, V8, P3, DOI 10.1016/S1047-2797(97)00177-4; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sempos CT, 2000, ANN EPIDEMIOL, V10, P441, DOI 10.1016/S1047-2797(00)00068-5; Stegmayr B, 1996, CEREBROVASC DIS, V6, P80, DOI 10.1159/000108002; STEWART AW, 1994, INT J EPIDEMIOL, V23, P505; Strasser T, 1998, AM J HYPERTENS, V11, P756, DOI 10.1016/S0895-7061(98)00070-3; THAMM M, 1999, GESUNDHEITSWESEN, V61; THOM TJ, 1994, CIRCULATION, V90, P574, DOI 10.1161/01.CIR.90.1.574; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TYROLER HA, 1979, NAT I HLTH PUBLICATI; *UN STAT DIV INT C, 2002, CAP REAL VAL FIN EXP; *WHO MONICA PROJ, 1988, WORLD HLTH STAT Q, V41, P115; *WHO REG OFF EUR, 2002, COUNTR INF; Wolf HK, 1997, J HUM HYPERTENS, V11, P733, DOI 10.1038/sj.jhh.1000531	40	1254	1324	1	68	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2003	289	18					2363	2369		10.1001/jama.289.18.2363	http://dx.doi.org/10.1001/jama.289.18.2363			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677WF	12746359	Bronze			2022-12-01	WOS:000182831200025
J	McClain, CS; Rosenfeld, B; Breitbart, W				McClain, CS; Rosenfeld, B; Breitbart, W			Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients	LANCET			English	Article							HOPELESSNESS; DEPRESSION; SUICIDE; DESIRE; DEATH; DISTRESS; RELIGION; SCALE	Background The importance of spirituality in coping with a terminal illness is becoming increasingly recognised. We aimed to assess the relation between spiritual well-being, depression, and end-of-life despair in terminally-ill cancer patients. Methods 160 patients in a palliative care hospital with a life expectancy of less than 3 months were interviewed with a series of standardised instruments, including the functional assessment of chronic illness therapy-spiritual well-being scale, the Hamilton depression rating scale, the Beck hopelessness scale, and the schedule of attitudes toward hastened death. Suicidal ideation was based on responses to the Hamilton depression rating scale. Findings Significant correlations were seen between spiritual well-being and desire for hastened death (r=-0.51), hopelessness (r=-0.68), and suicidal ideation (r=-0.41). Results of multiple regression analyses showed that spiritual well-being was the strongest predictor of each outcome variable and provided a unique significant contribution beyond that of depression and relevant covariates. Additionally, depression was highly correlated with desire for hastened death in participants low in spiritual well-being (r=-0.40, p<0.0001) but not in those high in spiritual well-being (r=0.20, p=0.06). Interpretation Spiritual well-being offers some protection against end-of-life despair in those for whom death is imminent. Our findings have important implications for palliative care practice. Controlled research assessing the effect of spirituality-based interventions is needed to establish what methods can help engender a sense of peace and meaning.	Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Fordham University; Memorial Sloan Kettering Cancer Center	Rosenfeld, B (corresponding author), Fordham Univ, Dept Psychol, 441 E Fordham Rd, Bronx, NY 10458 USA.	rosenfeld@fordham.edu	Pais-Ribeiro, Jose/K-1260-2013	Pais-Ribeiro, Jose/0000-0003-2882-8056	NINR NIH HHS [NR-05183] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005183] Funding Source: NIH RePORTER	NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Akechi T, 2001, PSYCHOSOMATICS, V42, P141, DOI 10.1176/appi.psy.42.2.141; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Brady MJ, 1999, PSYCHO-ONCOLOGY, V8, P417, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<417::AID-PON398>3.3.CO;2-W; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; COWARD DD, 1988, ONCOL NURS FORUM, V25, P75; Durkheim E., 1951, SUICIDE STUDY SOCIOL, DOI 10.2307/2088294; Fehring R J, 1997, Oncol Nurs Forum, V24, P663; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gil S, 2001, J PSYCHOSOC ONCOL, V19, P21, DOI 10.1300/J077v19n01_02; Greenstein M, 2000, AM J PSYCHOTHER, V54, P486, DOI 10.1176/appi.psychotherapy.2000.54.4.486; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; KARNOFSKY DA, 1949, EVALUATION CHEMOTHER, P191; Kearney M, 2000, HANDBOOK OF PSYCHIATRY IN PALLIATIVE MEDICINE, P357; KENNELLY L, 2001, DISS ABSTR INT, V61, P5236; Kleespies PM, 2000, J CLIN PSYCHOL, V56, P1153, DOI 10.1002/1097-4679(200009)56:9<1153::AID-JCLP4>3.0.CO;2-Y; McCullough M E, 1999, Twin Res, V2, P126, DOI 10.1375/136905299320565997; Mickley J R, 1992, Image J Nurs Sch, V24, P267; Muldoon M, 1995, J RELIG HEALTH, V34, P329, DOI 10.1007/BF02248742; Nelson CJ, 2002, PSYCHOSOMATICS, V43, P213, DOI 10.1176/appi.psy.43.3.213; Pessin H, 2002, AM BEHAV SCI, V46, P357, DOI 10.1177/000276402237769; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Rabkin JG, 2000, PSYCHOSOM MED, V62, P271, DOI 10.1097/00006842-200003000-00020; Siegrist M, 1996, J SOC PSYCHOL, V136, P559, DOI 10.1080/00224545.1996.9714040; STACK S, 1991, SOC PSYCH PSYCH EPID, V26, P168; Taylor EJ., 1998, PSYCHOSOCIAL NURSING, P71	27	461	470	1	86	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2003	361	9369					1603	1607		10.1016/S0140-6736(03)13310-7	http://dx.doi.org/10.1016/S0140-6736(03)13310-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	676HY	12747880				2022-12-01	WOS:000182746300010
J	Ramanan, SV				Ramanan, SV			The aggressive treatment of hypertension	LANCET			English	Editorial Material									Univ Connecticut, Sch Med, St Francis Hosp & Med Ctr, Hartford, CT 06105 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Ramanan, SV (corresponding author), Univ Connecticut, Sch Med, St Francis Hosp & Med Ctr, 1000 Asylum Ave,Suite 1012, Hartford, CT 06105 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 3	2003	361	9368					1510	1510		10.1016/S0140-6736(03)13176-5	http://dx.doi.org/10.1016/S0140-6736(03)13176-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737860				2022-12-01	WOS:000182658900009
J	Crampton, JS; Beu, AG; Cooper, RA; Jones, CM; Marshall, B; Maxwell, PA				Crampton, JS; Beu, AG; Cooper, RA; Jones, CM; Marshall, B; Maxwell, PA			Estimating the rock volume bias in paleobiodiversity studies	SCIENCE			English	Article							FOSSIL RECORD; BIODIVERSITY; EXTINCTION; DIVERSITY	To interpret changes in biodiversity through geological time, it is necessary first to correct for biases in sampling effort related to variations in the exposure of rocks and recovery of fossils with age. Data from New Zealand indicate that outcrop area is likely to be a reliable proxy of rock volume in both stable cratonic regions, where the paleobiodiversity record is strongly correlated with relative sea level, and on tectonically active margins. In contrast, another potential proxy, the number of rock formations, is a poor predictor of outcrop area or sampling effort in the New Zealand case.	Inst Geol & Nucl Sci, Lower Hutt, New Zealand; Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand	GNS Science - New Zealand	Crampton, JS (corresponding author), Inst Geol & Nucl Sci, POB 30-368, Lower Hutt, New Zealand.	j.crampton@gns.cri.nz	Crampton, James/G-1381-2012; Jones, Craig/C-9693-2011	Crampton, James/0000-0003-3270-9981; Jones, Craig/0000-0002-1495-9293				Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; CARTER RM, 1991, SPEC PUBL INT ASS SE, V12, P41; COOPER RA, IN PRESS I GEOLOGICA; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; KING PR, 1999, I GEOLOGICAL NUCL SC, V1, P1; Miller AI, 2000, PALEOBIOLOGY, V26, P53, DOI 10.1666/0094-8373(2000)26[53:CAPGD]2.0.CO;2; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; RAUP D M, 1976, Paleobiology, V2, P289; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; Smith AB, 2001, PALEOBIOLOGY, V27, P241, DOI 10.1666/0094-8373(2001)027<0241:SLCARR>2.0.CO;2; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Wignall PB, 1999, J GEOL SOC LONDON, V156, P453, DOI 10.1144/gsjgs.156.3.0453	13	132	134	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					358	360		10.1126/science.1085075	http://dx.doi.org/10.1126/science.1085075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12805555				2022-12-01	WOS:000184207300041
J	Chen, GN; Yanofsky, C				Chen, GN; Yanofsky, C			Tandem transcription and translation regulatory sensing of uncharged tryptophan tRNA	SCIENCE			English	Article							BINDING ATTENUATION PROTEIN; BACILLUS-SUBTILIS; LEADER RNA; TRAP; EXPRESSION; TRPG; REPEATS; GENES	The Bacillus subtilis AT (anti-TRAP) protein inhibits the regulatory protein TRAP (trp RNA-binding attenuation protein), thereby eliminating transcription termination in the leader region of the trp operon. Transcription of the AT operon is activated by uncharged tryptophan transfer RNA (tRNA(Trp)). Here we show that translation of AT also is regulated by uncharged tRNATrp. A 10-residue coding region containing three consecutive tryptophan codons is located immediately preceding the AT structural gene. Completion of translation of this coding region inhibits AT synthesis, whereas incomplete translation increases AT production. Tandem sensing of uncharged tRNATrp therefore regulates synthesis of AT, which in turn regulates TRAP's ability to inhibit trp operon expression.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Yanofsky, C (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	yanofsky@cmgm.stanford.edu						Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BABITZKE P, 1995, P NATL ACAD SCI USA, V92, P7916, DOI 10.1073/pnas.92.17.7916; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; BABITZKE P, 1994, J BIOL CHEM, V269, P16597; Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CREIGHTON TE, 1970, METHODS ENZYMOLOGY A, V17, P365, DOI DOI 10.1021/ACS.BIOCHEM.8B00167; Du HS, 1997, J BACTERIOL, V179, P2582, DOI 10.1128/jb.179.8.2582-2586.1997; Du HS, 1998, J BIOL CHEM, V273, P20494, DOI 10.1074/jbc.273.32.20494; GOLLNICK P, 2001, BACILLUS SUBTILIS IT, P233; Henkin TM, 2000, CURR OPIN MICROBIOL, V3, P149, DOI 10.1016/S1369-5274(00)00067-9; Henner Dennis, 1993, P269; Lee AI, 1996, J BACTERIOL, V178, P6518, DOI 10.1128/jb.178.22.6518-6524.1996; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; OTRIDGE J, 1993, P NATL ACAD SCI USA, V90, P128, DOI 10.1073/pnas.90.1.128; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEKIGUCHI J, 1975, J BACTERIOL, V121, P688, DOI 10.1128/JB.121.2.688-694.1975; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; STEINBERG W, 1974, J BACTERIOL, V117, P1023, DOI 10.1128/JB.117.3.1023-1034.1974; Sudershana S, 1999, J BACTERIOL, V181, P5742, DOI 10.1128/JB.181.18.5742-5749.1999; Valbuzzi A, 2001, SCIENCE, V293, P2057, DOI 10.1126/science.1062187; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; YANG M, 1995, J BACTERIOL, V177, P4272, DOI 10.1128/jb.177.15.4272-4278.1995	25	26	27	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					211	213		10.1126/science.1084902	http://dx.doi.org/10.1126/science.1084902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855807				2022-12-01	WOS:000184056200042
J	Orofino, MG; Argiolu, F; Sanna, MA; Rosatelli, MC; Tuveri, T; Scalas, MT; Badiali, M; Cossu, P; Puddu, R; Lai, ME; Cao, A				Orofino, MG; Argiolu, F; Sanna, MA; Rosatelli, MC; Tuveri, T; Scalas, MT; Badiali, M; Cossu, P; Puddu, R; Lai, ME; Cao, A			Fetal HLA typing in beta thalassaemia: implications for haemopoietic stem-cell transplantation	LANCET			English	Article								Stem-cell transplantation can cure beta thalassaemia. We aimed to assess whether fetal HLA typing done early in the-pregnancy of couples who were at risk of beta thalassaemia could provide an alternative to pregnancy termination if the prospect of a bone-marrow transplantation from a family member was available. In our clinic in Sardinia, we did fetal HLA typing for 49 couples at risk of having a baby with beta thalassaemia. Two affected children were born and successfully received a transplantation from a family donor. Five non-affected fetuses were HLA compatible with an affected sibling and their cord blood was harvested for a future transplantation.	Univ Cagliari, Dept Biomed Sci & Biotechnol, Paediat Clin Bone Marrow Transplant Ctr, Cagliari, Italy	University of Cagliari	Argiolu, F (corresponding author), Univ Cagliari, Dept Biomed Sci & Biotechnol, Paediat Clin Bone Marrow Transplant Ctr, Cagliari, Italy.			ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190				ARGIOLU F, 2000, HAEMATOLOGICA, V85, P37; Bugert P, 2001, TISSUE ANTIGENS, V58, P103, DOI 10.1034/j.1399-0039.2001.580208.x; DYER C, 2002, BRIT MED J, V321, P503; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; van den Berg H, 2000, BONE MARROW TRANSPL, V25, P579, DOI 10.1038/sj.bmt.1702219	5	16	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 5	2003	362	9377					41	42		10.1016/S0140-6736(03)13806-8	http://dx.doi.org/10.1016/S0140-6736(03)13806-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699KW	12853199				2022-12-01	WOS:000184056900013
J	Pedley, DK; Bissett, K; Connolly, EM; Goodman, CG; Golding, I; Pringle, TH; McNeill, GP; Pringle, SD; Jones, MC				Pedley, DK; Bissett, K; Connolly, EM; Goodman, CG; Golding, I; Pringle, TH; McNeill, GP; Pringle, SD; Jones, MC			Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics	BRITISH MEDICAL JOURNAL			English	Article							EARLY ANISTREPLASE TRIAL; NEEDLE TIMES; THERAPY; MORTALITY; CALL	Objectives To evaluate a system of prehospital thrombolysis, delivered by paramedics, in meeting the national service framework's targets for the management of acute myocardial infarction. Design Prospective observational cohort study comparing patients with suspected acute myocardial infarction considered for thrombolysis in the prehospital environment With patients treated in hospital. Setting The catchment area of a large teaching hospital, including urban and rural areas. Participants 201 patients presenting concurrently over a 12 month period who had changes to the electrocardiogram that were diagnostic of acute myocardial infarction or who received thrombolysis for suspected acute myocardial infarction. Main outcome measures Time from first medical contact to initiation of thrombolysis (call to needle time), number of patients given thrombolysis appropriately, and all cause mortality in hospital. Results The median call to needle time for patients treated before arriving in hospital (n=28) was 52 (95% confidence interval 41 to 62) minutes. Patients from similar rural areas who were treated in hospital (n=43) had a median time of 125 (104 to 140) minutes. This represents a median time saved of 73 minutes (P < 0.001). Sixty minutes after medical contact 64% of, patients (18/28) treated before arrival in hospital had received thrombolysis; this compares with 4% of patients (2/43) in a cohort from similar areas. Median call to needle time for patients from urban areas (n=107) was 80 (78 to 93) minutes. Myocardial infarction was confirmed in 89% of patients (25/28) who had received prehospital thrombolysis; this compares with 92% (138/150) in the two groups of patients receiving thrombolysis in hospital. Conclusions Thrombolysis delivered by paramedics with support from the base hospital can meet the national targets for early thrombolysis. The system has been shown to work well and can be introduced without delay.	Univ Dundee, Ninewells Hosp & Med Sch, Chest Pain Serv, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Med & Cardiovasc Grp, Dundee DD1 9SY, Scotland; Scottish Ambulance Serv, Dundee DD3 8PQ, Scotland	University of Dundee; University of Dundee	Pedley, DK (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Chest Pain Serv, Dundee DD1 9SY, Scotland.							[Anonymous], 1988, LANCET, V332, P349; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; *DEP HLTH, 2000, NAT SERV FRAM COR HE; GATENBY R, 1992, BMJ-BRIT MED J, V305, P548; LEIZOROVICZ A, 1993, NEW ENGL J MED, V329, P383; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Rawles J, 1998, BRIT MED J, V317, P576, DOI 10.1136/bmj.317.7158.576; Rawles J, 1999, BRIT MED J, V318, P1554; Rawles JM, 1997, J AM COLL CARDIOL, V30, P1181, DOI 10.1016/S0735-1097(97)00299-4; WEAVER WD, 1993, JAMA-J AM MED ASSOC, V270, P1211, DOI 10.1001/jama.270.10.1211; WESTON CFM, 1994, BMJ-BRIT MED J, V308, P767, DOI 10.1136/bmj.308.6931.767; 2002, J AM COLL CARDIOL, V3, P71	13	53	54	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2003	327	7405					22	26		10.1136/bmj.327.7405.22	http://dx.doi.org/10.1136/bmj.327.7405.22			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699NK	12842951	Green Published, Bronze			2022-12-01	WOS:000184062700018
J	Dacke, M; Nilsson, DE; Scholtz, CH; Byrne, M; Warrant, EJ				Dacke, M; Nilsson, DE; Scholtz, CH; Byrne, M; Warrant, EJ			Insect orientation to polarized moonlight	NATURE			English	Article									Lund Univ, Dept Cell & Organism Biol, S-22362 Lund, Sweden; Univ Witwatersrand, Dept Anim Plant & Environm Sci, Ecophysiol Studies Res Grp, ZA-2050 Johannesburg, South Africa; Univ Pretoria, Dept Zool & Entomol, ZA-0001 Pretoria, South Africa	Lund University; University of Witwatersrand; University of Pretoria	Dacke, M (corresponding author), Lund Univ, Dept Cell & Organism Biol, S-22362 Lund, Sweden.	marie.dacke@cob.lu.se	Byrne, Marcus/AAF-9789-2021; Scholtz, Clarke/E-7121-2010	Warrant, Eric/0000-0001-7480-7016; Byrne, Marcus/0000-0002-5155-2599				Dacke M, 2003, J EXP BIOL, V206, P1535, DOI 10.1242/jeb.00289; Gal J, 2001, J GEOPHYS RES-ATMOS, V106, P22647, DOI 10.1029/2000JD000085; Strutt J. W., 1871, PHILOS MAG, V41, P107, DOI DOI 10.1080/14786447108640452; Waterman T.H., 1981, HDB SENSORY PHYSL, P281; Wehner R, 2001, J EXP BIOL, V204, P2589	5	176	194	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2003	424	6944					33	33		10.1038/424033a	http://dx.doi.org/10.1038/424033a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	696XL	12840748				2022-12-01	WOS:000183912800029
J	Baglione, V; Canestrari, D; Marcos, JM; Ekman, J				Baglione, V; Canestrari, D; Marcos, JM; Ekman, J			Kin selection in cooperative alliances of carrion crows	SCIENCE			English	Article							DISPERSAL; BEHAVIOR	In most cooperative vertebrates, delayed natal dispersal is the mechanism that leads to the formation of kin societies. Under this condition, the possibility that kin-based cooperative breeding is an unselected consequence of dispersal patterns can never be ruled out because helpers can only help their relatives. Here we show that a population of carrion crows (Corvus corone corone) fully fits the central prediction of kin selection theory that cooperative breeding should arise among relatives. On their territory, resident breeders are aided not only by nonbreeding retained offspring but also by immigrants ( mainly males), with whom they share matings. Philopatry cannot account, however, for the high degree of genetic relatedness found between breeders and immigrants of the same sex that cooperate at a nest, indicating that crows actively choose to breed cooperatively with their relatives.	Uppsala Univ, Populat Biol Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; Univ Seville, Seville 41071, Spain	Uppsala University; University of Sevilla	Baglione, V (corresponding author), Uppsala Univ, Populat Biol Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	vittorio.baglione@ebc.uu.se	Baglione, Vittorio/D-6456-2014; Canestrari, Daniela/F-9696-2016	Canestrari, Daniela/0000-0001-9112-0208; Baglione, Vittorio/0000-0001-8464-7861				Baglione V, 2002, ANIM BEHAV, V64, P887, DOI 10.1006/anbe.2002.2007; Baglione V, 2002, AUK, V119, P790, DOI 10.1642/0004-8038(2002)119[0790:CBGOCC]2.0.CO;2; Baglione V, 2002, P ROY SOC B-BIOL SCI, V269, P1247, DOI 10.1098/rspb.2002.2016; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; EKMAN J, 1994, BEHAV ECOL, V5, P245, DOI 10.1093/beheco/5.3.245; EMLEN ST, 1988, BEHAV ECOL SOCIOBIOL, V23, P305, DOI 10.1007/BF00300577; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Koenig WD, 2000, CONDOR, V102, P492, DOI 10.1650/0010-5422(2000)102[0492:NDITCB]2.0.CO;2; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; QUELLER DC, 1992, TRENDS ECOL EVOL, V7, P322, DOI 10.1016/0169-5347(92)90120-Z; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Spong G, 2001, P ROY SOC B-BIOL SCI, V268, P2571, DOI 10.1098/rspb.2001.1835; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Zar JH., 1999, BIOSTAT ANAL; [No title captured]	20	81	82	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1947	1949		10.1126/science.1082429	http://dx.doi.org/10.1126/science.1082429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817149				2022-12-01	WOS:000183619400047
J	Garsin, DA; Villanueva, JM; Begun, J; Kim, DH; Sifri, CD; Calderwood, SB; Ruvkun, G; Ausubel, FM				Garsin, DA; Villanueva, JM; Begun, J; Kim, DH; Sifri, CD; Calderwood, SB; Ruvkun, G; Ausubel, FM			Long-lived C-elegans daf-2 mutants are resistant to bacterial pathogens	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HOST		Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	Ausubel@molbio.mgh.harvard.edu	Begun, Jakob/J-6793-2014	Begun, Jakob/0000-0001-5256-7672; Sifri, Costi/0000-0001-6033-2515	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707, R01GM048707] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48707] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	7	414	429	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1921	1921		10.1126/science.1080147	http://dx.doi.org/10.1126/science.1080147			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12817143				2022-12-01	WOS:000183619400038
J	Taylor, AF; Smith, GR				Taylor, AF; Smith, GR			RecBCD enzyme is a DNA helicase with fast and slow motors of opposite polarity	NATURE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; ATP-BINDING; HOMOLOGOUS RECOMBINATION; PURIFIED SUBUNITS; RECD SUBUNIT; TRANSLOCATION; SEQUENCE; PROTEIN; CHI	Helicases are molecular motors that move along and unwind double-stranded nucleic acids(1). RecBCD enzyme is a complex helicase and nuclease, essential for the major pathway of homologous recombination and DNA repair in Escherichia coli(2). It has sets of helicase motifs(1) in both RecB and RecD, two of its three subunits. This rapid, highly processive enzyme unwinds DNA in an unusual manner: the 5'-ended strand forms a long single-stranded tail, whereas the 3'-ended strand forms an ever-growing single-stranded loop and short single-stranded tail. Here we show by electron microscopy of individual molecules that RecD is a fast helicase acting on the 5'-ended strand and RecB is a slow helicase acting on the 3'-ended strand on which the single-stranded loop accumulates. Mutational inactivation of the helicase domain in RecB or in RecD, or removal of the RecD subunit, altered the rates of unwinding or the types of structure produced, or both. This dual-helicase mechanism explains how the looped recombination intermediates are generated and may serve as a general model for highly processive travelling machines with two active motors, such as other helicases and kinesins.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.			Smith, Gerald/0000-0002-8747-1352				Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BOEHMER PE, 1991, GENE, V102, P1, DOI 10.1016/0378-1119(91)90529-K; BRAEDT G, 1989, P NATL ACAD SCI USA, V86, P871, DOI 10.1073/pnas.86.3.871; CHAUDHURY AM, 1984, P NATL ACAD SCI-BIOL, V81, P7850, DOI 10.1073/pnas.81.24.7850; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; GEORGE JW, 1994, J MOL BIOL, V229, P67; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1992, J BIOL CHEM, V267, P1733; LEE MS, 1990, J BIOL CHEM, V265, P17078; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MASTERSON C, 1992, J BIOL CHEM, V267, P13564; Phillips RJ, 1997, MOL GEN GENET, V254, P319, DOI 10.1007/PL00008605; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127	30	158	167	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2003	423	6942					889	893		10.1038/nature01674	http://dx.doi.org/10.1038/nature01674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691BQ	12815437				2022-12-01	WOS:000183585300051
J	Berman, B				Berman, B			Integrative approaches to pain management: how to get the best of both worlds	BRITISH MEDICAL JOURNAL			English	Article									Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Berman, B (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.				NCCIH NIH HHS [N0 5-P50-AT00084-02] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000084] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)			0	9	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1320	+		10.1136/bmj.326.7402.1320-a	http://dx.doi.org/10.1136/bmj.326.7402.1320-a			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805175	Green Published			2022-12-01	WOS:000183626500040
J	Donaldson, L				Donaldson, L			Expert patients usher in a new era of opportunity for the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material									Dept Hlth, London SW1A 2NS, England		Donaldson, L (corresponding author), Dept Hlth, London SW1A 2NS, England.								0	94	94	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2003	326	7402					1279	1279		10.1136/bmj.326.7402.1279	http://dx.doi.org/10.1136/bmj.326.7402.1279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691VK	12805129	Green Published			2022-12-01	WOS:000183626500005
J	Hayes, EB; Piesman, J				Hayes, EB; Piesman, J			Current concepts - How can we prevent Lyme disease?	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IXODES-SCAPULARIS ACARI; DEER-TICK BITES; DAMMINI ACARI; IXODIDAE NYMPHS; SOUTHEASTERN CONNECTICUT; ANTIBIOTIC-TREATMENT; REDUCED ABUNDANCE; RESIDENTIAL AREA; NEW-YORK; RISK		Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Piesman, J (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, POB 2087,Rampart Rd, Ft Collins, CO 80522 USA.	jfp2@cdc.gov						*ADV COMM IMM PRAC, 1999, MMWR-MORBID MORTAL W, V48, P833; AGRE F, 1993, AM J DIS CHILD, V147, P945, DOI 10.1001/archpedi.1993.02160330035013; Allan SA, 1998, MED VET ENTOMOL, V12, P141, DOI 10.1046/j.1365-2915.1998.00080.x; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; BERGER BW, 1989, REV INFECT DIS, V11, pS1475; CDC, 1999, MMWR-MORBID MORTAL W, V48, P1; Costello C M, 1989, Conn Med, V53, P338; Crippa M, 2002, VECTOR-BORNE ZOONOT, V2, P3, DOI 10.1089/153036602760260724; CURRAN KL, 1993, J MED ENTOMOL, V30, P107, DOI 10.1093/jmedent/30.1.107; DANIELS TJ, 1995, J MED ENTOMOL, V32, P5, DOI 10.1093/jmedent/32.1.5; DANIELS TJ, 1991, J MED ENTOMOL, V28, P537, DOI 10.1093/jmedent/28.4.537; DEBLINGER RD, 1991, J MED ENTOMOL, V28, P708, DOI 10.1093/jmedent/28.5.708; DELBINGER RD, 1993, J MED ENTOMOL, V30, P144; Gresikova M, 1997, ACTA VIROL, V41, P115; HASSLER D, 1990, INFECTION, V18, P16, DOI 10.1007/BF01644175; Hayes E B, 1999, J Public Health Manag Pract, V5, P84; Herrington JE, 1997, AM J PUBLIC HEALTH, V87, P2035, DOI 10.2105/AJPH.87.12.2035; Kahl O, 1998, ZBL BAKT-INT J MED M, V287, P41; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Lathrop SL, 2002, VACCINE, V20, P1603, DOI 10.1016/S0264-410X(01)00500-X; LEY C, 1995, AM J EPIDEMIOL, V142, pS39, DOI 10.1093/aje/142.Supplement_9.S39; Logigian EL, 1999, J INFECT DIS, V180, P377, DOI 10.1086/314860; MALOUIN R, IN PRESS AM J EPIDEM; MAUPIN GO, 1991, AM J EPIDEMIOL, V133, P1105, DOI 10.1093/oxfordjournals.aje.a115823; Meltzer MI, 1999, EMERG INFECT DIS, V5, P321, DOI 10.3201/eid0503.990302; Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; O'Connell S, 1998, ZBL BAKT-INT J MED M, V287, P229, DOI 10.1016/S0934-8840(98)80124-2; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Orloski KA, 1998, AM J EPIDEMIOL, V147, P391; Panella NA, 1997, J MED ENTOMOL, V34, P340, DOI 10.1093/jmedent/34.3.340; Parola P, 2001, CLIN INFECT DIS, V33, P749; PATRICAN LA, 1995, J MED ENTOMOL, V32, P859, DOI 10.1093/jmedent/32.6.859; PFISTER HW, 1991, J INFECT DIS, V163, P311, DOI 10.1093/infdis/163.2.311; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Poland GA, 2001, MAYO CLIN PROC, V76, P713, DOI 10.4065/76.7.713; Pound JM, 2000, J MED ENTOMOL, V37, P588, DOI 10.1603/0022-2585-37.4.588; Rothermel H, 2001, PEDIATRICS, V108, P477, DOI 10.1542/peds.108.2.477; SCHULZE TL, 1995, J MED ENTOMOL, V32, P730, DOI 10.1093/jmedent/32.5.730; Schulze TL, 2001, J ECON ENTOMOL, V94, P123, DOI 10.1603/0022-0493-94.1.123; Schulze TL, 2001, J MED ENTOMOL, V38, P344, DOI 10.1603/0022-2585-38.2.344; Shapiro ED, 2001, NEW ENGL J MED, V345, P133, DOI 10.1056/NEJM200107123450210; SHAPIRO ED, 1992, NEW ENGL J MED, V327, P1769, DOI 10.1056/NEJM199212173272501; Sood SK, 1997, J INFECT DIS, V175, P996, DOI 10.1086/514009; STAFFORD KC, 1991, J MED ENTOMOL, V28, P32, DOI 10.1093/jmedent/28.1.32; Stafford KC, 1998, J MED ENTOMOL, V35, P510, DOI 10.1093/jmedent/35.4.510; STAFFORD KC, 1993, J MED ENTOMOL, V30, P762, DOI 10.1093/jmedent/30.4.762; STAFFORD KC, 1992, J MED ENTOMOL, V29, P717, DOI 10.1093/jmedent/29.4.717; Stafford KC, 1996, J MED ENTOMOL, V33, P183, DOI 10.1093/jmedent/33.1.183; Steere AC, 1998, NEW ENGL J MED, V339, P1638; Steere AC, 2001, J AUTOIMMUN, V16, P263, DOI 10.1006/jaut.2000.0495; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1994, ARTHRITIS RHEUM-US, V37, P878, DOI 10.1002/art.1780370616; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; WILSON ML, 1986, J ECON ENTOMOL, V79, P693, DOI 10.1093/jee/79.3.693; WILSON ML, 1988, J MED ENTOMOL, V25, P224, DOI 10.1093/jmedent/25.4.224; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Wormser GP, 1997, NEW ENGL J MED, V336, P1107; Zhioua E, 1997, J PARASITOL, V83, P815, DOI 10.2307/3284273; ZHIOUA E, 1995, J MED ENTOMOL, V32, P900, DOI 10.1093/jmedent/32.6.900; 2001, MMWR MORB MORTAL WKL, V50, P92	61	159	168	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2003	348	24					2424	2430		10.1056/NEJMra021397	http://dx.doi.org/10.1056/NEJMra021397			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688HU	12802029				2022-12-01	WOS:000183428900009
J	Chin-Dusting, JPF; Dart, AM				Chin-Dusting, JPF; Dart, AM			Age and the treatment gap in the use of statins	LANCET			English	Editorial Material							DISEASE; INTERVENTION; THERAPY		Baker Heart Res Inst, Alfred & Baker Med Unit, Melbourne, Vic 3004, Australia; Alfred Hosp, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health	Chin-Dusting, JPF (corresponding author), Baker Heart Res Inst, Alfred & Baker Med Unit, Wynn Domain, Melbourne, Vic 3004, Australia.	j.chin@alfred.org.au	Dart, Anthony M/E-7461-2010	Dart, Anthony M/0000-0003-1360-3778				*AM HEART ASS, 2003, CHOL LOW DRUGS; Bartlett C, 2003, HEART, V89, P327, DOI 10.1136/heart.89.3.327; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; DeWilde S, 2003, HEART, V89, P417, DOI 10.1136/heart.89.4.417; Hilleman DE, 2001, PHARMACOTHERAPY, V21, P1415, DOI 10.1592/phco.21.17.1415.34422; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Julian DG, 1997, EUR HEART J, V18, P394; *NAT HEART FDN AUS, 2003, RED RISK HEART DIS G; *NAT SERV FRAM COR, 1998, EM FIND REP; PEDERSEN TR, 1994, LANCET, V344, P1383; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; VALE MJ, IN PRESS ARCH INTERN; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	14	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2003	361	9373					1925	1926		10.1016/S0140-6736(03)13601-X	http://dx.doi.org/10.1016/S0140-6736(03)13601-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687DB	12801733				2022-12-01	WOS:000183359700005
J	Yao, MC; Fuller, P; Xi, XH				Yao, MC; Fuller, P; Xi, XH			Programmed DNA deletion as an RNA-guided system of genome defense	SCIENCE			English	Article							TETRAHYMENA-THERMOPHILA; DEVELOPMENTAL EXCISION; PARAMECIUM-TETRAURELIA; HISTONE H3; GENE; METHYLATION; REARRANGEMENTS; ELIMINATION; EXPRESSION; SEQUENCES	Genomewide DNA rearrangements occur in many eukaryotes during development, but their functions and mechanisms are poorly understood. Previous studies have implicated a sequence-recognition mechanism based on RNA-mediated interactions between nuclei in ciliated protozoa. In this study, we found that the process recognized and deleted a foreign gene integrated in a Tetrahymena chromosome, suggesting an unusual mechanism of genome surveillance. We further found that injection of double-stranded RNA into the cell at specific developmental stages triggers efficient deletion of the targeted genomic regions. Together the results indicate an RNA-based mechanism that directs genomewide DNA rearrangements and serves to disable invading genetic agents.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Yao, MC (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026210] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM26210] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; CASSIDYHANLEY D, 1994, GENETICS, V137, P95; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; CHALKER DL, UNPUB; COYNE R, UNPUB; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Duharcourt S, 2002, EUKARYOT CELL, V1, P293, DOI 10.1128/EC.1.2.293-303.2002; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; MARCZYNSKI GT, 1985, NUCLEIC ACIDS RES, V13, P8487, DOI 10.1093/nar/13.23.8487; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Matzke MA, 1996, TRENDS PLANT SCI, V1, P382, DOI 10.1016/S1360-1385(96)80313-X; MCGRATH KE, 1994, CELL MOTIL CYTOSKEL, V27, P272, DOI 10.1002/cm.970270308; Meyer E, 1996, CELL, V87, P9, DOI 10.1016/S0092-8674(00)81317-3; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; YAO MC, UNPUB; Yao MC, 2002, MOBILE DNA, P730; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	27	154	159	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2003	300	5625					1581	1584		10.1126/science.1084737	http://dx.doi.org/10.1126/science.1084737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12791996				2022-12-01	WOS:000183333100058
J	Spencer, RMC; Zelaznik, HN; Diedrichsen, J; Ivry, RB				Spencer, RMC; Zelaznik, HN; Diedrichsen, J; Ivry, RB			Disrupted timing of discontinuous but not continuous movements by cerebellar lesions	SCIENCE			English	Article							DRAWING MOVEMENTS; DISSOCIATION; PERCEPTION; HUMANS; FMRI	Patients with cerebellar damage are known to exhibit deficits in the temporal control of movements. We report that these deficits are restricted to discontinuous movements. Cerebellar patients exhibited no deficit in temporal variability when producing continuous, rhythmic movements. We hypothesize that the temporal properties of continuous movements are emergent and reflect the operation of other control parameters not associated with the cerebellum. In contrast, discontinuous movements require an explicit representation of the temporal goal, a function of the cerebellum. The requirement for explicit temporal representation provides a parsimonious account of cerebellar involvement in a range of tasks.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Purdue Univ, Dept Hlth & Kinesiol, Integrat Program Neurosci, W Lafayette, IN 47907 USA	University of California System; University of California Berkeley; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Spencer, RMC (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall 1650, Berkeley, CA 94720 USA.	rspencer@socrates.berkeley.edu	Diedrichsen, Jörn/AAQ-2242-2020; Diedrichsen, Jörn/A-7789-2010	Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532; Spencer, Rebecca/0000-0002-8674-2384; zelaznik, howard/0000-0003-0071-2377	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017778, P01NS040813, R29NS030256, R01NS030256, P50NS017778] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40813, NS17778, NS30256] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann H, 1997, BRAIN LANG, V60, P323, DOI 10.1006/brln.1997.1826; Ackermann H, 2001, NEUROREPORT, V12, P4087, DOI 10.1097/00001756-200112210-00045; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Bransford, 1977, PERCEIVING ACTING KN, P211; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; DAUM I, 1993, BEHAV NEUROSCI, V107, P748, DOI 10.1037/0735-7044.107.5.748; HOGAN N, 1987, TRENDS NEUROSCI, V10, P170, DOI 10.1016/0166-2236(87)90043-9; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; HORE J, 1991, J NEUROPHYSIOL, V65, P563, DOI 10.1152/jn.1991.65.3.563; IVRY R, 1993, ANN NY ACAD SCI, V682, P214, DOI 10.1111/j.1749-6632.1993.tb22970.x; IVRY R, 1997, INT REV NEUROBIOL, V41, P556; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; IVRY RB, 1993, ATTENTION PERFORM, V14, P771; JACIKSON J, 1991, NATO ADV STUDY I SER, V62, P169; JUEPTNER M, 1995, NEUROLOGY, V45, P1540, DOI 10.1212/WNL.45.8.1540; Kawashima R, 2000, J NEUROPHYSIOL, V83, P1079, DOI 10.1152/jn.2000.83.2.1079; Kennerley SW, 2002, NAT NEUROSCI, V5, P376, DOI 10.1038/nn822; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Mussa-Ivaldi FA, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P325; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Timmann D, 2000, EXP BRAIN RES, V130, P441, DOI 10.1007/s002219900277; TOPKA H, 1993, BRAIN, V116, P961, DOI 10.1093/brain/116.4.961; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; VORBERG D, 1996, HDB PERCEPTION ACTIO, V2, P1581; WoodruffPak DS, 1996, NEUROPSYCHOLOGY, V10, P443; Zelaznik HN, 2000, J MOTOR BEHAV, V32, P193, DOI 10.1080/00222890009601370; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	29	351	357	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2003	300	5624					1437	1439		10.1126/science.1083661	http://dx.doi.org/10.1126/science.1083661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	683ZW	12775842				2022-12-01	WOS:000183181800047
J	Wu, JG; Huang, JH; Han, XG; Xie, ZQ; Gao, XM				Wu, JG; Huang, JH; Han, XG; Xie, ZQ; Gao, XM			Three-Gorges Dam - Experiment in habitat fragmentation?	SCIENCE			English	Editorial Material							FOREST FRAGMENTS; ECOLOGY		Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA; Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Arizona State University; Arizona State University-Tempe; Chinese Academy of Sciences; Institute of Botany, CAS	Wu, JG (corresponding author), Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA.	jingle.wu@asu.edu	Han, Xingguo/K-7552-2016; Wu, Jianguo/G-6267-2010	Han, Xingguo/0000-0002-1836-975X; Wu, Jianguo/0000-0002-1182-3024				[Anonymous], 2000, DAMS DEV NEW FRAM DE; da Fonseca GAB, 2002, SCIENCE, V295, P1835; Diamond J, 2001, SCIENCE, V294, P1847, DOI 10.1126/science.1067012; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; EDMONDS RL, 1992, GLOBAL ECOL BIOGEOGR, V2, P105, DOI 10.2307/2997637; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.2307/3060944; Hubbell Stephen P., 2001, V32, pi; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Lei X, 1998, SCIENCE, V280, P25, DOI 10.1126/science.280.5360.25; LOVEJOY TE, 1986, CONSERVATION BIOL SC, P251; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Schrope M, 2000, NATURE, V408, P395, DOI 10.1038/35044245; Shen Z H, 2000, J WUHAN BOT RES, V18, P99; TERBORGH J, 1974, BIOSCIENCE, V24, P715, DOI 10.2307/1297090; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Wu J., 1995, ENCY ENV BIOL, P371; Wu J., 2007, LANDSCAPE ECOLOGY PA, V2; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; XIAO W, 2000, ECOLOGY TERRESTRIAL; Zhenli H., 2001, BIODIVERS SCI, V9, P472, DOI [DOI 10.3321/J.ISSN:1005-0094.2001.04.021, 10.17520/biods.2001068, DOI 10.17520/BIODS.2001068]	22	282	357	18	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1239	1240		10.1126/science.1083312	http://dx.doi.org/10.1126/science.1083312			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764179				2022-12-01	WOS:000183042400028
J	Platt, T; Fuentes-Yaco, C; Frank, KT				Platt, T; Fuentes-Yaco, C; Frank, KT			Spring algal bloom and larval fish survival	NATURE			English	Article									Fisheries & Oceans Canada, Bedford Inst Oceanog, Ocean Sci Div, Dartmouth, NS B2Y 4A2, Canada; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University	Platt, T (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Ocean Sci Div, Box 1006, Dartmouth, NS B2Y 4A2, Canada.							Cushing D.H., 1974, P399; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; KANE J, 1984, MAR ECOL PROG SER, V16, P9, DOI 10.3354/meps016009; MOHN RK, 2002, 2002102 CSAS RES; PLATT T, 1996, O3 CM INT COUN EXPL; Sverdrup H.U., 1953, J CONS CONS PERM INT, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]	7	423	435	6	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					398	399		10.1038/423398b	http://dx.doi.org/10.1038/423398b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761538				2022-12-01	WOS:000183012000029
J	So, LKY; Lau, ACW; Yam, LYC; Cheung, TMT; Poon, E; Yung, RWH; Yuen, KY				So, LKY; Lau, ACW; Yam, LYC; Cheung, TMT; Poon, E; Yung, RWH; Yuen, KY			Development of a standard treatment protocol for severe acute respiratory syndrome	LANCET			English	Editorial Material								A series of 31 patients with probable SARS, diagnosed from WHO criteria, were treated according to a treatment protocol consisting of antibacterials and a combination of ribavirin and methylprednisolone. Through experience with the first 11 patients, we were able to finalise standard dose regimens, including pulsed methylprednisolone. One patient recovered on antibacterial treatment alone, 17 showed rapid and sustained responses, and 13 achieved Improvement with step-up or pulsed methylprednisolone. Four patients required short periods of non-invasive ventilation. No patient required intubation or mechanical ventilation. There was no mortality or treatment morbidity in this series.	Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Pamela Youde Nethersole Eastern Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Pamela Youde Nethersole Eastern Hospital; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong	So, LKY (corresponding author), Dept Med, 3 Lok Man Rd, Chaiwan, Hong Kong, Peoples R China.	drewlau@hkstar.com		Yuen, Kwok-yung/0000-0002-2083-1552				Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; LEE N, MAJOR OUTBREAK SEVER; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; TSANG KW, CLUSTER CASES SEVERE; *WHO, CAS DEF SURV SEV AC	5	230	263	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2003	361	9369					1615	1617		10.1016/S0140-6736(03)13265-5	http://dx.doi.org/10.1016/S0140-6736(03)13265-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747883	Green Published, Bronze			2022-12-01	WOS:000182746300013
J	Bardelli, A; Parsons, DW; Silliman, N; Ptak, J; Szabo, S; Saha, S; Markowitz, S; Willson, JKV; Parmigiani, G; Kinzler, KW; Vogelstein, B; Velculescu, VE				Bardelli, A; Parsons, DW; Silliman, N; Ptak, J; Szabo, S; Saha, S; Markowitz, S; Willson, JKV; Parmigiani, G; Kinzler, KW; Vogelstein, B; Velculescu, VE			Mutational analysis of the tyrosine kinome in colorectal cancers	SCIENCE			English	Article							KINASE		Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins, Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Univ Hosp Cleveland, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ireland Canc Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University	Velculescu, VE (corresponding author), Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD 21231 USA.		Velculescu, Victor/ABF-4846-2020; BARDELLI, Alberto/J-9721-2018	Velculescu, Victor/0000-0003-1195-438X; Parsons, Donald/0000-0002-8775-3501; BARDELLI, Alberto/0000-0003-1647-5070	NCI NIH HHS [CA62924, CA57345, CA43460] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA043460, R01CA057345, R01CA043460, R37CA057345, P50CA062924] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Druker BJ, 2002, CANCER CELL, V1, P31, DOI 10.1016/S1535-6108(02)00025-9; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762	3	397	480	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					949	949		10.1126/science.1082596	http://dx.doi.org/10.1126/science.1082596			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738854				2022-12-01	WOS:000182719800046
J	Priori, SG; Schwartz, PJ; Napolitano, C; Bloise, R; Ronchetti, E; Grillo, M; Vicentini, A; Spazzolini, C; Nastoli, J; Bottelli, G; Folli, R; Cappelletti, D				Priori, SG; Schwartz, PJ; Napolitano, C; Bloise, R; Ronchetti, E; Grillo, M; Vicentini, A; Spazzolini, C; Nastoli, J; Bottelli, G; Folli, R; Cappelletti, D			Risk stratification in the long-QT syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-ARRHYTHMIAS; MUTATIONS; REGISTRY; GENOTYPE; CHANNEL; THERAPY; KVLQT1; IMPACT; SCN5A; GENES	BACKGROUND: Mutations in potassium-channel genes KCNQ1 (LQT1 locus) and KCNH2 (LQT2 locus) and the sodium-channel gene SCN5A (LQT3 locus) are the most common causes of the long-QT syndrome. We stratified risk according to the genotype, in conjunction with other clinical variables such as sex and the length of the QT interval. METHODS: We evaluated 647 patients (386 with a mutation at the LQT1 locus, 206 with a mutation at the LQT2 locus, and 55 with a mutation at the LQT3 locus) from 193 consecutively genotyped families with the long-QT syndrome. The cumulative probability of a first cardiac event, defined as the occurrence of syncope, cardiac arrest, or sudden death before the age of 40 years and before the initiation of therapy, was determined according to genotype, sex, and the QT interval corrected for heart rate (QTc). Within each genotype we also assessed risk in the four categories derived from the combination of sex and QTc (<500 msec or greater/equal 500 msec). RESULTS: The incidence of a first cardiac event before the age of 40 years and before the initiation of therapy was lower among patients with a mutation at the LQT1 locus (30 percent) than among those with a mutation at the LQT2 locus (46 percent) or those with a mutation at the LQT3 locus (42 percent) (P<0.001 by Fisher's exact test). Multivariate analysis showed that the genetic locus and the QTc, but not sex, were independent predictors of risk. The QTc was an independent predictor of risk among patients with a mutation at the LQT1 locus and those with a mutation at the LQT2 locus but not among those with a mutation at the LQT3 locus, whereas sex was an independent predictor of events only among those with a mutation at the LQT3 locus. CONCLUSIONS: The locus of the causative mutation affects the clinical course of the long-QT syndrome and modulates the effects of the QTc and sex on clinical manifestations. We propose an approach to risk stratification based on these variables.	Univ Pavia, Maugeri Fdn, I-27100 Pavia, Italy; Fdn S Maugeri, Ist Ric & Cura Carattere Sci, Dept Mol Cardiol, Pavia, Italy; Policlin San Matteo, Ist Ric & Cura Carattere, Dept Cardiol, I-27100 Pavia, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; IRCCS Fondazione San Matteo	Priori, SG (corresponding author), Univ Pavia, Maugeri Fdn, Via Ferrata 8, I-27100 Pavia, Italy.		Spazzolini, Carla/AAA-5023-2020; Priori, Silvia G/ABH-6894-2020; napolitano, carlo/ABI-4608-2020; bloise, raffaella/AAC-2922-2020; Schwartz, Peter J./J-4267-2016	Spazzolini, Carla/0000-0003-1209-0157; Priori, Silvia G/0000-0001-6877-0288; napolitano, carlo/0000-0002-7643-4628; bloise, raffaella/0000-0003-3485-9596; ronchetti, elena/0000-0002-9185-7848; Schwartz, Peter J./0000-0003-0367-1048; Nastoli, janni/0000-0002-5888-5951	Telethon [GP0227Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Locati EH, 1998, CIRCULATION, V97, P2237, DOI 10.1161/01.CIR.97.22.2237; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; MOSS AJ, 1995, CIRCULATION, V92, P2929, DOI 10.1161/01.CIR.92.10.2929; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; Priori SG, 2002, EUR HEART J, V23, P257; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Schwartz PJ, 2001, CIRCULATION, V103, P89; SCHWARTZ PJ, 1983, EUR HEART J, V4, P529, DOI 10.1093/oxfordjournals.eurheartj.a061517; SCHWARTZ PJ, 2000, CARDIAC ELECTROPHYSI, P597; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; WARD O C, 1964, J Ir Med Assoc, V54, P103; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404	20	964	1005	2	34	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2003	348	19					1866	1874		10.1056/NEJMoa022147	http://dx.doi.org/10.1056/NEJMoa022147			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	675FY	12736279				2022-12-01	WOS:000182684100005
J	Epshtein, V; Nudler, E				Epshtein, V; Nudler, E			Cooperation between RNA polymerase molecules in transcription elongation	SCIENCE			English	Article							ESCHERICHIA-COLI; II ELONGATION; FACTOR-SII; MECHANISM; TERMINATION; COMPLEX; DNA; TRANSLOCATION; PROMOTER; PROTEIN	Transcription elongation is responsible for rapid synthesis of RNA chains of thousands of nucleotides in vivo. In contrast, a single round of transcription performed in vitro is frequently interrupted by pauses and arrests that drastically reduce the elongation rate and the yield of the full-length transcript. Here we demonstrate that most transcriptional delays disappear if more than one RNA polymerase (RNAP) molecule initiates from the same promoter. Anti-arrest and anti-pause effects of trailing RNAP are due to forward translocation of leading (backtracked) complexes. Such cooperation between RNAP molecules links the rate of elongation to the rate of initiation and explains why elongation is still fast and processive in vivo even without anti-arrest factors.	NYU Med Ctr, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU Med Ctr, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@med.nyu.edu		Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; EPSHTEIN V, UNPUB; FOE VE, 1977, COLD SPRING HARB SYM, V42, P723, DOI 10.1101/SQB.1978.042.01.074; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; GIARDINA C, 1993, J BIOL CHEM, V268, P23806; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HAMMING J, 1981, NUCLEIC ACIDS RES, V9, P1339, DOI 10.1093/nar/9.6.1339; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; JACQUET MA, 1992, MOL MICROBIOL, V6, P1681, DOI 10.1111/j.1365-2958.1992.tb00893.x; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Reines D, 1996, TRENDS BIOCHEM SCI, V21, P351, DOI 10.1016/0968-0004(96)10045-1; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2	30	168	174	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					801	805		10.1126/science.1083219	http://dx.doi.org/10.1126/science.1083219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730602				2022-12-01	WOS:000182579800052
J	Groisman, R; Polanowska, J; Kuraoka, I; Sawada, J; Saijo, M; Drapkin, R; Kisselev, AF; Tanaka, K; Nakatani, Y				Groisman, R; Polanowska, J; Kuraoka, I; Sawada, J; Saijo, M; Drapkin, R; Kisselev, AF; Tanaka, K; Nakatani, Y			The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage	CELL			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; COCKAYNE-SYNDROME; PROTEIN; DEGRADATION; PROTEASOME; CELLS; NEDD8; PATHWAY; DEUBIQUITINATION	Nucleotide excision repair (NER) is a major cellular defense against the carcinogenic effects of ultraviolet light from the sun. Mutational inactivation of NER proteins, like DDB and CSA, leads to hereditary diseases such as xeroderma pigmentosum (XP) and Cockayne syndrome (CS). Here, we show that DDB2 and CSA are each integrated into nearly identical complexes via interaction with DDB1. Both complexes contain cullin 4A and Roc1 and display ubiquitin ligase activity. They also contain the COP9 signalosome (CSN), a known regulator of cullin-based ubiquitin ligases. Strikingly, CSN differentially regulates ubiquitin ligase activity of the DDB2 and CSA complexes in response to UV irradiation. Knockdown of CSN with RNA interference leads to defects in NER. These results suggest that the distinct UV response of the DDB2 and CSA complexes is involved in diverse mechanisms of NER.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Osaka 5650871, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Osaka University; Japan Science & Technology Agency (JST)	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Polanowska, Jolanta/P-9117-2016; Drapkin, Ronny/E-9944-2016	Polanowska, Jolanta/0000-0001-7666-7010; Drapkin, Ronny/0000-0002-6912-6977; Kuraoka, Isao/0000-0001-6391-3411; Groisman, Sonia/0000-0003-1153-3841; Groisman, Regina/0000-0003-3990-7622				Bootsma D., 1998, GENETIC BASIS HUMAN, P254; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; CARREAU M, 1992, MUTAT RES, V274, P57, DOI 10.1016/0921-8777(92)90043-3; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Friedberg EC, 1995, DNA REPAIR MUTAGENES; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lee SK, 2002, CELL, V109, P823, DOI 10.1016/S0092-8674(02)00795-X; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Reinberg D, 1998, COLD SPRING HARB SYM, V63, P83, DOI 10.1101/sqb.1998.63.83; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wakasugi M, 2001, J BIOL CHEM, V276, P15434, DOI 10.1074/jbc.M011177200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	39	575	612	2	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 2	2003	113	3					357	367		10.1016/S0092-8674(03)00316-7	http://dx.doi.org/10.1016/S0092-8674(03)00316-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732143	Bronze			2022-12-01	WOS:000182640800010
J	Sampaolesi, M; Torrente, Y; Innocenzi, A; Tonlorenzi, R; D'Antona, G; Pellegrino, MA; Barresi, R; Bresolin, N; De Angelis, MGC; Campbell, KP; Bottinelli, R; Cossu, G				Sampaolesi, M; Torrente, Y; Innocenzi, A; Tonlorenzi, R; D'Antona, G; Pellegrino, MA; Barresi, R; Bresolin, N; De Angelis, MGC; Campbell, KP; Bottinelli, R; Cossu, G			Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts	SCIENCE			English	Article							SKELETAL-MUSCLE FIBERS; MYOSIN HEAVY-CHAIN; STEM-CELLS; SHORTENING VELOCITY; MUSCULAR-DYSTROPHY; BONE-MARROW; ADENOASSOCIATED VIRUS; MDX MICE; MOUSE; TRANSPLANTATION	Preclinical or clinical trials for muscular dystrophies have met with modest success, mainly because of inefficient delivery of viral vectors or donor cells to dystrophic muscles. We report here that intra-arterial delivery of wildtype mesoangioblasts, a class of vessel-associated stem cells, corrects morphologically and functionally the dystrophic phenotype of virtually all downstream muscles in adult immunocompetent alpha-sarcoglycan (alpha-SG) null mice, a model organism for limb-girdle muscular dystrophy. When mesoangioblasts isolated from juvenile dystrophic mice and transduced with a lentiviral vector expressing alpha-SG were injected into the femoral artery of dystrophic mice, they reconstituted skeletal muscle in a manner similar to that seen in wild-type cells. The success of this protocol was mainly due to widespread distribution of donor stem cells through the capillary network, a distinct advantage of this strategy over previous approaches.	Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Osped Maggiore Policlin, Ctr Dino Ferrari, IRCCS, Dept Neurol Sci, I-20122 Milan, Italy; Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol Biophys & Neurol, Iowa City, IA 52242 USA; IRCCS E Medea, I-23842 Bosisio Parini, Lecco, Italy; Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00161 Rome, Italy; Inst Cell Biol & Tissue Engn, I-00128 Rome, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pavia; Howard Hughes Medical Institute; University of Iowa; IRCCS Eugenio Medea; Sapienza University Rome	Cossu, G (corresponding author), Hosp San Raffaele, Stem Cell Res Inst, Via Olgettina 58, I-20132 Milan, Italy.	cossu.giulio@hsr.it	Tonlorenzi, Rossana/AAN-2241-2020; Sampaolesi, Maurilio/H-6509-2013; Bottinelli, Roberto/AAC-1904-2020; Pellegrino, Maria Antonietta/AAC-4680-2022; Barresi, Rita/AAB-9569-2022; canepari, Monica MC/D-7677-2015; TORRENTE, YVAN/A-2964-2015	Sampaolesi, Maurilio/0000-0002-2422-3757; Bottinelli, Roberto/0000-0002-4960-7490; Pellegrino, Maria Antonietta/0000-0002-1653-1266; Barresi, Rita/0000-0001-7351-959X; D'Antona, Giuseppe/0000-0002-0683-5565; TORRENTE, YVAN/0000-0002-2705-3984; Tonlorenzi, Rossana/0000-0002-6060-8208; Bresolin, Nereo/0000-0001-6694-3595; Campbell, Kevin/0000-0003-2066-5889	Telethon [463/BI, 1322] Funding Source: Medline	Telethon(Fondazione Telethon)		Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V478, P341, DOI 10.1113/jphysiol.1994.sp020254; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898; Cossu G, 2000, J CLIN INVEST, V105, P1669, DOI 10.1172/JCI10376; De Angelis FG, 2002, P NATL ACAD SCI USA, V99, P9456, DOI 10.1073/pnas.142302299; DelloRusso C, 2002, P NATL ACAD SCI USA, V99, P12979, DOI 10.1073/pnas.202300099; Dressman D, 2002, HUM GENE THER, V13, P1631, DOI 10.1089/10430340260201725; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Ferrari G, 2001, NATURE, V411, P1014, DOI 10.1038/35082631; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; MacGregor R R, 2001, Hum Gene Ther, V12, P2028; Minasi MG, 2002, DEVELOPMENT, V129, P2773; PALUMBO R, UNPUB; Pansarasa O, 2002, EUR J APPL PHYSIOL, V87, P550, DOI 10.1007/s00421-002-0668-3; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; SAMPAOLESI M, UNPUB; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Skuk D, 2002, CURR OPIN NEUROL, V15, P563, DOI 10.1097/00019052-200210000-00007; TAGLIAFICO E, UNPUB; Takada T, 1997, NAT BIOTECHNOL, V15, P458, DOI 10.1038/nbt0597-458; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Weiss S, 2001, J BIOL CHEM, V276, P45902, DOI 10.1074/jbc.M107434200; Yuasa K, 2002, GENE THER, V9, P1576, DOI 10.1038/sj.gt.3301829	35	482	513	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					487	492		10.1126/science.1082254	http://dx.doi.org/10.1126/science.1082254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12855815	Green Accepted			2022-12-01	WOS:000184340500034
J	Park, S; Wolanin, PM; Yuzbashyan, EA; Silberzan, P; Stock, JB; Austin, RH				Park, S; Wolanin, PM; Yuzbashyan, EA; Silberzan, P; Stock, JB; Austin, RH			Motion to form a quorum	SCIENCE			English	Article							BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Inst Curie, F-75005 Paris, France	Princeton University; Princeton University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Stock, JB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.		Park, Sungsu/L-1920-2013; Silberzan, Pascal/L-5934-2016; Park, Sungsu/AAF-4792-2020	Silberzan, Pascal/0000-0002-8554-882X; Park, Sungsu/0000-0003-3062-1302	NHGRI NIH HHS [R01 HG001506] Funding Source: Medline; NIGMS NIH HHS [F32 GM064228] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064228] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER J, 1975, ANNU REV BIOCHEM, V44, P341, DOI 10.1146/annurev.bi.44.070175.002013; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; CLARKE S, 1979, J BIOL CHEM, V254, P9695; McClaine JW, 2002, BIOTECHNOL BIOENG, V78, P179, DOI 10.1002/bit.10192; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Swift S, 2001, ADV MICROB PHYSIOL, V45, P199, DOI 10.1016/S0065-2911(01)45005-3	8	114	114	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2003	301	5630					188	188		10.1126/science.1079805	http://dx.doi.org/10.1126/science.1079805			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12855801				2022-12-01	WOS:000184056200034
J	Keeling, P; Hughes, D; Price, L; Shaw, S; Barton, A				Keeling, P; Hughes, D; Price, L; Shaw, S; Barton, A			Safety and feasibility of prehospital thrombolysis carried out by paramedics	BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION		S Devon Healthcare Trust, Torquay TQ2 7AA, England; Peninsula Med Sch, Res & Dev Support Unit, Plymouth PL6 8BX, Devon, England; Univ Plymouth, Dept Math & Stat, Plymouth PL4 8AA, Devon, England	University of Plymouth; University of Plymouth	Keeling, P (corresponding author), S Devon Healthcare Trust, Lawes Bridge, Torquay TQ2 7AA, England.			barton, andy/0000-0003-2245-1446				Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; *DEP HLTH, 2001, NAT SERV FRAM COR HE; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; *NAT I CLIN EXC, 2002, GUID US DRUGS EARL T; *ROYAL COLL AMB LI, 2001, TECHN APPR PROC SER, V4	5	27	29	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2003	327	7405					27	28		10.1136/bmj.327.7405.27	http://dx.doi.org/10.1136/bmj.327.7405.27			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	699NK	12842952	Green Published, Bronze			2022-12-01	WOS:000184062700022
J	Bouvier, F; Dogbo, O; Camara, B				Bouvier, F; Dogbo, O; Camara, B			Biosynthesis of the food and cosmetic plant pigment bixin (annatto)	SCIENCE			English	Article							CAROTENOIDS; DIOXYGENASE; CLEAVAGE; FLOWERS; COLORS; SEEDS	Bixin, also known as annatto, is a seed-specific pigment widely used in foods and cosmetics since pre-Columbian times. We show that three genes from Bixa orellana, native to tropical America, govern bixin biosynthesis. These genes code for lycopene cleavage dioxygenase, bixin aldehyde dehydrogenase, and norbixin carboxyl methyltransferase, which catalyze the sequential conversion of lycopene into bixin. Introduction of these three genes in Escherichia coli engineered to produce lycopene induced bixin synthesis, thus expanding the supply of this economically important plant product.	Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Abobo Adjarne 02, UFR SN, Abidjan 02, Cote Ivoire	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Camara, B (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France.	Bilal.camara@ibmp-ulp.u-strasbg.fr						Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Britton G, 1998, CAROTENOIDS BIOSYNTH, P13; COLLINS P, 1992, FOODS INGRED PROCESS, V13, P23; Dudareva N, 2000, PLANT CELL, V12, P949, DOI 10.1105/tpc.12.6.949; LAURO GJ, 1991, CEREAL FOOD WORLD, V36, P949; Mercadante AZ, 1997, J AGR FOOD CHEM, V45, P1050, DOI 10.1021/jf960412k; Mercadante AZ, 1997, PHYTOCHEMISTRY, V46, P1379, DOI 10.1016/S0031-9422(97)00462-7; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Ross JR, 1999, ARCH BIOCHEM BIOPHYS, V367, P9, DOI 10.1006/abbi.1999.1255; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SKIBBE DS, 2002, PLANT MOL BIOL, V88, P751; TIMBERLAKE CF, 1986, ENDEAVOUR, V10, P31, DOI 10.1016/0160-9327(86)90048-7; Watillon B, 1998, PLANT MOL BIOL, V36, P909, DOI 10.1023/A:1005914506110; Zechmeister L, 1962, CIS T ISOMERIC CAROT	16	175	188	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2089	2091		10.1126/science.1085162	http://dx.doi.org/10.1126/science.1085162			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12829782				2022-12-01	WOS:000183774900045
J	Newman, JRS; Keating, AE				Newman, JRS; Keating, AE			Comprehensive identification of human bZIP interactions with coiled-coil arrays	SCIENCE			English	Article							DNA-BINDING; TRANSCRIPTION FACTORS; SPECIFICITY; PROTEINS; FOS; JUN; COMPLEXES; PROTEOME; DOMAINS; FAMILY	In eukaryotes, the combinatorial association of sequence-specific DNA binding proteins is essential for transcription. We have used protein arrays to test 49(2) pairings of a nearly complete set of coiled-coil strands from human basic-region leucine zipper ( bZIP) transcription factors. We find considerable partnering selectivity despite the bZIPs' homologous sequences. The interaction data are of high quality, as assessed by their reproducibility, reciprocity, and agreement with previous observations. Biophysical studies in solution support the relative binding strengths observed with the arrays. New associations provide insights into the circadian clock and the unfolded protein response.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Keating, AE (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keating@mit.edu		Keating, Amy/0000-0003-4074-8980				BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GREENBURY CL, 1965, IMMUNOLOGY, V8, P420; HAAS NB, 1995, MOL CELL BIOL, V15, P1923; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; MacBeath G, 2000, SCIENCE, V289, P1760; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Moll JR, 2000, J BIOL CHEM, V275, P34826, DOI 10.1074/jbc.M004545200; Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; PTASHNE M, 1987, GENETIC SWITCH GENE; SINGH M, 2001, P 5 ANN INT C COMP M, P279; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wolberger C, 1999, ANNU REV BIOPH BIOM, V28, P29, DOI 10.1146/annurev.biophys.28.1.29; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	33	367	383	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2003	300	5628					2097	2101		10.1126/science.1084648	http://dx.doi.org/10.1126/science.1084648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12805554				2022-12-01	WOS:000183774900048
J	Jiang, H; Stein, BE; McHaffie, JG				Jiang, H; Stein, BE; McHaffie, JG			Opposing basal ganglia processes shape midbrain visuomotor activity bilaterally	NATURE			English	Article							NIGRA PARS RETICULATA; SUPERIOR COLLICULUS; SUBSTANTIA-NIGRA; HORSERADISH-PEROXIDASE; TECTOSPINAL NEURONS; NIGROTECTAL PATHWAY; SUBTHALAMIC NUCLEUS; STRIATAL FUNCTIONS; BASIC PROCESS; CAT	The manner in which the nervous system allocates limited motor resources when confronted with conflicting behavioural demands is a crucial issue in understanding how sensory information is transformed into adaptive motor responses. Understanding this selection process is of particular concern in current models of functions of the basal ganglia(1). Here we report that the basal ganglia use simultaneous enhancing and suppressing processes synergistically to modulate sensory activity in the superior colliculi, which are bilaterally paired midbrain structures involved in the control of visual orientation behaviours(2). These complementary processes presumably ensure accurate gaze shifts mediated by the superior colliculi despite the presence of potential distractors.	Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	McHaffie, JG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.							ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BECKSTEAD RM, 1981, J NEUROSCI, V1, P121; BEHAN M, 1985, J COMP NEUROL, V234, P105, DOI 10.1002/cne.902340108; CHEVALIER G, 1985, BRAIN RES, V334, P215, DOI 10.1016/0006-8993(85)90213-6; CHEVALIER G, 1984, EXP BRAIN RES, V53, P320; CHEVALIER G, 1981, NEUROSCI LETT, V21, P67, DOI 10.1016/0304-3940(81)90059-8; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; Handel A, 2000, J NEUROPHYSIOL, V83, P3042, DOI 10.1152/jn.2000.83.5.3042; HARTING JK, 1988, J COMP NEUROL, V278, P615, DOI 10.1002/cne.902780412; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1285, DOI 10.1152/jn.1983.49.5.1285; INFANTE C, 1986, BRAIN RES, V381, P390, DOI 10.1016/0006-8993(86)90096-X; JOSEPH JP, 1985, EXP BRAIN RES, V57, P286; Kalesnykas R. P., 1999, Society for Neuroscience Abstracts, V25, P1920; KARABELAS AB, 1985, J COMP NEUROL, V239, P309, DOI 10.1002/cne.902390305; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Kha HT, 2001, J COMP NEUROL, V440, P20, DOI 10.1002/cne.1367; KITA H, 1987, J COMP NEUROL, V260, P435, DOI 10.1002/cne.902600309; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; MAY PJ, 1984, J COMP NEUROL, V226, P357, DOI 10.1002/cne.902260306; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; MIZE RR, 1992, J COMP NEUROL, V320, P243, DOI 10.1002/cne.903200208; MUNOZ DP, 1985, BRAIN RES, V341, P184, DOI 10.1016/0006-8993(85)91487-8; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; RYAN LJ, 1991, EXP BRAIN RES, V86, P641; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Stein BE., 1993, MERGING SENSES; WALLACE SF, 1990, J COMP NEUROL, V296, P222, DOI 10.1002/cne.902960204; WALLACE SF, 1989, J COMP NEUROL, V284, P429, DOI 10.1002/cne.902840309; Wang S, 1997, NEUROSCIENCE, V81, P967, DOI 10.1016/S0306-4522(97)00191-7	30	95	95	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					982	986		10.1038/nature01698	http://dx.doi.org/10.1038/nature01698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12827201				2022-12-01	WOS:000183753900049
J	Sisk, JE; Whang, W; Butler, JC; Sneller, VP; Whitney, CG				Sisk, JE; Whang, W; Butler, JC; Sneller, VP; Whitney, CG			Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: Role of comorbid conditions and race	ANNALS OF INTERNAL MEDICINE			English	Article							REVACCINATION; MORTALITY; HEALTH	Background: Guidelines are increasingly recommending preventive services starting at 50 years of age, and policymakers are considering such a recommendation for pneumococcal polysaccharide vaccination. The finding that pneumococcal vaccination is cost-saving for people 65 years of age or older raises the question of the vaccination's implications for other older adults, especially black people, whose disease incidence exceeds that of nonblack people, and those with high-risk conditions. Objective: To assess the implications of vaccinating black and nonblack people 50 through 64 years of age against invasive pneumococcal disease. Design: Cost-effectiveness analysis. Data Sources: Published literature for vaccination effectiveness and cost estimates; data on disease incidence and case-fatality rates from the Centers for Disease Control and Prevention. Target Population: Hypothetical cohort 50 through 64 years of age with the 1995 U.S. age distribution. Time Horizon: Lifetime. Perspective: Societal. Intervention: Pneumococcal polysaccharide vaccination compared with no vaccination. Outcome Measures: Incremental medical costs and health effects, in quality-adjusted life-years per vaccinee. Results of Base-Case Analysis: vaccination saved medical costs and improved health among high-risk black people ($27.55 savings per vaccinee) and nonblack people ($5.92 savings per vaccinee), excluding survivors' future costs. For low-risk black and nonblack people and the overall general population, vaccination cost $2477, $8195, and $3434, respectively, to gain 1 year of healthy life. Results of Sensitivity Analysis: Excluding survivors' future costs, in the general immunocompetent population, cost per quality-adjusted life-year in global worst-case results ranged from $21 513 for black people to $68 871 for nonblack people; in the high-risk population, cost ranged from $11 548 for black people to $39 000 for nonblack people. In the global best case, vaccination was cost-saving for black and nonblack people in the general immunocompetent and high-risk populations, excluding survivors' future costs. The cost-effectiveness range was narrower in probabilistic sensitivity analyses, with 95% probabilistic intervals ranging from cost-saving to $1594 for black people and from cost-saving to $12 273 for nonblack people in the general immunocompetent population. Costs per quality-adjusted life-year for low-risk people with case-fatality rates from 1998 were $2477 for black people and $8195 for nonblack people, excluding survivors' medical costs. Conclusions: These results support the current recommendation to vaccinate high-risk people and provide useful information for considering extending the recommendation to the general population 50 through 64 years of age. Lack of evidence about the effectiveness of revaccination for people 65 years of age or older, when disease risks are higher, argues for further research to guide vaccination policy.	CUNY Mt Sinai Sch Med, Dept Hlth Policy, New York, NY 10029 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Ctr Dis Control & Prevent, Anchorage, AK USA; Ctr Dis Control & Prevent, Atlanta, GA USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University; Harvard University; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Sisk, JE (corresponding author), CUNY Mt Sinai Sch Med, Dept Hlth Policy, Room 2-34,1425 Madison Ave, New York, NY 10029 USA.	jane.sisk@mssm.edu	Whang, William/AAE-3853-2019					*AG HLTH CAR POL R, 1997, DAT 1987 NMES HOUS S; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; BORGONO JM, 1978, P SOC EXP BIOL MED, V157, P148, DOI 10.3181/00379727-157-40010; Breiman RF, 2000, ARCH INTERN MED, V160, P2633, DOI 10.1001/archinte.160.17.2633; *CDCP, 2001, HLTH PEOPL 2010, V1, P14; CHIANG CL, 1991, ANNU REV PUBL HEALTH, V12, P281, DOI 10.1146/annurev.pu.12.050191.001433; ERICKSON P, 1995, HLTH PEOPLE 2000; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Gold MR., 1996, COST EFFECTIVENESS H; Jackson L, 1999, JAMA-J AM MED ASSOC, V281, P243, DOI 10.1001/jama.281.3.243; LASCHOBER MA, 1997, HLTH HLTH CARE MEDIC; LAUPACIS A, 1993, CAN MED ASSOC J, V148, P927; LAVE JR, 1994, MED CARE, V32, pJS77; MUFSON MA, 1991, VACCINE, V9, P403, DOI 10.1016/0264-410X(91)90126-Q; Nichol KL, 1997, AM J INFECT CONTROL, V25, P223, DOI 10.1016/S0196-6553(97)90008-0; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Singleton J A, 2000, MMWR CDC Surveill Summ, V49, P39; Sisk JE, 1997, JAMA-J AM MED ASSOC, V278, P1333, DOI 10.1001/jama.278.16.1333; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; TORRANCE GT, 1995, 7 CDCP NAT CTR HLTH; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, V2nd; WAGNER JL, 1996, PREVENTION EARLY DET; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; WINTER WP, 1986, HEMOGLOBIN VARIANTS; 2001, MMWR MORB MORTAL WKL, V50, P532; 1997, MMWR MORB MORTAL WKL, V46, P913	30	103	105	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2003	138	12					960	968		10.7326/0003-4819-138-12-200306170-00007	http://dx.doi.org/10.7326/0003-4819-138-12-200306170-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690YM	12809452				2022-12-01	WOS:000183578100003
J	Dindo, D; Muller, MK; Weber, M; Clavien, PA				Dindo, D; Muller, MK; Weber, M; Clavien, PA			Obesity in general elective surgery	LANCET			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; CARDIAC-SURGERY; MORBID-OBESITY; RISK-FACTORS; MORTALITY; OUTCOMES; CHOLECYSTECTOMY; COMPLICATIONS; OPERATIONS	Background Obese patients are generally believed to be at a higher risk for surgery than those who are not obese, although convincing data are lacking. Methods We prospectively investigated a cohort of 6336 patients undergoing general elective surgery at our institution to assess whether obesity affects the outcome of surgery. Exclusion criteria were emergency, vascular, thoracic, and bariatric operations; transplantation procedures; patients under immunosuppression; and operations done under local anaesthesia. Postoperative morbidity was analysed for nonobese and obese patients (body-mass index <30 kg/m(2) vs &GE;30 kg/m(2)). Obesity was further stratified into mild obesity (30.0-34.9 kg/m(2)) and severe obesity (&GE;35 kg/m(2)). Risk factors were analysed with univariate and multivariate models. Findings The cohort consisted of 6336 patients, of whom 808 (13%) were obese, 569 (9%) were mildly obese, and 239 (4%) had severe obesity. The morbidity rates in patients who were obese compared with those who were not were much the same (122 [15.1%] of 808 vs 901 [16.3%] of 5528; p=0.26), with the exception of an increased incidence of wound infections after open surgery in patients who were obese (17 [4%] of 431 vs 92 [3%] of 3555, p=0.03). Incidence of complications did not differ between patients who were mildly obese (91 [16.0%] of 569), severely obese (36 [15.1%] of 239), and non-obese (901 [16.3%] of 5528; p=0.19). In multivariate regression analyses, obesity was not a risk factor for development of postoperative complications. Of note, the additional medical resource use as estimated by a new classification of complications showed no differences between patients who were and were not obese. Interpretation Obesity alone is not a risk factor for postoperative complications. The regressive attitude towards general surgery in obese patients is no longer justified.	Univ Zurich Hosp, Dept Visceral Surg & Transplantat, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Clavien, PA (corresponding author), Univ Zurich Hosp, Dept Visceral Surg & Transplantat, Ramistr 100, CH-8091 Zurich, Switzerland.							Allison DB, 1999, OBES RES, V7, P342, DOI 10.1002/j.1550-8528.1999.tb00417.x; Benoist S, 2000, AM J SURG, V179, P275, DOI 10.1016/S0002-9610(00)00337-8; Berkalp B, 1995, INT J CARDIOL, V52, P23, DOI 10.1016/0167-5273(95)02431-U; Brandt M, 2001, EUR J CARDIO-THORAC, V19, P662, DOI 10.1016/S1010-7940(01)00647-9; CHAPMAN GW, 1988, J NATL MED ASSOC, V80, P417; CLAVIEN PA, 1992, SURGERY, V111, P518; DeMaria J, 2002, ANN SURG, V235, P640, DOI 10.1097/00000658-200205000-00005; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; Fazeli-Matin S, 1999, J UROLOGY, V162, P665, DOI 10.1097/00005392-199909010-00005; Flordal PA, 1996, EUR J SURG, V162, P783; Klotz HP, 1996, BRIT J SURG, V83, P1788, DOI 10.1002/bjs.1800831240; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Livingston EH, 2002, OBES RES, V10, P824, DOI 10.1038/oby.2002.111; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moulton MJ, 1996, CIRCULATION, V94, P87; Nair S, 2002, HEPATOLOGY, V35, P105, DOI 10.1053/jhep.2002.30318; Nguyen NT, 2001, ANN SURG, V234, P279, DOI 10.1097/00000658-200109000-00002; PASULKA PS, 1986, ANN INTERN MED, V104, P540, DOI 10.7326/0003-4819-104-4-540; PEMBERTON LB, 1971, AM J SURG, V121, P87, DOI 10.1016/0002-9610(71)90081-X; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; POSTLETH.RW, 1972, ARCH SURG-CHICAGO, V105, P438; Schauer PR, 2001, SURG CLIN N AM, V81, P1145, DOI 10.1016/S0039-6109(05)70189-4; Schutz Y, 2002, INT J OBESITY, V26, pS3, DOI 10.1038/sj.ijo.0802122; SHAPIRO M, 1982, NEW ENGL J MED, V307, P1661, DOI 10.1056/NEJM198212303072701; Spicer DDM, 2001, INT ORTHOP, V25, P286, DOI 10.1007/s002640100265; TANAKA S, 1993, INT J OBESITY, V17, P631; WELCH CE, 1986, ANN SURG, V204, P454, DOI 10.1097/00000658-198610000-00014; Westling A, 2002, WORLD J SURG, V26, P470, DOI 10.1007/s00268-001-0251-9; WHO, 1997, OB PREV MAN GLOB EP	30	449	463	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 14	2003	361	9374					2032	2035		10.1016/S0140-6736(03)13640-9	http://dx.doi.org/10.1016/S0140-6736(03)13640-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689JT	12814714				2022-12-01	WOS:000183488900010
J	Benton, MJ; Ayala, FJ				Benton, MJ; Ayala, FJ			Dating the tree of life	SCIENCE			English	Editorial Material							DIVERGENCE TIMES; MOLECULAR EVIDENCE; FOSSIL RECORD; ORIGIN; BIRDS; PHYLOGENY; SEQUENCES; SYSTEMATICS; EVOLUTION; PATTERNS	The relative merits of molecular and paleontological dates of major branching points in the tree of life are currently debated. In some cases, molecular date estimates are up to twice as old as paleontological dates. However, although it is true that paleontological dates are often too young (missing fossils), molecular dates are often too old (statistical bias). Intense study of the dating of major splits in the tree of mammals has shown rapprochement as fossil dates become older and molecular dates become younger.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of Bristol; University of California System; University of California Irvine	Benton, MJ (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.	Mike.Benton@bris.ac.uk	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824				Adoutte A, 1998, MOL PHYLOGENET EVOL, V9, P331, DOI 10.1006/mpev.1998.0547; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Arnason U, 1996, J MOL EVOL, V43, P650, DOI 10.1007/BF02202113; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Benton Michael J., 1996, Historical Biology, V12, P111; Benton MJ, 1998, MOL PHYLOGENET EVOL, V9, P398, DOI 10.1006/mpev.1998.0492; Benton MJ, 2000, NATURE, V403, P534, DOI 10.1038/35000558; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; BENTON MJ, TELLING EVOLUTIONARY; Bromham L, 1998, P NATL ACAD SCI USA, V95, P12386, DOI 10.1073/pnas.95.21.12386; Bromham LD, 2000, P ROY SOC B-BIOL SCI, V267, P1041, DOI 10.1098/rspb.2000.1108; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; DARWIN C, 1959, ORIGN SPECIES MEANS; DONOGHUE PJ, IN PRESS TELLING EVO; Dyke GJ, 2001, GEOL J, V36, P305; Easteal S, 1999, BIOESSAYS, V21, P1052, DOI 10.1002/(SICI)1521-1878(199912)22:1<1052::AID-BIES9>3.0.CO;2-6; Easteal S., 1995, MAMMALIAN MOL CLOCK; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; GRAUR D, 1993, TRENDS ECOL EVOL, V8, P141, DOI 10.1016/0169-5347(93)90027-M; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Janke A, 1997, P NATL ACAD SCI USA, V94, P1276, DOI 10.1073/pnas.94.4.1276; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kenrick P, 1999, NATURE, V402, P358, DOI 10.1038/46437; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lee MSY, 1999, J MOL EVOL, V49, P385, DOI 10.1007/PL00006562; Lynch M, 1999, EVOLUTION, V53, P319, DOI [10.2307/2640769, 10.1111/j.1558-5646.1999.tb03768.x]; Naylor GJP, 1998, SYST BIOL, V47, P61, DOI 10.1080/106351598261030; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Nikoh N, 1997, J MOL EVOL, V45, P97, DOI 10.1007/PL00006208; NORELL MA, 1992, SCIENCE, V255, P1690, DOI 10.1126/science.255.5052.1690; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Patterson C., 1987, MOL MORPHOLOGY EVOLU; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; Rodriguez-Trelles F, 2002, P NATL ACAD SCI USA, V99, P8112, DOI 10.1073/pnas.122231299; RODRIGUEZTRELLE.F, IN PRESS TELLING EVO; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2001, AM J BOT, V88, P1499, DOI 10.2307/3558458; Schutze J, 1999, P ROY SOC B-BIOL SCI, V266, P63, DOI 10.1098/rspb.1999.0605; Smith AB, 2002, ANNU REV EARTH PL SC, V30, P65, DOI 10.1146/annurev.earth.30.091201.140057; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Waddell PJ, 1999, SYST BIOL, V48, P119; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568; Xun G, 1998, J MOL EVOL, V47, P369, DOI 10.1007/PL00013150; [No title captured]	57	192	204	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1698	1700		10.1126/science.1077795	http://dx.doi.org/10.1126/science.1077795			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805535				2022-12-01	WOS:000183459700036
J	Daniel, RA; Errington, J				Daniel, RA; Errington, J			Control of cell morphogenesis in bacteria: Two distinct ways to make a rod-shaped cell	CELL			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; PEPTIDOGLYCAN SYNTHESIS; MUREIN SACCULUS; STRESS-BEARING; DIVISION SITE; WALL MATERIAL; GROWTH; PROTEIN; CYTOSKELETON	Cell shape in most eubacteria is maintained by a tough external peptidoglycan cell wall. Recently, cell shape determining proteins of the MreB family were shown to form helical, actin-like cables in the cell. We used a fluorescent derivative of the antibiotic vancomycin as a probe for nascent peptidoglycan synthesis in unfixed cells of various Gram-positive bacteria. In the rod-shaped bacterium B. subtilis, synthesis of the cylindrical part of the cell wall occurs in a helical pattern governed by an MreB homolog, Mbl. However, a few rod-shaped bacteria have no MreB system. Here, a rod-like shape can be achieved by a completely different mechanism based on use of polar growth zones derived from the division machinery. These results provide insights into the diverse molecular strategies used by bacteria to control their cellular morphology, as well as suggesting ways in which these strategies may impact on growth rates and cell envelope structure.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Errington, J (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388; Daniel, Richard/0000-0002-6483-5897				ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; Archibald A. R., 1993, P381; BURMAN LG, 1983, J BACTERIOL, V155, P983, DOI 10.1128/JB.155.3.983-988.1983; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; CLARKESTURMAN AJ, 1989, J GEN MICROBIOL, V135, P657; Daniel RA, 2000, MOL MICROBIOL, V35, P299, DOI 10.1046/j.1365-2958.2000.01724.x; DANIEL RA, 1993, J GEN MICROBIOL, V139, P361, DOI 10.1099/00221287-139-2-361; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; Errington J, 2003, NAT CELL BIOL, V5, P175, DOI 10.1038/ncb0303-175; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; GRAY DI, 1990, J GEN MICROBIOL, V136, P1077, DOI 10.1099/00221287-136-6-1077; Harry EJ, 1997, MOL MICROBIOL, V25, P275, DOI 10.1046/j.1365-2958.1997.4581822.x; HENRIQUES AO, 1992, BIOCHIMIE, V74, P735, DOI 10.1016/0300-9084(92)90146-6; Hoch J.A., 2001, BACILLUS SUBTILIS IT, P21, DOI 10.1128/9781555817992.ch4; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KOCH AL, 1988, MICROBIOL REV, V52, P337, DOI 10.1128/MMBR.52.3.337-353.1988; KOCH AL, 1990, ARCH MICROBIOL, V153, P569, DOI 10.1007/BF00245266; Koch AL, 2000, APPL ENVIRON MICROB, V66, P3657, DOI 10.1128/AEM.66.9.3657-3663.2000; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; MENDELSON NH, 1976, P NATL ACAD SCI USA, V73, P1740, DOI 10.1073/pnas.73.5.1740; MERAD T, 1989, J GEN MICROBIOL, V135, P645; MICHAUD C, 1990, EUR J BIOCHEM, V194, P853, DOI 10.1111/j.1432-1033.1990.tb19479.x; MOBLEY HLT, 1984, J BACTERIOL, V158, P169, DOI 10.1128/JB.158.1.169-179.1984; PARTRIDGE SR, 1993, MOL MICROBIOL, V8, P945, DOI 10.1111/j.1365-2958.1993.tb01639.x; POOLEY HM, 1976, J BACTERIOL, V125, P1127, DOI 10.1128/JB.125.3.1127-1138.1976; POOLEY HM, 1976, J BACTERIOL, V125, P1139, DOI 10.1128/JB.125.3.1139-1147.1976; Prescott L.M., 1999, MICROBIOLOGY; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; SCHLAEPPI JM, 1982, J BACTERIOL, V149, P329, DOI 10.1128/JB.149.1.329-337.1982; Shapiro L, 2000, CELL, V100, P89, DOI 10.1016/S0092-8674(00)81686-4; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; SHELDRICK GM, 1978, NATURE, V271, P223, DOI 10.1038/271223a0; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Trachtenberg S, 1998, J STRUCT BIOL, V124, P244, DOI 10.1006/jsbi.1998.4063; UMEDA A, 1983, MICROBIOL IMMUNOL, V27, P663, DOI 10.1111/j.1348-0421.1983.tb00629.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; VUORIO R, 1992, J BACTERIOL, V174, P7090, DOI 10.1128/jb.174.22.7090-7097.1992; WIENTJES FB, 1989, J BACTERIOL, V171, P3412, DOI 10.1128/jb.171.6.3412-3419.1989; WOLDRINGH CL, 1987, J GEN MICROBIOL, V133, P575	43	579	595	2	68	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 13	2003	113	6					767	776		10.1016/S0092-8674(03)00421-5	http://dx.doi.org/10.1016/S0092-8674(03)00421-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	689VV	12809607	Bronze			2022-12-01	WOS:000183514400011
J	Sharma, J; Dragoi, V; Tenenbaum, JB; Miller, EK; Sur, M				Sharma, J; Dragoi, V; Tenenbaum, JB; Miller, EK; Sur, M			V1 neurons signal acquisition of an internal representation of stimulus location	SCIENCE			English	Article							PRIMARY VISUAL-CORTEX; NEURAL BASIS; PARIETAL CORTEX; EYE-MOVEMENTS; ATTENTION; MONKEY; SACCADES; RESPONSES; DECISION; POSITION	A fundamental aspect of visuomotor behavior is deciding where to look or move next. Under certain conditions, the brain constructs an internal representation of stimulus location on the basis of previous knowledge and uses it to move the eyes or to make other movements. Neuronal responses in primary visual cortex were modulated when such an internal representation was acquired: Responses to a stimulus were affected progressively by sequential presentation of the stimulus at one location but not when the location was varied randomly. Responses of individual neurons were spatially tuned for gaze direction and tracked the Bayesian probability of stimulus appearance. We propose that the representation arises in a distributed cortical network and is associated with systematic changes in response selectivity and dynamics at the earliest stages of cortical visual processing.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN	Sharma, J (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	jeetu@mit.edu; msur@ai.mit.edu	Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1997, ANNU REV NEUROSCI, V12, P377; Ben Hamed S, 2002, EXP BRAIN RES, V142, P512, DOI 10.1007/s00221-001-0954-z; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; COLBY CL, 1995, CEREB CORTEX, V5, P470, DOI 10.1093/cercor/5.5.470; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Edwards A.W.F., 1972, LIKELIHOOD; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Glimcher PW, 2001, TRENDS NEUROSCI, V24, P654, DOI 10.1016/S0166-2236(00)01932-9; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; Kowler E, 1990, Rev Oculomot Res, V4, P1; Krauzlis RJ, 1999, TRENDS NEUROSCI, V22, P544, DOI 10.1016/S0166-2236(99)01464-2; LAL R, 1989, SCIENCE, V243, P93, DOI 10.1126/science.2911723; LUCE RD, 1986, RESPONSE TIMES THEIR, P253; Lyon DC, 2002, NEURON, V33, P453, DOI 10.1016/S0896-6273(02)00580-9; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Tootell RBH, 2000, NAT NEUROSCI, V3, P206, DOI 10.1038/72904; TOYAMA K, 1984, J NEUROPHYSIOL, V51, P649, DOI 10.1152/jn.1984.51.4.649; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; WEYAND TG, 1993, J NEUROPHYSIOL, V69, P2258, DOI 10.1152/jn.1993.69.6.2258	35	42	44	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1758	1763		10.1126/science.1081721	http://dx.doi.org/10.1126/science.1081721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12805552	Green Submitted			2022-12-01	WOS:000183459700055
J	Tamimi, RM; Lagiou, P; Mucci, LA; Hsieh, CC; Adami, HO; Trichopoulos, D				Tamimi, RM; Lagiou, P; Mucci, LA; Hsieh, CC; Adami, HO; Trichopoulos, D			Average energy intake among pregnant women carrying a boy compared with a girl	BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE		Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Univ Massachusetts, Ctr Canc, Worcester, MA 01655 USA; Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; Athens Medical School; National & Kapodistrian University of Athens; University of Massachusetts System; University of Massachusetts Worcester; Karolinska Institutet	Trichopoulos, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA054220] Funding Source: NIH RePORTER; NCI NIH HHS [CA54220] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Lipworth L, 1999, BRIT J CANCER, V79, P7, DOI 10.1038/sj.bjc.6690003; ROMIEU I, 1990, AM J EPIDEMIOL, V131, P864, DOI 10.1093/oxfordjournals.aje.a115577; SUSSER M, 1991, AM J CLIN NUTR, V53, P1384, DOI 10.1093/ajcn/53.6.1384; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; YEN SSC, 1999, REPROD ENDOCRINOLOGY	5	106	107	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2003	326	7401					1245	1246		10.1136/bmj.326.7401.1245	http://dx.doi.org/10.1136/bmj.326.7401.1245			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	689FJ	12791740	Green Published, Bronze			2022-12-01	WOS:000183480700017
J	Dispenzieri, A; Kyle, RA; Gertz, MA; Therneau, TM; Miller, WL; Chandrasekaran, K; McConnell, JP; Burritt, MF; Jaffe, AS				Dispenzieri, A; Kyle, RA; Gertz, MA; Therneau, TM; Miller, WL; Chandrasekaran, K; McConnell, JP; Burritt, MF; Jaffe, AS			Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins	LANCET			English	Article								Patients with primary systemic amyloidosis that affects the heart have a poor outlook. Cardiac troponins T and I (cTnT, cTnI) are highly specific and sensitive biomarkers of myocardial injury. Values of these troponins provide quantitative information about the disease. We retrospectively assessed 261 patients newly diagnosed as having primary systemic amyloidosis. Median survival for patients with detectable cTnT and cTnI (6 and 8 months, respectively), was worse than that for those with undetectable values (22 and 21 months, respectively). Median and 25th and, 75th percentile values for cTnT were 0.024 mug/l., less than 0.01 mug/L, and 0.084 mug/L, and for cTnI were 0.1 mug/L, 0.05 mug/L, and 0.24 mug/L, respectively. After multivariate analysis, cTnT proved a better predictor of survival than cTnI.	Mayo Clin, Div Haematol & Internal Med, Rochester, MN 55905 USA; Mayo Clin, Div Biostat, Rochester, MN 55905 USA; Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin, Div Internal Med, Rochester, MN 55905 USA; Mayo Clin, Div Lab Genet, Rochester, MN 55905 USA; Mayo Clin, Div Clin Biochem & Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Dispenzieri, A (corresponding author), Mayo Clin, Div Haematol & Internal Med, Rochester, MN 55905 USA.		Gertz, Morie/K-2873-2019	Dispenzieri, Angela/0000-0001-8780-9512	NCI NIH HHS [CA 62242, CA 91561] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA091561, P01CA062242] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048; CUETOGARCIA L, 1985, J AM COLL CARDIOL, V6, P737, DOI 10.1016/S0735-1097(85)80475-7; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; KYLE RA, 1986, BLOOD, V68, P220; Miller WL, 2001, AM J CARDIOL, V88, P813, DOI 10.1016/S0002-9149(01)01877-X	5	216	233	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1787	1789		10.1016/S0140-6736(03)13396-X	http://dx.doi.org/10.1016/S0140-6736(03)13396-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781539				2022-12-01	WOS:000183074800012
J	Hubner, K; Fuhrmann, G; Christenson, LK; Kehler, J; Reinbold, R; De La Fuente, R; Wood, J; Strauss, JF; Boiani, M; Scholer, HR				Hubner, K; Fuhrmann, G; Christenson, LK; Kehler, J; Reinbold, R; De La Fuente, R; Wood, J; Strauss, JF; Boiani, M; Scholer, HR			Derivation of oocytes from mouse embryonic stem cells	SCIENCE			English	Article							OCT-4 TRANSCRIPTION FACTOR; PRIMORDIAL GERM-CELLS; ZONA-PELLUCIDA GENES; H-Y ANTIGEN; CHROMOSOME SYNAPSIS; COORDINATE EXPRESSION; FIG-ALPHA; IN-VITRO; MICE; ACTIVATION	Continuation of mammalian species requires the formation and development of the sexually dimorphic germ cells. Cultured embryonic stem cells are generally considered pluripotent rather than totipotent because of the failure to detect germline cells under differentiating conditions. Here we show that mouse embryonic stem cells in culture can develop into oogonia that enter meiosis, recruit adjacent cells to form follicle-like structures, and later develop into blastocysts. Oogenesis in culture should contribute to various areas, including nuclear transfer and manipulation of the germ line, and advance studies on fertility treatment and germ and somatic cell interaction and differentiation.	Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Germline Dev Grp,New Bolton Ctr, Kennett Sq, PA 19348 USA; Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Female Germ Cell Biol Grp,New Bolton Ctr, Kennett Sq, PA 19348 USA; Ctr Neurochim, Lab Neurobiol Dev & Regenerat, CNRS, FRE 2373, F-67084 Strasbourg, France; Univ Penn, Sch Med, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Pennsylvania; Pennsylvania Medicine	Scholer, HR (corresponding author), Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Germline Dev Grp,New Bolton Ctr, 382 W St Rd, Kennett Sq, PA 19348 USA.		Boiani, Michele/M-3519-2015; Christenson, Lane K/G-6435-2013; , HS/AAB-4434-2019; reinbold, rolland/AAW-8940-2020	Boiani, Michele/0000-0003-2765-2781; , HS/0000-0003-2643-5136; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007305, R01HD042011] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD07305, 1RO1HD42011-01, HD06274] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; CARNEY EW, 1993, MOL REPROD DEV, V34, P357, DOI 10.1002/mrd.1080340403; CHISHOLM JC, 1987, DEVELOPMENT, V101, P565; Christenson LK, 2001, J BIOL CHEM, V276, P27392, DOI 10.1074/jbc.M101650200; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Crawford PA, 1997, MOL CELL BIOL, V17, P3997, DOI 10.1128/MCB.17.7.3997; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; EAST IJ, 1984, DEV BIOL, V104, P49, DOI 10.1016/0012-1606(84)90035-6; EPIFANO O, 1995, DEVELOPMENT, V121, P1947; Eppig JJ, 1996, CANCER RES, V56, P5047; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; HUBNER K, UNPUB; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liang LF, 1997, DEVELOPMENT, V124, P4939; Matzuk MM, 2000, MOL CELL ENDOCRINOL, V163, P61, DOI 10.1016/S0303-7207(99)00241-5; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; OHNO S, 1978, CYTOGENET CELL GENET, V20, P351, DOI 10.1159/000130863; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Rankin T, 1999, DEVELOPMENT, V126, P3847; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Simpson E, 1997, ANNU REV IMMUNOL, V15, P39, DOI 10.1146/annurev.immunol.15.1.39; Soyal SM, 2000, DEVELOPMENT, V127, P4645; STEVENS LC, 1974, DEV BIOL, V37, P369, DOI 10.1016/0012-1606(74)90155-9; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tarsounas M, 1999, J CELL SCI, V112, P423; Tilmann C, 2002, RECENT PROG HORM RES, V57, P1, DOI 10.1210/rp.57.1.1; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; ZENZES MT, 1978, CYTOGENET CELL GENET, V20, P365, DOI 10.1159/000130864	41	793	888	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1251	1256		10.1126/science.1083452	http://dx.doi.org/10.1126/science.1083452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12730498				2022-12-01	WOS:000183042400038
J	Pages, V; Fuchs, RP				Pages, V; Fuchs, RP			Uncoupling of leading- and lagging-strand DNA replication during lesion bypass in vivo	SCIENCE			English	Article							POLYMERASES POL-II; FRAMESHIFT MUTATIONS; MUTAGENESIS; CELLS; FORKS; IV	Numerous agents attack DNA, forming lesions that impair normal replication. Specialized DNA polymerases transiently replace the replicative polymerase and copy past lesions, thus generating mutations, the major initiating cause of cancer. We monitored, in Escherichia coli, the kinetics of replication of both strands of DNA molecules containing a single replication block in either the leading or lagging strand. Despite a block in the leading strand, lagging-strand synthesis proceeded further, implying transient uncoupling of concurrent strand synthesis. Replication through the lesion requires specialized DNA polymerases and is achieved with similar kinetics and efficiencies in both strands.	Ecole Super Biotechnol, CNRS, Unite Propre Rech 9003, F-67400 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Fuchs, RP (corresponding author), Ecole Super Biotechnol, CNRS, Unite Propre Rech 9003, Blvd S Brant, F-67400 Strasbourg, France.		Pagès, Vincent/L-8455-2016	Pagès, Vincent/0000-0002-3059-2903				Becherel OJ, 2001, P NATL ACAD SCI USA, V98, P8566, DOI 10.1073/pnas.141113398; Bresson A, 2002, EMBO J, V21, P3881, DOI 10.1093/emboj/cdf363; CORDEIROSTONE M, 1979, BIOPHYS J, V27, P287, DOI 10.1016/S0006-3495(79)85218-2; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; FUCHS RPP, 1981, NATURE, V294, P657, DOI 10.1038/294657a0; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hoffmann GR, 1997, CHEM RES TOXICOL, V10, P347, DOI 10.1021/tx960128n; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; MILLER JA, 1970, CANCER RES, V30, P559; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; PAGES V, UNPUB; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; TOMIZAWA JI, 1974, P NATL ACAD SCI USA, V71, P2260, DOI 10.1073/pnas.71.6.2260; Wagner J, 2002, DNA REPAIR, V1, P159, DOI 10.1016/S1568-7864(01)00012-X	21	160	161	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1300	1303		10.1126/science.1083964	http://dx.doi.org/10.1126/science.1083964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764199				2022-12-01	WOS:000183042400052
J	Prescott, ED; Julius, D				Prescott, ED; Julius, D			A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity	SCIENCE			English	Article							DIRECT ACTIVATION; CHANNELS; PAIN; HEAT; TRPV3; VR1	The capsaicin receptor (TRPV1), a heat-activated ion channel of the pain pathway, is sensitized by phosphatidylinositol-4,5-bisphosphate (PIP2) hydrolysis after phospholipase C activation. We identify a site within the C-terminal domain of TRPV1 that is required for PIP2-mediated inhibition of channel gating. Mutations that weaken PIP2-TRPV1 interaction reduce thresholds for chemical or thermal stimuli, whereas TRPV1 channels in which this region is replaced with a lipid-bindingdomain from PIP2-activated potassium channels remain inhibited by PIP2. The PIP2-interaction domain therefore serves as a critical determinant of thermal threshold and dynamic sensitivity range, tuning TRPV1, and thus the sensory neuron, to appropriately detect heat under normal or pathophysiological conditions.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu						Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; PRESCOTT ED, UNPUB; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	23	422	446	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1284	1288		10.1126/science.1083646	http://dx.doi.org/10.1126/science.1083646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764195				2022-12-01	WOS:000183042400047
J	Rosenblum, A; Joseph, H; Fong, C; Kipnis, S; Cleland, C; Portenoy, RK				Rosenblum, A; Joseph, H; Fong, C; Kipnis, S; Cleland, C; Portenoy, RK			Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMBULATORY AIDS PATIENTS; OPIATE WITHDRAWAL; CANCER; MANAGEMENT; SEVERITY	Context Little is known about the prevalence and characteristics of chronic pain among patients with different types of chemical dependency. Objectives To estimate the prevalence and to examine the characteristics of chronic severe pain in chemically dependent populations receiving methadone maintenance or inpatient residential treatment. Design, Setting, and Particiloants Representative samples of 390 patients from 2 methadone maintenance treatment programs (MMTPs) and 531 patients from 13 short-term residential substance abuse treatment (inpatient) programs, all in New York State, were surveyed in late 2000 and early 2001. Main Outcome Measure Prevalence of chronic severe pain, defined as pain that persisted for more than 6 months and was of moderate to severe intensity or that significantly interfered with daily activities. Results Chronic severe pain was experienced by 37% of MMTP patients (95% confidence. interval [CI], 32%-41%) and 24% of inpatients (95% CI, 20%-28%; P=.03). Pain of any type or duration during the past week was reported by 80% of MMTP patients and 78% of inpatients. Among those with chronic severe pain, 65% of MMTP patients and 48% of inpatients reported high levels of pain-related interference in physical and psychosocial functioning. Among MMTP patients, correlates of chronic pain in a multivariate model were age (odds ratio [OR], 2.08; 95% CI, 1.17-3.70), chronic illness (OR, 1.88; 95% CI, 1.07-3.29), lifetime psychiatric illness (OR, 1.77; 95% CI, 1.06-2.97), psychiatric distress (OR, 1.63; 95% CI, 1.22-2.18), and time in treatment (OR, 2.23; 95% CI, 1.06-4.68). Among inpatients, the correlates of chronic pain were race (blacks vs whites: OR, 0.52; 95% CI, 0.31-6.90; Hispanics vs whites: OR, 0.48; 95% CI, 0.24-0.95), drug craving (OR, 2.78; 95% CI, 1.54-5.02), chronic illness (OR, 2.17; 95% CI, 1.37-3.43), and psychiatric distress (OR, 1.36; 95% CI, 1.03-1.81). Among those with chronic severe pain, inpatients were significantly more likely than MMTP patients to have used illicit drugs, as well as alcohol, to treat their pain complaint (51% vs 34%, P=.005) but were less likely to have been prescribed pain medications (52% vs 67%, P=.01). Conclusions Chronic severe pain is prevalent among patients in substance abuse treatment, especially MMTP patients. Pain is associated with functional impairment and correlates of pain vary with the population. Self-medication for pain with psychoactive drugs appears especially problematic among substance users who enroll in drug-free treatment programs. Substance abuse treatment programs need to develop comprehensive and structured pain management programs.	Natl Dev & Res Inst Inc, Inst Treatment & Serv Res, New York, NY 10010 USA; New York State Off Alcoholism & Subst Abuse Serv, New York, NY USA; New York State Off Alcoholism & Subst Abuse Serv, Albany, NY USA; Beth Israel Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA	National Development & Research Institutes, Inc; Harvard University; Beth Israel Deaconess Medical Center	Rosenblum, A (corresponding author), Natl Dev & Res Inst Inc, Inst Treatment & Serv Res, 71 W 23rd St,8th Floor, New York, NY 10010 USA.			Cleland, Charles/0000-0002-6931-9904	NIDA NIH HHS [P30DA11041] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Breitbart W, 1996, PAIN, V68, P315, DOI 10.1016/S0304-3959(96)03215-0; Breitbart W, 1996, PAIN, V65, P243, DOI 10.1016/0304-3959(95)00217-0; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; COMPTON MA, 1994, J PAIN SYMPTOM MANAG, V9, P462, DOI 10.1016/0885-3924(94)90203-8; Compton P, 2001, DRUG ALCOHOL DEPEN, V63, P139, DOI 10.1016/S0376-8716(00)00200-3; Derogatis L., 1994, SCL 90 R ADM SCORING; FARRELL M, 1994, ADDICTION, V89, P1471, DOI 10.1111/j.1360-0443.1994.tb03745.x; FAUCETT J, 1994, J PAIN SYMPTOM MANAG, V9, P383, DOI 10.1016/0885-3924(94)90175-9; Ford B.L., 1983, INCOMPLETE DATA SAMP, V2, P185; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; HANDELSMAN L, 1987, AM J DRUG ALCOHOL AB, V13, P293, DOI 10.3109/00952998709001515; Hosmer DW, 1980, COMMUNICATIONS STA A, V10, P1043; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jamison RN, 2000, J PAIN SYMPTOM MANAG, V19, P53, DOI 10.1016/S0885-3924(99)00144-X; Jordan MS, 1998, ARTHRIT CARE RES, V11, P80, DOI 10.1002/art.1790110203; MacLeod DB, 1996, AM J EMERG MED, V14, P323, DOI 10.1016/S0735-6757(96)90187-4; *OFF ALC SUBST AB, 1998, EXPL STUD PHEN STREE; PANKRATZ L, 1989, DRUG ALCOHOL DEPEN, V24, P115, DOI 10.1016/0376-8716(89)90073-2; PORTENOY RK, 1994, CANCER-AM CANCER SOC, V74, P907, DOI 10.1002/1097-0142(19940801)74:3<907::AID-CNCR2820740318>3.0.CO;2-#; PORTENOY RK, 1992, CANCER-AM CANCER SOC, V70, P1616, DOI 10.1002/1097-0142(19920915)70:6<1616::AID-CNCR2820700630>3.0.CO;2-7; Portenoy RK, 1997, JAMA-J AM MED ASSOC, V278, P592, DOI 10.1001/jama.278.7.592; PORTENOY RK, 1997, SUBSTANCE ABUSE COMP, P563; RETTIG RA, 1995, FED REG METHADONE TR; Rosen CS, 2000, ASSESSMENT, V7, P103, DOI 10.1177/107319110000700201; Sande IG, 1983, INCOMPLETE DATA SAMP, V3, P334; Savage SR, 1996, J PAIN SYMPTOM MANAG, V11, P274, DOI 10.1016/0885-3924(95)00202-2; Scimeca MM, 2000, MT SINAI J MED, V67, P412; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; Von Korff M, 2001, HDB PAIN ASSESSMENT, P603	32	351	355	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2003	289	18					2370	2378		10.1001/jama.289.18.2370	http://dx.doi.org/10.1001/jama.289.18.2370			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	677WF	12746360	Bronze			2022-12-01	WOS:000182831200026
J	Hawton, K; Simkin, S; Deeks, J				Hawton, K; Simkin, S; Deeks, J			Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARACETAMOL; PREVENTION	Objectives To examine the incidence of suicides due to co-proxamol compared with tricyclic antidepressants and paracetamol, and to compare fatality rates for self poisonings with these drugs. Design Analysis of routinely collected national and local data on suicides and self poisonings. Setting Records of suicides in England and Wales 1997-9; non-fatal self poisonings in Oxford District 1997-9. Data sources Office for National Statistics and Oxford monitoring system for attempted suicide. Main outcome measures Incidence of suicides with co-proxamol or tricyclic antidepressants or paracetamol. Ratios of fatal to non-fatal self poisonings. Results Co-proxamol alone accounted for 5% of all suicides. Of 4162 drug related suicides, 18% (766) involved co-proxamol alone, 22% (927) tricyclic antidepressants alone, and 9% (368) paracetamol alone. A higher proportion of suicides in the 10-24 yearn age group were due to co-proxamol than in the other age groups. The odds of dying after overdose with co-proxamol was 2.3 times (95% confidence interval 2.1 to 2.5) that for tricyclic antidepressants and 28.1 times (24.9 to 32.9) that for paracetamol. Conclusions Self poisoning with co-proxamol is particularly dangerous and contributes substantially to drug related suicides. Restricting availability of co-proxamol could have an important role in suicide prevention.	Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England; Inst Hlth Sci, Ctr Stat Med, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Hawton, K (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971				Bialas MC, 1996, QJM-INT J MED, V89, P893; *COMM SAF MED, 1985, CURR PROBL, V14; Department of Health, 2002, NAT SUIC PREV STRAT; Dollery C., 1999, THERAPEUTIC DRUGS; Fishbain D A, 1999, Semin Clin Neuropsychiatry, V4, P221; Haigh S, 1996, LANCET, V347, P1840, DOI 10.1016/S0140-6736(96)91665-7; HAWTON K, 1995, BRIT MED J, V310, P164, DOI 10.1136/bmj.310.6973.164; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; Malmberg A, 1999, BRIT J PSYCHIAT, V175, P103, DOI 10.1192/bjp.175.2.103; OLIVER RG, 1972, MED J AUSTRALIA, V2, P919, DOI 10.5694/j.1326-5377.1972.tb103635.x; PENTTINEN J, 1995, AM J PUBLIC HEALTH, V85, P1452, DOI 10.2105/AJPH.85.10.1452-a; Po ALW, 1997, BRIT MED J, V315, P1565, DOI 10.1136/bmj.315.7122.1565; SELLAR C, 1990, J EPIDEMIOL COMMUN H, V44, P313, DOI 10.1136/jech.44.4.313; Sykes JV, 1996, LANCET, V348, P408, DOI 10.1016/S0140-6736(05)65028-3; Taylor SJ, 1997, ACTA PSYCHIAT SCAND, V95, P457, DOI 10.1111/j.1600-0447.1997.tb10132.x; YOUNG RJ, 1980, BRIT MED J, V280, P1045, DOI 10.1136/bmj.280.6220.1045	17	49	51	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2003	326	7397					1006	1008		10.1136/bmj.326.7397.1006	http://dx.doi.org/10.1136/bmj.326.7397.1006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	679KG	12742920	Green Published, Bronze			2022-12-01	WOS:000182920500014
J	Davidson, DW; Cook, SC; Snelling, RR; Chua, TH				Davidson, DW; Cook, SC; Snelling, RR; Chua, TH			Explaining the abundance of ants in lowland tropical rainforest canopies	SCIENCE			English	Article							CANDIDATUS-BLOCHMANNIA; SYMBIOTIC BACTERIA; NITROGEN ISOTOPES; ENDOSYMBIONTS; APHIDS	The extraordinary abundance of ants in tropical rainforest canopies has led to speculation that numerous arboreal ant taxa feed principally as "herbivores" of plant and insect exudates. Based on nitrogen (N) isotope ratios of plants, known herbivores, arthropod predators, and ants from Amazonia and Borneo, we find that many arboreal ant species obtain little N through predation and scavenging. Microsymbionts of ants and their hemipteran trophobionts might play key roles in the nutrition of taxa specializing on N-poor exudates. For plants, the combined costs of biotic defenses and herbivory by ants and tended Hemiptera are substantial, and forest losses to insect herbivores vastly exceed current estimates.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Nat Hist Museum Los Angeles, Entomol Sect, Los Angeles, CA 90007 USA; Univ Brunei Darussalam, Dept Biol, Bandar Seri Begawan, Brunei	Utah System of Higher Education; University of Utah; University Brunei Darussalam	Davidson, DW (corresponding author), Univ Utah, Dept Biol, 257 South,1400 East, Salt Lake City, UT 84112 USA.		Chua, Tock H./E-4157-2012	Chua, Tock H./0000-0002-8984-8723				BAKER HG, 1978, BOT GAZ, V139, P322, DOI 10.1086/337008; Bluthgen N, 2002, J ANIM ECOL, V71, P793, DOI 10.1046/j.1365-2656.2002.00647.x; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; CAETANO F H, 1985, Naturalia (Rio Claro), V10, P37; CAETANO FH, 1994, LES INSECTES SOCIAUX, P391; Davidson D. W., 1996, NEOTROPICAL BIODIVER, P127; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; DAVIDSON DW, UNPUB; Dejean A, 2000, SOCIOBIOLOGY, V35, P403; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Febvay G, 1999, J EXP BIOL, V202, P2639; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; FOLGARAIT PJ, 1995, OECOLOGIA, V104, P189, DOI 10.1007/BF00328584; Heil M, 1998, FUNCT ECOL, V12, P117, DOI 10.1046/j.1365-2435.1998.00158.x; Holldobler B., 1990, pi; Leigh Egbert G. Jr., 1996, P111; MACKO SA, 1986, GEOCHIM COSMOCHIM AC, V50, P2143, DOI 10.1016/0016-7037(86)90068-2; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Nakabachi A, 1997, INSECT BIOCHEM MOLEC, V27, P1057, DOI 10.1016/S0965-1748(97)00092-1; Sandstrom JP, 2001, PHYSIOL ENTOMOL, V26, P202, DOI 10.1046/j.0307-6962.2001.00235.x; Sauer C, 2000, INT J SYST EVOL MICR, V50, P1877, DOI 10.1099/00207713-50-5-1877; SCHUPP EW, 1991, ANT - PLANT INTERACTIONS, P175; Thao ML, 1998, CURR MICROBIOL, V36, P238, DOI 10.1007/s002849900301; Tobin John E., 1995, P129; Tobin John E., 1994, P279; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wernegreen JJ, 2002, MICROBIOL-SGM, V148, P2551, DOI 10.1099/00221287-148-8-2551; WHEELER GC, MEMOIRS ENTOMOLOGICA, V7; Wilkinson TL, 2001, J EXP BIOL, V204, P3027; Yoneyama T, 1997, NEW PHYTOL, V137, P205, DOI 10.1046/j.1469-8137.1997.00809.x	34	485	507	1	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2003	300	5621					969	972		10.1126/science.1082074	http://dx.doi.org/10.1126/science.1082074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738862				2022-12-01	WOS:000182719800054
J	Garlaschelli, D; Caldarelli, G; Pietronero, L				Garlaschelli, D; Caldarelli, G; Pietronero, L			Universal scaling relations in food webs	NATURE			English	Article							COMPLEX NETWORKS; CONNECTANCE; PATTERNS; SIZE	The structure of ecological communities is usually represented by food webs(1-3). In these webs, we describe species by means of vertices connected by links representing the predations. We can therefore study different webs by considering the shape (topology) of these networks(4,5). Comparing food webs by searching for regularities is of fundamental importance, because universal patterns would reveal common principles underlying the organization of different ecosystems. However, features observed in small food webs(1-3,6) are different from those found in large ones(7-15). Furthermore, food webs (except in isolated cases(16,17)) do not share(18,19) general features with other types of network (including the Internet, the World Wide Web and biological webs). These features are a small-world character(4,5) and a scale-free (power-law) distribution of the degree(4,5) (the number of links per vertex). Here we propose to describe food webs as transportation networks(20) by extending to them the concept of allometric scaling(20-22) (how branching properties change with network size). We then decompose food webs in spanning trees and loop-forming links. We show that, whereas the number of loops varies significantly across real webs, spanning trees are characterized by universal scaling relations.	Univ Roma La Sapienza, INFM, UdR Roma 1, I-00185 Rome, Italy; Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; Univ Siena, INFM, UdR Siena, I-53100 Siena, Italy; Univ Siena, Dipartimento Fis, I-53100 Siena, Italy; CNR, Ist Acust OM Corbino, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Siena; University of Siena; Consiglio Nazionale delle Ricerche (CNR)	Caldarelli, G (corresponding author), Univ Roma La Sapienza, INFM, UdR Roma 1, Piazzale Aldo Moro 5, I-00185 Rome, Italy.		Garlaschelli, Diego/P-2795-2019; Pietronero, Luciano/O-4473-2018; Caldarelli, Guido/A-5274-2010; Garlaschelli, Diego/O-4862-2014	Pietronero, Luciano/0000-0001-6424-8863; Caldarelli, Guido/0000-0001-9377-3616; Garlaschelli, Diego/0000-0001-6035-1783				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Caldarelli G, 1998, J THEOR BIOL, V193, P345, DOI 10.1006/jtbi.1998.0706; Camacho J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228102; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Cohen J., 1990, COMMUNITY FOOD WEBS; Cohen J.E., 1989, ECOLOGISTS COOPERATI; COUSINS SH, 1991, TRENDS ECOL EVOL, V6, P190, DOI 10.1016/0169-5347(91)90212-G; Drossel B, 2001, J THEOR BIOL, V208, P91, DOI 10.1006/jtbi.2000.2203; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HALL SJ, 1991, J ANIM ECOL, V60, P823, DOI 10.2307/5416; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; Lawton J.H., 1989, P43; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Martinez ND, 1999, ECOLOGY, V80, P1044, DOI 10.1890/0012-9658(1999)080[1044:EOSEOC]2.0.CO;2; MARTINEZ ND, 1992, AM NAT, V139, P1208, DOI 10.1086/285382; McMahon T., 1983, SIZE LIFE; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Pimm S.L., 1982, FOOD WEBS; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; RODRIGUEZITURBE.I, 1996, FRACTAL RIVER BASINS; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	30	207	214	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					165	168		10.1038/nature01604	http://dx.doi.org/10.1038/nature01604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736684				2022-12-01	WOS:000182699600045
J	Heo, WD; Meyer, T				Heo, WD; Meyer, T			Switch-of-function mutants based on morphology classification of Ras superfamily small GTPases	CELL			English	Article							GTP-BINDING PROTEINS; ACTIN CYTOSKELETON; RHO-GTPASE; FAMILY; DOMAIN; PATHWAYS; CDC42; ACTIVATION; COMPLEX; MEMBER	Signaling proteins from the same family can have markedly different roles in a given cellular context. Here, we show that expression of one hundred constitutively active human small GTPases induced cell morphologies that fell into nine distinct classes. We developed an algorithm for pairs of classes that predicted amino acid positions that can be exchanged to create mutants with switched functionality. The algorithm was validated by creating switch-of-function mutants for Rac1, CDC42, H-Ras, RalA, Rap2B, and R-Ras3. Contrary to expectations, the relevant residues were mostly outside known interaction surfaces and were structurally far apart from each other. Our study shows that specificity in protein families can be explored by combining genome-wide experimental functional classification with the creation of switch-of-function mutants.	Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA	Stanford University	Meyer, T (corresponding author), Stanford Univ, Dept Mol Pharmacol, Sch Med, 269 Campus Dr,Room 3215, Stanford, CA 94305 USA.	tobias1@stanford.edu	Heo, Won-Do/C-1696-2011	Meyer, Tobias/0000-0003-4339-3804				Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; COHEN L, 1994, P NATL ACAD SCI USA, V91, P12448, DOI 10.1073/pnas.91.26.12448; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Foster R, 1996, MOL CELL BIOL, V16, P2689; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez-Alcoceba R, 2000, CELL MOL LIFE SCI, V57, P65, DOI 10.1007/s000180050499; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Krzanowski W.J., 1988, PRINCIPLES MULTIVARI; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lichtarge O, 1996, P NATL ACAD SCI USA, V93, P7507, DOI 10.1073/pnas.93.15.7507; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Roux P, 1997, CURR BIOL, V7, P629, DOI 10.1016/S0960-9822(06)00289-2; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tanabe K, 2000, J NEUROSCI, V20, P4138; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	37	84	85	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					315	328						14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732140				2022-12-01	WOS:000182640800007
J	Michalek, J; Collins, RH; Hill, BJ; Brenchley, JM; Douek, DC				Michalek, J; Collins, RH; Hill, BJ; Brenchley, JM; Douek, DC			Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation	LANCET			English	Article							DISEASE	Allogeneic haemopoietic stem cell transplantation can be complicated by acute graft-versus-host disease (GVHD). If the alloreactive T-cell clones responsible for this disorder could be identified before stem cell transplantation, they could be quantitatively monitored afterwards to allow initiation of immunosuppression before GVHD becomes apparent. We identified an alloreactive CD4(+) T-cell clone from a donor before stem cell transplantation, and then monitored its frequency in the recipient's peripheral blood after transplantation by use of clonotypic quantitative real-time PCR. Greatly increased concentrations of this clone (nearly 100% of circulating CD4(+) T cells) preceded and closely correlated with the onset of clinical GVHD, suggesting that a sole alloreactive T-cell clone was responsible for initiation of this disease in vivo. This simple identification and monitoring of potentially GVHD-causing clones can be undertaken before stem cell transplantation with no previous knowledge of the alloantigen responsible, and could allow earlier diagnosis and intervention in GVHD.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Ctr Canc Immunobiol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Bone Marrow Transplant Unit, Dallas, TX USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Douek, DC (corresponding author), NIAID, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA.		Brenchley, Jason/AAC-5085-2019	Brenchley, Jason/0000-0001-8357-2984				Andre-Schmutz I, 2002, LANCET, V360, P130, DOI 10.1016/S0140-6736(02)09413-8; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Murphy WJ, 1999, CURR OPIN IMMUNOL, V11, P509, DOI 10.1016/S0952-7915(99)00002-3; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563	5	66	93	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 5	2003	361	9364					1183	1185		10.1016/S0140-6736(03)12917-0	http://dx.doi.org/10.1016/S0140-6736(03)12917-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12781582				2022-12-01	WOS:000182094600013
J	Seibert, C; Barbouche, E; Fagan, J; Myint, E; Wetterneck, T; Wittemyer, M				Seibert, C; Barbouche, E; Fagan, J; Myint, E; Wetterneck, T; Wittemyer, M			Prescribing oral contraceptives for women older than 35 years of age	ANNALS OF INTERNAL MEDICINE			English	Review							HORMONE REPLACEMENT THERAPY; VENOUS THROMBOEMBOLIC DISEASE; METABOLIC RISK MARKERS; BONE-MINERAL DENSITY; G ETHINYL ESTRADIOL; BREAST-CANCER RISK; FACTOR-V-LEIDEN; YOUNG-WOMEN; UNITED-STATES; MYOCARDIAL-INFARCTION	This paper addresses the use of combined oral contraceptives in women older than 35 years of age, including the potential risks and benefits, pretreatment assessment, common side effects and their management, appropriate follow-up, and diagnosis of menopause. The case-based discussion also focuses on issues that pertain to women who smoke, have hypertension, or have dyslipidemia.	Univ Wisconsin, Sch Med, UW Hlth Clin E, Dept Med, Madison, WI 53706 USA; Virginia Mason Med Ctr, Lynnwood, WA USA	University of Wisconsin System; University of Wisconsin Madison; University Wisconsin Health; Virginia Mason Medical Center	Seibert, C (corresponding author), Univ Wisconsin, Sch Med, UW Hlth Clin E, Dept Med, 5249 E Terrace Dr, Madison, WI 53706 USA.	cseibert@facstaff.wisc.edu						ABMA J, 1997, VITAL HLTH STAT, V23; Adesanya OO, 1996, J REPROD MED, V41, P431; AKERLUND M, 1993, BRIT J OBSTET GYNAEC, V100, P832, DOI 10.1111/j.1471-0528.1993.tb14309.x; *AM COLL OBST GYN, 1996, GUID WOM HLTH CAR; [Anonymous], 1983, JAMA, V249, P1596; [Anonymous], 1986, NEW ENGL J MED, V315, P405; Barrett D H, 1994, Arch Fam Med, V3, P438, DOI 10.1001/archfami.3.5.438; Berg AO, 2001, AM J PREV MED, V20, P73, DOI 10.1016/S0749-3797(01)00266-5; Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Bousser MG, 2000, CEPHALALGIA, V20, P147, DOI 10.1046/j.1468-2982.2000.00050.x; Brinton LA, 1998, MENOPAUSE, V5, P145; Brinton LA, 1997, CONTRACEPTION, V55, P197, DOI 10.1016/S0010-7824(97)00012-7; Burkman RT, 1998, CONTRACEPTION, V58, p35S, DOI 10.1016/S0010-7824(98)00081-X; BURKMAN RT, 2000, INT J FERTIL S2, V45, P134; Burt VK, 1998, HARVARD REV PSYCHIAT, V6, P121, DOI 10.3109/10673229809000320; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Cardoso F, 1997, INT J GYNECOL OBSTET, V59, P237, DOI 10.1016/S0020-7292(97)00239-7; CASPER RF, 1991, FERTIL STERIL, V55, P292; Castracane VD, 1995, CONTRACEPTION, V52, P371; CAUFIELD KA, 1998, WOMENS HLTH PRIMARY, P161; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; ChasanTaber L, 1996, CIRCULATION, V94, P483, DOI 10.1161/01.CIR.94.3.483; Coney P, 2001, CONTRACEPTION, V63, P297, DOI 10.1016/S0010-7824(01)00208-6; CONNELL EB, 1993, J REPROD MED, V38, P1036; Connelly PW, 1999, CAN J CARDIOL, V15, P419; COOPER C, 1993, BONE, V14, P41, DOI 10.1016/8756-3282(93)90254-8; Corson SL, 1996, INT J FERTIL MENOP S, V41, P77; Crook D, 1997, CONTRACEPTION, V55, P219, DOI 10.1016/S0010-7824(97)00010-3; Crosignani PG, 2000, HUM REPROD, V15, P1865; CULLBERG G, 1985, ACTA OBSTET GYN SCAN, V64, P195, DOI 10.3109/00016348509155112; DEWIS P, 1985, CLIN ENDOCRINOL, V22, P29, DOI 10.1111/j.1365-2265.1985.tb01061.x; DICKEY RP, 1994, MANAGING CONTRACEPTI, P60; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Dong W, 1997, J HYPERTENS, V15, P1063, DOI 10.1097/00004872-199715100-00003; Douketis JD, 1997, ARCH INTERN MED, V157, P1522, DOI 10.1001/archinte.157.14.1522; Dunn N, 1999, BRIT MED J, V318, P1579, DOI 10.1136/bmj.318.7198.1579; Eck LH, 1997, AM J CLIN NUTR, V65, P419, DOI 10.1093/ajcn/65.2.419; EDGREN RA, 1989, CONTRACEPTION, V40, P285, DOI 10.1016/0010-7824(89)90093-0; FARLEY TMM, 1995, LANCET, V346, P1582; Farley TMM, 1998, CONTRACEPTION, V57, P211, DOI 10.1016/S0010-7824(98)00019-5; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 1998, AM J OBSTET GYNECOL, V179, pS78, DOI 10.1053/ob.1998.v179.a92634; Franceschi S, 1998, CONTRACEPTION, V58, P335, DOI 10.1016/S0010-7824(98)00128-0; Fruzzetti F, 1999, AM J OBSTET GYNECOL, V180, pS369, DOI 10.1016/S0002-9378(99)70698-8; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; GAMBACCIANI M, 1994, MATURITAS, V19, P125, DOI 10.1016/0378-5122(94)90062-0; GERSTMAN BB, 1991, AM J EPIDEMIOL, V133, P32, DOI 10.1093/oxfordjournals.aje.a115799; Gillum LA, 2000, JAMA-J AM MED ASSOC, V284, P72, DOI 10.1001/jama.284.1.72; GODSLAND IF, 1995, CONTRACEPTION, V52, P143, DOI 10.1016/0010-7824(95)00153-2; Godsland IF, 1996, CONTRACEPTION, V53, P9, DOI 10.1016/0010-7824(95)00260-X; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Hankinson SE, 1997, CANCER CAUSE CONTROL, V8, P65, DOI 10.1023/A:1018435205695; HANKINSON SE, 1992, OBSTET GYNECOL, V80, P708; HANNAFORD PC, 1994, STROKE, V25, P935, DOI 10.1161/01.STR.25.5.935; Hannaford PC, 1996, CONTRACEPTION, V54, P125, DOI 10.1016/S0010-7824(96)00167-9; HATCHER RA, 1999, MANAGING CONTRACEPTI, P97; HATCHER RA, 1998, CONTRACEPTIVE TECHNO, P405; Heinemann LAJ, 1998, CONTRACEPTION, V57, P29, DOI 10.1016/S0010-7824(97)00204-7; Helmerhorst FM, 1998, HUM REPROD, V13, P2981, DOI 10.1093/humrep/13.11.2981; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kaunitz AM, 2001, AM J OBSTET GYNECOL, V185, pS32, DOI 10.1067/mob.2001.116525; KAUNITZ AM, 2001, DIALOGUES CONTRACEPT, V6, P4; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Klein NA, 1998, CLIN OBSTET GYNECOL, V41, P912, DOI 10.1097/00003081-199812000-00017; KNOPP RH, 1993, AM J OBSTET GYNECOL, V168, P1994, DOI 10.1016/S0002-9378(12)90941-2; KRETTEK JE, 1993, OBSTET GYNECOL, V81, P728; Kuohung W, 2000, CONTRACEPTION, V61, P77, DOI 10.1016/S0010-7824(00)00086-X; Lewis MA, 1997, CONTRACEPTION, V56, P129, DOI 10.1016/S0010-7824(97)00118-2; Lewis MA, 1998, AM J OBSTET GYNECOL, V179, pS68, DOI 10.1053/ob.1998.v179.a93122; Lewis MA, 1996, CONTRACEPTION, V54, P5, DOI 10.1016/0010-7824(96)00112-6; LIDEGAARD O, 1995, BRIT J OBSTET GYNAEC, V102, P153, DOI 10.1111/j.1471-0528.1995.tb09070.x; LIDEGAARD O, 1993, BRIT MED J, V306, P956, DOI 10.1136/bmj.306.6883.956; Lidegaard O, 1998, AM J OBSTET GYNECOL, V179, pS62, DOI 10.1053/ob.1998.v179.a91674; Lidegaard O, 1999, AM J OBSTET GYNECOL, V180, pS357, DOI 10.1016/S0002-9378(99)70696-4; Lidegaard O, 1998, CONTRACEPTION, V57, P303, DOI 10.1016/S0010-7824(98)00032-8; Lidegaard O, 1997, ACTA OBSTET GYN SCAN, V76, P252; Lobo RA, 1996, FERTIL STERIL, V65, P1100, DOI 10.1016/S0015-0282(16)58321-6; Lobo RA, 1998, CLIN OBSTET GYNECOL, V41, P895, DOI 10.1097/00003081-199812000-00015; Lucky AW, 1997, J AM ACAD DERMATOL, V37, P746, DOI 10.1016/S0190-9622(97)70112-9; Magnusson CM, 1999, INT J CANCER, V80, P231, DOI 10.1002/(SICI)1097-0215(19990118)80:2<231::AID-IJC11>3.3.CO;2-I; MALONE KE, 1993, EPIDEMIOL REV, V15, P80, DOI 10.1093/oxfordjournals.epirev.a036119; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; MCKINLAY SM, 1992, MATURITAS, V14, P103, DOI 10.1016/0378-5122(92)90003-M; MEADE TW, 1977, LANCET, V2, P948; *MED EC, 2000, RED BOOK 2000 DRUG T, P313; Michaelsson K, 1999, LANCET, V353, P1481, DOI 10.1016/S0140-6736(98)09044-8; Newcomb PA, 1996, CANCER CAUSE CONTROL, V7, P525, DOI 10.1007/BF00051885; Oddens BJ, 1999, CONTRACEPTION, V59, P277, DOI 10.1016/S0010-7824(99)00034-7; Petitti DB, 1996, NEW ENGL J MED, V335, P8, DOI 10.1056/NEJM199607043350102; PORTER JB, 1985, OBSTET GYNECOL, V66, P1; Poulter NR, 1996, LANCET, V348, P505; POULTER NR, 1995, LANCET, V346, P1575; Poulter NR, 1996, LANCET, V348, P498; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; RAMCHARAN S, 1981, NIH PUBLICATION, V3; Redmond GP, 1997, OBSTET GYNECOL, V89, P615, DOI 10.1016/S0029-7844(97)00059-8; REUBINOFF BE, 1995, FERTIL STERIL, V63, P516, DOI 10.1016/S0015-0282(16)57419-6; Rosenberg L, 1996, AM J EPIDEMIOL, V143, P25; Rosenberg M, 1998, CONTRACEPTION, V58, P345, DOI 10.1016/S0010-7824(98)00127-9; Rosenberg MJ, 1996, CONTRACEPTION, V53, P85, DOI 10.1016/0010-7824(95)00270-7; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; Rosenberg MJ, 1996, AM J OBSTET GYNECOL, V174, P628, DOI 10.1016/S0002-9378(96)70440-4; Rosing J, 1999, AM J OBSTET GYNECOL, V180, pS375, DOI 10.1016/S0002-9378(99)70699-X; Rossing MA, 1996, AM J EPIDEMIOL, V144, P161, DOI 10.1093/oxfordjournals.aje.a008903; SALEH WA, 1993, AM J OBSTET GYNECOL, V168, P1740, DOI 10.1016/0002-9378(93)90685-C; Schiff I, 1999, AM J OBSTET GYNECOL, V180, pS383, DOI 10.1016/S0002-9378(99)70700-3; Schlesselman JJ, 1997, HUM REPROD, V12, P1851, DOI 10.1093/humrep/12.9.1851; SCHLESSELMAN JJ, 1995, OBSTET GYNECOL, V85, P793, DOI 10.1016/0029-7844(95)00022-J; Schmidt PJ, 2000, AM J OBSTET GYNECOL, V183, P414, DOI 10.1067/mob.2000.106004; Schwartz SM, 1998, STROKE, V29, P2277, DOI 10.1161/01.STR.29.11.2277; Schwartz SM, 1997, ANN INTERN MED, V127, P596, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00003; Schwingl PJ, 1999, AM J OBSTET GYNECOL, V180, P241, DOI 10.1016/S0002-9378(99)70182-1; SCRAGG RKR, 1984, BRIT MED J, V288, P1795, DOI 10.1136/bmj.288.6433.1795; Seifer DB, 1998, FERTIL STERIL, V69, P387; SHARGIL AA, 1985, INT J FERTIL, V30, P15; Sherif K, 1999, AM J OBSTET GYNECOL, V180, pS343, DOI 10.1016/S0002-9378(99)70694-0; Shulman LP, 2000, OBSTET GYN CLIN N AM, V27, P695, DOI 10.1016/S0889-8545(05)70168-6; Shulman LP, 1999, INT J FERTIL WOMEN M, V44, P78; Sidney S, 1996, OBSTET GYNECOL, V88, P939, DOI 10.1016/S0029-7844(96)00351-1; SPEROFF L, 1993, OBSTET GYNECOL, V81, P1034; SPEROFF L, 1994, CLIN GYNECOLOGIC END, P722; Spitzer WO, 1998, AM J OBSTET GYNECOL, V179, pS43, DOI 10.1053/ob.1998.v179.a93059; Spitzer WO, 1996, BRIT MED J, V312, P83; Stahl SM, 1998, PSYCHOPHARMACOL BULL, V34, P319; STERGACHIS A, 1992, AM J OBSTET GYNECOL, V167, P1165, DOI 10.1016/S0002-9378(12)90406-8; Stern RS, 2000, J AM ACAD DERMATOL, V43, P1042, DOI 10.1067/mjd.2000.110901; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; STROM BL, 1986, CLIN PHARMACOL THER, V39, P335, DOI 10.1038/clpt.1986.49; Sulak P, 1999, CONTRACEPTION, V59, P161, DOI 10.1016/S0010-7824(99)00026-8; Tanis BC, 2001, NEW ENGL J MED, V345, P1787, DOI 10.1056/NEJMoa003216; Thorneycroft IH, 1999, AM J OBSTET GYNECOL, V180, pS280, DOI 10.1016/S0002-9378(99)70719-2; Thorneycroft IH, 1999, AM J OBSTET GYNECOL, V180, pS288, DOI 10.1016/S0002-9378(99)70720-9; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Tomasson H, 1996, ACTA OBSTET GYN SCAN, V75, P157, DOI 10.3109/00016349609033309; Tryggvadottir L, 1997, BRIT J CANCER, V75, P139, DOI 10.1038/bjc.1997.23; Tyden T, 1999, ADV CONTRACEPT, V15, P133, DOI 10.1023/A:1006749709993; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Ursin G, 1999, AM J EPIDEMIOL, V150, P561; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P73; Van Winter JT, 1998, AM FAM PHYSICIAN, V58, P1373; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; Vessey M, 1998, CONTRACEPTION, V57, P231, DOI 10.1016/S0010-7824(98)00026-2; VESSEY MP, 1984, BRIT MED J, V289, P530, DOI 10.1136/bmj.289.6444.530-a; VOLPE A, 1993, CONTRACEPTION, V47, P229, DOI 10.1016/0010-7824(93)90040-E; Warren MP, 1998, CLIN OBSTET GYNECOL, V41, P976, DOI 10.1097/00003081-199812000-00024; Weiss G, 1999, AM J OBSTET GYNECOL, V180, pS295, DOI 10.1016/S0002-9378(99)70721-0; Westhoff CL, 1998, AM J OBSTET GYNECOL, V179, pS38, DOI 10.1053/ob.1998.v179.a91673; *WHO, 2000, IMPR ACC QUAL CAR FA, P1; *WHO US AG INT DEV, 1994, REC UPD SEL PRACT CO, V1; WINGO PA, 1991, OBSTET GYNECOL, V78, P161; 1999, FERTIL STERIL S3, V71, pS1; 1998, HUM REPROD, V13, P2325; 2000, AM COLL OBSTERTRICIA, V18, P1071; 1996, CONTRACEPTION, V54, pS1	157	24	26	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					54	64		10.7326/0003-4819-138-1-200301070-00013	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00013			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513046				2022-12-01	WOS:000180996200008
